1	The	DT	O	the	det	4	SENT_1	[p1l427t81r465b103],
2	NEW	NNP	O	NEW	nn	4	SENT_1	[p1l477t83r557b103],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_1	[p1l571t83r746b103],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_1	[p1l760t83r926b110],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_1	[p1l940t81r1156b109],

1	REVIEW	NNP	O	REVIEW	_	0	SENT_2	[p1l594t235r776b261],
2	ARTICLE	NN	O	article	dep	1	SENT_2	[p1l791t235r990b261],

1	DRUG	NN	O	drug	nn	2	SENT_3	[p1l648t387r751b410],
2	THERAPY	NN	O	therapy	_	0	SENT_3	[p1l769t387r939b410],

1	Drug	NN	O	drug	_	0	SENT_4	[p1l315t457r467b522],
2	Metabolism	NN	O	metabolism	dep	1	SENT_4	[p1l480t452r835b507],
3	and	CC	O	and	_	0	SENT_4	[p1l852t452r961b507],
4	Variability	NN	O	variability	dep	1	SENT_4	[p1l975t452r1275b522],
5	among	IN	O	among	_	0	SENT_4	[p1l294t553r503b606],
6	Patients	NNS	O	patient	prep_among	2	SENT_4	[p1l517t536r749b590],
7	in	IN	O	in	_	0	SENT_4	[p1l768t536r824b589],
8	Drug	NN	MISC	drug	nn	9	SENT_4	[p1l841t540r994b606],
9	Response	NN	MISC	response	prep_in	6	SENT_4	[p1l1008t540r1293b605],

1	Grant	NNP	PERSON	Grant	nn	3	SENT_5	[p1l519t672r615b701],
2	R.	NNP	PERSON	R.	nn	3	SENT_5	[p1l630t673r657b701],
3	Wilkinson	NNP	PERSON	Wilkinson	_	0	SENT_5	[p1l670t670r849b707],
4	,	,	O	,	_	0	SENT_5	[p1l670t670r849b707],
5	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_5	[p1l866t670r965b707],
6	,	,	O	,	_	0	SENT_5	[p1l866t670r965b707],
7	D.	NNP	O	D.	nn	8	SENT_5	[p1l983t673r1067b701],
8	Sc	NNP	O	Sc	appos	5	SENT_5	[p1l983t673r1067b701],
9	.	.	O	.	_	0	SENT_5	[p1l983t673r1067b701],

1	HYSICIANS	NNS	O	hysician	nsubj	2	SENT_6	[p1l217t781r409b803],
2	PRESCRIBE	VBP	O	prescribe	_	0	SENT_6	[p1l422t781r618b803],
3	DRUGS	NNS	O	drug	nsubj	43	SENT_6	[p1l630t781r753b803],
4	ON	IN	O	on	_	0	SENT_6	[p1l765t781r819b803],
5	THE	DT	O	the	det	6	SENT_6	[p1l830t781r903b802],
6	BASIS	NNS	O	basis	prep_on	3	SENT_6	[p1l916t781r1011b803],
7	OF	IN	O	of	_	0	SENT_6	[p1l1023t781r1069b803],
8	THE	DT	O	the	det	9	SENT_6	[p1l1079t781r1152b802],
9	CHARACTERISTICS	NNS	O	characteristic	conj_and	9	SENT_6	[p1l1164t781r1492b803],
10	From	IN	O	from	_	0	SENT_6	[p1l1534t781r1597b803],
11	the	DT	O	the	det	12	SENT_6	[p1l1613t779r1654b803],
12	Department	NNP	ORGANIZATION	Department	prep_from	9	SENT_6	[p1l1672t781r1825b810],
13	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l1841t779r1869b803],
14	Pharmacology	NNP	ORGANIZATION	Pharmacology	prep_of	12	SENT_6	[p1l1883t779r2066b810],
15	,	,	O	,	_	0	SENT_6	[p1l1883t779r2066b810],
16	of	IN	O	of	_	0	SENT_6	[p1l216t822r255b853],
17	the	DT	O	the	det	18	SENT_6	[p1l257t822r307b853],
18	medications	NNS	O	medication	prep_of	12	SENT_6	[p1l315t822r516b853],
19	and	CC	O	and	_	0	SENT_6	[p1l525t822r585b853],
20	on	IN	O	on	_	0	SENT_6	[p1l594t832r636b853],
21	the	DT	O	the	det	22	SENT_6	[p1l644t822r695b853],
22	probability	NN	O	probability	prep_on	9	SENT_6	[p1l703t822r883b861],
23	that	WDT	O	that	dep	24	SENT_6	[p1l890t822r954b853],
24	reliable	JJ	O	reliable	rcmod	22	SENT_6	[p1l961t822r1081b853],
25	and	CC	O	and	_	0	SENT_6	[p1l1090t822r1150b853],
26	reproducible	JJ	O	reproducible	rcmod	22	SENT_6	[p1l1159t822r1368b861],
27	clinical	JJ	O	clinical	amod	28	SENT_6	[p1l1377t822r1493b853],
28	Va	NNP	O	Va	dep	9	SENT_6	[p1l1531t817r1662b860],
29	“‘	CD	NUMBER	“‘	num	28	SENT_6	[p1l1531t817r1662b860],
30	ie	FW	O	ie	dep	3	SENT_6	[p1l1531t817r1662b860],
31	'	''	O	'	_	0	SENT_6	[p1l1531t817r1662b860],
32	b	NN	O	b	dep	3	SENT_6	[p1l1531t817r1662b860],
33	"	''	O	"	punct	32	SENT_6	[p1l1531t817r1662b860],
34	*	CD	NUMBER	*	dep	32	SENT_6	[p1l1531t817r1662b860],
35	U	NNP	O	U	prep	34	SENT_6	[p1l1677t819r1808b848],
36	““	CD	NUMBER	““	num	37	SENT_6	[p1l1677t819r1808b848],
37	’	CD	NUMBER	’	dep	35	SENT_6	[p1l1677t819r1808b848],
38	e	SYM	O	e	dep	34	SENT_6	[p1l1677t819r1808b848],
39	’S	FW	O	’s	nn	41	SENT_6	[p1l1677t819r1808b848],
40	”	FW	O	”	nn	41	SENT_6	[p1l1677t819r1808b848],
41	Y	NN	O	y	dep	32	SENT_6	[p1l1677t819r1808b848],
42	'	''	O	'	_	0	SENT_6	[p1l1677t819r1808b848],
43	Na5	NN	O	na5	xcomp	2	SENT_6	[p1l1825t817r1949b877],
44	,	,	O	,	_	0	SENT_6	[p1l1825t817r1949b877],
45	l1	NN	O	l1	dobj	2	SENT_6	[p1l1825t817r1949b877],
46	’	CD	NUMBER	’	num	45	SENT_6	[p1l1825t817r1949b877],
47	F	NN	O	f	dep	45	SENT_6	[p1l1825t817r1949b877],
48	"	''	O	"	punct	47	SENT_6	[p1l1825t817r1949b877],
49	e	SYM	O	e	dep	45	SENT_6	[p1l1825t817r1949b877],
50	-	:	O	-	_	0	SENT_6	[p1l1825t817r1949b877],
51	Add	VB	O	add	parataxis	2	SENT_6	[p1l1963t817r2067b877],
52	’	CD	NUMBER	’	dobj	51	SENT_6	[p1l1963t817r2067b877],
53	?	.	O	?	_	0	SENT_6	[p1l1963t817r2067b877],

1	effects	NNS	O	effect	nsubj	3	SENT_7	[p1l216t872r321b903],
2	will	MD	O	will	aux	3	SENT_7	[p1l332t872r393b903],
3	result	VB	O	result	_	0	SENT_7	[p1l406t872r506b903],
4	.	.	O	.	_	0	SENT_7	[p1l406t872r506b903],

1	However	RB	O	however	advmod	10	SENT_8	[p1l521t875r673b909],
2	,	,	O	,	_	0	SENT_8	[p1l521t875r673b909],
3	differences	NNS	O	difference	nsubj	10	SENT_8	[p1l688t872r868b903],
4	in	IN	O	in	_	0	SENT_8	[p1l881t873r913b902],
5	drug	NN	O	drug	nn	6	SENT_8	[p1l926t872r1003b911],
6	response	NN	O	response	prep_in	3	SENT_8	[p1l1014t882r1161b911],
7	among	IN	O	among	_	0	SENT_8	[p1l1174t882r1290b911],
8	patients	NNS	O	patient	prep_among	6	SENT_8	[p1l1301t873r1431b911],
9	are	VBP	O	be	cop	10	SENT_8	[p1l1444t882r1493b903],
10	r	NN	O	r	_	0	SENT_8	[p1l1533t856r2068b923],
11	,	,	O	,	_	0	SENT_8	[p1l1533t856r2068b923],
12	§	CD	NUMBER	§	appos	10	SENT_8	[p1l1533t856r2068b923],
13	:	:	O	:	_	0	SENT_8	[p1l1533t856r2068b923],
14	F	NN	O	f	dep	12	SENT_8	[p1l1533t856r2068b923],
15	:	:	O	:	_	0	SENT_8	[p1l1533t856r2068b923],
16	;	:	O	;	_	0	SENT_8	[p1l1533t856r2068b923],
17	n	NN	O	n	dep	12	SENT_8	[p1l1533t856r2068b923],
18	,	,	O	,	_	0	SENT_8	[p1l1533t856r2068b923],
19	:	:	O	:	_	0	SENT_8	[p1l1533t856r2068b923],
20	nr	NN	O	nr	dep	10	SENT_8	[p1l1533t856r2068b923],
21	,	,	O	,	_	0	SENT_8	[p1l1533t856r2068b923],
22	:	:	O	:	_	0	SENT_8	[p1l1533t856r2068b923],
23	?	.	O	?	_	0	SENT_8	[p1l1533t856r2068b923],

1	:	:	O	:	_	0	SENT_9	[p1l1533t856r2068b923],
2	e	LS	O	e	_	0	SENT_9	[p1l1533t856r2068b923],
3	:	:	O	:	_	0	SENT_9	[p1l1533t856r2068b923],
4	;	:	O	;	_	0	SENT_9	[p1l1533t856r2068b923],
5	SP	NN	O	sp	dep	2	SENT_9	[p1l1533t856r2068b923],
6	:	:	O	:	_	0	SENT_9	[p1l1533t856r2068b923],
7	,	,	O	,	_	0	SENT_9	[p1l1533t856r2068b923],
8	:	:	O	:	_	0	SENT_9	[p1l1533t856r2068b923],
9	r	NN	O	r	dobj	2	SENT_9	[p1l1533t856r2068b923],
10	,	,	O	,	_	0	SENT_9	[p1l1533t856r2068b923],
11	|	NN	O	|	appos	9	SENT_9	[p1l1533t856r2068b923],
12	?	.	O	?	_	0	SENT_9	[p1l1533t856r2068b923],

1	,	,	O	,	_	0	SENT_10	[p1l1533t856r2068b923],
2	:	:	O	:	_	0	SENT_10	[p1l1533t856r2068b923],
3	C	NN	O	c	dep	1	SENT_10	[p1l1533t856r2068b923],
4	\	CD	NUMBER	\	num	5	SENT_10	[p1l1533t856r2068b923],
5	2L	NN	O	2l	dep	3	SENT_10	[p1l1533t856r2068b923],
6	;	:	O	;	_	0	SENT_10	[p1l1533t856r2068b923],
7	;	:	O	;	_	0	SENT_10	[p1l1533t856r2068b923],
8	:	:	O	:	_	0	SENT_10	[p1l1533t856r2068b923],
9	S	NN	O	s	nn	10	SENT_10	[p1l1533t856r2068b923],
10	\	NN	O	\	dep	1	SENT_10	[p1l1533t856r2068b923],
11	7	CD	NUMBER	7	dep	10	SENT_10	[p1l1533t856r2068b923],
12	:	:	O	:	_	0	SENT_10	[p1l1533t856r2068b923],
13	n	NN	O	n	dep	11	SENT_10	[p1l1533t856r2068b923],
14	:	:	O	:	_	0	SENT_10	[p1l1533t856r2068b923],
15	:	:	O	:	_	0	SENT_10	[p1l1533t856r2068b923],
16	,	,	O	,	_	0	SENT_10	[p1l1533t856r2068b923],
17	L	NN	O	l	dep	13	SENT_10	[p1l1533t856r2068b923],
18	,	,	O	,	_	0	SENT_10	[p1l1533t856r2068b923],
19	E	NN	O	e	appos	10	SENT_10	[p1l1533t856r2068b923],
20	common	JJ	O	common	dep	19	SENT_10	[p1l95t932r251b959],
21	,	,	O	,	_	0	SENT_10	[p1l95t932r251b959],
22	often	RB	O	often	advmod	19	SENT_10	[p1l262t922r346b953],
23	leading	VBG	O	lead	partmod	10	SENT_10	[p1l354t922r477b961],
24	to	TO	O	to	_	0	SENT_10	[p1l484t929r515b953],
25	challenges	NNS	O	challenge	prep_to	23	SENT_10	[p1l524t922r696b961],
26	in	IN	O	in	_	0	SENT_10	[p1l705t923r737b952],
27	optimizing	VBG	O	optimize	prepc_in	23	SENT_10	[p1l746t923r928b961],
28	a	DT	O	a	det	30	SENT_10	[p1l935t932r952b953],
29	dosage	NN	O	dosage	nn	30	SENT_10	[p1l961t922r1075b961],
30	regimen	NN	O	regimen	dobj	27	SENT_10	[p1l1083t923r1220b961],
31	for	IN	O	for	_	0	SENT_10	[p1l1228t922r1276b953],
32	an	DT	O	a	det	34	SENT_10	[p1l1283t932r1322b953],
33	individual	JJ	O	individual	amod	34	SENT_10	[p1l1330t922r1494b953],
34	University	NNP	ORGANIZATION	University	prep_for	27	SENT_10	[p1l1534t931r1664b960],
35	,	,	O	,	_	0	SENT_10	[p1l1534t931r1664b960],
36	542	CD	NUMBER	542	num	41	SENT_10	[p1l1678t931r1722b953],
37	Robinson	NNP	ORGANIZATION	Robinson	nn	41	SENT_10	[p1l1736t929r1854b953],
38	Research	NNP	ORGANIZATION	Research	nn	41	SENT_10	[p1l1870t929r1982b953],
39	B	NN	O	b	nn	41	SENT_10	[p1l1998t929r2067b960],
40	|	CD	NUMBER	|	num	41	SENT_10	[p1l1998t929r2067b960],
41	dg.	NN	O	dg.	appos	34	SENT_10	[p1l1998t929r2067b960],
42	,	,	O	,	_	0	SENT_10	[p1l1998t929r2067b960],
43	patient	NN	O	patient	appos	41	SENT_10	[p1l94t973r217b1011],
44	.	.	O	.	_	0	SENT_10	[p1l94t973r217b1011],

1	Most	JJS	O	most	amod	3	SENT_11	[p1l228t975r313b1003],
2	major	JJ	O	major	amod	3	SENT_11	[p1l321t973r418b1011],
3	drugs	NNS	O	drug	nsubj	5	SENT_11	[p1l427t972r519b1011],
4	are	VBP	O	be	cop	5	SENT_11	[p1l530t982r579b1003],
5	effective	JJ	O	effective	_	0	SENT_11	[p1l590t972r723b1003],
6	in	IN	O	in	_	0	SENT_11	[p1l733t973r765b1002],
7	only	RB	O	only	quantmod	10	SENT_11	[p1l776t972r846b1011],
8	25	CD	NUMBER	25	number	10	SENT_11	[p1l855t974r893b1003],
9	to	TO	O	to	dep	10	SENT_11	[p1l904t979r935b1003],
10	60	CD	PERCENT	60	num	11	SENT_11	[p1l946t974r985b1003],
11	percent	NN	PERCENT	percent	prep_in	5	SENT_11	[p1l995t979r1119b1011],
12	of	IN	O	of	_	0	SENT_11	[p1l1128t972r1167b1003],
13	patients	NNS	O	patient	prep_of	11	SENT_11	[p1l1169t970r1327b1011],
14	}	CD	NUMBER	}	num	13	SENT_11	[p1l1169t970r1327b1011],
15	and	CC	O	and	_	0	SENT_11	[p1l1337t972r1397b1003],
16	more	JJR	O	more	amod	17	SENT_11	[p1l1407t982r1493b1003],
17	N	NN	O	n	prep_of	11	SENT_11	[p1l1534t967r1657b1010],
18	?	.	O	?	_	0	SENT_11	[p1l1534t967r1657b1010],

1	5	CD	NUMBER	5	nsubj	9	SENT_12	[p1l1534t967r1657b1010],
2	,	,	O	,	_	0	SENT_12	[p1l1534t967r1657b1010],
3	“	CD	NUMBER	“	appos	1	SENT_12	[p1l1534t967r1657b1010],
4	V	NN	O	v	dep	3	SENT_12	[p1l1534t967r1657b1010],
5	"	''	O	"	punct	4	SENT_12	[p1l1534t967r1657b1010],
6	'	''	O	'	_	0	SENT_12	[p1l1534t967r1657b1010],
7	°	CD	NUMBER	°	advmod	9	SENT_12	[p1l1534t967r1657b1010],
8	v	LS	O	v	dep	9	SENT_12	[p1l1534t967r1657b1010],
9	TN	NN	O	tn	_	0	SENT_12	[p1l1676t969r1714b990],
10	3723	CD	NUMBER	3723	num	9	SENT_12	[p1l1735t968r1889b1010],
11	?	.	O	?	_	0	SENT_12	[p1l1735t968r1889b1010],
12	'	''	O	'	_	0	SENT_12	[p1l1735t968r1889b1010],

1	55	CD	NUMBER	55	num	2	SENT_13	[p1l1735t968r1889b1010],
2	°	CD	NUMBER	°	nsubj	9	SENT_13	[p1l1735t968r1889b1010],
3	°	CD	NUMBER	°	advmod	9	SENT_13	[p1l1735t968r1889b1010],
4	v	LS	O	v	dep	9	SENT_13	[p1l1735t968r1889b1010],
5	°	NN	O	°	dep	9	SENT_13	[p1l1909t975r1935b990],
6	'	''	O	'	_	0	SENT_13	[p1l1909t975r1935b990],
7	3	CD	NUMBER	3	number	8	SENT_13	[p1l1953t971r1976b990],
8	*	NN	O	*	amod	5	SENT_13	[p1l1953t971r1976b990],
9	5	CD	NUMBER	5	_	0	SENT_13	[p1l1994t971r2067b998, p1l94t1022r168b1053],
10	'	''	O	'	_	0	SENT_13	[p1l1994t971r2067b998, p1l94t1022r168b1053],
11	3	CD	NUMBER	3	dobj	9	SENT_13	[p1l1994t971r2067b998, p1l94t1022r168b1053],
12	"	``	O	"	punct	11	SENT_13	[p1l1994t971r2067b998, p1l94t1022r168b1053],
13	‘	NN	O	‘	dep	11	SENT_13	[p1l1994t971r2067b998, p1l94t1022r168b1053],
14	than	IN	O	than	mark	22	SENT_13	[p1l1994t971r2067b998, p1l94t1022r168b1053],
15	2	CD	NUMBER	2	number	16	SENT_13	[p1l178t1024r197b1052],
16	million	CD	NUMBER	million	num	17	SENT_13	[p1l208t1022r326b1053],
17	cases	NNS	O	case	nsubj	22	SENT_13	[p1l337t1032r422b1053],
18	of	IN	O	of	_	0	SENT_13	[p1l433t1022r472b1053],
19	adverse	JJ	O	adverse	amod	21	SENT_13	[p1l476t1022r597b1053],
20	drug	NN	O	drug	nn	21	SENT_13	[p1l609t1022r686b1061],
21	reactions	NNS	O	reaction	prep_of	17	SENT_13	[p1l695t1023r844b1053],
22	occur	VBP	O	occur	dep	13	SENT_13	[p1l856t1032r947b1053],
23	annually	RB	SET	annually	advmod	22	SENT_13	[p1l956t1022r1097b1061],
24	in	IN	O	in	_	0	SENT_13	[p1l1105t1023r1137b1052],
25	the	DT	O	the	det	27	SENT_13	[p1l1148t1022r1198b1053],
26	United	NNP	LOCATION	United	nn	27	SENT_13	[p1l1208t1022r1319b1053],
27	States	NNPS	LOCATION	States	prep_in	22	SENT_13	[p1l1331t1024r1436b1059],
28	,	,	O	,	_	0	SENT_13	[p1l1331t1024r1436b1059],
29	in	IN	O	in	dep	33	SENT_13	[p1l1448t1023r1493b1052],
30	—	CD	NUMBER	—	num	31	SENT_13	[p1l1448t1023r1493b1052],
31	Wilkinson@Vanderb'	NN	O	wilkinson@vanderb'	pobj	29	SENT_13	[p1l1531t1004r1876b1033],
32	|	NN	O	|	nn	33	SENT_13	[p1l1531t1004r1876b1033],
33	t	NN	O	t	dep	9	SENT_13	[p1l1531t1004r1876b1033],
34	'	''	O	'	_	0	SENT_13	[p1l1531t1004r1876b1033],
35	edu	FW	O	edu	dobj	9	SENT_13	[p1l1531t1004r1876b1033],
36	'	''	O	'	_	0	SENT_13	[p1l1531t1004r1876b1033],
37	eluding	VBG	O	elude	partmod	35	SENT_13	[p1l95t1072r219b1111],
38	100,000	CD	NUMBER	100,000	num	39	SENT_13	[p1l228t1074r359b1109],
39	deaths	NNS	O	death	dobj	37	SENT_13	[p1l368t1070r501b1103],
40	?	.	O	?	_	0	SENT_13	[p1l368t1070r501b1103],

1	Such	JJ	O	such	amod	2	SENT_14	[p1l511t1072r590b1103],
2	variability	NN	O	variability	nsubj	11	SENT_14	[p1l597t1072r759b1111],
3	in	IN	O	in	_	0	SENT_14	[p1l766t1072r798b1102],
4	drug	NN	O	drug	nn	5	SENT_14	[p1l807t1072r884b1111],
5	response	NN	O	response	prep_in	2	SENT_14	[p1l891t1082r1039b1111],
6	among	IN	O	among	_	0	SENT_14	[p1l1047t1082r1163b1111],
7	patients	NNS	O	patient	prep_among	5	SENT_14	[p1l1170t1072r1300b1111],
8	is	VBZ	O	be	cop	11	SENT_14	[p1l1309t1072r1335b1102],
9	multifac	JJ	O	multifac	amod	11	SENT_14	[p1l1344t1071r1493b1103],
10	—	NN	O	—	nn	11	SENT_14	[p1l1344t1071r1493b1103],
11	N	NN	O	n	_	0	SENT_14	[p1l1534t1081r1551b1103],
12	Engl	NNP	O	Engl	nn	13	SENT_14	[p1l1565t1079r1617b1110],
13	J	NNP	O	J	nsubj	14	SENT_14	[p1l1623t1081r1633b1109],
14	Med	VBD	O	med	rcmod	11	SENT_14	[p1l1646t1079r1700b1103],
15	2005	CD	DATE	2005	dobj	14	SENT_14	[p1l1710t1080r1943b1107],
16	;	:	O	;	_	0	SENT_14	[p1l1710t1080r1943b1107],
17	352:2211	CD	NUMBER	352:2211	num	18	SENT_14	[p1l1710t1080r1943b1107],
18	-21	CD	NUMBER	-21	dep	15	SENT_14	[p1l1710t1080r1943b1107],
19	.	.	O	.	_	0	SENT_14	[p1l1710t1080r1943b1107],

1	torial	JJ	O	torial	_	0	SENT_15	[p1l94t1121r189b1158],
2	,	,	O	,	_	0	SENT_15	[p1l94t1121r189b1158],
3	including	VBG	O	include	dep	1	SENT_15	[p1l201t1121r360b1160],
4	environmental	JJ	O	environmental	dobj	3	SENT_15	[p1l369t1121r618b1158],
5	,	,	O	,	_	0	SENT_15	[p1l369t1121r618b1158],
6	genetic	JJ	O	genetic	dobj	3	SENT_15	[p1l630t1122r757b1160],
7	,	,	O	,	_	0	SENT_15	[p1l630t1122r757b1160],
8	and	CC	O	and	_	0	SENT_15	[p1l769t1121r830b1152],
9	disease	NN	O	disease	nn	10	SENT_15	[p1l841t1121r958b1152],
10	determinants	NNS	O	determinant	dobj	3	SENT_15	[p1l969t1121r1187b1152],
11	that	WDT	O	that	nsubj	12	SENT_15	[p1l1198t1121r1263b1152],
12	affect	VBP	O	affect	rcmod	10	SENT_15	[p1l1271t1121r1363b1152],
13	the	DT	O	the	det	15	SENT_15	[p1l1372t1121r1422b1152],
14	dis	NN	O	di	nn	15	SENT_15	[p1l1433t1121r1493b1152],
15	—	NN	O	—	dobj	12	SENT_15	[p1l1433t1121r1493b1152],
16	C	NN	O	c	dep	15	SENT_15	[p1l1532t1120r1625b1145],
17	°	CD	NUMBER	°	num	18	SENT_15	[p1l1532t1120r1625b1145],
18	PY	NN	O	py	dobj	16	SENT_15	[p1l1532t1120r1625b1145],
19	’	NN	O	’	dep	18	SENT_15	[p1l1532t1120r1625b1145],
20	'	''	O	'	_	0	SENT_15	[p1l1532t1120r1625b1145],
21	1	CD	NUMBER	1	dep	18	SENT_15	[p1l1532t1120r1625b1145],
22	'	''	O	'	_	0	SENT_15	[p1l1532t1120r1625b1145],
23	=	JJ	O	=	prep	21	SENT_15	[p1l1532t1120r1625b1145],
24	’’	NN	O	’’	dep	23	SENT_15	[p1l1532t1120r1625b1145],
25	'	''	O	'	_	0	SENT_15	[p1l1532t1120r1625b1145],
26	‘	CD	NUMBER	‘	num	27	SENT_15	[p1l1532t1120r1625b1145],
27	(	CD	NUMBER	(	dep	21	SENT_15	[p1l1633t1122r1654b1143],
28	9	CD	NUMBER	9	number	29	SENT_15	[p1l1633t1122r1654b1143],
29	2	CD	NUMBER	2	num	30	SENT_15	[p1l1663t1121r1712b1139],
30	°	NN	O	°	dep	27	SENT_15	[p1l1663t1121r1712b1139],
31	05	CD	NUMBER	05	number	32	SENT_15	[p1l1663t1121r1712b1139],
32	“”	CD	NUMBER	“”	num	30	SENT_15	[p1l1720t1120r1860b1139],
33	"	``	O	"	punct	30	SENT_15	[p1l1720t1120r1860b1139],
34	““	CD	NUMBER	““	number	35	SENT_15	[p1l1720t1120r1860b1139],
35	‘“	CD	NUMBER	‘“	dep	30	SENT_15	[p1l1720t1120r1860b1139],
36	“‘	NN	O	“‘	dep	35	SENT_15	[p1l1720t1120r1860b1139],
37	““	CD	NUMBER	““	num	36	SENT_15	[p1l1720t1120r1860b1139],
38	"	``	O	"	punct	39	SENT_15	[p1l1868t1120r1945b1139],
39	”	NN	O	”	dep	35	SENT_15	[p1l1868t1120r1945b1139],
40	e	SYM	O	e	dep	18	SENT_15	[p1l1868t1120r1945b1139],
41	"	``	O	"	punct	15	SENT_15	[p1l1868t1120r1945b1139],
42	"	``	O	"	punct	45	SENT_15	[p1l1868t1120r1945b1139],
43	"	``	O	"	punct	45	SENT_15	[p1l1868t1120r1945b1139],
44	"	``	O	"	punct	45	SENT_15	[p1l1868t1120r1945b1139],
45	5	CD	NUMBER	5	dep	15	SENT_15	[p1l1952t1121r2023b1145, p1l94t1171r229b1209],
46	°	CD	NUMBER	°	dep	45	SENT_15	[p1l1952t1121r2023b1145, p1l94t1171r229b1209],
47	“	NN	O	“	dep	45	SENT_15	[p1l1952t1121r2023b1145, p1l94t1171r229b1209],
48	'	''	O	'	_	0	SENT_15	[p1l1952t1121r2023b1145, p1l94t1171r229b1209],
49	”	CD	NUMBER	”	num	52	SENT_15	[p1l1952t1121r2023b1145, p1l94t1171r229b1209],
50	Vposition	NN	O	vposition	nn	52	SENT_15	[p1l1952t1121r2023b1145, p1l94t1171r229b1209],
51	(	NN	O	(	nn	52	SENT_15	[p1l245t1170r444b1209],
52	absorption	NN	O	absorption	dep	47	SENT_15	[p1l245t1170r444b1209],
53	,	,	O	,	_	0	SENT_15	[p1l245t1170r444b1209],
54	distribution	NN	O	distribution	appos	45	SENT_15	[p1l461t1170r663b1207],
55	,	,	O	,	_	0	SENT_15	[p1l461t1170r663b1207],
56	metabolism	NN	O	metabolism	dep	54	SENT_15	[p1l679t1170r884b1207],
57	,	,	O	,	_	0	SENT_15	[p1l679t1170r884b1207],
58	and	CC	O	and	_	0	SENT_15	[p1l900t1170r961b1201],
59	excretion	NN	O	excretion	conj_and	45	SENT_15	[p1l975t1171r1136b1205],
60	)	NN	O	)	dep	59	SENT_15	[p1l975t1171r1136b1205],
61	of	IN	O	of	_	0	SENT_15	[p1l1153t1170r1192b1201],
62	a	DT	O	a	det	64	SENT_15	[p1l1199t1180r1216b1201],
63	given	VBN	O	give	amod	64	SENT_15	[p1l1229t1171r1316b1209],
64	drug	NN	O	drug	prep_of	15	SENT_15	[p1l1330t1170r1416b1209],
65	.	.	O	.	_	0	SENT_15	[p1l1330t1170r1416b1209],

1	The	DT	O	the	det	2	SENT_16	[p1l1430t1170r1493b1201],
2	interplay	NN	O	interplay	nsubj	6	SENT_16	[p1l94t1219r239b1258],
3	of	IN	O	of	_	0	SENT_16	[p1l247t1219r286b1250],
4	these	DT	O	these	det	5	SENT_16	[p1l289t1219r374b1250],
5	factors	NNS	O	factor	prep_of	2	SENT_16	[p1l384t1219r494b1250],
6	determines	VBZ	O	determine	_	0	SENT_16	[p1l505t1219r687b1250],
7	the	DT	O	the	det	8	SENT_16	[p1l698t1219r748b1250],
8	proﬁle	NN	O	proﬁle	dobj	6	SENT_16	[p1l757t1219r866b1258],
9	of	IN	O	of	_	0	SENT_16	[p1l876t1219r915b1250],
10	the	DT	O	the	det	12	SENT_16	[p1l918t1219r968b1250],
11	plasma	NN	O	plasma	nn	12	SENT_16	[p1l977t1219r1096b1258],
12	concentration	NN	O	concentration	prep_of	8	SENT_16	[p1l1105t1220r1333b1250],
13	over	IN	O	over	_	0	SENT_16	[p1l1343t1229r1412b1250],
14	time	NN	O	time	prep_over	12	SENT_16	[p1l1421t1220r1493b1250],
15	for	IN	O	for	_	0	SENT_16	[p1l94t1268r142b1299],
16	a	DT	O	a	det	17	SENT_16	[p1l149t1278r167b1299],
17	drug	NN	O	drug	prep_for	14	SENT_16	[p1l175t1268r252b1307],
18	and	CC	O	and	_	0	SENT_16	[p1l259t1268r329b1305],
19	,	,	O	,	_	0	SENT_16	[p1l259t1268r329b1305],
20	therefore	RB	O	therefore	dep	17	SENT_16	[p1l340t1268r498b1305],
21	,	,	O	,	_	0	SENT_16	[p1l340t1268r498b1305],
22	its	PRP$	O	its	prep_for	14	SENT_16	[p1l508t1269r546b1299],
23	elicited	VBN	O	elicit	partmod	12	SENT_16	[p1l555t1268r672b1299],
24	pharmacologic	JJ	O	pharmacologic	amod	25	SENT_16	[p1l680t1268r928b1307],
25	effect	NN	O	effect	dobj	23	SENT_16	[p1l937t1268r1027b1299],
26	at	IN	O	at	_	0	SENT_16	[p1l1034t1275r1064b1298],
27	the	DT	O	the	det	28	SENT_16	[p1l1071t1268r1121b1299],
28	site	NN	O	site	prep_at	23	SENT_16	[p1l1131t1269r1186b1299],
29	of	IN	O	of	_	0	SENT_16	[p1l1195t1268r1234b1299],
30	interaction	NN	O	interaction	prep_of	28	SENT_16	[p1l1235t1269r1413b1299],
31	with	IN	O	with	_	0	SENT_16	[p1l1420t1268r1493b1299],
32	targets	NNS	O	target	prep_with	23	SENT_16	[p1l94t1324r205b1356],
33	(	CD	NUMBER	(	num	32	SENT_16	[p1l216t1317r304b1352],
34	such	JJ	O	such	_	0	SENT_16	[p1l216t1317r304b1352],
35	as	IN	O	as	_	0	SENT_16	[p1l312t1327r345b1348],
36	receptors	NNS	O	receptor	prep_such_as	32	SENT_16	[p1l353t1324r505b1356],
37	and	CC	O	and	_	0	SENT_16	[p1l514t1317r574b1348],
38	enzymes	NNS	O	enzyme	conj_and	36	SENT_16	[p1l583t1320r747b1356],
39	)	CD	NUMBER	)	num	38	SENT_16	[p1l583t1320r747b1356],
40	.	.	O	.	_	0	SENT_16	[p1l583t1320r747b1356],

1	Too	RB	O	too	advmod	3	SENT_17	[p1l756t1319r818b1348],
2	little	JJ	O	little	amod	3	SENT_17	[p1l826t1317r899b1348],
3	exposure	NN	O	exposure	nsubj	14	SENT_17	[p1l908t1327r1055b1356],
4	leads	VBZ	O	lead	_	0	SENT_17	[p1l1062t1317r1145b1348],
5	to	TO	O	to	_	0	SENT_17	[p1l1155t1324r1186b1348],
6	an	DT	O	a	det	9	SENT_17	[p1l1194t1327r1233b1348],
7	ineffective	JJ	O	ineffective	amod	9	SENT_17	[p1l1241t1317r1409b1348],
8	drug	NN	O	drug	nn	9	SENT_17	[p1l1417t1317r1495b1356],
9	regimen	NNS	O	regimen	prep_to	4	SENT_17	[p1l94t1367r240b1405],
10	,	,	O	,	_	0	SENT_17	[p1l94t1367r240b1405],
11	and	CC	O	and	_	0	SENT_17	[p1l253t1366r314b1397],
12	too	RB	O	too	advmod	13	SENT_17	[p1l326t1373r378b1397],
13	much	JJ	O	much	advmod	14	SENT_17	[p1l390t1366r483b1397],
14	creates	VBZ	O	create	conj_and	4	SENT_17	[p1l496t1373r607b1397],
15	the	DT	O	the	det	16	SENT_17	[p1l620t1366r670b1397],
16	potential	NN	O	potential	dobj	14	SENT_17	[p1l682t1366r828b1405],
17	for	IN	O	for	_	0	SENT_17	[p1l840t1366r887b1397],
18	adverse	JJ	O	adverse	amod	19	SENT_17	[p1l898t1366r1020b1397],
19	effects	NNS	O	effect	prep_for	16	SENT_17	[p1l1032t1366r1147b1397],
20	.	.	O	.	_	0	SENT_17	[p1l1032t1366r1147b1397],

1	Recognition	NN	O	recognition	nsubj	9	SENT_18	[p1l1160t1367r1361b1405],
2	of	IN	O	of	_	0	SENT_18	[p1l1373t1366r1412b1397],
3	such	JJ	O	such	amod	5	SENT_18	[p1l1418t1366r1493b1397],
4	general	JJ	O	general	amod	5	SENT_18	[p1l94t1415r215b1454],
5	relationships	NNS	O	relationship	prep_of	1	SENT_18	[p1l229t1415r442b1454],
6	is	VBZ	O	be	cop	9	SENT_18	[p1l456t1416r482b1446],
7	long	JJ	O	long	amod	9	SENT_18	[p1l496t1415r738b1454],
8	—	NN	O	—	nn	9	SENT_18	[p1l496t1415r738b1454],
9	standing	NN	O	standing	_	0	SENT_18	[p1l496t1415r738b1454],
10	,	,	O	,	_	0	SENT_18	[p1l496t1415r738b1454],
11	and	CC	O	and	_	0	SENT_18	[p1l754t1415r814b1446],
12	information	NN	O	information	nsubj	17	SENT_18	[p1l827t1415r1026b1446],
13	about	IN	O	about	_	0	SENT_18	[p1l1039t1415r1134b1446],
14	some	DT	O	some	det	15	SENT_18	[p1l1146t1425r1233b1446],
15	drugs	NNS	O	drug	prep_about	12	SENT_18	[p1l1247t1415r1339b1454],
16	is	VBZ	O	be	cop	17	SENT_18	[p1l1354t1416r1379b1445],
17	extensive	JJ	O	extensive	conj_and	9	SENT_18	[p1l1394t1422r1493b1446, p1l95t1465r164b1495],
18	.	.	O	.	_	0	SENT_18	[p1l1394t1422r1493b1446, p1l95t1465r164b1495],

1	In	IN	O	in	_	0	SENT_19	[p1l175t1467r209b1494],
2	contrast	NN	O	contrast	prep_in	11	SENT_19	[p1l219t1471r360b1501],
3	,	,	O	,	_	0	SENT_19	[p1l219t1471r360b1501],
4	the	DT	O	the	det	5	SENT_19	[p1l372t1464r422b1495],
5	application	NN	O	application	nsubj	11	SENT_19	[p1l432t1464r615b1503],
6	of	IN	O	of	_	0	SENT_19	[p1l625t1464r664b1495],
7	the	DT	O	the	det	8	SENT_19	[p1l667t1464r717b1495],
8	information	NN	O	information	prep_of	5	SENT_19	[p1l726t1464r925b1495],
9	is	VBZ	O	be	cop	11	SENT_19	[p1l934t1465r959b1494],
10	often	RB	O	often	advmod	11	SENT_19	[p1l970t1464r1054b1495],
11	less	JJR	O	less	_	0	SENT_19	[p1l1063t1464r1124b1495],
12	than	IN	O	than	_	0	SENT_19	[p1l1134t1464r1207b1495],
13	ideal	NN	O	ideal	prep_than	11	SENT_19	[p1l1216t1464r1303b1495],
14	.	.	O	.	_	0	SENT_19	[p1l1216t1464r1303b1495],

1	There	EX	O	there	expl	2	SENT_20	[p1l143t1513r238b1544],
2	is	VBZ	O	be	_	0	SENT_20	[p1l247t1514r272b1544],
3	now	RB	DATE	now	nsubj	2	SENT_20	[p1l282t1523r358b1550],
4	,	,	O	,	_	0	SENT_20	[p1l282t1523r358b1550],
5	however	RB	O	however	advmod	3	SENT_20	[p1l369t1513r513b1550],
6	,	,	O	,	_	0	SENT_20	[p1l369t1513r513b1550],
7	a	DT	O	a	det	9	SENT_20	[p1l524t1523r541b1544],
8	general	JJ	O	general	amod	9	SENT_20	[p1l549t1513r671b1552],
9	understanding	NN	O	understanding	conj_and	3	SENT_20	[p1l679t1513r922b1552],
10	of	IN	O	of	_	0	SENT_20	[p1l930t1513r969b1544],
11	the	DT	O	the	det	13	SENT_20	[p1l971t1513r1021b1544],
12	many	JJ	O	many	amod	13	SENT_20	[p1l1030t1523r1121b1552],
13	differences	NNS	O	difference	prep_of	9	SENT_20	[p1l1129t1513r1308b1544],
14	among	IN	O	among	_	0	SENT_20	[p1l1318t1523r1434b1552],
15	patients	NNS	O	patient	prep_among	13	SENT_20	[p1l1441t1523r1493b1552, p1l94t1563r184b1593],
16	in	IN	O	in	_	0	SENT_20	[p1l200t1563r232b1592],
17	the	DT	O	the	det	18	SENT_20	[p1l248t1562r298b1593],
18	disposition	NN	O	disposition	prep_in	15	SENT_20	[p1l314t1562r498b1601],
19	and	CC	O	and	_	0	SENT_20	[p1l514t1562r574b1593],
20	clinical	JJ	O	clinical	amod	21	SENT_20	[p1l591t1562r707b1593],
21	consequences	NNS	O	consequence	nsubj	2	SENT_20	[p1l723t1572r951b1601],
22	of	IN	O	of	_	0	SENT_20	[p1l968t1562r1007b1593],
23	drugs	NNS	O	drug	prep_of	21	SENT_20	[p1l1016t1562r1118b1601],
24	,	,	O	,	_	0	SENT_20	[p1l1016t1562r1118b1601],
25	especially	RB	O	especially	advmod	26	SENT_20	[p1l1137t1562r1295b1601],
26	when	WRB	O	when	advmod	43	SENT_20	[p1l1308t1562r1399b1593],
27	cytochrome	NN	O	cytochrome	nn	28	SENT_20	[p1l1415t1569r1493b1601, p1l95t1611r219b1642],
28	P	NN	O	p	nsubjpass	43	SENT_20	[p1l227t1613r322b1642],
29	—	CD	NUMBER	—	num	31	SENT_20	[p1l227t1613r322b1642],
30	45O	NN	O	45o	nn	31	SENT_20	[p1l227t1613r322b1642],
31	enzymes	NNS	O	enzyme	dep	28	SENT_20	[p1l331t1621r481b1650],
32	,	,	O	,	_	0	SENT_20	[p1l331t1621r481b1650],
33	a	DT	O	a	det	34	SENT_20	[p1l492t1621r509b1642],
34	superfamily	NN	O	superfamily	appos	28	SENT_20	[p1l518t1611r712b1650],
35	of	IN	O	of	_	0	SENT_20	[p1l719t1611r758b1642],
36	microsomal	JJ	O	microsomal	amod	40	SENT_20	[p1l759t1611r956b1642],
37	drug	NN	O	drug	nn	40	SENT_20	[p1l965t1611r1276b1650],
38	—	NN	O	—	nn	40	SENT_20	[p1l965t1611r1276b1650],
39	metabolizing	VBG	O	metabolize	amod	40	SENT_20	[p1l965t1611r1276b1650],
40	enzymes	NNS	O	enzyme	prep_of	34	SENT_20	[p1l1283t1621r1434b1650],
41	,	,	O	,	_	0	SENT_20	[p1l1283t1621r1434b1650],
42	are	VBP	O	be	auxpass	43	SENT_20	[p1l1444t1621r1493b1642],
43	involved	VBN	O	involve	advcl	2	SENT_20	[p1l94t1660r230b1691],
44	in	IN	O	in	_	0	SENT_20	[p1l243t1661r275b1690],
45	the	DT	O	the	det	46	SENT_20	[p1l288t1660r338b1691],
46	metabolism	NN	O	metabolism	prep_in	43	SENT_20	[p1l351t1660r548b1691],
47	of	IN	O	of	_	0	SENT_20	[p1l561t1660r600b1691],
48	a	DT	O	a	det	49	SENT_20	[p1l606t1670r623b1690],
49	drug	NN	O	drug	prep_of	46	SENT_20	[p1l636t1660r722b1699],
50	.	.	O	.	_	0	SENT_20	[p1l636t1660r722b1699],

1	The	DT	O	the	det	2	SENT_21	[p1l736t1660r799b1691],
2	characteristics	NNS	O	characteristic	nsubjpass	13	SENT_21	[p1l812t1660r1047b1691],
3	of	IN	O	of	_	0	SENT_21	[p1l1061t1660r1100b1691],
4	the	DT	O	the	det	7	SENT_21	[p1l1106t1660r1157b1691],
5	various	JJ	O	various	amod	7	SENT_21	[p1l1168t1661r1287b1691],
6	cytochrome	NN	O	cytochrome	nn	7	SENT_21	[p1l1301t1660r1493b1699],
7	P	NN	O	p	prep_of	2	SENT_21	[p1l94t1711r188b1740],
8	—	CD	NUMBER	—	num	10	SENT_21	[p1l94t1711r188b1740],
9	45O	NN	O	45o	nn	10	SENT_21	[p1l94t1711r188b1740],
10	enzymes	NNS	O	enzyme	dep	7	SENT_21	[p1l199t1719r340b1748],
11	are	VBP	O	be	auxpass	13	SENT_21	[p1l351t1719r400b1740],
12	well	RB	O	well	advmod	13	SENT_21	[p1l409t1709r477b1740],
13	established	VBN	O	establish	_	0	SENT_21	[p1l487t1709r682b1746],
14	,	,	O	,	_	0	SENT_21	[p1l487t1709r682b1746],
15	and	CC	O	and	_	0	SENT_21	[p1l694t1709r755b1740],
16	the	DT	O	the	det	17	SENT_21	[p1l765t1709r815b1740],
17	involvement	NN	O	involvement	nsubjpass	30	SENT_21	[p1l825t1709r1028b1740],
18	of	IN	O	of	_	0	SENT_21	[p1l1037t1709r1076b1740],
19	these	DT	O	these	det	20	SENT_21	[p1l1079t1709r1164b1740],
20	enzymes	NNS	O	enzyme	prep_of	17	SENT_21	[p1l1175t1719r1316b1748],
21	in	IN	O	in	_	0	SENT_21	[p1l1327t1710r1359b1739],
22	the	DT	O	the	det	23	SENT_21	[p1l1369t1709r1419b1740],
23	metabolism	NN	O	metabolism	prep_in	20	SENT_21	[p1l1430t1719r1493b1740, p1l94t1758r239b1789],
24	of	IN	O	of	_	0	SENT_21	[p1l247t1758r286b1789],
25	most	JJS	O	most	prep_of	23	SENT_21	[p1l287t1765r371b1789],
26	commonly	RB	O	commonly	advmod	27	SENT_21	[p1l378t1758r555b1797],
27	used	VBN	O	use	partmod	25	SENT_21	[p1l561t1758r637b1789],
28	drugs	NNS	O	drug	dobj	27	SENT_21	[p1l645t1758r737b1797],
29	is	VBZ	O	be	auxpass	30	SENT_21	[p1l746t1759r772b1788],
30	known	VBN	O	know	conj_and	13	SENT_21	[p1l780t1758r903b1789],
31	.	.	O	.	_	0	SENT_21	[p1l780t1758r903b1789],

1	This	DT	O	this	det	2	SENT_22	[p1l912t1758r984b1788],
2	knowledge	NN	O	knowledge	nsubj	10	SENT_22	[p1l992t1758r1172b1797],
3	may	MD	O	may	aux	4	SENT_22	[p1l1181t1768r1249b1797],
4	provide	VB	O	provide	_	0	SENT_22	[p1l1255t1758r1378b1797],
5	a	DT	O	a	det	6	SENT_22	[p1l1386t1768r1403b1789],
6	basis	NN	O	basis	dobj	4	SENT_22	[p1l1411t1758r1492b1789],
7	for	IN	O	for	_	0	SENT_22	[p1l94t1807r142b1838],
8	understanding	NN	O	understanding	prep_for	6	SENT_22	[p1l153t1807r396b1846],
9	and	CC	O	and	_	0	SENT_22	[p1l406t1807r466b1838],
10	predicting	VBG	O	predict	conj_and	4	SENT_22	[p1l477t1807r647b1846],
11	individual	JJ	O	individual	amod	12	SENT_22	[p1l657t1807r821b1838],
12	differences	NNS	O	difference	dobj	10	SENT_22	[p1l832t1807r1012b1838],
13	in	IN	O	in	_	0	SENT_22	[p1l1024t1808r1056b1837],
14	drug	NN	O	drug	nn	15	SENT_22	[p1l1068t1807r1145b1846],
15	response	NN	O	response	prep_in	10	SENT_22	[p1l1156t1817r1312b1846],
16	,	,	O	,	_	0	SENT_22	[p1l1156t1817r1312b1846],
17	which	WDT	O	which	nsubjpass	20	SENT_22	[p1l1324t1807r1425b1838],
18	can	MD	O	can	aux	20	SENT_22	[p1l1437t1817r1493b1838],
19	be	VB	O	be	auxpass	20	SENT_22	[p1l94t1856r132b1887],
20	caused	VBN	O	cause	rcmod	15	SENT_22	[p1l142t1856r253b1887],
21	by	IN	O	by	_	0	SENT_22	[p1l262t1856r300b1895],
22	drug	NN	O	drug	nn	23	SENT_22	[p1l308t1856r386b1895],
23	interactions	NNS	O	interaction	agent	20	SENT_22	[p1l394t1857r588b1887],
24	and	CC	O	and	_	0	SENT_22	[p1l598t1856r658b1887],
25	genetic	JJ	O	genetic	amod	26	SENT_22	[p1l668t1857r786b1895],
26	variability	NN	O	variability	agent	20	SENT_22	[p1l793t1856r960b1895],
27	.	.	O	.	_	0	SENT_22	[p1l793t1856r960b1895],

1	Drugs	NNS	O	drug	nsubjpass	4	SENT_23	[p1l144t1908r243b1944],
2	may	MD	O	may	aux	4	SENT_23	[p1l256t1915r325b1944],
3	be	VB	O	be	auxpass	4	SENT_23	[p1l335t1905r372b1936],
4	metabolized	VBN	O	metabolize	_	0	SENT_23	[p1l384t1905r588b1936],
5	by	IN	O	by	_	0	SENT_23	[p1l600t1905r638b1944],
6	a	DT	O	a	det	7	SENT_23	[p1l648t1915r665b1936],
7	variety	NN	O	variety	agent	4	SENT_23	[p1l675t1906r783b1944],
8	of	IN	O	of	_	0	SENT_23	[p1l794t1905r833b1936],
9	sequential	JJ	O	sequential	amod	13	SENT_23	[p1l838t1905r1006b1944],
10	or	CC	O	or	_	0	SENT_23	[p1l1018t1915r1052b1936],
11	competitive	JJ	O	competitive	amod	13	SENT_23	[p1l1063t1906r1253b1944],
12	chemical	NN	O	chemical	nn	13	SENT_23	[p1l1266t1905r1413b1936],
13	processes	NNS	O	process	prep_of	7	SENT_23	[p1l1424t1915r1493b1944, p1l95t1964r195b1985],
14	involving	VBG	O	involve	xcomp	4	SENT_23	[p1l206t1954r358b1993],
15	oxidation	NN	O	oxidation	dobj	14	SENT_23	[p1l367t1954r530b1991],
16	,	,	O	,	_	0	SENT_23	[p1l367t1954r530b1991],
17	reduction	NN	O	reduction	dobj	14	SENT_23	[p1l542t1954r708b1991],
18	,	,	O	,	_	0	SENT_23	[p1l542t1954r708b1991],
19	and	CC	O	and	_	0	SENT_23	[p1l720t1954r780b1985],
20	hydrolysis	NN	O	hydrolysis	dobj	14	SENT_23	[p1l790t1954r955b1993],
21	(	CD	NUMBER	(	num	22	SENT_23	[p1l967t1954r1074b1993],
22	phase	NN	O	phase	dep	25	SENT_23	[p1l967t1954r1074b1993],
23	I	PRP	O	I	dep	22	SENT_23	[p1l1083t1957r1096b1984],
24	reactions	NNS	O	reaction	dep	25	SENT_23	[p1l1105t1955r1266b1989],
25	)	CD	NUMBER	)	dep	28	SENT_23	[p1l1105t1955r1266b1989],
26	or	CC	O	or	_	0	SENT_23	[p1l1278t1964r1312b1985],
27	glucuroni	NNS	O	glucuronus	conj_or	25	SENT_23	[p1l1321t1954r1493b1993],
28	—	CD	NUMBER	—	dep	29	SENT_23	[p1l1321t1954r1493b1993],
29	dation	NN	O	dation	dep	41	SENT_23	[p1l95t2003r208b2040],
30	,	,	O	,	_	0	SENT_23	[p1l95t2003r208b2040],
31	sulfation	NN	O	sulfation	dep	41	SENT_23	[p1l221t2003r374b2040],
32	,	,	O	,	_	0	SENT_23	[p1l221t2003r374b2040],
33	acetylation	NN	O	acetylation	dep	41	SENT_23	[p1l386t2003r571b2042],
34	,	,	O	,	_	0	SENT_23	[p1l386t2003r571b2042],
35	and	CC	O	and	_	0	SENT_23	[p1l584t2003r644b2034],
36	methylation	NN	O	methylation	conj_and	29	SENT_23	[p1l654t2003r851b2042],
37	(	CD	NUMBER	(	num	40	SENT_23	[p1l863t2003r970b2042],
38	phase	NN	O	phase	nn	40	SENT_23	[p1l863t2003r970b2042],
39	H	NN	O	h	nn	40	SENT_23	[p1l979t2006r1004b2033],
40	reactions	NNS	O	reaction	dep	29	SENT_23	[p1l1014t2004r1186b2038],
41	)	CD	NUMBER	)	dep	14	SENT_23	[p1l1014t2004r1186b2038],
42	.	.	O	.	_	0	SENT_23	[p1l1014t2004r1186b2038],

1	Generally	RB	O	generally	advmod	11	SENT_24	[p1l1199t2003r1362b2042],
2	,	,	O	,	_	0	SENT_24	[p1l1199t2003r1362b2042],
3	the	DT	O	the	det	5	SENT_24	[p1l1374t2003r1425b2034],
4	water	NN	O	water	nn	5	SENT_24	[p1l1433t2013r1493b2034, p1l94t2059r138b2083],
5	solubility	NN	O	solubility	nsubj	11	SENT_24	[p1l146t2052r298b2091],
6	of	IN	O	of	_	0	SENT_24	[p1l305t2052r344b2083],
7	the	DT	O	the	det	9	SENT_24	[p1l346t2052r396b2083],
8	resulting	VBG	O	result	amod	9	SENT_24	[p1l404t2052r552b2091],
9	metabolites	NNS	O	metabolite	prep_of	5	SENT_24	[p1l559t2052r750b2083],
10	is	VBZ	O	be	cop	11	SENT_24	[p1l759t2053r785b2083],
11	greater	JJR	O	greater	_	0	SENT_24	[p1l794t2059r916b2091],
12	,	,	O	,	_	0	SENT_24	[p1l794t2059r916b2091],
13	thus	RB	O	thus	advmod	14	SENT_24	[p1l926t2052r996b2083],
14	enhancing	VBG	O	enhance	xcomp	11	SENT_24	[p1l1006t2052r1180b2091],
15	their	PRP$	O	they	poss	16	SENT_24	[p1l1187t2052r1264b2083],
16	removal	NN	O	removal	dobj	14	SENT_24	[p1l1271t2052r1411b2083],
17	.	.	O	.	_	0	SENT_24	[p1l1271t2052r1411b2083],

1	This	DT	O	this	det	2	SENT_25	[p1l1421t2052r1493b2083],
2	review	NN	O	review	nsubj	4	SENT_25	[p1l94t2102r200b2132],
3	will	MD	O	will	aux	4	SENT_25	[p1l209t2101r270b2132],
4	focus	VB	O	focus	_	0	SENT_25	[p1l282t2101r369b2132],
5	on	IN	O	on	_	0	SENT_25	[p1l382t2111r424b2132],
6	cytochrome	NN	O	cytochrome	nn	7	SENT_25	[p1l436t2101r628b2140],
7	P	NN	O	p	prep_on	4	SENT_25	[p1l640t2103r734b2132],
8	—	CD	NUMBER	—	number	9	SENT_25	[p1l640t2103r734b2132],
9	450	CD	NUMBER	450	num	10	SENT_25	[p1l640t2103r734b2132],
10	enzymes	NNS	O	enzyme	dobj	4	SENT_25	[p1l747t2111r888b2140],
11	that	WDT	O	that	nsubj	13	SENT_25	[p1l901t2101r966b2132],
12	are	VBP	O	be	cop	13	SENT_25	[p1l976t2111r1025b2132],
13	important	JJ	O	important	rcmod	10	SENT_25	[p1l1037t2102r1205b2140],
14	in	IN	O	in	_	0	SENT_25	[p1l1215t2102r1247b2131],
15	oxidative	JJ	O	oxidative	amod	17	SENT_25	[p1l1259t2101r1404b2132],
16	drug	NN	O	drug	nn	17	SENT_25	[p1l1417t2101r1495b2140],
17	metabolism	NN	O	metabolism	prep_in	13	SENT_25	[p1l94t2151r299b2182],
18	.	.	O	.	_	0	SENT_25	[p1l94t2151r299b2182],

1	CYTOCHROME	NN	O	cytochrome	nn	2	SENT_26	[p1l571t2275r873b2298],
2	P-450	NN	O	p-450	_	0	SENT_26	[p1l894t2274r1011b2299],

1	Cytochrome	NN	O	cytochrome	nn	5	SENT_27	[p1l94t2367r294b2406],
2	P	NN	O	p	nn	5	SENT_27	[p1l303t2369r398b2398],
3	—	CD	NUMBER	—	num	5	SENT_27	[p1l303t2369r398b2398],
4	45O	NN	O	45o	nn	5	SENT_27	[p1l303t2369r398b2398],
5	enzymes	NNS	O	enzyme	nsubj	6	SENT_27	[p1l408t2377r549b2406],
6	(	VBP	O	(	_	0	SENT_27	[p1l561t2369r666b2402],
7	CYPs	NNS	O	cyp	dobj	6	SENT_27	[p1l561t2369r666b2402],
8	)	CD	NUMBER	)	nsubj	10	SENT_27	[p1l561t2369r666b2402],
9	are	VBP	O	be	cop	10	SENT_27	[p1l677t2377r726b2398],
10	important	JJ	O	important	rcmod	7	SENT_27	[p1l736t2368r904b2406],
11	in	IN	O	in	_	0	SENT_27	[p1l911t2368r943b2397],
12	the	DT	O	the	det	13	SENT_27	[p1l953t2367r1003b2398],
13	biosynthesis	NN	O	biosynthesis	prep_in	10	SENT_27	[p1l1013t2367r1216b2406],
14	and	CC	O	and	_	0	SENT_27	[p1l1226t2367r1286b2398],
15	degradation	NN	O	degradation	conj_and	13	SENT_27	[p1l1296t2367r1493b2406],
16	of	IN	O	of	_	0	SENT_27	[p1l95t2416r133b2447],
17	endogenous	JJ	O	endogenous	amod	18	SENT_27	[p1l134t2416r330b2455],
18	compounds	NNS	O	compound	prep_of	13	SENT_27	[p1l339t2416r530b2455],
19	such	JJ	O	such	_	0	SENT_27	[p1l539t2416r613b2447],
20	as	IN	O	as	_	0	SENT_27	[p1l620t2426r653b2447],
21	steroids	NNS	O	steroid	prep_such_as	18	SENT_27	[p1l662t2416r796b2453],
22	,	,	O	,	_	0	SENT_27	[p1l662t2416r796b2453],
23	lipids	NNS	O	lipid	prep_such_as	18	SENT_27	[p1l805t2416r903b2455],
24	,	,	O	,	_	0	SENT_27	[p1l805t2416r903b2455],
25	and	CC	O	and	_	0	SENT_27	[p1l913t2416r972b2447],
26	vitamins	NNS	O	vitamin	prep_such_as	18	SENT_27	[p1l978t2417r1126b2447],
27	.	.	O	.	_	0	SENT_27	[p1l978t2417r1126b2447],

1	They	PRP	O	they	nsubj	2	SENT_28	[p1l1134t2416r1214b2455],
2	metabolize	VBZ	O	metabolize	_	0	SENT_28	[p1l1220t2416r1398b2447],
3	many	JJ	O	many	amod	4	SENT_28	[p1l1406t2426r1495b2455],
4	chemicals	NNS	O	chemical	nsubj	5	SENT_28	[p1l95t2466r260b2496],
5	present	JJ	DATE	present	xcomp	2	SENT_28	[p1l270t2472r397b2505],
6	in	IN	O	in	_	0	SENT_28	[p1l404t2466r436b2496],
7	the	DT	O	the	det	8	SENT_28	[p1l446t2466r497b2496],
8	diet	NN	O	diet	prep_in	5	SENT_28	[p1l507t2466r570b2497],
9	and	CC	O	and	_	0	SENT_28	[p1l577t2466r639b2497],
10	environment	NN	O	environment	conj_and	8	SENT_28	[p1l648t2466r871b2503],
11	,	,	O	,	_	0	SENT_28	[p1l648t2466r871b2503],
12	as	RB	O	as	_	0	SENT_28	[p1l883t2476r916b2496],
13	well	RB	O	well	_	0	SENT_28	[p1l925t2466r994b2497],
14	as	IN	O	as	_	0	SENT_28	[p1l1003t2476r1036b2496],
15	medications	NNS	O	medication	prep_in	5	SENT_28	[p1l1047t2464r1278b2497],
16	.	.	O	.	_	0	SENT_28	[p1l1047t2464r1278b2497],

1	-	:	O	-	_	0	SENT_29	[p1l1047t2464r1278b2497],
2	"	``	O	"	punct	7	SENT_29	[p1l1047t2464r1278b2497],
3	Cytochrome	NN	O	cytochrome	nn	7	SENT_29	[p1l1289t2466r1492b2505],
4	P	NN	O	p	nn	7	SENT_29	[p1l94t2517r189b2546],
5	—	CD	NUMBER	—	num	7	SENT_29	[p1l94t2517r189b2546],
6	45O	NN	O	45o	nn	7	SENT_29	[p1l94t2517r189b2546],
7	enzymes	NNS	O	enzyme	nsubj	10	SENT_29	[p1l200t2525r341b2554],
8	reduce	VB	O	reduce	_	0	SENT_29	[p1l351t2515r460b2546],
9	or	CC	O	or	_	0	SENT_29	[p1l471t2525r505b2546],
10	alter	VB	O	alter	conj_or	8	SENT_29	[p1l514t2515r587b2546],
11	the	DT	O	the	det	13	SENT_29	[p1l596t2515r647b2546],
12	pharmacologic	JJ	O	pharmacologic	amod	13	SENT_29	[p1l656t2515r904b2554],
13	activity	NN	O	activity	dobj	8	SENT_29	[p1l914t2516r1029b2554],
14	of	IN	O	of	_	0	SENT_29	[p1l1037t2515r1076b2546],
15	many	JJ	O	many	amod	16	SENT_29	[p1l1079t2525r1170b2554],
16	drugs	NNS	O	drug	prep_of	13	SENT_29	[p1l1179t2515r1271b2554],
17	and	CC	O	and	_	0	SENT_29	[p1l1282t2515r1343b2546],
18	facilitate	VB	O	facilitate	conj_and	8	SENT_29	[p1l1353t2515r1493b2546],
19	their	PRP$	O	they	poss	20	SENT_29	[p1l94t2564r171b2595],
20	elimination	NN	O	elimination	dobj	18	SENT_29	[p1l182t2564r379b2595],
21	.	.	O	.	_	0	SENT_29	[p1l182t2564r379b2595],

1	Individual	JJ	O	individual	amod	3	SENT_30	[p1l392t2564r558b2595],
2	cytochrome	NN	O	cytochrome	nn	3	SENT_30	[p1l569t2564r761b2603],
3	P	NN	O	p	nsubj	57	SENT_30	[p1l772t2566r866b2595],
4	—	CD	NUMBER	—	number	5	SENT_30	[p1l772t2566r866b2595],
5	450	CD	NUMBER	450	num	6	SENT_30	[p1l772t2566r866b2595],
6	enzymes	NNS	O	enzyme	nsubjpass	8	SENT_30	[p1l878t2574r1019b2603],
7	are	VBP	O	be	auxpass	8	SENT_30	[p1l1031t2574r1080b2595],
8	classiﬁed	VBN	O	classiﬁed	rcmod	3	SENT_30	[p1l1091t2564r1243b2595],
9	by	IN	O	by	_	0	SENT_30	[p1l1255t2564r1292b2603],
10	their	PRP$	O	they	poss	13	SENT_30	[p1l1302t2564r1379b2595],
11	amino	NN	O	amino	nn	13	SENT_30	[p1l1388t2565r1493b2595],
12	acid	NN	O	acid	nn	13	SENT_30	[p1l94t2613r160b2644],
13	similarities	NNS	O	similarity	agent	8	SENT_30	[p1l169t2613r348b2644],
14	and	CC	O	and	_	0	SENT_30	[p1l357t2613r417b2644],
15	are	VBP	O	be	auxpass	16	SENT_30	[p1l425t2623r474b2644],
16	designated	VBN	O	designate	rcmod	3	SENT_30	[p1l483t2613r659b2652],
17	by	IN	O	by	_	0	SENT_30	[p1l667t2613r705b2652],
18	a	DT	O	a	det	20	SENT_30	[p1l712t2623r729b2644],
19	family	NN	O	family	nn	20	SENT_30	[p1l737t2613r839b2652],
20	number	NN	O	number	agent	16	SENT_30	[p1l846t2613r981b2650],
21	,	,	O	,	_	0	SENT_30	[p1l846t2613r981b2650],
22	a	DT	O	a	det	24	SENT_30	[p1l992t2623r1009b2644],
23	subfamily	NN	O	subfamily	nn	24	SENT_30	[p1l1018t2613r1178b2652],
24	letter	NN	O	letter	conj_and	20	SENT_30	[p1l1184t2613r1274b2650],
25	,	,	O	,	_	0	SENT_30	[p1l1184t2613r1274b2650],
26	a	DT	O	a	det	27	SENT_30	[p1l1285t2623r1302b2644],
27	number	NN	O	number	conj_and	20	SENT_30	[p1l1310t2613r1440b2644],
28	for	IN	O	for	_	0	SENT_30	[p1l1447t2613r1495b2644],
29	an	DT	O	a	det	31	SENT_30	[p1l94t2672r133b2693],
30	individual	JJ	O	individual	amod	31	SENT_30	[p1l141t2662r305b2693],
31	enzyme	NN	O	enzyme	prep_for	27	SENT_30	[p1l313t2672r438b2701],
32	within	IN	O	within	_	0	SENT_30	[p1l445t2662r552b2693],
33	the	DT	O	the	det	34	SENT_30	[p1l561t2662r611b2693],
34	subfamily	NN	O	subfamily	prep_within	31	SENT_30	[p1l620t2662r786b2701],
35	,	,	O	,	_	0	SENT_30	[p1l620t2662r786b2701],
36	and	CC	O	and	_	0	SENT_30	[p1l797t2662r858b2693],
37	an	DT	O	a	det	38	SENT_30	[p1l866t2672r905b2693],
38	asterisk	NN	O	asterisk	conj_and	20	SENT_30	[p1l913t2662r1042b2693],
39	followed	VBN	O	follow	partmod	38	SENT_30	[p1l1048t2662r1191b2693],
40	by	IN	O	by	_	0	SENT_30	[p1l1200t2662r1238b2701],
41	a	DT	O	a	det	42	SENT_30	[p1l1244t2672r1262b2693],
42	number	NN	O	number	agent	39	SENT_30	[p1l1270t2662r1400b2693],
43	and	CC	O	and	_	0	SENT_30	[p1l1408t2662r1468b2693],
44	a	DT	O	a	det	45	SENT_30	[p1l1477t2672r1494b2693],
45	letter	NN	O	letter	conj_and	42	SENT_30	[p1l94t2711r178b2742],
46	for	IN	O	for	_	0	SENT_30	[p1l185t2711r233b2742],
47	each	DT	O	each	det	51	SENT_30	[p1l241t2711r314b2742],
48	genetic	JJ	O	genetic	amod	51	SENT_30	[p1l322t2712r439b2750],
49	(	NN	O	(	nn	51	SENT_30	[p1l449t2711r565b2746],
50	allelic	JJ	O	allelic	amod	51	SENT_30	[p1l449t2711r565b2746],
51	)	NN	O	)	prep_for	39	SENT_30	[p1l449t2711r565b2746],
52	variant	JJ	O	variant	amod	53	SENT_30	[p1l574t2712r688b2742],
53	(	NN	O	(	npadvmod	54	SENT_30	[p1l696t2714r792b2746],
54	more	RBR	O	more	advmod	39	SENT_30	[p1l696t2714r792b2746],
55	information	NN	O	information	dobj	8	SENT_30	[p1l801t2711r997b2742],
56	is	VBZ	O	be	cop	57	SENT_30	[p1l1006t2712r1031b2742],
57	available	JJ	O	available	_	0	SENT_30	[p1l1040t2711r1180b2742],
58	at	IN	O	at	_	0	SENT_30	[p1l1189t2718r1219b2742],
59	wvvw	NN	O	wvvw	prep_at	57	SENT_30	[p1l1224t2711r1493b2746],
60	.	.	O	.	_	0	SENT_30	[p1l1224t2711r1493b2746],

1	imm	NN	O	imm	_	0	SENT_31	[p1l1224t2711r1493b2746],
2	.	.	O	.	_	0	SENT_31	[p1l1224t2711r1493b2746],

1	ki	NN	O	kus	_	0	SENT_32	[p1l1224t2711r1493b2746],
2	.	.	O	.	_	0	SENT_32	[p1l1224t2711r1493b2746],

1	se	FW	O	se	_	0	SENT_33	[p1l1224t2711r1493b2746],
2	/	:	O	/	punct	1	SENT_33	[p1l1224t2711r1493b2746],

1	N	NN	O	n	nn	3	SENT_34	[p1l426t2831r440b2846],
2	ENGLJ	NN	O	englj	nn	3	SENT_34	[p1l455t2830r539b2852],
3	MED	NN	O	med	_	0	SENT_34	[p1l554t2831r606b2846],
4	352	CD	NUMBER	352	dep	3	SENT_34	[p1l619t2830r695b2852],
5	;	:	O	;	_	0	SENT_34	[p1l619t2830r695b2852],
6	21	CD	NUMBER	21	num	8	SENT_34	[p1l619t2830r695b2852],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_34	[p1l732t2830r944b2852],
8	MAY	NNP	DATE	MAY	dep	4	SENT_34	[p1l983t2830r1035b2846],
9	26,2005	CD	DATE	26,2005	number	10	SENT_34	[p1l1046t2825r1161b2852],
10	2211	CD	DATE	2211	dep	8	SENT_34	[p1l1991t2829r2067b2850],

1	The	DT	O	the	det	5	SENT_35	[p1l753t2927r803b2951],
2	New	NNP	O	New	nn	5	SENT_35	[p1l813t2928r875b2951],
3	England	NNP	O	England	nn	5	SENT_35	[p1l884t2927r995b2958],
4	J	NNP	O	J	nn	5	SENT_35	[p1l1003t2928r1016b2951],
5	oumal	NN	O	oumal	_	0	SENT_35	[p1l1017t2927r1101b2951],
6	of	IN	O	of	_	0	SENT_35	[p1l1111t2927r1139b2951],
7	Medicine	NN	O	medicine	prep_of	5	SENT_35	[p1l1146t2927r1271b2951],

1	Downloaded	VBN	O	download	_	0	SENT_36	[p1l195t2968r365b2991],
2	from	IN	O	from	_	0	SENT_36	[p1l373t2968r438b2991],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_36	[p1l447t2968r565b2998],
4	at	IN	O	at	_	0	SENT_36	[p1l575t2972r598b2991],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_36	[p1l607t2968r789b2991],
6	on	IN	O	on	_	0	SENT_36	[p1l799t2975r831b2991],
7	January	NNP	DATE	January	prep_on	1	SENT_36	[p1l840t2968r942b2998],
8	5	CD	DATE	5	num	7	SENT_36	[p1l953t2968r975b2995],
9	,	,	DATE	,	_	0	SENT_36	[p1l953t2968r975b2995],
10	2014	CD	DATE	2014	num	7	SENT_36	[p1l986t2968r1058b2991],
11	.	.	O	.	_	0	SENT_36	[p1l986t2968r1058b2991],

1	For	IN	O	for	_	0	SENT_37	[p1l1069t2968r1115b2991],
2	personal	JJ	O	personal	amod	3	SENT_37	[p1l1123t2968r1236b2998],
3	use	NN	O	use	pobj	1	SENT_37	[p1l1245t2975r1288b2991],
4	only	RB	O	only	advmod	3	SENT_37	[p1l1298t2968r1363b2998],
5	.	.	O	.	_	0	SENT_37	[p1l1298t2968r1363b2998],

1	No	DT	O	no	det	3	SENT_38	[p1l1373t2968r1413b2991],
2	other	JJ	O	other	amod	3	SENT_38	[p1l1423t2968r1491b2991],
3	uses	NNS	O	use	_	0	SENT_38	[p1l1499t2975r1555b2991],
4	without	IN	O	without	_	0	SENT_38	[p1l1566t2968r1667b2991],
5	permission	NN	O	permission	prep_without	3	SENT_38	[p1l1675t2968r1828b2998],
6	.	.	O	.	_	0	SENT_38	[p1l1675t2968r1828b2998],

1	Copyright	NN	O	copyright	_	0	SENT_39	[p1l545t3009r679b3040],
2	©	CD	NUMBER	©	num	6	SENT_39	[p1l689t3009r712b3033],
3	2005	CD	DATE	2005	num	6	SENT_39	[p1l722t3009r786b3033],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_39	[p1l797t3009r988b3033],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_39	[p1l998t3009r1106b3033],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_39	[p1l1116t3009r1221b3040],
7	.	.	O	.	_	0	SENT_39	[p1l1116t3009r1221b3040],

1	All	DT	O	all	det	2	SENT_40	[p1l1232t3009r1273b3033],
2	rights	NNS	O	rights	nsubj	3	SENT_40	[p1l1283t3009r1357b3040],
3	reserved	VBN	O	reserve	_	0	SENT_40	[p1l1367t3009r1486b3033],
4	.	.	O	.	_	0	SENT_40	[p1l1367t3009r1486b3033],

1	The	DT	O	the	det	4	SENT_41	[p1l715t3115r752b3136],
2	NEW	NNP	O	NEW	nn	4	SENT_41	[p1l764t3117r845b3136],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_41	[p1l859t3117r1034b3136],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_41	[p1l1048t3117r1214b3143],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_41	[p1l1228t3115r1444b3142],

1	CYPalleles	NNS	O	cypallele	_	0	SENT_42	[p1l10t3337r532b3429],
2	/	:	O	/	punct	1	SENT_42	[p1l10t3337r532b3429],
3	)	CD	NUMBER	)	dep	1	SENT_42	[p1l10t3337r532b3429],
4	.	.	O	.	_	0	SENT_42	[p1l10t3337r532b3429],

1	For	IN	O	for	_	0	SENT_43	[p1l588t3345r732b3416],
2	example	NN	O	example	prep_for	15	SENT_43	[p1l782t3338r1157b3438],
3	,	,	O	,	_	0	SENT_43	[p1l782t3338r1157b3438],
4	the	DT	O	the	det	6	SENT_43	[p1l1215t3338r1344b3416],
5	CYP2D6	NN	O	cyp2d6	nn	6	SENT_43	[p1l1396t3341r1853b3416],
6	‘	NN	O	‘	nsubj	15	SENT_43	[p1l1396t3341r1853b3416],
7	*	CD	NUMBER	*	number	8	SENT_43	[p1l1396t3341r1853b3416],
8	’	CD	NUMBER	’	num	10	SENT_43	[p1l1396t3341r1853b3416],
9	1a	NN	O	1a	nn	10	SENT_43	[p1l1396t3341r1853b3416],
10	gene	NN	O	gene	dep	6	SENT_43	[p1l1906t3363r2128b3438],
11	,	,	O	,	_	0	SENT_43	[p1l1906t3363r2128b3438],
12	identiﬁed	VBN	O	identiﬁed	partmod	6	SENT_43	[p1l10t3464r414b3542],
13	in	IN	O	in	_	0	SENT_43	[p1l445t3465r526b3541],
14	1989,4	CD	NUMBER	1989,4	prep_in	12	SENT_43	[p1l562t3460r836b3559],
15	encodes	VBZ	O	encode	_	0	SENT_43	[p1l869t3465r1210b3542],
16	the	DT	O	the	det	19	SENT_43	[p1l1244t3465r1374b3542],
17	wild	JJ	O	wild	amod	19	SENT_43	[p1l1402t3465r1796b3564],
18	—	NN	O	—	nn	19	SENT_43	[p1l1402t3465r1796b3564],
19	type	NN	O	type	dobj	15	SENT_43	[p1l1402t3465r1796b3564],
20	protein	NN	O	protein	nn	22	SENT_43	[p1l1827t3465r2135b3564],
21	CYP2D6	NN	O	cyp2d6	nn	22	SENT_43	[p1l10t3599r462b3671],
22	.1	NN	NUMBER	.1	dep	19	SENT_43	[p1l10t3599r462b3671],
23	.	.	O	.	_	0	SENT_43	[p1l10t3599r462b3671],

1	In	IN	O	in	_	0	SENT_44	[p2l138t39r225b109],
2	humans	NNS	O	human	prep_in	12	SENT_44	[p2l269t31r636b127],
3	,	,	O	,	_	0	SENT_44	[p2l269t31r636b127],
4	57	CD	NUMBER	57	num	6	SENT_44	[p2l688t39r786b110],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_44	[p2l833t32r1327b132],
6	P	NN	O	p	nsubjpass	12	SENT_44	[p2l1371t37r1614b110],
7	—	CD	NUMBER	—	num	9	SENT_44	[p2l1371t37r1614b110],
8	45O	NN	O	45o	nn	9	SENT_44	[p2l1371t37r1614b110],
9	genes	NNS	O	gene	dep	6	SENT_44	[p2l1659t57r1899b132],
10	have	VBP	O	have	aux	12	SENT_44	[p2l1946t32r2134b111],
11	been	VBN	O	be	auxpass	12	SENT_44	[p2l11t160r210b238],
12	identiﬁed	VBN	O	identiﬁed	_	0	SENT_44	[p2l238t159r665b255],
13	,	,	O	,	_	0	SENT_44	[p2l238t159r665b255],
14	but	CC	O	but	_	0	SENT_44	[p2l701t160r842b239],
15	only	RB	O	only	advmod	19	SENT_44	[p2l866t160r1048b260],
16	a	DT	O	a	det	19	SENT_44	[p2l1071t186r1116b238],
17	relatively	RB	O	relatively	advmod	18	SENT_44	[p2l1143t159r1519b260],
18	small	JJ	O	small	amod	19	SENT_44	[p2l1545t159r1773b238],
19	number	NN	O	number	nsubj	36	SENT_44	[p2l1801t160r2137b239],
20	of	IN	O	of	_	0	SENT_44	[p2l11t287r112b366],
21	the	DT	O	the	prep_of	19	SENT_44	[p2l117t287r245b366],
22	encoded	VBN	O	encode	partmod	21	SENT_44	[p2l269t287r624b366],
23	proteins	NNS	O	protein	dobj	22	SENT_44	[p2l645t288r1019b388],
24	,	,	O	,	_	0	SENT_44	[p2l645t288r1019b388],
25	mainly	RB	O	mainly	advmod	22	SENT_44	[p2l1047t287r1338b388],
26	in	IN	O	in	_	0	SENT_44	[p2l1355t288r1437b365],
27	the	DT	O	the	det	28	SENT_44	[p2l1460t288r1589b366],
28	CYP1	NN	O	cyp1	prep_in	22	SENT_44	[p2l1612t293r1856b383],
29	,	,	O	,	_	0	SENT_44	[p2l1612t293r1856b383],
30	CYP2	NN	O	cyp2	conj_and	28	SENT_44	[p2l1885t293r2129b383],
31	,	,	O	,	_	0	SENT_44	[p2l1885t293r2129b383],
32	and	CC	O	and	_	0	SENT_44	[p2l10t415r165b494],
33	CYP3	NN	O	cyp3	nn	34	SENT_44	[p2l192t421r409b494],
34	families	NNS	O	family	conj_and	28	SENT_44	[p2l438t415r797b511],
35	,	,	O	,	_	0	SENT_44	[p2l438t415r797b511],
36	appear	VBP	O	appear	conj_but	12	SENT_44	[p2l829t442r1117b516],
37	to	TO	O	to	aux	38	SENT_44	[p2l1140t432r1219b494],
38	contribute	VB	O	contribute	xcomp	36	SENT_44	[p2l1248t416r1682b495],
39	to	TO	O	to	_	0	SENT_44	[p2l1709t432r1788b494],
40	the	DT	O	the	det	41	SENT_44	[p2l1816t416r1945b494],
41	metabolism	NN	O	metabolism	prep_to	38	SENT_44	[p2l1972t442r2133b494, p2l11t544r390b622],
42	of	IN	O	of	_	0	SENT_44	[p2l437t543r539b622],
43	drugs	NNS	O	drug	prep_of	41	SENT_44	[p2l568t543r836b644],
44	.	.	O	.	_	0	SENT_44	[p2l568t543r836b644],

1	Collectively	RB	O	collectively	advmod	14	SENT_45	[p2l888t544r1397b644],
2	,	,	O	,	_	0	SENT_45	[p2l888t544r1397b644],
3	the	DT	O	the	det	5	SENT_45	[p2l1450t544r1581b622],
4	cytochrome	NN	O	cytochrome	nn	5	SENT_45	[p2l1629t544r2133b644],
5	P	NN	O	p	nsubjpass	14	SENT_45	[p2l9t677r256b750],
6	—	CD	NUMBER	—	num	8	SENT_45	[p2l9t677r256b750],
7	45O	NN	O	45o	nn	8	SENT_45	[p2l9t677r256b750],
8	enzymes	NNS	O	enzyme	dep	5	SENT_45	[p2l299t697r661b772],
9	emphasized	VBN	O	emphasize	partmod	5	SENT_45	[p2l702t672r1211b772],
10	in	IN	O	in	_	0	SENT_45	[p2l1248t672r1330b749],
11	this	DT	O	this	det	12	SENT_45	[p2l1368t672r1521b750],
12	article	NN	O	article	prep_in	9	SENT_45	[p2l1560t672r1818b750],
13	are	VBP	O	be	auxpass	14	SENT_45	[p2l1856t698r1981b750],
14	involved	VBN	O	involve	_	0	SENT_45	[p2l2019t672r2133b749, p2l6t800r270b879],
15	in	IN	O	in	_	0	SENT_45	[p2l290t800r370b877],
16	approximately	RB	O	approximately	quantmod	17	SENT_45	[p2l389t800r987b900],
17	80	CD	PERCENT	80	num	18	SENT_45	[p2l1003t805r1102b878],
18	percent	NN	PERCENT	percent	prep_in	14	SENT_45	[p2l1122t816r1437b900],
19	of	IN	O	of	_	0	SENT_45	[p2l1452t799r1552b878],
20	oxidative	JJ	O	oxidative	amod	22	SENT_45	[p2l1554t800r1921b879],
21	drug	NN	O	drug	nn	22	SENT_45	[p2l1942t799r2139b900],
22	metabolism	NN	O	metabolism	prep_of	18	SENT_45	[p2l10t928r516b1006],
23	and	CC	O	and	_	0	SENT_45	[p2l548t927r704b1006],
24	account	NN	O	account	prep_of	18	SENT_45	[p2l736t944r1072b1007],
25	for	IN	O	for	_	0	SENT_45	[p2l1099t927r1222b1006],
26	almost	RB	O	almost	advmod	28	SENT_45	[p2l1251t928r1544b1006],
27	50	CD	PERCENT	50	num	28	SENT_45	[p2l1573t933r1671b1006],
28	percent	NN	PERCENT	percent	prep_for	14	SENT_45	[p2l1704t944r2024b1028],
29	of	IN	O	of	_	0	SENT_45	[p2l2052t927r2153b1006],
30	the	DT	O	the	det	32	SENT_45	[p2l11t1056r138b1134],
31	overall	JJ	O	overall	amod	32	SENT_45	[p2l159t1056r432b1135],
32	elimination	NN	O	elimination	prep_of	28	SENT_45	[p2l453t1055r931b1134],
33	of	IN	O	of	_	0	SENT_45	[p2l953t1055r1051b1134],
34	commonly	RB	O	commonly	advmod	35	SENT_45	[p2l1055t1056r1504b1156],
35	used	VBN	O	use	amod	36	SENT_45	[p2l1519t1055r1712b1135],
36	drugs	NNS	O	drug	prep_of	32	SENT_45	[p2l1732t1056r1992b1156],
37	.	.	O	.	_	0	SENT_45	[p2l1732t1056r1992b1156],

1	Individual	JJ	O	individual	amod	3	SENT_46	[p2l2016t1063r2134b1133, p2l11t1184r352b1263],
2	cytochrome	NN	O	cytochrome	nn	3	SENT_46	[p2l390t1184r895b1284],
3	P	NN	O	p	nsubj	8	SENT_46	[p2l932t1189r1179b1262],
4	—	CD	NUMBER	—	num	6	SENT_46	[p2l932t1189r1179b1262],
5	450	CD	NUMBER	450	num	6	SENT_46	[p2l932t1189r1179b1262],
6	enzymes	NNS	O	enzyme	dep	3	SENT_46	[p2l1220t1209r1589b1284],
7	each	DT	O	each	dep	8	SENT_46	[p2l1630t1184r1823b1262],
8	have	VBP	O	have	_	0	SENT_46	[p2l1861t1184r2052b1263],
9	a	DT	O	a	det	12	SENT_46	[p2l2091t1210r2135b1262],
10	unique	JJ	O	unique	amod	12	SENT_46	[p2l10t1312r299b1412],
11	substrate	NN	O	substrate	nn	12	SENT_46	[p2l325t1312r703b1391],
12	speciﬁcity	NN	O	speciﬁcity	dobj	8	SENT_46	[p2l729t1311r1158b1412],
13	,	,	O	,	_	0	SENT_46	[p2l729t1311r1158b1412],
14	often	RB	O	often	advmod	8	SENT_46	[p2l1189t1311r1403b1390],
15	to	TO	O	to	_	0	SENT_46	[p2l1428t1328r1506b1390],
16	a	DT	O	a	det	18	SENT_46	[p2l1531t1338r1575b1390],
17	particular	JJ	O	particular	amod	18	SENT_46	[p2l1596t1312r2003b1412],
18	region	NN	O	region	prep_to	8	SENT_46	[p2l2023t1338r2134b1390, p2l10t1440r198b1540],
19	of	IN	O	of	_	0	SENT_46	[p2l221t1439r321b1518],
20	a	DT	O	a	det	22	SENT_46	[p2l323t1466r368b1518],
21	drug	NN	O	drug	nn	22	SENT_46	[p2l389t1440r588b1540],
22	molecule	NN	O	molecule	prep_of	18	SENT_46	[p2l606t1440r1010b1535],
23	,	,	O	,	_	0	SENT_46	[p2l606t1440r1010b1535],
24	to	TO	O	to	_	0	SENT_46	[p2l1038t1456r1117b1518],
25	a	DT	O	a	det	27	SENT_46	[p2l1140t1466r1184b1518],
26	particular	JJ	O	particular	amod	27	SENT_46	[p2l1203t1440r1610b1540],
27	enantiomer	NN	O	enantiomer	prep_to	8	SENT_46	[p2l1629t1440r2130b1535],
28	,	,	O	,	_	0	SENT_46	[p2l1629t1440r2130b1535],
29	or	CC	O	or	_	0	SENT_46	[p2l11t1593r100b1646],
30	to	TO	O	to	_	0	SENT_46	[p2l119t1584r198b1646],
31	both	DT	O	both	prep_to	8	SENT_46	[p2l222t1568r438b1646],
32	.	.	O	.	_	0	SENT_46	[p2l222t1568r438b1646],

1	However	RB	O	however	advmod	4	SENT_47	[p2l465t1575r857b1663],
2	,	,	O	,	_	0	SENT_47	[p2l465t1575r857b1663],
3	considerable	JJ	O	considerable	nsubj	4	SENT_47	[p2l886t1568r1423b1646],
4	overlap	VBP	O	overlap	_	0	SENT_47	[p2l1445t1568r1749b1668],
5	may	MD	O	may	aux	8	SENT_47	[p2l1773t1594r1949b1668],
6	also	RB	O	also	advmod	8	SENT_47	[p2l1966t1568r2133b1646],
7	be	VB	O	be	cop	8	SENT_47	[p2l11t1696r107b1774],
8	present	JJ	DATE	present	ccomp	4	SENT_47	[p2l141t1712r486b1796],
9	.	.	O	.	_	0	SENT_47	[p2l141t1712r486b1796],

1	Thus	RB	O	thus	advmod	34	SENT_48	[p2l523t1696r766b1791],
2	,	,	O	,	_	0	SENT_48	[p2l523t1696r766b1791],
3	a	DT	O	a	det	6	SENT_48	[p2l806t1722r850b1774],
4	single	JJ	O	single	amod	6	SENT_48	[p2l885t1696r1140b1796],
5	cytochrome	NN	O	cytochrome	nn	6	SENT_48	[p2l1177t1696r1681b1796],
6	P	NN	O	p	nsubj	34	SENT_48	[p2l1715t1701r1962b1774],
7	—	CD	NUMBER	—	number	8	SENT_48	[p2l1715t1701r1962b1774],
8	450	CD	NUMBER	450	num	9	SENT_48	[p2l1715t1701r1962b1774],
9	enzyme	NN	O	enzyme	nsubj	13	SENT_48	[p2l1999t1721r2132b1774, p2l10t1850r227b1924],
10	may	MD	O	may	aux	13	SENT_48	[p2l248t1850r424b1924],
11	be	VB	O	be	cop	13	SENT_48	[p2l441t1823r535b1902],
12	largely	RB	O	largely	advmod	13	SENT_48	[p2l555t1823r836b1924],
13	responsible	JJ	O	responsible	rcmod	6	SENT_48	[p2l852t1823r1337b1924],
14	for	IN	O	for	_	0	SENT_48	[p2l1358t1823r1480b1902],
15	all	PDT	O	all	predet	18	SENT_48	[p2l1497t1824r1595b1902],
16	the	DT	O	the	det	18	SENT_48	[p2l1616t1824r1744b1902],
17	oxidative	JJ	O	oxidative	amod	18	SENT_48	[p2l1766t1823r2135b1903],
18	metabolism	NN	O	metabolism	prep_for	13	SENT_48	[p2l10t1952r504b2030],
19	of	IN	O	of	_	0	SENT_48	[p2l549t1951r649b2030],
20	a	DT	O	a	det	22	SENT_48	[p2l674t1978r718b2030],
21	given	VBN	O	give	amod	22	SENT_48	[p2l761t1952r979b2052],
22	drug	NN	O	drug	prep_of	18	SENT_48	[p2l1025t1952r1238b2052],
23	,	,	O	,	_	0	SENT_48	[p2l1025t1952r1238b2052],
24	or	CC	O	or	_	0	SENT_48	[p2l1289t1977r1378b2030],
25	a	DT	O	a	det	26	SENT_48	[p2l1418t1978r1463b2030],
26	variety	NN	O	variety	prep_for	13	SENT_48	[p2l1501t1952r1772b2052],
27	of	IN	O	of	_	0	SENT_48	[p2l1813t1951r1912b2030],
28	cytochrome	NN	O	cytochrome	nn	32	SENT_48	[p2l1939t1968r2135b2052, p2l11t2080r326b2157],
29	P	NN	O	p	nn	32	SENT_48	[p2l348t2085r591b2157],
30	—	CD	NUMBER	—	num	32	SENT_48	[p2l348t2085r591b2157],
31	45O	NN	O	45o	nn	32	SENT_48	[p2l348t2085r591b2157],
32	enzymes	NNS	O	enzyme	prep_of	26	SENT_48	[p2l617t2105r980b2179],
33	may	MD	O	may	aux	34	SENT_48	[p2l1007t2105r1184b2179],
34	contribute	VB	O	contribute	_	0	SENT_48	[p2l1205t2080r1664b2158],
35	.	.	O	.	_	0	SENT_48	[p2l1205t2080r1664b2158],

1	The	DT	O	the	det	2	SENT_49	[p2l136t2207r298b2286],
2	liver	NN	O	liver	nsubj	6	SENT_49	[p2l322t2208r503b2287],
3	is	VBZ	O	be	cop	6	SENT_49	[p2l524t2208r589b2286],
4	the	DT	O	the	det	6	SENT_49	[p2l617t2207r746b2286],
5	major	JJ	O	major	amod	6	SENT_49	[p2l771t2208r1020b2308],
6	site	NN	O	site	_	0	SENT_49	[p2l1044t2208r1185b2286],
7	of	IN	O	of	_	0	SENT_49	[p2l1212t2207r1312b2286],
8	cytochrome	NN	O	cytochrome	nn	9	SENT_49	[p2l1320t2208r1815b2308],
9	P	NN	O	p	prep_of	6	SENT_49	[p2l1839t2213r2137b2286],
10	—	CD	NUMBER	—	number	11	SENT_49	[p2l1839t2213r2137b2286],
11	450	CD	NUMBER	450	num	12	SENT_49	[p2l1839t2213r2137b2286],
12	—	NN	O	—	dep	9	SENT_49	[p2l1839t2213r2137b2286],
13	mediated	VBN	O	mediate	partmod	9	SENT_49	[p2l10t2335r396b2414],
14	metabolism	NN	O	metabolism	dobj	13	SENT_49	[p2l416t2336r936b2431],
15	,	,	O	,	_	0	SENT_49	[p2l416t2336r936b2431],
16	but	CC	O	but	_	0	SENT_49	[p2l963t2336r1103b2415],
17	the	DT	O	the	det	18	SENT_49	[p2l1119t2336r1247b2414],
18	enterocytes	NNS	O	enterocyte	nsubj	31	SENT_49	[p2l1269t2352r1733b2436],
19	in	IN	O	in	_	0	SENT_49	[p2l1755t2336r1836b2413],
20	the	DT	O	the	det	21	SENT_49	[p2l1857t2336r1985b2414],
21	epithelium	NN	O	epithelium	prep_in	18	SENT_49	[p2l2007t2362r2134b2436, p2l10t2464r361b2543],
22	of	IN	O	of	_	0	SENT_49	[p2l385t2463r485b2542],
23	the	DT	O	the	det	25	SENT_49	[p2l490t2464r619b2542],
24	small	JJ	O	small	amod	25	SENT_49	[p2l644t2464r872b2542],
25	intestine	NN	O	intestine	prep_of	21	SENT_49	[p2l895t2464r1259b2542],
26	are	VBP	O	be	cop	31	SENT_49	[p2l1282t2490r1407b2542],
27	also	RB	O	also	advmod	31	SENT_49	[p2l1431t2464r1598b2542],
28	a	DT	O	a	det	31	SENT_49	[p2l1624t2490r1668b2542],
29	potentially	RB	O	potentially	advmod	30	SENT_49	[p2l1688t2463r2139b2564],
30	important	JJ	O	important	amod	31	SENT_49	[p2l10t2592r443b2691],
31	site	NN	O	site	conj_but	6	SENT_49	[p2l473t2592r639b2669],
32	.	.	O	.	_	0	SENT_49	[p2l473t2592r639b2669],

1	CYP3A	NN	O	cyp3a	nsubj	7	SENT_50	[p2l679t2597r987b2686],
2	,	,	O	,	_	0	SENT_50	[p2l679t2597r987b2686],
3	in	IN	O	in	_	0	SENT_50	[p2l1026t2592r1107b2668],
4	particular	JJ	O	particular	prep_in	1	SENT_50	[p2l1140t2592r1567b2691],
5	,	,	O	,	_	0	SENT_50	[p2l1140t2592r1567b2691],
6	is	VBZ	O	be	cop	7	SENT_50	[p2l1607t2592r1671b2669],
7	present	JJ	DATE	present	_	0	SENT_50	[p2l1706t2607r2025b2691],
8	in	IN	O	in	_	0	SENT_50	[p2l2053t2592r2135b2668],
9	these	DT	O	these	det	10	SENT_50	[p2l11t2720r227b2798],
10	enterocytes	NNS	O	enterocyte	prep_in	7	SENT_50	[p2l248t2736r740b2820],
11	.	.	O	.	_	0	SENT_50	[p2l248t2736r740b2820],

1	Thus	RB	O	thus	advmod	46	SENT_51	[p2l763t2719r998b2815],
2	,	,	O	,	_	0	SENT_51	[p2l763t2719r998b2815],
3	after	IN	O	after	_	0	SENT_51	[p2l1024t2719r1215b2798],
4	oral	JJ	O	oral	amod	5	SENT_51	[p2l1233t2719r1393b2798],
5	administration	NN	O	administration	prep_after	46	SENT_51	[p2l1412t2720r2033b2798],
6	of	IN	O	of	_	0	SENT_51	[p2l2054t2719r2154b2798],
7	a	DT	O	a	det	8	SENT_51	[p2l10t2874r54b2926],
8	drug	NN	O	drug	prep_of	5	SENT_51	[p2l73t2848r289b2948],
9	,	,	O	,	_	0	SENT_51	[p2l73t2848r289b2948],
10	cytochrome	NN	O	cytochrome	nn	11	SENT_51	[p2l314t2847r801b2948],
11	P	NN	O	p	appos	8	SENT_51	[p2l820t2853r1059b2926],
12	—	CD	NUMBER	—	number	13	SENT_51	[p2l820t2853r1059b2926],
13	450	CD	NUMBER	450	num	14	SENT_51	[p2l820t2853r1059b2926],
14	enzymes	NNS	O	enzyme	nsubj	24	SENT_51	[p2l1080t2873r1438b2948],
15	located	JJ	O	located	amod	14	SENT_51	[p2l1458t2847r1757b2926],
16	in	IN	O	in	_	0	SENT_51	[p2l1775t2848r1855b2925],
17	the	DT	O	the	det	18	SENT_51	[p2l1875t2848r2003b2926],
18	intestine	NN	O	intestine	prep_in	15	SENT_51	[p2l2022t2848r2134b2925, p2l11t2976r282b3054],
19	and	CC	O	and	_	0	SENT_51	[p2l305t2975r458b3054],
20	in	IN	O	in	_	0	SENT_51	[p2l481t2976r561b3053],
21	the	DT	O	the	det	22	SENT_51	[p2l585t2975r712b3054],
22	liver	NN	O	liver	prep_in	15	SENT_51	[p2l734t2976r911b3055],
23	may	MD	O	may	aux	24	SENT_51	[p2l931t3002r1105b3076],
24	reduce	VB	O	reduce	rcmod	11	SENT_51	[p2l1124t2975r1398b3055],
25	the	DT	O	the	det	26	SENT_51	[p2l1422t2976r1549b3054],
26	portion	NN	O	portion	dobj	24	SENT_51	[p2l1571t2976r1880b3076],
27	of	IN	O	of	_	0	SENT_51	[p2l1904t2975r2003b3054],
28	the	DT	O	the	det	29	SENT_51	[p2l2008t2976r2135b3054],
29	dose	NN	O	dose	prep_of	26	SENT_51	[p2l11t3104r204b3182],
30	that	WDT	O	that	nsubj	31	SENT_51	[p2l232t3104r399b3182],
31	reaches	VBZ	O	reach	rcmod	29	SENT_51	[p2l421t3104r736b3182],
32	the	DT	O	the	det	34	SENT_51	[p2l766t3104r895b3182],
33	systemic	JJ	O	systemic	amod	34	SENT_51	[p2l924t3104r1286b3204],
34	circulation	NN	O	circulation	dobj	31	SENT_51	[p2l1313t3103r1763b3183],
35	(	CD	NUMBER	(	num	34	SENT_51	[p2l1795t3104r1975b3199],
36	i.e.	FW	O	i.e.	dep	34	SENT_51	[p2l1795t3104r1975b3199],
37	,	,	O	,	_	0	SENT_51	[p2l1795t3104r1975b3199],
38	the	DT	O	the	det	40	SENT_51	[p2l2008t3104r2135b3182],
39	bioavailability	NN	O	bioavailability	nn	40	SENT_51	[p2l11t3232r641b3332],
40	)	NN	O	)	conj_and	34	SENT_51	[p2l11t3232r641b3332],
41	and	CC	O	and	_	0	SENT_51	[p2l680t3231r862b3327],
42	,	,	O	,	_	0	SENT_51	[p2l680t3231r862b3327],
43	subsequently	RB	O	subsequently	advmod	34	SENT_51	[p2l904t3231r1485b3332],
44	,	,	O	,	_	0	SENT_51	[p2l904t3231r1485b3332],
45	may	MD	O	may	aux	46	SENT_51	[p2l1525t3258r1704b3332],
46	inﬂuence	VB	O	inﬂuence	_	0	SENT_51	[p2l1733t3231r2133b3311],
47	the	DT	O	the	det	49	SENT_51	[p2l11t3359r142b3438],
48	drug	NN	O	drug	nn	49	SENT_51	[p2l182t3360r382b3460],
49	effects	NNS	O	effect	nsubj	50	SENT_51	[p2l416t3359r686b3438],
50	(	VBP	O	(	ccomp	46	SENT_51	[p2l729t3360r912b3460],
51	Fig	NN	O	fig	dobj	50	SENT_51	[p2l729t3360r912b3460],
52	.	.	O	.	_	0	SENT_51	[p2l729t3360r912b3460],

1	1	CD	NUMBER	1	number	4	SENT_52	[p2l958t3365r1002b3437],
2	and	CC	O	and	_	0	SENT_52	[p2l1039t3360r1194b3438],
3	2	CD	NUMBER	2	num	5	SENT_52	[p2l1230t3365r1308b3451],
4	)	CD	NUMBER	)	num	5	SENT_52	[p2l1230t3365r1308b3451],
5	—	NN	O	—	_	0	SENT_52	[p2l1346t3405r1454b3412],
6	a	DT	O	a	det	7	SENT_52	[p2l1486t3386r1530b3438],
7	phenomenon	NN	O	phenomenon	dep	5	SENT_52	[p2l1564t3360r2135b3460],
8	termed	VBN	O	term	partmod	5	SENT_52	[p2l11t3487r308b3565],
9	ﬁrst	IN	O	ﬁrst	_	0	SENT_52	[p2l341t3486r731b3587],
10	—	CD	NUMBER	—	num	12	SENT_52	[p2l341t3486r731b3587],
11	pass	NN	O	pass	nn	12	SENT_52	[p2l341t3486r731b3587],
12	metabolism	NN	O	metabolism	prep_ﬁrst	8	SENT_52	[p2l767t3484r1341b3565],
13	.7	CD	NUMBER	.7	dobj	8	SENT_52	[p2l767t3484r1341b3565],
14	Less	RBR	O	less	advmod	13	SENT_52	[p2l1373t3494r1554b3565],
15	than	IN	O	than	_	0	SENT_52	[p2l1590t3487r1777b3565],
16	half	PDT	O	half	predet	17	SENT_52	[p2l1811t3486r1990b3565],
17	the	DT	O	the	prep_than	13	SENT_52	[p2l2005t3487r2134b3565],
18	administered	VBN	O	administer	partmod	13	SENT_52	[p2l10t3616r567b3694],
19	oral	JJ	O	oral	amod	20	SENT_52	[p2l590t3615r752b3694],
20	dose	NN	O	dose	dobj	18	SENT_52	[p2l774t3616r967b3694],
21	of	IN	O	of	prep	20	SENT_52	[p2l990t3615r1091b3694],
22	about	IN	O	about	pcomp	21	SENT_52	[p2l1093t3616r1338b3695],
23	40	CD	PERCENT	40	num	24	SENT_52	[p2l1353t3621r1455b3694],
24	percent	NN	PERCENT	percent	pobj	22	SENT_52	[p2l1476t3632r1797b3716],
25	of	IN	O	of	prep	24	SENT_52	[p2l1815t3615r1915b3694],
26	commonly	RB	O	commonly	pcomp	25	SENT_52	[p2l1919t3641r2133b3694, p3l10t20r277b121],

1	used	VBN	O	use	amod	2	SENT_53	[p3l296t20r490b100],
2	drugs	NNS	O	drug	nsubj	4	SENT_53	[p3l513t21r748b121],
3	is	VBZ	O	be	cop	4	SENT_53	[p3l773t21r837b99],
4	bioavailable	JJ	O	bioavailable	_	0	SENT_53	[p3l864t20r1358b100],
5	because	IN	O	because	_	0	SENT_53	[p3l1382t21r1711b100],
6	of	IN	O	of	prepc_because_of	4	SENT_53	[p3l1736t20r1835b99],
7	limited	JJ	O	limited	amod	8	SENT_53	[p3l1839t20r2135b99],
8	absorption	NN	O	absorption	pobj	4	SENT_53	[p3l10t148r504b249],
9	,	,	O	,	_	0	SENT_53	[p3l10t148r504b249],
10	f1rst	CD	NUMBER	f1rst	number	11	SENT_53	[p3l535t148r935b249],
11	—	CD	NUMBER	—	num	13	SENT_53	[p3l535t148r935b249],
12	pass	NN	O	pass	nn	13	SENT_53	[p3l535t148r935b249],
13	metabolism	NN	O	metabolism	appos	8	SENT_53	[p3l963t148r1503b244],
14	,	,	O	,	_	0	SENT_53	[p3l963t148r1503b244],
15	or	CC	O	or	_	0	SENT_53	[p3l1534t174r1624b227],
16	both	DT	O	both	appos	8	SENT_53	[p3l1648t149r1844b227],
17	(	RB	O	(	dep	18	SENT_53	[p3l1874t149r2133b240],
18	Table	NNP	O	Table	dep	16	SENT_53	[p3l1874t149r2133b240],
19	1	CD	NUMBER	1	number	20	SENT_53	[p3l14t282r118b368],
20	)	CD	NUMBER	)	num	18	SENT_53	[p3l14t282r118b368],
21	.	.	O	.	_	0	SENT_53	[p3l14t282r118b368],

1	Drug	NN	O	drug	nn	2	SENT_54	[p3l145t283r367b377],
2	interactions	NNS	O	interaction	nsubj	23	SENT_54	[p3l386t277r898b355],
3	resulting	VBG	O	result	partmod	2	SENT_54	[p3l923t277r1311b377],
4	in	IN	O	in	_	0	SENT_54	[p3l1330t277r1412b354],
5	either	CC	O	either	preconj	6	SENT_54	[p3l1435t276r1684b355],
6	inhibition	NN	O	inhibition	prep_in	3	SENT_54	[p3l1703t277r2134b355],
7	or	CC	O	or	_	0	SENT_54	[p3l11t430r101b483],
8	induction	NN	O	induction	prep_in	3	SENT_54	[p3l136t404r552b484],
9	of	IN	O	of	_	0	SENT_54	[p3l591t404r692b483],
10	the	DT	O	the	det	12	SENT_54	[p3l713t405r844b483],
11	involved	VBN	O	involve	amod	12	SENT_54	[p3l882t404r1240b484],
12	enzymes	NNS	O	enzyme	prep_of	3	SENT_54	[p3l1279t430r1675b505],
13	,	,	O	,	_	0	SENT_54	[p3l1279t430r1675b505],
14	especially	RB	O	especially	advmod	2	SENT_54	[p3l1720t405r2138b505],
15	those	DT	O	those	dep	2	SENT_54	[p3l11t532r233b611],
16	in	IN	O	in	_	0	SENT_54	[p3l263t533r343b610],
17	the	DT	O	the	det	19	SENT_54	[p3l373t533r500b611],
18	intestinal	JJ	O	intestinal	amod	19	SENT_54	[p3l529t532r913b611],
19	epithelium	NN	O	epithelium	prep_in	15	SENT_54	[p3l943t532r1412b633],
20	,	,	O	,	_	0	SENT_54	[p3l943t532r1412b633],
21	can	MD	O	can	aux	23	SENT_54	[p3l1448t558r1590b611],
22	markedly	RB	O	markedly	advmod	23	SENT_54	[p3l1620t532r2008b633],
23	alter	VB	O	alter	_	0	SENT_54	[p3l2033t533r2135b611, p3l11t677r121b739],
24	oral	JJ	O	oral	amod	25	SENT_54	[p3l161t661r321b739],
25	bioavailability	NN	O	bioavailability	dobj	23	SENT_54	[p3l365t661r948b761],
26	(	CD	NUMBER	(	num	27	SENT_54	[p3l990t661r1171b761],
27	Fig	NN	O	fig	dep	25	SENT_54	[p3l990t661r1171b761],
28	.	.	O	.	_	0	SENT_54	[p3l990t661r1171b761],

1	1	CD	NUMBER	1	_	0	SENT_55	[p3l1222t666r1267b738],
2	and	CC	O	and	_	0	SENT_55	[p3l1309t660r1463b739],
3	3	CD	NUMBER	3	conj_and	1	SENT_55	[p3l1506t666r1610b752],
4	)	NN	O	)	dep	1	SENT_55	[p3l1506t666r1610b752],
5	.	.	O	.	_	0	SENT_55	[p3l1506t666r1610b752],

1	Differences	NNS	O	difference	nsubj	13	SENT_56	[p3l1656t660r2133b739],
2	among	IN	O	among	_	0	SENT_56	[p3l10t814r307b889],
3	patients	NNS	O	patient	prep_among	1	SENT_56	[p3l325t789r655b889],
4	in	IN	O	in	_	0	SENT_56	[p3l679t789r760b866],
5	drug	NN	O	drug	nn	6	SENT_56	[p3l783t789r980b889],
6	metabolism	NN	O	metabolism	prep_in	3	SENT_56	[p3l1000t788r1500b867],
7	in	IN	O	in	_	0	SENT_56	[p3l1522t789r1602b866],
8	the	DT	O	the	det	9	SENT_56	[p3l1625t789r1753b867],
9	intestine	NN	O	intestine	prep_in	6	SENT_56	[p3l1776t789r2135b867],
10	and	CC	O	and	_	0	SENT_56	[p3l10t915r165b994],
11	liver	NN	O	liver	prep_in	6	SENT_56	[p3l199t915r380b994],
12	are	VBP	O	be	cop	13	SENT_56	[p3l412t942r538b993],
13	common	JJ	O	common	_	0	SENT_56	[p3l575t941r978b1010],
14	,	,	O	,	_	0	SENT_56	[p3l575t941r978b1010],
15	are	VBP	O	be	cop	17	SENT_56	[p3l1019t942r1144b993],
16	often	RB	O	often	advmod	17	SENT_56	[p3l1181t915r1397b994],
17	marked	JJ	O	marked	conj_and	13	SENT_56	[p3l1433t916r1778b1010],
18	,	,	O	,	_	0	SENT_56	[p3l1433t916r1778b1010],
19	and	CC	O	and	_	0	SENT_56	[p3l1818t915r1974b994],
20	are	VBP	O	be	conj_and	13	SENT_56	[p3l2008t942r2134b993],
21	frequently	RB	O	frequently	advmod	20	SENT_56	[p3l10t1043r440b1144],
22	major	JJ	O	major	amod	23	SENT_56	[p3l456t1044r703b1144],
23	contributors	NNS	O	contributor	pobj	21	SENT_56	[p3l722t1044r1238b1123],
24	to	TO	O	to	_	0	SENT_56	[p3l1260t1060r1339b1122],
25	differences	NNS	O	difference	prep_to	21	SENT_56	[p3l1361t1043r1818b1122],
26	in	IN	O	in	_	0	SENT_56	[p3l1839t1044r1920b1121],
27	drug	NN	O	drug	nn	28	SENT_56	[p3l1941t1044r2139b1144],
28	response	NN	O	response	prep_in	20	SENT_56	[p3l10t1197r409b1272],
29	,	,	O	,	_	0	SENT_56	[p3l10t1197r409b1272],
30	including	VBG	O	include	conj_and	13	SENT_56	[p3l437t1171r845b1272],
31	adverse	JJ	O	adverse	amod	32	SENT_56	[p3l865t1172r1179b1251],
32	effects	NNS	O	effect	pobj	30	SENT_56	[p3l1205t1171r1500b1250],
33	.	.	O	.	_	0	SENT_56	[p3l1205t1171r1500b1250],

1	DRUG	NN	O	drug	nn	2	SENT_57	[p3l237t1487r553b1546],
2	METABOLISM	NN	O	metabolism	_	0	SENT_57	[p3l604t1487r1345b1547],
3	BY	IN	O	by	dep	2	SENT_57	[p3l1401t1487r1522b1546],
4	CYP3A	NN	O	cyp3a	pobj	3	SENT_57	[p3l1569t1487r1902b1550],

1	The	DT	O	the	det	3	SENT_58	[p3l7t1683r167b1761],
2	CYP3A	NN	O	cyp3a	nn	3	SENT_58	[p3l190t1688r476b1761],
3	family	NN	O	family	nsubj	10	SENT_58	[p3l495t1682r758b1783],
4	of	IN	O	of	_	0	SENT_58	[p3l777t1682r877b1761],
5	P	NN	O	p	prep_of	3	SENT_58	[p3l879t1688r1121b1761],
6	—	CD	NUMBER	—	number	7	SENT_58	[p3l879t1688r1121b1761],
7	450	CD	NUMBER	450	num	8	SENT_58	[p3l879t1688r1121b1761],
8	enzymes	NNS	O	enzyme	dep	5	SENT_58	[p3l1145t1708r1504b1783],
9	collectively	RB	O	collectively	advmod	10	SENT_58	[p3l1530t1682r1987b1783],
10	describes	VBZ	O	describe	_	0	SENT_58	[p3l2007t1683r2134b1761, p3l12t1810r296b1889],
11	metabolism	NN	O	metabolism	nsubj	24	SENT_58	[p3l318t1810r815b1889],
12	that	IN	O	that	nsubj	13	SENT_58	[p3l835t1811r999b1889],
13	occurs	VBZ	O	occur	rcmod	11	SENT_58	[p3l1015t1836r1282b1890],
14	essentially	RB	O	essentially	advmod	13	SENT_58	[p3l1305t1811r1736b1911],
15	by	IN	O	by	_	0	SENT_58	[p3l1751t1811r1847b1911],
16	means	NNS	O	means	_	0	SENT_58	[p3l1862t1836r2133b1889],
17	of	IN	O	of	_	0	SENT_58	[p3l11t1938r112b2017],
18	two	CD	NUMBER	two	num	19	SENT_58	[p3l149t1955r303b2018],
19	enzymes	NNS	O	enzyme	prep_by_means_of	13	SENT_58	[p3l360t1964r729b2039],
20	With	IN	O	with	_	0	SENT_58	[p3l781t1939r974b2018],
21	substrate	NN	O	substrate	nn	22	SENT_58	[p3l1030t1939r1422b2018],
22	specificities	NNS	O	specificity	prep_with	19	SENT_58	[p3l1478t1938r1983b2039],
23	so	RB	O	so	advmod	24	SENT_58	[p3l2041t1964r2132b2017],
24	similar	JJ	O	similar	xcomp	10	SENT_58	[p3l12t2066r313b2145],
25	that	IN	O	that	complm	31	SENT_58	[p3l335t2067r504b2145],
26	they	PRP	O	they	nsubjpass	31	SENT_58	[p3l523t2067r703b2167],
27	can	MD	O	can	aux	31	SENT_58	[p3l723t2083r1021b2145],
28	not	RB	O	not	neg	31	SENT_58	[p3l723t2083r1021b2145],
29	be	VB	O	be	auxpass	31	SENT_58	[p3l1040t2067r1136b2145],
30	easily	RB	O	easily	advmod	31	SENT_58	[p3l1162t2066r1401b2167],
31	distinguished	VBN	O	distinguish	ccomp	24	SENT_58	[p3l1421t2066r2010b2167],
32	—	NN	O	—	nn	33	SENT_58	[p3l2030t2111r2138b2119],
33	CYP3A4	NN	O	cyp3a4	dobj	31	SENT_58	[p3l10t2199r353b2272],
34	and	CC	O	and	_	0	SENT_58	[p3l375t2194r556b2288],
35	,	,	O	,	_	0	SENT_58	[p3l375t2194r556b2288],
36	to	TO	O	to	dep	33	SENT_58	[p3l582t2210r661b2272],
37	a	DT	O	a	det	39	SENT_58	[p3l683t2220r727b2271],
38	lesser	JJR	O	lesser	amod	39	SENT_58	[p3l745t2193r988b2271],
39	extent	NN	O	extent	pobj	36	SENT_58	[p3l1007t2210r1284b2288],
40	,	,	O	,	_	0	SENT_58	[p3l1007t2210r1284b2288],
41	CYP3A5	NN	O	cyp3a5	conj_and	33	SENT_58	[p3l1310t2199r1672b2272],
42	.	.	O	.	_	0	SENT_58	[p3l1310t2199r1672b2272],

1	(	NN	O	(	nn	3	SENT_59	[p3l1702t2193r1890b2284],
2	The	DT	O	the	det	3	SENT_59	[p3l1702t2193r1890b2284],
3	activity	NN	O	activity	nsubj	19	SENT_59	[p3l1911t2194r2133b2272, p3l10t2322r112b2422],
4	of	IN	O	of	_	0	SENT_59	[p3l137t2321r237b2400],
5	other	JJ	O	other	amod	6	SENT_59	[p3l249t2322r473b2400],
6	members	NNS	O	member	prep_of	3	SENT_59	[p3l500t2322r895b2400],
7	of	IN	O	of	_	0	SENT_59	[p3l927t2321r1028b2400],
8	the	DT	O	the	det	10	SENT_59	[p3l1039t2322r1168b2400],
9	CYP3A	NN	O	cyp3a	nn	10	SENT_59	[p3l1198t2327r1486b2400],
10	family	NN	O	family	prep_of	6	SENT_59	[p3l1512t2321r1789b2422],
11	,	,	O	,	_	0	SENT_59	[p3l1512t2321r1789b2422],
12	such	JJ	O	such	_	0	SENT_59	[p3l1825t2322r2020b2401],
13	as	IN	O	as	_	0	SENT_59	[p3l2048t2348r2132b2400],
14	CYP3A43	NN	O	cyp3a43	prep_such_as	3	SENT_59	[p3l10t2455r424b2545],
15	,	,	O	,	_	0	SENT_59	[p3l10t2455r424b2545],
16	is	VBZ	O	be	cop	19	SENT_59	[p3l458t2450r523b2528],
17	either	CC	O	either	advmod	19	SENT_59	[p3l555t2450r798b2528],
18	extremely	RB	O	extremely	advmod	19	SENT_59	[p3l824t2449r1234b2550],
19	low	JJ	O	low	_	0	SENT_59	[p3l1257t2450r1413b2529],
20	or	CC	O	or	_	0	SENT_59	[p3l1439t2475r1544b2545],
21	,	,	O	,	_	0	SENT_59	[p3l1439t2475r1544b2545],
22	in	IN	O	in	dep	19	SENT_59	[p3l1578t2450r1659b2527],
23	the	DT	O	the	det	24	SENT_59	[p3l1688t2450r1817b2528],
24	case	NN	O	case	pobj	22	SENT_59	[p3l1847t2476r2023b2528],
25	of	IN	O	of	_	0	SENT_59	[p3l2053t2449r2153b2528],
26	CYP3A7	NN	O	cyp3a7	prep_of	24	SENT_59	[p3l10t2583r378b2673],
27	,	,	O	,	_	0	SENT_59	[p3l10t2583r378b2673],
28	present	JJ	DATE	present	conj_or	19	SENT_59	[p3l424t2594r750b2678],
29	primarily	RB	O	primarily	advmod	19	SENT_59	[p3l785t2578r1186b2678],
30	in	IN	O	in	_	0	SENT_59	[p3l1223t2578r1305b2655],
31	fetuses	NNS	O	fetus	prep_in	19	SENT_59	[p3l1348t2577r1645b2657],
32	but	CC	O	but	_	0	SENT_59	[p3l1690t2577r1833b2657],
33	not	RB	O	not	_	0	SENT_59	[p3l1870t2594r2015b2656],
34	in	IN	O	in	_	0	SENT_59	[p3l2051t2578r2134b2655],
35	adults	NNS	O	adult	dep	19	SENT_59	[p3l10t2705r317b2797],
36	.	.	O	.	_	0	SENT_59	[p3l10t2705r317b2797],
37	)	SYM	O	)	dep	19	SENT_59	[p3l10t2705r317b2797],

1	CYP3A	NN	O	cyp3a	nsubj	6	SENT_60	[p3l343t2711r628b2784],
2	is	VBZ	O	be	cop	6	SENT_60	[p3l645t2706r708b2784],
3	probably	RB	O	probably	advmod	6	SENT_60	[p3l730t2706r1101b2806],
4	the	DT	O	the	det	6	SENT_60	[p3l1118t2706r1245b2784],
5	most	RBS	O	most	advmod	6	SENT_60	[p3l1266t2722r1480b2784],
6	important	JJ	O	important	_	0	SENT_60	[p3l1495t2706r1922b2806],
7	of	IN	O	of	_	0	SENT_60	[p3l1938t2705r2037b2784],
8	all	DT	O	all	det	10	SENT_60	[p3l2039t2706r2136b2784],
9	drug	NN	O	drug	nn	10	SENT_60	[p3l11t2834r812b2934],
10	—	NN	O	—	prep_of	6	SENT_60	[p3l11t2834r812b2934],
11	metabolizing	VBG	O	metabolize	partmod	10	SENT_60	[p3l11t2834r812b2934],
12	enzymes	NNS	O	enzyme	dobj	11	SENT_60	[p3l830t2859r1193b2934],
13	because	IN	O	because	mark	16	SENT_60	[p3l1217t2834r1549b2913],
14	it	PRP	O	it	nsubj	16	SENT_60	[p3l1570t2834r1630b2912],
15	is	VBZ	O	be	cop	16	SENT_60	[p3l1646t2834r1711b2912],
16	abundant	JJ	O	abundant	dep	11	SENT_60	[p3l1733t2834r2140b2913],
17	in	IN	O	in	_	0	SENT_60	[p3l10t2962r91b3039],
18	both	CC	O	both	prep_in	16	SENT_60	[p3l130t2961r322b3040],
19	the	DT	O	the	det	21	SENT_60	[p3l361t2961r490b3040],
20	intestinal	JJ	O	intestinal	amod	21	SENT_60	[p3l527t2962r921b3040],
21	epithelium	NN	O	epithelium	dep	11	SENT_60	[p3l959t2962r1416b3062],
22	and	CC	O	and	_	0	SENT_60	[p3l1454t2961r1610b3040],
23	in	IN	O	in	_	0	SENT_60	[p3l1647t2962r1727b3039],
24	the	DT	O	the	det	25	SENT_60	[p3l1766t2962r1895b3040],
25	liver	NN	O	liver	conj_and	18	SENT_60	[p3l1932t2961r2130b3057],
26	,	,	O	,	_	0	SENT_60	[p3l1932t2961r2130b3057],
27	Where	WRB	O	where	advmod	29	SENT_60	[p3l6t3090r265b3169],
28	it	PRP	O	it	nsubj	29	SENT_60	[p3l291t3090r351b3168],
29	accounts	VBZ	O	account	rcmod	25	SENT_60	[p3l371t3106r744b3169],
30	for	IN	O	for	_	0	SENT_60	[p3l772t3089r895b3168],
31	nearly	RB	O	nearly	quantmod	32	SENT_60	[p3l918t3089r1177b3190],
32	50	CD	PERCENT	50	num	33	SENT_60	[p3l1201t3095r1299b3168],
33	percent	NN	PERCENT	percent	prep_for	29	SENT_60	[p3l1325t3106r1646b3190],
34	of	IN	O	of	_	0	SENT_60	[p3l1668t3089r1768b3168],
35	the	DT	O	the	det	40	SENT_60	[p3l1776t3090r1905b3168],
36	cytochrome	NN	O	cytochrome	nn	40	SENT_60	[p3l1933t3106r2134b3190, p3l11t3218r330b3296],
37	P	NN	O	p	nn	40	SENT_60	[p3l352t3223r592b3296],
38	—	CD	NUMBER	—	num	40	SENT_60	[p3l352t3223r592b3296],
39	45O	NN	O	45o	nn	40	SENT_60	[p3l352t3223r592b3296],
40	enzymes	NNS	O	enzyme	prep_of	33	SENT_60	[p3l616t3243r1001b3318],
41	,	,	O	,	_	0	SENT_60	[p3l616t3243r1001b3318],
42	and	CC	O	and	_	0	SENT_60	[p3l1029t3217r1183b3296],
43	because	IN	O	because	mark	45	SENT_60	[p3l1206t3217r1535b3297],
44	it	PRP	O	it	nsubj	45	SENT_60	[p3l1557t3218r1616b3296],
45	has	VBZ	O	have	dep	11	SENT_60	[p3l1634t3218r1774b3296],
46	the	DT	O	the	det	47	SENT_60	[p3l1799t3218r1927b3296],
47	ability	NN	O	ability	dobj	45	SENT_60	[p3l1949t3217r2134b3296, p3l10t3346r112b3446],
48	to	TO	O	to	aux	49	SENT_60	[p3l131t3362r210b3424],
49	metabolize	VBZ	O	metabolize	infmod	47	SENT_60	[p3l234t3346r702b3424],
50	a	DT	O	a	det	51	SENT_60	[p3l726t3372r770b3424],
51	multitude	NN	O	multitude	dobj	49	SENT_60	[p3l791t3345r1202b3425],
52	of	IN	O	of	_	0	SENT_60	[p3l1226t3345r1327b3424],
53	chemically	RB	O	chemically	advmod	54	SENT_60	[p3l1332t3346r1785b3446],
54	unrelated	JJ	O	unrelated	amod	55	SENT_60	[p3l1803t3345r2134b3425, p3l11t3473r107b3552],
55	drugs	NNS	O	drug	prep_of	51	SENT_60	[p3l128t3474r363b3574],
56	from	IN	O	from	_	0	SENT_60	[p3l385t3473r592b3552],
57	almost	RB	O	almost	advmod	59	SENT_60	[p3l611t3474r901b3552],
58	every	DT	O	every	det	59	SENT_60	[p3l917t3500r1129b3574],
59	drug	NN	O	drug	prep_from	49	SENT_60	[p3l1146t3474r1344b3574],
60	class	NN	O	class	nn	62	SENT_60	[p3l1362t3473r1558b3552],
61	(	CD	NUMBER	(	num	62	SENT_60	[p3l1586t3473r1837b3565],
62	Table	NNP	O	Table	dep	59	SENT_60	[p3l1586t3473r1837b3565],
63	2	CD	NUMBER	2	number	64	SENT_60	[p3l1859t3479r1964b3565],
64	)	CD	NUMBER	)	dep	62	SENT_60	[p3l1859t3479r1964b3565],
65	.	.	O	.	_	0	SENT_60	[p3l1859t3479r1964b3565],

1	It	PRP	O	it	nsubj	3	SENT_61	[p3l1989t3481r2054b3552],
2	is	VBZ	O	be	cop	3	SENT_61	[p3l2069t3474r2134b3552],
3	likely	JJ	O	likely	_	0	SENT_61	[p3l9t3602r236b3702],
4	that	IN	O	that	complm	7	SENT_61	[p3l262t3602r428b3680],
5	CYP3A	NN	O	cyp3a	nsubjpass	7	SENT_61	[p3l454t3607r742b3680],
6	is	VBZ	O	be	auxpass	7	SENT_61	[p3l768t3602r833b3680],
7	involved	VBN	O	involve	ccomp	3	SENT_61	[p3l865t3601r1215b3681],
8	in	IN	O	in	_	0	SENT_61	[p3l1245t3602r1326b3679],
9	the	DT	O	the	det	10	SENT_61	[p3l1357t3602r1486b3680],
10	metabolism	NN	O	metabolism	prep_in	7	SENT_61	[p3l1517t3601r2022b3680],
11	of	IN	O	of	_	0	SENT_61	[p3l2053t3601r2153b3680],
12	more	JJR	O	more	quantmod	14	SENT_61	[p4l10t46r230b99],
13	than	IN	O	than	quantmod	14	SENT_61	[p4l254t20r441b99],
14	half	PDT	O	half	prep_of	10	SENT_61	[p4l464t20r644b99],
15	the	DT	O	the	det	17	SENT_61	[p4l648t20r777b99],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_61	[p4l801t20r1276b121],
17	agents	NNS	O	agent	dobj	7	SENT_61	[p4l1297t37r1570b121],
18	that	WDT	O	that	nsubj	19	SENT_61	[p4l1596t21r1762b99],
19	undergo	VBP	O	undergo	rcmod	17	SENT_61	[p4l1780t20r2134b121],
20	alteration	NN	O	alteration	dobj	19	SENT_61	[p4l10t148r413b227],
21	by	IN	O	by	_	0	SENT_61	[p4l438t149r535b249],
22	oxidation	NN	O	oxidation	prep_by	19	SENT_61	[p4l557t149r978b227],
23	.	.	O	.	_	0	SENT_61	[p4l557t149r978b227],

1	The	DT	O	the	det	2	SENT_62	[p4l136t276r298b355],
2	activity	NN	O	activity	nsubj	6	SENT_62	[p4l323t277r619b377],
3	of	IN	O	of	_	0	SENT_62	[p4l641t276r742b355],
4	CYP3A	NN	O	cyp3a	prep_of	2	SENT_62	[p4l749t282r1037b355],
5	can	MD	O	can	aux	6	SENT_62	[p4l1060t302r1205b355],
6	vary	VB	O	vary	_	0	SENT_62	[p4l1226t303r1400b377],
7	markedly	RB	O	markedly	advmod	6	SENT_62	[p4l1421t276r1818b377],
8	among	IN	O	among	_	0	SENT_62	[p4l1838t302r2138b377],
9	members	NNS	O	member	prep_among	7	SENT_62	[p4l10t405r406b483],
10	of	IN	O	of	_	0	SENT_62	[p4l430t404r531b483],
11	a	DT	O	a	det	13	SENT_62	[p4l534t431r578b483],
12	given	VBN	O	give	amod	13	SENT_62	[p4l598t405r822b505],
13	population	NN	O	population	prep_of	9	SENT_62	[p4l843t405r1330b505],
14	,	,	O	,	_	0	SENT_62	[p4l843t405r1330b505],
15	but	CC	O	but	_	0	SENT_62	[p4l1358t404r1499b484],
16	its	PRP$	O	its	poss	17	SENT_62	[p4l1515t405r1611b483],
17	distribution	NN	O	distribution	nsubj	19	SENT_62	[p4l1637t404r2135b484],
18	is	VBZ	O	be	cop	19	SENT_62	[p4l10t533r76b611],
19	continuous	JJ	O	continuous	conj_but	6	SENT_62	[p4l119t533r602b612],
20	and	CC	O	and	_	0	SENT_62	[p4l644t533r802b611],
21	unimodal	JJ	O	unimodal	conj_and	19	SENT_62	[p4l842t533r1281b612],
22	.	.	O	.	_	0	SENT_62	[p4l842t533r1281b612],

1	This	DT	O	this	nsubj	2	SENT_63	[p4l1324t533r1512b611],
2	suggests	VBZ	O	suggest	_	0	SENT_63	[p4l1557t549r1926b633],
3	that	IN	O	that	complm	7	SENT_63	[p4l1969t533r2139b611],
4	multiple	JJ	O	multiple	amod	5	SENT_63	[p4l10t660r360b761],
5	genes	NNS	O	gene	nsubjpass	7	SENT_63	[p4l380t686r619b761],
6	are	VBP	O	be	auxpass	7	SENT_63	[p4l641t687r766b739],
7	involved	VBN	O	involve	ccomp	2	SENT_63	[p4l786t661r1132b740],
8	in	IN	O	in	_	0	SENT_63	[p4l1152t661r1232b738],
9	its	PRP$	O	its	poss	10	SENT_63	[p4l1252t661r1347b739],
10	regulation	NN	O	regulation	prep_in	7	SENT_63	[p4l1370t660r1798b761],
11	but	CC	O	but	_	0	SENT_63	[p4l1820t660r1960b740],
12	that	IN	O	that	complm	16	SENT_63	[p4l1976t661r2140b739],
13	individual	JJ	O	individual	amod	15	SENT_63	[p4l10t789r425b868],
14	genetic	JJ	O	genetic	amod	15	SENT_63	[p4l445t789r745b889],
15	factors	NNS	O	factor	nsubj	16	SENT_63	[p4l765t788r1046b867],
16	play	VBP	O	play	ccomp	2	SENT_63	[p4l1068t788r1241b889],
17	a	DT	O	a	det	19	SENT_63	[p4l1256t815r1300b867],
18	minor	JJ	O	minor	amod	19	SENT_63	[p4l1319t789r1579b867],
19	role	NN	O	role	dobj	16	SENT_63	[p4l1597t789r1779b867],
20	.	.	O	.	_	0	SENT_63	[p4l1597t789r1779b867],

1	Though	IN	O	though	mark	6	SENT_64	[p4l1802t789r2135b889],
2	constitutive	JJ	O	constitutive	amod	3	SENT_64	[p4l11t917r498b996],
3	variability	NN	O	variability	nsubj	6	SENT_64	[p4l523t916r942b1017],
4	is	VBZ	O	be	cop	6	SENT_64	[p4l965t917r1029b995],
5	about	IN	O	about	dep	6	SENT_64	[p4l1060t916r1304b996],
6	ﬁvefold	JJ	O	ﬁvefold	advcl	12	SENT_64	[p4l1327t916r1666b1012],
7	,	,	O	,	_	0	SENT_64	[p4l1327t916r1666b1012],
8	CYP3A	NN	O	cyp3a	nn	9	SENT_64	[p4l1700t922r1988b995],
9	activity	NN	O	activity	nsubjpass	12	SENT_64	[p4l2012t943r2134b995, p4l11t1045r210b1145],
10	is	VBZ	O	be	auxpass	12	SENT_64	[p4l228t1045r292b1123],
11	readily	RB	O	readily	advmod	12	SENT_64	[p4l317t1045r597b1145],
12	modulated	VBN	O	modulate	_	0	SENT_64	[p4l615t1044r1065b1124],
13	by	IN	O	by	_	0	SENT_64	[p4l1088t1045r1184b1145],
14	several	JJ	O	several	amod	15	SENT_64	[p4l1203t1045r1485b1124],
15	factors	NNS	O	factor	agent	12	SENT_64	[p4l1506t1044r1813b1140],
16	,	,	O	,	_	0	SENT_64	[p4l1506t1044r1813b1140],
17	includ	JJ	O	includ	amod	21	SENT_64	[p4l1840t1044r2134b1124],
18	—	NN	O	—	nn	21	SENT_64	[p4l1840t1044r2134b1124],
19	ing	NN	O	ing	nn	21	SENT_64	[p4l10t1173r148b1273],
20	drug	NN	O	drug	nn	21	SENT_64	[p4l170t1172r369b1273],
21	administration	NN	O	administration	appos	15	SENT_64	[p4l390t1173r1041b1251],
22	.	.	O	.	_	0	SENT_64	[p4l390t1173r1041b1251],

1	Drug	NN	O	drug	nn	2	SENT_65	[p4l138t1307r357b1401],
2	interactions	NNS	O	interaction	nsubj	11	SENT_65	[p4l403t1301r903b1379],
3	may	MD	O	may	aux	4	SENT_65	[p4l956t1327r1133b1401],
4	reduce	VB	O	reduce	_	0	SENT_65	[p4l1179t1300r1458b1380],
5	CYP3A	NN	O	cyp3a	nn	6	SENT_65	[p4l1509t1306r1797b1379],
6	activity	NN	O	activity	dobj	4	SENT_65	[p4l1843t1301r2139b1401],
7	through	IN	O	through	_	0	SENT_65	[p4l11t1428r349b1529],
8	inhibition	NN	O	inhibition	prep_through	4	SENT_65	[p4l371t1429r787b1507],
9	or	CC	O	or	_	0	SENT_65	[p4l811t1454r899b1507],
10	may	MD	O	may	aux	11	SENT_65	[p4l919t1455r1094b1529],
11	increase	VB	O	increase	conj_or	4	SENT_65	[p4l1112t1429r1454b1507],
12	metabolic	JJ	O	metabolic	amod	13	SENT_65	[p4l1477t1428r1893b1507],
13	activity	NN	O	activity	dobj	11	SENT_65	[p4l1914t1429r2134b1508, p4l10t1557r110b1657],
14	through	IN	O	through	_	0	SENT_65	[p4l127t1557r464b1657],
15	induction	NN	O	induction	prep_through	11	SENT_65	[p4l484t1556r908b1636],
16	.	.	O	.	_	0	SENT_65	[p4l484t1556r908b1636],

1	Such	JJ	O	such	amod	2	SENT_66	[p4l936t1556r1137b1636],
2	interactions	NNS	O	interaction	nsubj	4	SENT_66	[p4l1158t1557r1648b1635],
3	can	MD	O	can	aux	4	SENT_66	[p4l1673t1582r1815b1635],
4	expand	VB	O	expand	_	0	SENT_66	[p4l1837t1556r2136b1657],
5	the	DT	O	the	det	6	SENT_66	[p4l11t1685r139b1763],
6	range	NN	O	range	dobj	4	SENT_66	[p4l166t1710r402b1785],
7	of	IN	O	of	_	0	SENT_66	[p4l429t1684r530b1763],
8	variability	NN	O	variability	prep_of	6	SENT_66	[p4l532t1685r951b1785],
9	to	TO	O	to	aux	14	SENT_66	[p4l972t1701r1051b1763],
10	about	IN	O	about	_	0	SENT_66	[p4l1078t1685r1321b1764],
11	4OO	NN	O	4oo	prep_about	14	SENT_66	[p4l1340t1679r1874b1763],
12	—	CD	NUMBER	—	num	14	SENT_66	[p4l1340t1679r1874b1763],
13	fold	JJ	O	fold	amod	14	SENT_66	[p4l1340t1679r1874b1763],
14	.9	NN	NUMBER	.9	xcomp	4	SENT_66	[p4l1340t1679r1874b1763],
15	>	JJR	O	>	nsubj	36	SENT_66	[p4l1340t1679r1874b1763],
16	1	CD	NUMBER	1	num	17	SENT_66	[p4l1340t1679r1874b1763],
17	°	NN	O	°	tmod	15	SENT_66	[p4l1340t1679r1874b1763],
18	However	RB	O	however	advmod	17	SENT_66	[p4l1899t1692r2133b1764, p4l11t1839r194b1908],
19	,	,	O	,	_	0	SENT_66	[p4l1899t1692r2133b1764, p4l11t1839r194b1908],
20	such	JJ	O	such	amod	21	SENT_66	[p4l225t1813r418b1892],
21	differences	NNS	O	difference	appos	15	SENT_66	[p4l442t1812r899b1891],
22	in	IN	O	in	_	0	SENT_66	[p4l923t1813r1005b1890],
23	metabolism	NN	O	metabolism	prep_in	21	SENT_66	[p4l1028t1813r1551b1908],
24	,	,	O	,	_	0	SENT_66	[p4l1028t1813r1551b1908],
25	together	RB	O	together	advmod	15	SENT_66	[p4l1580t1813r1932b1913],
26	with	IN	O	with	amod	15	SENT_66	[p4l1948t1813r2135b1892],
27	associated	VBN	O	associate	amod	28	SENT_66	[p4l10t1940r446b2019],
28	differences	NNS	O	difference	dep	15	SENT_66	[p4l485t1940r948b2019],
29	in	IN	O	in	_	0	SENT_66	[p4l988t1941r1069b2018],
30	plasma	NN	O	plasma	nn	32	SENT_66	[p4l1105t1941r1413b2041],
31	drug	NN	O	drug	nn	32	SENT_66	[p4l1450t1940r1650b2041],
32	concentrations	NNS	O	concentration	prep_in	28	SENT_66	[p4l1685t1957r2134b2019, p4l11t2069r239b2164],
33	,	,	O	,	_	0	SENT_66	[p4l1685t1957r2134b2019, p4l11t2069r239b2164],
34	do	VBP	O	do	aux	36	SENT_66	[p4l266t2069r367b2147],
35	not	RB	O	not	neg	36	SENT_66	[p4l389t2085r531b2147],
36	translate	VB	O	translate	rcmod	14	SENT_66	[p4l548t2068r904b2147],
37	into	IN	O	into	_	0	SENT_66	[p4l923t2069r1086b2147],
38	linear	JJ	O	linear	amod	39	SENT_66	[p4l1108t2069r1346b2147],
39	differences	NNS	O	difference	prep_into	36	SENT_66	[p4l1364t2068r1819b2147],
40	in	IN	O	in	_	0	SENT_66	[p4l1841t2069r1921b2146],
41	drug	NN	O	drug	nn	42	SENT_66	[p4l1942t2068r2139b2169],
42	effects	NNS	O	effect	prep_in	36	SENT_66	[p4l11t2196r306b2292],
43	,	,	O	,	_	0	SENT_66	[p4l11t2196r306b2292],
44	which	WDT	O	which	nsubj	45	SENT_66	[p4l334t2197r594b2276],
45	depend	VBP	O	depend	rcmod	42	SENT_66	[p4l621t2196r932b2297],
46	on	IN	O	on	_	0	SENT_66	[p4l959t2222r1066b2275],
47	the	DT	O	the	det	48	SENT_66	[p4l1093t2197r1222b2275],
48	relationship	NN	O	relationship	prep_on	45	SENT_66	[p4l1248t2196r1757b2297],
49	between	IN	O	between	_	0	SENT_66	[p4l1785t2197r2135b2276],
50	drug	NN	O	drug	nn	51	SENT_66	[p4l11t2325r210b2425],
51	concentration	NN	O	concentration	prep_between	48	SENT_66	[p4l233t2325r819b2403],
52	and	CC	O	and	_	0	SENT_66	[p4l843t2325r1000b2403],
53	the	DT	O	the	det	54	SENT_66	[p4l1025t2325r1154b2403],
54	response	NN	O	response	prep_between	48	SENT_66	[p4l1179t2350r1582b2425],
55	.	.	O	.	_	0	SENT_66	[p4l1179t2350r1582b2425],

1	Variability	NN	O	variability	nsubj	16	SENT_67	[p4l136t2453r560b2553],
2	in	IN	O	in	_	0	SENT_67	[p4l576t2453r657b2530],
3	drug	NN	O	drug	nn	4	SENT_67	[p4l679t2452r877b2553],
4	levels	NNS	O	level	prep_in	1	SENT_67	[p4l893t2453r1118b2532],
5	of	IN	O	of	_	0	SENT_67	[p4l1143t2452r1242b2531],
6	this	DT	O	this	det	7	SENT_67	[p4l1246t2453r1397b2531],
7	magnitude	NN	O	magnitude	prep_of	4	SENT_67	[p4l1420t2452r1895b2553],
8	,	,	O	,	_	0	SENT_67	[p4l1420t2452r1895b2553],
9	if	IN	O	if	mark	11	SENT_67	[p4l1921t2452r1996b2530],
10	not	RB	O	not	neg	11	SENT_67	[p4l1998t2469r2140b2531],
11	recognized	VBN	O	recognize	dep	1	SENT_67	[p4l10t2581r477b2681],
12	and	CC	O	and	_	0	SENT_67	[p4l505t2581r661b2659],
13	understood	VBN	O	understand	conj_and	11	SENT_67	[p4l690t2580r1198b2676],
14	,	,	O	,	_	0	SENT_67	[p4l690t2580r1198b2676],
15	potentially	RB	O	potentially	advmod	16	SENT_67	[p4l1232t2581r1682b2681],
16	presents	VBZ	O	present	_	0	SENT_67	[p4l1706t2597r2061b2681],
17	a	DT	O	a	det	20	SENT_67	[p4l2092t2607r2136b2659],
18	major	JJ	O	major	amod	20	SENT_67	[p4l10t2709r256b2809],
19	therapeutic	JJ	O	therapeutic	amod	20	SENT_67	[p4l277t2709r747b2809],
20	problem	NN	O	problem	dobj	16	SENT_67	[p4l767t2709r1125b2809],
21	in	IN	O	in	_	0	SENT_67	[p4l1148t2709r1228b2786],
22	dosage	NN	O	dosage	nn	23	SENT_67	[p4l1251t2709r1544b2809],
23	optimization	NN	O	optimization	prep_in	20	SENT_67	[p4l1567t2709r2130b2809],
24	.	.	O	.	_	0	SENT_67	[p4l1567t2709r2130b2809],

1	For	IN	O	for	_	0	SENT_68	[p4l9t2844r153b2915],
2	example	NN	O	example	prep_for	13	SENT_68	[p4l198t2836r573b2937],
3	,	,	O	,	_	0	SENT_68	[p4l198t2836r573b2937],
4	dosage	NN	O	dosage	nsubjpass	13	SENT_68	[p4l626t2837r920b2937],
5	of	IN	O	of	_	0	SENT_68	[p4l968t2836r1068b2915],
6	the	DT	O	the	det	9	SENT_68	[p4l1097t2836r1227b2915],
7	immunosuppressive	JJ	O	immunosuppressive	amod	9	SENT_68	[p4l1273t2837r2134b2937],
8	drug	NN	O	drug	nn	9	SENT_68	[p4l11t2965r206b3065],
9	cyclosporine	NN	O	cyclosporine	prep_of	4	SENT_68	[p4l250t2965r782b3065],
10	generally	RB	O	generally	advmod	13	SENT_68	[p4l828t2965r1215b3065],
11	must	MD	O	must	aux	13	SENT_68	[p4l1257t2981r1474b3044],
12	be	VB	O	be	auxpass	13	SENT_68	[p4l1517t2964r1612b3043],
13	reduced	VBN	O	reduce	_	0	SENT_68	[p4l1660t2964r1995b3044],
14	by	IN	O	by	_	0	SENT_68	[p4l2042t2964r2139b3065],
15	about	RB	O	about	quantmod	16	SENT_68	[p4l10t3093r254b3172],
16	75	CD	PERCENT	75	num	17	SENT_68	[p4l281t3100r377b3171],
17	percent	NN	PERCENT	percent	agent	13	SENT_68	[p4l411t3109r731b3193],
18	in	IN	O	in	mark	21	SENT_68	[p4l757t3093r838b3170],
19	order	NN	O	order	dep	21	SENT_68	[p4l870t3092r1098b3171],
20	to	TO	O	to	aux	21	SENT_68	[p4l1127t3109r1206b3171],
21	prevent	VB	O	prevent	purpcl	13	SENT_68	[p4l1237t3109r1555b3193],
22	unacceptably	RB	O	unacceptably	advmod	23	SENT_68	[p4l1581t3093r2139b3193],
23	high	JJ	O	high	amod	25	SENT_68	[p4l10t3220r202b3321],
24	drug	NN	O	drug	nn	25	SENT_68	[p4l237t3220r436b3321],
25	levels	NNS	O	level	dobj	21	SENT_68	[p4l465t3220r693b3300],
26	(	CD	NUMBER	(	dep	25	SENT_68	[p4l734t3221r918b3312],
27	and	CC	O	and	_	0	SENT_68	[p4l734t3221r918b3312],
28	cyclosporine	NN	O	cyclosporine	nn	30	SENT_68	[p4l953t3220r1484b3321],
29	toxicity	NN	O	toxicity	nn	30	SENT_68	[p4l1518t3221r1850b3321],
30	)	NN	O	)	dobj	21	SENT_68	[p4l1518t3221r1850b3321],
31	in	IN	O	in	_	0	SENT_68	[p4l1888t3221r1969b3298],
32	patients	NNS	O	patient	prep_in	30	SENT_68	[p4l2001t3247r2134b3321, p4l11t3349r240b3427],
33	concomitantly	RB	O	concomitantly	advmod	34	SENT_68	[p4l265t3349r876b3449],
34	receiving	VBG	O	receive	partmod	32	SENT_68	[p4l894t3349r1277b3449],
35	the	DT	O	the	det	38	SENT_68	[p4l1296t3349r1425b3427],
36	antifungal	JJ	O	antifungal	amod	38	SENT_68	[p4l1447t3348r1882b3449],
37	agent	NN	O	agent	nn	38	SENT_68	[p4l1903t3365r2140b3449],
38	ketoconazole	NN	O	ketoconazole	dobj	34	SENT_68	[p4l10t3476r594b3556],
39	.	.	O	.	_	0	SENT_68	[p4l10t3476r594b3556],

1	(	NN	O	(	nsubj	69	SENT_69	[p4l640t3477r851b3568],
2	This	DT	O	this	det	3	SENT_69	[p4l640t3477r851b3568],
3	increase	NN	O	increase	nsubj	18	SENT_69	[p4l888t3477r1234b3555],
4	in	IN	O	in	_	0	SENT_69	[p4l1269t3477r1351b3554],
5	the	DT	O	the	det	6	SENT_69	[p4l1386t3476r1516b3555],
6	level	NN	O	level	prep_in	3	SENT_69	[p4l1550t3476r1737b3556],
7	of	IN	O	of	_	0	SENT_69	[p4l1773t3476r1873b3555],
8	cyclosporine	NN	O	cyclosporine	prep_of	6	SENT_69	[p4l1891t3477r2134b3577, p4l12t3605r352b3705],
9	,	,	O	,	_	0	SENT_69	[p4l1891t3477r2134b3577, p4l12t3605r352b3705],
10	which	WDT	O	which	nsubjpass	13	SENT_69	[p4l387t3605r647b3684],
11	is	VBZ	O	be	auxpass	13	SENT_69	[p4l681t3605r746b3683],
12	often	RB	O	often	advmod	13	SENT_69	[p4l783t3604r1000b3683],
13	monitored	VBN	O	monitor	rcmod	3	SENT_69	[p4l1033t3604r1480b3683],
14	clinically	RB	O	clinically	advmod	13	SENT_69	[p4l1515t3604r1902b3705],
15	,	,	O	,	_	0	SENT_69	[p4l1515t3604r1902b3705],
16	is	VBZ	O	be	cop	18	SENT_69	[p4l1941t3605r2006b3683],
17	so	RB	O	so	advmod	18	SENT_69	[p4l2043t3630r2134b3683],
18	predictable	JJ	O	predictable	rcmod	1	SENT_69	[p5l9t20r482b121],
19	that	IN	O	that	complm	29	SENT_69	[p5l513t21r680b99],
20	coadministration	NN	O	coadministration	nsubjpass	29	SENT_69	[p5l705t21r1432b99],
21	of	IN	O	of	_	0	SENT_69	[p5l1463t20r1563b99],
22	ketoconazole	NN	O	ketoconazole	prep_of	20	SENT_69	[p5l1574t20r2135b100],
23	with	IN	O	with	_	0	SENT_69	[p5l6t148r195b228],
24	cyclosporine	NN	O	cyclosporine	prep_with	22	SENT_69	[p5l233t148r765b249],
25	has	VBZ	O	have	aux	29	SENT_69	[p5l802t149r943b227],
26	at	IN	O	at	_	0	SENT_69	[p5l982t165r1061b227],
27	times	NNS	O	time	prep_at	29	SENT_69	[p5l1093t149r1321b227],
28	been	VBN	O	be	auxpass	29	SENT_69	[p5l1362t149r1561b227],
29	advocated	VBN	O	advocate	ccomp	18	SENT_69	[p5l1598t148r2018b228],
30	in	IN	O	in	_	0	SENT_69	[p5l2054t149r2135b226],
31	order	NN	O	order	prep_in	29	SENT_69	[p5l11t277r239b355],
32	to	TO	O	to	aux	33	SENT_69	[p5l259t293r338b355],
33	reduce	VB	O	reduce	xcomp	29	SENT_69	[p5l362t277r642b356],
34	the	DT	O	the	det	35	SENT_69	[p5l665t277r795b355],
35	cost	NN	O	cost	dobj	33	SENT_69	[p5l819t293r992b355],
36	of	IN	O	of	_	0	SENT_69	[p5l1011t276r1112b355],
37	long	JJ	O	long	amod	42	SENT_69	[p5l1114t277r1541b377],
38	—	JJ	O	—	amod	42	SENT_69	[p5l1114t277r1541b377],
39	term	NN	O	term	nn	42	SENT_69	[p5l1114t277r1541b377],
40	immunother	NN	O	immunother	nn	42	SENT_69	[p5l1563t277r2134b356],
41	—	CD	NUMBER	—	num	42	SENT_69	[p5l1563t277r2134b356],
42	apy	NN	O	apy	prep_of	35	SENT_69	[p5l10t399r346b505],
43	.9	CD	NUMBER	.9	num	44	SENT_69	[p5l10t399r346b505],
44	’	NN	O	’	dep	42	SENT_69	[p5l10t399r346b505],
45	1	CD	NUMBER	1	number	46	SENT_69	[p5l10t399r346b505],
46	°	CD	NUMBER	°	num	47	SENT_69	[p5l10t399r346b505],
47	)	NN	O	)	dep	44	SENT_69	[p5l10t399r346b505],
48	In	IN	O	in	_	0	SENT_69	[p5l377t412r464b482],
49	contrast	NN	O	contrast	prep_in	29	SENT_69	[p5l491t421r856b500],
50	,	,	O	,	_	0	SENT_69	[p5l491t421r856b500],
51	patients	NNS	O	patient	appos	49	SENT_69	[p5l887t406r1222b505],
52	on	IN	O	on	_	0	SENT_69	[p5l1251t430r1358b483],
53	a	DT	O	a	det	54	SENT_69	[p5l1384t431r1428b483],
54	regimen	NN	O	regimen	prep_on	51	SENT_69	[p5l1453t406r1805b505],
55	that	WDT	O	that	nsubj	56	SENT_69	[p5l1832t405r1998b483],
56	includes	VBZ	O	include	rcmod	54	SENT_69	[p5l2020t406r2134b482, p5l11t532r281b612],
57	cyclosporine	NN	O	cyclosporine	dobj	56	SENT_69	[p5l317t532r861b633],
58	who	WP	O	who	nsubj	59	SENT_69	[p5l890t532r1076b612],
59	require	VBP	O	require	rcmod	57	SENT_69	[p5l1110t533r1416b633],
60	rifampin	NN	O	rifampin	dobj	59	SENT_69	[p5l1450t532r1827b633],
61	for	IN	O	for	_	0	SENT_69	[p5l1860t532r1985b611],
62	tu	FW	O	tu	nn	65	SENT_69	[p5l2016t549r2133b612],
63	—	FW	O	—	nn	65	SENT_69	[p5l2016t549r2133b612],
64	berculosis	NN	O	berculosis	nn	65	SENT_69	[p5l11t661r449b740],
65	therapy	NN	O	therapy	prep_for	60	SENT_69	[p5l483t660r806b761],
66	or	CC	O	or	_	0	SENT_69	[p5l834t686r925b739],
67	prophylaxis	NN	O	prophylaxis	prep_for	60	SENT_69	[p5l952t661r1455b761],
68	may	MD	O	may	aux	69	SENT_69	[p5l1488t687r1668b761],
69	require	VB	O	require	_	0	SENT_69	[p5l1695t661r2001b761],
70	an	DT	O	a	det	71	SENT_69	[p5l2033t686r2134b739],
71	increase	NN	O	increase	dobj	69	SENT_69	[p5l10t789r363b867],
72	in	IN	O	in	_	0	SENT_69	[p5l397t789r480b866],
73	their	PRP$	O	they	poss	75	SENT_69	[p5l515t789r717b867],
74	cyclosporine	NN	O	cyclosporine	nn	75	SENT_69	[p5l749t788r1293b889],
75	dose	NN	O	dose	prep_in	71	SENT_69	[p5l1329t788r1525b867],
76	by	IN	O	by	_	0	SENT_69	[p5l1561t788r1659b889],
77	a	DT	O	a	det	78	SENT_69	[p5l1689t815r1733b867],
78	factor	NN	O	factor	prep_by	69	SENT_69	[p5l1767t788r2018b867],
79	of	IN	O	of	_	0	SENT_69	[p5l2051t788r2152b867],
80	two	CD	NUMBER	two	prep_of	78	SENT_69	[p5l11t933r165b996],
81	or	CC	O	or	_	0	SENT_69	[p5l197t942r287b995],
82	three	CD	NUMBER	three	prep_of	78	SENT_69	[p5l314t916r530b995],
83	to	TO	O	to	aux	84	SENT_69	[p5l561t933r641b995],
84	achieve	VB	O	achieve	xcomp	69	SENT_69	[p5l672t917r985b996],
85	the	DT	O	the	det	88	SENT_69	[p5l1016t917r1147b995],
86	same	JJ	O	same	amod	88	SENT_69	[p5l1179t943r1398b995],
87	therapeutic	JJ	O	therapeutic	amod	88	SENT_69	[p5l1429t917r1916b1017],
88	level	NN	O	level	nsubj	94	SENT_69	[p5l1943t917r2134b995],
89	of	IN	O	of	_	0	SENT_69	[p5l11t1044r112b1123],
90	cyclosporine	NN	O	cyclosporine	prep_of	88	SENT_69	[p5l136t1045r680b1145],
91	present	JJ	DATE	present	dep	94	SENT_69	[p5l719t1061r1045b1145],
92	before	IN	O	before	mark	94	SENT_69	[p5l1082t1044r1353b1123],
93	they	PRP	O	they	nsubj	94	SENT_69	[p5l1395t1044r1575b1145],
94	received	VBD	O	receive	xcomp	84	SENT_69	[p5l1612t1045r1961b1124],
95	the	DT	O	the	det	96	SENT_69	[p5l2002t1045r2134b1123],
96	rifampin	NN	O	rifampin	dobj	94	SENT_69	[p5l10t1172r411b1273],
97	.	.	O	.	_	0	SENT_69	[p5l10t1172r411b1273],

1	Fortunately	RB	O	fortunately	advmod	22	SENT_70	[p5l138t1301r633b1401],
2	,	,	O	,	_	0	SENT_70	[p5l138t1301r633b1401],
3	the	DT	O	the	det	4	SENT_70	[p5l663t1301r792b1379],
4	identiﬁcation	NN	O	identiﬁcation	nsubjpass	30	SENT_70	[p5l815t1300r1380b1379],
5	and	CC	O	and	_	0	SENT_70	[p5l1402t1301r1558b1379],
6	classiﬁcation	NN	O	classiﬁcation	conj_and	4	SENT_70	[p5l1582t1300r2135b1379],
7	of	IN	O	of	_	0	SENT_70	[p5l11t1428r111b1507],
8	many	JJ	O	many	amod	10	SENT_70	[p5l114t1454r347b1529],
9	CYP3A	NN	O	cyp3a	nn	10	SENT_70	[p5l363t1434r649b1507],
10	substrates	NNS	O	substrate	prep_of	4	SENT_70	[p5l669t1429r1114b1524],
11	,	,	O	,	_	0	SENT_70	[p5l669t1429r1114b1524],
12	inhibitors	NNS	O	inhibitor	conj_and	10	SENT_70	[p5l1140t1429r1574b1524],
13	,	,	O	,	_	0	SENT_70	[p5l1140t1429r1574b1524],
14	and	CC	O	and	_	0	SENT_70	[p5l1601t1429r1756b1507],
15	inducers	NNS	O	inducer	conj_and	10	SENT_70	[p5l1776t1428r2134b1508],
16	of	IN	O	of	_	0	SENT_70	[p5l11t1556r112b1635],
17	major	JJ	O	major	amod	19	SENT_70	[p5l124t1557r377b1657],
18	clinical	JJ	O	clinical	amod	19	SENT_70	[p5l405t1556r713b1635],
19	importance	NN	O	importance	prep_of	15	SENT_70	[p5l742t1557r1240b1657],
20	are	VBP	O	be	auxpass	22	SENT_70	[p5l1269t1583r1397b1635],
21	now	RB	DATE	now	advmod	22	SENT_70	[p5l1428t1582r1614b1636],
22	known	VBN	O	know	_	0	SENT_70	[p5l1640t1557r1936b1636],
23	(	CD	NUMBER	(	num	26	SENT_70	[p5l1971t1562r2133b1648, p5l11t1684r136b1763],
24	Table	NNP	O	Table	nn	26	SENT_70	[p5l1971t1562r2133b1648, p5l11t1684r136b1763],
25	2	CD	NUMBER	2	num	26	SENT_70	[p5l168t1690r246b1776],
26	)	NN	O	)	xcomp	22	SENT_70	[p5l168t1690r246b1776],
27	and	CC	O	and	_	0	SENT_70	[p5l283t1685r441b1763],
28	can	MD	O	can	aux	30	SENT_70	[p5l473t1710r619b1763],
29	be	VB	O	be	auxpass	30	SENT_70	[p5l651t1684r748b1763],
30	used	VBN	O	use	conj_and	22	SENT_70	[p5l780t1684r978b1764],
31	to	TO	O	to	aux	32	SENT_70	[p5l1010t1701r1090b1763],
32	arrive	VB	O	arrive	xcomp	30	SENT_70	[p5l1122t1685r1361b1764],
33	at	IN	O	at	_	0	SENT_70	[p5l1393t1701r1473b1763],
34	an	DT	O	a	det	35	SENT_70	[p5l1499t1710r1600b1763],
35	appropriate	JJ	O	appropriate	prep_at	32	SENT_70	[p5l1631t1685r2134b1785],

1	2212	CD	DATE	2212	num	3	SENT_71	[p5l149t1864r226b1885],
2	N	NN	O	n	nn	3	SENT_71	[p5l912t1866r925b1881],
3	ENGL	NN	ORGANIZATION	engl	_	0	SENT_71	[p5l941t1865r1025b1887],
4	)	CD	NUMBER	)	num	5	SENT_71	[p5l941t1865r1025b1887],
5	MED	NN	O	med	dep	3	SENT_71	[p5l1040t1866r1092b1881],
6	352	CD	NUMBER	352	dep	5	SENT_71	[p5l1104t1865r1181b1887],
7	;	:	O	;	_	0	SENT_71	[p5l1104t1865r1181b1887],
8	21	CD	NUMBER	21	num	10	SENT_71	[p5l1104t1865r1181b1887],
9	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	10	SENT_71	[p5l1218t1865r1430b1887],
10	MAY	NNP	DATE	MAY	dep	5	SENT_71	[p5l1469t1865r1520b1881],
11	26	CD	DATE	26	num	10	SENT_71	[p5l1532t1860r1570b1885],
12	,	,	O	,	_	0	SENT_71	[p5l1532t1860r1570b1885],
13	zoos	NNS	O	zoo	appos	10	SENT_71	[p5l1584t1865r1647b1887],

1	The	DT	O	the	det	4	SENT_72	[p5l936t1898r987b1922],
2	New	NNP	O	New	nn	4	SENT_72	[p5l996t1899r1058b1922],
3	England	NNP	O	England	nn	4	SENT_72	[p5l1067t1898r1178b1929],
4	Journal	NNP	O	Journal	_	0	SENT_72	[p5l1187t1898r1284b1922],
5	of	IN	O	of	_	0	SENT_72	[p5l1294t1898r1323b1922],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_72	[p5l1330t1898r1455b1922],

1	Downloaded	VBN	O	download	_	0	SENT_73	[p5l378t1939r548b1962],
2	from	IN	O	from	_	0	SENT_73	[p5l557t1939r621b1962],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_73	[p5l630t1939r748b1969],
4	at	IN	O	at	_	0	SENT_73	[p5l759t1943r782b1962],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_73	[p5l790t1939r973b1962],
6	on	IN	O	on	_	0	SENT_73	[p5l982t1946r1015b1962],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_73	[p5l1023t1939r1084b1962],
8	5	CD	DATE	5	num	7	SENT_73	[p5l1136t1939r1159b1966],
9	,	,	DATE	,	_	0	SENT_73	[p5l1136t1939r1159b1966],
10	2014	CD	DATE	2014	num	7	SENT_73	[p5l1170t1939r1242b1962],
11	.	.	O	.	_	0	SENT_73	[p5l1170t1939r1242b1962],

1	For	IN	O	for	_	0	SENT_74	[p5l1252t1939r1299b1962],
2	personal	JJ	O	personal	amod	3	SENT_74	[p5l1307t1939r1419b1969],
3	use	NN	O	use	pobj	1	SENT_74	[p5l1428t1946r1472b1962],
4	only	RB	O	only	advmod	3	SENT_74	[p5l1482t1939r1546b1969],
5	.	.	O	.	_	0	SENT_74	[p5l1482t1939r1546b1969],

1	No	DT	O	no	det	3	SENT_75	[p5l1557t1939r1597b1962],
2	other	JJ	O	other	amod	3	SENT_75	[p5l1607t1939r1675b1962],
3	uses	NNS	O	use	_	0	SENT_75	[p5l1683t1946r1739b1962],
4	without	IN	O	without	_	0	SENT_75	[p5l1749t1939r1850b1962],
5	permission	NN	O	permission	prep_without	3	SENT_75	[p5l1859t1939r2011b1969],
6	.	.	O	.	_	0	SENT_75	[p5l1859t1939r2011b1969],

1	Copyright	NN	O	copyright	nsubj	6	SENT_76	[p5l728t1980r863b2011],
2	©	CD	NUMBER	©	num	1	SENT_76	[p5l872t1980r896b2004],
3	2005	CD	DATE	2005	num	5	SENT_76	[p5l906t1980r970b2004],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_76	[p5l980t1981r1065b2004],
5	u	NN	O	u	dep	1	SENT_76	[p5l1097t1988r1113b2004],
6	etts	VBZ	O	ett	_	0	SENT_76	[p5l1127t1984r1171b2004],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_76	[p5l1181t1980r1289b2004],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_76	[p5l1300t1980r1405b2011],
9	.	.	O	.	_	0	SENT_76	[p5l1300t1980r1405b2011],

1	All	DT	O	all	det	2	SENT_77	[p5l1416t1980r1457b2004],
2	rights	NNS	O	rights	nsubj	3	SENT_77	[p5l1466t1980r1541b2011],
3	reserved	VBN	O	reserve	_	0	SENT_77	[p5l1551t1980r1670b2004],
4	.	.	O	.	_	0	SENT_77	[p5l1551t1980r1670b2004],

1	D	NN	O	d	nn	2	SENT_78	[p5l806t2024r827b2043],
2	RU	NN	O	ru	_	0	SENT_78	[p5l832t2024r876b2043],
3	G	NN	O	g	nn	6	SENT_78	[p5l881t2024r902b2043],
4	TH	NN	O	th	nn	6	SENT_78	[p5l914t2024r958b2043],
5	E	NN	O	e	nn	6	SENT_78	[p5l964t2024r980b2043],
6	RAPY	NN	O	rapy	dep	2	SENT_78	[p5l986t2024r1066b2043],

1	100	CD	NUMBER	100	number	2	SENT_79	[p6l1129t40r1214b67],
2	°	CD	NUMBER	°	num	3	SENT_79	[p6l1129t40r1214b67],
3	o	NN	O	o	_	0	SENT_79	[p6l1129t40r1214b67],

1	15	CD	PERCENT	15	num	2	SENT_80	[p6l851t126r917b154],
2	%	NN	PERCENT	%	_	0	SENT_80	[p6l851t126r917b154],
3	45	CD	PERCENT	45	num	4	SENT_80	[p6l977t126r1064b154],
4	%	NN	PERCENT	%	dep	2	SENT_80	[p6l977t126r1064b154],
5	.	.	O	.	_	0	SENT_80	[p6l977t126r1064b154],

1	,	,	O	,	_	0	SENT_81	[p6l977t126r1064b154],
2	-	:	O	-	_	0	SENT_81	[p6l977t126r1064b154],
3	,	,	O	,	_	0	SENT_81	[p6l977t126r1064b154],
4	‘	CD	NUMBER	‘	num	6	SENT_81	[p6l1116t72r1267b178],
5	Felodipine	NN	O	felodipine	nn	6	SENT_81	[p6l1275t115r1399b143],
6	dose	NN	O	dose	_	0	SENT_81	[p6l1273t150r1330b173],

1	Felodipine	NN	O	felodipine	nn	2	SENT_82	[p6l650t192r774b221],
2	bioavailability	NN	O	bioavailability	_	0	SENT_82	[p6l610t228r774b256],
3	ortal	JJ	O	ortal	amod	4	SENT_82	[p6l1085t841r1137b864],
4	vein	NN	O	vein	dep	2	SENT_82	[p6l1147t843r1194b864],

1	Gut	NN	O	gut	nn	2	SENT_83	[p6l328t1208r372b1228],
2	lumen	NN	O	luman	_	0	SENT_83	[p6l382t1206r455b1228],

1	V	NN	O	v	nn	2	SENT_84	[p6l458t1303r461b1304],
2	Enterocyte	NN	ORGANIZATION	enterocyte	_	0	SENT_84	[p6l474t1317r597b1344],
3	p	NN	O	p	nn	4	SENT_84	[p6l610t1317r620b1336],
4	X	NN	O	x	dep	2	SENT_84	[p6l610t1317r620b1336],
5	+	CC	O	+	_	0	SENT_84	[p6l610t1317r620b1336],
6	_	NN	O	_	dep	2	SENT_84	[p6l644t1341r649b1345],

1	CYP3A4	NN	O	cyp3a4	_	0	SENT_85	[p6l288t1380r384b1400],

1	Grapefruit	NN	O	grapefruit	_	0	SENT_86	[p6l403t1715r564b1758],
2	“	CD	NUMBER	“	num	1	SENT_86	[p6l403t1715r564b1758],
3	_	NN	O	_	nn	6	SENT_86	[p6l608t1719r630b1760],
4	“	CD	NUMBER	“	num	6	SENT_86	[p6l608t1719r630b1760],
5	wee	NN	O	wee	nn	6	SENT_86	[p6l430t1760r493b1789],
6	o	NN	O	o	dep	1	SENT_86	[p6l527t1734r600b1793],
7	vi	LS	O	vi	prep	6	SENT_86	[p6l616t1763r620b1768],
8	.4	CD	NUMBER	.4	dep	7	SENT_86	[p6l454t1813r484b1823],

1	Figure	NNP	O	Figure	_	0	SENT_87	[p6l122t1923r207b1956],
2	1	CD	NUMBER	1	dep	1	SENT_87	[p6l217t1925r238b1948],
3	.	.	O	.	_	0	SENT_87	[p6l217t1925r238b1948],

1	First-Pass	NNP	MISC	First-Pass	nn	2	SENT_88	[p6l250t1923r382b1948],
2	Metabolism	NNP	MISC	Metabolism	_	0	SENT_88	[p6l394t1923r553b1948],
3	after	IN	O	after	_	0	SENT_88	[p6l564t1922r626b1948],
4	Oral	NNP	O	Oral	nn	5	SENT_88	[p6l634t1923r692b1948],
5	Administration	NNP	O	Administration	prep_after	2	SENT_88	[p6l702t1923r906b1948],
6	of	IN	O	of	_	0	SENT_88	[p6l916t1922r947b1948],
7	a	DT	O	a	det	8	SENT_88	[p6l951t1931r965b1948],
8	Drug	NN	O	drug	prep_of	5	SENT_88	[p6l976t1925r1051b1956],
9	,	,	O	,	_	0	SENT_88	[p6l976t1925r1051b1956],
10	as	IN	O	as	mark	11	SENT_88	[p6l1060t1931r1089b1948],
11	Exempliﬁed	JJ	O	exempliﬁed	dep	5	SENT_88	[p6l1101t1922r1258b1955],
12	by	IN	O	by	_	0	SENT_88	[p6l1269t1923r1299b1956],
13	Felodipine	NN	PERSON	felodipine	prep_by	11	SENT_88	[p6l1310t1923r1450b1955],
14	and	CC	O	and	_	0	SENT_88	[p6l1458t1923r1507b1948],
15	Its	PRP$	O	its	poss	16	SENT_88	[p6l1520t1925r1551b1948],
16	Interaction	NN	O	interaction	conj_and	5	SENT_88	[p6l1563t1923r1708b1948],
17	with	IN	O	with	_	0	SENT_88	[p6l1718t1923r1776b1948],
18	Grapefruit	NN	LOCATION	grapefruit	nn	19	SENT_88	[p6l1786t1922r1927b1955],
19	Juice	NN	LOCATION	juice	prep_with	16	SENT_88	[p6l1932t1923r2009b1955],
20	.	.	O	.	_	0	SENT_88	[p6l1932t1923r2009b1955],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_89	[p6l121t1974r213b1998],
2	enzymes	NNS	O	enzyme	nsubj	3	SENT_89	[p6l222t1982r340b2006],
3	(	VBP	O	(	_	0	SENT_89	[p6l354t1975r417b2006],
4	e.g.	FW	O	e.g.	dobj	3	SENT_89	[p6l354t1975r417b2006],
5	,	,	O	,	_	0	SENT_89	[p6l354t1975r417b2006],
6	CYP3A4	NN	O	cyp3a4	nsubj	11	SENT_89	[p6l429t1974r546b2006],
7	)	CD	NUMBER	)	num	6	SENT_89	[p6l429t1974r546b2006],
8	present	JJ	DATE	present	amod	6	SENT_89	[p6l560t1978r661b2006],
9	in	IN	O	in	_	0	SENT_89	[p6l671t1975r693b1998],
10	enterocytes	NNS	O	enterocyte	prep_in	8	SENT_89	[p6l705t1978r859b2006],
11	ofthe	VBP	O	ofthe	ccomp	3	SENT_89	[p6l870t1972r947b1998],
12	intestinal	JJ	O	intestinal	amod	13	SENT_89	[p6l958t1973r1081b1998],
13	epithelium	NN	O	epithelium	nsubj	15	SENT_89	[p6l1092t1973r1237b2006],
14	extensively	RB	O	extensively	advmod	15	SENT_89	[p6l1248t1973r1395b2006],
15	metabolize	VBZ	O	metabolize	ccomp	11	SENT_89	[p6l1406t1973r1555b1998],
16	felodipine	NN	O	felodipine	dobj	15	SENT_89	[p6l1564t1972r1699b2006],
17	during	IN	O	during	_	0	SENT_89	[p6l1709t1973r1798b2006],
18	its	PRP$	O	its	poss	19	SENT_89	[p6l1809t1975r1838b1998],
19	absorption	NN	O	absorption	prep_during	15	SENT_89	[p6l1849t1973r2004b2006],
20	,	,	O	,	_	0	SENT_89	[p6l1849t1973r2004b2006],
21	and	CC	O	and	_	0	SENT_89	[p6l121t2014r169b2040],
22	on	IN	O	on	_	0	SENT_89	[p6l180t2023r212b2040],
23	average	NN	O	average	prep_on	30	SENT_89	[p6l223t2023r327b2048],
24	only	RB	O	only	advmod	28	SENT_89	[p6l336t2014r392b2047],
25	30	CD	PERCENT	30	num	27	SENT_89	[p6l401t2016r433b2040],
26	percent	NN	PERCENT	percent	nn	27	SENT_89	[p6l443t2019r544b2047],
27	ofthe	NN	O	ofthe	pobj	24	SENT_89	[p6l553t2014r629b2040],
28	administered	VBN	O	administer	partmod	23	SENT_89	[p6l638t2014r817b2040],
29	dose	NN	O	dose	nsubj	30	SENT_89	[p6l828t2014r892b2040],
30	enters	VBZ	O	enter	conj_and	3	SENT_89	[p6l901t2019r984b2040],
31	the	DT	O	the	det	37	SENT_89	[p6l993t2014r1036b2040],
32	portal	JJ	O	portal	amod	37	SENT_89	[p6l1047t2014r1123b2047],
33	vein	NN	O	vein	nn	37	SENT_89	[p6l1133t2017r1187b2040],
34	(	NN	O	(	nn	37	SENT_89	[p6l1201t2014r1273b2047],
35	solid	JJ	O	solid	amod	37	SENT_89	[p6l1201t2014r1273b2047],
36	line	NN	O	line	nn	37	SENT_89	[p6l1285t2014r1351b2047],
37	)	NN	O	)	dobj	30	SENT_89	[p6l1285t2014r1351b2047],
38	.	.	O	.	_	0	SENT_89	[p6l1285t2014r1351b2047],

1	Subsequently	RB	O	subsequently	advmod	9	SENT_90	[p6l1362t2014r1549b2047],
2	,	,	O	,	_	0	SENT_90	[p6l1362t2014r1549b2047],
3	CYP3A	NN	O	cyp3a	nn	4	SENT_90	[p6l1560t2016r1652b2040],
4	enzymes	NNS	O	enzyme	nsubj	9	SENT_90	[p6l1660t2023r1779b2047],
5	in	IN	O	in	_	0	SENT_90	[p6l1790t2017r1812b2039],
6	the	DT	O	the	det	7	SENT_90	[p6l1822t2014r1864b2040],
7	liver	NN	O	liver	prep_in	4	SENT_90	[p6l1875t2014r1931b2040],
8	further	RB	O	further	advmod	9	SENT_90	[p6l1938t2014r2031b2040],
9	metabolize	VBZ	O	metabolize	_	0	SENT_90	[p6l122t2056r271b2081],
10	the	DT	O	the	det	11	SENT_90	[p6l280t2056r323b2081],
11	drug	NN	O	drug	dobj	9	SENT_90	[p6l332t2056r395b2089],
12	so	IN	O	so	mark	23	SENT_90	[p6l405t2065r435b2081],
13	that	IN	O	that	dep	23	SENT_90	[p6l444t2056r498b2081],
14	only	RB	O	only	advmod	16	SENT_90	[p6l507t2056r563b2089],
15	15	CD	PERCENT	15	num	16	SENT_90	[p6l574t2058r602b2081],
16	percent	NN	PERCENT	percent	nsubj	29	SENT_90	[p6l614t2061r715b2089],
17	ofthe	NN	O	ofthe	nn	18	SENT_90	[p6l725t2056r801b2081],
18	dose	NN	O	dose	nsubj	20	SENT_90	[p6l811t2056r875b2081],
19	is	VBZ	O	be	cop	20	SENT_90	[p6l886t2058r905b2081],
20	bioavailable	JJ	O	bioavailable	rcmod	16	SENT_90	[p6l917t2056r1077b2081],
21	and	CC	O	and	cc	20	SENT_90	[p6l1088t2056r1136b2081],
22	ﬁnally	RB	O	ﬁnally	advmod	20	SENT_90	[p6l1146t2056r1227b2089],
23	reaches	VBZ	O	reach	advcl	9	SENT_90	[p6l1237t2056r1339b2081],
24	the	DT	O	the	det	26	SENT_90	[p6l1349t2056r1391b2081],
25	systemic	JJ	O	systemic	amod	26	SENT_90	[p6l1402t2058r1520b2089],
26	circulation	NN	O	circulation	dobj	23	SENT_90	[p6l1529t2056r1671b2081],
27	and	CC	O	and	_	0	SENT_90	[p6l1683t2056r1731b2081],
28	is	VBZ	O	be	cop	29	SENT_90	[p6l1743t2058r1762b2081],
29	able	JJ	O	able	conj_and	23	SENT_90	[p6l1774t2056r1828b2081],
30	to	TO	O	to	aux	31	SENT_90	[p6l1837t2061r1864b2081],
31	exert	VB	O	exert	xcomp	29	SENT_90	[p6l1874t2061r1938b2081],
32	its	PRP$	O	its	poss	33	SENT_90	[p6l1949t2058r1978b2081],
33	effects	NNS	O	effect	dobj	31	SENT_90	[p6l1989t2056r2021b2081, p6l120t2097r191b2123],
34	.	.	O	.	_	0	SENT_90	[p6l1989t2056r2021b2081, p6l120t2097r191b2123],

1	Grapefruit	NN	O	grapefruit	nn	2	SENT_91	[p6l201t2097r341b2131],
2	juice	NN	O	juice	nsubj	4	SENT_91	[p6l349t2100r413b2131],
3	selectively	RB	O	selectively	advmod	4	SENT_91	[p6l423t2098r560b2131],
4	inhibits	VBZ	O	inhibit	_	0	SENT_91	[p6l570t2098r669b2123],
5	CYP3A	NN	O	cyp3a	dobj	4	SENT_91	[p6l679t2099r771b2123],
6	in	IN	O	in	_	0	SENT_91	[p6l781t2100r802b2123],
7	the	DT	O	the	det	8	SENT_91	[p6l812t2098r855b2123],
8	enterocyte	NN	O	enterocyte	prep_in	4	SENT_91	[p6l864t2102r1012b2131],
9	,	,	O	,	_	0	SENT_91	[p6l864t2102r1012b2131],
10	with	IN	O	with	_	0	SENT_91	[p6l1022t2098r1078b2123],
11	the	DT	O	the	det	13	SENT_91	[p6l1087t2098r1130b2123],
12	net	JJ	O	net	amod	13	SENT_91	[p6l1141t2102r1182b2123],
13	result	NN	O	result	prep_with	8	SENT_91	[p6l1192t2098r1267b2123],
14	being	VBG	O	be	aux	16	SENT_91	[p6l1277t2098r1351b2131],
15	an	DT	O	a	det	16	SENT_91	[p6l1360t2107r1390b2123],
16	increase	NN	O	increase	partmod	13	SENT_91	[p6l1401t2100r1513b2123],
17	in	IN	O	in	_	0	SENT_91	[p6l1523t2100r1545b2123],
18	the	DT	O	the	det	21	SENT_91	[p6l1554t2098r1597b2123],
19	oral	JJ	O	oral	amod	21	SENT_91	[p6l1606t2098r1656b2123],
20	bioavailability	NN	O	bioavailability	nn	21	SENT_91	[p6l1667t2098r1853b2131],
21	offelodipine	NN	O	offelodipine	prep_in	16	SENT_91	[p6l1861t2097r2031b2131],
22	by	IN	O	by	_	0	SENT_91	[p6l122t2139r150b2172],
23	a	DT	O	a	det	25	SENT_91	[p6l160t2148r173b2165],
24	factor	NN	O	factor	nn	25	SENT_91	[p6l182t2139r261b2165],
25	ofthree	NN	O	ofthree	agent	16	SENT_91	[p6l270t2139r381b2169],
26	,	,	O	,	_	0	SENT_91	[p6l270t2139r381b2169],
27	denoted	VBN	O	denote	partmod	8	SENT_91	[p6l392t2139r502b2165],
28	by	IN	O	by	_	0	SENT_91	[p6l514t2139r543b2172],
29	the	DT	O	the	det	30	SENT_91	[p6l551t2139r594b2165],
30	asterisks	NNS	O	asterisk	agent	27	SENT_91	[p6l604t2139r722b2165],
31	and	CC	O	and	_	0	SENT_91	[p6l733t2139r781b2165],
32	the	DT	O	the	det	34	SENT_91	[p6l791t2139r834b2165],
33	dashed	VBN	O	dash	amod	34	SENT_91	[p6l844t2139r940b2165],
34	lines	NNS	O	line	agent	27	SENT_91	[p6l953t2139r1022b2165],
35	.	.	O	.	_	0	SENT_91	[p6l953t2139r1022b2165],

1	f	LS	O	f	dep	2	SENT_92	[p6l367t2297r385b2327],
2	I.	NN	O	i.	_	0	SENT_92	[p6l444t2297r463b2327],
3	.	.	O	.	_	0	SENT_92	[p6l492t2298r497b2303],

1	1	CD	NUMBER	1	num	2	SENT_93	[p6l537t2297r547b2327],
2	. . .	CD	NUMBER	. . .	_	0	SENT_93	[p6l728t2322r733b2328],[p6l579t2298r584b2303],

1	dosage	NN	O	dosage	nn	3	SENT_94	[p6l94t2297r210b2337],
2	Slrategy	NN	O	slrategy	nn	3	SENT_94	[p6l224t2304r355b2353],
3	O.r	NN	O	o.r	_	0	SENT_94	[p6l380t2307r415b2353],
4	C	NN	O	c	nn	6	SENT_94	[p6l427t2308r443b2328],
5	lmca	NN	O	lmca	nn	6	SENT_94	[p6l456t2307r536b2328],
6	Sltuatlclns	NNS	O	sltuatlcln	dep	3	SENT_94	[p6l560t2304r723b2353],
7	M	NN	O	m	nn	8	SENT_94	[p6l747t2300r915b2353],
8	°	NN	O	°	dep	6	SENT_94	[p6l747t2300r915b2353],
9	.	.	O	.	_	0	SENT_94	[p6l747t2300r915b2353],

1	’	NN	O	’	nsubj	4	SENT_95	[p6l747t2300r915b2353],
2	e	SYM	O	e	dep	4	SENT_95	[p6l747t2300r915b2353],
3	°	CD	NUMBER	°	num	4	SENT_95	[p6l747t2300r915b2353],
4	Ve	NNP	O	Ve	_	0	SENT_95	[p6l747t2300r915b2353],
5	.	.	O	.	_	0	SENT_95	[p6l747t2300r915b2353],

1	”	NN	O	”	nn	4	SENT_96	[p6l747t2300r915b2353],
2	D	NN	O	d	nn	4	SENT_96	[p6l990t2327r1015b2350],
3	RU	NN	O	ru	nn	4	SENT_96	[p6l1023t2327r1079b2350],
4	G	NN	O	g	_	0	SENT_96	[p6l1087t2327r1113b2350],
5	I	PRP	O	I	dep	10	SENT_96	[p6l1133t2327r1145b2350],
6	N	NN	O	n	nn	7	SENT_96	[p6l1154t2327r1182b2350],
7	T	NN	O	t	dep	5	SENT_96	[p6l1189t2327r1211b2350],
8	E	NN	O	e	nn	9	SENT_96	[p6l1218t2327r1238b2350],
9	RACT	NN	O	ract	dep	10	SENT_96	[p6l1246t2327r1354b2350],
10	I	PRP	O	I	dep	15	SENT_96	[p6l1361t2327r1373b2350],
11	o	NN	O	o	nn	13	SENT_96	[p6l1381t2327r1407b2350],
12	N	NN	O	n	nn	13	SENT_96	[p6l1415t2327r1443b2350],
13	s	NNS	O	s	dep	10	SENT_96	[p6l1452t2327r1467b2350],
14	I	PRP	O	I	nsubj	15	SENT_96	[p6l1489t2327r1501b2350],
15	NVO	VBP	O	nvo	dep	4	SENT_96	[p6l1510t2327r1598b2350],
16	LV	NN	O	lv	dobj	15	SENT_96	[p6l1606t2327r1653b2350],
17	I	PRP	O	I	nsubj	18	SENT_96	[p6l1660t2327r1672b2350],
18	N	NN	O	n	rcmod	16	SENT_96	[p6l1681t2327r1708b2350],
19	G	NN	O	g	nn	21	SENT_96	[p6l1717t2327r1743b2350],
20	updated	VBN	O	update	amod	21	SENT_96	[p6l94t2347r225b2386],
21	information	NN	O	information	nsubj	26	SENT_96	[p6l245t2347r444b2378],
22	about	IN	O	about	_	0	SENT_96	[p6l465t2347r559b2378],
23	drug	NN	O	drug	nn	24	SENT_96	[p6l579t2347r656b2387],
24	interactions	NNS	O	interaction	prep_about	21	SENT_96	[p6l675t2354r869b2378],
25	IS	VBZ	O	be	cop	26	SENT_96	[p6l891t2358r916b2378],
26	I	PRP	O	I	ccomp	18	SENT_96	[p6l1118t2369r1130b2391],
27	N	NN	O	n	nn	33	SENT_96	[p6l1139t2369r1167b2392],
28	H	NN	O	h	nn	33	SENT_96	[p6l1176t2369r1204b2391],
29	I	NN	O	i	nn	33	SENT_96	[p6l1213t2369r1225b2391],
30	B	NN	O	b	nn	33	SENT_96	[p6l1234t2369r1255b2392],
31	1	CD	NUMBER	1	num	33	SENT_96	[p6l1263t2369r1275b2391],
32	TI	NNP	O	TI	nn	33	SENT_96	[p6l1282t2369r1323b2391],
33	o	NN	O	o	dep	26	SENT_96	[p6l1332t2369r1357b2392],
34	N	NN	O	n	nn	38	SENT_96	[p6l1365t2369r1393b2392],
35	O	NN	O	o	nn	38	SENT_96	[p6l1414t2369r1439b2392],
36	F	NN	O	f	nn	38	SENT_96	[p6l1448t2369r1466b2391],
37	CY	NN	O	cy	nn	38	SENT_96	[p6l1486t2369r1534b2392],
38	P	NN	O	p	dep	48	SENT_96	[p6l1540t2369r1559b2391],
39	3	CD	NUMBER	3	num	40	SENT_96	[p6l1567t2369r1585b2393],
40	A	NN	O	a	npadvmod	41	SENT_96	[p6l1591t2369r1616b2391],
41	available	JJ	O	available	amod	38	SENT_96	[p6l93t2397r238b2429],
42	on	IN	O	on	_	0	SENT_96	[p6l255t2407r297b2428],
43	a	DT	O	a	det	44	SENT_96	[p6l313t2408r330b2428],
44	number	NN	O	number	prep_on	38	SENT_96	[p6l346t2397r478b2429],
45	of	IN	O	of	_	0	SENT_96	[p6l493t2397r533b2428],
46	Web	NN	MISC	web	nn	47	SENT_96	[p6l541t2397r614b2428],
47	sites	NNS	O	site	prep_of	44	SENT_96	[p6l631t2398r704b2428],
48	(	CD	NUMBER	(	dep	26	SENT_96	[p6l723t2400r806b2437],
49	e.g.	FW	O	e.g.	dep	48	SENT_96	[p6l723t2400r806b2437],
50	,	,	O	,	_	0	SENT_96	[p6l723t2400r806b2437],
51	WWW	NNP	O	WWW	appos	49	SENT_96	[p6l822t2408r915b2429],
52	.	.	O	.	_	0	SENT_96	[p6l822t2408r915b2429],

1	themedicallettencom	NNP	O	themedicallettencom	nn	3	SENT_97	[p6l94t2442r442b2480],
2	,	,	O	,	_	0	SENT_97	[p6l94t2442r442b2480],
3	www.drug-interactions.com	NNP	O	www.drug-interactions.com	_	0	SENT_97	[p6l452t2442r915b2482],
4	,	,	O	,	_	0	SENT_97	[p6l452t2442r915b2482],
5	Inhibition	NN	O	inhibition	appos	3	SENT_97	[p6l956t2442r1121b2473],
6	of	IN	O	of	_	0	SENT_97	[p6l1130t2442r1169b2473],
7	the	DT	O	the	det	8	SENT_97	[p6l1170t2442r1220b2473],
8	metabolism	NN	O	metabolism	prep_of	5	SENT_97	[p6l1228t2442r1424b2473],
9	of	IN	O	of	_	0	SENT_97	[p6l1433t2442r1472b2473],
10	one	CD	NUMBER	one	num	11	SENT_97	[p6l1473t2452r1532b2473],
11	drug	NN	O	drug	prep_of	8	SENT_97	[p6l1541t2442r1619b2482],
12	by	IN	O	by	_	0	SENT_97	[p6l1626t2442r1663b2482],
13	the	DT	O	the	det	14	SENT_97	[p6l1670t2442r1720b2473],
14	adwvvw.depts.washington.edu/didbase/	NN	O	adwvvw.depts.washington.edu/didbase/	prep_by	11	SENT_97	[p6l1728t2442r1779b2473, p6l92t2494r725b2534],
15	,	,	O	,	_	0	SENT_97	[p6l1728t2442r1779b2473, p6l92t2494r725b2534],
16	and	CC	O	and	_	0	SENT_97	[p6l745t2494r806b2525],
17	vvww	NN	O	vvww	appos	3	SENT_97	[p6l822t2505r915b2526],
18	.	.	O	.	_	0	SENT_97	[p6l822t2505r915b2526],

1	dition	NN	O	dition	nsubj	4	SENT_98	[p6l956t2494r1053b2525],
2	of	IN	O	of	_	0	SENT_98	[p6l1069t2494r1108b2525],
3	another	DT	O	another	prep_of	1	SENT_98	[p6l1116t2494r1244b2525],
4	causes	VBZ	O	cause	_	0	SENT_98	[p6l1258t2504r1364b2525],
5	problems	NNS	O	problem	dobj	4	SENT_98	[p6l1380t2494r1545b2534],
6	,	,	O	,	_	0	SENT_98	[p6l1380t2494r1545b2534],
7	since	IN	O	since	_	0	SENT_98	[p6l1564t2495r1646b2525],
8	plasma	NN	O	plasma	nn	9	SENT_98	[p6l1661t2494r1780b2534],
9	imm	NN	O	imm	prep_since	4	SENT_98	[p6l93t2546r475b2582],
10	.	.	O	.	_	0	SENT_98	[p6l93t2546r475b2582],

1	ki	NN	O	kus	_	0	SENT_99	[p6l93t2546r475b2582],
2	.	.	O	.	_	0	SENT_99	[p6l93t2546r475b2582],

1	selCYPalleles	NNS	O	selcypallele	_	0	SENT_100	[p6l93t2546r475b2582],
2	/	:	O	/	punct	1	SENT_100	[p6l93t2546r475b2582],
3	)	CD	NUMBER	)	dep	1	SENT_100	[p6l93t2546r475b2582],
4	.	.	O	.	_	0	SENT_100	[p6l93t2546r475b2582],

1	drug	NN	O	drug	nn	2	SENT_101	[p6l956t2546r1034b2585],
2	concentrations	NNS	O	concentration	nsubj	5	SENT_101	[p6l1042t2547r1286b2577],
3	may	MD	O	may	aux	5	SENT_101	[p6l1296t2556r1365b2585],
4	rapidly	RB	O	rapidly	advmod	5	SENT_101	[p6l1372t2546r1486b2585],
5	increase	VB	O	increase	_	0	SENT_101	[p6l1493t2547r1628b2577],
6	after	IN	O	after	_	0	SENT_101	[p6l1637t2546r1712b2577],
7	one	CD	NUMBER	one	prep_after	5	SENT_101	[p6l1720t2556r1780b2577],

1	N	NN	O	n	nn	3	SENT_102	[p6l569t2666r583b2681],
2	ENGLJ	NN	O	englj	nn	3	SENT_102	[p6l598t2665r682b2687],
3	MED	NN	O	med	_	0	SENT_102	[p6l697t2666r750b2681],
4	352	CD	NUMBER	352	num	6	SENT_102	[p6l762t2665r838b2687],
5	;	:	O	;	_	0	SENT_102	[p6l762t2665r838b2687],
6	21	CD	NUMBER	21	dep	3	SENT_102	[p6l762t2665r838b2687],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_102	[p6l875t2665r1087b2687],
8	MAY	NNP	DATE	MAY	dep	6	SENT_102	[p6l1126t2665r1178b2681],
9	26	CD	DATE	26	num	8	SENT_102	[p6l1189t2660r1228b2685],
10	,	,	DATE	,	_	0	SENT_102	[p6l1189t2660r1228b2685],
11	2005	CD	DATE	2005	num	8	SENT_102	[p6l1241t2665r1304b2687],
12	2213	CD	DATE	2213	dep	3	SENT_102	[p6l1990t2664r2065b2686],

1	The	DT	O	the	det	4	SENT_103	[p6l752t2762r803b2785],
2	New	NNP	O	New	nn	4	SENT_103	[p6l812t2762r874b2785],
3	England	NNP	O	England	nn	4	SENT_103	[p6l883t2762r994b2792],
4	Journal	NNP	O	Journal	_	0	SENT_103	[p6l1003t2762r1100b2785],
5	of	IN	O	of	_	0	SENT_103	[p6l1110t2762r1139b2785],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_103	[p6l1145t2762r1270b2785],

1	Downloaded	VBN	O	download	_	0	SENT_104	[p6l194t2802r364b2825],
2	from	IN	O	from	_	0	SENT_104	[p6l373t2802r437b2825],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_104	[p6l446t2802r564b2832],
4	at	IN	O	at	_	0	SENT_104	[p6l574t2806r598b2825],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_104	[p6l606t2802r789b2826],
6	on	IN	O	on	_	0	SENT_104	[p6l798t2809r830b2825],
7	January	NNP	DATE	January	prep_on	1	SENT_104	[p6l839t2802r942b2832],
8	5	CD	DATE	5	num	7	SENT_104	[p6l952t2802r974b2830],
9	,	,	DATE	,	_	0	SENT_104	[p6l952t2802r974b2830],
10	2014	CD	DATE	2014	num	7	SENT_104	[p6l985t2802r1057b2826],
11	.	.	O	.	_	0	SENT_104	[p6l985t2802r1057b2826],

1	For	IN	O	for	_	0	SENT_105	[p6l1068t2802r1114b2825],
2	personal	JJ	O	personal	amod	3	SENT_105	[p6l1122t2802r1235b2832],
3	use	NN	O	use	pobj	1	SENT_105	[p6l1244t2809r1287b2825],
4	only	RB	O	only	advmod	3	SENT_105	[p6l1297t2802r1362b2832],
5	.	.	O	.	_	0	SENT_105	[p6l1297t2802r1362b2832],

1	N	NN	O	n	nn	2	SENT_106	[p6l1372t2802r1396b2825],
2	o	NN	O	o	_	0	SENT_106	[p6l1397t2809r1412b2825],
3	other	JJ	O	other	amod	4	SENT_106	[p6l1422t2802r1490b2825],
4	uses	NNS	O	use	dep	2	SENT_106	[p6l1498t2809r1554b2825],
5	without	IN	O	without	_	0	SENT_106	[p6l1565t2802r1666b2825],
6	permission	NN	O	permission	prep_without	4	SENT_106	[p6l1674t2802r1827b2832],
7	.	.	O	.	_	0	SENT_106	[p6l1674t2802r1827b2832],

1	Copyright	NN	O	copyright	_	0	SENT_107	[p6l544t2843r679b2873],
2	©	CD	NUMBER	©	num	6	SENT_107	[p6l688t2843r711b2867],
3	2005	CD	DATE	2005	num	6	SENT_107	[p6l722t2843r786b2867],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_107	[p6l796t2843r987b2866],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_107	[p6l997t2843r1105b2866],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_107	[p6l1115t2843r1220b2873],
7	.	.	O	.	_	0	SENT_107	[p6l1115t2843r1220b2873],

1	All	DT	O	all	det	2	SENT_108	[p6l1231t2843r1273b2866],
2	rights	NNS	O	rights	nsubj	3	SENT_108	[p6l1282t2843r1357b2873],
3	reserved	VBN	O	reserve	_	0	SENT_108	[p6l1366t2843r1485b2866],
4	.	.	O	.	_	0	SENT_108	[p6l1366t2843r1485b2866],

1	The	DT	O	the	det	4	SENT_109	[p6l715t2948r752b2969],
2	NEW	NNP	O	NEW	nn	4	SENT_109	[p6l764t2950r845b2969],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_109	[p6l859t2950r1034b2969],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_109	[p6l1048t2950r1214b2976],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_109	[p6l1228t2948r1444b2975],

1	(	NN	O	(	nn	2	SENT_110	[p7l151t435r210b712],
2	nmol/liter	NN	O	nmol/liter	_	0	SENT_110	[p7l151t435r210b712],
3	)	CD	NUMBER	)	dep	2	SENT_110	[p7l151t435r210b712],

1	Grapefruit	NN	O	grapefruit	nn	2	SENT_111	[p7l1598t872r1833b927],
2	juice	NN	O	juice	_	0	SENT_111	[p7l1849t876r1956b928],

1	-	:	O	-	_	0	SENT_112	[p7l1546t978r1561b992],
2	Water	NN	O	water	_	0	SENT_112	[p7l1596t966r1729b1004],

1	8	CD	NUMBER	8	num	3	SENT_113	[p7l1539t1062r1563b1102],
2	:	:	O	:	_	0	SENT_113	[p7l98t163r127b188],
3	.9	CD	NUMBER	.9	_	0	SENT_113	[p7l84t193r128b235],
4	4-5	CD	NUMBER	4-5	num	5	SENT_113	[p7l90t238r128b257],
5	cu	NN	O	cu	dep	3	SENT_113	[p7l98t259r128b283],
6	&	SYM	O	&	dep	5	SENT_113	[p7l98t285r127b302],
7	-	:	O	-	_	0	SENT_113	[p7l90t305r128b324],
8	I-3	NN	O	i-3	dep	5	SENT_113	[p7l90t305r128b324],
9	:	:	O	:	_	0	SENT_113	[p7l98t328r127b353],
10	cu	NN	O	cu	nn	11	SENT_113	[p7l98t358r128b384],
11	u	NN	O	u	dep	8	SENT_113	[p7l98t386r128b410],
12	:	:	O	:	_	0	SENT_113	[p7l98t416r127b441],
13	o	NN	O	o	nn	14	SENT_113	[p7l98t446r128b474],
14	U	NNP	O	U	dep	5	SENT_113	[p7l86t477r128b511],
15	en	IN	O	en	_	0	SENT_113	[p7l98t528r128b554],
16	E	NNP	O	E	prep_en	14	SENT_113	[p7l84t559r127b600],
17	.9	CD	NUMBER	.9	number	18	SENT_113	[p7l84t605r141b647, p7l83t654r128b681],
18	‘	CD	NUMBER	‘	num	22	SENT_113	[p7l84t605r141b647, p7l83t654r128b681],
19	U	NNP	O	U	nn	22	SENT_113	[p7l84t605r141b647, p7l83t654r128b681],
20	2	CD	NUMBER	2	num	22	SENT_113	[p7l87t683r128b726],
21	cu	NN	O	cu	nn	22	SENT_113	[p7l98t732r128b758],
22	u.	NN	O	u.	dep	14	SENT_113	[p7l87t761r127b786],
23	cu	NN	O	cu	nn	28	SENT_113	[p7l98t808r128b833],
24	E	NN	O	e	nn	28	SENT_113	[p7l98t839r127b881],
25	(	NN	O	(	nn	28	SENT_113	[p7l98t887r128b910],
26	D	NN	O	d	nn	28	SENT_113	[p7l98t887r128b910],
27	L’	NN	O	l’	nn	28	SENT_113	[p7l83t913r128b951],
28	n.	NN	O	n.	dep	3	SENT_113	[p7l87t955r127b983],

1	Grapefruit	NN	O	grapefruit	nn	2	SENT_114	[p7l1594t1498r1829b1553],
2	juice	NN	O	juice	_	0	SENT_114	[p7l1845t1502r1952b1554],

1	90	CD	NUMBER	90	num	2	SENT_115	[p7l278t1620r330b1659],
2	Water	NN	O	water	_	0	SENT_115	[p7l1596t1600r1729b1639],

1	Heart	NNP	O	Heart	nn	2	SENT_116	[p7l93t1920r134b2057],
2	Rate	NNP	O	Rate	_	0	SENT_116	[p7l93t1795r134b1900],
3	(	CD	NUMBER	(	num	5	SENT_116	[p7l89t1491r148b1774],
4	beats/min	JJ	O	beats/min	amod	5	SENT_116	[p7l89t1491r148b1774],
5	)	NN	O	)	dep	2	SENT_116	[p7l89t1491r148b1774],

1	Systolic	JJ	MISC	systolic	_	0	SENT_117	[p7l133t2424r322b2484],
2	150	CD	NUMBER	150	tmod	1	SENT_117	[p7l253t2519r330b2558],

1	120	CD	NUMBER	120	num	2	SENT_118	[p7l253t2933r330b2972],
2	Water	NN	O	water	_	0	SENT_118	[p7l1594t2908r1728b2947],

1	Grapefruit	NN	O	grapefruit	nn	2	SENT_119	[p7l1600t3002r1835b3058],
2	juice	NN	O	juice	_	0	SENT_119	[p7l1850t3007r1958b3058],

1	Blood	NN	O	blood	nn	2	SENT_120	[p7l89t3178r134b3314],
2	Pressure	NN	O	pressure	_	0	SENT_120	[p7l93t2943r134b3154],
3	(	CD	NUMBER	(	num	5	SENT_120	[p7l93t2812r148b2923],
4	mm	NN	O	mm	nn	5	SENT_120	[p7l93t2812r148b2923],
5	Hg	NN	O	hg	dep	2	SENT_120	[p7l93t2702r148b2788],
6	)	CD	NUMBER	)	dep	2	SENT_120	[p7l93t2702r148b2788],

1	Diastolic	JJ	O	diastolic	_	0	SENT_121	[p7l145t3673r358b3718],

1	100-I	NN	O	100-i	_	0	SENT_122	[p7l253t3766r366b3834],

1	Water	NN	O	water	_	0	SENT_123	[p8l1602t305r1735b343],

1	Grapefruit	NN	O	grapefruit	nn	2	SENT_124	[p8l1604t397r1839b452],
2	juice	NN	O	juice	_	0	SENT_124	[p8l1854t401r1962b453],

1	Blood	NN	O	blood	nn	2	SENT_125	[p8l89t599r134b735],
2	Pressure	NN	O	pressure	_	0	SENT_125	[p8l93t364r134b575],
3	(	CD	NUMBER	(	num	5	SENT_125	[p8l93t233r148b343],
4	mm	NN	O	mm	nn	5	SENT_125	[p8l93t233r148b343],
5	Hg	NN	O	hg	dep	2	SENT_125	[p8l93t123r148b209],
6	)	CD	NUMBER	)	dep	2	SENT_125	[p8l93t123r148b209],

1	Figure	NN	O	figure	_	0	SENT_126	[p8l92t1430r309b1512],
2	2	CD	NUMBER	2	dep	1	SENT_126	[p8l332t1434r390b1492],
3	.	.	O	.	_	0	SENT_126	[p8l332t1434r390b1492],

1	Consequences	NNS	O	consequence	_	0	SENT_127	[p8l416t1433r925b1512],
2	of	IN	O	of	_	0	SENT_127	[p8l949t1427r1029b1493],
3	the	DT	O	the	det	4	SENT_127	[p8l1036t1428r1148b1493],
4	Inhibition	NN	O	inhibition	prep_of	1	SENT_127	[p8l1176t1428r1508b1493],
5	of	IN	O	of	_	0	SENT_127	[p8l1535t1427r1615b1493],
6	First-Pass	NNP	O	First-Pass	nn	7	SENT_127	[p8l1630t1430r1967b1493],
7	Metabolism	NNP	O	Metabolism	prep_of	4	SENT_127	[p8l93t1535r529b1612],
8	,	,	O	,	_	0	SENT_127	[p8l93t1535r529b1612],
9	as	IN	O	as	mark	10	SENT_127	[p8l557t1557r631b1599],
10	Exempliﬁed	JJ	O	exempliﬁed	dep	4	SENT_127	[p8l661t1534r1069b1619],
11	by	IN	O	by	_	0	SENT_127	[p8l1100t1535r1177b1620],
12	the	DT	O	the	det	13	SENT_127	[p8l1197t1535r1310b1599],
13	Interaction	NN	O	interaction	prep_by	10	SENT_127	[p8l1339t1536r1716b1599],
14	between	IN	O	between	_	0	SENT_127	[p8l90t1642r378b1707],
15	Felodipine	NNP	O	Felodipine	prep_between	1	SENT_127	[p8l410t1642r768b1725],
16	and	CC	O	and	_	0	SENT_127	[p8l792t1643r917b1706],
17	Grapefruitjuice	NNP	O	Grapefruitjuice	conj_and	15	SENT_127	[p8l945t1641r1516b1725],
18	.	.	O	.	_	0	SENT_127	[p8l945t1641r1516b1725],

1	The	DT	O	the	det	2	SENT_128	[p8l85t1771r216b1835],
2	increase	NN	O	increase	nsubj	32	SENT_128	[p8l245t1776r533b1835],
3	in	IN	O	in	_	0	SENT_128	[p8l563t1777r619b1834],
4	the	DT	O	the	det	7	SENT_128	[p8l647t1771r757b1835],
5	plasma	NN	O	plasma	nn	7	SENT_128	[p8l787t1771r1038b1855],
6	concentration	NN	O	concentration	nn	7	SENT_128	[p8l1066t1777r1552b1835],
7	offelodipine	NN	O	offelodipine	prep_in	2	SENT_128	[p8l1583t1770r2024b1855],
8	as	IN	O	as	_	0	SENT_128	[p8l89t1901r160b1942],
9	a	DT	O	a	det	11	SENT_128	[p8l190t1901r222b1942],
10	result	NN	O	result	nn	11	SENT_128	[p8l254t1878r448b1942],
11	ofthe	NN	O	ofthe	prep_as	7	SENT_128	[p8l474t1877r672b1942],
12	concomitant	JJ	O	concomitant	amod	18	SENT_128	[p8l699t1884r1147b1942],
13	ingestion	NN	O	ingestion	nn	18	SENT_128	[p8l1175t1884r1495b1963],
14	ofgrapefruit	NN	O	ofgrapefruit	nn	18	SENT_128	[p8l1526t1877r1963b1963],
15	juice	NN	O	juice	nn	18	SENT_128	[p8l85t1991r251b2070],
16	(	CD	NUMBER	(	num	18	SENT_128	[p8l285t1985r497b2069],
17	Panel	NN	O	panel	nn	18	SENT_128	[p8l285t1985r497b2069],
18	A	NN	O	a	dep	11	SENT_128	[p8l525t1989r592b2061],
19	;	:	O	;	_	0	SENT_128	[p8l525t1989r592b2061],
20	I	PRP	O	I	dep	21	SENT_128	[p8l620t1992r644b2048],
21	bars	NNS	O	bar	nsubj	22	SENT_128	[p8l673t1985r816b2049],
22	denote	VBP	O	denote	dep	11	SENT_128	[p8l845t1985r1086b2049],
23	SE5	NN	O	se5	nn	24	SENT_128	[p8l1113t1990r1262b2069],
24	)	NN	O	)	nsubj	25	SENT_128	[p8l1113t1990r1262b2069],
25	leads	VBZ	O	lead	ccomp	22	SENT_128	[p8l1299t1985r1476b2049],
26	to	TO	O	to	_	0	SENT_128	[p8l1502t1997r1570b2049],
27	increases	NNS	O	increase	prep_to	25	SENT_128	[p8l1600t1991r1926b2049],
28	in	IN	O	in	_	0	SENT_128	[p8l91t2098r147b2156],
29	the	DT	O	the	det	31	SENT_128	[p8l175t2092r285b2156],
30	cardiovascular	JJ	O	cardiovascular	amod	31	SENT_128	[p8l312t2092r827b2157],
31	effects	NNS	O	effect	prep_in	27	SENT_128	[p8l850t2091r1076b2156],
32	ofthe	VBP	O	ofthe	_	0	SENT_128	[p8l1106t2091r1304b2156],
33	drug	NN	O	drug	nn	36	SENT_128	[p8l1330t2092r1492b2177],
34	(	CD	NUMBER	(	num	36	SENT_128	[p8l1525t2092r1736b2176],
35	Panel	NN	O	panel	nn	36	SENT_128	[p8l1525t2092r1736b2176],
36	B	NN	O	b	dobj	32	SENT_128	[p8l1773t2098r1831b2167],
37	;	:	O	;	_	0	SENT_128	[p8l1773t2098r1831b2167],
38	I	PRP	O	I	dep	39	SENT_128	[p8l87t2207r111b2263],
39	bars	NNS	O	bar	nsubj	40	SENT_128	[p8l139t2199r283b2264],
40	denote	VBP	O	denote	dep	36	SENT_128	[p8l312t2199r553b2264],
41	SDS	NN	O	sd	nn	42	SENT_128	[p8l580t2204r770b2283],
42	)	NN	O	)	dobj	40	SENT_128	[p8l580t2204r770b2283],
43	.	.	O	.	_	0	SENT_128	[p8l580t2204r770b2283],

1	Blood	NN	O	blood	nn	2	SENT_129	[p8l805t2199r1001b2264],
2	pressure	NN	O	pressure	nsubjpass	7	SENT_129	[p8l1034t2222r1335b2283],
3	and	CC	O	and	_	0	SENT_129	[p8l1363t2199r1486b2264],
4	heart	NN	O	heart	nn	5	SENT_129	[p8l1520t2199r1697b2264],
5	rate	NN	O	rate	conj_and	2	SENT_129	[p8l1725t2212r1854b2264],
6	were	VBD	O	be	auxpass	7	SENT_129	[p8l86t2329r250b2370],
7	measured	VBN	O	measure	_	0	SENT_129	[p8l281t2306r624b2370],
8	while	IN	O	while	mark	12	SENT_129	[p8l651t2306r835b2370],
9	the	DT	O	the	det	10	SENT_129	[p8l859t2306r969b2370],
10	patients	NNS	O	patient	nsubj	12	SENT_129	[p8l999t2312r1277b2390],
11	were	VBD	O	be	aux	12	SENT_129	[p8l1303t2329r1467b2370],
12	standing	VBG	O	stand	advcl	7	SENT_129	[p8l1496t2306r1820b2391],
13	.	.	O	.	_	0	SENT_129	[p8l1496t2306r1820b2391],

1	Adapted	VBN	O	adapt	_	0	SENT_130	[p8l86t2413r379b2497],
2	from	IN	O	from	_	0	SENT_130	[p8l408t2412r572b2477],
3	Bailey	NNP	PERSON	Bailey	prep_from	1	SENT_130	[p8l608t2413r808b2498],
4	et	FW	O	et	nn	6	SENT_130	[p8l833t2425r895b2477],
5	a	FW	O	a	nn	6	SENT_130	[p8l922t2413r1105b2489],
6	|	NN	O	|	dep	3	SENT_130	[p8l922t2413r1105b2489],
7	.	.	O	.	_	0	SENT_130	[p8l922t2413r1105b2489],

1	,5	CD	NUMBER	,5	_	0	SENT_131	[p8l922t2413r1105b2489],
2	»	CD	NUMBER	»	number	3	SENT_131	[p8l922t2413r1105b2489],
3	5	CD	NUMBER	5	dep	1	SENT_131	[p8l922t2413r1105b2489],
4	with	IN	O	with	_	0	SENT_131	[p8l1129t2413r1274b2477],
5	the	DT	O	the	det	8	SENT_131	[p8l1302t2413r1412b2477],
6	permission	NN	O	permission	nn	8	SENT_131	[p8l1442t2419r1832b2497],
7	ofthe	NN	O	ofthe	nn	8	SENT_131	[p8l88t2519r287b2585],
8	publisher	NN	O	publisher	prep_with	3	SENT_131	[p8l317t2520r656b2604],
9	.	.	O	.	_	0	SENT_131	[p8l317t2520r656b2604],

1	or	CC	O	or	dep	3	SENT_132	[p8l20t2893r109b2945],
2	two	CD	NUMBER	two	num	3	SENT_132	[p8l133t2884r284b2947],
3	doses	NNS	O	dose	_	0	SENT_132	[p8l312t2868r546b2945],
4	of	IN	O	of	_	0	SENT_132	[p8l575t2867r676b2945],
5	the	DT	O	the	det	6	SENT_132	[p8l683t2868r812b2945],
6	drug	NN	O	drug	prep_of	3	SENT_132	[p8l840t2868r1038b2967],
7	that	WDT	O	that	nsubjpass	9	SENT_132	[p8l1061t2868r1227b2945],
8	was	VBD	O	be	auxpass	9	SENT_132	[p8l1244t2894r1404b2946],
9	added	VBN	O	add	rcmod	3	SENT_132	[p8l1432t2867r1709b2945],
10	.	.	O	.	_	0	SENT_132	[p8l1432t2867r1709b2945],

1	Thus	RB	O	thus	advmod	22	SENT_133	[p8l1738t2868r1974b2962],
2	,	,	O	,	_	0	SENT_133	[p8l1738t2868r1974b2962],
3	the	DT	O	the	det	4	SENT_133	[p8l2006t2868r2135b2945],
4	possibility	NN	O	possibility	nsubj	22	SENT_133	[p8l18t2995r455b3094],
5	of	IN	O	of	_	0	SENT_133	[p8l480t2994r579b3072],
6	an	DT	O	a	det	8	SENT_133	[p8l589t3020r688b3072],
7	adverse	JJ	O	adverse	amod	8	SENT_133	[p8l716t2995r1029b3073],
8	effect	NN	O	effect	prep_of	4	SENT_133	[p8l1058t2994r1291b3072],
9	caused	VBN	O	cause	partmod	8	SENT_133	[p8l1315t2995r1599b3073],
10	by	IN	O	by	_	0	SENT_133	[p8l1629t2995r1725b3094],
11	the	DT	O	the	det	12	SENT_133	[p8l1749t2995r1878b3072],
12	interaction	NN	O	interaction	agent	9	SENT_133	[p8l1906t2995r2134b3072, p8l19t3122r276b3199],
13	of	IN	O	of	_	0	SENT_133	[p8l307t3121r407b3199],
14	the	DT	O	the	det	16	SENT_133	[p8l418t3122r547b3199],
15	new	JJ	O	new	amod	16	SENT_133	[p8l576t3147r751b3200],
16	agent	NN	O	agent	prep_of	12	SENT_133	[p8l776t3138r1012b3221],
17	with	IN	O	with	_	0	SENT_133	[p8l1032t3122r1220b3200],
18	the	DT	O	the	det	20	SENT_133	[p8l1250t3122r1378b3199],
19	original	JJ	O	original	amod	20	SENT_133	[p8l1409t3121r1737b3221],
20	drug	NN	O	drug	prep_with	9	SENT_133	[p8l1766t3122r1965b3221],
21	immediately	RB	O	immediately	advmod	22	SENT_133	[p8l1991t3122r2134b3198, p8l19t3249r437b3348],
22	increases	VBZ	O	increase	_	0	SENT_133	[p8l480t3249r900b3343],
23	,	,	O	,	_	0	SENT_133	[p8l480t3249r900b3343],
24	despite	IN	O	despite	_	0	SENT_133	[p8l954t3249r1259b3348],
25	a	DT	O	a	det	28	SENT_133	[p8l1306t3275r1351b3326],
26	previously	RB	DATE	previously	advmod	27	SENT_133	[p8l1396t3249r1837b3348],
27	stable	JJ	O	stable	amod	28	SENT_133	[p8l1883t3249r2134b3326],
28	course	NN	O	course	prep_despite	22	SENT_133	[p8l20t3402r299b3456],
29	on	IN	O	on	_	0	SENT_133	[p8l326t3402r433b3455],
30	that	DT	O	that	det	33	SENT_133	[p8l458t3377r624b3455],
31	medication	NN	O	medication	nn	33	SENT_133	[p8l643t3371r1288b3455],
32	.9	CD	NUMBER	.9	num	33	SENT_133	[p8l643t3371r1288b3455],
33	’	NN	O	’	prep_on	28	SENT_133	[p8l643t3371r1288b3455],
34	1	CD	NUMBER	1	num	35	SENT_133	[p8l643t3371r1288b3455],
35	°	NN	O	°	dep	33	SENT_133	[p8l643t3371r1288b3455],

1	The	DT	O	the	det	2	SENT_134	[p8l144t3504r304b3581],
2	problem	NN	O	problem	nsubj	8	SENT_134	[p8l323t3504r679b3603],
3	of	IN	O	of	_	0	SENT_134	[p8l700t3503r800b3581],
4	drug	NN	O	drug	nn	5	SENT_134	[p8l802t3503r999b3603],
5	interactions	NNS	O	interaction	prep_of	2	SENT_134	[p8l1016t3504r1508b3581],
6	can	MD	O	can	aux	8	SENT_134	[p8l1531t3529r1673b3581],
7	be	VB	O	be	cop	8	SENT_134	[p8l1694t3504r1788b3581],
8	serious	JJ	O	serious	_	0	SENT_134	[p8l1811t3504r2130b3598],
9	,	,	O	,	_	0	SENT_134	[p8l1811t3504r2130b3598],
10	as	IN	O	as	mark	11	SENT_134	[p8l19t3657r102b3708],
11	exempliﬁed	VBN	O	exempliﬁed	advcl	8	SENT_134	[p8l126t3630r619b3730],
12	by	IN	O	by	_	0	SENT_134	[p8l640t3631r737b3730],
13	the	DT	O	the	det	14	SENT_134	[p8l754t3631r882b3708],
14	interaction	NN	O	interaction	prep_by	11	SENT_134	[p8l903t3631r1359b3708],
15	of	IN	O	of	_	0	SENT_134	[p8l1381t3630r1481b3708],
16	erythromycin	NN	O	erythromycin	prep_of	14	SENT_134	[p8l1485t3631r2067b3730],
17	,	,	O	,	_	0	SENT_134	[p8l1485t3631r2067b3730],
18	a	DT	O	a	det	19	SENT_134	[p8l2092t3657r2136b3708],
19	drug	NN	O	drug	appos	16	SENT_134	[p9l20t20r218b120],
20	that	WDT	O	that	nsubjpass	23	SENT_134	[p9l238t21r404b98],
21	is	VBZ	O	be	auxpass	23	SENT_134	[p9l422t21r486b98],
22	extensively	RB	O	extensively	advmod	23	SENT_134	[p9l512t20r967b120],
23	metabolized	VBN	O	metabolize	rcmod	19	SENT_134	[p9l985t20r1507b98],
24	by	IN	O	by	_	0	SENT_134	[p9l1531t21r1627b120],
25	CYP3A	NN	O	cyp3a	agent	23	SENT_134	[p9l1645t26r1952b115],
26	,	,	O	,	_	0	SENT_134	[p9l1645t26r1952b115],
27	and	CC	O	and	_	0	SENT_134	[p9l1980t21r2135b98],
28	inhibitory	JJ	O	inhibitory	amod	29	SENT_134	[p9l19t147r437b247],
29	drugs	NNS	O	drug	appos	16	SENT_134	[p9l458t148r695b247],
30	such	JJ	O	such	_	0	SENT_134	[p9l725t148r918b226],
31	as	IN	O	as	_	0	SENT_134	[p9l944t174r1027b225],
32	nitroimidazole	JJ	O	nitroimidazole	amod	34	SENT_134	[p9l1055t148r1678b225],
33	antifungal	JJ	O	antifungal	amod	34	SENT_134	[p9l1703t147r2135b247],
34	agents	NNS	O	agent	prep_such_as	29	SENT_134	[p9l19t291r316b374],
35	,	,	O	,	_	0	SENT_134	[p9l19t291r316b374],
36	diltiazem	NN	O	diltiazem	appos	34	SENT_134	[p9l349t275r763b369],
37	,	,	O	,	_	0	SENT_134	[p9l349t275r763b369],
38	verapamil	NN	O	verapamil	appos	34	SENT_134	[p9l790t275r1230b374],
39	,	,	O	,	_	0	SENT_134	[p9l790t275r1230b374],
40	and	CC	O	and	_	0	SENT_134	[p9l1261t274r1417b352],
41	troleandomycin	NN	O	troleandomycin	conj_and	36	SENT_134	[p9l1442t275r2130b374],
42	.	.	O	.	_	0	SENT_134	[p9l1442t275r2130b374],

1	Increased	VBN	O	increase	amod	3	SENT_135	[p9l18t402r424b479],
2	erythromycin	NN	O	erythromycin	nn	3	SENT_135	[p9l449t402r1008b501],
3	levels	NNS	O	level	nsubj	5	SENT_135	[p9l1032t402r1259b480],
4	may	MD	O	may	aux	5	SENT_135	[p9l1287t427r1462b501],
5	develop	VB	O	develop	_	0	SENT_135	[p9l1484t401r1804b501],
6	in	IN	O	in	_	0	SENT_135	[p9l1829t402r1910b478],
7	a	DT	O	a	det	8	SENT_135	[p9l1935t428r1979b479],
8	patient	NN	O	patient	prep_in	5	SENT_135	[p9l2001t428r2134b501, p9l20t529r213b606],
9	taking	VBG	O	take	partmod	8	SENT_135	[p9l231t528r502b628],
10	both	CC	O	both	dep	11	SENT_135	[p9l522t528r714b606],
11	erythromycin	NN	O	erythromycin	dobj	9	SENT_135	[p9l738t529r1297b628],
12	and	CC	O	and	_	0	SENT_135	[p9l1320t529r1475b606],
13	one	CD	NUMBER	one	prep_in	5	SENT_135	[p9l1499t554r1650b606],
14	of	IN	O	of	_	0	SENT_135	[p9l1674t528r1774b606],
15	these	DT	O	these	det	16	SENT_135	[p9l1779t529r1997b606],
16	inhibitors	NNS	O	inhibitor	prep_of	13	SENT_135	[p9l2020t529r2134b605, p9l19t656r362b733],
17	.	.	O	.	_	0	SENT_135	[p9l2020t529r2134b605, p9l19t656r362b733],

1	In	IN	O	in	_	0	SENT_136	[p9l386t663r472b732],
2	turn	NN	O	turn	prep_in	18	SENT_136	[p9l493t672r687b750],
3	,	,	O	,	_	0	SENT_136	[p9l493t672r687b750],
4	since	IN	O	since	mark	6	SENT_136	[p9l714t656r921b733],
5	erythromycin	NN	O	erythromycin	nsubj	6	SENT_136	[p9l942t656r1489b755],
6	prolongs	VBZ	O	prolong	advcl	18	SENT_136	[p9l1508t656r1878b755],
7	cardiac	JJ	O	cardiac	amod	8	SENT_136	[p9l1901t655r2135b733, p9l19t809r105b860],
8	repolarization	NN	O	repolarization	dobj	6	SENT_136	[p9l128t782r744b882],
9	,	,	O	,	_	0	SENT_136	[p9l128t782r744b882],
10	sudden	JJ	O	sudden	amod	11	SENT_136	[p9l774t783r1079b861],
11	death	NN	O	death	nsubj	18	SENT_136	[p9l1103t782r1333b860],
12	caused	VBN	O	cause	partmod	11	SENT_136	[p9l1358t782r1643b861],
13	by	IN	O	by	_	0	SENT_136	[p9l1667t783r1764b882],
14	torsades	NNS	O	torsade	agent	12	SENT_136	[p9l1783t783r2133b860],
15	de	IN	O	de	_	0	SENT_136	[p9l20t910r116b987],
16	pointes	NNS	O	pointe	prep_de	14	SENT_136	[p9l145t910r461b1009],
17	may	MD	O	may	aux	18	SENT_136	[p9l494t936r672b1009],
18	occur	VB	O	occur	_	0	SENT_136	[p9l698t904r1041b988],
19	.	.	O	.	_	0	SENT_136	[p9l698t904r1041b988],

1	“	NN	O	“	_	0	SENT_137	[p9l698t904r1041b988],
2	When	WRB	O	when	advmod	7	SENT_137	[p9l1067t910r1324b987],
3	an	DT	O	a	det	6	SENT_137	[p9l1354t935r1454b987],
4	orally	RB	O	orally	advmod	5	SENT_137	[p9l1486t910r1726b1009],
5	administered	VBN	O	administer	amod	6	SENT_137	[p9l1752t910r2132b987, p9l20t1037r234b1114],
6	drug	NN	O	drug	nsubj	7	SENT_137	[p9l263t1036r461b1136],
7	undergoes	VBZ	O	undergo	dep	1	SENT_137	[p9l486t1037r926b1136],
8	extensive	JJ	O	extensive	acomp	7	SENT_137	[p9l957t1037r1337b1115],
9	ﬁrst	IN	O	ﬁrst	_	0	SENT_137	[p9l1364t1036r1753b1136],
10	—	CD	NUMBER	—	num	12	SENT_137	[p9l1364t1036r1753b1136],
11	pass	NN	O	pass	nn	12	SENT_137	[p9l1364t1036r1753b1136],
12	metabolism	NN	O	metabolism	prep_ﬁrst	8	SENT_137	[p9l1783t1037r2133b1114, p9l19t1164r223b1258],
13	,	,	O	,	_	0	SENT_137	[p9l1783t1037r2133b1114, p9l19t1164r223b1258],
14	its	PRP$	O	its	poss	15	SENT_137	[p9l254t1164r349b1241],
15	bioavailability	NN	O	bioavailability	nsubj	23	SENT_137	[p9l377t1164r964b1263],
16	in	IN	O	in	_	0	SENT_137	[p9l984t1164r1065b1240],
17	the	DT	O	the	det	18	SENT_137	[p9l1091t1164r1219b1241],
18	face	NN	O	face	prep_in	15	SENT_137	[p9l1245t1163r1410b1241],
19	of	IN	O	of	_	0	SENT_137	[p9l1437t1163r1537b1241],
20	CYP3A	NN	O	cyp3a	nn	21	SENT_137	[p9l1544t1169r1831b1242],
21	inhibition	NN	O	inhibition	prep_of	18	SENT_137	[p9l1852t1164r2134b1241, p9l20t1291r185b1368],
22	may	MD	O	may	aux	23	SENT_137	[p9l219t1317r394b1390],
23	increase	VB	O	increase	parataxis	7	SENT_137	[p9l424t1291r768b1368],
24	severalfold	JJ	O	severalfold	acomp	23	SENT_137	[p9l804t1290r1281b1385],
25	,	,	O	,	_	0	SENT_137	[p9l804t1290r1281b1385],
26	whereas	IN	O	whereas	mark	33	SENT_137	[p9l1315t1290r1662b1369],
27	the	DT	O	the	det	28	SENT_137	[p9l1699t1291r1828b1368],
28	rate	NN	O	rate	nsubjpass	33	SENT_137	[p9l1862t1307r2018b1368],
29	of	IN	O	of	_	0	SENT_137	[p9l2053t1290r2153b1368],
30	elimination	NN	O	elimination	prep_of	28	SENT_137	[p9l20t1418r505b1495],
31	may	MD	O	may	aux	33	SENT_137	[p9l541t1444r717b1517],
32	be	VB	O	be	auxpass	33	SENT_137	[p9l748t1418r844b1495],
33	reduced	VBN	O	reduce	advcl	23	SENT_137	[p9l880t1417r1237b1512],
34	,	,	O	,	_	0	SENT_137	[p9l880t1417r1237b1512],
35	thus	RB	O	thus	advmod	36	SENT_137	[p9l1278t1418r1457b1496],
36	prolonging	VBG	O	prolong	ccomp	7	SENT_137	[p9l1494t1418r1973b1517],
37	the	DT	O	the	det	38	SENT_137	[p9l2006t1418r2135b1495],
38	presence	NN	O	presence	dobj	36	SENT_137	[p9l18t1571r389b1645],
39	of	IN	O	of	_	0	SENT_137	[p9l416t1544r516b1623],
40	the	DT	O	the	det	41	SENT_137	[p9l523t1545r651b1623],
41	drug	NN	O	drug	prep_of	38	SENT_137	[p9l677t1545r876b1645],
42	in	IN	O	in	_	0	SENT_137	[p9l897t1546r978b1622],
43	the	DT	O	the	det	44	SENT_137	[p9l1003t1545r1132b1623],
44	body	NN	O	body	prep_in	41	SENT_137	[p9l1157t1542r1420b1645],
45	.7	CD	NUMBER	.7	num	44	SENT_137	[p9l1157t1542r1420b1645],

1	When	WRB	O	when	advmod	5	SENT_138	[p9l144t1673r397b1750],
2	a	DT	O	a	det	3	SENT_138	[p9l423t1699r467b1750],
3	drug	NN	O	drug	nsubjpass	5	SENT_138	[p9l493t1672r691b1772],
4	is	VBZ	O	be	auxpass	5	SENT_138	[p9l714t1673r778b1750],
5	administered	VBN	O	administer	advcl	13	SENT_138	[p9l806t1673r1362b1750],
6	by	IN	O	by	_	0	SENT_138	[p9l1388t1673r1485b1772],
7	mouth	NN	O	mouth	agent	5	SENT_138	[p9l1507t1673r1810b1767],
8	,	,	O	,	_	0	SENT_138	[p9l1507t1673r1810b1767],
9	intestinal	JJ	O	intestinal	amod	11	SENT_138	[p9l1841t1673r2134b1750, p9l19t1800r146b1877],
10	CYP3A	NN	O	cyp3a	nn	11	SENT_138	[p9l173t1805r459b1878],
11	enzymes	NNS	O	enzyme	nsubjpass	23	SENT_138	[p9l483t1825r844b1899],
12	are	VBP	O	be	auxpass	13	SENT_138	[p9l872t1826r997b1877],
13	exposed	VBN	O	expose	_	0	SENT_138	[p9l1025t1800r1366b1899],
14	to	TO	O	to	_	0	SENT_138	[p9l1392t1816r1471b1877],
15	higher	JJR	O	higher	amod	16	SENT_138	[p9l1498t1799r1775b1899],
16	levels	NNS	O	level	prep_to	13	SENT_138	[p9l1797t1800r2025b1878],
17	of	IN	O	of	_	0	SENT_138	[p9l2054t1799r2153b1877],
18	the	DT	O	the	det	20	SENT_138	[p9l20t1926r148b2004],
19	interacting	VBG	O	interact	amod	20	SENT_138	[p9l181t1927r640b2026],
20	drug	NN	O	drug	prep_of	16	SENT_138	[p9l670t1927r868b2026],
21	and	CC	O	and	_	0	SENT_138	[p9l897t1926r1052b2004],
22	are	VBP	O	be	auxpass	23	SENT_138	[p9l1084t1953r1209b2004],
23	inhibited	VBN	O	inhibit	conj_and	13	SENT_138	[p9l1242t1927r1622b2004],
24	to	TO	O	to	_	0	SENT_138	[p9l1655t1943r1733b2004],
25	a	DT	O	a	det	27	SENT_138	[p9l1767t1953r1811b2004],
26	greater	JJR	O	greater	amod	27	SENT_138	[p9l1842t1943r2138b2026],
27	extent	NN	O	extent	prep_to	23	SENT_138	[p9l20t2070r275b2131],
28	than	IN	O	than	mark	32	SENT_138	[p9l293t2054r479b2131],
29	are	VBP	O	be	cop	32	SENT_138	[p9l501t2080r625b2131],
30	hepatic	JJ	O	hepatic	amod	32	SENT_138	[p9l648t2054r950b2153],
31	CYP3A	NN	O	cyp3a	nn	32	SENT_138	[p9l973t2059r1257b2132],
32	enzymes	NNS	O	enzyme	advcl	23	SENT_138	[p9l1278t2079r1661b2153],
33	,	,	O	,	_	0	SENT_138	[p9l1278t2079r1661b2153],
34	which	WDT	O	which	nsubj	37	SENT_138	[p9l1685t2054r1942b2132],
35	may	MD	O	may	aux	37	SENT_138	[p9l1965t2080r2140b2153],
36	be	VB	O	be	cop	37	SENT_138	[p9l20t2181r115b2258],
37	unaffected	JJ	O	unaffected	rcmod	32	SENT_138	[p9l148t2180r614b2259],
38	.	.	O	.	_	0	SENT_138	[p9l148t2180r614b2259],

1	The	DT	O	the	det	2	SENT_139	[p9l650t2181r811b2258],
2	interaction	NN	O	interaction	nsubj	9	SENT_139	[p9l844t2181r1301b2258],
3	between	IN	O	between	_	0	SENT_139	[p9l1335t2181r1683b2259],
4	grapefruit	NN	O	grapefruit	nn	5	SENT_139	[p9l1716t2180r2140b2280],
5	juice	NN	O	juice	prep_between	2	SENT_139	[p9l6t2309r211b2408],
6	and	CC	O	and	_	0	SENT_139	[p9l236t2308r392b2386],
7	CYP3A	NN	O	cyp3a	nn	8	SENT_139	[p9l417t2314r704b2386],
8	substrates	NNS	O	substrate	conj_and	5	SENT_139	[p9l728t2308r1151b2387],
9	is	VBZ	O	be	_	0	SENT_139	[p9l1178t2309r1242b2386],
10	such	JJ	O	such	prep	9	SENT_139	[p9l1272t2308r1466b2387],
11	a	DT	O	a	det	16	SENT_139	[p9l1491t2334r1535b2386],
12	situation5	NN	O	situation5	nn	16	SENT_139	[p9l1560t2301r2134b2387],
13	’	NN	O	’	nn	16	SENT_139	[p9l1560t2301r2134b2387],
14	6	CD	NUMBER	6	number	15	SENT_139	[p9l1560t2301r2134b2387],
15	’12	CD	NUMBER	’12	num	16	SENT_139	[p9l1560t2301r2134b2387],
16	—	NN	O	—	dep	10	SENT_139	[p9l16t2480r123b2488],
17	peak	NN	O	peak	nn	19	SENT_139	[p9l144t2435r347b2535],
18	drug	NN	O	drug	nn	19	SENT_139	[p9l370t2436r569b2535],
19	levels	NNS	O	level	nsubjpass	22	SENT_139	[p9l592t2436r818b2514],
20	may	MD	O	may	aux	22	SENT_139	[p9l847t2462r1024b2535],
21	be	VB	O	be	auxpass	22	SENT_139	[p9l1047t2436r1141b2513],
22	increased	VBN	O	increase	rcmod	16	SENT_139	[p9l1168t2436r1567b2513],
23	by	IN	O	by	_	0	SENT_139	[p9l1595t2436r1692b2535],
24	a	DT	O	a	det	25	SENT_139	[p9l1713t2462r1758b2513],
25	factor	NN	O	factor	agent	22	SENT_139	[p9l1783t2435r2029b2513],
26	of	IN	O	of	_	0	SENT_139	[p9l2053t2435r2153b2513],
27	three	CD	NUMBER	three	prep_of	25	SENT_139	[p9l20t2563r229b2640],
28	Without	IN	O	without	_	0	SENT_139	[p9l246t2563r577b2642],
29	any	DT	O	any	det	35	SENT_139	[p9l592t2588r737b2662],
30	change	NN	O	change	dep	35	SENT_139	[p9l755t2562r1052b2662],
31	in	IN	O	in	_	0	SENT_139	[p9l1072t2563r1153b2639],
32	the	DT	O	the	det	33	SENT_139	[p9l1174t2562r1301b2640],
33	half	NN	O	half	prep_in	30	SENT_139	[p9l1323t2562r1647b2640],
34	—	JJ	O	—	amod	35	SENT_139	[p9l1323t2562r1647b2640],
35	life	NN	O	life	prep_without	22	SENT_139	[p9l1323t2562r1647b2640],
36	of	IN	O	of	_	0	SENT_139	[p9l1669t2562r1768b2640],
37	the	DT	O	the	det	38	SENT_139	[p9l1771t2563r1899b2640],
38	medication	NN	O	medication	prep_of	35	SENT_139	[p9l1920t2562r2134b2640, p9l19t2690r325b2767],
39	.	.	O	.	_	0	SENT_139	[p9l1920t2562r2134b2640, p9l19t2690r325b2767],

1	However	RB	O	however	advmod	9	SENT_140	[p9l355t2697r745b2784],
2	,	,	O	,	_	0	SENT_140	[p9l355t2697r745b2784],
3	the	DT	O	the	det	4	SENT_140	[p9l778t2690r906b2767],
4	magnitude	NN	O	magnitude	nsubj	9	SENT_140	[p9l932t2690r1386b2789],
5	of	IN	O	of	_	0	SENT_140	[p9l1414t2689r1514b2767],
6	this	DT	O	this	det	7	SENT_140	[p9l1522t2690r1674b2767],
7	phenomenon	NN	O	phenomenon	prep_of	4	SENT_140	[p9l1701t2690r2134b2789, p9l19t2842r183b2894],
8	is	VBZ	O	be	cop	9	SENT_140	[p9l214t2817r278b2894],
9	unpredictable	JJ	O	unpredictable	_	0	SENT_140	[p9l311t2817r894b2916],
10	and	CC	O	and	_	0	SENT_140	[p9l924t2816r1079b2894],
11	varies	VBZ	O	vary	conj_and	9	SENT_140	[p9l1106t2817r1346b2895],
12	Widely	RB	O	widely	advmod	11	SENT_140	[p9l1375t2816r1651b2916],
13	among	IN	O	among	_	0	SENT_140	[p9l1677t2842r1975b2916],
14	patients	NNS	O	patient	prep_among	11	SENT_140	[p9l2001t2843r2134b2916, p9l20t2945r274b3022],
15	.	.	O	.	_	0	SENT_140	[p9l2001t2843r2134b2916, p9l20t2945r274b3022],

1	A	DT	O	a	det	11	SENT_141	[p9l144t3078r210b3147],
2	single	JJ	O	single	amod	8	SENT_141	[p9l240t3071r488b3170],
3	8	CD	NUMBER	8	number	4	SENT_141	[p9l521t3076r704b3148],
4	—	CD	NUMBER	—	dep	5	SENT_141	[p9l521t3076r704b3148],
5	oz	NN	O	oz	dep	8	SENT_141	[p9l521t3076r704b3148],
6	(	NN	O	(	nn	8	SENT_141	[p9l741t3071r1101b3161],
7	250	CD	NUMBER	250	num	8	SENT_141	[p9l741t3071r1101b3161],
8	—	NN	O	—	nn	11	SENT_141	[p9l741t3071r1101b3161],
9	ml	NN	O	ml	nn	11	SENT_141	[p9l741t3071r1101b3161],
10	)	NN	O	)	nn	11	SENT_141	[p9l741t3071r1101b3161],
11	glass	NN	O	glass	nsubj	16	SENT_141	[p9l1138t3071r1346b3170],
12	of	IN	O	of	_	0	SENT_141	[p9l1380t3070r1480b3148],
13	grapefruit	NN	O	grapefruit	nn	14	SENT_141	[p9l1493t3070r1917b3170],
14	juice	NN	O	juice	prep_of	11	SENT_141	[p9l1929t3071r2135b3170],
15	can	MD	O	can	aux	16	SENT_141	[p9l20t3223r163b3275],
16	cause	VB	O	cause	_	0	SENT_141	[p9l187t3224r417b3276],
17	CYP3A	NN	O	cyp3a	nn	18	SENT_141	[p9l441t3203r728b3276],
18	inhibition	NN	O	inhibition	dobj	16	SENT_141	[p9l747t3198r1166b3276],
19	for	IN	O	for	_	0	SENT_141	[p9l1190t3197r1313b3276],
20	24	CD	DURATION	24	number	22	SENT_141	[p9l1333t3203r1434b3276],
21	to	TO	DURATION	to	dep	22	SENT_141	[p9l1458t3214r1537b3276],
22	48	CD	DURATION	48	num	23	SENT_141	[p9l1560t3203r1660b3276],
23	hours	NNS	NUMBER	hour	prep_for	18	SENT_141	[p9l1686t3198r1951b3292],
24	,	,	O	,	_	0	SENT_141	[p9l1686t3198r1951b3292],
25	and	CC	O	and	_	0	SENT_141	[p9l1980t3198r2135b3276],
26	regular	JJ	O	regular	amod	27	SENT_141	[p9l19t3324r317b3424],
27	consumption	NN	O	consumption	nsubj	30	SENT_141	[p9l340t3325r897b3424],
28	may	MD	O	may	aux	30	SENT_141	[p9l921t3350r1096b3424],
29	continually	RB	O	continually	advmod	30	SENT_141	[p9l1117t3325r1583b3424],
30	inhibit	VB	O	inhibit	conj_and	16	SENT_141	[p9l1603t3324r1883b3402],
31	intestinal	JJ	O	intestinal	amod	33	SENT_141	[p9l1903t3325r2134b3402, p9l20t3452r204b3529],
32	CYP3A	NN	O	cyp3a	nn	33	SENT_141	[p9l238t3457r524b3530],
33	activity	NN	O	activity	dobj	30	SENT_141	[p9l555t3452r861b3551],
34	.	.	O	.	_	0	SENT_141	[p9l555t3452r861b3551],

1	For	IN	O	for	_	0	SENT_142	[p9l900t3459r1043b3529],
2	these	DT	O	these	det	3	SENT_142	[p9l1076t3452r1294b3529],
3	reasons	NNS	O	reason	prep_for	8	SENT_142	[p9l1329t3477r1676b3546],
4	,	,	O	,	_	0	SENT_142	[p9l1329t3477r1676b3546],
5	grapefruit	NN	O	grapefruit	nn	6	SENT_142	[p9l1716t3451r2140b3551],
6	juice	NN	O	juice	nsubjpass	8	SENT_142	[p9l6t3579r211b3678],
7	is	VBZ	O	be	auxpass	8	SENT_142	[p9l238t3579r303b3656],
8	contraindicated	VBN	O	contraindicate	_	0	SENT_142	[p9l335t3578r992b3656],
9	in	IN	O	in	_	0	SENT_142	[p9l1019t3579r1100b3655],
10	patients	NNS	O	patient	prep_in	8	SENT_142	[p9l1126t3579r1459b3678],
11	receiving	VBG	O	receive	partmod	10	SENT_142	[p9l1490t3579r1871b3678],
12	drugs	NNS	O	drug	dobj	11	SENT_142	[p9l1896t3579r2133b3678],
13	that	WDT	O	that	nsubjpass	16	SENT_142	[p9l20t3706r189b3783],
14	are	VBP	O	be	auxpass	16	SENT_142	[p9l227t3732r354b3783],
15	extensively	RB	O	extensively	advmod	16	SENT_142	[p9l399t3706r864b3805],
16	metabolized	VBN	O	metabolize	rcmod	12	SENT_142	[p9l903t3706r1436b3783],
17	by	IN	O	by	_	0	SENT_142	[p9l1480t3706r1577b3805],
18	CYP3A	NN	O	cyp3a	agent	16	SENT_142	[p9l1616t3711r1928b3800],
19	,	,	O	,	_	0	SENT_142	[p9l1616t3711r1928b3800],
20	and	CC	O	and	cc	16	SENT_142	[p9l1977t3705r2134b3783],
21	especially	RB	O	especially	advmod	16	SENT_142	[p10l20t21r437b120],
22	in	IN	O	in	dep	16	SENT_142	[p10l458t21r540b97],
23	patients	NNS	O	patient	pobj	22	SENT_142	[p10l566t21r907b120],
24	receiving	VBG	O	receive	xcomp	16	SENT_142	[p10l935t21r1326b120],
25	drugs	NNS	O	drug	dobj	24	SENT_142	[p10l1350t21r1590b120],
26	with	IN	O	with	_	0	SENT_142	[p10l1615t20r1806b99],
27	a	DT	O	a	det	30	SENT_142	[p10l1833t47r1877b98],
28	small	JJ	O	small	amod	30	SENT_142	[p10l1904t21r2134b98],
29	therapeutic	JJ	O	therapeutic	amod	30	SENT_142	[p10l20t148r504b247],
30	window	NN	O	window	prep_with	24	SENT_142	[p10l526t147r881b226],
31	.	.	O	.	_	0	SENT_142	[p10l526t147r881b226],

1	The	DT	O	the	det	2	SENT_143	[p10l910t148r1071b225],
2	mechanism	NN	O	mechanism	nsubj	7	SENT_143	[p10l1098t148r1590b225],
3	of	IN	O	of	_	0	SENT_143	[p10l1617t147r1718b225],
4	this	DT	O	this	det	5	SENT_143	[p10l1726t148r1878b225],
5	interaction	NN	O	interaction	prep_of	2	SENT_143	[p10l1906t148r2134b225, p10l19t275r276b352],
6	probably	RB	O	probably	advmod	7	SENT_143	[p10l297t275r673b374],
7	involves	VBZ	O	involve	_	0	SENT_143	[p10l689t275r1024b354],
8	direct	JJ	O	direct	amod	9	SENT_143	[p10l1049t275r1290b352],
9	inhibition	NN	O	inhibition	dobj	7	SENT_143	[p10l1306t275r1725b352],
10	of	IN	O	of	_	0	SENT_143	[p10l1748t274r1848b352],
11	CYP3A	NN	O	cyp3a	prep_of	9	SENT_143	[p10l1851t280r2138b353],

1	2214	CD	DATE	2214	num	4	SENT_144	[p10l149t453r226b474],
2	N	NN	O	n	nn	4	SENT_144	[p10l912t455r925b470],
3	ENGLJ	NN	O	englj	nn	4	SENT_144	[p10l941t454r1025b476],
4	MED	NN	O	med	_	0	SENT_144	[p10l1040t455r1092b470],
5	352	CD	NUMBER	352	dep	4	SENT_144	[p10l1104t454r1181b476],
6	;	:	O	;	_	0	SENT_144	[p10l1104t454r1181b476],
7	21	CD	NUMBER	21	num	9	SENT_144	[p10l1104t454r1181b476],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_144	[p10l1218t454r1430b476],
9	MAY	NNP	DATE	MAY	dep	5	SENT_144	[p10l1469t454r1520b470],
10	26	CD	DATE	26	num	9	SENT_144	[p10l1532t449r1570b474],
11	,	,	O	,	_	0	SENT_144	[p10l1532t449r1570b474],
12	mos	NNS	DURATION	mo	appos	9	SENT_144	[p10l1584t454r1647b476],

1	The	DT	O	the	det	4	SENT_145	[p10l936t487r987b511],
2	New	NNP	O	New	nn	4	SENT_145	[p10l996t488r1058b511],
3	England	NNP	O	England	nn	4	SENT_145	[p10l1067t487r1178b518],
4	Journal	NNP	O	Journal	_	0	SENT_145	[p10l1187t487r1284b511],
5	of	IN	O	of	_	0	SENT_145	[p10l1294t487r1323b511],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_145	[p10l1330t487r1455b511],

1	Downloaded	VBN	O	download	_	0	SENT_146	[p10l378t528r548b551],
2	from	IN	O	from	_	0	SENT_146	[p10l557t528r621b551],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_146	[p10l630t528r748b558],
4	at	IN	O	at	_	0	SENT_146	[p10l759t532r782b551],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_146	[p10l790t528r973b551],
6	on	IN	O	on	_	0	SENT_146	[p10l982t535r1015b551],
7	January	NNP	DATE	January	prep_on	1	SENT_146	[p10l1023t528r1126b558],
8	5	CD	DATE	5	num	7	SENT_146	[p10l1136t528r1159b555],
9	,	,	DATE	,	_	0	SENT_146	[p10l1136t528r1159b555],
10	2014	CD	DATE	2014	num	7	SENT_146	[p10l1169t528r1242b551],
11	.	.	O	.	_	0	SENT_146	[p10l1169t528r1242b551],

1	For	IN	O	for	_	0	SENT_147	[p10l1252t528r1299b551],
2	personal	JJ	O	personal	amod	3	SENT_147	[p10l1307t528r1419b558],
3	use	NN	O	use	pobj	1	SENT_147	[p10l1428t535r1472b551],
4	only	RB	O	only	advmod	3	SENT_147	[p10l1482t528r1546b558],
5	.	.	O	.	_	0	SENT_147	[p10l1482t528r1546b558],

1	No	DT	O	no	det	3	SENT_148	[p10l1557t528r1597b551],
2	other	JJ	O	other	amod	3	SENT_148	[p10l1607t528r1675b551],
3	uses	NNS	O	use	_	0	SENT_148	[p10l1683t535r1739b551],
4	without	IN	O	without	_	0	SENT_148	[p10l1749t528r1850b551],
5	permission	NN	O	permission	prep_without	3	SENT_148	[p10l1859t528r2011b558],
6	.	.	O	.	_	0	SENT_148	[p10l1859t528r2011b558],

1	Copyright	NN	O	copyright	_	0	SENT_149	[p10l728t569r863b600],
2	©	CD	NUMBER	©	num	6	SENT_149	[p10l872t569r896b593],
3	2005	CD	DATE	2005	num	6	SENT_149	[p10l906t569r970b593],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_149	[p10l980t569r1171b593],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_149	[p10l1181t569r1289b593],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_149	[p10l1300t569r1405b600],
7	.	.	O	.	_	0	SENT_149	[p10l1300t569r1405b600],

1	All	DT	O	all	det	2	SENT_150	[p10l1416t569r1457b593],
2	rights	NNS	O	rights	nsubj	3	SENT_150	[p10l1466t569r1541b600],
3	reserved	VBN	O	reserve	_	0	SENT_150	[p10l1551t569r1670b593],
4	.	.	O	.	_	0	SENT_150	[p10l1551t569r1670b593],

1	DRUG	NN	O	drug	nn	2	SENT_151	[p10l950t675r1045b694],
2	THERAPY	NN	O	therapy	_	0	SENT_151	[p10l1057t675r1210b694],

1	activity	NN	O	activity	nsubj	14	SENT_152	[p10l10t889r302b989],
2	as	RB	O	as	_	0	SENT_152	[p10l318t915r401b967],
3	well	RB	O	well	_	0	SENT_152	[p10l420t889r593b968],
4	as	IN	O	as	_	0	SENT_152	[p10l614t915r698b967],
5	destruction	NN	O	destruction	nsubj	14	SENT_152	[p10l722t888r1194b968],
6	of	IN	O	of	_	0	SENT_152	[p10l1216t888r1317b967],
7	the	DT	O	the	det	9	SENT_152	[p10l1319t889r1447b967],
8	CYP3A	NN	O	cyp3a	nn	9	SENT_152	[p10l1469t894r1755b967],
9	enzymes	NNS	O	enzyme	prep_of	5	SENT_152	[p10l1774t914r2134b989],
10	by	IN	O	by	_	0	SENT_152	[p10l11t1017r108b1117],
11	phytochemicals	NNS	O	phytochemical	prep_by	9	SENT_152	[p10l127t1017r790b1117],
12	in	IN	O	in	_	0	SENT_152	[p10l817t1017r898b1094],
13	grapefruit	NN	O	grapefruit	prep_in	11	SENT_152	[p10l923t1016r1348b1117],
14	juice	NN	O	juice	_	0	SENT_152	[p10l1354t1017r1584b1117],
15	.	.	O	.	_	0	SENT_152	[p10l1354t1017r1584b1117],

1	Ingestion	NN	O	ingestion	nsubj	17	SENT_153	[p10l138t1145r548b1245],
2	of	IN	O	of	_	0	SENT_153	[p10l598t1144r699b1223],
3	the	DT	O	the	det	8	SENT_153	[p10l730t1145r860b1223],
4	calcium	NN	O	calcium	nn	8	SENT_153	[p10l910t1144r1628b1224],
5	—	NN	O	—	nn	8	SENT_153	[p10l910t1144r1628b1224],
6	channel	NN	O	channel	nn	8	SENT_153	[p10l910t1144r1628b1224],
7	antagonist	NN	O	antagonist	nn	8	SENT_153	[p10l1674t1145r2139b1245],
8	felodipine	NN	O	felodipine	prep_of	1	SENT_153	[p10l11t1272r429b1373],
9	with	IN	O	with	_	0	SENT_153	[p10l445t1273r632b1352],
10	one	CD	NUMBER	one	prep_with	8	SENT_153	[p10l652t1298r802b1351],
11	or	CC	O	or	_	0	SENT_153	[p10l822t1298r911b1351],
12	two	CD	NUMBER	two	num	13	SENT_153	[p10l927t1289r1078b1352],
13	glasses	NNS	O	glass	prep_of	1	SENT_153	[p10l1098t1273r1392b1373],
14	of	IN	O	of	_	0	SENT_153	[p10l1414t1272r1514b1351],
15	grapefruit	NN	O	grapefruit	nn	16	SENT_153	[p10l1514t1272r1932b1373],
16	juice	NN	O	juice	prep_of	13	SENT_153	[p10l1933t1273r2136b1373],
17	leads	VBZ	O	lead	_	0	SENT_153	[p10l10t1400r223b1479],
18	to	TO	O	to	_	0	SENT_153	[p10l255t1417r334b1479],
19	an	DT	O	a	det	21	SENT_153	[p10l364t1426r464b1479],
20	enhanced	VBN	O	enhance	amod	21	SENT_153	[p10l495t1401r901b1479],
21	reduction	NN	O	reduction	prep_to	17	SENT_153	[p10l931t1400r1335b1480],
22	in	IN	O	in	_	0	SENT_153	[p10l1364t1401r1445b1478],
23	blood	NN	O	blood	nn	24	SENT_153	[p10l1475t1400r1717b1479],
24	pressure	NN	O	pressure	prep_in	21	SENT_153	[p10l1745t1427r2130b1501],
25	,	,	O	,	_	0	SENT_153	[p10l1745t1427r2130b1501],
26	an	DT	O	a	det	27	SENT_153	[p10l10t1553r111b1605],
27	increase	NN	O	increase	appos	24	SENT_153	[p10l134t1528r480b1605],
28	in	IN	O	in	_	0	SENT_153	[p10l504t1528r584b1604],
29	heart	NN	O	heart	nn	30	SENT_153	[p10l609t1527r828b1605],
30	rate	NN	O	rate	prep_in	27	SENT_153	[p10l847t1544r1028b1622],
31	,	,	O	,	_	0	SENT_153	[p10l847t1544r1028b1622],
32	and	CC	O	and	_	0	SENT_153	[p10l1057t1528r1212b1606],
33	an	DT	O	a	det	34	SENT_153	[p10l1236t1553r1336b1605],
34	increase	NN	O	increase	nsubj	42	SENT_153	[p10l1360t1528r1705b1605],
35	in	IN	O	in	_	0	SENT_153	[p10l1729t1528r1811b1604],
36	the	DT	O	the	det	37	SENT_153	[p10l1835t1528r1964b1605],
37	frequency	NN	O	frequency	prep_in	34	SENT_153	[p10l1989t1527r2134b1605, p10l11t1681r312b1756],
38	of	IN	O	of	_	0	SENT_153	[p10l341t1655r442b1734],
39	vasodilatory	JJ	O	vasodilatory	amod	41	SENT_153	[p10l452t1656r968b1756],
40	adverse	JJ	O	adverse	amod	41	SENT_153	[p10l996t1655r1309b1735],
41	effects	NNS	O	effect	prep_of	37	SENT_153	[p10l1344t1655r1614b1734],
42	(	VBP	O	(	conj_and	17	SENT_153	[p10l1654t1663r1748b1747],
43	e.	NN	O	e.	nn	44	SENT_153	[p10l1654t1663r1748b1747],
44	g.	NN	O	g.	dobj	42	SENT_153	[p10l1759t1682r1860b1756],
45	,	,	O	,	_	0	SENT_153	[p10l1759t1682r1860b1756],
46	head	NN	O	head	nn	49	SENT_153	[p10l1900t1655r2134b1734],
47	—	CD	NUMBER	—	num	49	SENT_153	[p10l1900t1655r2134b1734],
48	ache	NN	O	ache	nn	49	SENT_153	[p10l10t1784r256b1879],
49	)	NN	O	)	appos	44	SENT_153	[p10l10t1784r256b1879],
50	,	,	O	,	_	0	SENT_153	[p10l10t1784r256b1879],
51	as	IN	O	as	_	0	SENT_153	[p10l285t1810r369b1862],
52	compared	VBN	O	compare	prepc_as	42	SENT_153	[p10l395t1783r814b1884],
53	with	IN	O	with	pcomp	52	SENT_153	[p10l833t1784r1020b1863],
54	the	DT	O	the	det	55	SENT_153	[p10l1044t1783r1172b1862],
55	administration	NN	O	administration	pobj	53	SENT_153	[p10l1196t1784r1817b1862],
56	of	IN	O	of	_	0	SENT_153	[p10l1842t1783r1941b1862],
57	felodipine	NN	O	felodipine	prep_of	55	SENT_153	[p10l1947t1783r2135b1862, p10l11t1912r274b2012],
58	with	IN	O	with	_	0	SENT_153	[p10l292t1912r481b1991],
59	water	NN	O	water	nn	61	SENT_153	[p10l499t1928r736b1991],
60	(	CD	NUMBER	(	num	61	SENT_153	[p10l761t1912r944b2012],
61	Fig	NN	O	fig	prep_with	57	SENT_153	[p10l761t1912r944b2012],
62	.	.	O	.	_	0	SENT_153	[p10l761t1912r944b2012],

1	2B	NN	O	2b	_	0	SENT_154	[p10l972t1917r1140b2003],
2	)	NN	O	)	dep	1	SENT_154	[p10l972t1917r1140b2003],
3	.	.	O	.	_	0	SENT_154	[p10l972t1917r1140b2003],

1	Other	JJ	O	other	amod	5	SENT_155	[p10l1168t1912r1412b1990],
2	calcium	NN	O	calcium	nn	5	SENT_155	[p10l1433t1911r2136b1991],
3	—	NN	O	—	nn	5	SENT_155	[p10l1433t1911r2136b1991],
4	channel	NN	O	channel	nn	5	SENT_155	[p10l1433t1911r2136b1991],
5	antagonists	NNS	O	antagonist	nsubj	25	SENT_155	[p10l10t2040r512b2140],
6	(	CD	NUMBER	(	npadvmod	7	SENT_155	[p10l559t2040r1083b2140],
7	particularly	RB	O	particularly	advmod	25	SENT_155	[p10l559t2040r1083b2140],
8	amlodipine	NN	O	amlodipine	nsubj	25	SENT_155	[p10l1118t2040r1635b2140],
9	,	,	O	,	_	0	SENT_155	[p10l1118t2040r1635b2140],
10	verapamil	NN	O	verapamil	nsubj	25	SENT_155	[p10l1677t2040r2128b2140],
11	,	,	O	,	_	0	SENT_155	[p10l1677t2040r2128b2140],
12	and	CC	O	and	_	0	SENT_155	[p10l10t2168r164b2246],
13	diltiazem	NN	O	diltiazem	nsubj	25	SENT_155	[p10l193t2168r576b2246],
14	but	CC	O	but	_	0	SENT_155	[p10l606t2167r744b2247],
15	also	RB	O	also	_	0	SENT_155	[p10l767t2168r931b2246],
16	nisoldipine	NN	O	nisoldipine	nsubj	25	SENT_155	[p10l962t2167r1450b2268],
17	,	,	O	,	_	0	SENT_155	[p10l962t2167r1450b2268],
18	nimodipine	NN	O	nimodipine	conj_and	16	SENT_155	[p10l1484t2167r1989b2268],
19	,	,	O	,	_	0	SENT_155	[p10l1484t2167r1989b2268],
20	nitrendipine	NN	O	nitrendipine	conj_and	8	SENT_155	[p10l2023t2168r2135b2245, p10l11t2295r482b2396],
21	,	,	O	,	_	0	SENT_155	[p10l2023t2168r2135b2245, p10l11t2295r482b2396],
22	and	CC	O	and	_	0	SENT_155	[p10l537t2296r695b2374],
23	pranidipine	NN	O	pranidipine	conj_and	8	SENT_155	[p10l743t2296r1277b2396],
24	)	CD	NUMBER	)	dep	16	SENT_155	[p10l743t2296r1277b2396],
25	seem	VBP	O	seem	_	0	SENT_155	[p10l1333t2322r1553b2374],
26	to	TO	O	to	aux	27	SENT_155	[p10l1603t2312r1683b2374],
27	cause	VB	O	cause	xcomp	25	SENT_155	[p10l1735t2322r1969b2375],
28	far	RB	O	far	advmod	29	SENT_155	[p10l2019t2295r2137b2374],
29	smaller	JJR	O	smaller	amod	31	SENT_155	[p10l12t2423r332b2502],
30	hemodynamic	JJ	O	hemodynamic	amod	31	SENT_155	[p10l357t2424r961b2524],
31	alterations	NNS	O	alteration	dobj	27	SENT_155	[p10l985t2424r1429b2502],
32	and	CC	O	and	_	0	SENT_155	[p10l1457t2424r1636b2519],
33	,	,	O	,	_	0	SENT_155	[p10l1457t2424r1636b2519],
34	thus	RB	O	thus	advmod	31	SENT_155	[p10l1668t2424r1873b2519],
35	,	,	O	,	_	0	SENT_155	[p10l1668t2424r1873b2519],
36	fewer	JJR	O	fewer	amod	41	SENT_155	[p10l1905t2423r2138b2503],
37	and	CC	O	and	_	0	SENT_155	[p10l10t2552r166b2630],
38	less	JJR	O	less	amod	41	SENT_155	[p10l186t2551r342b2630],
39	consequential	JJ	O	consequential	amod	41	SENT_155	[p10l366t2552r955b2652],
40	adverse	JJ	O	adverse	amod	41	SENT_155	[p10l976t2552r1290b2631],
41	effects	NNS	O	effect	dobj	27	SENT_155	[p10l1313t2551r1608b2630],
42	.	.	O	.	_	0	SENT_155	[p10l1313t2551r1608b2630],

1	Other	JJ	O	other	amod	2	SENT_156	[p10l1636t2552r1879b2630],
2	classes	NNS	O	class	nsubjpass	7	SENT_156	[p10l1900t2551r2134b2630, p10l11t2706r93b2758],
3	of	IN	O	of	_	0	SENT_156	[p10l148t2679r247b2758],
4	medication	NN	O	medication	prep_of	2	SENT_156	[p10l281t2679r756b2758],
5	can	MD	O	can	aux	7	SENT_156	[p10l807t2705r951b2758],
6	be	VB	O	be	auxpass	7	SENT_156	[p10l1003t2680r1099b2758],
7	affected	VBN	O	affect	_	0	SENT_156	[p10l1150t2679r1505b2758],
8	.	.	O	.	_	0	SENT_156	[p10l1150t2679r1505b2758],

1	For	IN	O	for	_	0	SENT_157	[p10l1561t2687r1705b2758],
2	example	NN	O	example	prep_for	11	SENT_157	[p10l1754t2680r2130b2780],
3	,	,	O	,	_	0	SENT_157	[p10l1754t2680r2130b2780],
4	trough	NN	O	trough	nn	6	SENT_157	[p10l11t2808r295b2908],
5	blood	NN	O	blood	nn	6	SENT_157	[p10l328t2807r571b2886],
6	concentrations	NNS	O	concentration	nsubjpass	11	SENT_157	[p10l604t2808r1232b2886],
7	of	IN	O	of	_	0	SENT_157	[p10l1267t2807r1367b2886],
8	cyclosporine	NN	O	cyclosporine	prep_of	6	SENT_157	[p10l1382t2808r1914b2908],
9	have	VBP	O	have	aux	11	SENT_157	[p10l1946t2808r2135b2887],
10	been	VBN	O	be	auxpass	11	SENT_157	[p10l11t2935r210b3014],
11	reported	VBN	O	report	_	0	SENT_157	[p10l241t2936r600b3036],
12	to	TO	O	to	aux	13	SENT_157	[p10l630t2952r709b3014],
13	increase	VB	O	increase	xcomp	11	SENT_157	[p10l740t2936r1085b3014],
14	by	IN	O	by	_	0	SENT_157	[p10l1117t2936r1214b3036],
15	a	DT	O	a	det	16	SENT_157	[p10l1238t2962r1283b3014],
16	factor	NN	O	factor	prep_by	13	SENT_157	[p10l1311t2935r1557b3014],
17	of	IN	O	of	_	0	SENT_157	[p10l1585t2935r1686b3014],
18	nearly	RB	O	nearly	quantmod	19	SENT_157	[p10l1697t2935r1956b3036],
19	two	CD	NUMBER	two	prep_of	16	SENT_157	[p10l1981t2952r2134b3015],
20	in	IN	O	in	_	0	SENT_157	[p10l10t3064r91b3141],
21	patients	NNS	O	patient	prep_in	13	SENT_157	[p10l116t3064r451b3164],
22	who	WP	O	who	nsubj	23	SENT_157	[p10l475t3064r658b3143],
23	ingest	VBP	O	ingest	rcmod	21	SENT_157	[p10l685t3064r946b3164],
24	grapefruit	NN	O	grapefruit	nn	25	SENT_157	[p10l967t3063r1393b3164],
25	juice	NN	O	juice	dobj	23	SENT_157	[p10l1400t3064r1606b3164],
26	on	IN	O	on	_	0	SENT_157	[p10l1634t3089r1740b3142],
27	a	DT	O	a	det	29	SENT_157	[p10l1766t3090r1811b3142],
28	regular	JJ	O	regular	amod	29	SENT_157	[p10l1835t3064r2138b3164],
29	basis	NN	O	basis	prep_on	25	SENT_157	[p10l11t3186r333b3270],
30	.	.	O	.	_	0	SENT_157	[p10l11t3186r333b3270],

1	”	NN	O	”	_	0	SENT_158	[p10l11t3186r333b3270],

1	In	IN	O	in	_	0	SENT_159	[p10l138t3327r225b3397],
2	addition	NN	O	addition	_	0	SENT_159	[p10l256t3319r609b3398],
3	to	TO	O	to	_	0	SENT_159	[p10l642t3336r721b3398],
4	the	DT	O	the	det	7	SENT_159	[p10l754t3320r883b3398],
5	previously	RB	DATE	previously	advmod	6	SENT_159	[p10l914t3320r1348b3420],
6	mentioned	VBN	O	mention	amod	7	SENT_159	[p10l1376t3320r1834b3398],
7	drugs	NNS	O	drug	prep_in_addition_to	10	SENT_159	[p10l1866t3320r2130b3420],
8	,	,	O	,	_	0	SENT_159	[p10l1866t3320r2130b3420],
9	there	EX	O	there	expl	10	SENT_159	[p10l11t3448r223b3526],
10	are	VBP	O	be	_	0	SENT_159	[p10l263t3474r388b3526],
11	many	JJ	O	many	amod	15	SENT_159	[p10l428t3473r662b3548],
12	other	JJ	O	other	amod	15	SENT_159	[p10l697t3447r921b3526],
13	known	JJ	O	known	amod	15	SENT_159	[p10l957t3447r1248b3527],
14	potent	JJ	O	potent	amod	15	SENT_159	[p10l1286t3464r1563b3548],
15	inhibitors	NNS	O	inhibitor	nsubj	10	SENT_159	[p10l1597t3448r2011b3526],
16	of	IN	O	of	_	0	SENT_159	[p10l2053t3447r2153b3526],
17	CYP3A	NN	O	cyp3a	prep_of	15	SENT_159	[p10l11t3581r299b3654],
18	that	IN	O	that	complm	28	SENT_159	[p10l323t3576r508b3671],
19	,	,	O	,	_	0	SENT_159	[p10l323t3576r508b3671],
20	even	RB	O	even	advmod	21	SENT_159	[p10l541t3601r728b3655],
21	when	WRB	O	when	advmod	22	SENT_159	[p10l751t3576r984b3655],
22	administered	VBN	O	administer	advcl	28	SENT_159	[p10l1011t3576r1569b3654],
23	at	IN	O	at	_	0	SENT_159	[p10l1595t3592r1674b3654],
24	customary	JJ	O	customary	amod	25	SENT_159	[p10l1697t3592r2140b3676],
25	doses	NNS	O	dose	prep_at	22	SENT_159	[p10l11t3704r272b3799],
26	,	,	O	,	_	0	SENT_159	[p10l11t3704r272b3799],
27	are	VBP	O	be	cop	28	SENT_159	[p10l305t3730r432b3782],
28	likely	JJ	O	likely	ccomp	10	SENT_159	[p10l459t3703r686b3804],
29	to	TO	O	to	aux	30	SENT_159	[p10l710t3720r789b3782],
30	increase	VB	O	increase	xcomp	28	SENT_159	[p10l819t3704r1165b3782],
31	the	DT	O	the	det	33	SENT_159	[p10l1194t3704r1323b3782],
32	plasma	NN	O	plasma	nn	33	SENT_159	[p10l1350t3704r1657b3804],
33	concentrations	NNS	O	concentration	dobj	30	SENT_159	[p10l1685t3720r2134b3782, p11l11t21r218b99],

1	of	IN	O	of	_	0	SENT_160	[p11l244t20r344b99],
2	drugs	NNS	O	drug	prep_of	7	SENT_160	[p11l349t21r587b121],
3	metabolized	VBN	O	metabolize	partmod	2	SENT_160	[p11l612t20r1136b99],
4	by	IN	O	by	_	0	SENT_160	[p11l1159t21r1256b121],
5	CYP3A	NN	O	cyp3a	agent	3	SENT_160	[p11l1274t26r1562b99],
6	enzymes	NNS	O	enzyme	nsubj	7	SENT_160	[p11l1583t46r1945b121],
7	(	VBP	O	(	_	0	SENT_160	[p11l1976t26r2134b112, p11l11t149r134b227],
8	Table	NNP	O	Table	nsubj	10	SENT_160	[p11l1976t26r2134b112, p11l11t149r134b227],
9	2	CD	NUMBER	2	num	10	SENT_160	[p11l157t154r262b240],
10	)	CD	NUMBER	)	xcomp	7	SENT_160	[p11l157t154r262b240],
11	.	.	O	.	_	0	SENT_160	[p11l157t154r262b240],

1	Adverse	JJ	O	adverse	amod	2	SENT_161	[p11l287t148r617b228],
2	effects	NNS	O	effect	nsubj	4	SENT_161	[p11l642t148r908b227],
3	are	VBP	O	be	cop	4	SENT_161	[p11l933t175r1058b227],
4	predictable	JJ	O	predictable	_	0	SENT_161	[p11l1080t148r1571b249],
5	,	,	O	,	_	0	SENT_161	[p11l1080t148r1571b249],
6	unless	IN	O	unless	mark	11	SENT_161	[p11l1600t149r1864b228],
7	a	DT	O	a	det	9	SENT_161	[p11l1888t175r1932b227],
8	dosage	NN	O	dosage	nn	9	SENT_161	[p11l1955t148r2134b227, p11l10t303r151b377],
9	adjustment	NN	O	adjustment	nsubjpass	11	SENT_161	[p11l170t276r641b377],
10	is	VBZ	O	be	auxpass	11	SENT_161	[p11l655t277r718b355],
11	made	VBN	O	make	advcl	4	SENT_161	[p11l740t277r991b355],
12	.	.	O	.	_	0	SENT_161	[p11l740t277r991b355],

1	However	RB	O	however	advmod	14	SENT_162	[p11l1015t284r1401b372],
2	,	,	O	,	_	0	SENT_162	[p11l1015t284r1401b372],
3	drugs	NNS	O	drug	nsubjpass	14	SENT_162	[p11l1427t277r1660b377],
4	that	WDT	O	that	nsubj	5	SENT_162	[p11l1683t276r1847b355],
5	inhibit	VBP	O	inhibit	rcmod	3	SENT_162	[p11l1861t276r2141b355],
6	CYP3A	NN	O	cyp3a	nn	7	SENT_162	[p11l11t410r299b483],
7	activity	NN	O	activity	dobj	5	SENT_162	[p11l319t405r615b505],
8	can	MD	O	can	aux	14	SENT_162	[p11l635t430r803b500],
9	,	,	O	,	_	0	SENT_162	[p11l635t430r803b500],
10	at	IN	O	at	_	0	SENT_162	[p11l833t421r911b483],
11	times	NNS	O	time	prep_at	14	SENT_162	[p11l931t405r1185b500],
12	,	,	O	,	_	0	SENT_162	[p11l931t405r1185b500],
13	be	VB	O	be	auxpass	14	SENT_162	[p11l1216t405r1311b483],
14	used	VBN	O	use	_	0	SENT_162	[p11l1336t404r1531b484],
15	to	TO	O	to	_	0	SENT_162	[p11l1555t421r1634b483],
16	therapeutic	JJ	O	therapeutic	amod	17	SENT_162	[p11l1660t405r2136b505],
17	advantage	NN	O	advantage	prep_to	14	SENT_162	[p11l10t532r452b633],
18	.	.	O	.	_	0	SENT_162	[p11l10t532r452b633],

1	For	IN	O	for	_	0	SENT_163	[p11l478t540r621b611],
2	example	NN	O	example	prep_for	6	SENT_163	[p11l641t533r1010b633],
3	,	,	O	,	_	0	SENT_163	[p11l641t533r1010b633],
4	ritonavir	NN	O	ritonavir	nsubj	6	SENT_163	[p11l1037t533r1392b612],
5	markedly	RB	O	markedly	advmod	6	SENT_163	[p11l1410t532r1801b633],
6	reduces	VBZ	O	reduce	dep	10	SENT_163	[p11l1818t533r2134b612],
7	the	DT	O	the	det	9	SENT_163	[p11l11t661r140b739],
8	CYP3A	NN	O	cyp3a	nn	9	SENT_163	[p11l170t660r882b739],
9	—	NN	O	—	dobj	6	SENT_163	[p11l170t660r882b739],
10	mediated	VBD	O	mediate	_	0	SENT_163	[p11l170t660r882b739],
11	ﬁrst	JJ	O	ﬁrst	amod	14	SENT_163	[p11l911t660r1301b761],
12	—	NN	O	—	nn	14	SENT_163	[p11l911t660r1301b761],
13	pass	NN	O	pass	nn	14	SENT_163	[p11l911t660r1301b761],
14	metabolism	NN	O	metabolism	dobj	10	SENT_163	[p11l1332t661r1837b739],
15	of	IN	O	of	_	0	SENT_163	[p11l1867t660r1967b739],
16	certain	JJ	O	certain	amod	17	SENT_163	[p11l1978t687r2134b739, p11l11t789r172b867],
17	inhibitors	NNS	O	inhibitor	prep_of	14	SENT_163	[p11l206t789r620b867],
18	of	IN	O	of	_	0	SENT_163	[p11l657t788r758b867],
19	human	JJ	O	human	amod	21	SENT_163	[p11l775t788r1074b868],
20	immunodeﬁciency	NN	O	immunodeﬁciency	nn	21	SENT_163	[p11l1108t788r1904b889],
21	virus	NN	O	virus	prep_of	17	SENT_163	[p11l1929t789r2132b868],
22	(	CD	NUMBER	(	num	24	SENT_163	[p11l15t916r658b1008],
23	HIV	NN	O	hiv	nn	24	SENT_163	[p11l15t916r658b1008],
24	)	NN	O	)	nsubj	10	SENT_163	[p11l15t916r658b1008],
25	.	.	O	.	_	0	SENT_163	[p11l15t916r658b1008],

1	—	NN	O	—	_	0	SENT_164	[p11l15t916r658b1008],
2	.	.	O	.	_	0	SENT_164	[p11l15t916r658b1008],

1	encoded	VBN	O	encode	_	0	SENT_165	[p11l15t916r658b1008],
2	protease	NN	O	protease	dobj	1	SENT_165	[p11l681t933r1038b1017],
3	and	CC	O	and	_	0	SENT_165	[p11l1062t916r1218b995],
4	substantially	RB	O	substantially	advmod	5	SENT_165	[p11l1243t917r1781b1017],
5	increases	VBZ	O	increase	conj_and	1	SENT_165	[p11l1800t917r2134b995, p11l11t1071r93b1123],
6	their	PRP$	O	they	poss	7	SENT_165	[p11l126t1045r324b1123],
7	levels	NNS	O	level	dobj	5	SENT_165	[p11l350t1045r578b1124],
8	in	IN	O	in	_	0	SENT_165	[p11l610t1045r691b1122],
9	plasma	NN	O	plasma	nn	11	SENT_165	[p11l720t1044r1027b1145],
10	(	CD	NUMBER	(	num	11	SENT_165	[p11l1060t1044r1314b1136],
11	Table	NNP	O	Table	prep_in	5	SENT_165	[p11l1060t1044r1314b1136],
12	1	CD	NUMBER	1	number	13	SENT_165	[p11l1348t1050r1451b1136],
13	)	CD	NUMBER	)	dep	11	SENT_165	[p11l1348t1050r1451b1136],
14	.	.	O	.	_	0	SENT_165	[p11l1348t1050r1451b1136],

1	This	DT	O	this	det	2	SENT_166	[p11l1483t1045r1668b1123],
2	phenomenon	NN	O	phenomenon	nsubj	7	SENT_166	[p11l1700t1045r2134b1145, p11l11t1198r198b1268],
3	,	,	O	,	_	0	SENT_166	[p11l1700t1045r2134b1145, p11l11t1198r198b1268],
4	in	IN	O	in	_	0	SENT_166	[p11l230t1173r311b1250],
5	fact	NN	O	fact	prep_in	2	SENT_166	[p11l337t1172r512b1268],
6	,	,	O	,	_	0	SENT_166	[p11l337t1172r512b1268],
7	forms	VBZ	O	form	_	0	SENT_166	[p11l544t1172r793b1251],
8	the	DT	O	the	det	9	SENT_166	[p11l821t1173r951b1251],
9	basis	NN	O	basis	dobj	7	SENT_166	[p11l978t1173r1187b1251],
10	for	IN	O	for	_	0	SENT_166	[p11l1216t1172r1339b1251],
11	combining	VBG	O	combine	prepc_for	7	SENT_166	[p11l1363t1172r1828b1273],
12	ritonavir	NN	O	ritonavir	dobj	11	SENT_166	[p11l1850t1173r2134b1251, p11l6t1301r116b1380],
13	with	IN	O	with	_	0	SENT_166	[p11l128t1301r316b1380],
14	other	JJ	O	other	amod	16	SENT_166	[p11l337t1301r558b1379],
15	protease	NN	O	protease	nn	16	SENT_166	[p11l574t1317r928b1401],
16	inhibitors	NNS	O	inhibitor	prep_with	11	SENT_166	[p11l948t1301r1357b1379],
17	in	IN	O	in	_	0	SENT_166	[p11l1378t1301r1459b1378],
18	the	DT	O	the	det	19	SENT_166	[p11l1479t1301r1607b1379],
19	treatment	NN	O	treatment	prep_in	16	SENT_166	[p11l1629t1317r2038b1379],
20	of	IN	O	of	_	0	SENT_166	[p11l2054t1300r2154b1379],
21	infection	NN	O	infection	prep_of	19	SENT_166	[p11l10t1428r387b1507],
22	with	IN	O	with	_	0	SENT_166	[p11l407t1429r596b1508],
23	HIV	NN	MISC	hiv	nn	24	SENT_166	[p11l620t1436r790b1507],
24	type	NN	O	type	prep_with	11	SENT_166	[p11l812t1445r983b1529],
25	1.13	CD	NUMBER	1.13	num	24	SENT_166	[p11l1011t1423r1164b1507],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_167	[p11l140t1562r428b1635],
2	inhibition	NN	O	inhibition	nsubj	5	SENT_167	[p11l455t1557r875b1635],
3	is	VBZ	O	be	cop	5	SENT_167	[p11l905t1557r970b1635],
4	usually	RB	O	usually	advmod	5	SENT_167	[p11l1003t1556r1301b1657],
5	reversible	JJ	O	reversible	ccomp	19	SENT_167	[p11l1327t1557r1756b1652],
6	,	,	O	,	_	0	SENT_167	[p11l1327t1557r1756b1652],
7	typically	RB	O	typically	advmod	5	SENT_167	[p11l1793t1557r2140b1657],
8	within	IN	O	within	_	0	SENT_167	[p11l6t1685r281b1764],
9	two	CD	DURATION	two	number	11	SENT_167	[p11l308t1701r460b1764],
10	to	TO	DURATION	to	dep	11	SENT_167	[p11l488t1701r567b1763],
11	three	CD	DURATION	three	num	12	SENT_167	[p11l595t1684r807b1763],
12	days	NNS	NUMBER	day	prep_within	5	SENT_167	[p11l835t1684r1041b1785],
13	,	,	O	,	_	0	SENT_167	[p11l835t1684r1041b1785],
14	once	RB	DATE	once	advmod	17	SENT_167	[p11l1074t1710r1271b1763],
15	the	DT	O	the	det	17	SENT_167	[p11l1298t1684r1428b1763],
16	interacting	VBG	O	interact	amod	17	SENT_167	[p11l1453t1685r1915b1785],
17	drug	NN	O	drug	nsubjpass	19	SENT_167	[p11l1939t1685r2139b1785],
18	is	VBZ	O	be	auxpass	19	SENT_167	[p11l10t1813r74b1891],
19	discontinued	VBN	O	discontinue	_	0	SENT_167	[p11l98t1812r665b1892],
20	.	.	O	.	_	0	SENT_167	[p11l98t1812r665b1892],

1	In	IN	O	in	_	0	SENT_168	[p11l691t1820r777b1890],
2	the	DT	O	the	det	3	SENT_168	[p11l798t1813r926b1891],
3	case	NN	O	case	prep_in	7	SENT_168	[p11l948t1839r1121b1891],
4	of	IN	O	of	_	0	SENT_168	[p11l1143t1812r1243b1891],
5	some	DT	O	some	prep_of	3	SENT_168	[p11l1247t1838r1469b1891],
6	inhibitors	NNS	O	inhibitor	nsubj	7	SENT_168	[p11l1489t1812r1899b1891],
7	(	VBP	O	(	_	0	SENT_168	[p11l1927t1820r2130b1913],
8	e.g.	FW	O	e.g.	dobj	7	SENT_168	[p11l1927t1820r2130b1913],
9	,	,	O	,	_	0	SENT_168	[p11l1927t1820r2130b1913],
10	diltiazem	NN	O	diltiazem	dobj	7	SENT_168	[p11l11t1941r423b2036],
11	,	,	O	,	_	0	SENT_168	[p11l11t1941r423b2036],
12	macrolide	NN	O	macrolide	nn	13	SENT_168	[p11l453t1940r872b2019],
13	antibiotics	NNS	O	antibiotic	dobj	7	SENT_168	[p11l897t1940r1359b2036],
14	,	,	O	,	_	0	SENT_168	[p11l897t1940r1359b2036],
15	mifepristone	NN	O	mifepristone	dobj	7	SENT_168	[p11l1390t1940r1950b2041],
16	,	,	O	,	_	0	SENT_168	[p11l1390t1940r1950b2041],
17	and	CC	O	and	_	0	SENT_168	[p11l1981t1941r2136b2019],
18	delavirdine	NN	O	delavirdine	nn	19	SENT_168	[p11l11t2069r547b2164],
19	)	NN	O	)	dobj	7	SENT_168	[p11l11t2069r547b2164],
20	,	,	O	,	_	0	SENT_168	[p11l11t2069r547b2164],
21	however	RB	O	however	advmod	26	SENT_168	[p11l597t2069r976b2164],
22	,	,	O	,	_	0	SENT_168	[p11l597t2069r976b2164],
23	the	DT	O	the	det	24	SENT_168	[p11l1026t2068r1157b2147],
24	effect	NN	O	effect	nsubj	26	SENT_168	[p11l1202t2068r1442b2147],
25	may	MD	O	may	aux	26	SENT_168	[p11l1481t2095r1659b2169],
26	last	VB	O	last	conj_and	7	SENT_168	[p11l1698t2069r1852b2147],
27	much	RB	O	much	advmod	28	SENT_168	[p11l1891t2069r2134b2148],
28	longer	RBR	O	longer	advmod	26	SENT_168	[p11l10t2197r299b2297],
29	,	,	O	,	_	0	SENT_168	[p11l10t2197r299b2297],
30	because	IN	O	because	mark	33	SENT_168	[p11l326t2196r654b2276],
31	CYP3A	NN	O	cyp3a	nsubjpass	33	SENT_168	[p11l675t2202r961b2275],
32	is	VBZ	O	be	auxpass	33	SENT_168	[p11l977t2197r1042b2275],
33	destroyed	VBN	O	destroy	dep	28	SENT_168	[p11l1065t2196r1467b2297],
34	and	CC	O	and	_	0	SENT_168	[p11l1487t2196r1642b2275],
35	new	JJ	O	new	amod	37	SENT_168	[p11l1662t2222r1837b2276],
36	CYP3A	NN	O	cyp3a	nn	37	SENT_168	[p11l1853t2202r2139b2275],
37	enzyme	NN	O	enzyme	nsubjpass	40	SENT_168	[p11l11t2349r333b2423],
38	must	MD	O	must	aux	40	SENT_168	[p11l358t2339r575b2402],
39	be	VB	O	be	auxpass	40	SENT_168	[p11l596t2324r691b2401],
40	synthesized	VBN	O	synthesize	conj_and	7	SENT_168	[p11l718t2319r1279b2423],
41	.9	CD	NUMBER	.9	dobj	40	SENT_168	[p11l718t2319r1279b2423],

1	DRUG	NN	O	drug	nn	2	SENT_169	[p11l97t2658r415b2717],
2	INTERACTIONS	NNS	O	interaction	_	0	SENT_169	[p11l468t2658r1329b2717],
3	INVOLVING	VBG	O	involve	partmod	2	SENT_169	[p11l1385t2658r2039b2717],

1	INDUCTION	NN	O	induction	_	0	SENT_170	[p11l444t2763r1121b2822],
2	OF	IN	O	of	_	0	SENT_170	[p11l1176t2763r1310b2822],
3	CYP3A	NN	O	cyp3a	prep_of	1	SENT_170	[p11l1362t2763r1695b2826],

1	Treatment	NN	O	treatment	nsubj	12	SENT_171	[p11l7t2996r450b3069],
2	with	IN	O	with	_	0	SENT_171	[p11l477t2991r666b3070],
3	drugs	NNS	O	drug	prep_with	1	SENT_171	[p11l704t2991r940b3091],
4	such	JJ	O	such	_	0	SENT_171	[p11l981t2991r1175b3070],
5	as	IN	O	as	_	0	SENT_171	[p11l1211t3017r1295b3069],
6	the	DT	O	the	det	7	SENT_171	[p11l1334t2991r1463b3069],
7	rifamycins	NNS	O	rifamycin	prep_such_as	3	SENT_171	[p11l1500t2990r1941b3091],
8	and	CC	O	and	_	0	SENT_171	[p11l1980t2990r2135b3069],
9	some	DT	O	some	det	10	SENT_171	[p11l12t3144r241b3197],
10	anticonvulsants	NNS	O	anticonvulsant	conj_and	7	SENT_171	[p11l303t3119r988b3198],
11	predictably	RB	O	predictably	advmod	12	SENT_171	[p11l1050t3118r1540b3219],
12	results	VBZ	O	result	dep	17	SENT_171	[p11l1598t3119r1884b3198],
13	in	IN	O	in	_	0	SENT_171	[p11l1947t3119r2030b3196],
14	a	DT	O	a	det	16	SENT_171	[p11l2091t3145r2135b3197],
15	marked	JJ	O	marked	amod	16	SENT_171	[p11l11t3247r332b3326],
16	reduction	NN	O	reduction	prep_in	12	SENT_171	[p11l358t3247r763b3326],
17	(	VBD	O	(	_	0	SENT_171	[p11l795t3254r929b3347],
18	up	RP	O	up	prt	17	SENT_171	[p11l795t3254r929b3347],
19	to	TO	O	to	_	0	SENT_171	[p11l958t3263r1037b3325],
20	95	CD	PERCENT	95	num	22	SENT_171	[p11l1065t3252r1162b3325],
21	percent	NN	PERCENT	percent	nn	22	SENT_171	[p11l1191t3254r1536b3347],
22	)	NN	O	)	prep_to	17	SENT_171	[p11l1191t3254r1536b3347],
23	in	IN	O	in	_	0	SENT_171	[p11l1567t3247r1648b3324],
24	the	DT	O	the	det	26	SENT_171	[p11l1675t3247r1804b3325],
25	plasma	NN	O	plasma	nn	26	SENT_171	[p11l1830t3247r2136b3347],
26	concentrations	NNS	O	concentration	prep_in	17	SENT_171	[p11l11t3375r639b3453],
27	of	IN	O	of	_	0	SENT_171	[p11l669t3374r770b3453],
28	certain	JJ	O	certain	amod	29	SENT_171	[p11l780t3375r1069b3453],
29	drugs	NNS	O	drug	prep_of	26	SENT_171	[p11l1097t3374r1334b3475],
30	administered	VBN	O	administer	partmod	29	SENT_171	[p11l1363t3374r1921b3453],
31	concurrently	RB	O	concurrently	advmod	30	SENT_171	[p11l1949t3400r2134b3453, p11l11t3503r390b3603],
32	(	CD	NUMBER	(	num	33	SENT_171	[p11l432t3503r615b3603],
33	Fig	NN	O	fig	nsubj	17	SENT_171	[p11l432t3503r615b3603],
34	.	.	O	.	_	0	SENT_171	[p11l432t3503r615b3603],

1	3	CD	NUMBER	3	_	0	SENT_172	[p11l662t3508r767b3594],
2	)	NN	O	)	dep	1	SENT_172	[p11l662t3508r767b3594],
3	.	.	O	.	_	0	SENT_172	[p11l662t3508r767b3594],

1	Such	JJ	O	such	amod	3	SENT_173	[p11l816t3503r1019b3582],
2	drug	NN	O	drug	nn	3	SENT_173	[p11l1061t3502r1260b3603],
3	interactions	NNS	O	interaction	nsubj	4	SENT_173	[p11l1297t3503r1797b3581],
4	involve	VBP	O	involve	_	0	SENT_173	[p11l1840t3502r2135b3582],
5	up	RP	O	up	prt	4	SENT_173	[p11l11t3631r589b3731],
6	—	CD	NUMBER	—	num	8	SENT_173	[p11l11t3631r589b3731],
7	regulation	NN	O	regulation	nn	8	SENT_173	[p11l11t3631r589b3731],
8	(	NN	O	(	dobj	4	SENT_173	[p11l636t3630r1101b3722],
9	induction	NN	O	induction	nn	10	SENT_173	[p11l636t3630r1101b3722],
10	)	NN	O	)	tmod	4	SENT_173	[p11l636t3630r1101b3722],
11	of	IN	O	of	_	0	SENT_173	[p11l1149t3630r1250b3709],
12	several	JJ	O	several	amod	13	SENT_173	[p11l1274t3631r1559b3710],
13	proteins	NNS	O	protein	prep_of	10	SENT_173	[p11l1599t3631r1947b3731],
14	imTable	JJ	O	imtable	amod	13	SENT_173	[p11l1990t3631r2134b3708, p12l61t162r197b210],

1	1	LS	NUMBER	1	_	0	SENT_174	[p12l214t166r255b210],
2	.	.	O	.	_	0	SENT_174	[p12l214t166r255b210],

1	Some	DT	O	some	det	3	SENT_175	[p12l270t165r419b210],
2	Common	JJ	O	common	amod	3	SENT_175	[p12l433t165r673b210],
3	Drugs	NNS	O	drug	_	0	SENT_175	[p12l694t166r850b225],
4	with	IN	O	with	_	0	SENT_175	[p12l864t162r975b210],
5	Low	JJ	O	low	amod	7	SENT_175	[p12l996t166r1100b210],
6	Oral	JJ	O	oral	amod	7	SENT_175	[p12l1114t162r1226b210],
7	Bioavailability	NN	O	bioavailability	prep_with	3	SENT_175	[p12l1246t162r1608b225],
8	and	CC	O	and	_	0	SENT_175	[p12l1622t162r1716b210],
9	Susceptibility	NN	O	susceptibility	prep_with	3	SENT_175	[p12l1732t162r2086b225],
10	to	TO	O	to	_	0	SENT_175	[p12l60t250r112b291],
11	First-Pass	NNP	O	First-Pass	nn	13	SENT_175	[p12l134t243r387b291],
12	Drug	NNP	O	Drug	nn	13	SENT_175	[p12l409t246r539b305],
13	Interactions	NNS	O	interaction	prep_to	3	SENT_175	[p12l559t243r885b291],
14	.	.	O	.	_	0	SENT_175	[p12l559t243r885b291],

1	Drug	NN	O	drug	_	0	SENT_176	[p12l65t385r195b443],

1	Anﬂodarone	NNP	O	Anﬂodarone	nn	31	SENT_177	[p12l61t614r387b663],
2	Amitriptyline	NNP	O	Amitriptyline	nn	31	SENT_177	[p12l61t720r401b783],
3	Aspkhi	NNP	O	Aspkhi	nn	31	SENT_177	[p12l61t829r245b889],
4	Bromocriptine	NNP	O	Bromocriptine	nn	31	SENT_177	[p12l67t937r442b995],
5	Captoprﬂ	NNP	O	Captoprﬂ	nn	31	SENT_177	[p12l63t1038r299b1101],
6	Coddne	NNP	O	Coddne	nn	31	SENT_177	[p12l63t1144r275b1192],
7	Cydospoﬁne	NNP	O	Cydospoﬁne	nn	31	SENT_177	[p12l63t1250r400b1313],
8	Desipramine	NNP	O	Desipramine	nn	31	SENT_177	[p12l67t1360r401b1419],
9	Diclofenac	NNP	O	Diclofenac	nn	31	SENT_177	[p12l67t1461r341b1510],
10	DHﬁazen1	NNP	O	DHﬁazen1	nn	31	SENT_177	[p12l67t1568r313b1616],
11	Erythrornycin	NNP	O	Erythrornycin	nn	31	SENT_177	[p12l67t1674r408b1737],
12	Felodipine	NNP	O	Felodipine	nn	31	SENT_177	[p12l67t1780r335b1842],
13	Imipramine	NNP	O	Imipramine	nn	31	SENT_177	[p12l67t1890r370b1948],
14	Labetalol	NNP	O	Labetalol	nn	31	SENT_177	[p12l67t1991r297b2040],
15	Losanan	NNP	O	Losanan	nn	31	SENT_177	[p12l67t2102r288b2146],
16	Lovastatin	NNP	O	Lovastatin	nn	31	SENT_177	[p12l67t2208r331b2252],
17	6-Mercaptopurine	NNP	O	6-Mercaptopurine	nn	31	SENT_177	[p12l64t2313r536b2372],
18	Metoprolol	NNP	ORGANIZATION	Metoprolol	nn	31	SENT_177	[p12l67t2415r351b2478],
19	Midazolam	NNP	ORGANIZATION	Midazolam	nn	31	SENT_177	[p12l67t2521r357b2570],
20	Morphine	NNP	ORGANIZATION	Morphine	nn	31	SENT_177	[p12l67t2627r320b2690],
21	Naloxone	NNP	ORGANIZATION	Naloxone	nn	31	SENT_177	[p12l67t2733r312b2782],
22	Nefazodone	NNP	ORGANIZATION	Nefazodone	nn	31	SENT_177	[p12l67t2838r384b2887],
23	Nicardipine	NNP	ORGANIZATION	Nicardipine	nn	31	SENT_177	[p12l67t2945r370b3008],
24	Nimodipine	NNP	ORGANIZATION	Nimodipine	nn	31	SENT_177	[p12l67t3051r378b3114],
25	Omeprazole	NNP	ORGANIZATION	Omeprazole	nn	31	SENT_177	[p12l63t3157r388b3220],
26	Propafenone	NNP	O	Propafenone	nn	31	SENT_177	[p12l67t3262r398b3326],
27	Propranolol	NNP	O	Propranolol	nn	31	SENT_177	[p12l67t3369r368b3432],
28	Saquinavn	NNP	O	Saquinavn	nn	31	SENT_177	[p12l64t3479r341b3538],
29	Spironolactone	NNP	O	Spironolactone	nn	31	SENT_177	[p12l64t3581r462b3644],
30	Tacrine	NNP	O	Tacrine	nn	31	SENT_177	[p12l60t3691r248b3735],
31	Tarmlimuc	NNP	O	Tarmlimuc	_	0	SENT_177	[p12l60t3793r349b3834],

1	Metabolizing	VBG	O	metabolize	_	0	SENT_178	[p12l861t380r1201b443],
2	Enzyme	NN	O	enzyme	dobj	1	SENT_178	[p12l1221t385r1423b444],

1	CYP3A	NN	O	cyp3a	_	0	SENT_179	[p12l1053t617r1229b663],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_180	[p12l927t723r1355b777],
2	,	,	O	,	_	0	SENT_180	[p12l927t723r1355b777],
3	CYP3A	NN	O	cyp3a	appos	1	SENT_180	[p12l927t723r1355b777],

1	Esterases	NNS	O	esterase	_	0	SENT_181	[p12l1020t831r1263b874],
2	CYP3A	NN	O	cyp3a	dep	1	SENT_181	[p12l1053t935r1229b980],

1	S-methyltransferase	NN	O	s-methyltransferase	_	0	SENT_182	[p12l879t1037r1401b1101],

1	Glucuronosyltransferase	NN	O	glucuronosyltransferase	_	0	SENT_183	[p12l818t1143r1462b1207],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_184	[p12l930t1253r1351b1307],
2	,	,	O	,	_	0	SENT_184	[p12l930t1253r1351b1307],
3	CYP3A	NN	O	cyp3a	appos	1	SENT_184	[p12l930t1253r1351b1307],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_185	[p12l1033t1360r1247b1404],
2	CYP2C9	NN	O	cyp2c9	nn	5	SENT_185	[p12l1036t1466r1243b1510],
3	CYP3A	NN	O	cyp3a	nn	5	SENT_185	[p12l1053t1571r1229b1616],
4	CYP3A	NN	O	cyp3a	nn	5	SENT_185	[p12l1053t1677r1229b1722],
5	CYP3A	NN	O	cyp3a	dep	1	SENT_185	[p12l1053t1783r1229b1828],

1	CYP1A2	NN	O	cyp1a2	_	0	SENT_186	[p12l805t1889r1476b1942],
2	,	,	O	,	_	0	SENT_186	[p12l805t1889r1476b1942],
3	CYP2D6	NN	O	cyp2d6	appos	1	SENT_186	[p12l805t1889r1476b1942],
4	,	,	O	,	_	0	SENT_186	[p12l805t1889r1476b1942],
5	CYP3A	NN	O	cyp3a	nn	6	SENT_186	[p12l805t1889r1476b1942],
6	G	NN	O	g	appos	1	SENT_186	[p12l818t1995r855b2040],
7	I	PRP	O	I	nsubj	8	SENT_186	[p12l866t1992r871b2039],
8	ucu	VBP	O	ucu	rcmod	6	SENT_186	[p12l881t2009r969b2040],
9	ronosyltransferase	NN	O	ronosyltransferase	dobj	8	SENT_186	[p12l979t1991r1462b2055],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_187	[p12l930t2101r1351b2154],
2	,	,	O	,	_	0	SENT_187	[p12l930t2101r1351b2154],
3	CYP3A	NN	O	cyp3a	appos	1	SENT_187	[p12l930t2101r1351b2154],

1	CYP3A	NN	O	cyp3a	nn	4	SENT_188	[p12l1053t2207r1229b2252],
2	TPMT	NN	O	tpmt	nn	4	SENT_188	[p12l1059t2314r1220b2357],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_188	[p12l1033t2419r1247b2464],
4	CYP3A	NN	O	cyp3a	_	0	SENT_188	[p12l1053t2524r1229b2570],

1	Glucuronosyltransferase	NN	O	glucuronosyltransferase	nn	2	SENT_189	[p12l818t2627r1462b2691],
2	Glucuronosyltransferase	NN	O	glucuronosyltransferase	_	0	SENT_189	[p12l818t2732r1462b2797],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_190	[p12l930t2842r1351b2896],
2	,	,	O	,	_	0	SENT_190	[p12l930t2842r1351b2896],
3	CYP3A	NN	O	cyp3a	appos	1	SENT_190	[p12l930t2842r1351b2896],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_191	[p12l1053t2948r1229b2993],
2	CYP3A	NN	O	cyp3a	_	0	SENT_191	[p12l1053t3054r1229b3099],

1	CYP2C19	NN	O	cyp2c19	_	0	SENT_192	[p12l914t3160r1367b3214],
2	,	,	O	,	_	0	SENT_192	[p12l914t3160r1367b3214],
3	CYP3A	NN	O	cyp3a	appos	1	SENT_192	[p12l914t3160r1367b3214],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_193	[p12l1033t3267r1247b3311],

1	CYP2D6	NN	O	cyp2d6	_	0	SENT_194	[p12l911t3372r1368b3426],
2	,	,	O	,	_	0	SENT_194	[p12l911t3372r1368b3426],
3	CYPlA2	NN	O	cypla2	appos	1	SENT_194	[p12l911t3372r1368b3426],

1	CYP3A	NN	O	cyp3a	_	0	SENT_195	[p12l1053t3478r1229b3523],

1	Thioesterase	NN	O	thioesterase	_	0	SENT_196	[p12l970t3581r1307b3629],

1	CYP1A2	NN	O	cyp1a2	nn	2	SENT_197	[p12l1037t3690r1243b3735],
2	CYP3A	NN	O	cyp3a	_	0	SENT_197	[p12l1053t3796r1227b3834],

1	Bioavai	NNP	O	Bioavai	_	0	SENT_198	[p12l1651t380r2044b444],
2	|	NN	O	|	nn	3	SENT_198	[p12l1651t380r2044b444],
3	abi	NN	O	abus	dep	1	SENT_198	[p12l1651t380r2044b444],
4	|	CD	NUMBER	|	num	6	SENT_198	[p12l1651t380r2044b444],
5	ity	NN	O	ity	nn	6	SENT_198	[p12l1651t380r2044b444],
6	*	NN	O	*	dep	1	SENT_198	[p12l1651t380r2044b444],

1	percent	NN	O	percent	_	0	SENT_199	[p12l1746t517r1930b571],
2	46:22	CD	NUMBER	46:22	number	3	SENT_199	[p12l1758t618r1917b663],
3	48:11	CD	NUMBER	48:11	dep	1	SENT_199	[p12l1758t723r1915b769],
4	68:3	CD	NUMBER	68:3	num	5	SENT_199	[p12l1760t829r1882b875],
5	3-6	CD	NUMBER	3-6	dep	3	SENT_199	[p12l1801t936r1891b980],

1	cu	NN	O	cu	_	0	SENT_200	[p13l1059t6r1136b13],
2	.	.	O	.	_	0	SENT_200	[p13l1059t6r1136b13],

1	vnu	NN	O	vnu	_	0	SENT_201	[p13l1163t6r1229b13],
2	.	.	O	.	_	0	SENT_201	[p13l1759t6r1915b13],

1	_	SYM	O	_	dep	4	SENT_202	[p13l1759t6r1915b13],
2	-	:	O	-	_	0	SENT_202	[p13l1759t6r1915b13],
3	j	NN	O	j	nn	4	SENT_202	[p13l1759t6r1915b13],
4	_	NN	O	_	_	0	SENT_202	[p13l1759t6r1915b13],
5	.	.	O	.	_	0	SENT_202	[p13l1759t6r1915b13],

1	v	LS	O	v	dep	6	SENT_203	[p13l1759t6r1915b13],
2	Terbutaline	NN	O	terbutaline	nn	6	SENT_203	[p13l60t71r353b119],
3	Sulfotransferase	NN	O	sulfotransferase	nn	6	SENT_203	[p13l934t70r1361b119],
4	14:2	CD	NUMBER	14:2	num	6	SENT_203	[p13l1762t75r1884b118],
5	Triazolam	NN	O	triazolam	nn	6	SENT_203	[p13l60t177r315b225],
6	CYP3A	NN	O	cyp3a	_	0	SENT_203	[p13l1053t180r1229b225],
7	44	CD	NUMBER	44	num	10	SENT_203	[p13l1767t181r1827b224],
8	Venlafaxine	NNP	O	Venlafaxine	nn	10	SENT_203	[p13l61t282r358b331],
9	CYP2	NN	O	cyp2	nn	10	SENT_203	[p13l927t286r1063b331],
10	D6	NN	O	d6	dep	6	SENT_203	[p13l1073t286r1155b339],
11	,	,	O	,	_	0	SENT_203	[p13l1073t286r1155b339],
12	CYP3A	NN	O	cyp3a	nn	14	SENT_203	[p13l1178t286r1355b331],
13	10-45	CD	NUMBER	10-45	num	14	SENT_203	[p13l1764t286r1913b331],
14	Verapamil	NNP	O	Verapamil	appos	10	SENT_203	[p13l61t388r322b451],
15	CYP3A	NN	O	cyp3a	dep	6	SENT_203	[p13l1053t392r1229b437],
16	22:8	CD	NUMBER	22:8	num	15	SENT_203	[p13l1759t391r1885b437],

1	@	IN	O	@	mark	5	SENT_204	[p13l10t570r39b598],
2	lW	NN	O	lw	nsubj	5	SENT_204	[p13l10t570r39b598],
3	+	CC	O	+	_	0	SENT_204	[p13l10t570r39b598],
4	P	NN	O	p	conj_+	2	SENT_204	[p13l63t566r368b614],
5	|	VBP	O	|	advcl	11	SENT_204	[p13l63t566r368b614],
6	us	PRP	O	we	dobj	5	SENT_204	[p13l63t566r368b614],
7	—	RB	O	—	advmod	5	SENT_204	[p13l63t566r368b614],
8	minus	CC	O	minus	advmod	5	SENT_204	[p13l63t566r368b614],
9	values	NNS	O	value	nsubj	11	SENT_204	[p13l387t566r551b614],
10	are	VBP	O	be	cop	11	SENT_204	[p13l573t583r650b614],
11	means	NNS	O	means	_	0	SENT_204	[p13l672t583r842b614],
12	:	:	O	:	_	0	SENT_204	[p13l862t570r988b614],
13	SD	NN	O	sd	dep	11	SENT_204	[p13l862t570r988b614],
14	.	.	O	.	_	0	SENT_204	[p13l862t570r988b614],

1	portant	NN	O	portant	_	0	SENT_205	[p13l9t806r248b868],
2	in	IN	O	in	_	0	SENT_205	[p13l259t794r320b851],
3	drug	NN	O	drug	nn	4	SENT_205	[p13l336t793r485b868],
4	disposition	NN	O	disposition	prep_in	1	SENT_205	[p13l499t794r870b868],
5	.	.	O	.	_	0	SENT_205	[p13l499t794r870b868],

1	However	RB	O	however	advmod	7	SENT_206	[p13l889t799r1182b864],
2	,	,	O	,	_	0	SENT_206	[p13l889t799r1182b864],
3	CYP3A	NN	O	cyp3a	nn	4	SENT_206	[p13l1202t798r1417b852],
4	activity	NN	O	activity	nsubj	7	SENT_206	[p13l1429t794r1596b852, p13l10t889r86b963],
5	is	VBZ	O	be	cop	7	SENT_206	[p13l104t889r152b947],
6	especially	RB	O	especially	advmod	7	SENT_206	[p13l176t888r481b963],
7	sensitive	JJ	O	sensitive	_	0	SENT_206	[p13l500t889r768b948],
8	to	TO	O	to	_	0	SENT_206	[p13l790t900r849b947],
9	such	JJ	O	such	amod	11	SENT_206	[p13l873t888r1018b947],
10	modulation	NN	O	modulation	nn	11	SENT_206	[p13l1039t885r1459b959],
11	,9	NN	O	,9	prep_to	7	SENT_206	[p13l1039t885r1459b959],
12	and	CC	O	and	_	0	SENT_206	[p13l1480t888r1596b947],
13	the	DT	O	the	det	14	SENT_206	[p13l11t984r107b1042],
14	metabolism	NN	O	metabolism	nsubjpass	20	SENT_206	[p13l126t983r503b1042],
15	of	IN	O	of	_	0	SENT_206	[p13l523t983r598b1042],
16	CYP3A	NN	O	cyp3a	nn	17	SENT_206	[p13l602t988r817b1042],
17	substrates	NNS	O	substrate	prep_of	14	SENT_206	[p13l835t983r1152b1042],
18	is	VBZ	O	be	auxpass	20	SENT_206	[p13l1171t984r1220b1042],
19	particularly	RB	O	particularly	advmod	20	SENT_206	[p13l1239t984r1600b1058],
20	affected	VBN	O	affect	conj_and	7	SENT_206	[p13l10t1078r258b1137],
21	by	IN	O	by	_	0	SENT_206	[p13l288t1079r361b1153],
22	treatment	NN	O	treatment	agent	20	SENT_206	[p13l387t1091r696b1137],
23	with	IN	O	with	_	0	SENT_206	[p13l718t1079r860b1137],
24	these	DT	O	these	nsubj	25	SENT_206	[p13l889t1079r1052b1137],
25	inducing	VBG	O	induce	prepc_with	20	SENT_206	[p13l1082t1078r1365b1153],
26	agents	NNS	O	agent	dobj	25	SENT_206	[p13l1391t1091r1595b1153],
27	(	RB	O	(	dep	28	SENT_206	[p13l14t1174r202b1241],
28	Table	NNP	O	Table	dep	26	SENT_206	[p13l14t1174r202b1241],
29	2	CD	NUMBER	2	number	30	SENT_206	[p13l219t1178r298b1241],
30	)	CD	NUMBER	)	num	28	SENT_206	[p13l219t1178r298b1241],
31	.	.	O	.	_	0	SENT_206	[p13l219t1178r298b1241],

1	In	IN	O	in	_	0	SENT_207	[p13l318t1179r383b1231],
2	this	DT	O	this	det	3	SENT_207	[p13l401t1174r514b1232],
3	situation	NN	O	situation	pobj	1	SENT_207	[p13l534t1174r823b1245],
4	,	,	O	,	_	0	SENT_207	[p13l534t1174r823b1245],
5	previously	RB	DATE	previously	advmod	6	SENT_207	[p13l844t1174r1165b1248],
6	effective	JJ	O	effective	amod	7	SENT_207	[p13l1179t1173r1434b1232],
7	drug	NN	O	drug	appos	3	SENT_207	[p13l1452t1174r1599b1248],

1	N	NN	O	n	nn	3	SENT_208	[p13l519t1329r532b1344],
2	ENGLJ	NN	O	englj	nn	3	SENT_208	[p13l548t1328r632b1350],
3	MED	NN	O	med	_	0	SENT_208	[p13l647t1329r699b1344],
4	352	CD	NUMBER	352	num	6	SENT_208	[p13l711t1328r788b1350],
5	;	:	O	;	_	0	SENT_208	[p13l711t1328r788b1350],
6	21	CD	NUMBER	21	dep	3	SENT_208	[p13l711t1328r788b1350],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_208	[p13l825t1328r1037b1350],
8	MAY	NNP	DATE	MAY	dep	6	SENT_208	[p13l1076t1328r1127b1344],
9	26	CD	DATE	26	num	8	SENT_208	[p13l1139t1323r1177b1348],
10	,	,	DATE	,	_	0	SENT_208	[p13l1139t1323r1177b1348],
11	2005	CD	DATE	2005	num	8	SENT_208	[p13l1191t1328r1254b1350],
12	2215	CD	DATE	2215	dep	3	SENT_208	[p13l1940t1327r2015b1349],

1	The	DT	O	the	det	4	SENT_209	[p13l702t1361r752b1385],
2	New	NNP	O	New	nn	4	SENT_209	[p13l762t1362r824b1385],
3	England	NNP	O	England	nn	4	SENT_209	[p13l833t1361r944b1392],
4	Journal	NNP	O	Journal	_	0	SENT_209	[p13l952t1361r1050b1385],
5	of	IN	O	of	_	0	SENT_209	[p13l1060t1361r1088b1385],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_209	[p13l1095t1361r1220b1385],

1	Downloaded	VBN	O	download	_	0	SENT_210	[p13l144t1402r314b1425],
2	from	IN	O	from	_	0	SENT_210	[p13l322t1402r387b1425],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_210	[p13l396t1402r514b1432],
4	at	IN	O	at	_	0	SENT_210	[p13l524t1406r547b1425],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_210	[p13l556t1402r738b1425],
6	on	IN	O	on	_	0	SENT_210	[p13l748t1409r780b1425],
7	January	NNP	DATE	January	prep_on	1	SENT_210	[p13l789t1402r892b1432],
8	5	CD	DATE	5	num	7	SENT_210	[p13l902t1402r924b1429],
9	,	,	DATE	,	_	0	SENT_210	[p13l902t1402r924b1429],
10	2014	CD	DATE	2014	num	7	SENT_210	[p13l935t1402r1007b1425],
11	.	.	O	.	_	0	SENT_210	[p13l935t1402r1007b1425],

1	For	IN	O	for	_	0	SENT_211	[p13l1018t1402r1064b1425],
2	personal	JJ	O	personal	amod	3	SENT_211	[p13l1072t1402r1184b1432],
3	use	NN	O	use	pobj	1	SENT_211	[p13l1194t1409r1237b1425],
4	only	RB	O	only	advmod	3	SENT_211	[p13l1247t1402r1312b1432],
5	.	.	O	.	_	0	SENT_211	[p13l1247t1402r1312b1432],

1	No	DT	O	no	det	3	SENT_212	[p13l1322t1402r1362b1425],
2	other	JJ	O	other	amod	3	SENT_212	[p13l1372t1402r1440b1425],
3	uses	NNS	O	use	_	0	SENT_212	[p13l1448t1409r1504b1425],
4	without	IN	O	without	_	0	SENT_212	[p13l1515t1402r1616b1425],
5	permission	NN	O	permission	prep_without	3	SENT_212	[p13l1624t1402r1777b1432],
6	.	.	O	.	_	0	SENT_212	[p13l1624t1402r1777b1432],

1	Copyright	NN	O	copyright	_	0	SENT_213	[p13l494t1443r628b1474],
2	©	CD	NUMBER	©	num	6	SENT_213	[p13l638t1443r661b1467],
3	2005	CD	DATE	2005	num	6	SENT_213	[p13l671t1443r735b1467],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_213	[p13l746t1443r937b1467],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_213	[p13l947t1443r1055b1467],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_213	[p13l1065t1443r1170b1474],
7	.	.	O	.	_	0	SENT_213	[p13l1065t1443r1170b1474],

1	All	DT	O	all	det	2	SENT_214	[p13l1181t1443r1222b1467],
2	rights	NNS	O	rights	nsubj	3	SENT_214	[p13l1232t1443r1306b1474],
3	reserved	VBN	O	reserve	_	0	SENT_214	[p13l1316t1443r1435b1467],
4	.	.	O	.	_	0	SENT_214	[p13l1316t1443r1435b1467],

1	The	DT	O	the	det	4	SENT_215	[p13l715t1549r752b1570],
2	NEW	NNP	O	NEW	nn	4	SENT_215	[p13l764t1551r845b1570],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_215	[p13l859t1551r1034b1570],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_215	[p13l1048t1551r1214b1577],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_215	[p13l1228t1549r1444b1576],

1	Rifampin	NNP	O	Rifampin	nn	4	SENT_216	[p14l92t345r293b401],
2	Phenytoin	NNP	O	Phenytoin	nn	4	SENT_216	[p14l92t410r314b465],
3	Ritonavir	NNP	O	Ritonavir	nn	4	SENT_216	[p14l92t477r295b516],
4	V	NNP	O	V	_	0	SENT_216	[p14l501t529r503b531],
5	St.	NNP	O	St.	nn	6	SENT_216	[p14l89t537r304b591],
6	John	NNP	PERSON	John	poss	8	SENT_216	[p14l89t537r304b591],
7	’s	POS	O	’s	_	0	SENT_216	[p14l89t537r304b591],
8	wort	NN	O	wort	dep	4	SENT_216	[p14l322t545r424b580],
9	i	FW	O	i	dep	8	SENT_216	[p14l497t544r498b547],

1	Liver	NN	O	liver	_	0	SENT_217	[p14l1648t983r1755b1022],
2	an	DT	O	a	det	3	SENT_217	[p14l1771t956r1856b1022],
3	—	NN	O	—	dep	1	SENT_217	[p14l1771t956r1856b1022],
4	di	FW	O	di	dep	3	SENT_217	[p14l1771t956r1856b1022],
5	intestine	NN	O	intestine	dep	1	SENT_217	[p14l1873t983r2069b1022],

1	W	NN	O	w	_	0	SENT_218	[p14l631t1560r646b1573],

1	Calcium-channel	JJ	O	calcium-channel	amod	2	SENT_219	[p14l144t1598r524b1641],
2	block	NN	O	block	_	0	SENT_219	[p14l546t1598r665b1641],
3	Cyclosporine	NNP	MISC	Cyclosporine	nn	4	SENT_219	[p14l144t1662r438b1718],
4	Triazolam	NNP	MISC	Triazolam	dep	2	SENT_219	[p14l142t1726r365b1768],

1	Lovastatin	NNP	MISC	Lovastatin	nn	2	SENT_220	[p14l148t1794r377b1833],
2	Erythromycin	NNP	MISC	Erythromycin	_	0	SENT_220	[p14l148t1854r444b1909],
3	HIV-protease	NN	MISC	hiv-protease	nn	4	SENT_220	[p14l148t1921r449b1973],
4	inhibitors	NNS	O	inhibitor	dep	2	SENT_220	[p14l468t1918r684b1960],
5	Sﬂdenaﬁl	NN	O	sﬂdenaﬁl	dep	2	SENT_220	[p14l145t1981r351b2024],

1	Metabolite	NN	O	metabolite	_	0	SENT_221	[p14l898t2030r1140b2091],

1	Healthy	JJ	O	healthy	amod	2	SENT_222	[p14l1115t3083r1288b3138],
2	subjects	NNS	O	subject	_	0	SENT_222	[p14l1306t3083r1491b3138],

1	Plasma	NN	O	plasma	nn	3	SENT_223	[p14l435t3284r480b3458],
2	Felodipine	NN	O	felodipine	nn	3	SENT_223	[p14l435t3005r493b3262],
3	Concentration	NN	O	concentration	_	0	SENT_223	[p14l436t2642r480b2989],
4	(	CD	NUMBER	(	num	6	SENT_223	[p14l503t2905r562b3181],
5	nmol/liter	NN	O	nmol/liter	nn	6	SENT_223	[p14l503t2905r562b3181],
6	)	NN	O	)	dep	3	SENT_223	[p14l503t2905r562b3181],

1	Patients	NNS	O	patient	_	0	SENT_224	[p14l968t3525r1147b3563],
2	with	IN	O	with	_	0	SENT_224	[p14l1165t3521r1259b3563],
3	increased	VBN	O	increase	prep_with	1	SENT_224	[p14l966t3585r1180b3627],

1	CYP3A4	NN	O	cyp3a4	nn	2	SENT_225	[p14l965t3651r1145b3691],
2	activity	NN	O	activity	_	0	SENT_225	[p14l1164t3653r1322b3704],

1	H	NN	O	h	dep	15	SENT_226	[p14l697t3812r722b3834],
2	1	CD	NUMBER	1	number	3	SENT_226	[p14l780t3813r792b3834],
3	’	CD	NUMBER	’	dep	1	SENT_226	[p14l857t3813r879b3834],
4	)	NN	O	)	dep	3	SENT_226	[p14l857t3813r879b3834],
5	'	''	O	'	_	0	SENT_226	[p14l938t3813r957b3834],
6	2	CD	NUMBER	2	dep	15	SENT_226	[p14l938t3813r957b3834],
7	A	DT	O	a	det	15	SENT_226	[p14l1019t3813r1036b3834],
8	E	NN	O	e	nn	15	SENT_226	[p14l1100t3813r1117b3834],
9	ﬁ	NN	O	ﬁ	nn	15	SENT_226	[p14l1178t3813r1200b3834],
10	7	CD	NUMBER	7	num	15	SENT_226	[p14l1259t3813r1281b3834],
11	Q	NNP	O	Q	nn	15	SENT_226	[p14l1338t3812r1358b3834],
12	C	NNP	O	C	nn	15	SENT_226	[p14l1417t3812r1692b3834],
13	|	NN	O	|	nn	15	SENT_226	[p14l1417t3812r1692b3834],
14	'	''	O	'	_	0	SENT_226	[p14l1417t3812r1692b3834],
15	l	NN	O	l	dep	21	SENT_226	[p14l1417t3812r1692b3834],
16	(	CD	NUMBER	(	dep	15	SENT_226	[p14l1417t3812r1692b3834],
17	\	NN	O	\	nn	19	SENT_226	[p14l1417t3812r1692b3834],
18	'	''	O	'	_	0	SENT_226	[p14l1417t3812r1692b3834],
19	l'l1	NN	O	l'l1	dep	16	SENT_226	[p14l1417t3812r1692b3834],
20	‘	CD	NUMBER	‘	num	21	SENT_226	[p14l1417t3812r1692b3834],
21	)	NN	O	)	_	0	SENT_226	[p14l1417t3812r1692b3834],

1	V	NNP	O	V	nn	4	SENT_227	[p15l697t6r722b23],
2	J.	NNP	O	J.	nn	4	SENT_227	[p15l780t6r799b23],
3	L	NNP	O	L	nn	4	SENT_227	[p15l857t6r880b23],
4	J	NNP	O	J	_	0	SENT_227	[p15l938t6r958b23],
5	‘	CD	NUMBER	‘	num	4	SENT_227	[p15l1016t6r1041b23],
6	I	PRP	O	I	nsubj	7	SENT_227	[p15l1016t6r1041b23],
7	’	VBP	O	’	rcmod	4	SENT_227	[p15l1016t6r1041b23],
8	J	NN	O	j	nn	9	SENT_227	[p15l1098t6r1118b23],
9	U	NN	O	u	dobj	7	SENT_227	[p15l1178t6r1201b23],
10	I	PRP	O	I	nsubj	11	SENT_227	[p15l1261t6r1273b23],
11	O	VBP	O	o	rcmod	9	SENT_227	[p15l1337t6r1360b24],
12	7	CD	NUMBER	7	dobj	11	SENT_227	[p15l1420t6r1440b23],
13	J.U	NNP	O	J.U	nn	15	SENT_227	[p15l1486t6r1535b23],
14	J.J.	NNP	PERSON	J.J.	nn	15	SENT_227	[p15l1566t6r1612b23],
15	J.L	NNP	PERSON	J.L	dep	12	SENT_227	[p15l1646t6r1694b23],

1	|	NN	O	|	nn	2	SENT_228	[p15l8t6r16b163],
2	Hours	NNS	DURATION	hour	nsubj	3	SENT_228	[p15l1116t81r1265b122],
3	|	VBP	O	|	_	0	SENT_228	[p15l2132t6r2140b163],

1	dosages	NNS	O	dosage	nsubj	3	SENT_229	[p15l562t330r811b404],
2	become	VBP	O	become	cop	3	SENT_229	[p15l834t330r1078b388],
3	ineffective	JJ	O	ineffective	_	0	SENT_229	[p15l1098t329r1437b388],
4	.	.	O	.	_	0	SENT_229	[p15l1098t329r1437b388],

1	For	IN	O	for	_	0	SENT_230	[p15l1461t335r1568b388],
2	example	NN	O	example	prep_for	9	SENT_230	[p15l1587t330r1866b404],
3	,	,	O	,	_	0	SENT_230	[p15l1587t330r1866b404],
4	patients	NNS	O	patient	nsubj	16	SENT_230	[p15l1889t330r2138b404],
5	taking	VBG	O	take	partmod	4	SENT_230	[p15l562t425r763b499],
6	oral	JJ	O	oral	amod	7	SENT_230	[p15l783t425r903b483],
7	contraceptives	NNS	O	contraceptive	dobj	5	SENT_230	[p15l925t425r1373b499],
8	may	MD	O	may	aux	9	SENT_230	[p15l1397t444r1527b499],
9	have	VB	O	have	_	0	SENT_230	[p15l1546t425r1686b483],
10	breakthrough	NN	O	breakthrough	nn	12	SENT_230	[p15l1708t425r2140b499],
11	vaginal	JJ	O	vaginal	amod	12	SENT_230	[p15l558t520r784b594],
12	bleeding	NN	O	bleeding	dobj	9	SENT_230	[p15l805t520r1078b594],
13	and	CC	O	and	_	0	SENT_230	[p15l1096t520r1211b578],
14	may	MD	O	may	aux	16	SENT_230	[p15l1232t539r1363b594],
15	become	VB	O	become	cop	16	SENT_230	[p15l1380t520r1624b578],
16	pregnant	JJ	O	pregnant	conj_and	9	SENT_230	[p15l1644t532r1933b594],
17	if	IN	O	if	mark	19	SENT_230	[p15l1949t519r2005b577],
18	they	PRP	O	they	nsubj	19	SENT_230	[p15l2012t520r2143b594],
19	ingest	VBP	O	ingest	advcl	16	SENT_230	[p15l561t615r755b689],
20	inducing	VBG	O	induce	xcomp	19	SENT_230	[p15l767t615r1049b689],
21	agents	NNS	O	agent	dobj	20	SENT_230	[p15l1062t627r1286b689],
22	;	:	O	;	_	0	SENT_230	[p15l1062t627r1286b689],
23	these	DT	O	these	nsubj	25	SENT_230	[p15l1306t615r1468b673],
24	may	MD	O	may	aux	25	SENT_230	[p15l1485t634r1616b689],
25	be	VB	O	be	parataxis	9	SENT_230	[p15l1630t615r1701b673],
26	in	IN	O	in	_	0	SENT_230	[p15l1717t615r1778b672],
27	the	DT	O	the	det	28	SENT_230	[p15l1794t615r1891b673],
28	form	NN	O	form	prep_in	25	SENT_230	[p15l1907t614r2061b673],
29	of	IN	O	of	_	0	SENT_230	[p15l2079t614r2153b673],
30	either	CC	O	either	preconj	32	SENT_230	[p15l562t710r742b768],
31	prescription	NN	O	prescription	nn	32	SENT_230	[p15l797t710r1189b784],
32	drugs	NNS	O	drug	prep_of	28	SENT_230	[p15l1251t710r1430b784],
33	or	CC	O	or	_	0	SENT_230	[p15l1493t728r1560b768],
34	nonprescription	JJ	O	nonprescription	amod	35	SENT_230	[p15l1619t710r2139b784],
35	products	NNS	O	product	prep_of	28	SENT_230	[p15l560t805r842b879],
36	such	JJ	O	such	_	0	SENT_230	[p15l875t805r1022b863],
37	as	IN	O	as	_	0	SENT_230	[p15l1052t824r1114b863],
38	those	DT	O	those	prep_such_as	28	SENT_230	[p15l1144t805r1313b863],
39	used	VBN	O	use	partmod	38	SENT_230	[p15l1342t805r1487b863],
40	in	IN	O	in	_	0	SENT_230	[p15l1515t805r1575b862],
41	alternative	JJ	O	alternative	amod	42	SENT_230	[p15l1603t805r1928b864],
42	medicine	NN	O	medicine	prep_in	39	SENT_230	[p15l1957t805r2138b863, p15l562t900r689b958],
43	(	CD	NUMBER	(	num	42	SENT_230	[p15l708t904r861b974],
44	e.g.	FW	O	e.g.	dep	42	SENT_230	[p15l708t904r861b974],
45	,	,	O	,	_	0	SENT_230	[p15l708t904r861b974],
46	St.	NNP	PERSON	St.	nn	47	SENT_230	[p15l883t904r957b958],
47	John	NNP	PERSON	John	poss	51	SENT_230	[p15l970t899r1173b967],
48	’s	POS	O	’s	_	0	SENT_230	[p15l970t899r1173b967],
49	wort	NN	O	wort	nn	51	SENT_230	[p15l1188t895r1436b967],
50	“	NN	O	“	nn	51	SENT_230	[p15l1188t895r1436b967],
51	)	NN	O	)	appos	42	SENT_230	[p15l1188t895r1436b967],
52	.	.	O	.	_	0	SENT_230	[p15l1188t895r1436b967],

1	St.	NNP	PERSON	St.	nn	2	SENT_231	[p15l1458t904r1532b958],
2	John	NNP	PERSON	John	poss	4	SENT_231	[p15l1544t899r1748b967],
3	’s	POS	O	’s	_	0	SENT_231	[p15l1544t899r1748b967],
4	Wort	NN	O	wort	nsubj	8	SENT_231	[p15l1762t912r1911b958],
5	is	VBZ	O	be	cop	8	SENT_231	[p15l1923t900r1971b958],
6	a	DT	O	a	det	8	SENT_231	[p15l1988t919r2021b958],
7	potent	JJ	O	potent	amod	8	SENT_231	[p15l2034t918r2138b974, p15l562t1007r685b1053],
8	inducer	NN	O	inducer	_	0	SENT_231	[p15l701t995r940b1053],
9	of	IN	O	of	_	0	SENT_231	[p15l959t994r1033b1053],
10	CYP3A	NN	O	cyp3a	prep_of	8	SENT_231	[p15l1039t999r1267b1065],
11	;	:	O	;	_	0	SENT_231	[p15l1039t999r1267b1065],
12	thus	RB	O	thus	advmod	8	SENT_231	[p15l1290t995r1441b1065],
13	,	,	O	,	_	0	SENT_231	[p15l1290t995r1441b1065],
14	when	WRB	O	when	dep	17	SENT_231	[p15l1462t995r1634b1053],
15	a	DT	O	a	det	17	SENT_231	[p15l1653t1014r1686b1053],
16	patient	NN	O	patient	nn	17	SENT_231	[p15l1703t995r1923b1069],
17	receivFigure	NN	O	receivfigure	attr	8	SENT_231	[p15l1939t995r2139b1053, p15l86t1361r303b1444],

1	3	LS	NUMBER	3	_	0	SENT_232	[p15l328t1365r385b1424],
2	.	.	O	.	_	0	SENT_232	[p15l328t1365r385b1424],

1	Mechanism	NN	O	mechanism	nsubj	17	SENT_233	[p15l417t1360r825b1424],
2	of	IN	O	of	_	0	SENT_233	[p15l852t1359r932b1424],
3	Induction	NN	MISC	induction	prep_of	1	SENT_233	[p15l946t1360r1277b1424],
4	of	IN	MISC	of	_	0	SENT_233	[p15l1304t1359r1385b1424],
5	CYP3A4-Mediated	JJ	MISC	cyp3a4-mediated	amod	6	SENT_233	[p15l1395t1360r2033b1424],
6	Metabolism	NN	MISC	metabolism	prep_of	3	SENT_233	[p15l86t1467r497b1532],
7	of	IN	MISC	of	_	0	SENT_233	[p15l523t1466r604b1532],
8	Drug	NN	MISC	drug	nn	9	SENT_233	[p15l617t1474r791b1552],
9	Substrates	NNS	MISC	substrate	prep_of	6	SENT_233	[p15l812t1467r1186b1532],
10	(	CD	NUMBER	(	num	11	SENT_233	[p15l1215t1467r1426b1553],
11	Panel	NN	O	panel	dep	9	SENT_233	[p15l1215t1467r1426b1553],
12	A	DT	O	a	det	13	SENT_233	[p15l1450t1474r1522b1553],
13	)	NN	O	)	dep	9	SENT_233	[p15l1450t1474r1522b1553],
14	and	CC	O	and	_	0	SENT_233	[p15l1550t1467r1676b1532],
15	the	DT	O	the	prep_of	6	SENT_233	[p15l1700t1467r1813b1532],
16	Resulting	VBG	O	result	amod	15	SENT_233	[p15l1841t1467r2078b1532, p15l82t1577r190b1660],
17	Reduced	VBN	O	reduce	_	0	SENT_233	[p15l217t1575r513b1640],
18	Plasma	NN	O	plasma	nn	20	SENT_233	[p15l545t1575r796b1640],
19	Drug	NN	O	drug	nn	20	SENT_233	[p15l826t1581r999b1660],
20	Concentration	NN	O	concentration	tmod	17	SENT_233	[p15l1022t1577r1518b1640],
21	(	CD	NUMBER	(	num	24	SENT_233	[p15l1550t1575r1762b1660],
22	Panel	NN	O	panel	nn	24	SENT_233	[p15l1550t1575r1762b1660],
23	B	NN	O	b	nn	24	SENT_233	[p15l1793t1581r1883b1660],
24	)	NN	O	)	dep	20	SENT_233	[p15l1793t1581r1883b1660],
25	.	.	O	.	_	0	SENT_233	[p15l1793t1581r1883b1660],

1	In	IN	O	in	_	0	SENT_234	[p15l87t1726r144b1784],
2	Panel	NN	O	panel	nn	3	SENT_234	[p15l179t1721r360b1786],
3	A	NN	O	a	prep_in	12	SENT_234	[p15l388t1725r454b1796],
4	,	,	O	,	_	0	SENT_234	[p15l388t1725r454b1796],
5	an	DT	O	a	det	7	SENT_234	[p15l484t1743r561b1785],
6	inducing	VBG	O	induce	amod	7	SENT_234	[p15l594t1721r898b1806],
7	agent	NN	O	agent	appos	3	SENT_234	[p15l923t1733r1116b1806],
8	(	CD	NUMBER	(	num	9	SENT_234	[p15l1148t1726r1348b1806],
9	Drug	NN	O	drug	nsubj	12	SENT_234	[p15l1148t1726r1348b1806],
10	I	PRP	O	I	nsubj	11	SENT_234	[p15l1371t1726r1418b1805],
11	)	VBP	O	)	rcmod	9	SENT_234	[p15l1371t1726r1418b1805],
12	interacts	VBZ	O	interact	_	0	SENT_234	[p15l1454t1727r1752b1786],
13	with	IN	O	with	_	0	SENT_234	[p15l1778t1721r1922b1786],
14	the	DT	O	the	det	20	SENT_234	[p15l1950t1721r2059b1786],
15	nuclear	JJ	O	nuclear	amod	20	SENT_234	[p15l84t1828r341b1893],
16	receptor	NN	O	receptor	nn	20	SENT_234	[p15l368t1841r658b1913],
17	PXR	NN	O	pxr	nn	20	SENT_234	[p15l686t1835r822b1892],
18	(	CD	NUMBER	(	num	20	SENT_234	[p15l857t1834r1209b1914],
19	pregnane	NN	O	pregnane	nn	20	SENT_234	[p15l857t1834r1209b1914],
20	X	NN	O	x	prep_with	12	SENT_234	[p15l1233t1835r1281b1892],
21	receptor	NN	O	receptor	nn	22	SENT_234	[p15l1308t1834r1645b1913],
22	)	NN	O	)	tmod	20	SENT_234	[p15l1308t1834r1645b1913],
23	,	,	O	,	_	0	SENT_234	[p15l1308t1834r1645b1913],
24	which	WDT	O	which	nsubj	25	SENT_234	[p15l1672t1828r1875b1893],
25	forms	VBZ	O	form	rcmod	22	SENT_234	[p15l79t1935r284b2001],
26	a	DT	O	a	det	27	SENT_234	[p15l313t1959r346b2001],
27	heterodimer	NN	O	heterodimer	dobj	25	SENT_234	[p15l376t1937r809b2001],
28	with	IN	O	with	_	0	SENT_234	[p15l830t1937r974b2001],
29	the	DT	O	the	det	35	SENT_234	[p15l1002t1937r1112b2001],
30	retinoid	NN	O	retinoid	nn	35	SENT_234	[p15l1141t1937r1406b2001],
31	X	NN	O	x	nn	35	SENT_234	[p15l1434t1942r1481b2000],
32	receptor	NN	O	receptor	nn	35	SENT_234	[p15l1509t1949r1799b2021],
33	(	CD	NUMBER	(	num	35	SENT_234	[p15l1829t1942r2047b2021],
34	RXR	NN	O	rxr	nn	35	SENT_234	[p15l1829t1942r2047b2021],
35	)	NN	O	)	prep_with	25	SENT_234	[p15l1829t1942r2047b2021],
36	,	,	O	,	_	0	SENT_234	[p15l1829t1942r2047b2021],
37	which	WDT	O	which	nsubj	40	SENT_234	[p15l78t2044r281b2109],
38	in	IN	O	in	_	0	SENT_234	[p15l312t2050r367b2108],
39	turn	NN	O	turn	prep_in	40	SENT_234	[p15l394t2056r535b2109],
40	binds	VBZ	O	bind	rcmod	35	SENT_234	[p15l567t2044r754b2109],
41	to	TO	O	to	_	0	SENT_234	[p15l778t2056r847b2109],
42	cognate	JJ	O	cognate	amod	44	SENT_234	[p15l872t2056r1149b2130],
43	recognition	NN	O	recognition	nn	44	SENT_234	[p15l1177t2050r1570b2130],
44	sites	NNS	O	site	prep_to	40	SENT_234	[p15l1600t2050r1756b2109],
45	in	IN	O	in	_	0	SENT_234	[p15l1785t2050r1840b2108],
46	the	DT	O	the	det	47	SENT_234	[p15l1867t2044r1976b2109],
47	5	CD	NUMBER	5	prep_in	44	SENT_234	[p15l2001t2050r2055b2109],
48	'	''	O	'	_	0	SENT_234	[p15l2001t2050r2055b2109],
49	regulatory	JJ	O	regulatory	amod	50	SENT_234	[p15l84t2152r435b2237],
50	region	NN	O	region	nsubj	51	SENT_234	[p15l463t2158r677b2237],
51	ofthe	VBP	O	ofthe	rcmod	47	SENT_234	[p15l707t2151r905b2217],
52	CYP3A4	NN	O	cyp3a4	nn	53	SENT_234	[p15l933t2156r1213b2217],
53	gene	NN	O	gene	dobj	51	SENT_234	[p15l1237t2175r1421b2237],
54	.	.	O	.	_	0	SENT_234	[p15l1237t2175r1421b2237],

1	As	IN	O	as	_	0	SENT_235	[p15l1447t2156r1531b2217],
2	a	DT	O	a	det	3	SENT_235	[p15l1560t2175r1593b2217],
3	result	NN	O	result	prep_as	8	SENT_235	[p15l1625t2152r1835b2228],
4	,	,	O	,	_	0	SENT_235	[p15l1625t2152r1835b2228],
5	transcription	NN	O	transcription	nn	6	SENT_235	[p15l1862t2164r2025b2217, p15l82t2266r386b2344],
6	ofDNA	NN	O	ofdna	nsubjpass	17	SENT_235	[p15l416t2259r680b2324],
7	is	VBZ	O	be	auxpass	8	SENT_235	[p15l707t2265r756b2324],
8	up-regulated	VBN	O	up-regulate	_	0	SENT_235	[p15l788t2260r1249b2345],
9	,	,	O	,	_	0	SENT_235	[p15l788t2260r1249b2345],
10	leading	VBG	O	lead	xcomp	8	SENT_235	[p15l1282t2260r1535b2345],
11	to	TO	O	to	_	0	SENT_235	[p15l1557t2272r1625b2324],
12	increased	VBN	O	increase	amod	15	SENT_235	[p15l1655t2260r1985b2324],
13	synthesis	NN	O	synthesis	nn	15	SENT_235	[p15l83t2368r405b2452],
14	ofCYP3A4	NN	O	ofcyp3a4	nn	15	SENT_235	[p15l434t2366r802b2432],
15	enzyme	NN	O	enzyme	prep_to	10	SENT_235	[p15l829t2390r1098b2452],
16	and	CC	O	and	_	0	SENT_235	[p15l1126t2368r1249b2432],
17	enhanced	VBD	O	enhance	conj_and	8	SENT_235	[p15l1279t2368r1616b2432],
18	oxidative	JJ	O	oxidative	amod	21	SENT_235	[p15l1646t2368r1957b2432],
19	metabolism	NN	O	metabolism	nn	21	SENT_235	[p15l84t2475r497b2540],
20	ofits	NNS	O	ofit	nn	21	SENT_235	[p15l527t2475r695b2540],
21	substrates	NNS	O	substrate	dobj	17	SENT_235	[p15l726t2475r1087b2540],
22	(	CD	NUMBER	(	num	23	SENT_235	[p15l1123t2480r1323b2561],
23	Drug	NN	O	drug	dobj	8	SENT_235	[p15l1123t2480r1323b2561],
24	S	NN	O	s	prep	23	SENT_235	[p15l1349t2480r1438b2560],
25	)	CD	NUMBER	)	dep	24	SENT_235	[p15l1349t2480r1438b2560],
26	.	.	O	.	_	0	SENT_235	[p15l1349t2480r1438b2560],

1	This	DT	O	this	nsubj	2	SENT_236	[p15l1463t2475r1611b2540],
2	causes	VBZ	O	cause	_	0	SENT_236	[p15l1639t2498r1875b2540],
3	a	DT	O	a	det	4	SENT_236	[p15l1904t2498r1936b2540],
4	reduction	NN	O	reduction	dobj	2	SENT_236	[p15l1968t2498r2051b2540, p15l81t2583r343b2648],
5	in	IN	O	in	_	0	SENT_236	[p15l373t2589r429b2647],
6	the	DT	O	the	det	9	SENT_236	[p15l453t2583r563b2648],
7	plasma	NN	O	plasma	nn	9	SENT_236	[p15l590t2583r840b2668],
8	drug	NN	O	drug	nn	9	SENT_236	[p15l865t2583r1027b2668],
9	concentration	NN	O	concentration	prep_in	4	SENT_236	[p15l1048t2589r1532b2648],
10	as	IN	O	as	advmod	11	SENT_236	[p15l1561t2606r1631b2648],
11	exemplified	VBN	O	exemplify	dep	9	SENT_236	[p15l1657t2582r2057b2668],
12	by	IN	O	by	_	0	SENT_236	[p15l84t2691r157b2776],
13	felodipine	NN	O	felodipine	nn	17	SENT_236	[p15l180t2690r530b2775],
14	(	CD	NUMBER	(	num	17	SENT_236	[p15l564t2691r774b2775],
15	Panel	NN	O	panel	nn	17	SENT_236	[p15l564t2691r774b2775],
16	B	NN	O	b	nn	17	SENT_236	[p15l810t2696r874b2775],
17	)	NN	O	)	prep_by	11	SENT_236	[p15l810t2696r874b2775],
18	and	CC	O	and	_	0	SENT_236	[p15l908t2691r1054b2767],
19	,	,	O	,	_	0	SENT_236	[p15l908t2691r1054b2767],
20	subsequently	RB	O	subsequently	dep	11	SENT_236	[p15l1085t2691r1559b2776],
21	,	,	O	,	_	0	SENT_236	[p15l1085t2691r1559b2776],
22	decreased	VBD	O	decrease	conj_and	11	SENT_236	[p15l1589t2691r1940b2756],
23	drug	NN	O	drug	nn	24	SENT_236	[p15l81t2798r243b2884],
24	effects	NNS	O	effect	dobj	22	SENT_236	[p15l267t2798r513b2863],
25	.	.	O	.	_	0	SENT_236	[p15l267t2798r513b2863],

1	The	DT	O	the	det	4	SENT_237	[p15l538t2798r668b2863],
2	same	JJ	O	same	amod	4	SENT_237	[p15l696t2822r882b2863],
3	molecular	JJ	O	molecular	amod	4	SENT_237	[p15l912t2798r1261b2863],
4	mechanism	NN	O	mechanism	nsubj	7	SENT_237	[p15l1287t2798r1693b2863],
5	is	VBZ	O	be	cop	7	SENT_237	[p15l1726t2805r1774b2863],
6	also	RB	O	also	advmod	7	SENT_237	[p15l1804t2798r1942b2863],
7	responsible	JJ	O	responsible	_	0	SENT_237	[p15l1973t2822r2056b2863, p15l83t2907r420b2991],
8	for	IN	O	for	_	0	SENT_237	[p15l444t2906r542b2971],
9	the	DT	O	the	det	11	SENT_237	[p15l563t2907r672b2971],
10	induction	NN	O	induction	nn	11	SENT_237	[p15l701t2907r1029b2971],
11	ofother	NN	O	ofother	prep_for	7	SENT_237	[p15l1059t2906r1334b2971],
12	metabolizing	VBG	O	metabolize	xcomp	7	SENT_237	[p15l1361t2907r1819b2992],
13	enzymes	NNS	O	enzyme	nsubj	17	SENT_237	[p15l1844t2929r1949b2971, p15l80t3037r300b3099],
14	and	CC	O	and	_	0	SENT_237	[p15l329t3014r452b3079],
15	membrane	NN	O	membrane	nn	16	SENT_237	[p15l486t3014r866b3079],
16	transporters	NNS	O	transporter	conj_and	13	SENT_237	[p15l889t3026r1323b3099],
17	important	JJ	O	important	xcomp	12	SENT_237	[p15l1353t3020r1703b3099],
18	in	IN	O	in	_	0	SENT_237	[p15l1731t3020r1787b3078],
19	drug	NN	O	drug	nn	20	SENT_237	[p15l1817t3014r1978b3100],
20	disposition	NN	O	disposition	prep_in	17	SENT_237	[p15l81t3122r494b3206],
21	.	.	O	.	_	0	SENT_237	[p15l81t3122r494b3206],

1	Comparison	NN	O	comparison	nn	8	SENT_238	[p15l523t3127r952b3206],
2	ofthe	NN	O	ofthe	nn	8	SENT_238	[p15l981t3122r1179b3187],
3	plasma	NN	O	plasma	nn	8	SENT_238	[p15l1209t3122r1459b3206],
4	felodipine	NN	O	felodipine	nn	8	SENT_238	[p15l1485t3122r1835b3206],
5	concentration	NN	O	concentration	nn	8	SENT_238	[p15l1861t3145r2010b3187, p15l81t3236r642b3294],
6	—	CD	NUMBER	—	num	8	SENT_238	[p15l1861t3145r2010b3187, p15l81t3236r642b3294],
7	time	NN	O	time	nn	8	SENT_238	[p15l1861t3145r2010b3187, p15l81t3236r642b3294],
8	profiles	NNS	O	profile	nsubj	17	SENT_238	[p15l673t3229r928b3314],
9	in	IN	O	in	_	0	SENT_238	[p15l959t3236r1015b3294],
10	Panel	NN	O	panel	nn	11	SENT_238	[p15l1051t3230r1232b3294],
11	B	NN	O	b	prep_in	17	SENT_238	[p15l1267t3236r1305b3294],
12	with	IN	O	with	_	0	SENT_238	[p15l1330t3230r1474b3294],
13	those	DT	O	those	prep_with	11	SENT_238	[p15l1502t3230r1696b3294],
14	in	IN	O	in	_	0	SENT_238	[p15l1725t3236r1781b3294],
15	Figure	NNP	O	Figure	nn	16	SENT_238	[p15l1816t3236r2030b3315],
16	2A	NN	O	2a	prep_in	13	SENT_238	[p15l81t3342r171b3402],
17	indicates	VBZ	O	indicate	_	0	SENT_238	[p15l197t3338r508b3403],
18	the	DT	O	the	det	20	SENT_238	[p15l532t3338r642b3403],
19	wide	JJ	O	wide	amod	20	SENT_238	[p15l664t3338r827b3403],
20	range	NN	O	range	dobj	17	SENT_238	[p15l855t3360r1047b3423],
21	of	IN	O	of	_	0	SENT_238	[p15l1072t3337r1149b3403],
22	CYP3A	NN	O	cyp3a	nn	23	SENT_238	[p15l1162t3342r1399b3403],
23	activity	NN	O	activity	prep_of	20	SENT_238	[p15l1423t3343r1667b3422],
24	that	WDT	O	that	nsubj	26	SENT_238	[p15l1687t3338r1826b3403],
25	is	VBZ	O	be	cop	26	SENT_238	[p15l1853t3343r1901b3403],
26	possible	JJ	O	possible	rcmod	20	SENT_238	[p15l1933t3360r2077b3422, p15l82t3445r260b3510],
27	.	.	O	.	_	0	SENT_238	[p15l1933t3360r2077b3422, p15l82t3445r260b3510],

1	I	PRP	O	I	dep	2	SENT_239	[p15l287t3453r312b3509],
2	bars	NNS	O	bar	nsubj	3	SENT_239	[p15l340t3445r483b3510],
3	denote	VBP	O	denote	_	0	SENT_239	[p15l511t3445r752b3510],
4	SEs	NNS	O	se	dobj	3	SENT_239	[p15l779t3450r922b3510],
5	.	.	O	.	_	0	SENT_239	[p15l779t3450r922b3510],

1	Panel	NN	O	panel	nn	2	SENT_240	[p15l956t3445r1138b3510],
2	B	NN	O	b	nsubjpass	4	SENT_240	[p15l1174t3452r1210b3509],
3	was	VBD	O	be	auxpass	4	SENT_240	[p15l1236t3468r1368b3510],
4	adapted	VBN	O	adapt	_	0	SENT_240	[p15l1397t3445r1675b3530],
5	from	IN	O	from	_	0	SENT_240	[p15l1703t3445r1867b3510],
6	Capewell	NNP	O	Capewell	nn	7	SENT_240	[p15l82t3554r389b3638],
7	et	NNP	O	et	prep_from	4	SENT_240	[p15l418t3566r498b3618],
8	.	.	O	.	_	0	SENT_240	[p15l418t3566r498b3618],

1	aI.	NN	O	ai.	_	0	SENT_241	[p15l528t3554r660b3629],
2	,8	CD	NUMBER	,8	num	1	SENT_241	[p15l528t3554r660b3629],
3	with	IN	O	with	_	0	SENT_241	[p15l683t3554r827b3618],
4	the	DT	O	the	det	7	SENT_241	[p15l855t3554r965b3618],
5	permission	NN	O	permission	nn	7	SENT_241	[p15l995t3559r1383b3638],
6	ofthe	NN	O	ofthe	nn	7	SENT_241	[p15l1413t3553r1611b3618],
7	publisher	NN	O	publisher	prep_with	1	SENT_241	[p15l1641t3554r1977b3638],
8	.	.	O	.	_	0	SENT_241	[p15l1641t3554r1977b3638],

1	ing	NN	O	ing	nn	2	SENT_242	[p16l11t68r148b167],
2	cyclosporine	NN	O	cyclosporine	nsubj	8	SENT_242	[p16l186t67r713b167],
3	or	CC	O	or	_	0	SENT_242	[p16l754t92r843b145],
4	HIV	NN	MISC	hiv	nn	7	SENT_242	[p16l880t74r1433b167],
5	—	NN	O	—	nn	7	SENT_242	[p16l880t74r1433b167],
6	protease	NN	O	protease	nn	7	SENT_242	[p16l880t74r1433b167],
7	inhibitors	NNS	O	inhibitor	nsubj	8	SENT_242	[p16l1472t67r1883b145],
8	takes	VBZ	O	take	_	0	SENT_242	[p16l1925t67r2140b146],
9	St.	NNP	O	St.	nn	10	SENT_242	[p16l13t202r112b274],
10	John	NNP	PERSON	John	poss	12	SENT_242	[p16l139t196r412b287],
11	’s	POS	O	’s	_	0	SENT_242	[p16l139t196r412b287],
12	wort	NN	O	wort	dobj	8	SENT_242	[p16l440t212r658b291],
13	,	,	O	,	_	0	SENT_242	[p16l440t212r658b291],
14	therapeutic	JJ	O	therapeutic	amod	15	SENT_242	[p16l696t196r1168b296],
15	failure	NN	O	failure	nsubj	17	SENT_242	[p16l1198t195r1465b275],
16	may	MD	O	may	aux	17	SENT_242	[p16l1497t222r1672b296],
17	occur	VB	O	occur	ccomp	8	SENT_242	[p16l1700t189r2140b275],
18	.13	CD	NUMBER	.13	number	19	SENT_242	[p16l1700t189r2140b275],
19	‘	CD	NUMBER	‘	num	20	SENT_242	[p16l1700t189r2140b275],
20	16	CD	NUMBER	16	dobj	17	SENT_242	[p16l1700t189r2140b275],
21	Characteristically	RB	O	characteristically	advmod	17	SENT_242	[p16l11t325r747b425],
22	,	,	O	,	_	0	SENT_242	[p16l11t325r747b425],
23	the	DT	O	the	det	24	SENT_242	[p16l793t325r922b403],
24	consequences	NNS	O	consequence	nsubj	30	SENT_242	[p16l963t350r1541b425],
25	of	IN	O	of	_	0	SENT_242	[p16l1585t324r1685b403],
26	CYP3A	NN	O	cyp3a	nn	27	SENT_242	[p16l1707t330r1992b403],
27	induction	NN	O	induction	prep_of	24	SENT_242	[p16l2028t325r2140b402, p16l12t454r328b533],
28	are	VBP	O	be	cop	30	SENT_242	[p16l351t480r475b532],
29	not	RB	O	not	neg	30	SENT_242	[p16l500t470r642b532],
30	immediate	JJ	O	immediate	ccomp	8	SENT_242	[p16l660t454r1129b549],
31	,	,	O	,	_	0	SENT_242	[p16l660t454r1129b549],
32	since	IN	O	since	mark	37	SENT_242	[p16l1160t454r1373b532],
33	new	JJ	O	new	amod	34	SENT_242	[p16l1399t479r1575b533],
34	protein	NN	O	protein	nsubjpass	37	SENT_242	[p16l1595t454r1904b554],
35	must	MD	O	must	aux	37	SENT_242	[p16l1929t470r2147b533],
36	be	VB	O	be	auxpass	37	SENT_242	[p16l12t583r108b661],
37	synthesized	VBN	O	synthesize	advcl	30	SENT_242	[p16l155t583r684b683],
38	.	.	O	.	_	0	SENT_242	[p16l155t583r684b683],

1	Steady	JJ	O	steady	amod	4	SENT_243	[p16l736t583r1253b683],
2	—	NN	O	—	nn	4	SENT_243	[p16l736t583r1253b683],
3	state	NN	O	state	nn	4	SENT_243	[p16l736t583r1253b683],
4	levels	NNS	O	level	nsubjpass	7	SENT_243	[p16l1296t583r1530b662],
5	generally	RB	O	generally	advmod	7	SENT_243	[p16l1576t583r1972b683],
6	are	VBP	O	be	auxpass	7	SENT_243	[p16l2012t609r2140b661],
7	reached	VBN	O	reach	_	0	SENT_243	[p16l11t712r342b790],
8	in	IN	O	in	_	0	SENT_243	[p16l369t712r451b789],
9	two	CD	DURATION	two	number	11	SENT_243	[p16l480t728r632b791],
10	to	TO	DURATION	to	dep	11	SENT_243	[p16l663t728r742b790],
11	three	CD	DURATION	three	num	12	SENT_243	[p16l771t712r983b790],
12	weeks	NNS	NUMBER	week	prep_in	7	SENT_243	[p16l1007t712r1289b791],
13	.	.	O	.	_	0	SENT_243	[p16l1007t712r1289b791],

1	Similarly	RB	O	similarly	advmod	16	SENT_244	[p16l1325t712r1708b812],
2	,	,	O	,	_	0	SENT_244	[p16l1325t712r1708b812],
3	“	CD	NUMBER	“	nsubj	16	SENT_244	[p16l1745t712r2145b812],
4	Washing	VBG	O	wash	partmod	3	SENT_244	[p16l1745t712r2145b812],
5	out	RP	O	out	prt	4	SENT_244	[p16l12t845r188b919],
6	”	IN	O	”	_	0	SENT_244	[p16l12t845r188b919],
7	the	DT	O	the	det	9	SENT_244	[p16l215t840r344b918],
8	induction	NN	O	induction	nn	9	SENT_244	[p16l365t840r769b919],
9	effect	NN	O	effect	prep_”	4	SENT_244	[p16l793t839r1027b918],
10	after	IN	O	after	_	0	SENT_244	[p16l1044t839r1238b918],
11	discontinuing	VBG	O	discontinue	prepc_after	9	SENT_244	[p16l1259t840r1853b940],
12	the	DT	O	the	det	14	SENT_244	[p16l1873t840r2003b918],
13	inducing	VBG	O	induce	amod	14	SENT_244	[p16l2026t840r2140b917, p16l12t969r305b1069],
14	agent	NN	O	agent	dobj	11	SENT_244	[p16l330t984r567b1069],
15	also	RB	O	also	advmod	11	SENT_244	[p16l591t969r759b1047],
16	takes	VBZ	O	take	_	0	SENT_244	[p16l790t969r1006b1048],
17	several	JJ	DURATION	several	amod	18	SENT_244	[p16l1039t969r1320b1048],
18	weeks	NNS	DURATION	week	tmod	16	SENT_244	[p16l1344t969r1627b1048],
19	.	.	O	.	_	0	SENT_244	[p16l1344t969r1627b1048],

1	During	IN	O	during	prep	12	SENT_245	[p16l1660t969r1962b1069],
2	and	CC	O	and	dep	3	SENT_245	[p16l1987t969r2142b1047],
3	after	IN	O	after	dep	1	SENT_245	[p16l11t1096r209b1175],
4	these	DT	O	these	det	5	SENT_245	[p16l238t1097r461b1175],
5	periods	NNS	O	period	pobj	3	SENT_245	[p16l493t1097r842b1197],
6	,	,	O	,	_	0	SENT_245	[p16l493t1097r842b1197],
7	adequate	JJ	O	adequate	amod	9	SENT_245	[p16l879t1097r1266b1197],
8	drug	NN	O	drug	nn	9	SENT_245	[p16l1298t1097r1501b1197],
9	therapy	NN	O	therapy	nsubj	19	SENT_245	[p16l1531t1097r1855b1197],
10	is	VBZ	O	be	cop	12	SENT_245	[p16l1882t1097r1948b1175],
11	still	RB	O	still	advmod	12	SENT_245	[p16l1984t1097r2140b1175],
12	achievable	JJ	O	achievable	_	0	SENT_245	[p16l11t1226r459b1305],
13	by	IN	O	by	_	0	SENT_245	[p16l489t1226r587b1326],
14	instituting	VBG	O	institute	prepc_by	12	SENT_245	[p16l611t1226r1067b1326],
15	appropriate	JJ	O	appropriate	amod	17	SENT_245	[p16l1091t1226r1594b1326],
16	stepwise	JJ	O	stepwise	amod	17	SENT_245	[p16l1625t1226r1994b1326],
17	increases	NNS	O	increase	dobj	14	SENT_245	[p16l2022t1226r2139b1303, p16l12t1381r313b1433],
18	or	CC	O	or	_	0	SENT_245	[p16l346t1380r435b1433],
19	decreases	VBZ	O	decrease	conj_or	12	SENT_245	[p16l463t1355r866b1433],
20	in	IN	O	in	_	0	SENT_245	[p16l897t1355r977b1432],
21	the	DT	O	the	det	23	SENT_245	[p16l1007t1355r1135b1433],
22	medication	NN	O	medication	nn	23	SENT_245	[p16l1164t1355r1632b1433],
23	dose	NN	O	dose	prep_in	19	SENT_245	[p16l1661t1355r1875b1450],
24	,	,	O	,	_	0	SENT_245	[p16l1661t1355r1875b1450],
25	along	IN	O	along	dep	26	SENT_245	[p16l1908t1355r2145b1455],
26	with	IN	O	with	conj_or	12	SENT_245	[p16l7t1484r194b1563],
27	monitoring	VBG	O	monitor	amod	29	SENT_245	[p16l218t1484r699b1584],
28	plasma	NN	O	plasma	nn	29	SENT_245	[p16l717t1484r1021b1584],
29	levels	NNS	O	level	pobj	26	SENT_245	[p16l1043t1484r1297b1579],
30	,	,	O	,	_	0	SENT_245	[p16l1043t1484r1297b1579],
31	when	WRB	O	when	dep	32	SENT_245	[p16l1324t1484r1558b1563],
32	available	JJ	O	available	dep	12	SENT_245	[p16l1582t1484r1971b1563],
33	.	.	O	.	_	0	SENT_245	[p16l1582t1484r1971b1563],

1	The	DT	O	the	det	2	SENT_246	[p16l137t1613r298b1691],
2	mechanism	NN	O	mechanism	nsubj	10	SENT_246	[p16l320t1613r812b1691],
3	by	IN	O	by	_	0	SENT_246	[p16l835t1613r931b1713],
4	which	WDT	O	which	agent	9	SENT_246	[p16l945t1613r1204b1692],
5	CYP3A4	NN	O	cyp3a4	nsubjpass	9	SENT_246	[p16l1225t1618r1562b1691],
6	is	VBZ	O	be	auxpass	9	SENT_246	[p16l1584t1613r1648b1691],
7	up	RB	O	up	advmod	9	SENT_246	[p16l1673t1613r2140b1713, p16l12t1741r108b1819],
8	—	RB	O	—	advmod	9	SENT_246	[p16l1673t1613r2140b1713, p16l12t1741r108b1819],
9	regulated	VBN	O	regulate	rcmod	2	SENT_246	[p16l1673t1613r2140b1713, p16l12t1741r108b1819],
10	involves	VBZ	O	involve	ccomp	25	SENT_246	[p16l141t1741r478b1820],
11	intracellular	JJ	O	intracellular	amod	12	SENT_246	[p16l514t1741r1029b1820],
12	binding	NN	O	binding	dobj	10	SENT_246	[p16l1061t1741r1395b1841],
13	of	IN	O	of	_	0	SENT_246	[p16l1426t1740r1527b1819],
14	the	DT	O	the	det	15	SENT_246	[p16l1543t1741r1672b1819],
15	inducer	NN	O	inducer	prep_of	12	SENT_246	[p16l1705t1741r2029b1820],
16	to	TO	O	to	_	0	SENT_246	[p16l2061t1757r2140b1819],
17	the	DT	O	the	det	19	SENT_246	[p16l12t1870r143b1948],
18	nuclear	JJ	O	nuclear	amod	19	SENT_246	[p16l172t1870r494b1949],
19	receptor	NN	O	receptor	prep_to	10	SENT_246	[p16l519t1885r897b1970],
20	,	,	O	,	_	0	SENT_246	[p16l519t1885r897b1970],
21	N	NN	O	n	nn	22	SENT_246	[p16l929t1876r1004b1948],
22	R112	NN	O	r112	appos	19	SENT_246	[p16l1007t1875r1236b1965],
23	,	,	O	,	_	0	SENT_246	[p16l1007t1875r1236b1965],
24	also	RB	O	also	advmod	25	SENT_246	[p16l1271t1870r1442b1948],
25	called	VBD	O	call	_	0	SENT_246	[p16l1473t1870r1722b1948],
26	the	DT	O	the	det	30	SENT_246	[p16l1752t1870r1883b1948],
27	pregnane	NN	O	pregnane	nn	30	SENT_246	[p16l1911t1896r2139b1970, p16l11t2024r218b2077],
28	X	NN	O	x	nn	30	SENT_246	[p16l253t2005r315b2076],
29	receptor	NN	O	receptor	nn	30	SENT_246	[p16l350t2015r710b2099],
30	(	NN	O	(	dobj	25	SENT_246	[p16l749t2005r988b2090],
31	PXR	NN	O	pxr	nsubj	25	SENT_246	[p16l749t2005r988b2090],
32	)	CD	NUMBER	)	num	31	SENT_246	[p16l749t2005r988b2090],
33	or	CC	O	or	_	0	SENT_246	[p16l1032t2024r1122b2077],
34	the	DT	O	the	det	37	SENT_246	[p16l1158t1999r1289b2077],
35	steroid	NN	O	steroid	nn	37	SENT_246	[p16l1330t1999r1626b2077],
36	X	NN	O	x	nn	37	SENT_246	[p16l1660t2005r1722b2076],
37	receptor	NN	O	receptor	conj_or	31	SENT_246	[p16l1757t2015r2135b2099],
38	.	.	O	.	_	0	SENT_246	[p16l1757t2015r2135b2099],

1	Subsequently	RB	O	subsequently	advmod	5	SENT_247	[p16l13t2127r604b2227],
2	,	,	O	,	_	0	SENT_247	[p16l13t2127r604b2227],
3	this	DT	O	this	det	4	SENT_247	[p16l647t2127r803b2205],
4	receptor	NN	O	receptor	nsubj	5	SENT_247	[p16l842t2143r1201b2227],
5	forms	VBZ	O	form	_	0	SENT_247	[p16l1236t2126r1488b2205],
6	a	DT	O	a	det	7	SENT_247	[p16l1527t2153r1572b2205],
7	heterodimer	NN	O	heterodimer	dobj	5	SENT_247	[p16l1607t2127r2143b2205],
8	with	IN	O	with	_	0	SENT_247	[p16l7t2256r192b2335],
9	the	DT	O	the	det	10	SENT_247	[p16l216t2256r342b2334],
10	retinoid	NN	O	retinoid	prep_with	5	SENT_247	[p16l365t2256r690b2334],
11	X	NN	O	x	prep	10	SENT_247	[p16l709t2262r770b2333],
12	receptor	NN	O	receptor	nn	15	SENT_247	[p16l791t2272r1134b2356],
13	(	CD	NUMBER	(	num	15	SENT_247	[p16l1158t2262r1426b2347],
14	RXR	NN	O	rxr	nn	15	SENT_247	[p16l1158t2262r1426b2347],
15	)	NN	O	)	dep	11	SENT_247	[p16l1158t2262r1426b2347],
16	.	.	O	.	_	0	SENT_247	[p16l1158t2262r1426b2347],

1	The	DT	O	the	det	2	SENT_248	[p16l1450t2256r1610b2334],
2	heterodimer	NN	O	heterodimer	nsubj	4	SENT_248	[p16l1633t2256r2145b2334],
3	then	RB	O	then	advmod	4	SENT_248	[p16l12t2384r199b2462],
4	functions	VBZ	O	function	_	0	SENT_248	[p16l224t2383r623b2463],
5	as	IN	O	as	_	0	SENT_248	[p16l651t2410r734b2462],
6	a	DT	O	a	det	8	SENT_248	[p16l762t2410r806b2462],
7	transcription	NN	O	transcription	nn	8	SENT_248	[p16l831t2384r1381b2484],
8	factor	NN	O	factor	prep_as	4	SENT_248	[p16l1406t2383r1653b2462],
9	by	IN	O	by	_	0	SENT_248	[p16l1676t2384r1773b2484],
10	interacting	VBG	O	interact	prepc_by	4	SENT_248	[p16l1793t2384r2140b2462, p16l11t2513r152b2613],
11	With	IN	O	with	_	0	SENT_248	[p16l167t2513r360b2592],
12	cognate	JJ	O	cognate	amod	14	SENT_248	[p16l385t2529r721b2613],
13	response	NN	O	response	nn	14	SENT_248	[p16l745t2538r1133b2613],
14	elements	NNS	O	element	prep_with	10	SENT_248	[p16l1158t2513r1544b2591],
15	located	JJ	O	located	amod	21	SENT_248	[p16l1568t2513r1879b2591],
16	in	IN	O	in	_	0	SENT_248	[p16l1902t2513r1984b2590],
17	the	DT	O	the	det	19	SENT_248	[p16l2009t2513r2140b2591],
18	5	CD	NUMBER	5	num	19	SENT_248	[p16l13t2647r82b2719],
19	’	NN	O	’	prep_in	15	SENT_248	[p16l13t2647r82b2719],
20	regulatory	JJ	O	regulatory	amod	21	SENT_248	[p16l113t2641r547b2741],
21	region	NN	O	region	dobj	10	SENT_248	[p16l568t2641r841b2741],
22	of	IN	O	of	_	0	SENT_248	[p16l868t2640r968b2719],
23	the	DT	O	the	det	25	SENT_248	[p16l976t2641r1105b2719],
24	CYP3A4	NN	O	cyp3a4	nn	25	SENT_248	[p16l1131t2646r1434b2719],
25	gene	NN	O	gene	prep_of	21	SENT_248	[p16l1458t2666r1658b2741],
26	but	CC	O	but	_	0	SENT_248	[p16l1685t2641r1826b2720],
27	not	RB	O	not	_	0	SENT_248	[p16l1846t2657r1990b2719],
28	the	DT	O	the	det	30	SENT_248	[p16l2011t2641r2140b2719],
29	CYP3A5	NN	O	cyp3a5	nn	30	SENT_248	[p16l11t2774r308b2847],
30	gene	NN	O	gene	dobj	10	SENT_248	[p16l333t2763r640b2869],
31	.	.	O	.	_	0	SENT_248	[p16l333t2763r640b2869],

1	“	NN	O	“	nsubj	7	SENT_249	[p16l333t2763r640b2869],
2	The	DT	O	the	det	4	SENT_249	[p16l659t2769r820b2847],
3	net	JJ	O	net	amod	4	SENT_249	[p16l842t2785r976b2847],
4	result	NN	O	result	dep	1	SENT_249	[p16l994t2769r1232b2848],
5	is	VBZ	O	be	cop	7	SENT_249	[p16l1249t2770r1313b2847],
6	increased	VBN	O	increase	amod	7	SENT_249	[p16l1337t2769r1735b2847],
7	synthesis	NN	O	synthesis	_	0	SENT_249	[p16l1758t2769r2139b2869],
8	of	IN	O	of	_	0	SENT_249	[p16l12t2896r113b2975],
9	new	JJ	O	new	amod	13	SENT_249	[p16l119t2922r295b2976],
10	CYP3A4	NN	O	cyp3a4	nn	13	SENT_249	[p16l317t2902r655b2975],
11	protein	NN	O	protein	nn	13	SENT_249	[p16l679t2897r986b2997],
12	(	CD	NUMBER	(	num	13	SENT_249	[p16l1017t2897r1200b2997],
13	Fig	NN	O	fig	prep_of	7	SENT_249	[p16l1017t2897r1200b2997],
14	.	.	O	.	_	0	SENT_249	[p16l1017t2897r1200b2997],

1	3A	NN	O	3a	_	0	SENT_250	[p16l1232t2902r1402b2988],
2	)	NN	O	)	dep	1	SENT_250	[p16l1232t2902r1402b2988],
3	.	.	O	.	_	0	SENT_250	[p16l1232t2902r1402b2988],

1	This	DT	O	this	det	2	SENT_251	[p16l137t3026r323b3104],
2	mechanism	NN	O	mechanism	nsubj	5	SENT_251	[p16l352t3026r848b3104],
3	is	VBZ	O	be	cop	5	SENT_251	[p16l875t3026r940b3104],
4	not	RB	O	not	neg	5	SENT_251	[p16l970t3042r1114b3104],
5	unique	JJ	O	unique	_	0	SENT_251	[p16l1137t3026r1429b3126],
6	to	TO	O	to	_	0	SENT_251	[p16l1458t3042r1537b3104],
7	CYP3A4	NN	O	cyp3a4	prep_to	5	SENT_251	[p16l1566t3031r1893b3121],
8	,	,	O	,	_	0	SENT_251	[p16l1566t3031r1893b3121],
9	since	IN	O	since	mark	14	SENT_251	[p16l1927t3026r2140b3104],
10	many	JJ	O	many	amod	12	SENT_251	[p16l11t3180r246b3255],
11	other	JJ	O	other	amod	12	SENT_251	[p16l268t3155r492b3233],
12	genes	NNS	O	gene	nsubj	14	SENT_251	[p16l515t3180r756b3255],
13	also	RB	O	also	advmod	14	SENT_251	[p16l783t3155r951b3233],
14	have	VBP	O	have	advcl	5	SENT_251	[p16l978t3155r1166b3234],
15	PXR	NN	O	pxr	dobj	14	SENT_251	[p16l1192t3161r1616b3238],
16	.	.	O	.	_	0	SENT_251	[p16l1192t3161r1616b3238],

1	—	NN	O	—	_	0	SENT_252	[p16l1192t3161r1616b3238],
2	.	.	O	.	_	0	SENT_252	[p16l1192t3161r1616b3238],

1	RXR	NN	O	rxr	nn	3	SENT_253	[p16l1192t3161r1616b3238],
2	response	NN	O	response	nn	3	SENT_253	[p16l1631t3180r2012b3255],
3	elements	NNS	O	element	_	0	SENT_253	[p16l2038t3155r2140b3233, p16l12t3299r314b3361],
4	in	IN	O	in	_	0	SENT_253	[p16l338t3283r419b3360],
5	their	PRP$	O	they	poss	9	SENT_253	[p16l443t3283r638b3361],
6	5	CD	NUMBER	5	num	9	SENT_253	[p16l660t3289r728b3361],
7	’	NN	O	’	nn	9	SENT_253	[p16l660t3289r728b3361],
8	regulatory	JJ	O	regulatory	amod	9	SENT_253	[p16l754t3283r1183b3383],
9	regions	NNS	O	region	prep_in	3	SENT_253	[p16l1202t3283r1538b3383],
10	.	.	O	.	_	0	SENT_253	[p16l1202t3283r1538b3383],

1	Therefore	RB	O	therefore	advmod	50	SENT_254	[p16l1563t3282r1999b3378],
2	,	,	O	,	_	0	SENT_254	[p16l1563t3282r1999b3378],
3	inducing	VBG	O	induce	partmod	50	SENT_254	[p16l2027t3283r2140b3360, p16l12t3411r300b3511],
4	agents	NNS	O	agent	dobj	3	SENT_254	[p16l316t3427r584b3511],
5	such	JJ	O	such	_	0	SENT_254	[p16l607t3411r799b3490],
6	as	IN	O	as	_	0	SENT_254	[p16l818t3437r901b3489],
7	rifampin	NN	O	rifampin	prep_such_as	4	SENT_254	[p16l923t3410r1285b3511],
8	up	IN	O	up	advmod	10	SENT_254	[p16l1305t3411r1780b3511],
9	—	CD	NUMBER	—	pobj	8	SENT_254	[p16l1305t3411r1780b3511],
10	regulate	VBP	O	regulate	dep	7	SENT_254	[p16l1305t3411r1780b3511],
11	a	DT	O	a	det	12	SENT_254	[p16l1800t3437r1844b3489],
12	battery	NN	O	battery	dobj	10	SENT_254	[p16l1863t3411r2147b3511],
13	of	IN	O	of	_	0	SENT_254	[p16l12t3538r113b3617],
14	other	JJ	O	other	amod	15	SENT_254	[p16l128t3539r353b3617],
15	proteins	NNS	O	protein	prep_of	12	SENT_254	[p16l382t3539r756b3639],
16	,	,	O	,	_	0	SENT_254	[p16l382t3539r756b3639],
17	including	VBG	O	include	_	0	SENT_254	[p16l795t3539r1202b3639],
18	CYPZC9	NN	O	cypzc9	prep_including	7	SENT_254	[p16l1232t3544r1596b3634],
19	,	,	O	,	_	0	SENT_254	[p16l1232t3544r1596b3634],
20	phase	NN	O	phase	conj_and	18	SENT_254	[p16l1633t3539r1880b3639],
21	11	CD	NUMBER	11	num	22	SENT_254	[p16l1912t3546r1976b3616],
22	enzymes	NNS	O	enzyme	dep	20	SENT_254	[p16l2009t3564r2140b3617, p16l11t3694r298b3768],
23	,	,	O	,	_	0	SENT_254	[p16l2009t3564r2140b3617, p16l11t3694r298b3768],
24	and	CC	O	and	_	0	SENT_254	[p16l333t3668r489b3746],
25	membrane	NN	O	membrane	nn	26	SENT_254	[p16l519t3668r979b3746],
26	transporters	NNS	O	transporter	conj_and	18	SENT_254	[p16l1010t3684r1526b3768],
27	that	WDT	O	that	nsubj	28	SENT_254	[p16l1559t3668r1726b3746],
28	limit	VBP	O	limit	rcmod	26	SENT_254	[p16l1750t3668r1954b3746],
29	oral	JJ	O	oral	amod	30	SENT_254	[p16l1980t3668r2142b3746],
30	absorption	NN	O	absorption	dobj	28	SENT_254	[p17l11t21r473b121],
31	and	CC	O	and	_	0	SENT_254	[p17l495t21r651b99],
32	distribution	NN	O	distribution	dobj	28	SENT_254	[p17l675t21r1175b100],
33	and	CC	O	and	_	0	SENT_254	[p17l1197t21r1354b99],
34	enhance	VBP	O	enhance	conj_and	28	SENT_254	[p17l1378t21r1729b99],
35	excretion	NN	O	excretion	dobj	34	SENT_254	[p17l1753t21r2142b99],
36	of	IN	O	of	_	0	SENT_254	[p17l12t148r113b227],
37	drugs	NNS	O	drug	prep_of	35	SENT_254	[p17l118t143r468b249],
38	.18	CD	NUMBER	.18	dobj	28	SENT_254	[p17l118t143r468b249],
39	Furthermore	RB	O	furthermore	advmod	28	SENT_254	[p17l492t149r1055b244],
40	,	,	O	,	_	0	SENT_254	[p17l492t149r1055b244],
41	nuclear	JJ	O	nuclear	amod	42	SENT_254	[p17l1084t149r1399b228],
42	receptors	NNS	O	receptor	nsubj	50	SENT_254	[p17l1419t165r1810b249],
43	such	JJ	O	such	_	0	SENT_254	[p17l1837t149r2032b228],
44	as	IN	O	as	_	0	SENT_254	[p17l2054t175r2139b227],
45	the	DT	O	the	det	48	SENT_254	[p17l12t278r141b356],
46	constitutive	JJ	O	constitutive	amod	48	SENT_254	[p17l179t278r667b357],
47	androstane	NN	O	androstane	nn	48	SENT_254	[p17l703t278r1179b356],
48	receptor	NN	O	receptor	prep_such_as	42	SENT_254	[p17l1215t294r1568b378],
49	also	RB	O	also	advmod	50	SENT_254	[p17l1600t278r1768b356],
50	seem	VBP	O	seem	_	0	SENT_254	[p17l1807t304r2024b356],
51	to	TO	O	to	prep	50	SENT_254	[p17l2061t294r2140b356],

1	2216	CD	DATE	2216	num	4	SENT_255	[p17l149t456r226b478],
2	N	NN	O	n	nn	4	SENT_255	[p17l912t459r925b474],
3	ENGLJ	NN	O	englj	nn	4	SENT_255	[p17l941t458r1024b480],
4	MED	NN	O	med	_	0	SENT_255	[p17l1040t459r1092b474],
5	352	CD	NUMBER	352	dep	4	SENT_255	[p17l1105t458r1181b480],
6	;	:	O	;	_	0	SENT_255	[p17l1105t458r1181b480],
7	21	CD	NUMBER	21	num	9	SENT_255	[p17l1105t458r1181b480],
8	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	9	SENT_255	[p17l1218t458r1430b480],
9	MAY	NNP	DATE	MAY	dep	5	SENT_255	[p17l1469t458r1520b474],
10	26	CD	DATE	26	num	9	SENT_255	[p17l1532t453r1571b478],
11	,	,	O	,	_	0	SENT_255	[p17l1532t453r1571b478],
12	zoos	NNS	O	zoo	appos	9	SENT_255	[p17l1584t458r1647b480],

1	The	DT	O	the	det	4	SENT_256	[p17l936t492r987b515],
2	New	NNP	O	New	nn	4	SENT_256	[p17l996t492r1058b515],
3	England	NNP	O	England	nn	4	SENT_256	[p17l1068t492r1178b522],
4	Journal	NNP	O	Journal	_	0	SENT_256	[p17l1187t492r1284b515],
5	of	IN	O	of	_	0	SENT_256	[p17l1294t492r1323b515],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_256	[p17l1330t492r1455b515],

1	Downloaded	VBN	O	download	_	0	SENT_257	[p17l378t532r548b555],
2	from	IN	O	from	_	0	SENT_257	[p17l557t532r621b555],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_257	[p17l630t532r748b562],
4	at	IN	O	at	_	0	SENT_257	[p17l759t536r782b555],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_257	[p17l790t532r973b555],
6	on	IN	O	on	_	0	SENT_257	[p17l982t539r1014b555],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_257	[p17l1023t532r1084b555],
8	5	CD	DATE	5	num	7	SENT_257	[p17l1136t532r1159b559],
9	,	,	DATE	,	_	0	SENT_257	[p17l1136t532r1159b559],
10	2014	CD	DATE	2014	num	7	SENT_257	[p17l1169t532r1242b555],
11	.	.	O	.	_	0	SENT_257	[p17l1169t532r1242b555],

1	For	IN	O	for	_	0	SENT_258	[p17l1252t532r1299b555],
2	personal	JJ	O	personal	amod	3	SENT_258	[p17l1307t532r1419b562],
3	use	NN	O	use	pobj	1	SENT_258	[p17l1428t539r1472b555],
4	only	RB	O	only	advmod	3	SENT_258	[p17l1482t532r1546b562],
5	.	.	O	.	_	0	SENT_258	[p17l1482t532r1546b562],

1	No	DT	O	no	det	3	SENT_259	[p17l1557t532r1597b555],
2	other	JJ	O	other	amod	3	SENT_259	[p17l1607t532r1675b555],
3	uses	NNS	O	use	_	0	SENT_259	[p17l1683t539r1739b555],
4	without	IN	O	without	_	0	SENT_259	[p17l1749t532r1850b555],
5	permission	NN	O	permission	prep_without	3	SENT_259	[p17l1859t532r2011b562],
6	.	.	O	.	_	0	SENT_259	[p17l1859t532r2011b562],

1	Copyright	NN	O	copyright	nn	5	SENT_260	[p17l728t573r863b603],
2	©	CD	NUMBER	©	num	5	SENT_260	[p17l872t573r896b597],
3	2005	CD	DATE	2005	num	5	SENT_260	[p17l906t573r970b597],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_260	[p17l980t574r1079b596],
5	usetts	NNP	O	usetts	_	0	SENT_260	[p17l1097t577r1172b596],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_260	[p17l1181t573r1290b596],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_260	[p17l1300t573r1405b603],
8	.	.	O	.	_	0	SENT_260	[p17l1300t573r1405b603],

1	All	DT	O	all	det	2	SENT_261	[p17l1416t573r1457b596],
2	rights	NNS	O	rights	nsubj	3	SENT_261	[p17l1466t573r1541b603],
3	reserved	VBN	O	reserve	_	0	SENT_261	[p17l1551t573r1670b596],
4	.	.	O	.	_	0	SENT_261	[p17l1551t573r1670b596],

1	DRUG	NN	O	drug	nn	2	SENT_262	[p17l950t678r1045b697],
2	THERAPY	NN	O	therapy	_	0	SENT_262	[p17l1057t678r1210b697],

1	play	VB	O	play	_	0	SENT_263	[p17l9t891r184b992],
2	a	DT	O	a	det	3	SENT_263	[p17l201t918r245b970],
3	role	NN	O	role	dobj	1	SENT_263	[p17l266t892r427b970],
4	in	IN	O	in	_	0	SENT_263	[p17l448t892r530b969],
5	the	DT	O	the	det	6	SENT_263	[p17l552t892r681b970],
6	induction	NN	O	induction	prep_in	1	SENT_263	[p17l703t892r1110b971],
7	of	IN	O	of	_	0	SENT_263	[p17l1133t891r1233b970],
8	CYP3A4	NN	O	cyp3a4	nn	17	SENT_263	[p17l1237t897r1575b970],
9	and	CC	O	and	_	0	SENT_263	[p17l1597t891r1752b970],
10	other	JJ	O	other	nn	17	SENT_263	[p17l1775t892r1998b970],
11	cy	NN	O	cy	nn	17	SENT_263	[p17l2019t918r2134b992],
12	—	NN	O	—	nn	17	SENT_263	[p17l2019t918r2134b992],
13	tochrome	NN	O	tochrome	nn	17	SENT_263	[p17l11t1020r419b1098],
14	P	NN	O	p	nn	17	SENT_263	[p17l439t1025r682b1098],
15	—	CD	NUMBER	—	num	17	SENT_263	[p17l439t1025r682b1098],
16	45O	NN	O	45o	nn	17	SENT_263	[p17l439t1025r682b1098],
17	enzymes	NNS	O	enzyme	prep_of	6	SENT_263	[p17l705t1045r1094b1120],
18	.	.	O	.	_	0	SENT_263	[p17l705t1045r1094b1120],

1	The	DT	O	the	det	2	SENT_264	[p17l1118t1020r1278b1098],
2	notion	NN	O	notion	nsubj	26	SENT_264	[p17l1301t1020r1579b1098],
3	that	IN	O	that	complm	18	SENT_264	[p17l1601t1020r1767b1098],
4	PXR	NN	O	pxr	nsubj	18	SENT_264	[p17l1783t1026r1969b1103],
5	and	CC	O	and	_	0	SENT_264	[p17l1980t1019r2135b1098],
6	the	DT	O	the	det	10	SENT_264	[p17l11t1148r140b1226],
7	constitutive	JJ	O	constitutive	amod	10	SENT_264	[p17l189t1148r677b1227],
8	androstane	NN	O	androstane	nn	10	SENT_264	[p17l724t1147r1200b1226],
9	receptor	NN	O	receptor	nn	10	SENT_264	[p17l1248t1164r1599b1248],
10	function	NN	O	function	nsubj	18	SENT_264	[p17l1644t1147r2001b1227],
11	as	IN	O	as	_	0	SENT_264	[p17l2049t1174r2132b1226],
12	“	NN	O	“	nn	15	SENT_264	[p17l15t1276r746b1354],
13	chemo	NN	O	chemo	nn	15	SENT_264	[p17l15t1276r746b1354],
14	—	NN	O	—	nn	15	SENT_264	[p17l15t1276r746b1354],
15	sensors	NNS	O	sensor	prep_as	10	SENT_264	[p17l15t1276r746b1354],
16	”	CD	NUMBER	”	dep	10	SENT_264	[p17l15t1276r746b1354],
17	to	TO	O	to	aux	18	SENT_264	[p17l773t1292r852b1354],
18	facilitate	VB	O	facilitate	infmod	2	SENT_264	[p17l877t1275r1238b1354],
19	an	DT	O	a	det	21	SENT_264	[p17l1261t1301r1362b1354],
20	adaptive	JJ	O	adaptive	amod	21	SENT_264	[p17l1384t1276r1732b1376],
21	response	NN	O	response	dobj	18	SENT_264	[p17l1755t1301r2135b1376],
22	in	IN	O	in	_	0	SENT_264	[p17l10t1404r91b1481],
23	hepatic	JJ	O	hepatic	amod	24	SENT_264	[p17l113t1404r419b1504],
24	tissue	NN	O	tissue	prep_in	21	SENT_264	[p17l441t1404r682b1483],
25	also	RB	O	also	advmod	18	SENT_264	[p17l704t1403r871b1482],
26	appears	VBZ	O	appear	_	0	SENT_264	[p17l894t1430r1220b1504],
27	to	TO	O	to	aux	28	SENT_264	[p17l1244t1420r1323b1482],
28	extend	VB	O	extend	xcomp	26	SENT_264	[p17l1348t1404r1625b1482],
29	to	TO	O	to	_	0	SENT_264	[p17l1647t1420r1726b1482],
30	other	JJ	O	other	amod	32	SENT_264	[p17l1750t1404r1975b1482],
31	nuclear	JJ	O	nuclear	amod	32	SENT_264	[p17l1993t1429r2134b1483, p17l11t1532r212b1610],
32	receptors	NNS	O	receptor	prep_to	28	SENT_264	[p17l239t1548r629b1632],
33	and	CC	O	and	_	0	SENT_264	[p17l661t1532r817b1610],
34	ligands	NNS	O	ligand	prep_to	28	SENT_264	[p17l847t1531r1153b1632],
35	involved	VBN	O	involve	partmod	32	SENT_264	[p17l1186t1531r1536b1611],
36	in	IN	O	in	_	0	SENT_264	[p17l1566t1532r1647b1609],
37	the	DT	O	the	det	38	SENT_264	[p17l1678t1532r1807b1610],
38	regulation	NN	O	regulation	prep_in	35	SENT_264	[p17l1838t1532r2134b1632, p17l11t1660r175b1738],
39	of	IN	O	of	_	0	SENT_264	[p17l199t1659r299b1738],
40	fatty	JJ	O	fatty	amod	41	SENT_264	[p17l304t1659r486b1760],
41	acids	NNS	O	acid	prep_of	38	SENT_264	[p17l505t1660r715b1738],
42	(	CD	NUMBER	(	num	44	SENT_264	[p17l745t1659r2135b1760],
43	peroxisome	NN	O	peroxisome	nn	44	SENT_264	[p17l745t1659r2135b1760],
44	—	NN	O	—	tmod	35	SENT_264	[p17l745t1659r2135b1760],
45	proliferator	NN	O	proliferator	nn	47	SENT_264	[p17l745t1659r2135b1760],
46	—	NN	O	—	nn	47	SENT_264	[p17l745t1659r2135b1760],
47	activat	NN	O	activat	nsubj	49	SENT_264	[p17l745t1659r2135b1760],
48	—	CD	NUMBER	—	dep	47	SENT_264	[p17l745t1659r2135b1760],
49	ed	VBD	O	ed	rcmod	44	SENT_264	[p17l11t1787r107b1866],
50	receptors	NNS	O	receptor	nsubj	54	SENT_264	[p17l131t1795r580b1888],
51	)	RB	O	)	advmod	54	SENT_264	[p17l131t1795r580b1888],
52	,	,	O	,	_	0	SENT_264	[p17l131t1795r580b1888],
53	oxysterols	NNS	O	oxysterol	nsubj	54	SENT_264	[p17l610t1787r1030b1888],
54	(	VBP	O	(	ccomp	49	SENT_264	[p17l1061t1788r1269b1879],
55	liver	NN	O	liver	nn	58	SENT_264	[p17l1061t1788r1269b1879],
56	X	NN	O	x	nn	58	SENT_264	[p17l1287t1795r1348b1865],
57	receptor	NN	O	receptor	nn	58	SENT_264	[p17l1369t1794r1775b1888],
58	)	NN	O	)	dobj	54	SENT_264	[p17l1369t1794r1775b1888],
59	,	,	O	,	_	0	SENT_264	[p17l1369t1794r1775b1888],
60	and	CC	O	and	_	0	SENT_264	[p17l1804t1788r1959b1866],
61	bile	NN	O	bile	nn	62	SENT_264	[p17l1984t1788r2135b1866],
62	acids	NNS	O	acid	dobj	54	SENT_264	[p17l10t1916r222b1994],
63	(	CD	NUMBER	(	dep	62	SENT_264	[p17l254t1915r681b2007],
64	farnesoid	NN	O	farnesoid	nn	67	SENT_264	[p17l254t1915r681b2007],
65	X	NN	O	x	nn	67	SENT_264	[p17l702t1923r764b1993],
66	receptor	NN	O	receptor	nn	67	SENT_264	[p17l786t1910r1383b2016],
67	)	NN	O	)	dep	54	SENT_264	[p17l786t1910r1383b2016],
68	.18	CD	NUMBER	.18	num	69	SENT_264	[p17l786t1910r1383b2016],
69	’19	CD	NUMBER	’19	dep	67	SENT_264	[p17l786t1910r1383b2016],

1	GENETIC	JJ	O	genetic	amod	2	SENT_265	[p17l299t2251r802b2310],
2	POLYMORPHISMS	NNS	O	polymorphism	_	0	SENT_265	[p17l857t2251r1832b2310],

1	IN	IN	O	in	_	0	SENT_266	[p17l421t2357r547b2415],
2	DRUG	NN	O	drug	nn	3	SENT_266	[p17l604t2356r922b2415],
3	METABOLISM	NN	O	metabolism	pobj	1	SENT_266	[p17l972t2356r1713b2415],

1	In	IN	O	in	_	0	SENT_267	[p17l9t2596r96b2666],
2	contrast	NN	O	contrast	prep_in	22	SENT_267	[p17l118t2605r465b2667],
3	to	TO	O	to	_	0	SENT_267	[p17l482t2605r561b2667],
4	CYP3A	NN	O	cyp3a	prep_to	2	SENT_267	[p17l583t2594r891b2684],
5	,	,	O	,	_	0	SENT_267	[p17l583t2594r891b2684],
6	the	DT	O	the	det	7	SENT_267	[p17l918t2589r1047b2667],
7	distribution	NN	O	distribution	nsubj	22	SENT_267	[p17l1070t2588r1568b2668],
8	of	IN	O	of	_	0	SENT_267	[p17l1590t2588r1691b2667],
9	the	DT	O	the	det	10	SENT_267	[p17l1694t2588r1823b2667],
10	activity	NN	O	activity	prep_of	7	SENT_267	[p17l1844t2589r2140b2689],
11	of	IN	O	of	_	0	SENT_267	[p17l11t2716r113b2795],
12	other	JJ	O	other	amod	14	SENT_267	[p17l138t2717r366b2795],
13	cytochrome	NN	O	cytochrome	nn	14	SENT_267	[p17l407t2716r912b2817],
14	P	NN	O	p	prep_of	10	SENT_267	[p17l953t2722r1201b2795],
15	—	CD	NUMBER	—	number	16	SENT_267	[p17l953t2722r1201b2795],
16	450	CD	NUMBER	450	num	17	SENT_267	[p17l953t2722r1201b2795],
17	enzymes	NNS	O	enzyme	dep	14	SENT_267	[p17l1244t2742r1614b2817],
18	among	IN	O	among	_	0	SENT_267	[p17l1658t2742r1962b2817],
19	the	DT	O	the	det	20	SENT_267	[p17l2003t2717r2134b2795],
20	population	NN	O	population	prep_among	17	SENT_267	[p17l9t2844r483b2945],
21	is	VBZ	O	be	cop	22	SENT_267	[p17l519t2845r584b2923],
22	polymodal	JJ	O	polymodal	_	0	SENT_267	[p17l622t2845r1096b2945],
23	;	:	O	;	_	0	SENT_267	[p17l622t2845r1096b2945],
24	people	NNS	O	people	nsubjpass	27	SENT_267	[p17l1136t2845r1418b2945],
25	are	VBP	O	be	auxpass	27	SENT_267	[p17l1455t2871r1580b2923],
26	often	RB	O	often	advmod	27	SENT_267	[p17l1618t2844r1834b2923],
27	classiﬁed	VBN	O	classiﬁed	parataxis	22	SENT_267	[p17l1872t2844r2134b2923, p17l11t2972r168b3051],
28	as	IN	O	as	_	0	SENT_267	[p17l189t2999r273b3051],
29	having	VBG	O	have	prepc_as	27	SENT_267	[p17l296t2973r582b3073],
30	either	CC	O	either	preconj	32	SENT_267	[p17l601t2973r844b3051],
31	an	DT	O	a	det	32	SENT_267	[p17l861t2998r962b3051],
32	extensive	JJ	O	extensive	nsubj	38	SENT_267	[p17l984t2973r1366b3052],
33	or	CC	O	or	_	0	SENT_267	[p17l1388t2998r1477b3051],
34	a	DT	O	a	det	36	SENT_267	[p17l1495t2999r1540b3051],
35	poor	JJ	O	poor	amod	36	SENT_267	[p17l1558t2998r1760b3073],
36	ability	NN	O	ability	nsubj	38	SENT_267	[p17l1777t2972r2037b3073],
37	to	TO	O	to	aux	38	SENT_267	[p17l2055t2989r2134b3051],
38	metabolize	VBZ	O	metabolize	ccomp	29	SENT_267	[p17l11t3100r503b3179],
39	.	.	O	.	_	0	SENT_267	[p17l11t3100r503b3179],

1	This	DT	O	this	det	2	SENT_268	[p17l533t3100r718b3179],
2	distribution	NN	O	distribution	nsubjpass	4	SENT_268	[p17l749t3101r1248b3180],
3	is	VBZ	O	be	auxpass	4	SENT_268	[p17l1275t3101r1340b3179],
4	determined	VBN	O	determine	_	0	SENT_268	[p17l1372t3100r1856b3179],
5	by	IN	O	by	_	0	SENT_268	[p17l1885t3101r1981b3201],
6	genetic	JJ	O	genetic	amod	7	SENT_268	[p17l2005t3127r2134b3201, p17l11t3229r214b3307],
7	polymorphisms	NNS	O	polymorphism	agent	4	SENT_268	[p17l234t3228r904b3329],
8	and	CC	O	and	_	0	SENT_268	[p17l929t3228r1085b3307],
9	variant	JJ	O	variant	amod	10	SENT_268	[p17l1103t3229r1398b3308],
10	alleles	NNS	O	allele	nsubj	11	SENT_268	[p17l1416t3228r1675b3307],
11	—	VBP	O	—	conj_and	4	SENT_268	[p17l1696t3273r1803b3281],
12	present	JJ	DATE	present	acomp	11	SENT_268	[p17l1821t3245r2140b3329],
13	in	IN	O	in	_	0	SENT_268	[p17l10t3357r90b3434],
14	more	JJR	O	more	mwe	15	SENT_268	[p17l110t3382r329b3435],
15	than	IN	O	than	quantmod	16	SENT_268	[p17l349t3357r536b3435],
16	1	CD	PERCENT	1	num	17	SENT_268	[p17l559t3362r603b3434],
17	percent	NN	PERCENT	percent	prep_in	12	SENT_268	[p17l623t3373r940b3457],
18	of	IN	O	of	_	0	SENT_268	[p17l955t3356r1055b3435],
19	a	DT	O	a	det	23	SENT_268	[p17l1056t3383r1100b3435],
20	given	VBN	O	give	amod	23	SENT_268	[p17l1119t3357r1340b3457],
21	human	JJ	O	human	amod	23	SENT_268	[p17l1360t3356r1657b3436],
22	population	NN	O	population	nn	23	SENT_268	[p17l1676t3357r2135b3457],
23	—	NN	O	—	prep_of	17	SENT_268	[p17l7t3530r115b3537],
24	that	WDT	O	that	nsubj	25	SENT_268	[p17l144t3485r311b3563],
25	confer	VBP	O	confer	rcmod	23	SENT_268	[p17l340t3484r611b3563],
26	increased	VBN	O	increase	dep	25	SENT_268	[p17l641t3485r1065b3580],
27	,	,	O	,	_	0	SENT_268	[p17l641t3485r1065b3580],
28	decreased	VBN	O	decrease	dep	26	SENT_268	[p17l1105t3484r1544b3580],
29	,	,	O	,	_	0	SENT_268	[p17l1105t3484r1544b3580],
30	or	CC	O	or	_	0	SENT_268	[p17l1584t3510r1673b3563],
31	no	DT	O	no	det	32	SENT_268	[p17l1704t3510r1810b3563],
32	activity	NN	O	activity	conj_or	23	SENT_268	[p17l1844t3485r2140b3585],
33	(	CD	NUMBER	(	num	35	SENT_268	[p17l15t3613r267b3704],
34	null	JJ	O	null	amod	35	SENT_268	[p17l15t3613r267b3704],
35	)	NN	O	)	dep	32	SENT_268	[p17l15t3613r267b3704],
36	.	.	O	.	_	0	SENT_268	[p17l15t3613r267b3704],

1	As	IN	O	as	_	0	SENT_269	[p17l296t3620r401b3691],
2	a	DT	O	a	det	3	SENT_269	[p17l430t3639r475b3691],
3	result	NN	O	result	prep_as	11	SENT_269	[p17l501t3613r761b3708],
4	,	,	O	,	_	0	SENT_269	[p17l501t3613r761b3708],
5	variability	NN	O	variability	nsubj	11	SENT_269	[p17l790t3612r1209b3713],
6	among	IN	O	among	_	0	SENT_269	[p17l1232t3638r1531b3713],
7	people	NNS	O	people	prep_among	5	SENT_269	[p17l1555t3613r1837b3713],
8	can	MD	O	can	aux	11	SENT_269	[p17l1867t3638r2011b3691],
9	be	VB	O	be	cop	11	SENT_269	[p17l2039t3613r2135b3691],
10	extremely	RB	O	extremely	advmod	11	SENT_269	[p18l11t24r422b124],
11	large	JJ	O	large	_	0	SENT_269	[p18l445t18r868b124],
12	.2	NN	NUMBER	.2	tmod	11	SENT_269	[p18l445t18r868b124],
13	°	CD	NUMBER	°	num	14	SENT_269	[p18l445t18r868b124],
14	’21	CD	NUMBER	’21	dep	12	SENT_269	[p18l445t18r868b124],
15	If	IN	O	if	mark	23	SENT_269	[p18l895t23r976b101],
16	the	DT	O	the	det	17	SENT_269	[p18l986t24r1116b102],
17	elimination	NN	O	elimination	nsubjpass	23	SENT_269	[p18l1145t24r1632b102],
18	of	IN	O	of	_	0	SENT_269	[p18l1661t23r1762b102],
19	a	DT	O	a	det	20	SENT_269	[p18l1772t50r1816b102],
20	drug	NN	O	drug	prep_of	17	SENT_269	[p18l1844t24r2043b124],
21	is	VBZ	O	be	auxpass	23	SENT_269	[p18l2068t25r2132b102],
22	predominantly	RB	O	predominantly	advmod	23	SENT_269	[p18l9t151r638b252],
23	determined	VBN	O	determine	advcl	43	SENT_269	[p18l673t151r1157b230],
24	by	IN	O	by	_	0	SENT_269	[p18l1196t152r1292b252],
25	metabolism	NN	O	metabolism	agent	23	SENT_269	[p18l1327t151r1855b247],
26	,	,	O	,	_	0	SENT_269	[p18l1327t151r1855b247],
27	and	CC	O	and	_	0	SENT_269	[p18l1898t152r2055b230],
28	a	DT	O	a	det	34	SENT_269	[p18l2092t178r2136b230],
29	single	JJ	O	single	amod	34	SENT_269	[p18l12t280r262b380],
30	cytochrome	NN	O	cytochrome	nn	34	SENT_269	[p18l304t280r800b380],
31	P	NN	O	p	nn	34	SENT_269	[p18l839t285r1082b358],
32	—	CD	NUMBER	—	num	34	SENT_269	[p18l839t285r1082b358],
33	45O	NN	O	45o	nn	34	SENT_269	[p18l839t285r1082b358],
34	enzyme	NN	O	enzyme	nsubj	37	SENT_269	[p18l1125t305r1446b380],
35	is	VBZ	O	be	cop	37	SENT_269	[p18l1487t280r1552b358],
36	primarily	RB	O	primarily	advmod	37	SENT_269	[p18l1594t280r1985b380],
37	responsible	JJ	O	responsible	advcl	43	SENT_269	[p18l2022t306r2134b358, p18l12t408r441b508],
38	,	,	O	,	_	0	SENT_269	[p18l2022t306r2134b358, p18l12t408r441b508],
39	a	DT	O	a	det	41	SENT_269	[p18l491t434r536b486],
40	ﬁmctional	JJ	O	ﬁmctional	amod	41	SENT_269	[p18l580t407r1011b487],
41	polymorphism	NN	O	polymorphism	nsubj	43	SENT_269	[p18l1055t408r1684b508],
42	may	MD	O	may	aux	43	SENT_269	[p18l1729t434r1905b508],
43	have	VB	O	have	ccomp	11	SENT_269	[p18l1946t408r2135b487],
44	important	JJ	O	important	amod	46	SENT_269	[p18l10t536r439b636],
45	clinical	JJ	O	clinical	amod	46	SENT_269	[p18l464t535r761b614],
46	consequences	NNS	O	consequence	dobj	43	SENT_269	[p18l789t561r1395b636],
47	.	.	O	.	_	0	SENT_269	[p18l789t561r1395b636],

1	The	DT	O	the	det	2	SENT_270	[p18l1426t535r1587b614],
2	frequency	NN	O	frequency	nsubj	10	SENT_270	[p18l1616t535r2029b636],
3	of	IN	O	of	_	0	SENT_270	[p18l2054t535r2154b614],
4	variant	JJ	O	variant	amod	5	SENT_270	[p18l6t664r308b743],
5	alleles	NNS	O	allele	prep_of	2	SENT_270	[p18l343t664r609b742],
6	and	CC	O	and	_	0	SENT_270	[p18l651t663r810b742],
7	their	PRP$	O	they	prep_of	2	SENT_270	[p18l851t664r1052b742],
8	encoded	VBN	O	encode	partmod	7	SENT_270	[p18l1091t663r1451b742],
9	proteins	NNS	O	protein	dobj	8	SENT_270	[p18l1491t664r1846b764],
10	varies	VBZ	O	vary	_	0	SENT_270	[p18l1884t664r2132b743],
11	among	IN	O	among	_	0	SENT_270	[p18l10t817r314b892],
12	populations	NNS	O	population	prep_among	10	SENT_270	[p18l349t792r854b892],
13	according	VBG	O	accord	_	0	SENT_270	[p18l895t791r1317b892],
14	to	TO	O	to	prepc_according_to	10	SENT_270	[p18l1353t808r1432b870],
15	race	NN	O	race	pobj	10	SENT_270	[p18l1472t818r1642b870],
16	and	CC	O	and	_	0	SENT_270	[p18l1680t791r1837b870],
17	ethnic	JJ	O	ethnic	amod	18	SENT_270	[p18l1875t791r2136b870],
18	background	NN	O	background	pobj	10	SENT_270	[p18l11t914r630b1018],
19	.	.	O	.	_	0	SENT_270	[p18l11t914r630b1018],

1	”	NN	O	”	nsubj	13	SENT_271	[p18l11t914r630b1018],
2	However	RB	O	however	advmod	1	SENT_271	[p18l665t925r1057b1013],
3	,	,	O	,	_	0	SENT_271	[p18l665t925r1057b1013],
4	for	IN	O	for	_	0	SENT_271	[p18l1097t918r1220b996],
5	a	DT	O	a	det	6	SENT_271	[p18l1252t945r1296b996],
6	patient	NN	O	patient	prep_for	13	SENT_271	[p18l1328t919r1646b1018],
7	,	,	O	,	_	0	SENT_271	[p18l1328t919r1646b1018],
8	the	DT	O	the	det	10	SENT_271	[p18l1687t919r1816b996],
9	critical	JJ	O	critical	amod	10	SENT_271	[p18l1852t919r2135b996],
10	determinant	NN	O	determinant	nsubj	13	SENT_271	[p18l11t1047r535b1125],
11	is	VBZ	O	be	cop	13	SENT_271	[p18l568t1047r633b1125],
12	the	DT	O	the	det	13	SENT_271	[p18l675t1046r804b1125],
13	genotype	NN	O	genotype	_	0	SENT_271	[p18l843t1063r1226b1147],
14	of	IN	O	of	_	0	SENT_271	[p18l1266t1046r1367b1125],
15	the	DT	O	the	det	17	SENT_271	[p18l1388t1047r1517b1125],
16	particular	JJ	O	particular	amod	17	SENT_271	[p18l1555t1047r1966b1147],
17	enzyme	NN	O	enzyme	prep_of	13	SENT_271	[p18l2003t1072r2134b1125, p18l10t1201r232b1275],
18	and	CC	O	and	_	0	SENT_271	[p18l270t1174r428b1253],
19	not	RB	O	not	neg	20	SENT_271	[p18l465t1191r611b1253],
20	race	NN	O	race	prep_of	13	SENT_271	[p18l643t1201r817b1253],
21	or	CC	O	or	_	0	SENT_271	[p18l856t1200r946b1253],
22	ethnic	JJ	O	ethnic	amod	23	SENT_271	[p18l982t1175r1247b1253],
23	group	NN	O	group	prep_of	13	SENT_271	[p18l1284t1200r1565b1275],
24	,	,	O	,	_	0	SENT_271	[p18l1284t1200r1565b1275],
25	which	WDT	O	which	nsubjpass	27	SENT_271	[p18l1604t1175r1869b1254],
26	is	VBZ	O	be	auxpass	27	SENT_271	[p18l1906t1175r1972b1253],
27	assigned	VBN	O	assign	rcmod	23	SENT_271	[p18l2011t1201r2132b1253, p18l12t1302r295b1401],
28	by	IN	O	by	_	0	SENT_271	[p18l322t1301r419b1401],
29	subjective	JJ	O	subjective	amod	30	SENT_271	[p18l441t1301r851b1401],
30	criteria	NNS	O	criterion	agent	27	SENT_271	[p18l877t1297r1383b1379],
31	.22	CD	NUMBER	.22	number	32	SENT_271	[p18l877t1297r1383b1379],
32	’23	CD	NUMBER	’23	dep	30	SENT_271	[p18l877t1297r1383b1379],

1	DRUG	NN	O	drug	nn	2	SENT_272	[p18l195t1617r513b1676],
2	METABOLISM	NN	O	metabolism	_	0	SENT_272	[p18l563t1617r1304b1676],
3	BY	IN	O	by	dep	2	SENT_272	[p18l1360t1617r1481b1676],
4	CYPZD6	NN	O	cypzd6	pobj	3	SENT_272	[p18l1528t1614r1939b1676],

1	In	IN	O	in	_	0	SENT_273	[p18l9t1820r96b1890],
2	the	DT	O	the	det	3	SENT_273	[p18l129t1812r258b1891],
3	superfamily	NN	O	superfamily	prep_in	15	SENT_273	[p18l292t1812r794b1913],
4	of	IN	O	of	_	0	SENT_273	[p18l823t1812r923b1891],
5	cytochrome	NN	O	cytochrome	nn	9	SENT_273	[p18l938t1813r1433b1913],
6	P	NN	O	p	nn	9	SENT_273	[p18l1464t1818r1707b1891],
7	—	CD	NUMBER	—	number	8	SENT_273	[p18l1464t1818r1707b1891],
8	450	CD	NUMBER	450	num	9	SENT_273	[p18l1464t1818r1707b1891],
9	enzymes	NNS	O	enzyme	prep_of	3	SENT_273	[p18l1741t1838r2130b1913],
10	,	,	O	,	_	0	SENT_273	[p18l1741t1838r2130b1913],
11	CYPZD6	NN	O	cypzd6	nsubj	15	SENT_273	[p18l11t1946r356b2019],
12	was	VBD	O	be	cop	15	SENT_273	[p18l380t1967r541b2020],
13	the	DT	O	the	det	15	SENT_273	[p18l571t1941r700b2019],
14	first	JJ	ORDINAL	first	amod	15	SENT_273	[p18l728t1940r902b2019],
15	example	NN	O	example	_	0	SENT_273	[p18l925t1941r1276b2041],
16	of	IN	O	of	_	0	SENT_273	[p18l1305t1940r1406b2019],
17	genetic	JJ	O	genetic	amod	20	SENT_273	[p18l1415t1941r1718b2041],
18	polymor	JJ	O	polymor	amod	20	SENT_273	[p18l1744t1941r2134b2041],
19	—	NN	O	—	nn	20	SENT_273	[p18l1744t1941r2134b2041],
20	phism	NN	O	phism	prep_of	15	SENT_273	[p18l9t2068r278b2167],
21	identif1ed	VBD	O	identif1e	partmod	20	SENT_273	[p18l331t2063r799b2145],
22	.4	CD	NUMBER	.4	dobj	21	SENT_273	[p18l331t2063r799b2145],
23	Some	DT	O	some	det	25	SENT_273	[p18l852t2073r1082b2145],
24	78	CD	NUMBER	78	num	25	SENT_273	[p18l1136t2073r1232b2145],
25	variants	NNS	O	variant	nsubjpass	30	SENT_273	[p18l1282t2068r1607b2146],
26	of	IN	O	of	_	0	SENT_273	[p18l1661t2067r1761b2145],
27	CYP2D6	NN	O	cyp2d6	prep_of	25	SENT_273	[p18l1794t2073r2135b2145],
28	have	VBP	O	have	aux	30	SENT_273	[p18l11t2196r196b2275],
29	been	VBN	O	be	auxpass	30	SENT_273	[p18l215t2195r411b2274],
30	identiﬁed	VBN	O	identiﬁed	dep	21	SENT_273	[p18l429t2195r846b2291],
31	;	:	O	;	_	0	SENT_273	[p18l429t2195r846b2291],
32	many	JJ	O	many	nsubj	33	SENT_273	[p18l869t2221r1100b2296],
33	result	VBP	O	result	parataxis	15	SENT_273	[p18l1114t2196r1349b2275],
34	in	IN	O	in	_	0	SENT_273	[p18l1362t2196r1442b2273],
35	inactive	JJ	O	inactive	amod	36	SENT_273	[p18l1461t2196r1773b2275],
36	enzyme	NN	O	enzyme	prep_in	33	SENT_273	[p18l1793t2221r2131b2296],
37	,	,	O	,	_	0	SENT_273	[p18l1793t2221r2131b2296],
38	Whereas	IN	O	whereas	mark	40	SENT_273	[p18l6t2324r361b2403],
39	some	DT	O	some	nsubj	40	SENT_273	[p18l402t2349r629b2402],
40	reduce	VBP	O	reduce	dep	15	SENT_273	[p18l666t2323r951b2403],
41	the	DT	O	the	det	43	SENT_273	[p18l989t2324r1120b2402],
42	catalytic	JJ	O	catalytic	amod	43	SENT_273	[p18l1158t2323r1509b2424],
43	activity	NN	O	activity	dobj	40	SENT_273	[p18l1545t2324r1848b2424],
44	of	IN	O	of	_	0	SENT_273	[p18l1882t2323r1984b2402],
45	the	DT	O	the	det	46	SENT_273	[p18l2003t2324r2134b2402],
46	enzyme	NN	O	enzyme	prep_of	43	SENT_273	[p18l11t2477r358b2552],
47	.	.	O	.	_	0	SENT_273	[p18l11t2477r358b2552],

1	Gene	NNP	O	Gene	nn	3	SENT_274	[p18l389t2457r610b2530],
2	duplication	NN	O	duplication	nn	3	SENT_274	[p18l637t2451r1116b2552],
3	—	NN	O	—	nsubj	17	SENT_274	[p18l1137t2497r1245b2504],
4	ranging	VBG	O	range	partmod	3	SENT_274	[p18l1266t2452r1600b2552],
5	from	IN	O	from	_	0	SENT_274	[p18l1622t2451r1829b2530],
6	3	CD	NUMBER	3	number	8	SENT_274	[p18l1855t2457r1899b2530],
7	to	TO	NUMBER	to	dep	8	SENT_274	[p18l1928t2468r2007b2530],
8	13	CD	NUMBER	13	num	9	SENT_274	[p18l2038t2457r2131b2530],
9	copies	NNS	O	copy	prep_from	4	SENT_274	[p18l11t2580r271b2680],
10	—	CD	NUMBER	—	dobj	4	SENT_274	[p18l289t2625r397b2632],
11	resulting	VBG	O	result	partmod	10	SENT_274	[p18l412t2580r782b2680],
12	in	IN	O	in	_	0	SENT_274	[p18l798t2580r878b2657],
13	increased	VBN	O	increase	amod	15	SENT_274	[p18l896t2579r1290b2658],
14	CYPZD6	NN	O	cypzd6	nn	15	SENT_274	[p18l1309t2585r1648b2658],
15	activity	NN	O	activity	prep_in	11	SENT_274	[p18l1669t2580r1957b2680],
16	also	RB	O	also	advmod	17	SENT_274	[p18l1971t2580r2135b2658],
17	occurs	VBZ	O	occur	_	0	SENT_274	[p18l11t2702r387b2785],
18	.	.	O	.	_	0	SENT_274	[p18l11t2702r387b2785],

1	”	NN	O	”	nn	3	SENT_275	[p18l11t2702r387b2785],
2	Gene	NN	PERSON	gene	nn	3	SENT_275	[p18l407t2712r624b2784],
3	duplication	NN	O	duplication	nsubj	12	SENT_275	[p18l644t2706r1112b2806],
4	is	VBZ	O	be	cop	6	SENT_275	[p18l1131t2707r1194b2784],
5	relatively	RB	O	relatively	advmod	6	SENT_275	[p18l1216t2707r1582b2806],
6	rare	JJ	O	rare	_	0	SENT_275	[p18l1597t2733r1756b2784],
7	in	IN	O	in	_	0	SENT_275	[p18l1775t2707r1855b2783],
8	northern	JJ	O	northern	amod	9	SENT_275	[p18l1874t2706r2135b2784, p18l11t2860r147b2913],
9	Europeans	NNPS	MISC	Europeans	prep_in	6	SENT_275	[p18l168t2842r617b2935],
10	but	CC	O	but	_	0	SENT_275	[p18l643t2835r784b2914],
11	may	MD	O	may	aux	12	SENT_275	[p18l802t2861r979b2935],
12	occur	VB	O	occur	conj_but	6	SENT_275	[p18l999t2860r1233b2914],
13	in	IN	O	in	advmod	12	SENT_275	[p18l1252t2835r1334b2912],
14	up	RB	O	up	advmod	13	SENT_275	[p18l1357t2861r1461b2935],
15	to	TO	O	to	_	0	SENT_275	[p18l1487t2851r1566b2913],
16	29	CD	PERCENT	29	num	17	SENT_275	[p18l1590t2840r1690b2913],
17	percent	NN	PERCENT	percent	prep_to	12	SENT_275	[p18l1714t2851r2034b2935],
18	of	IN	O	of	_	0	SENT_275	[p18l2053t2834r2153b2913],
19	persons	NNS	O	person	prep_of	17	SENT_275	[p18l9t2988r342b3063],
20	with	IN	O	with	_	0	SENT_275	[p18l375t2963r564b3042],
21	a	DT	O	a	det	24	SENT_275	[p18l599t2989r643b3041],
22	northeastern	JJ	O	northeastern	amod	24	SENT_275	[p18l677t2963r1219b3041],
23	African	JJ	MISC	african	amod	24	SENT_275	[p18l1251t2962r1561b3041],
24	background	NN	O	background	prep_with	19	SENT_275	[p18l1597t2963r2130b3063],
25	.	.	O	.	_	0	SENT_275	[p18l1597t2963r2130b3063],

1	The	DT	O	the	nsubj	6	SENT_276	[p18l7t3091r169b3169],
2	following	VBG	O	follow	_	0	SENT_276	[p18l190t3090r592b3191],
3	four	CD	NUMBER	four	num	5	SENT_276	[p18l608t3090r784b3170],
4	phenotypic	JJ	O	phenotypic	amod	5	SENT_276	[p18l798t3091r1262b3191],
5	subpopulations	NNS	O	subpopulation	prep_following	1	SENT_276	[p18l1282t3091r1927b3191],
6	exist	VBP	O	exist	_	0	SENT_276	[p18l1950t3091r2141b3169],
7	that	IN	O	that	complm	33	SENT_276	[p18l11t3219r176b3297],
8	deﬁne	NN	O	deﬁne	nsubj	33	SENT_276	[p18l194t3218r451b3297],
9	the	DT	O	the	det	10	SENT_276	[p18l475t3219r602b3297],
10	rate	NN	O	rate	dep	8	SENT_276	[p18l625t3235r780b3297],
11	of	IN	O	of	_	0	SENT_276	[p18l804t3218r904b3297],
12	drug	NN	O	drug	nn	13	SENT_276	[p18l909t3219r1107b3319],
13	metabolism	NN	O	metabolism	prep_of	10	SENT_276	[p18l1126t3219r1626b3297],
14	by	IN	O	by	_	0	SENT_276	[p18l1650t3219r1746b3319],
15	CYPZD6	NN	O	cypzd6	prep_by	13	SENT_276	[p18l1764t3224r2132b3297],
16	:	:	O	:	_	0	SENT_276	[p18l1764t3224r2132b3297],
17	persons	NNS	O	person	nsubj	33	SENT_276	[p18l9t3372r340b3447],
18	with	IN	O	with	_	0	SENT_276	[p18l362t3347r550b3426],
19	a	DT	O	a	det	20	SENT_276	[p18l573t3373r618b3425],
20	poor	JJ	O	poor	prep_with	17	SENT_276	[p18l638t3372r856b3447],
21	,	,	O	,	_	0	SENT_276	[p18l638t3372r856b3447],
22	an	DT	O	a	det	23	SENT_276	[p18l886t3372r986b3425],
23	intermediate	JJ	O	intermediate	nsubj	33	SENT_276	[p18l1010t3347r1569b3442],
24	,	,	O	,	_	0	SENT_276	[p18l1010t3347r1569b3442],
25	an	DT	O	a	det	26	SENT_276	[p18l1599t3372r1699b3425],
26	extensive	JJ	O	extensive	appos	23	SENT_276	[p18l1724t3347r2130b3442],
27	,	,	O	,	_	0	SENT_276	[p18l1724t3347r2130b3442],
28	or	CC	O	or	_	0	SENT_276	[p18l11t3500r100b3553],
29	an	DT	O	a	det	31	SENT_276	[p18l122t3500r222b3553],
30	ultrarapid	NN	O	ultrarapid	nn	31	SENT_276	[p18l245t3474r652b3575],
31	ability	NN	O	ability	conj_or	8	SENT_276	[p18l674t3474r928b3575],
32	to	TO	O	to	infmod	31	SENT_276	[p18l948t3491r1025b3553],
33	metabolize	VBZ	O	metabolize	ccomp	6	SENT_276	[p18l1050t3474r1531b3553],
34	.	.	O	.	_	0	SENT_276	[p18l1050t3474r1531b3553],

1	Five	CD	NUMBER	five	number	3	SENT_277	[p18l1558t3475r1721b3554],
2	to	TO	O	to	dep	3	SENT_277	[p18l1745t3491r1823b3553],
3	10	CD	PERCENT	10	num	4	SENT_277	[p18l1851t3480r1946b3553],
4	percent	NN	PERCENT	percent	nsubj	7	SENT_277	[p18l1969t3501r2135b3575, p18l11t3619r188b3681],
5	of	IN	O	of	_	0	SENT_277	[p18l208t3602r308b3681],
6	Whites	NNS	O	whites	prep_of	4	SENT_277	[p18l309t3603r581b3682],
7	have	VBP	O	have	dep	12	SENT_277	[p18l607t3603r792b3682],
8	a	DT	O	a	det	10	SENT_277	[p18l816t3629r860b3681],
9	poor	JJ	O	poor	amod	10	SENT_277	[p18l881t3628r1080b3703],
10	ability	NN	O	ability	dobj	7	SENT_277	[p18l1100t3602r1355b3703],
11	to	TO	O	to	prep	7	SENT_277	[p18l1375t3619r1453b3681],
12	metabolize	VBZ	O	metabolize	_	0	SENT_277	[p18l1478t3602r1938b3681],
13	(	CD	NUMBER	(	num	15	SENT_277	[p18l1967t3602r2135b3694],
14	ho	NN	O	ho	nn	15	SENT_277	[p18l1967t3602r2135b3694],
15	—	NN	O	—	nsubj	12	SENT_277	[p18l1967t3602r2135b3694],

1	mozygous	JJ	O	mozygous	_	0	SENT_278	[p19l11t46r439b121],
2	for	IN	O	for	_	0	SENT_278	[p19l468t20r590b99],
3	null	JJ	O	null	amod	4	SENT_278	[p19l613t20r776b100],
4	variants	NNS	O	variant	prep_for	1	SENT_278	[p19l798t21r1184b116],
5	)	RB	O	)	advmod	4	SENT_278	[p19l798t21r1184b116],
6	,	,	O	,	_	0	SENT_278	[p19l798t21r1184b116],
7	as	IN	O	as	mark	8	SENT_278	[p19l1216t47r1299b99],
8	do	VBP	O	do	dep	4	SENT_278	[p19l1329t20r1432b99],
9	1	CD	NUMBER	1	number	11	SENT_278	[p19l1463t26r1507b98],
10	to	TO	O	to	dep	11	SENT_278	[p19l1535t37r1614b99],
11	2	CD	PERCENT	2	num	12	SENT_278	[p19l1642t26r1688b98],
12	percent	NN	PERCENT	percent	dobj	8	SENT_278	[p19l1715t37r2032b121],
13	of	IN	O	of	prep	12	SENT_278	[p19l2055t20r2154b99],

1	Table	NNP	O	Table	_	0	SENT_279	[p19l61t327r197b375],
2	2	CD	NUMBER	2	dep	1	SENT_279	[p19l214t331r258b375],
3	.	.	O	.	_	0	SENT_279	[p19l214t331r258b375],

1	Common	JJ	O	common	amod	3	SENT_280	[p19l277t331r517b375],
2	Drug	NN	O	drug	nn	3	SENT_280	[p19l541t331r671b390],
3	Substrates	NNS	O	substrate	_	0	SENT_280	[p19l687t327r981b385],
4	,	,	O	,	_	0	SENT_280	[p19l687t327r981b385],
5	Inhibitors	NNS	O	inhibitor	appos	3	SENT_280	[p19l1004t327r1270b385],
6	,	,	O	,	_	0	SENT_280	[p19l1004t327r1270b385],
7	and	CC	O	and	_	0	SENT_280	[p19l1289t327r1383b375],
8	lnducers	NNS	O	lnducer	conj_and	5	SENT_280	[p19l1407t327r1632b375],
9	of	IN	O	of	_	0	SENT_280	[p19l1650t326r1710b375],
10	CYP3A	NN	O	cyp3a	prep_of	8	SENT_280	[p19l1717t331r1909b385],
11	,	,	O	,	_	0	SENT_280	[p19l1717t331r1909b385],
12	According	VBG	O	accord	_	0	SENT_280	[p19l60t407r328b470],
13	to	TO	O	to	prepc_according_to	5	SENT_280	[p19l342t415r394b456],
14	Drug	NNP	MISC	Drug	nn	15	SENT_280	[p19l415t412r545b470],
15	Class	NNP	MISC	Class	pobj	5	SENT_280	[p19l562t407r750b456],
16	.	.	O	.	_	0	SENT_280	[p19l562t407r750b456],

1	*	NN	O	*	_	0	SENT_281	[p19l562t407r750b456],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_282	[p19l62t547r240b592],
2	Substrates	NNS	O	substrate	_	0	SENT_282	[p19l257t544r535b592],

1	Calcium-channel	JJ	O	calcium-channel	amod	2	SENT_283	[p19l63t670r498b719],
2	blockers	NNS	O	blocker	_	0	SENT_283	[p19l258t742r471b791],

1	Diltiazem	NNP	O	Diltiazem	nn	4	SENT_284	[p19l163t815r409b863],
2	Felodipine	NNP	O	Felodipine	nn	4	SENT_284	[p19l163t887r432b950],
3	Nifedipine	NNP	O	Nifedipine	nn	4	SENT_284	[p19l163t958r434b1022],
4	Verapamil	NNP	O	Verapamil	_	0	SENT_284	[p19l157t1031r418b1094],

1	|	NN	O	|	_	0	SENT_285	[p19l67t1124r521b1182, p19l256t1201r366b1240],
2	mmunosuppressant	JJ	O	mmunosuppressant	amod	3	SENT_285	[p19l67t1124r521b1182, p19l256t1201r366b1240],
3	agents	NNS	O	agent	dep	1	SENT_285	[p19l385t1201r555b1255],

1	Cyclosporine	NN	O	cyclosporine	nn	2	SENT_286	[p19l159t1264r496b1327],
2	Tacrolimus	NN	O	tacrolimus	_	0	SENT_286	[p19l157t1336r445b1385],

1	Benzodiazepines	NNS	O	benzodiazepine	_	0	SENT_287	[p19l67t1424r509b1487],

1	Alprazolam	NNP	O	Alprazolam	nn	3	SENT_288	[p19l157t1497r456b1560],
2	Midazolam	NNP	O	Midazolam	nn	3	SENT_288	[p19l163t1569r453b1617],
3	Triazolam	NNP	O	Triazolam	_	0	SENT_288	[p19l157t1641r412b1690],

1	Stati	FW	PERSON	stati	_	0	SENT_289	[p19l63t1733r176b1778],
2	n	NN	O	n	nn	3	SENT_289	[p19l186t1746r210b1777],
3	s	NNS	O	s	dep	1	SENT_289	[p19l219t1747r241b1778],

1	Atorvastati	NNP	PERSON	Atorvastati	nn	4	SENT_290	[p19l157t1805r440b1850],
2	n	NN	O	n	nn	4	SENT_290	[p19l450t1819r474b1849],
3	Lovastati	NN	PERSON	lovastatus	nn	4	SENT_290	[p19l163t1878r392b1922],
4	n	NN	O	n	_	0	SENT_290	[p19l402t1891r427b1922],
5	(	CD	NUMBER	(	num	7	SENT_290	[p19l165t1950r282b2009],
6	Not	RB	O	not	neg	7	SENT_290	[p19l165t1950r282b2009],
7	pravastatin	NN	O	pravastatin	dep	4	SENT_290	[p19l303t1950r609b2009],
8	)	CD	NUMBER	)	num	10	SENT_290	[p19l303t1950r609b2009],
9	Macrolide	NNP	O	Macrolide	nn	10	SENT_290	[p19l67t2035r325b2083],
10	antibiotics	NNS	O	antibiotic	dep	4	SENT_290	[p19l346t2035r617b2083],

1	Clarithromycin	NNP	O	Clarithromycin	nn	2	SENT_291	[p19l159t2107r544b2170],
2	Eryth	NNP	O	Eryth	_	0	SENT_291	[p19l163t2179r288b2242],
3	romycin	NN	O	romycin	nn	5	SENT_291	[p19l298t2183r504b2242],
4	Anti-HIV	NN	O	anti-hiv	nn	5	SENT_291	[p19l61t2271r292b2316],
5	agents	NNS	O	agent	dep	2	SENT_291	[p19l311t2277r481b2331],

1	Indinavir	NNP	O	Indinavir	nn	4	SENT_292	[p19l163t2339r393b2388],
2	Nelflnavir	NNP	O	Nelflnavir	nn	4	SENT_292	[p19l163t2411r417b2460],
3	Ritonavir	NNP	O	Ritonavir	nn	4	SENT_292	[p19l163t2489r396b2532],
4	Saquinavir	NNP	O	Saquinavir	_	0	SENT_292	[p19l160t2560r437b2619],

1	Others	NNS	O	other	_	0	SENT_293	[p19l63t2645r240b2693],

1	Losartan	NN	O	losartan	nn	2	SENT_294	[p19l163t2721r384b2765],
2	Sﬂdenaﬁl	NN	O	sﬂdenaﬁl	_	0	SENT_294	[p19l160t2788r397b2837],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_295	[p19l720t547r898b592],
2	Inhibitors	NNS	O	inhibitor	_	0	SENT_295	[p19l919t544r1169b592],

1	Calcium-channel	JJ	O	calcium-channel	amod	2	SENT_296	[p19l721t670r1156b718],
2	blockers	NNS	O	blocker	_	0	SENT_296	[p19l1181t670r1394b718],

1	Diltiazem	NNP	O	Diltiazem	nn	2	SENT_297	[p19l822t742r1067b791],
2	Verapamil	NNP	O	Verapamil	_	0	SENT_297	[p19l815t815r1077b877],

1	Azole	JJ	MISC	azole	_	0	SENT_298	[p19l719t903r864b951],
2	antifungal	JJ	O	antifungal	amod	3	SENT_298	[p19l884t902r1144b967],
3	agents	NNS	O	agent	dep	1	SENT_298	[p19l1166t912r1336b967],

1	Itraconazole	NNP	O	Itraconazole	nn	2	SENT_299	[p19l822t975r1142b1023],
2	Ketoconazole	NNP	O	Ketoconazole	_	0	SENT_299	[p19l822t1048r1171b1096],

1	Macrolide	NN	O	macrolide	nn	2	SENT_300	[p19l725t1136r984b1184],
2	antibiotics	NNS	O	antibiotic	_	0	SENT_300	[p19l1004t1136r1275b1184],

1	Clarithromycin	NNP	O	Clarithromycin	nn	4	SENT_301	[p19l818t1208r1202b1271],
2	Erythromycin	NNP	O	Erythromycin	nn	4	SENT_301	[p19l821t1280r1162b1344],
3	Troleandomycin	NNP	O	Troleandomycin	nn	4	SENT_301	[p19l815t1352r1233b1416],
4	(	NNP	O	(	_	0	SENT_301	[p19l823t1429r940b1488],
5	Not	RB	O	not	neg	6	SENT_301	[p19l823t1429r940b1488],
6	azithromycin	NN	O	azithromycin	dep	4	SENT_301	[p19l959t1424r1317b1488],
7	)	CD	NUMBER	)	dep	4	SENT_301	[p19l959t1424r1317b1488],

1	Anti-HIV	JJ	O	anti-hiv	amod	2	SENT_302	[p19l719t1516r951b1561],
2	agents	NNS	O	agent	_	0	SENT_302	[p19l969t1522r1139b1577],
3	Delavirdine	NNP	O	Delavirdine	nn	6	SENT_302	[p19l822t1585r1116b1633],
4	Indinavir	NNP	O	Indinavir	nn	6	SENT_302	[p19l822t1657r1051b1706],
5	Rhonavn	NNP	O	Rhonavn	nn	6	SENT_302	[p19l822t1734r1054b1778],
6	Saquinavir	NNP	O	Saquinavir	dep	2	SENT_302	[p19l818t1806r1095b1865],

1	Others	NNS	O	other	_	0	SENT_303	[p19l721t1890r898b1938],

1	Grapefruit	NN	O	grapefruit	nn	2	SENT_304	[p19l818t1962r1086b2025],
2	juice	NN	O	juice	_	0	SENT_304	[p19l1103t1967r1225b2026],
3	Mifepristone	NNP	O	Mifepristone	nn	4	SENT_304	[p19l822t2034r1153b2097],
4	Nefazodone	NNP	O	Nefazodone	dep	2	SENT_304	[p19l822t2106r1138b2155],

1	CYP3A	NN	O	cyp3a	nn	2	SENT_305	[p19l1498t547r1677b592],
2	lnducers	NNS	O	lnducer	_	0	SENT_305	[p19l1697t544r1922b592],

1	Rifamycins	NNS	MISC	rifamycin	_	0	SENT_306	[p19l1504t669r1784b733],
2	Rifabutin	NNP	MISC	Rifabutin	nn	4	SENT_306	[p19l1600t742r1830b791],
3	Rifampin	NNP	MISC	Rifampin	nn	4	SENT_306	[p19l1600t814r1830b878],
4	Rifapentine	NNP	MISC	Rifapentine	dep	1	SENT_306	[p19l1600t886r1894b950],

1	Anticonvulsant	JJ	O	anticonvulsant	amod	2	SENT_307	[p19l1497t975r1895b1023],
2	agents	NNS	O	agent	_	0	SENT_307	[p19l1915t984r2085b1039],

1	Carbamazepine	NNP	O	Carbamazepine	nn	3	SENT_308	[p19l1596t1048r2005b1110],
2	Phenobarbital	NNP	O	Phenobarbital	nn	3	SENT_308	[p19l1600t1120r1959b1168],
3	Phenytoin	NNP	O	Phenytoin	_	0	SENT_308	[p19l1600t1192r1854b1255],

1	Anti-HIV	JJ	O	anti-hiv	amod	2	SENT_309	[p19l1497t1283r1729b1329],
2	agents	NNS	O	agent	_	0	SENT_309	[p19l1748t1289r1918b1344],

1	Efavirenz	NNP	PERSON	Efavirenz	nn	2	SENT_310	[p19l1600t1352r1835b1401],
2	Nevirapine	NNP	PERSON	Nevirapine	_	0	SENT_310	[p19l1600t1429r1883b1487],

1	Others	NNS	O	other	_	0	SENT_311	[p19l1500t1513r1677b1561],

1	St.	NNP	PERSON	St.	nn	2	SENT_312	[p19l1596t1585r1843b1647],
2	John	NNP	PERSON	John	poss	4	SENT_312	[p19l1596t1585r1843b1647],
3	’s	POS	O	’s	_	0	SENT_312	[p19l1596t1585r1843b1647],
4	wort	NN	O	wort	_	0	SENT_312	[p19l1862t1594r1979b1633],

1	7	CD	NUMBER	7	nsubj	8	SENT_313	[p19l10t2970r38b2998],
2	"	``	O	"	punct	4	SENT_313	[p19l10t2970r38b2998],
3	These	DT	O	these	det	4	SENT_313	[p19l56t2965r212b3014],
4	inhibitors	NNS	O	inhibitor	dep	1	SENT_313	[p19l232t2965r479b3014],
5	and	CC	O	and	_	0	SENT_313	[p19l500t2965r592b3014],
6	inducers	NNS	O	inducer	dep	1	SENT_313	[p19l615t2965r836b3014],
7	can	MD	O	can	aux	8	SENT_313	[p19l856t2983r942b3014],
8	interact	VB	O	interact	_	0	SENT_313	[p19l965t2970r1161b3014],
9	with	IN	O	with	_	0	SENT_313	[p19l1176t2965r1284b3014],
10	any	DT	O	any	det	12	SENT_313	[p19l1306t2983r1393b3029],
11	CYP3A	NN	O	cyp3a	nn	12	SENT_313	[p19l1410t2969r1587b3014],
12	substrate	NN	O	substrate	prep_with	8	SENT_313	[p19l1605t2965r1847b3014],
13	and	CC	O	and	_	0	SENT_313	[p19l1866t2965r1959b3014],
14	may	MD	O	may	aux	15	SENT_313	[p19l1982t2983r2087b3029],
15	have	VB	O	have	conj_and	8	SENT_313	[p19l61t3038r178b3087],
16	important	JJ	O	important	amod	18	SENT_313	[p19l199t3043r460b3101],
17	clinical	JJ	O	clinical	amod	18	SENT_313	[p19l479t3038r656b3087],
18	consequences	NNS	O	consequence	dobj	15	SENT_313	[p19l678t3055r1065b3101],
19	.	.	O	.	_	0	SENT_313	[p19l678t3055r1065b3101],

1	HIV	NN	O	hiv	nsubj	2	SENT_314	[p19l1091t3043r1190b3087],
2	denotes	VBZ	O	denote	_	0	SENT_314	[p19l1208t3038r1414b3087],
3	human	JJ	O	human	amod	5	SENT_314	[p19l1437t3038r1617b3087],
4	immunodeﬁciency	NN	O	immunodeﬁciency	nn	5	SENT_314	[p19l1641t3038r2089b3087, p19l59t3132r110b3179],
5	virus	NN	O	virus	dobj	2	SENT_314	[p19l127t3120r267b3164],
6	.	.	O	.	_	0	SENT_314	[p19l127t3120r267b3164],

1	Southeast	NNP	MISC	Southeast	nn	2	SENT_315	[p19l12t3348r317b3408],
2	Asians	NNPS	MISC	Asians	_	0	SENT_315	[p19l329t3349r553b3407],
3	.	.	O	.	_	0	SENT_315	[p19l329t3349r553b3407],

1	Some	DT	O	some	det	2	SENT_316	[p19l577t3353r749b3407],
2	Variants	NNS	O	variant	nsubj	5	SENT_316	[p19l764t3349r1006b3408],
3	are	VBP	O	be	cop	5	SENT_316	[p19l1026t3368r1118b3407],
4	more	RBR	O	more	advmod	5	SENT_316	[p19l1137t3367r1298b3407],
5	common	JJ	O	common	_	0	SENT_316	[p19l1318t3367r1597b3407],
6	in	IN	O	in	_	0	SENT_316	[p20l10t25r70b82],
7	certain	JJ	O	certain	amod	8	SENT_316	[p20l95t25r306b83],
8	populations	NNS	O	population	prep_in	5	SENT_316	[p20l330t25r727b99],
9	.	.	O	.	_	0	SENT_316	[p20l330t25r727b99],

1	For	IN	O	for	_	0	SENT_317	[p20l756t30r864b83],
2	example	NN	O	example	prep_for	14	SENT_317	[p20l889t24r1169b99],
3	,	,	O	,	_	0	SENT_317	[p20l889t24r1169b99],
4	CYP2D6	NN	O	cyp2d6	nsubjpass	14	SENT_317	[p20l1200t25r1592b95],
5	*	CD	NUMBER	*	number	6	SENT_317	[p20l1200t25r1592b95],
6	17	CD	NUMBER	17	dep	4	SENT_317	[p20l1200t25r1592b95],
7	,	,	O	,	_	0	SENT_317	[p20l1200t25r1592b95],
8	which	WDT	O	which	nsubj	10	SENT_317	[p20l7t119r202b178],
9	has	VBZ	O	have	aux	10	SENT_317	[p20l218t120r325b178],
10	reduced	VBN	O	reduce	rcmod	4	SENT_317	[p20l344t119r599b178],
11	activity	NN	O	activity	dobj	10	SENT_317	[p20l616t120r851b194],
12	,	,	O	,	_	0	SENT_317	[p20l616t120r851b194],
13	is	VBZ	O	be	auxpass	14	SENT_317	[p20l873t120r922b178],
14	found	VBN	O	find	_	0	SENT_317	[p20l941t119r1131b178],
15	predominantly	RB	O	predominantly	advmod	14	SENT_317	[p20l1147t119r1595b194, p20l10t215r64b289],
16	in	IN	O	in	_	0	SENT_317	[p20l85t215r147b272],
17	blacks	NNS	O	black	prep_in	14	SENT_317	[p20l172t215r385b286],
18	,	,	O	,	_	0	SENT_317	[p20l172t215r385b286],
19	whereas	IN	O	whereas	mark	31	SENT_317	[p20l407t215r663b274],
20	CYP2D6	NN	O	cyp2d6	nn	23	SENT_317	[p20l687t215r1056b273],
21	*	CD	NUMBER	*	num	23	SENT_317	[p20l687t215r1056b273],
22	1O	NN	O	1o	nn	23	SENT_317	[p20l687t215r1056b273],
23	(	NN	O	(	nsubj	31	SENT_317	[p20l1082t215r1292b282],
24	which	WDT	O	which	nsubj	26	SENT_317	[p20l1082t215r1292b282],
25	also	RB	O	also	advmod	26	SENT_317	[p20l1314t215r1437b273],
26	confers	VBZ	O	confer	rcmod	23	SENT_317	[p20l1460t233r1596b273, p20l10t309r123b368],
27	reduced	JJ	O	reduced	amod	29	SENT_317	[p20l146t309r394b368],
28	activity	NN	O	activity	nn	29	SENT_317	[p20l415t310r651b384],
29	)	NN	O	)	dobj	26	SENT_317	[p20l415t310r651b384],
30	is	VBZ	O	be	cop	31	SENT_317	[p20l676t310r724b368],
31	common	JJ	O	common	advcl	14	SENT_317	[p20l748t328r1030b368],
32	among	IN	O	among	_	0	SENT_317	[p20l1051t328r1273b384],
33	Southeast	NNP	MISC	Southeast	nn	34	SENT_317	[p20l1294t309r1601b368],
34	Asians	NNPS	MISC	Asians	prep_among	31	SENT_317	[p20l8t405r216b463],
35	but	CC	O	but	_	0	SENT_317	[p20l245t404r350b463],
36	not	RB	O	not	_	0	SENT_317	[p20l373t417r480b463],
37	among	IN	O	among	_	0	SENT_317	[p20l503t423r726b479],
38	other	JJ	O	other	amod	39	SENT_317	[p20l752t404r919b463],
39	populations	NNS	O	population	prep_among	31	SENT_317	[p20l943t401r1404b479],
40	.	.	O	.	_	0	SENT_317	[p20l943t401r1404b479],

1	”	NN	O	”	nsubjpass	9	SENT_318	[p20l943t401r1404b479],
2	More	JJR	O	more	mwe	3	SENT_318	[p20l1429t410r1596b463],
3	than	IN	O	than	quantmod	4	SENT_318	[p20l11t500r150b558],
4	65	CD	NUMBER	65	npadvmod	5	SENT_318	[p20l174t504r247b558],
5	commonly	RB	O	commonly	advmod	6	SENT_318	[p20l274t500r612b574],
6	used	VBN	O	use	partmod	1	SENT_318	[p20l632t499r777b559],
7	drugs	NNS	O	drug	dobj	6	SENT_318	[p20l800t499r976b574],
8	are	VBP	O	be	auxpass	9	SENT_318	[p20l1001t519r1094b558],
9	metabolized	VBN	O	metabolize	_	0	SENT_318	[p20l1117t499r1505b558],
10	by	IN	O	by	_	0	SENT_318	[p20l1528t500r1600b574],
11	CYPZD6	NN	O	cypzd6	agent	9	SENT_318	[p20l11t599r285b665],
12	,	,	O	,	_	0	SENT_318	[p20l11t599r285b665],
13	some	DT	O	some	nsubjpass	17	SENT_318	[p20l309t613r476b653],
14	of	IN	O	of	_	0	SENT_318	[p20l495t594r570b653],
15	which	WDT	O	which	prep_of	13	SENT_318	[p20l571t594r765b653],
16	are	VBP	O	be	auxpass	17	SENT_318	[p20l783t614r878b653],
17	listed	VBN	O	list	rcmod	11	SENT_318	[p20l896t594r1066b653],
18	in	IN	O	in	_	0	SENT_318	[p20l1084t595r1145b652],
19	Table	NNP	O	Table	prep_in	17	SENT_318	[p20l1161t594r1331b653],
20	3	CD	NUMBER	3	num	19	SENT_318	[p20l1350t599r1403b653],
21	.	.	O	.	_	0	SENT_318	[p20l1350t599r1403b653],

1	CYP2D6	NN	O	cyp2d6	nn	2	SENT_319	[p20l107t694r361b748],
2	polymorphisms	NNS	O	polymorphism	nsubj	5	SENT_319	[p20l377t690r869b764],
3	are	VBP	O	be	cop	5	SENT_319	[p20l886t709r979b748],
4	clinically	RB	O	clinically	advmod	5	SENT_319	[p20l996t690r1271b764],
5	important	JJ	O	important	_	0	SENT_319	[p20l1283t690r1601b764],
6	mainly	RB	O	mainly	advmod	5	SENT_319	[p20l10t784r227b859],
7	because	IN	O	because	_	0	SENT_319	[p20l243t785r491b843],
8	of	IN	O	of	_	0	SENT_319	[p20l510t784r585b843],
9	the	DT	O	the	det	11	SENT_319	[p20l590t785r687b843],
10	greater	JJR	O	greater	amod	11	SENT_319	[p20l706t797r928b859],
11	likelihood	NN	O	likelihood	prep_because_of	5	SENT_319	[p20l943t784r1264b844],
12	of	IN	O	of	_	0	SENT_319	[p20l1283t784r1358b843],
13	adverse	JJ	O	adverse	amod	14	SENT_319	[p20l1362t784r1596b843],
14	reactions	NNS	O	reaction	prep_of	11	SENT_319	[p20l10t880r296b938],
15	among	IN	O	among	_	0	SENT_319	[p20l327t898r550b954],
16	persons	NNS	O	person	prep_among	14	SENT_319	[p20l575t898r824b954],
17	with	IN	O	with	_	0	SENT_319	[p20l851t880r992b938],
18	poor	JJ	O	poor	amod	19	SENT_319	[p20l1020t898r1171b954],
19	metabolism	NN	O	metabolism	prep_with	16	SENT_319	[p20l1197t880r1592b950],
20	,	,	O	,	_	0	SENT_319	[p20l1197t880r1592b950],
21	because	IN	O	because	_	0	SENT_319	[p20l11t975r263b1033],
22	of	IN	O	of	_	0	SENT_319	[p20l291t974r367b1033],
23	the	DT	O	the	det	26	SENT_319	[p20l380t975r478b1033],
24	high	JJ	O	high	amod	26	SENT_319	[p20l504t975r650b1049],
25	plasma	NN	O	plasma	nn	26	SENT_319	[p20l675t975r909b1049],
26	concentration	NN	O	concentration	prep_because_of	5	SENT_319	[p20l934t975r1382b1033],
27	of	IN	O	of	_	0	SENT_319	[p20l1409t974r1485b1033],
28	the	DT	O	the	det	30	SENT_319	[p20l1498t975r1595b1033],
29	affected	VBN	O	affect	amod	30	SENT_319	[p20l10t1069r260b1128],
30	drug	NN	O	drug	prep_of	26	SENT_319	[p20l283t1069r447b1144],
31	,	,	O	,	_	0	SENT_319	[p20l283t1069r447b1144],
32	and	CC	O	and	_	0	SENT_319	[p20l474t1069r590b1128],
33	lack	NN	O	lack	prep_because_of	5	SENT_319	[p20l612t1070r742b1129],
34	of	IN	O	of	_	0	SENT_319	[p20l762t1069r837b1128],
35	efﬁcacy	NN	O	efﬁcacy	prep_of	33	SENT_319	[p20l847t1069r1085b1144],
36	among	IN	O	among	_	0	SENT_319	[p20l1104t1088r1327b1144],
37	persons	NNS	O	person	prep_among	35	SENT_319	[p20l1347t1088r1595b1144],
38	with	IN	O	with	_	0	SENT_319	[p20l7t1165r151b1224],
39	ultrarapid	JJ	O	ultrarapid	amod	40	SENT_319	[p20l176t1165r495b1239],
40	metabolism	NN	O	metabolism	prep_with	37	SENT_319	[p20l519t1165r922b1235],
41	,	,	O	,	_	0	SENT_319	[p20l519t1165r922b1235],
42	owing	VBG	O	owe	partmod	35	SENT_319	[p20l952t1165r1153b1239],
43	to	TO	O	to	_	0	SENT_319	[p20l1176t1177r1236b1223],
44	the	DT	O	the	det	48	SENT_319	[p20l1263t1165r1360b1223],
45	consequently	RB	O	consequently	advmod	46	SENT_319	[p20l1386t1183r1595b1223, p20l11t1259r251b1334],
46	low	JJ	O	low	amod	48	SENT_319	[p20l276t1259r392b1319],
47	plasma	NN	O	plasma	nn	48	SENT_319	[p20l415t1260r645b1334],
48	concentration	NN	O	concentration	prep_to	42	SENT_319	[p20l671t1260r1109b1318],
49	of	IN	O	of	_	0	SENT_319	[p20l1136t1259r1211b1318],
50	the	DT	O	the	det	52	SENT_319	[p20l1225t1259r1321b1318],
51	affected	VBN	O	affect	amod	52	SENT_319	[p20l1348t1259r1596b1318],
52	drug	NN	O	drug	prep_of	48	SENT_319	[p20l11t1355r175b1429],
53	.	.	O	.	_	0	SENT_319	[p20l11t1355r175b1429],

1	Because	IN	O	because	mark	6	SENT_320	[p20l197t1359r451b1414],
2	genotyping	NN	O	genotyping	nsubjpass	6	SENT_320	[p20l470t1355r829b1429],
3	has	VBZ	O	have	aux	6	SENT_320	[p20l845t1355r951b1413],
4	not	RB	O	not	neg	6	SENT_320	[p20l971t1367r1078b1413],
5	been	VBN	O	be	auxpass	6	SENT_320	[p20l1094t1354r1243b1413],
6	performed	VBN	O	perform	advcl	18	SENT_320	[p20l1261t1354r1596b1429],
7	in	IN	O	in	_	0	SENT_320	[p20l10t1450r71b1507],
8	most	JJS	O	most	amod	9	SENT_320	[p20l91t1461r253b1508],
9	people	NNS	O	people	prep_in	6	SENT_320	[p20l268t1450r497b1524],
10	,	,	O	,	_	0	SENT_320	[p20l268t1450r497b1524],
11	the	DT	O	the	det	12	SENT_320	[p20l522t1449r618b1508],
12	response	NN	O	response	nsubj	18	SENT_320	[p20l639t1468r922b1524],
13	to	TO	O	to	_	0	SENT_320	[p20l943t1462r1002b1508],
14	particular	JJ	O	particular	amod	15	SENT_320	[p20l1022t1450r1329b1524],
15	drugs	NNS	O	drug	prep_to	12	SENT_320	[p20l1348t1450r1525b1524],
16	is	VBZ	O	be	cop	18	SENT_320	[p20l1547t1450r1595b1508],
17	usually	RB	O	usually	advmod	18	SENT_320	[p20l11t1545r233b1619],
18	unanticipated	JJ	O	unanticipated	_	0	SENT_320	[p20l251t1544r701b1619],
19	.	.	O	.	_	0	SENT_320	[p20l251t1544r701b1619],

1	For	IN	O	for	_	0	SENT_321	[p20l725t1550r833b1603],
2	example	NN	O	example	prep_for	4	SENT_321	[p20l853t1545r1132b1619],
3	,	,	O	,	_	0	SENT_321	[p20l853t1545r1132b1619],
4	increased	VBD	O	increase	_	0	SENT_321	[p20l1157t1544r1457b1603],
5	cardiovascular	JJ	O	cardiovascular	amod	6	SENT_321	[p20l1479t1564r1595b1603, p20l11t1639r369b1698],
6	toxicity	NN	O	toxicity	nsubj	9	SENT_321	[p20l387t1640r616b1714],
7	is	VBZ	O	be	cop	9	SENT_321	[p20l632t1640r681b1698],
8	more	RBR	O	more	advmod	9	SENT_321	[p20l702t1658r866b1698],
9	likely	JJ	O	likely	ccomp	4	SENT_321	[p20l885t1639r1054b1714],
10	after	IN	O	after	_	0	SENT_321	[p20l1070t1639r1215b1698],
11	usual	JJ	O	usual	amod	12	SENT_321	[p20l1232t1639r1400b1698],
12	doses	NNS	O	dose	prep_after	9	SENT_321	[p20l1420t1640r1595b1698],
13	of	IN	O	of	_	0	SENT_321	[p20l11t1734r86b1793],
14	venlafaxine	NN	O	venlafaxine	prep_of	12	SENT_321	[p20l101t1734r476b1805],
15	,	,	O	,	_	0	SENT_321	[p20l101t1734r476b1805],
16	a	DT	O	a	det	19	SENT_321	[p20l512t1754r546b1793],
17	selective	JJ	O	selective	amod	19	SENT_321	[p20l578t1734r838b1794],
18	serotonin-reuptake	JJ	O	serotonin-reuptake	amod	19	SENT_321	[p20l872t1734r1478b1809],
19	inN	NN	O	inn	nsubj	4	SENT_321	[p20l1510t1735r1595b1792, p20l519t1890r533b1905],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_322	[p20l548t1889r632b1911],
2	MED	NNP	O	MED	_	0	SENT_322	[p20l647t1890r700b1905],
3	352	CD	NUMBER	352	num	5	SENT_322	[p20l712t1889r788b1911],
4	;	:	O	;	_	0	SENT_322	[p20l712t1889r788b1911],
5	21	CD	NUMBER	21	dep	2	SENT_322	[p20l712t1889r788b1911],
6	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	7	SENT_322	[p20l825t1889r1037b1911],
7	MAY	NNP	DATE	MAY	dep	5	SENT_322	[p20l1076t1889r1127b1905],
8	26	CD	DATE	26	num	7	SENT_322	[p20l1139t1884r1178b1909],
9	,	,	DATE	,	_	0	SENT_322	[p20l1139t1884r1178b1909],
10	2005	CD	DATE	2005	num	7	SENT_322	[p20l1191t1889r1254b1911],
11	2217	CD	DATE	2217	dep	2	SENT_322	[p20l1940t1888r2016b1909],

1	The	DT	O	the	det	4	SENT_323	[p20l702t1922r753b1946],
2	New	NNP	O	New	nn	4	SENT_323	[p20l762t1923r824b1946],
3	England	NNP	O	England	nn	4	SENT_323	[p20l833t1922r944b1953],
4	Journal	NNP	O	Journal	_	0	SENT_323	[p20l953t1922r1050b1946],
5	of	IN	O	of	_	0	SENT_323	[p20l1060t1922r1089b1946],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_323	[p20l1095t1922r1220b1946],

1	Downloaded	VBN	O	download	_	0	SENT_324	[p20l144t1963r314b1986],
2	from	IN	O	from	_	0	SENT_324	[p20l323t1963r387b1986],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_324	[p20l396t1963r514b1993],
4	at	IN	O	at	_	0	SENT_324	[p20l524t1967r548b1986],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_324	[p20l556t1963r739b1986],
6	on	IN	O	on	_	0	SENT_324	[p20l748t1970r780b1986],
7	January	NNP	DATE	January	prep_on	1	SENT_324	[p20l789t1963r892b1993],
8	5	CD	DATE	5	num	7	SENT_324	[p20l902t1963r924b1991],
9	,	,	DATE	,	_	0	SENT_324	[p20l902t1963r924b1991],
10	2014	CD	DATE	2014	num	7	SENT_324	[p20l935t1963r1007b1986],
11	.	.	O	.	_	0	SENT_324	[p20l935t1963r1007b1986],

1	For	IN	O	for	_	0	SENT_325	[p20l1018t1963r1064b1986],
2	personal	JJ	O	personal	amod	3	SENT_325	[p20l1072t1963r1185b1993],
3	use	NN	O	use	pobj	1	SENT_325	[p20l1194t1970r1237b1986],
4	only	RB	O	only	advmod	3	SENT_325	[p20l1247t1963r1312b1993],
5	.	.	O	.	_	0	SENT_325	[p20l1247t1963r1312b1993],

1	No	DT	O	no	det	3	SENT_326	[p20l1322t1963r1362b1986],
2	other	JJ	O	other	amod	3	SENT_326	[p20l1372t1963r1440b1986],
3	uses	NNS	O	use	_	0	SENT_326	[p20l1449t1970r1504b1986],
4	without	IN	O	without	_	0	SENT_326	[p20l1515t1963r1616b1986],
5	permission	NN	O	permission	prep_without	3	SENT_326	[p20l1624t1963r1777b1993],
6	.	.	O	.	_	0	SENT_326	[p20l1624t1963r1777b1993],

1	Copyright	NN	O	copyright	_	0	SENT_327	[p20l494t2004r629b2035],
2	©	CD	NUMBER	©	num	6	SENT_327	[p20l638t2004r661b2028],
3	2005	CD	DATE	2005	num	6	SENT_327	[p20l672t2004r736b2028],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_327	[p20l746t2004r937b2028],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_327	[p20l947t2004r1055b2028],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_327	[p20l1065t2004r1170b2035],
7	.	.	O	.	_	0	SENT_327	[p20l1065t2004r1170b2035],

1	All	DT	O	all	det	2	SENT_328	[p20l1181t2004r1223b2028],
2	rights	NNS	O	rights	nsubj	3	SENT_328	[p20l1232t2004r1307b2035],
3	reserved	VBN	O	reserve	_	0	SENT_328	[p20l1316t2004r1435b2028],
4	.	.	O	.	_	0	SENT_328	[p20l1316t2004r1435b2028],

1	The	DT	O	the	det	4	SENT_329	[p20l715t2110r752b2131],
2	NEW	NNP	O	NEW	nn	4	SENT_329	[p20l764t2112r845b2131],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_329	[p20l859t2112r1034b2131],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_329	[p20l1048t2112r1214b2138],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_329	[p20l1228t2110r1444b2137],

1	Table	NNP	O	Table	_	0	SENT_330	[p21l77t70r260b135],
2	3	CD	NUMBER	3	dep	1	SENT_330	[p21l283t76r342b135],
3	.	.	O	.	_	0	SENT_330	[p21l283t76r342b135],

1	Common	JJ	O	common	amod	2	SENT_331	[p21l367t75r689b135],
2	Drug	NN	O	drug	_	0	SENT_331	[p21l721t76r895b154],
3	Substrates	NNS	O	substrate	dep	2	SENT_331	[p21l917t70r1290b135],
4	and	CC	O	and	_	0	SENT_331	[p21l1315t70r1441b135],
5	Clinically	RB	O	clinically	advmod	3	SENT_331	[p21l1468t70r1785b155],
6	Important	JJ	O	important	amod	8	SENT_331	[p21l84t184r435b261],
7	Inhibitors	NNS	O	inhibitor	nn	8	SENT_331	[p21l461t177r797b242],
8	ofCYP2D6	NN	O	ofcyp2d6	dep	2	SENT_331	[p21l821t176r1222b242],
9	.	.	O	.	_	0	SENT_331	[p21l821t176r1222b242],

1	CYP2D6	NNP	O	CYP2D6	nn	3	SENT_332	[p21l79t361r370b421],
2	Substrates	NNPS	O	Substrates	nn	3	SENT_332	[p21l393t356r766b421],
3	CYP2D6	NNP	O	CYP2D6	_	0	SENT_332	[p21l1405t361r1695b421],
4	Inhibitors	NNS	O	inhibitor	dep	3	SENT_332	[p21l1724t356r2059b420],

1	Beta-blockers	NNS	O	beta-blocker	_	0	SENT_333	[p21l86t522r551b586],
2	Alprenolol	NNP	O	Alprenolol	nn	6	SENT_333	[p21l207t639r566b723],
3	Bufu	NNP	O	Bufu	nn	6	SENT_333	[p21l215t736r367b801],
4	ralol	NN	O	ralol	nn	6	SENT_333	[p21l381t736r525b801],
5	Carvedilol	NNP	O	Carvedilol	nn	6	SENT_333	[p21l210t833r552b898],
6	Metoprolol	NNP	O	Metoprolol	dep	1	SENT_333	[p21l215t930r596b1014],
7	Propranolol	NNP	O	Propranolol	nn	8	SENT_333	[p21l215t1026r618b1111],
8	Timolol	NNP	O	Timolol	dep	1	SENT_333	[p21l206t1123r473b1188],

1	Tricyclic	JJ	MISC	tricyclic	amod	2	SENT_334	[p21l77t1259r355b1344],
2	antidepressants	NNS	O	antidepressant	_	0	SENT_334	[p21l380t1259r939b1343],

1	Amitriptyline	NNP	O	Amitriptyline	nn	2	SENT_335	[p21l207t1377r663b1462],
2	(	NNP	O	(	_	0	SENT_335	[p21l696t1382r778b1461],
3	in	IN	O	in	_	0	SENT_335	[p21l696t1382r778b1461],
4	part	NN	O	part	nn	8	SENT_335	[p21l811t1382r969b1461],
5	)	CD	NUMBER	)	num	8	SENT_335	[p21l811t1382r969b1461],
6	Clomipramine	NNP	O	Clomipramine	nn	8	SENT_335	[p21l1403t1377r1907b1461],
7	Clomipramine	NNP	O	Clomipramine	nn	8	SENT_335	[p21l210t1474r713b1558],
8	(	NN	O	(	prep_in	2	SENT_335	[p21l747t1479r829b1558],
9	in	IN	O	in	_	0	SENT_335	[p21l747t1479r829b1558],
10	part	NN	O	part	nn	14	SENT_335	[p21l863t1479r1020b1558],
11	)	CD	NUMBER	)	num	14	SENT_335	[p21l863t1479r1020b1558],
12	Desipramine	NNP	O	Desipramine	nn	14	SENT_335	[p21l215t1576r662b1655],
13	Imipramine	NNP	O	Imipramine	nn	14	SENT_335	[p21l215t1673r621b1752],
14	(	NN	O	(	prep_in	2	SENT_335	[p21l655t1673r736b1752],
15	in	IN	O	in	_	0	SENT_335	[p21l655t1673r736b1752],
16	part	NN	O	part	prep_in	2	SENT_335	[p21l770t1673r927b1752],
17	)	CD	NUMBER	)	num	16	SENT_335	[p21l770t1673r927b1752],
18	Nortriptyline	NNP	O	Nortriptyline	dep	2	SENT_335	[p21l215t1764r658b1849],

1	Antiarrhythmic	JJ	MISC	antiarrhythmic	amod	2	SENT_336	[p21l78t1900r606b1984],
2	agents	NNS	O	agent	_	0	SENT_336	[p21l632t1912r859b1985],

1	Flecainide	NNP	O	Flecainide	nn	4	SENT_337	[p21l215t2018r564b2082],
2	Quinidine	NNP	O	Quinidine	nn	4	SENT_337	[p21l1403t2018r1753b2100],
3	Mexiletine	NNP	O	Mexiletine	nn	4	SENT_337	[p21l215t2115r571b2179],
4	Propafenone	NNP	O	Propafenone	_	0	SENT_337	[p21l215t2211r658b2296],

1	Antipsychotic	JJ	MISC	antipsychotic	amod	2	SENT_338	[p21l78t2347r557b2432],
2	agents	NNS	O	agent	_	0	SENT_338	[p21l583t2359r811b2432],
3	and	CC	O	and	_	0	SENT_338	[p21l840t2347r963b2411],
4	SSR	NNP	O	SSR	conj_and	2	SENT_338	[p21l994t2352r1237b2411],
5	|	CD	NUMBER	|	num	6	SENT_338	[p21l994t2352r1237b2411],
6	s	NNS	O	s	dep	2	SENT_338	[p21l994t2352r1237b2411],
7	*	IN	O	*	amod	6	SENT_338	[p21l994t2352r1237b2411],

1	Fluoxetine	NNP	O	Fluoxetine	nn	5	SENT_339	[p21l215t2465r571b2530],
2	Fluoxetine	NNP	O	Fluoxetine	nn	5	SENT_339	[p21l1408t2465r1764b2530],
3	Haloperidol	NNP	O	Haloperidol	nn	5	SENT_339	[p21l215t2562r623b2646],
4	Haloperidol	NNP	O	Haloperidol	nn	5	SENT_339	[p21l1408t2562r1816b2646],
5	Pa	NNP	O	Pa	_	0	SENT_339	[p21l215t2665r290b2723],
6	roxetine	NN	O	roxetine	dep	5	SENT_339	[p21l301t2665r577b2723],
7	Pa	NNP	O	Pa	nn	10	SENT_339	[p21l1408t2665r1484b2723],
8	roxetine	NN	O	roxetine	nn	10	SENT_339	[p21l1495t2665r1770b2723],
9	Perphenazine	NNP	O	Perphenazine	nn	10	SENT_339	[p21l215t2755r689b2840],
10	Venlafaxine	NNP	O	Venlafaxine	dep	5	SENT_339	[p21l206t2852r605b2917],

1	Opioids	NNS	O	opioid	_	0	SENT_340	[p21l81t2988r357b3072],

1	Codeine	NNP	O	Codeine	nn	2	SENT_341	[p21l210t3106r494b3171],
2	Dextromethorphan	NNP	O	Dextromethorphan	_	0	SENT_341	[p21l215t3203r878b3287],

1	*	JJ	O	*	amod	2	SENT_342	[p21l9t3443r48b3481],
2	SSRIS	NN	O	ssri	nsubj	3	SENT_342	[p21l75t3442r273b3502],
3	denotes	VBZ	O	denote	_	0	SENT_342	[p21l301t3438r578b3502],
4	selective	JJ	O	selective	amod	6	SENT_342	[p21l607t3438r904b3502],
5	serotonin-reuptake	NN	O	serotonin-reuptake	nn	6	SENT_342	[p21l932t3438r1598b3522],
6	inhibitors	NNS	O	inhibitor	dobj	3	SENT_342	[p21l1628t3438r1979b3502],
7	.	.	O	.	_	0	SENT_342	[p21l1628t3438r1979b3502],

1	hibitor	NN	O	hibitor	nn	3	SENT_343	[p22l10t73r300b151],
2	(	CD	NUMBER	(	num	3	SENT_343	[p22l327t68r700b168],
3	SSRI	NNP	ORGANIZATION	SSRI	nsubj	14	SENT_343	[p22l327t68r700b168],
4	)	CD	NUMBER	)	number	5	SENT_343	[p22l327t68r700b168],
5	,24	CD	NUMBER	,24	dep	3	SENT_343	[p22l327t68r700b168],
6	and	CC	O	and	_	0	SENT_343	[p22l725t72r881b151],
7	adverse	JJ	O	adverse	amod	8	SENT_343	[p22l905t73r1218b152],
8	effects	NNS	O	effect	conj_and	3	SENT_343	[p22l1245t72r1515b151],
9	of	IN	O	of	_	0	SENT_343	[p22l1543t72r1644b151],
10	tricyclic	JJ	O	tricyclic	amod	11	SENT_343	[p22l1651t73r1976b173],
11	antidepressants	NNS	O	antidepressant	prep_of	8	SENT_343	[p22l2000t98r2134b151, p22l11t201r569b301],
12	are	VBP	O	be	cop	14	SENT_343	[p22l615t227r740b279],
13	more	RBR	O	more	advmod	14	SENT_343	[p22l784t226r1004b279],
14	frequent	JJ	O	frequent	_	0	SENT_343	[p22l1048t200r1410b301],
15	in	IN	O	in	_	0	SENT_343	[p22l1448t201r1529b278],
16	persons	NNS	O	person	prep_in	14	SENT_343	[p22l1571t226r1904b301],
17	With	IN	O	with	_	0	SENT_343	[p22l1945t201r2135b280],
18	poor	JJ	O	poor	amod	19	SENT_343	[p22l9t354r210b429],
19	metabolism	NN	O	metabolism	prep_with	16	SENT_343	[p22l236t328r741b407],
20	than	IN	O	than	dep	14	SENT_343	[p22l769t328r957b407],
21	in	IN	O	in	_	0	SENT_343	[p22l984t329r1065b406],
22	those	DT	O	those	prep_in	14	SENT_343	[p22l1094t328r1321b407],
23	With	IN	O	with	_	0	SENT_343	[p22l1344t329r1534b408],
24	extensive	JJ	O	extensive	amod	25	SENT_343	[p22l1562t329r1944b408],
25	metabolism	NN	O	metabolism	prep_with	22	SENT_343	[p22l1972t355r2134b407, p22l11t453r500b536],
26	.	.	O	.	_	0	SENT_343	[p22l1972t355r2134b407, p22l11t453r500b536],

1	”	NN	O	”	ccomp	8	SENT_344	[p22l1972t355r2134b407, p22l11t453r500b536],
2	Similarly	RB	O	similarly	advmod	1	SENT_344	[p22l533t458r930b558],
3	,	,	O	,	_	0	SENT_344	[p22l533t458r930b558],
4	persons	NNS	O	person	nsubj	8	SENT_344	[p22l961t483r1300b558],
5	with	IN	O	with	_	0	SENT_344	[p22l1326t458r1518b537],
6	poor	JJ	O	poor	amod	7	SENT_344	[p22l1544t483r1749b558],
7	metabolism	NN	O	metabolism	prep_with	4	SENT_344	[p22l1774t457r2132b536, p22l9t586r195b664],
8	have	VBP	O	have	_	0	SENT_344	[p22l219t586r406b665],
9	a	DT	O	a	det	11	SENT_344	[p22l428t612r473b664],
10	greater	JJR	O	greater	amod	11	SENT_344	[p22l492t602r790b686],
11	risk	NN	O	risk	dobj	8	SENT_344	[p22l809t586r971b665],
12	of	IN	O	of	_	0	SENT_344	[p22l989t585r1089b664],
13	adverse	JJ	O	adverse	amod	14	SENT_344	[p22l1092t586r1405b665],
14	effects	NNS	O	effect	prep_of	11	SENT_344	[p22l1428t585r1698b664],
15	when	WRB	O	when	advmod	16	SENT_344	[p22l1718t585r1952b665],
16	taking	VBG	O	take	advcl	8	SENT_344	[p22l1974t585r2134b665, p22l10t714r148b814],
17	metoprolol	NN	O	metoprolol	dobj	16	SENT_344	[p22l168t713r641b814],
18	than	IN	O	than	_	0	SENT_344	[p22l664t714r853b792],
19	do	VB	O	do	prepc_than	16	SENT_344	[p22l877t713r979b792],
20	persons	NNS	O	person	dobj	19	SENT_344	[p22l1003t739r1335b814],
21	with	IN	O	with	_	0	SENT_344	[p22l1357t713r1546b793],
22	other	JJ	O	other	amod	23	SENT_344	[p22l1570t714r1793b792],
23	types	NNS	O	type	prep_with	19	SENT_344	[p22l1815t730r2027b814],
24	of	IN	O	of	_	0	SENT_344	[p22l2053t713r2153b792],
25	metabolism	NN	O	metabolism	prep_of	23	SENT_344	[p22l10t834r625b919],
26	.	.	O	.	_	0	SENT_344	[p22l10t834r625b919],

1	”	NN	O	”	nn	2	SENT_345	[p22l10t834r625b919],
2	CYP2D6	NN	O	cyp2d6	nsubj	4	SENT_345	[p22l655t847r1000b919],
3	is	VBZ	O	be	cop	4	SENT_345	[p22l1028t842r1093b919],
4	responsible	JJ	O	responsible	ccomp	25	SENT_345	[p22l1123t841r1614b941],
5	for	IN	O	for	_	0	SENT_345	[p22l1642t840r1765b919],
6	the	DT	O	the	det	7	SENT_345	[p22l1790t841r1920b919],
7	conversion	NN	O	conversion	prep_for	4	SENT_345	[p22l1949t866r2134b919, p22l6t970r315b1049],
8	of	IN	O	of	_	0	SENT_345	[p22l343t969r444b1048],
9	codeine	NN	O	codeine	prep_of	7	SENT_345	[p22l454t970r779b1048],
10	to	TO	O	to	_	0	SENT_345	[p22l808t986r887b1048],
11	morphine	NN	O	morphine	prep_to	4	SENT_345	[p22l916t969r1358b1070],
12	,	,	O	,	_	0	SENT_345	[p22l916t969r1358b1070],
13	an	DT	O	a	det	15	SENT_345	[p22l1391t995r1491b1048],
14	active	JJ	O	active	amod	15	SENT_345	[p22l1518t970r1753b1049],
15	metabolite	NN	O	metabolite	nsubj	25	SENT_345	[p22l1781t970r2134b1048, p22l9t1098r163b1193],
16	;	:	O	;	_	0	SENT_345	[p22l1781t970r2134b1048, p22l9t1098r163b1193],
17	adequate	JJ	O	adequate	amod	18	SENT_345	[p22l193t1098r571b1198],
18	experimental	JJ	O	experimental	amod	15	SENT_345	[p22l598t1097r1153b1198],
19	or	CC	O	or	_	0	SENT_345	[p22l1180t1123r1269b1176],
20	clinical	JJ	O	clinical	amod	22	SENT_345	[p22l1293t1097r1593b1176],
21	pain	NN	O	pain	nn	22	SENT_345	[p22l1618t1098r1802b1198],
22	relief	NN	O	relief	conj_or	15	SENT_345	[p22l1829t1097r2061b1176],
23	is	VBZ	O	be	cop	25	SENT_345	[p22l2068t1098r2133b1176],
24	more	RBR	O	more	advmod	25	SENT_345	[p22l10t1251r230b1304],
25	difficult	JJ	O	difficult	_	0	SENT_345	[p22l260t1225r595b1305],
26	to	TO	O	to	aux	27	SENT_345	[p22l619t1242r698b1304],
27	achieve	VB	O	achieve	xcomp	25	SENT_345	[p22l727t1226r1034b1305],
28	in	IN	O	in	_	0	SENT_345	[p22l1062t1226r1144b1303],
29	persons	NNS	O	person	prep_in	27	SENT_345	[p22l1170t1251r1503b1326],
30	with	IN	O	with	_	0	SENT_345	[p22l1529t1226r1718b1305],
31	poor	JJ	O	poor	amod	32	SENT_345	[p22l1745t1251r1947b1326],
32	metabolism	NN	O	metabolism	prep_with	29	SENT_345	[p22l1972t1252r2134b1304, p22l11t1350r493b1433],
33	.	.	O	.	_	0	SENT_345	[p22l1972t1252r2134b1304, p22l11t1350r493b1433],

1	”	NN	O	”	npadvmod	9	SENT_346	[p22l1972t1252r2134b1304, p22l11t1350r493b1433],
2	In	IN	O	in	_	0	SENT_346	[p22l531t1362r618b1432],
3	contrast	NN	O	contrast	prep_in	9	SENT_346	[p22l657t1371r1022b1450],
4	,	,	O	,	_	0	SENT_346	[p22l657t1371r1022b1450],
5	several	JJ	O	several	amod	7	SENT_346	[p22l1068t1355r1353b1434],
6	case	NN	O	case	nn	7	SENT_346	[p22l1392t1381r1567b1433],
7	reports	NNS	O	report	nsubj	9	SENT_346	[p22l1606t1371r1905b1455],
8	have	VBP	O	have	aux	9	SENT_346	[p22l1946t1355r2134b1434],
9	noted	VBN	O	note	_	0	SENT_346	[p22l10t1482r246b1561],
10	morphine	NN	O	morphine	dobj	9	SENT_346	[p22l266t1482r862b1583],
11	—	CD	NUMBER	—	num	10	SENT_346	[p22l266t1482r862b1583],
12	like	IN	O	like	_	0	SENT_346	[p22l266t1482r862b1583],
13	adverse	JJ	O	adverse	amod	14	SENT_346	[p22l882t1482r1189b1562],
14	effects	NNS	O	effect	prep_like	10	SENT_346	[p22l1211t1482r1474b1561],
15	among	IN	O	among	_	0	SENT_346	[p22l1496t1508r1792b1583],
16	persons	NNS	O	person	prep_among	9	SENT_346	[p22l1807t1508r2134b1583],
17	with	IN	O	with	_	0	SENT_346	[p22l6t1612r195b1691],
18	the	DT	O	the	det	19	SENT_346	[p22l220t1612r349b1690],
19	phenotype	NN	O	phenotype	prep_with	16	SENT_346	[p22l374t1611r818b1712],
20	of	IN	O	of	_	0	SENT_346	[p22l843t1611r944b1690],
21	ultrarapid	JJ	O	ultrarapid	amod	22	SENT_346	[p22l950t1612r1367b1712],
22	metabolism	NN	O	metabolism	prep_of	19	SENT_346	[p22l1393t1607r2111b1690],
23	.28	CD	NUMBER	.28	number	24	SENT_346	[p22l1393t1607r2111b1690],
24	’29	CD	NUMBER	’29	dep	33	SENT_346	[p22l1393t1607r2111b1690],
25	A	DT	O	a	det	26	SENT_346	[p22l136t1747r202b1817],
26	disposition	NN	O	disposition	dobj	33	SENT_346	[p22l229t1740r703b1840],
27	to	TO	O	to	_	0	SENT_346	[p22l734t1756r813b1818],
28	impaired	JJ	O	impaired	prep_to	26	SENT_346	[p22l843t1740r1224b1840],
29	CYPZD6	NN	O	cypzd6	nn	30	SENT_346	[p22l1254t1745r1598b1818],
30	metabolism	NN	O	metabolism	nsubjpass	33	SENT_346	[p22l1629t1740r2135b1818],
31	is	VBZ	O	be	auxpass	33	SENT_346	[p22l10t1868r75b1946],
32	generally	RB	O	generally	advmod	33	SENT_346	[p22l105t1868r492b1968],
33	inherited	VBN	O	inherit	dep	9	SENT_346	[p22l516t1867r923b1963],
34	;	:	O	;	_	0	SENT_346	[p22l516t1867r923b1963],
35	in	IN	O	in	_	0	SENT_346	[p22l955t1868r1037b1945],
36	addition	NN	O	addition	prep_in	42	SENT_346	[p22l1065t1867r1441b1963],
37	,	,	O	,	_	0	SENT_346	[p22l1065t1867r1441b1963],
38	certain	JJ	O	certain	amod	40	SENT_346	[p22l1476t1868r1765b1946],
39	drug	NN	O	drug	nn	40	SENT_346	[p22l1795t1868r1994b1968],
40	interactions	NNS	O	interaction	nsubj	42	SENT_346	[p22l2019t1868r2134b1945, p22l11t1996r424b2074],
41	can	MD	O	can	aux	42	SENT_346	[p22l465t2021r609b2074],
42	result	VB	O	result	parataxis	9	SENT_346	[p22l647t1996r888b2075],
43	in	IN	O	in	_	0	SENT_346	[p22l921t1996r1001b2073],
44	such	JJ	O	such	amod	46	SENT_346	[p22l1041t1996r1236b2075],
45	a	DT	O	a	det	46	SENT_346	[p22l1273t2022r1317b2074],
46	phenotype	NN	O	phenotype	prep_in	42	SENT_346	[p22l1353t1996r1820b2096],
47	.	.	O	.	_	0	SENT_346	[p22l1353t1996r1820b2096],

1	Quini	NNP	O	Quini	nsubj	3	SENT_347	[p22l1864t1996r2134b2094],
2	—	CD	NUMBER	—	num	1	SENT_347	[p22l1864t1996r2134b2094],
3	dine	VB	O	dine	_	0	SENT_347	[p22l11t2124r215b2219],
4	,	,	O	,	_	0	SENT_347	[p22l11t2124r215b2219],
5	ﬂuoxetine	NN	O	ﬂuoxetine	nsubj	11	SENT_347	[p22l251t2123r696b2219],
6	,	,	O	,	_	0	SENT_347	[p22l251t2123r696b2219],
7	and	CC	O	and	_	0	SENT_347	[p22l731t2124r887b2202],
8	paroxetine	NN	O	paroxetine	conj_and	5	SENT_347	[p22l916t2124r1363b2224],
9	are	VBP	O	be	cop	11	SENT_347	[p22l1393t2150r1519b2202],
10	potent	JJ	O	potent	amod	11	SENT_347	[p22l1548t2140r1826b2224],
11	inhibitors	NNS	O	inhibitor	ccomp	3	SENT_347	[p22l1851t2123r2134b2202, p22l11t2268r170b2330],
12	of	IN	O	of	_	0	SENT_347	[p22l202t2251r302b2330],
13	CYP2D6	NN	O	cyp2d6	prep_of	11	SENT_347	[p22l313t2257r682b2347],
14	,	,	O	,	_	0	SENT_347	[p22l313t2257r682b2347],
15	and	CC	O	and	_	0	SENT_347	[p22l716t2252r872b2330],
16	each	DT	O	each	nsubj	21	SENT_347	[p22l901t2251r1091b2330],
17	of	IN	O	of	_	0	SENT_347	[p22l1121t2251r1222b2330],
18	those	DT	O	those	det	19	SENT_347	[p22l1233t2252r1459b2330],
19	drugs	NNS	O	drug	prep_of	16	SENT_347	[p22l1490t2251r1727b2352],
20	is	VBZ	O	be	cop	21	SENT_347	[p22l1758t2252r1823b2330],
21	able	JJ	O	able	conj_and	3	SENT_347	[p22l1853t2251r2025b2330],
22	to	TO	O	to	aux	23	SENT_347	[p22l2055t2268r2134b2330],
23	convert	VB	O	convert	xcomp	21	SENT_347	[p22l11t2396r325b2458],
24	extensive	JJ	O	extensive	amod	25	SENT_347	[p22l342t2380r724b2459],
25	metabolism	NN	O	metabolism	dobj	23	SENT_347	[p22l745t2380r1251b2457],
26	in	IN	O	in	_	0	SENT_347	[p22l1272t2380r1353b2456],
27	a	DT	O	a	det	28	SENT_347	[p22l1374t2406r1418b2457],
28	person	NN	O	person	prep_in	25	SENT_347	[p22l1437t2404r1728b2479],
29	into	IN	O	into	_	0	SENT_347	[p22l1749t2380r1914b2457],
30	poor	JJ	O	poor	amod	31	SENT_347	[p22l1936t2404r2138b2479],
31	metabolism	NN	O	metabolism	prep_into	23	SENT_347	[p22l10t2508r516b2586],
32	—	VBD	O	—	rcmod	31	SENT_347	[p22l534t2552r642b2560],
33	a	DT	O	a	det	34	SENT_347	[p22l659t2534r703b2586],
34	phenomenon	NN	O	phenomenon	dobj	32	SENT_347	[p22l722t2508r1294b2608],
35	termed	VBN	O	term	partmod	34	SENT_347	[p22l1316t2508r1614b2586],
36	phenocopy	JJ	O	phenocopy	amod	38	SENT_347	[p22l1634t2508r2134b2608],
37	—	NN	O	—	nn	38	SENT_347	[p22l1634t2508r2134b2608],
38	ing	NN	O	ing	dobj	35	SENT_347	[p22l10t2636r166b2736],
39	.	.	O	.	_	0	SENT_347	[p22l10t2636r166b2736],

1	This	DT	O	this	nsubj	2	SENT_348	[p22l190t2635r374b2714],
2	has	VBZ	O	have	_	0	SENT_348	[p22l397t2636r537b2714],
3	clinical	JJ	O	clinical	amod	4	SENT_348	[p22l561t2635r858b2714],
4	relevance	NN	O	relevance	dobj	2	SENT_348	[p22l879t2636r1264b2715],
5	when	WRB	O	when	advmod	8	SENT_348	[p22l1282t2636r1514b2715],
6	SSRIs	NNS	MISC	ssri	nsubjpass	8	SENT_348	[p22l1537t2641r1773b2719],
7	are	VBP	O	be	auxpass	8	SENT_348	[p22l1796t2662r1921b2714],
8	used	VBN	O	use	dep	4	SENT_348	[p22l1942t2635r2135b2715],
9	in	IN	O	in	_	0	SENT_348	[p22l10t2764r92b2841],
10	combination	NN	O	combination	prep_in	8	SENT_348	[p22l127t2763r677b2842],
11	with	IN	O	with	_	0	SENT_348	[p22l708t2764r900b2843],
12	tricyclic	JJ	O	tricyclic	amod	13	SENT_348	[p22l935t2763r1268b2864],
13	antidepressants	NNS	O	antidepressant	prep_with	8	SENT_348	[p22l1301t2764r2007b2864],
14	.	.	O	.	_	0	SENT_348	[p22l1301t2764r2007b2864],

1	In	IN	O	in	_	0	SENT_349	[p22l2046t2771r2134b2841],
2	this	DT	O	this	det	3	SENT_349	[p22l11t2891r166b2970],
3	situation	NN	O	situation	prep_in	12	SENT_349	[p22l197t2892r589b2987],
4	,	,	O	,	_	0	SENT_349	[p22l197t2892r589b2987],
5	plasma	NN	O	plasma	nn	6	SENT_349	[p22l619t2892r926b2992],
6	levels	NNS	O	level	nsubjpass	12	SENT_349	[p22l949t2891r1176b2971],
7	of	IN	O	of	_	0	SENT_349	[p22l1205t2891r1305b2970],
8	tricyclic	JJ	O	tricyclic	amod	9	SENT_349	[p22l1313t2892r1638b2992],
9	agents	NNS	O	agent	prep_of	6	SENT_349	[p22l1662t2908r1935b2992],
10	may	MD	O	may	aux	12	SENT_349	[p22l1963t2918r2139b2992],
11	be	VB	O	be	auxpass	12	SENT_349	[p22l11t3020r106b3098],
12	increased	VBN	O	increase	_	0	SENT_349	[p22l125t3019r520b3098],
13	by	IN	O	by	_	0	SENT_349	[p22l542t3020r638b3120],
14	a	DT	O	a	det	15	SENT_349	[p22l652t3046r697b3098],
15	factor	NN	O	factor	agent	12	SENT_349	[p22l716t3019r958b3098],
16	of	IN	O	of	_	0	SENT_349	[p22l976t3019r1076b3098],
17	two	CD	NUMBER	two	number	19	SENT_349	[p22l1078t3036r1229b3099],
18	to	TO	O	to	dep	19	SENT_349	[p22l1251t3036r1329b3098],
19	four	CD	NUMBER	four	prep_of	15	SENT_349	[p22l1351t3019r1526b3099],
20	after	IN	O	after	_	0	SENT_349	[p22l1543t3019r1733b3098],
21	coadmin	JJ	O	coadmin	amod	23	SENT_349	[p22l1751t3020r2148b3098],
22	—	NN	O	—	nn	23	SENT_349	[p22l1751t3020r2148b3098],
23	istration	NN	O	istration	prep_after	12	SENT_349	[p22l10t3149r357b3227],
24	of	IN	O	of	_	0	SENT_349	[p22l386t3148r488b3227],
25	SSRIs	NNS	MISC	ssri	prep_of	23	SENT_349	[p22l502t3144r854b3232],
26	.3	NN	NUMBER	.3	nsubj	32	SENT_349	[p22l502t3144r854b3232],
27	°	CD	NUMBER	°	num	26	SENT_349	[p22l502t3144r854b3232],
28	Moreover	RB	O	moreover	advmod	32	SENT_349	[p22l882t3156r1308b3244],
29	,	,	O	,	_	0	SENT_349	[p22l882t3156r1308b3244],
30	inhibition	NN	O	inhibition	nsubj	32	SENT_349	[p22l1343t3149r1767b3227],
31	may	MD	O	may	aux	32	SENT_349	[p22l1798t3175r1975b3249],
32	last	VB	O	last	rcmod	25	SENT_349	[p22l2001t3148r2153b3227],
33	for	IN	O	for	_	0	SENT_349	[p22l10t3276r133b3355],
34	several	JJ	DURATION	several	amod	35	SENT_349	[p22l155t3276r438b3356],
35	Weeks	NNS	DURATION	week	prep_for	32	SENT_349	[p22l457t3277r716b3356],
36	after	IN	O	after	_	0	SENT_349	[p22l741t3276r934b3355],
37	the	DT	O	the	det	38	SENT_349	[p22l955t3277r1084b3355],
38	discontinuation	NN	O	discontinuation	prep_after	32	SENT_349	[p22l1108t3277r1773b3356],
39	of	IN	O	of	_	0	SENT_349	[p22l1797t3276r1897b3355],
40	ﬂuox	NN	O	ﬂuox	nn	41	SENT_349	[p22l1902t3276r2147b3356],
41	—	NN	O	—	prep_of	38	SENT_349	[p22l1902t3276r2147b3356],

1	etine	NN	O	etine	_	0	SENT_350	[p22l11t3405r237b3500],
2	,	,	O	,	_	0	SENT_350	[p22l11t3405r237b3500],
3	because	IN	O	because	_	0	SENT_350	[p22l268t3404r601b3484],
4	of	IN	O	of	prepc_because_of	1	SENT_350	[p22l627t3404r728b3483],
5	persistent	JJ	O	persistent	amod	7	SENT_350	[p22l733t3405r1158b3505],
6	inhibitory	JJ	O	inhibitory	amod	7	SENT_350	[p22l1177t3405r1599b3505],
7	metabolites	NNS	O	metabolite	pobj	1	SENT_350	[p22l1620t3404r2142b3483],
8	.	.	O	.	_	0	SENT_350	[p22l1620t3404r2142b3483],

1	In	IN	O	in	_	0	SENT_351	[p22l9t3540r97b3610],
2	the	DT	O	the	det	3	SENT_351	[p22l132t3533r261b3611],
3	case	NN	O	case	prep_in	11	SENT_351	[p22l297t3559r473b3611],
4	of	IN	O	of	_	0	SENT_351	[p22l508t3532r610b3611],
5	codeine	NN	O	codeine	prep_of	3	SENT_351	[p22l626t3532r978b3628],
6	,	,	O	,	_	0	SENT_351	[p22l626t3532r978b3628],
7	inhibition	NN	O	inhibition	nsubj	11	SENT_351	[p22l1017t3533r1441b3611],
8	of	IN	O	of	_	0	SENT_351	[p22l1475t3532r1577b3611],
9	CYPZD6	NN	O	cypzd6	prep_of	7	SENT_351	[p22l1592t3538r1939b3611],
10	may	MD	O	may	aux	11	SENT_351	[p22l1975t3559r2152b3633],
11	result	VB	O	result	_	0	SENT_351	[p22l10t3661r253b3740],
12	in	IN	O	in	_	0	SENT_351	[p22l272t3661r354b3738],
13	a	DT	O	a	det	14	SENT_351	[p22l378t3687r423b3739],
14	loss	NN	O	loss	prep_in	11	SENT_351	[p22l446t3661r610b3739],
15	of	IN	O	of	_	0	SENT_351	[p22l638t3660r739b3739],
16	analgesic	JJ	O	analgesic	amod	17	SENT_351	[p22l745t3661r1139b3761],
17	efficacy	NN	O	efficacy	prep_of	14	SENT_351	[p22l1165t3660r1497b3761],
18	.	.	O	.	_	0	SENT_351	[p22l1165t3660r1497b3761],

1	Inhibitory	JJ	O	inhibitory	amod	2	SENT_352	[p23l138t21r567b121],
2	interactions	NNS	O	interaction	nsubj	5	SENT_352	[p23l593t21r1096b99],
3	do	VBP	O	do	aux	5	SENT_352	[p23l1130t20r1233b99],
4	not	RB	O	not	neg	5	SENT_352	[p23l1266t37r1410b99],
5	occur	VB	O	occur	_	0	SENT_352	[p23l1437t46r1672b100],
6	in	IN	O	in	_	0	SENT_352	[p23l1700t21r1781b98],
7	persons	NNS	O	person	prep_in	5	SENT_352	[p23l1811t46r2145b121],
8	with	IN	O	with	_	0	SENT_352	[p23l6t149r196b228],
9	poor	JJ	O	poor	amod	10	SENT_352	[p23l225t174r428b249],
10	metabolism	NN	O	metabolism	prep_with	5	SENT_352	[p23l455t149r963b227],
11	who	WP	O	who	nsubj	12	SENT_352	[p23l989t148r1173b228],
12	lack	VBP	O	lack	rcmod	10	SENT_352	[p23l1204t148r1378b228],
13	active	JJ	O	active	amod	14	SENT_352	[p23l1404t149r1640b228],
14	enzyme	NN	O	enzyme	dobj	12	SENT_352	[p23l1671t174r2018b249],
15	,	,	O	,	_	0	SENT_352	[p23l1671t174r2018b249],
16	so	RB	O	so	advmod	5	SENT_352	[p23l2056t174r2147b227],
17	genotype	NN	O	genotype	nsubjpass	20	SENT_352	[p23l10t293r396b377],
18	should	MD	O	should	aux	20	SENT_352	[p23l427t276r716b356],
19	be	VB	O	be	auxpass	20	SENT_352	[p23l746t277r842b355],
20	considered	VBN	O	consider	ccomp	5	SENT_352	[p23l872t276r1361b355],
21	.	.	O	.	_	0	SENT_352	[p23l872t276r1361b355],

1	Coadministration	NN	O	coadministration	nsubj	13	SENT_353	[p23l1396t277r2148b355],
2	of	IN	O	of	_	0	SENT_353	[p23l11t404r112b483],
3	inhibitors	NNS	O	inhibitor	prep_of	1	SENT_353	[p23l128t404r544b483],
4	of	IN	O	of	_	0	SENT_353	[p23l582t404r683b483],
5	CYPZD6	NN	O	cypzd6	prep_of	3	SENT_353	[p23l699t410r1071b500],
6	,	,	O	,	_	0	SENT_353	[p23l699t410r1071b500],
7	such	JJ	O	such	_	0	SENT_353	[p23l1112t405r1308b484],
8	as	IN	O	as	_	0	SENT_353	[p23l1342t431r1427b483],
9	SSRIS	NNP	O	SSRIS	prep_such_as	1	SENT_353	[p23l1466t410r1730b500],
10	,	,	O	,	_	0	SENT_353	[p23l1466t410r1730b500],
11	may	MD	O	may	aux	13	SENT_353	[p23l1771t431r1948b505],
12	also	RB	O	also	advmod	13	SENT_353	[p23l1978t405r2147b483],
13	result	VB	O	result	_	0	SENT_353	[p23l10t533r253b612],
14	in	IN	O	in	_	0	SENT_353	[p23l273t533r354b610],
15	the	DT	O	the	det	16	SENT_353	[p23l381t533r511b611],
16	inhibition	NN	O	inhibition	prep_in	13	SENT_353	[p23l537t533r960b611],
17	of	IN	O	of	_	0	SENT_353	[p23l987t532r1088b611],
18	other	JJ	O	other	amod	20	SENT_353	[p23l1096t533r1321b611],
19	drug	NN	O	drug	nn	20	SENT_353	[p23l1345t532r2151b633],
20	—	NN	O	—	prep_of	16	SENT_353	[p23l1345t532r2151b633],
21	metabolizing	VBG	O	metabolize	partmod	20	SENT_353	[p23l1345t532r2151b633],
22	enzymes	NNS	O	enzyme	dobj	21	SENT_353	[p23l11t686r402b761],
23	,	,	O	,	_	0	SENT_353	[p23l11t686r402b761],
24	including	VBG	O	include	_	0	SENT_353	[p23l458t660r867b761],
25	CYPZC9	NN	O	cypzc9	prep_including	22	SENT_353	[p23l915t666r1279b756],
26	,	,	O	,	_	0	SENT_353	[p23l915t666r1279b756],
27	CYPZC19	NN	O	cypzc19	prep_including	22	SENT_353	[p23l1336t666r1753b756],
28	,	,	O	,	_	0	SENT_353	[p23l1336t666r1753b756],
29	and	CC	O	and	_	0	SENT_353	[p23l1810t661r1966b739],
30	the	DT	O	the	det	32	SENT_353	[p23l2018t661r2148b739],
31	CYP3A	NN	O	cyp3a	nn	32	SENT_353	[p23l10t794r300b867],
32	enzymes.-31	NN	O	enzymes.-31	prep_including	22	SENT_353	[p23l323t783r801b889],

1	DRUG	NN	O	drug	nn	2	SENT_354	[p23l168t1105r488b1165],
2	METABOLISM	NN	O	metabolism	_	0	SENT_354	[p23l539t1105r1284b1166],
3	BY	IN	O	by	dep	2	SENT_354	[p23l1340t1105r1462b1165],
4	CYPZC19	NN	O	cypzc19	pobj	3	SENT_354	[p23l1509t1104r1978b1169],

1	CYPZC19	NN	O	cypzc19	nsubj	3	SENT_355	[p23l10t1307r403b1380],
2	is	VBZ	O	be	cop	3	SENT_355	[p23l441t1302r507b1380],
3	important	JJ	O	important	dep	12	SENT_355	[p23l546t1302r982b1402],
4	in	IN	O	in	_	0	SENT_355	[p23l1014t1302r1096b1379],
5	the	DT	O	the	det	6	SENT_355	[p23l1134t1302r1264b1380],
6	metabolism	NN	O	metabolism	prep_in	3	SENT_355	[p23l1302t1301r1810b1380],
7	of	IN	O	of	_	0	SENT_355	[p23l1849t1301r1950b1380],
8	proton	NN	O	proton	nn	11	SENT_355	[p23l1968t1327r2147b1402, p23l11t1446r438b1530],
9	—	CD	NUMBER	—	num	11	SENT_355	[p23l1968t1327r2147b1402, p23l11t1446r438b1530],
10	pump	NN	O	pump	nn	11	SENT_355	[p23l1968t1327r2147b1402, p23l11t1446r438b1530],
11	inhibitors	NNS	O	inhibitor	prep_of	6	SENT_355	[p23l489t1429r905b1508],
12	(	VBP	O	(	_	0	SENT_355	[p23l962t1430r1518b1530],
13	omeprazole	NN	O	omeprazole	nsubj	12	SENT_355	[p23l962t1430r1518b1530],
14	,	,	O	,	_	0	SENT_355	[p23l962t1430r1518b1530],
15	lansoprazole	NN	O	lansoprazole	nsubj	12	SENT_355	[p23l1572t1430r2142b1530],
16	,	,	O	,	_	0	SENT_355	[p23l1572t1430r2142b1530],
17	rabeprazole	NN	O	rabeprazole	nsubj	12	SENT_355	[p23l10t1558r534b1658],
18	,	,	O	,	_	0	SENT_355	[p23l10t1558r534b1658],
19	and	CC	O	and	_	0	SENT_355	[p23l564t1558r721b1636],
20	pantoprazole	NN	O	pantoprazole	nn	21	SENT_355	[p23l744t1558r1365b1658],
21	)	NN	O	)	nsubj	12	SENT_355	[p23l744t1558r1365b1658],
22	,	,	O	,	_	0	SENT_355	[p23l744t1558r1365b1658],
23	ﬂuoxetine	NN	O	ﬂuoxetine	conj_and	13	SENT_355	[p23l1396t1557r1844b1653],
24	,	,	O	,	_	0	SENT_355	[p23l1396t1557r1844b1653],
25	sertra	NN	O	sertra	nn	27	SENT_355	[p23l1876t1574r2147b1636],
26	—	CD	NUMBER	—	num	27	SENT_355	[p23l1876t1574r2147b1636],
27	line	NN	O	line	conj_and	13	SENT_355	[p23l10t1686r187b1781],
28	,	,	O	,	_	0	SENT_355	[p23l10t1686r187b1781],
29	and	CC	O	and	_	0	SENT_355	[p23l215t1686r371b1764],
30	nelﬁnavir	NN	O	nelﬁnavir	conj_and	13	SENT_355	[p23l394t1685r810b1765],
31	.	.	O	.	_	0	SENT_355	[p23l394t1685r810b1765],

1	Several	JJ	O	several	amod	4	SENT_356	[p23l841t1686r1132b1765],
2	inactive	JJ	O	inactive	amod	4	SENT_356	[p23l1154t1686r1473b1765],
3	genetic	JJ	O	genetic	amod	4	SENT_356	[p23l1496t1686r1799b1786],
4	variants	NNS	O	variant	nsubj	5	SENT_356	[p23l1817t1686r2146b1765],
5	exist	VBP	O	exist	_	0	SENT_356	[p23l11t1814r223b1909],
6	,	,	O	,	_	0	SENT_356	[p23l11t1814r223b1909],
7	though	IN	O	though	advmod	5	SENT_356	[p23l251t1814r554b1914],
8	two	CD	NUMBER	two	number	9	SENT_356	[p23l577t1830r728b1893],
9	(	CD	NUMBER	(	num	11	SENT_356	[p23l756t1814r1278b1905],
10	CYP2C19	NN	O	cyp2c19	nn	11	SENT_356	[p23l756t1814r1278b1905],
11	*	NN	O	*	pobj	7	SENT_356	[p23l756t1814r1278b1905],
12	2	CD	NUMBER	2	npadvmod	5	SENT_356	[p23l756t1814r1278b1905],
13	and	CC	O	and	_	0	SENT_356	[p23l1300t1814r1456b1892],
14	CYP2C19	NN	O	cyp2c19	npadvmod	5	SENT_356	[p23l1478t1814r2000b1905],
15	*	CD	NUMBER	*	number	16	SENT_356	[p23l1478t1814r2000b1905],
16	3	CD	NUMBER	3	num	18	SENT_356	[p23l1478t1814r2000b1905],
17	)	NN	O	)	nn	18	SENT_356	[p23l1478t1814r2000b1905],
18	account	NN	O	account	dep	14	SENT_356	[p23l2027t1840r2147b1892, p23l11t1958r259b2021],
19	for	IN	O	for	_	0	SENT_356	[p23l291t1941r417b2020],
20	more	JJR	O	more	mwe	21	SENT_356	[p23l451t1967r675b2020],
21	than	IN	O	than	quantmod	22	SENT_356	[p23l712t1942r905b2020],
22	95	CD	PERCENT	95	num	23	SENT_356	[p23l942t1947r1041b2020],
23	percent	NN	PERCENT	percent	prep_for	5	SENT_356	[p23l1079t1958r1409b2042],
24	of	IN	O	of	_	0	SENT_356	[p23l1441t1941r1543b2020],
25	cases	NNS	O	case	prep_of	5	SENT_356	[p23l1562t1968r1785b2020],
26	of	IN	O	of	_	0	SENT_356	[p23l1824t1941r1927b2020],
27	poor	JJ	O	poor	amod	28	SENT_356	[p23l1944t1967r2149b2042],
28	metabolism	NN	O	metabolism	prep_of	25	SENT_356	[p23l10t2070r528b2148],
29	of	IN	O	of	_	0	SENT_356	[p23l563t2069r664b2148],
30	the	DT	O	the	det	32	SENT_356	[p23l680t2070r812b2148],
31	relevant	JJ	O	relevant	amod	32	SENT_356	[p23l846t2069r1191b2149],
32	medications	NNS	O	medication	prep_of	28	SENT_356	[p23l1219t2070r1775b2148],
33	.	.	O	.	_	0	SENT_356	[p23l1219t2070r1775b2148],

1	Population	NNP	O	Population	nn	2	SENT_357	[p23l1813t2070r2145b2170, p23l11t2198r180b2276],
2	heterogeneities	NNS	O	heterogeneity	nsubj	8	SENT_357	[p23l208t2197r872b2298],
3	in	IN	O	in	_	0	SENT_357	[p23l901t2198r984b2275],
4	alleles	NNS	O	allele	prep_in	2	SENT_357	[p23l1010t2197r1278b2276],
5	and	CC	O	and	_	0	SENT_357	[p23l1307t2197r1465b2276],
6	phenotypes	NNS	O	phenotype	prep_in	2	SENT_357	[p23l1491t2197r1989b2298],
7	are	VBP	O	be	cop	8	SENT_357	[p23l2018t2224r2147b2276],
8	present	JJ	DATE	present	_	0	SENT_357	[p23l9t2342r348b2426],
9	.	.	O	.	_	0	SENT_357	[p23l9t2342r348b2426],

1	Two	CD	NUMBER	two	nsubj	12	SENT_358	[p23l381t2331r559b2405],
2	to	TO	O	to	_	0	SENT_358	[p23l592t2342r671b2404],
3	three	CD	PERCENT	three	num	4	SENT_358	[p23l703t2326r917b2404],
4	percent	NN	PERCENT	percent	prep_to	1	SENT_358	[p23l946t2342r1269b2426],
5	of	IN	O	of	_	0	SENT_358	[p23l1295t2325r1395b2404],
6	whites	NNS	O	whites	prep_of	4	SENT_358	[p23l1403t2326r1681b2405],
7	and	CC	O	and	_	0	SENT_358	[p23l1713t2325r1869b2404],
8	4	CD	PERCENT	4	num	9	SENT_358	[p23l1897t2331r1948b2404],
9	percent	NN	PERCENT	percent	conj_and	4	SENT_358	[p23l1976t2352r2147b2426, p23l11t2470r194b2532],
10	of	IN	O	of	_	0	SENT_358	[p23l219t2453r320b2532],
11	blacks	NNS	O	black	prep_of	9	SENT_358	[p23l331t2453r602b2533],
12	have	VBP	O	have	_	0	SENT_358	[p23l633t2454r825b2533],
13	poor	JJ	O	poor	amod	14	SENT_358	[p23l852t2479r1059b2554],
14	metabolism	NN	O	metabolism	dobj	12	SENT_358	[p23l1084t2454r1627b2549],
15	,	,	O	,	_	0	SENT_358	[p23l1084t2454r1627b2549],
16	whereas	IN	O	whereas	mark	24	SENT_358	[p23l1657t2454r2013b2533],
17	10	CD	NUMBER	10	number	19	SENT_358	[p23l2048t2459r2145b2532],
18	to	TO	O	to	dep	19	SENT_358	[p23l11t2598r92b2660],
19	25	CD	PERCENT	25	num	20	SENT_358	[p23l127t2587r226b2660],
20	percent	NN	PERCENT	percent	nsubj	24	SENT_358	[p23l263t2598r592b2682],
21	of	IN	O	of	_	0	SENT_358	[p23l621t2581r724b2660],
22	Southeast	NNP	MISC	Southeast	nn	23	SENT_358	[p23l742t2582r1169b2661],
23	Asians	NNPS	MISC	Asians	prep_of	20	SENT_358	[p23l1194t2582r1481b2660],
24	have	VBP	O	have	advcl	12	SENT_358	[p23l1518t2582r1710b2661],
25	poor	JJ	O	poor	amod	26	SENT_358	[p23l1744t2607r1949b2682],
26	metabolism	NN	O	metabolism	dobj	24	SENT_358	[p23l1981t2608r2145b2660, p23l11t2706r506b2789],
27	.32	CD	NUMBER	.32	tmod	24	SENT_358	[p23l1981t2608r2145b2660, p23l11t2706r506b2789],

1	Marked	JJ	O	marked	amod	2	SENT_359	[p23l137t2839r469b2918],
2	differences	NNS	O	difference	nsubj	12	SENT_359	[p23l494t2838r971b2917],
3	in	IN	O	in	_	0	SENT_359	[p23l996t2839r1079b2916],
4	the	DT	O	the	det	6	SENT_359	[p23l1104t2838r1236b2917],
5	plasma	NN	O	plasma	nn	6	SENT_359	[p23l1260t2838r1573b2939],
6	levels	NNS	O	level	prep_in	2	SENT_359	[p23l1595t2839r1830b2918],
7	of	IN	O	of	_	0	SENT_359	[p23l1857t2838r1960b2917],
8	proton	NN	O	proton	nn	11	SENT_359	[p23l1963t2864r2145b2939, p23l11t2983r446b3067],
9	—	CD	NUMBER	—	num	11	SENT_359	[p23l1963t2864r2145b2939, p23l11t2983r446b3067],
10	pump	NN	O	pump	nn	11	SENT_359	[p23l1963t2864r2145b2939, p23l11t2983r446b3067],
11	inhibitors	NNS	O	inhibitor	prep_of	6	SENT_359	[p23l506t2967r932b3045],
12	occur	VBP	O	occur	dep	23	SENT_359	[p23l995t2992r1234b3046],
13	between	IN	O	between	_	0	SENT_359	[p23l1291t2966r1649b3046],
14	genotypes	NNS	O	genotype	prep_between	12	SENT_359	[p23l1709t2983r2144b3067],
15	and	CC	O	and	_	0	SENT_359	[p23l10t3095r168b3173],
16	phenotypes	NNS	O	phenotype	prep_between	12	SENT_359	[p23l192t3095r690b3195],
17	and	CC	O	and	_	0	SENT_359	[p23l716t3094r875b3173],
18	are	VBP	O	be	auxpass	19	SENT_359	[p23l899t3121r1028b3173],
19	reﬂected	VBN	O	reﬂected	conj_and	12	SENT_359	[p23l1053t3094r1426b3173],
20	in	IN	O	in	_	0	SENT_359	[p23l1451t3095r1534b3172],
21	drug	NN	O	drug	nn	22	SENT_359	[p23l1559t3094r2147b3195],
22	—	NN	O	—	prep_in	19	SENT_359	[p23l1559t3094r2147b3195],
23	induced	VBD	O	induce	_	0	SENT_359	[p23l1559t3094r2147b3195],
24	changes	NNS	O	change	dobj	23	SENT_359	[p23l11t3224r363b3324],
25	in	IN	O	in	_	0	SENT_359	[p23l399t3224r481b3301],
26	gastric	JJ	O	gastric	amod	27	SENT_359	[p23l514t3224r798b3324],
27	pH.	NN	O	ph.	prep_in	24	SENT_359	[p23l829t3219r1069b3324],
28	33	CD	NUMBER	33	num	27	SENT_359	[p23l829t3219r1069b3324],
29	Accordingly	RB	O	accordingly	advmod	27	SENT_359	[p23l1100t3224r1630b3324],
30	,	,	O	,	_	0	SENT_359	[p23l1100t3224r1630b3324],
31	the	DT	O	the	det	33	SENT_359	[p23l1669t3224r1799b3302],
32	healing	NN	O	healing	nn	33	SENT_359	[p23l1832t3224r2151b3324],
33	rate	NN	O	rate	nsubj	40	SENT_359	[p23l10t3368r167b3430],
34	for	IN	O	for	_	0	SENT_359	[p23l202t3351r325b3430],
35	both	DT	O	both	det	39	SENT_359	[p23l356t3352r550b3430],
36	gastric	JJ	O	gastric	amod	39	SENT_359	[p23l583t3352r867b3452],
37	and	CC	O	and	_	0	SENT_359	[p23l899t3352r1056b3430],
38	duodenal	JJ	O	duodenal	conj_and	36	SENT_359	[p23l1090t3351r1486b3431],
39	ulcers	NNS	O	ulcer	prep_for	33	SENT_359	[p23l1518t3352r1768b3431],
40	shows	VBZ	O	show	dep	24	SENT_359	[p23l1805t3352r2070b3431],
41	a	DT	O	a	det	44	SENT_359	[p23l2105t3378r2149b3430],
42	CYPZCI9	NN	O	cypzci9	nn	44	SENT_359	[p23l10t3487r362b3559],
43	gene	NN	O	gene	nn	44	SENT_359	[p23l390t3506r590b3581],
44	dose	NN	O	dose	dobj	40	SENT_359	[p23l619t3481r814b3559],
45	effect	NN	O	effect	tmod	40	SENT_359	[p23l842t3476r1184b3559],
46	.34	CD	NUMBER	.34	num	45	SENT_359	[p23l842t3476r1184b3559],
47	Furthermore	RB	O	furthermore	advmod	45	SENT_359	[p23l1210t3480r1775b3576],
48	,	,	O	,	_	0	SENT_359	[p23l1210t3480r1775b3576],
49	the	DT	O	the	det	51	SENT_359	[p23l1810t3480r1940b3559],
50	cure	NN	O	cure	nn	51	SENT_359	[p23l1969t3507r2147b3560],
51	rate	NN	O	rate	dep	24	SENT_359	[p23l10t3625r167b3687],
52	for	IN	O	for	_	0	SENT_359	[p23l200t3608r324b3687],
53	Helicobacter	NNP	PERSON	Helicobacter	nn	55	SENT_359	[p23l351t3608r802b3687],
54	pylori	NN	O	pylorus	nn	55	SENT_359	[p23l824t3608r1047b3709],
55	infection	NN	O	infection	prep_for	51	SENT_359	[p23l1078t3608r1456b3687],
56	when	WRB	O	when	dep	55	SENT_359	[p23l1483t3608r1718b3688],
57	a	DT	O	a	det	58	SENT_359	[p23l1750t3635r1795b3687],
58	protonpump	NN	O	protonpump	nsubj	23	SENT_359	[p23l1823t3625r2146b3709, p24l9t47r259b121],

1	inhibitor	NN	O	inhibitor	nsubjpass	5	SENT_360	[p24l294t20r672b99],
2	and	CC	O	and	_	0	SENT_360	[p24l702t21r859b99],
3	amoxicillin	NNP	O	amoxicillin	nsubjpass	5	SENT_360	[p24l891t20r1368b99],
4	are	VBP	O	be	auxpass	5	SENT_360	[p24l1401t47r1527b99],
5	used	VBN	O	use	dep	6	SENT_360	[p24l1561t20r1757b100],
6	depends	VBZ	O	depend	_	0	SENT_360	[p24l1792t20r2145b121],
7	on	IN	O	on	_	0	SENT_360	[p24l11t175r118b228],
8	the	DT	O	the	det	10	SENT_360	[p24l138t150r266b228],
9	CYPZCI9	NN	O	cypzci9	nn	10	SENT_360	[p24l286t156r633b228],
10	genotype	NN	O	genotype	prep_on	6	SENT_360	[p24l654t145r1241b250],
11	.34	CD	NUMBER	.34	num	12	SENT_360	[p24l654t145r1241b250],
12	>	JJR	O	>	dobj	6	SENT_360	[p24l654t145r1241b250],
13	35	CD	NUMBER	35	nsubj	24	SENT_360	[p24l654t145r1241b250],
14	For	IN	O	for	_	0	SENT_360	[p24l1264t157r1407b228],
15	example	NN	O	example	prep_for	13	SENT_360	[p24l1425t150r1796b250],
16	,	,	O	,	_	0	SENT_360	[p24l1425t150r1796b250],
17	the	DT	O	the	det	19	SENT_360	[p24l1823t150r1951b228],
18	cure	NN	O	cure	nn	19	SENT_360	[p24l1972t176r2148b229],
19	rate	NN	O	rate	appos	15	SENT_360	[p24l10t295r168b357],
20	with	IN	O	with	_	0	SENT_360	[p24l207t279r398b358],
21	omeprazole	NN	O	omeprazole	prep_with	19	SENT_360	[p24l442t279r944b379],
22	is	VBZ	O	be	cop	24	SENT_360	[p24l987t279r1053b357],
23	28.6	CD	PERCENT	28.6	num	24	SENT_360	[p24l1099t284r1282b357],
24	percent	NN	PERCENT	percent	rcmod	12	SENT_360	[p24l1326t295r1648b379],
25	in	IN	O	in	_	0	SENT_360	[p24l1687t279r1769b356],
26	persons	NNS	O	person	prep_in	24	SENT_360	[p24l1811t304r2145b379],
27	homozygous	JJ	O	homozygous	amod	26	SENT_360	[p24l10t407r558b507],
28	for	IN	O	for	_	0	SENT_360	[p24l585t406r709b485],
29	extensive	JJ	O	extensive	amod	30	SENT_360	[p24l732t407r1116b486],
30	metabolism	NN	O	metabolism	prep_for	27	SENT_360	[p24l1142t407r1674b502],
31	,	,	O	,	_	0	SENT_360	[p24l1142t407r1674b502],
32	60	CD	PERCENT	60	num	33	SENT_360	[p24l1705t412r1805b485],
33	percent	NN	PERCENT	percent	appos	30	SENT_360	[p24l1831t423r2153b507],
34	in	IN	O	in	_	0	SENT_360	[p24l10t535r92b612],
35	those	DT	O	those	det	39	SENT_360	[p24l134t535r363b613],
36	heterozygous	JJ	O	heterozygous	amod	39	SENT_360	[p24l406t535r973b635],
37	for	IN	O	for	_	0	SENT_360	[p24l1018t534r1142b613],
38	extensive	JJ	O	extensive	prep_for	36	SENT_360	[p24l1182t535r1567b614],
39	metabolism	NN	O	metabolism	prep_in	33	SENT_360	[p24l1610t534r2142b630],
40	,	,	O	,	_	0	SENT_360	[p24l1610t534r2142b630],
41	and	CC	O	and	_	0	SENT_360	[p24l10t662r166b741],
42	100	CD	PERCENT	100	num	43	SENT_360	[p24l190t668r341b741],
43	percent	NN	PERCENT	percent	prep_in	33	SENT_360	[p24l362t679r684b763],
44	in	IN	O	in	_	0	SENT_360	[p24l699t663r781b740],
45	those	DT	O	those	det	52	SENT_360	[p24l803t663r1031b741],
46	homozygous	JJ	O	homozygous	amod	52	SENT_360	[p24l1052t663r1600b763],
47	for	IN	O	for	_	0	SENT_360	[p24l1623t662r1747b741],
48	poor	JJ	O	poor	amod	50	SENT_360	[p24l1763t688r1966b763],
49	metabolism	NN	O	metabolism	nn	50	SENT_360	[p24l1984t689r2147b741, p24l11t791r381b869],
50	(	NN	O	(	prep_for	46	SENT_360	[p24l411t791r717b882],
51	overall	JJ	O	overall	amod	52	SENT_360	[p24l411t791r717b882],
52	rate	NN	O	rate	prep_in	43	SENT_360	[p24l741t807r920b886],
53	,	,	O	,	_	0	SENT_360	[p24l741t807r920b886],
54	51.6	CD	PERCENT	51.6	num	56	SENT_360	[p24l952t796r1132b869],
55	percent	NN	PERCENT	percent	nn	56	SENT_360	[p24l1156t798r1527b891],
56	)	NN	O	)	nsubj	6	SENT_360	[p24l1156t798r1527b891],
57	.	.	O	.	_	0	SENT_360	[p24l1156t798r1527b891],

1	The	DT	O	the	det	2	SENT_361	[p24l1554t791r1716b869],
2	differences	NNS	O	difference	nsubj	6	SENT_361	[p24l1741t790r2147b869, p24l11t945r93b997],
3	in	IN	O	in	_	0	SENT_361	[p24l116t919r198b996],
4	efﬁcacy	NN	O	efﬁcacy	prep_in	2	SENT_361	[p24l221t918r538b1019],
5	are	VBP	O	be	cop	6	SENT_361	[p24l555t945r681b997],
6	smaller	JJR	O	smaller	_	0	SENT_361	[p24l705t919r1017b997],
7	when	WRB	O	when	advmod	11	SENT_361	[p24l1033t918r1266b998],
8	triple	JJ	O	triple	amod	9	SENT_361	[p24l1289t919r1508b1019],
9	therapy	NN	O	therapy	nsubjpass	11	SENT_361	[p24l1531t918r1847b1019],
10	is	VBZ	O	be	auxpass	11	SENT_361	[p24l1865t919r1929b997],
11	used	VBN	O	use	ccomp	6	SENT_361	[p24l1954t918r2148b998],
12	(	IN	O	(	_	0	SENT_361	[p24l15t1054r89b1138],
13	a	DT	O	a	det	17	SENT_361	[p24l15t1054r89b1138],
14	proton	NN	O	proton	nn	17	SENT_361	[p24l110t1063r688b1147],
15	—	CD	NUMBER	—	num	17	SENT_361	[p24l110t1063r688b1147],
16	pump	NN	O	pump	nn	17	SENT_361	[p24l110t1063r688b1147],
17	inhibitor	NN	O	inhibitor	prep_(	11	SENT_361	[p24l712t1046r1106b1142],
18	,	,	O	,	_	0	SENT_361	[p24l712t1046r1106b1142],
19	amoxicillin	NNP	O	amoxicillin	prep_(	11	SENT_361	[p24l1135t1047r1634b1142],
20	,	,	O	,	_	0	SENT_361	[p24l1135t1047r1634b1142],
21	and	CC	O	and	_	0	SENT_361	[p24l1662t1047r1820b1125],
22	clarith	NN	O	clarith	nn	24	SENT_361	[p24l1844t1046r2147b1125],
23	—	NN	O	—	nn	24	SENT_361	[p24l1844t1046r2147b1125],
24	romycin	NN	O	romycin	prep_(	11	SENT_361	[p24l10t1175r359b1275],
25	or	CC	O	or	_	0	SENT_361	[p24l393t1200r482b1253],
26	metronidazole	NN	O	metronidazole	nn	27	SENT_361	[p24l511t1175r1190b1270],
27	)	NN	O	)	conj_and	17	SENT_361	[p24l511t1175r1190b1270],
28	;	:	O	;	_	0	SENT_361	[p24l511t1175r1190b1270],
29	nevertheless	RB	O	nevertheless	advmod	40	SENT_361	[p24l1226t1174r1773b1270],
30	,	,	O	,	_	0	SENT_361	[p24l1226t1174r1773b1270],
31	patients	NNS	O	patient	nsubj	40	SENT_361	[p24l1809t1175r2145b1275],
32	not	RB	O	not	neg	33	SENT_361	[p24l10t1319r154b1381],
33	cured	VBN	O	cure	partmod	31	SENT_361	[p24l178t1303r412b1382],
34	by	IN	O	by	_	0	SENT_361	[p24l441t1303r538b1403],
35	this	DT	O	this	det	37	SENT_361	[p24l562t1303r715b1381],
36	standard	JJ	O	standard	amod	37	SENT_361	[p24l747t1302r1120b1381],
37	regimen	NN	O	regimen	agent	33	SENT_361	[p24l1147t1303r1500b1403],
38	are	VBP	O	be	cop	40	SENT_361	[p24l1527t1329r1654b1381],
39	usually	RB	O	usually	advmod	40	SENT_361	[p24l1682t1303r1982b1403],
40	homozygous	JJ	O	homozygous	parataxis	6	SENT_361	[p24l2005t1303r2147b1381, p24l10t1456r445b1531],
41	for	IN	O	for	_	0	SENT_361	[p24l480t1430r604b1509],
42	extensive	JJ	O	extensive	amod	43	SENT_361	[p24l634t1431r1019b1510],
43	metabolism	NN	O	metabolism	prep_for	40	SENT_361	[p24l1052t1430r1583b1526],
44	,	,	O	,	_	0	SENT_361	[p24l1052t1430r1583b1526],
45	and	CC	O	and	_	0	SENT_361	[p24l1622t1431r1778b1509],
46	eradication	NN	O	eradication	nsubjpass	52	SENT_361	[p24l1811t1430r2146b1509, p24l11t1559r178b1637],
47	can	MD	O	can	aux	52	SENT_361	[p24l200t1584r368b1654],
48	,	,	O	,	_	0	SENT_361	[p24l200t1584r368b1654],
49	generally	RB	O	generally	advmod	52	SENT_361	[p24l395t1559r795b1659],
50	,	,	O	,	_	0	SENT_361	[p24l395t1559r795b1659],
51	be	VB	O	be	auxpass	52	SENT_361	[p24l824t1558r920b1637],
52	achieved	VBN	O	achieve	parataxis	6	SENT_361	[p24l941t1558r1307b1638],
53	by	IN	O	by	_	0	SENT_361	[p24l1329t1558r1426b1659],
54	retreatment	NN	O	retreatment	agent	52	SENT_361	[p24l1444t1575r1945b1637],
55	with	IN	O	with	_	0	SENT_361	[p24l1957t1559r2148b1638],
56	a	DT	O	a	det	60	SENT_361	[p24l10t1714r54b1766],
57	higher	JJR	O	higher	amod	60	SENT_361	[p24l106t1687r628b1788],
58	—	NN	O	—	nn	60	SENT_361	[p24l106t1687r628b1788],
59	dose	NN	O	dose	nn	60	SENT_361	[p24l106t1687r628b1788],
60	regimen	NN	O	regimen	prep_with	54	SENT_361	[p24l681t1680r1155b1788],
61	.36	CD	NUMBER	.36	tmod	52	SENT_361	[p24l681t1680r1155b1788],
62	The	DT	O	the	det	63	SENT_361	[p24l1204t1687r1369b1766],
63	relevance	NN	O	relevance	nsubj	85	SENT_361	[p24l1422t1687r1823b1767],
64	of	IN	O	of	_	0	SENT_361	[p24l1877t1686r1979b1766],
65	the	DT	O	the	det	67	SENT_361	[p24l2014t1687r2146b1766],
66	CYPZCI9	NN	O	cypzci9	nn	67	SENT_361	[p24l10t1822r359b1894],
67	genotype	NN	O	genotype	prep_of	63	SENT_361	[p24l380t1832r762b1916],
68	in	IN	O	in	_	0	SENT_361	[p24l782t1816r864b1893],
69	the	DT	O	the	det	70	SENT_361	[p24l885t1816r1014b1894],
70	use	NN	O	use	prep_in	67	SENT_361	[p24l1035t1842r1174b1895],
71	of	IN	O	of	_	0	SENT_361	[p24l1197t1815r1297b1894],
72	proton	NN	O	proton	nn	75	SENT_361	[p24l1299t1832r1871b1916],
73	—	CD	NUMBER	—	num	75	SENT_361	[p24l1299t1832r1871b1916],
74	pump	NN	O	pump	nn	75	SENT_361	[p24l1299t1832r1871b1916],
75	inhibitors	NNS	O	inhibitor	prep_of	70	SENT_361	[p24l1893t1816r2147b1894, p24l10t1944r198b2022],
76	for	IN	O	for	_	0	SENT_361	[p24l235t1943r359b2022],
77	the	DT	O	the	det	78	SENT_361	[p24l391t1943r520b2022],
78	treatment	NN	O	treatment	prep_for	70	SENT_361	[p24l556t1960r973b2022],
79	of	IN	O	of	_	0	SENT_361	[p24l1004t1943r1106b2022],
80	gastroesophageal	NN	O	gastroesophageal	nn	82	SENT_361	[p24l1122t1943r1870b2044],
81	reﬂux	NN	O	reﬂux	nn	82	SENT_361	[p24l1905t1943r2151b2023],
82	disease	NN	O	disease	prep_of	78	SENT_361	[p24l11t2072r316b2151],
83	is	VBZ	O	be	cop	85	SENT_361	[p24l341t2073r406b2151],
84	less	RBR	O	less	advmod	85	SENT_361	[p24l433t2073r588b2151],
85	clear	JJ	O	clear	rcmod	61	SENT_361	[p24l616t2073r834b2151],
86	.	.	O	.	_	0	SENT_361	[p24l616t2073r834b2151],

1	2218	CD	DATE	2218	num	3	SENT_362	[p24l149t2230r225b2251],
2	N	NN	O	n	nn	3	SENT_362	[p24l912t2232r925b2247],
3	ENGL	NN	ORGANIZATION	engl	_	0	SENT_362	[p24l941t2231r1025b2253],
4	)	CD	NUMBER	)	num	5	SENT_362	[p24l941t2231r1025b2253],
5	MED	NN	O	med	dep	3	SENT_362	[p24l1040t2232r1092b2247],
6	352	CD	NUMBER	352	num	8	SENT_362	[p24l1104t2231r1180b2253],
7	;	:	O	;	_	0	SENT_362	[p24l1104t2231r1180b2253],
8	21	CD	NUMBER	21	dep	5	SENT_362	[p24l1104t2231r1180b2253],
9	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	10	SENT_362	[p24l1218t2231r1430b2253],
10	MAY	NNP	DATE	MAY	dep	3	SENT_362	[p24l1469t2231r1520b2247],
11	26	CD	DATE	26	num	10	SENT_362	[p24l1532t2226r1571b2251],
12	,	,	DATE	,	_	0	SENT_362	[p24l1532t2226r1571b2251],
13	2005	CD	DATE	2005	num	10	SENT_362	[p24l1584t2231r1647b2253],

1	The	DT	O	the	det	4	SENT_363	[p24l936t2264r987b2288],
2	New	NNP	O	New	nn	4	SENT_363	[p24l996t2265r1058b2288],
3	England	NNP	O	England	nn	4	SENT_363	[p24l1067t2264r1178b2295],
4	Journal	NNP	O	Journal	_	0	SENT_363	[p24l1187t2264r1284b2288],
5	of	IN	O	of	_	0	SENT_363	[p24l1294t2264r1323b2288],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_363	[p24l1330t2264r1455b2288],

1	Downloaded	VBN	O	download	_	0	SENT_364	[p24l378t2305r548b2328],
2	from	IN	O	from	_	0	SENT_364	[p24l557t2305r621b2328],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_364	[p24l630t2305r748b2335],
4	at	IN	O	at	_	0	SENT_364	[p24l759t2309r782b2328],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_364	[p24l790t2305r973b2328],
6	on	IN	O	on	_	0	SENT_364	[p24l982t2312r1015b2328],
7	January	NNP	DATE	January	prep_on	1	SENT_364	[p24l1023t2305r1126b2335],
8	5	CD	DATE	5	num	7	SENT_364	[p24l1136t2305r1159b2332],
9	,	,	DATE	,	_	0	SENT_364	[p24l1136t2305r1159b2332],
10	2014	CD	DATE	2014	num	7	SENT_364	[p24l1170t2305r1242b2328],
11	.	.	O	.	_	0	SENT_364	[p24l1170t2305r1242b2328],

1	For	IN	O	for	_	0	SENT_365	[p24l1252t2305r1299b2328],
2	personal	JJ	O	personal	amod	3	SENT_365	[p24l1307t2305r1419b2335],
3	use	NN	O	use	pobj	1	SENT_365	[p24l1428t2312r1472b2328],
4	only	RB	O	only	advmod	3	SENT_365	[p24l1482t2305r1546b2335],
5	.	.	O	.	_	0	SENT_365	[p24l1482t2305r1546b2335],

1	No	DT	O	no	det	3	SENT_366	[p24l1557t2305r1597b2328],
2	other	JJ	O	other	amod	3	SENT_366	[p24l1607t2305r1675b2328],
3	uses	NNS	O	use	_	0	SENT_366	[p24l1683t2312r1739b2328],
4	without	IN	O	without	_	0	SENT_366	[p24l1749t2305r1850b2328],
5	permission	NN	O	permission	prep_without	3	SENT_366	[p24l1859t2305r2011b2335],
6	.	.	O	.	_	0	SENT_366	[p24l1859t2305r2011b2335],

1	Copyright	NN	O	copyright	_	0	SENT_367	[p24l728t2346r863b2377],
2	©	CD	NUMBER	©	num	6	SENT_367	[p24l872t2346r896b2370],
3	2005	CD	DATE	2005	num	6	SENT_367	[p24l906t2346r970b2370],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_367	[p24l980t2346r1171b2370],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_367	[p24l1181t2346r1289b2370],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_367	[p24l1300t2346r1405b2377],
7	.	.	O	.	_	0	SENT_367	[p24l1300t2346r1405b2377],

1	All	DT	O	all	det	2	SENT_368	[p24l1416t2346r1457b2370],
2	rights	NNS	O	rights	nsubj	3	SENT_368	[p24l1466t2346r1541b2377],
3	reserved	VBN	O	reserve	_	0	SENT_368	[p24l1551t2346r1670b2370],
4	.	.	O	.	_	0	SENT_368	[p24l1551t2346r1670b2370],

1	DRUG	NN	O	drug	nn	2	SENT_369	[p24l950t2452r1045b2471],
2	THERAPY	NN	O	therapy	_	0	SENT_369	[p24l1057t2452r1210b2471],

1	DRUG	NN	O	drug	nn	2	SENT_370	[p24l202t2730r520b2789],
2	METABOLISM	NN	O	metabolism	_	0	SENT_370	[p24l570t2730r1311b2790],
3	BY	IN	O	by	dep	2	SENT_370	[p24l1367t2730r1488b2788],
4	CYP2C9	NN	O	cyp2c9	pobj	3	SENT_370	[p24l1535t2729r1932b2792],

1	Rarely	RB	O	rarely	dep	127	SENT_371	[p24l9t2908r288b3008],
2	,	,	O	,	_	0	SENT_371	[p24l9t2908r288b3008],
3	patients	NNS	O	patient	dep	127	SENT_371	[p24l318t2908r654b3008],
4	requiring	VBG	O	require	dep	127	SENT_371	[p24l682t2908r1078b3008],
5	unusually	RB	O	unusually	dep	127	SENT_371	[p24l1101t2908r1512b3008],
6	small	JJ	O	small	dep	127	SENT_371	[p24l1535t2907r1763b2986],
7	doses	NNS	O	dose	dep	127	SENT_371	[p24l1789t2908r2024b2986],
8	of	IN	O	of	dep	127	SENT_371	[p24l2053t2907r2153b2986],
9	phenytoin	NN	O	phenytoin	dep	127	SENT_371	[p24l9t3036r437b3135],
10	to	TO	O	to	dep	127	SENT_371	[p24l473t3051r552b3113],
11	achieve	VB	O	achieve	dep	127	SENT_371	[p24l589t3036r897b3114],
12	therapeutic	JJ	O	therapeutic	dep	127	SENT_371	[p24l934t3036r1410b3135],
13	levels	NNS	O	level	dep	127	SENT_371	[p24l1444t3036r1672b3114],
14	have	VBP	O	have	dep	127	SENT_371	[p24l1710t3036r1899b3114],
15	been	VBN	O	be	dep	127	SENT_371	[p24l1936t3036r2135b3113],
16	reported	VBN	O	report	dep	127	SENT_371	[p24l11t3163r393b3264],
17	,	,	O	,	_	0	SENT_371	[p24l11t3163r393b3264],
18	and	CC	O	and	dep	127	SENT_371	[p24l428t3164r584b3242],
19	this	DT	O	this	dep	127	SENT_371	[p24l615t3164r767b3242],
20	is	VBZ	O	be	dep	127	SENT_371	[p24l799t3164r864b3242],
21	now	RB	DATE	now	dep	127	SENT_371	[p24l896t3189r1081b3243],
22	known	VBN	O	know	dep	127	SENT_371	[p24l1107t3164r1399b3243],
23	to	TO	O	to	dep	127	SENT_371	[p24l1430t3180r1508b3242],
24	reﬂect	VB	O	reﬂect	dep	127	SENT_371	[p24l1540t3163r1807b3242],
25	genetic	JJ	O	genetic	dep	127	SENT_371	[p24l1832t3164r2136b3264],
26	polymorphism	NN	O	polymorphism	dep	127	SENT_371	[p24l9t3293r638b3393],
27	in	IN	O	in	dep	127	SENT_371	[p24l670t3293r752b3370],
28	CYP2C9	NN	O	cyp2c9	dep	127	SENT_371	[p24l785t3288r1233b3371],
29	.37	CD	NUMBER	.37	dep	127	SENT_371	[p24l785t3288r1233b3371],
30	Two	CD	NUMBER	two	dep	127	SENT_371	[p24l1264t3298r1441b3372],
31	common	JJ	O	common	dep	127	SENT_371	[p24l1477t3318r1857b3371],
32	allelic	JJ	O	allelic	dep	127	SENT_371	[p24l1890t3292r2135b3371],
33	variants	NNS	O	variant	dep	127	SENT_371	[p24l6t3421r338b3500],
34	of	IN	O	of	dep	127	SENT_371	[p24l368t3420r468b3499],
35	the	DT	O	the	dep	127	SENT_371	[p24l478t3421r607b3499],
36	enzyme	NN	O	enzyme	dep	127	SENT_371	[p24l636t3446r957b3521],
37	have	VBP	O	have	dep	127	SENT_371	[p24l985t3421r1173b3500],
38	markedly	RB	O	markedly	dep	127	SENT_371	[p24l1201t3421r1597b3521],
39	reduced	VBN	O	reduce	dep	127	SENT_371	[p24l1620t3420r1956b3500],
40	catalytic	JJ	O	catalytic	dep	127	SENT_371	[p24l1983t3437r2134b3499, p24l10t3549r228b3649],
41	activity	NN	O	activity	dep	127	SENT_371	[p24l257t3549r553b3649],
42	(	CD	NUMBER	(	dep	127	SENT_371	[p24l584t3549r856b3640],
43	about	IN	O	about	dep	127	SENT_371	[p24l584t3549r856b3640],
44	20	CD	PERCENT	20	dep	127	SENT_371	[p24l881t3554r982b3627],
45	percent	NN	PERCENT	percent	dep	127	SENT_371	[p24l1012t3565r1332b3649],
46	for	IN	O	for	dep	127	SENT_371	[p24l1358t3548r1481b3627],
47	CYP2C9	NN	O	cyp2c9	dep	127	SENT_371	[p24l1508t3549r1949b3627],
48	*	NN	O	*	dep	127	SENT_371	[p24l1508t3549r1949b3627],
49	2	CD	NUMBER	2	dep	127	SENT_371	[p24l1508t3549r1949b3627],
50	and	CC	O	and	dep	127	SENT_371	[p24l1980t3548r2135b3627],
51	less	JJR	O	less	dep	127	SENT_371	[p24l10t3677r165b3755],
52	than	IN	O	than	dep	127	SENT_371	[p24l204t3676r392b3755],
53	10	CD	PERCENT	10	dep	127	SENT_371	[p24l433t3682r529b3755],
54	percent	NN	PERCENT	percent	dep	127	SENT_371	[p24l566t3693r886b3777],
55	for	IN	O	for	dep	127	SENT_371	[p24l918t3676r1042b3755],
56	CYP2C9	NN	O	cyp2c9	dep	127	SENT_371	[p24l1075t3677r1547b3768],
57	*	CD	NUMBER	*	dep	127	SENT_371	[p24l1075t3677r1547b3768],
58	3	CD	NUMBER	3	dep	127	SENT_371	[p24l1075t3677r1547b3768],
59	)	NN	O	)	dep	127	SENT_371	[p24l1075t3677r1547b3768],
60	as	IN	O	as	dep	127	SENT_371	[p24l1589t3703r1673b3755],
61	compared	VBN	O	compare	dep	127	SENT_371	[p24l1713t3676r2135b3777],
62	with	IN	O	with	dep	127	SENT_371	[p25l6t24r196b103],
63	the	DT	O	the	dep	127	SENT_371	[p25l225t24r354b102],
64	wild	JJ	O	wild	dep	127	SENT_371	[p25l379t24r773b124],
65	—	NN	O	—	dep	127	SENT_371	[p25l379t24r773b124],
66	type	NN	O	type	dep	127	SENT_371	[p25l379t24r773b124],
67	enzyme	NN	O	enzyme	dep	127	SENT_371	[p25l803t49r1125b124],
68	(	CD	NUMBER	(	dep	127	SENT_371	[p25l1158t19r1774b115],
69	CYP2C9	NN	O	cyp2c9	dep	127	SENT_371	[p25l1158t19r1774b115],
70	*	NN	O	*	dep	127	SENT_371	[p25l1158t19r1774b115],
71	1	CD	NUMBER	1	dep	127	SENT_371	[p25l1158t19r1774b115],
72	)	CD	NUMBER	)	dep	127	SENT_371	[p25l1158t19r1774b115],
73	.38	CD	NUMBER	.38	dep	127	SENT_371	[p25l1158t19r1774b115],
74	Accordingly	RB	O	accordingly	dep	127	SENT_371	[p25l1801t24r2134b102, p25l10t151r232b252],
75	,	,	O	,	_	0	SENT_371	[p25l1801t24r2134b102, p25l10t151r232b252],
76	homozygous	JJ	O	homozygous	dep	127	SENT_371	[p25l264t152r808b252],
77	carriers	NNS	O	carrier	dep	127	SENT_371	[p25l837t152r1151b230],
78	of	IN	O	of	dep	127	SENT_371	[p25l1180t151r1280b230],
79	these	DT	O	these	dep	127	SENT_371	[p25l1288t151r1507b230],
80	variant	JJ	O	variant	dep	127	SENT_371	[p25l1528t152r1824b231],
81	alleles	NNS	O	allele	dep	127	SENT_371	[p25l1844t152r2130b247],
82	,	,	O	,	_	0	SENT_371	[p25l1844t152r2130b247],
83	although	IN	O	although	dep	127	SENT_371	[p25l10t279r387b380],
84	uncommon	JJ	O	uncommon	dep	127	SENT_371	[p25l410t305r900b359],
85	(	NN	O	(	dep	127	SENT_371	[p25l928t285r1085b371],
86	0.2	CD	NUMBER	0.2	dep	127	SENT_371	[p25l928t285r1085b371],
87	to	TO	O	to	dep	127	SENT_371	[p25l1110t296r1188b358],
88	1.0	CD	PERCENT	1.0	dep	127	SENT_371	[p25l1217t285r1342b358],
89	percent	NN	PERCENT	percent	dep	127	SENT_371	[p25l1365t296r1682b380],
90	of	IN	O	of	dep	127	SENT_371	[p25l1701t279r1801b358],
91	persons	NNS	O	person	dep	127	SENT_371	[p25l1804t305r2134b380],
92	of	IN	O	of	dep	127	SENT_371	[p25l11t407r111b486],
93	European	JJ	MISC	european	dep	127	SENT_371	[p25l112t415r513b508],
94	descent	NN	O	descent	dep	127	SENT_371	[p25l534t407r853b486],
95	but	CC	O	but	dep	127	SENT_371	[p25l868t407r1007b487],
96	essentially	RB	O	essentially	dep	127	SENT_371	[p25l1024t408r1455b508],
97	o	NN	O	o	dep	127	SENT_371	[p25l1470t413r1517b486],
98	percent	NN	O	percent	dep	127	SENT_371	[p25l1537t424r1853b508],
99	of	IN	O	of	dep	127	SENT_371	[p25l1869t407r1968b486],
100	persons	NNS	O	person	dep	127	SENT_371	[p25l1968t434r2135b508, p25l12t561r201b614],
101	of	IN	O	of	dep	127	SENT_371	[p25l230t535r330b614],
102	Southeast	JJ	MISC	southeast	dep	127	SENT_371	[p25l340t536r757b615],
103	Asian	JJ	MISC	asian	dep	127	SENT_371	[p25l775t536r1014b614],
104	descent	NN	O	descent	dep	127	SENT_371	[p25l1042t536r1418b631],
105	)	NN	O	)	dep	127	SENT_371	[p25l1042t536r1418b631],
106	,	,	O	,	_	0	SENT_371	[p25l1042t536r1418b631],
107	have	VBP	O	have	dep	127	SENT_371	[p25l1451t536r1639b615],
108	profoundly	RB	O	profoundly	dep	127	SENT_371	[p25l1665t535r2140b636],
109	impaired	JJ	O	impaired	dep	127	SENT_371	[p25l10t663r384b764],
110	metabolism	NN	O	metabolism	dep	127	SENT_371	[p25l405t664r902b742],
111	not	RB	O	not	dep	127	SENT_371	[p25l922t680r1064b742],
112	only	RB	O	only	dep	127	SENT_371	[p25l1080t664r1259b764],
113	of	IN	O	of	dep	127	SENT_371	[p25l1275t663r1375b742],
114	phenytoin	NN	O	phenytoin	dep	127	SENT_371	[p25l1375t664r1796b764],
115	but	CC	O	but	dep	127	SENT_371	[p25l1816t664r1956b743],
116	also	RB	O	also	dep	127	SENT_371	[p25l1970t663r2135b742],
117	of	IN	O	of	dep	127	SENT_371	[p25l11t791r112b870],
118	other	JJ	O	other	dep	127	SENT_371	[p25l123t792r347b870],
119	drugs	NNS	O	drug	dep	127	SENT_371	[p25l374t791r611b892],
120	such	JJ	O	such	dep	127	SENT_371	[p25l644t791r838b871],
121	as	IN	O	as	dep	127	SENT_371	[p25l867t818r951b870],
122	tolbutamide	NN	O	tolbutamide	dep	127	SENT_371	[p25l983t792r1522b887],
123	,	,	O	,	_	0	SENT_371	[p25l983t792r1522b887],
124	glipizide	NN	O	glipizide	dep	127	SENT_371	[p25l1556t791r1945b892],
125	,	,	O	,	_	0	SENT_371	[p25l1556t791r1945b892],
126	and	CC	O	and	dep	127	SENT_371	[p25l1980t791r2135b870],
127	Warfarin	NNP	O	Warfarin	_	0	SENT_371	[p25l6t919r389b999],
128	.	.	O	.	_	0	SENT_371	[p25l6t919r389b999],

1	Because	IN	O	because	mark	5	SENT_372	[p25l138t1054r478b1127],
2	warfarin	NN	O	warfarin	nsubjpass	5	SENT_372	[p25l506t1047r867b1127],
3	is	VBZ	O	be	auxpass	5	SENT_372	[p25l899t1048r963b1126],
4	widely	RB	O	widely	advmod	5	SENT_372	[p25l993t1047r1271b1148],
5	used	VBN	O	use	advcl	31	SENT_372	[p25l1299t1047r1494b1127],
6	and	CC	O	and	_	0	SENT_372	[p25l1526t1048r1681b1126],
7	has	VBZ	O	have	conj_and	5	SENT_372	[p25l1713t1048r1854b1126],
8	a	DT	O	a	det	11	SENT_372	[p25l1888t1074r1933b1126],
9	narrow	JJ	O	narrow	amod	11	SENT_372	[p25l1964t1073r2134b1126, p25l11t1201r174b1255],
10	therapeutic	JJ	O	therapeutic	amod	11	SENT_372	[p25l226t1175r702b1276],
11	index	NN	O	index	dobj	7	SENT_372	[p25l756t1176r1009b1271],
12	,	,	O	,	_	0	SENT_372	[p25l756t1176r1009b1271],
13	its	PRP$	O	its	poss	15	SENT_372	[p25l1069t1176r1165b1254],
14	concentration	NN	O	concentration	nn	15	SENT_372	[p25l1224t1175r2135b1254],
15	—	NN	O	—	appos	11	SENT_372	[p25l1224t1175r2135b1254],
16	related	JJ	O	related	amod	18	SENT_372	[p25l1224t1175r2135b1254],
17	adverse	JJ	O	adverse	amod	18	SENT_372	[p25l10t1303r324b1382],
18	effects	NNS	O	effect	nsubj	19	SENT_372	[p25l355t1303r624b1382],
19	(	VBP	O	(	rcmod	15	SENT_372	[p25l662t1311r756b1395],
20	e.	NN	O	e.	nn	21	SENT_372	[p25l662t1311r756b1395],
21	g.	NN	O	g.	dobj	19	SENT_372	[p25l767t1330r868b1404],
22	,	,	O	,	_	0	SENT_372	[p25l767t1330r868b1404],
23	the	DT	O	the	det	24	SENT_372	[p25l905t1304r1034b1382],
24	risk	NN	O	risk	nsubj	31	SENT_372	[p25l1065t1304r1227b1383],
25	of	IN	O	of	_	0	SENT_372	[p25l1253t1303r1353b1382],
26	bleeding	VBG	O	bleed	amod	27	SENT_372	[p25l1366t1303r1760b1404],
27	)	NN	O	)	prep_of	24	SENT_372	[p25l1366t1303r1760b1404],
28	are	VBP	O	be	cop	31	SENT_372	[p25l1794t1330r1921b1382],
29	seri	NN	O	serus	nn	31	SENT_372	[p25l1953t1304r2134b1382],
30	—	NN	O	—	nn	31	SENT_372	[p25l1953t1304r2134b1382],
31	ous	NN	O	ous	_	0	SENT_372	[p25l11t1457r182b1511],
32	.	.	O	.	_	0	SENT_372	[p25l11t1457r182b1511],

1	Genetic	JJ	O	genetic	amod	2	SENT_373	[p25l234t1432r560b1510],
2	variability	NN	O	variability	nsubj	7	SENT_373	[p25l602t1432r1020b1532],
3	in	IN	O	in	_	0	SENT_373	[p25l1062t1432r1143b1509],
4	the	DT	O	the	det	6	SENT_373	[p25l1190t1432r1320b1510],
5	CYP2C9	NN	O	cyp2c9	nn	6	SENT_373	[p25l1366t1431r2135b1510],
6	—	NN	O	—	prep_in	2	SENT_373	[p25l1366t1431r2135b1510],
7	mediated	VBD	O	mediate	_	0	SENT_373	[p25l1366t1431r2135b1510],
8	metabolism	NN	O	metabolism	nsubj	14	SENT_373	[p25l11t1560r516b1638],
9	of	IN	O	of	_	0	SENT_373	[p25l540t1559r640b1638],
10	warfarin	NN	O	warfarin	prep_of	8	SENT_373	[p25l639t1559r1000b1639],
11	is	VBZ	O	be	cop	14	SENT_373	[p25l1021t1560r1086b1638],
12	a	DT	O	a	det	14	SENT_373	[p25l1111t1586r1155b1638],
13	major	JJ	O	major	amod	14	SENT_373	[p25l1176t1560r1424b1660],
14	factor	NN	O	factor	ccomp	7	SENT_373	[p25l1444t1559r1691b1638],
15	in	IN	O	in	_	0	SENT_373	[p25l1709t1560r1791b1637],
16	the	DT	O	the	det	18	SENT_373	[p25l1814t1560r1943b1638],
17	efﬁ	NN	O	efﬁ	nn	18	SENT_373	[p25l1967t1559r2134b1638],
18	cacy	NN	O	cacy	prep_in	14	SENT_373	[p25l11t1714r190b1788],
19	and	CC	O	and	_	0	SENT_373	[p25l216t1688r372b1766],
20	toxicity	NN	O	toxicity	conj_and	18	SENT_373	[p25l404t1688r711b1788],
21	of	IN	O	of	_	0	SENT_373	[p25l739t1687r838b1766],
22	the	DT	O	the	det	23	SENT_373	[p25l852t1688r982b1766],
23	drug	NN	O	drug	prep_of	18	SENT_373	[p25l1014t1688r1233b1788],
24	.	.	O	.	_	0	SENT_373	[p25l1014t1688r1233b1788],

1	This	DT	O	this	nsubj	2	SENT_374	[p25l1267t1688r1452b1766],
2	is	VBZ	O	be	_	0	SENT_374	[p25l1485t1688r1550b1766],
3	because	IN	O	because	mark	6	SENT_374	[p25l1585t1688r1916b1767],
4	warfarin	NN	O	warfarin	nsubjpass	6	SENT_374	[p25l1944t1714r2134b1767, p25l11t1815r213b1894],
5	is	VBZ	O	be	auxpass	6	SENT_374	[p25l237t1816r303b1894],
6	administered	VBN	O	administer	advcl	2	SENT_374	[p25l328t1815r898b1894],
7	as	IN	O	as	_	0	SENT_374	[p25l921t1842r1006b1894],
8	a	DT	O	a	det	10	SENT_374	[p25l1032t1842r1076b1894],
9	racemate	NN	O	racemate	nn	10	SENT_374	[p25l1099t1832r1488b1894],
10	(	NN	O	(	prep_as	6	SENT_374	[p25l1517t1815r1779b1916],
11	equal	JJ	O	equal	amod	12	SENT_374	[p25l1517t1815r1779b1916],
12	proportions	NNS	O	proportion	dobj	6	SENT_374	[p25l1802t1841r2133b1916, p25l11t1943r223b2021],
13	of	IN	O	of	_	0	SENT_374	[p25l268t1942r369b2021],
14	S	NN	O	s	amod	18	SENT_374	[p25l393t1948r471b2021],
15	-	:	O	-	_	0	SENT_374	[p25l393t1948r471b2021],
16	and	CC	O	and	_	0	SENT_374	[p25l512t1942r667b2021],
17	R-enantiomers	JJ	O	r-enantiomers	conj_and	14	SENT_374	[p25l706t1943r1391b2037],
18	)	NN	O	)	prep_of	12	SENT_374	[p25l706t1943r1391b2037],
19	,	,	O	,	_	0	SENT_374	[p25l706t1943r1391b2037],
20	and	CC	O	and	_	0	SENT_374	[p25l1436t1942r1592b2021],
21	most	JJS	O	most	nsubjpass	27	SENT_374	[p25l1632t1959r1848b2021],
22	of	IN	O	of	_	0	SENT_374	[p25l1883t1942r1984b2021],
23	the	DT	O	the	det	25	SENT_374	[p25l2006t1943r2135b2020],
24	anticoagulant	JJ	O	anticoagulant	amod	25	SENT_374	[p25l10t2070r594b2171],
25	effect	NN	O	effect	prep_of	21	SENT_374	[p25l619t2070r853b2149],
26	is	VBZ	O	be	auxpass	27	SENT_374	[p25l876t2071r941b2149],
27	associated	VBN	O	associate	conj_and	2	SENT_374	[p25l972t2070r1409b2149],
28	with	IN	O	with	_	0	SENT_374	[p25l1433t2071r1623b2150],
29	the	DT	O	the	det	34	SENT_374	[p25l1652t2071r1782b2149],
30	S	NN	O	s	nn	34	SENT_374	[p25l1813t2076r2134b2149],
31	—	CD	NUMBER	—	num	34	SENT_374	[p25l1813t2076r2134b2149],
32	enan	NN	O	enan	nn	34	SENT_374	[p25l1813t2076r2134b2149],
33	—	NN	O	—	nn	34	SENT_374	[p25l1813t2076r2134b2149],
34	tiomer	NN	O	tiomer	prep_with	27	SENT_374	[p25l11t2199r304b2294],
35	,	,	O	,	_	0	SENT_374	[p25l11t2199r304b2294],
36	which	WDT	O	which	nsubjpass	41	SENT_374	[p25l326t2199r583b2278],
37	in	IN	O	in	_	0	SENT_374	[p25l604t2199r684b2276],
38	turn	NN	O	turn	prep_in	41	SENT_374	[p25l705t2215r879b2278],
39	is	VBZ	O	be	auxpass	41	SENT_374	[p25l900t2199r964b2277],
40	predominantly	RB	O	predominantly	advmod	41	SENT_374	[p25l985t2198r1605b2299],
41	metabolized	VBN	O	metabolize	rcmod	34	SENT_374	[p25l1621t2199r2136b2277],
42	by	IN	O	by	_	0	SENT_374	[p25l11t2326r108b2427],
43	CYPZC9	NN	O	cypzc9	agent	41	SENT_374	[p25l129t2332r491b2405],
44	.	.	O	.	_	0	SENT_374	[p25l129t2332r491b2405],

1	A	DT	O	a	det	2	SENT_375	[p25l136t2462r202b2532],
2	review	NN	O	review	nsubj	15	SENT_375	[p25l227t2455r499b2534],
3	of	IN	O	of	_	0	SENT_375	[p25l523t2454r624b2533],
4	several	JJ	O	several	amod	6	SENT_375	[p25l635t2455r920b2534],
5	retrospective	JJ	O	retrospective	amod	6	SENT_375	[p25l947t2455r1486b2555],
6	studies	NNS	O	study	prep_of	2	SENT_375	[p25l1516t2454r1810b2534],
7	among	IN	O	among	_	0	SENT_375	[p25l1839t2480r2139b2555],
8	outpatients	NNS	O	outpatient	prep_among	6	SENT_375	[p25l11t2583r485b2683],
9	receiving	VBG	O	receive	partmod	8	SENT_375	[p25l531t2583r913b2683],
10	long	JJ	O	long	amod	14	SENT_375	[p25l953t2583r1379b2683],
11	—	NN	O	—	nn	14	SENT_375	[p25l953t2583r1379b2683],
12	term	NN	O	term	nn	14	SENT_375	[p25l953t2583r1379b2683],
13	warfarin	NN	O	warfarin	nn	14	SENT_375	[p25l1419t2582r1779b2662],
14	therapy	NN	O	therapy	dobj	9	SENT_375	[p25l1823t2583r2140b2683],
15	indicates	VBZ	O	indicate	_	0	SENT_375	[p25l10t2711r384b2789],
16	that	IN	O	that	_	0	SENT_375	[p25l418t2711r584b2789],
17	the	DT	O	the	det	20	SENT_375	[p25l611t2711r740b2789],
18	mean	NN	O	mean	nn	20	SENT_375	[p25l771t2736r1004b2789],
19	maintenance	NN	O	maintenance	nn	20	SENT_375	[p25l1034t2711r1579b2789],
20	dose	NN	O	dose	prep_that	15	SENT_375	[p25l1611t2711r1804b2789],
21	of	IN	O	of	_	0	SENT_375	[p25l1836t2710r1936b2789],
22	warfarin	NN	O	warfarin	prep_of	20	SENT_375	[p25l1944t2737r2134b2790, p25l11t2839r209b2918],

1	depends	VBZ	O	depend	_	0	SENT_376	[p25l234t2839r586b2940],
2	on	IN	O	on	_	0	SENT_376	[p25l614t2865r720b2918],
3	the	DT	O	the	det	5	SENT_376	[p25l746t2840r875b2918],
4	CYPZC9	NN	O	cypzc9	nn	5	SENT_376	[p25l900t2846r1197b2918],
5	genotype	NN	O	genotype	prep_on	1	SENT_376	[p25l1221t2835r1715b2940],
6	.	.	O	.	_	0	SENT_376	[p25l1221t2835r1715b2940],

1	”	NN	O	”	_	0	SENT_377	[p25l1221t2835r1715b2940],
2	Thus	RB	O	thus	advmod	1	SENT_377	[p25l1737t2839r1975b2935],
3	,	,	O	,	_	0	SENT_377	[p25l1737t2839r1975b2935],
4	the	DT	O	the	det	7	SENT_377	[p25l2006t2839r2135b2918],
5	maintenance	NN	O	maintenance	nn	7	SENT_377	[p25l11t2968r556b3046],
6	dose	NN	O	dose	nn	7	SENT_377	[p25l580t2968r773b3046],
7	ofwarfarin	NN	O	ofwarfarin	appos	1	SENT_377	[p25l798t2967r1259b3047],
8	in	IN	O	in	_	0	SENT_377	[p25l1282t2968r1362b3045],
9	persons	NNS	O	person	prep_in	7	SENT_377	[p25l1385t2993r1717b3068],
10	heterozygous	JJ	O	heterozygous	amod	9	SENT_377	[p25l1743t2968r2134b3068, p25l10t3121r214b3196],
11	for	IN	O	for	_	0	SENT_377	[p25l254t3095r379b3174],
12	CYP2C9	NN	O	cyp2c9	nn	13	SENT_377	[p25l414t3096r997b3186],
13	*	NN	O	*	prep_for	10	SENT_377	[p25l414t3096r997b3186],
14	2	CD	NUMBER	2	num	13	SENT_377	[p25l414t3096r997b3186],
15	/	:	O	/	punct	1	SENT_377	[p25l414t3096r997b3186],
16	*	CD	NUMBER	*	num	17	SENT_377	[p25l414t3096r997b3186],
17	3	CD	NUMBER	3	nsubj	19	SENT_377	[p25l414t3096r997b3186],
18	is	VBZ	O	be	cop	19	SENT_377	[p25l1037t3096r1103b3174],
19	lower	JJR	O	lower	dep	1	SENT_377	[p25l1141t3095r1384b3175],
20	than	IN	O	than	_	0	SENT_377	[p25l1419t3096r1610b3174],
21	the	DT	O	the	det	22	SENT_377	[p25l1648t3095r1779b3174],
22	dose	NN	O	dose	prep_than	19	SENT_377	[p25l1819t3096r2015b3174],
23	in	IN	O	in	_	0	SENT_377	[p25l2052t3096r2134b3173],
24	patients	NNS	O	patient	prep_in	22	SENT_377	[p25l9t3224r346b3324],
25	who	WP	O	who	nsubj	27	SENT_377	[p25l379t3224r562b3303],
26	are	VBP	O	be	cop	27	SENT_377	[p25l598t3250r724b3302],
27	homozygous	JJ	O	homozygous	dep	19	SENT_377	[p25l759t3223r1303b3324],
28	for	IN	O	for	_	0	SENT_377	[p25l1340t3223r1464b3302],
29	the	DT	O	the	det	31	SENT_377	[p25l1496t3224r1625b3302],
30	normal	JJ	O	normal	amod	31	SENT_377	[p25l1660t3224r1967b3302],
31	enzyme	NN	O	enzyme	prep_for	27	SENT_377	[p25l2003t3249r2134b3302, p25l10t3378r229b3452],
32	or	CC	O	or	_	0	SENT_377	[p25l254t3377r343b3430],
33	who	WP	O	who	nsubj	36	SENT_377	[p25l359t3352r543b3431],
34	are	VBP	O	be	cop	36	SENT_377	[p25l567t3378r694b3430],
35	compound	JJ	O	compound	amod	36	SENT_377	[p25l718t3351r1178b3452],
36	heterozygotes	NNS	O	heterozygote	conj_or	27	SENT_377	[p25l1201t3352r1812b3452],
37	.	.	O	.	_	0	SENT_377	[p25l1201t3352r1812b3452],

1	For	IN	O	for	_	0	SENT_378	[p25l1840t3359r1984b3430],
2	the	DT	O	the	det	4	SENT_378	[p25l2006t3352r2135b3430],
3	small	JJ	O	small	amod	4	SENT_378	[p25l12t3480r240b3558],
4	group	NN	O	group	prep_for	22	SENT_378	[p25l263t3505r513b3580],
5	of	IN	O	of	_	0	SENT_378	[p25l539t3479r640b3558],
6	patients	NNS	O	patient	prep_of	4	SENT_378	[p25l643t3480r978b3580],
7	who	WP	O	who	nsubj	8	SENT_378	[p25l999t3480r1183b3559],
8	carry	VBP	O	carry	rcmod	6	SENT_378	[p25l1208t3506r1416b3580],
9	the	DT	O	the	det	14	SENT_378	[p25l1436t3480r1565b3558],
10	homozygous	JJ	O	homozygous	amod	14	SENT_378	[p25l1589t3480r2134b3580],
11	CYP2C9	NN	O	cyp2c9	nn	14	SENT_378	[p25l11t3608r444b3686],
12	*	NN	O	*	nn	14	SENT_378	[p25l11t3608r444b3686],
13	3	CD	NUMBER	3	num	14	SENT_378	[p25l11t3608r444b3686],
14	genotype	NN	O	genotype	dobj	8	SENT_378	[p25l468t3624r868b3708],
15	,	,	O	,	_	0	SENT_378	[p25l468t3624r868b3708],
16	even	RB	O	even	advmod	17	SENT_378	[p25l895t3633r1079b3687],
17	smaller	JJR	O	smaller	amod	18	SENT_378	[p25l1102t3607r1410b3686],
18	doses	NNS	O	dose	nsubj	22	SENT_378	[p25l1429t3608r1660b3686],
19	of	IN	O	of	_	0	SENT_378	[p25l1684t3607r1784b3686],
20	warfarin	NN	O	warfarin	prep_of	18	SENT_378	[p25l1782t3607r2136b3687],
21	are	VBP	O	be	cop	22	SENT_378	[p26l10t47r135b99],
22	necessary	JJ	O	necessary	_	0	SENT_378	[p26l158t46r562b121],
23	to	TO	O	to	aux	24	SENT_378	[p26l580t37r659b99],
24	achieve	VB	O	achieve	xcomp	22	SENT_378	[p26l682t20r987b100],
25	target	NN	O	target	nn	27	SENT_378	[p26l1011t37r1257b121],
26	anticoagulation	NN	O	anticoagulation	nn	27	SENT_378	[p26l1274t20r1928b121],
27	(	NN	O	(	dobj	24	SENT_378	[p26l1955t26r2032b112],
28	1	CD	NUMBER	1	number	30	SENT_378	[p26l1955t26r2032b112],
29	to	TO	O	to	dep	30	SENT_378	[p26l2056t37r2134b99],
30	1.5	CD	NUMBER	1.5	num	31	SENT_378	[p26l14t154r137b227],
31	mg	NN	O	mg	dep	27	SENT_378	[p26l162t175r302b249],
32	a	DT	DURATION	a	det	33	SENT_378	[p26l319t175r364b227],
33	day	NN	DURATION	day	dep	27	SENT_378	[p26l384t149r529b249],
34	vs.	FW	O	vs.	prep	24	SENT_378	[p26l541t175r650b228],
35	4	CD	NUMBER	4	number	37	SENT_378	[p26l675t154r725b227],
36	to	TO	O	to	dep	37	SENT_378	[p26l747t165r826b227],
37	6	CD	NUMBER	6	num	38	SENT_378	[p26l850t154r896b227],
38	mg	NN	O	mg	pobj	34	SENT_378	[p26l918t175r1058b249],
39	a	DT	DURATION	a	det	40	SENT_378	[p26l1075t175r1120b227],
40	day	NN	DURATION	day	dep	38	SENT_378	[p26l1140t149r1285b249],
41	for	IN	O	for	_	0	SENT_378	[p26l1301t148r1424b227],
42	patients	NNS	O	patient	prep_for	24	SENT_378	[p26l1442t149r1776b249],
43	with	IN	O	with	_	0	SENT_378	[p26l1795t149r1984b228],
44	the	DT	O	the	det	49	SENT_378	[p26l2006t149r2135b227],
45	Wild	NNP	O	Wild	nn	49	SENT_378	[p26l6t277r400b377],
46	—	CD	NUMBER	—	num	49	SENT_378	[p26l6t277r400b377],
47	type	NN	O	type	nn	49	SENT_378	[p26l6t277r400b377],
48	genotype	NN	O	genotype	nn	49	SENT_378	[p26l425t284r867b377],
49	)	NN	O	)	prep_with	42	SENT_378	[p26l425t284r867b377],
50	.	.	O	.	_	0	SENT_378	[p26l425t284r867b377],

1	Patients	NNS	O	patient	nsubj	6	SENT_379	[p26l138t405r471b483],
2	with	IN	O	with	_	0	SENT_379	[p26l500t404r689b484],
3	a	DT	O	a	det	5	SENT_379	[p26l719t431r764b483],
4	variant	JJ	O	variant	amod	5	SENT_379	[p26l789t405r1085b484],
5	allele	NN	O	allele	prep_with	1	SENT_379	[p26l1110t405r1328b483],
6	have	VBP	O	have	_	0	SENT_379	[p26l1359t405r1548b484],
7	a	DT	O	a	det	9	SENT_379	[p26l1579t431r1623b483],
8	greater	JJR	O	greater	amod	9	SENT_379	[p26l1652t421r1950b505],
9	risk	NN	O	risk	dobj	6	SENT_379	[p26l1978t405r2140b484],
10	of	IN	O	of	_	0	SENT_379	[p26l11t532r112b611],
11	both	CC	O	both	preconj	12	SENT_379	[p26l131t532r325b611],
12	minor	JJ	O	minor	amod	16	SENT_379	[p26l362t533r624b611],
13	and	CC	O	and	_	0	SENT_379	[p26l658t532r814b611],
14	major	JJ	O	major	amod	16	SENT_379	[p26l851t533r1099b633],
15	bleeding	NN	O	bleeding	nn	16	SENT_379	[p26l1134t532r1502b633],
16	complications	NNS	O	complication	prep_of	9	SENT_379	[p26l1536t533r2133b633],
17	not	RB	O	not	neg	18	SENT_379	[p26l11t677r154b739],
18	only	RB	O	only	preconj	6	SENT_379	[p26l193t661r375b761],
19	during	IN	O	during	_	0	SENT_379	[p26l415t661r699b761],
20	initiation	NN	O	initiation	prep_during	6	SENT_379	[p26l739t661r1125b739],
21	of	IN	O	of	_	0	SENT_379	[p26l1169t660r1270b739],
22	anticoagulation	NN	O	anticoagulation	prep_of	20	SENT_379	[p26l1295t661r1956b761],
23	but	CC	O	but	_	0	SENT_379	[p26l1999t661r2140b740],
24	also	RB	O	also	_	0	SENT_379	[p26l10t789r177b867],
25	during	IN	O	during	_	0	SENT_379	[p26l216t789r500b889],
26	the	DT	O	the	det	28	SENT_379	[p26l534t789r663b867],
27	maintenance	NN	O	maintenance	nn	28	SENT_379	[p26l700t789r1244b867],
28	phase	NN	O	phase	conj_and	20	SENT_379	[p26l1279t788r1549b889],
29	.	.	O	.	_	0	SENT_379	[p26l1279t788r1549b889],

1	CYPZC9	NN	O	cypzc9	nn	2	SENT_380	[p26l1591t795r1888b867],
2	polymorphisms	NNS	O	polymorphism	nsubj	3	SENT_380	[p26l1923t789r2134b889, p26l11t917r498b1017],
3	appear	VBP	O	appear	_	0	SENT_380	[p26l521t943r809b1017],
4	to	TO	O	to	aux	5	SENT_380	[p26l828t933r907b995],
5	play	VB	O	play	xcomp	3	SENT_380	[p26l928t916r1103b1017],
6	a	DT	O	a	det	8	SENT_380	[p26l1119t943r1164b995],
7	smaller	JJR	O	smaller	amod	8	SENT_380	[p26l1185t917r1499b995],
8	role	NN	O	role	dobj	5	SENT_380	[p26l1517t916r1677b995],
9	in	IN	O	in	_	0	SENT_380	[p26l1699t917r1780b994],
10	the	DT	O	the	det	12	SENT_380	[p26l1802t917r1931b995],
11	dosage	NN	O	dosage	nn	12	SENT_380	[p26l1953t917r2134b995, p26l10t1071r153b1145],
12	requirements	NNS	O	requirement	prep_in	5	SENT_380	[p26l193t1045r756b1145],
13	and	CC	O	and	_	0	SENT_380	[p26l797t1044r952b1123],
14	adverse	JJ	O	adverse	amod	15	SENT_380	[p26l990t1044r1304b1124],
15	events	NNS	O	event	prep_in	5	SENT_380	[p26l1344t1061r1603b1124],
16	when	WRB	O	when	advmod	27	SENT_380	[p26l1641t1045r1874b1124],
17	other	JJ	O	other	amod	18	SENT_380	[p26l1914t1045r2138b1123],
18	anticoagulants	NNS	O	anticoagulant	nsubjpass	27	SENT_380	[p26l10t1172r630b1273],
19	such	JJ	O	such	_	0	SENT_380	[p26l667t1173r862b1252],
20	as	IN	O	as	_	0	SENT_380	[p26l894t1199r978b1251],
21	acenocoumarol	NN	O	acenocoumarol	nn	25	SENT_380	[p26l1013t1172r1668b1252],
22	and	CC	O	and	_	0	SENT_380	[p26l1700t1172r1855b1251],
23	phen	NN	O	phen	conj_and	21	SENT_380	[p26l1887t1173r2134b1273],
24	—	NN	O	—	nn	25	SENT_380	[p26l1887t1173r2134b1273],
25	procoumon	NNS	O	procoumon	prep_such_as	18	SENT_380	[p26l9t1326r500b1401],
26	are	VBP	O	be	auxpass	27	SENT_380	[p26l519t1327r644b1379],
27	used	VBN	O	use	dep	5	SENT_380	[p26l664t1301r878b1396],
28	,	,	O	,	_	0	SENT_380	[p26l664t1301r878b1396],
29	presumably	RB	O	presumably	advmod	27	SENT_380	[p26l903t1300r1394b1401],
30	because	IN	O	because	mark	34	SENT_380	[p26l1410t1300r1736b1380],
31	additional	JJ	O	additional	amod	32	SENT_380	[p26l1756t1301r2135b1379, p26l10t1429r80b1507],
32	enzymes	NNS	O	enzyme	nsubjpass	34	SENT_380	[p26l104t1454r467b1529],
33	are	VBP	O	be	auxpass	34	SENT_380	[p26l491t1455r618b1507],
34	involved	VBN	O	involve	dep	27	SENT_380	[p26l641t1428r991b1508],
35	in	IN	O	in	_	0	SENT_380	[p26l1014t1429r1095b1506],
36	the	DT	O	the	det	37	SENT_380	[p26l1119t1428r1248b1507],
37	metabolism	NN	O	metabolism	prep_in	34	SENT_380	[p26l1272t1429r1778b1507],
38	of	IN	O	of	_	0	SENT_380	[p26l1802t1428r1903b1507],
39	those	DT	O	those	det	40	SENT_380	[p26l1908t1429r2135b1507],
40	medications	NNS	O	medication	prep_of	37	SENT_380	[p26l11t1553r639b1636],
41	.4	VBP	NUMBER	.4	dep	40	SENT_380	[p26l11t1553r639b1636],
42	°	CD	NUMBER	°	dobj	41	SENT_380	[p26l11t1553r639b1636],

1	Administration	NN	O	administration	nsubj	10	SENT_381	[p26l136t1685r784b1764],
2	of	IN	O	of	_	0	SENT_381	[p26l839t1685r939b1764],
3	other	JJ	O	other	amod	4	SENT_381	[p26l975t1686r1200b1764],
4	drugs	NNS	O	drug	prep_of	1	SENT_381	[p26l1251t1686r1488b1786],
5	together	RB	O	together	_	0	SENT_381	[p26l1544t1686r1900b1786],
6	with	IN	O	with	_	0	SENT_381	[p26l1946t1686r2135b1765],
7	Warfarin	NNP	O	Warfarin	prep_together_with	4	SENT_381	[p26l6t1813r366b1893],
8	also	RB	O	also	advmod	10	SENT_381	[p26l390t1814r557b1892],
9	may	MD	O	may	aux	10	SENT_381	[p26l584t1840r760b1914],
10	contribute	VB	O	contribute	_	0	SENT_381	[p26l781t1814r1215b1893],
11	to	TO	O	to	_	0	SENT_381	[p26l1241t1830r1320b1892],
12	interindividual	JJ	O	interindividual	amod	15	SENT_381	[p26l1345t1813r1966b1893],
13	dif	NN	O	dif	nn	15	SENT_381	[p26l1990t1813r2134b1892],
14	—	NN	O	—	nn	15	SENT_381	[p26l1990t1813r2134b1892],
15	ferences	NNS	O	ference	prep_to	10	SENT_381	[p26l11t1941r358b2020],
16	in	IN	O	in	_	0	SENT_381	[p26l381t1942r463b2019],
17	the	DT	O	the	det	18	SENT_381	[p26l485t1942r614b2020],
18	response	NN	O	response	prep_in	15	SENT_381	[p26l636t1967r1015b2042],
19	to	TO	O	to	_	0	SENT_381	[p26l1038t1958r1117b2020],
20	anticoagulation	NN	O	anticoagulation	nn	21	SENT_381	[p26l1140t1942r1800b2042],
21	therapy	NN	O	therapy	prep_to	18	SENT_381	[p26l1822t1942r2140b2042],
22	through	IN	O	through	_	0	SENT_381	[p26l11t2070r349b2170],
23	a	DT	O	a	det	24	SENT_381	[p26l372t2096r416b2148],
24	variety	NN	O	variety	prep_through	10	SENT_381	[p26l433t2071r708b2170],
25	of	IN	O	of	_	0	SENT_381	[p26l727t2069r827b2148],
26	mechanisms	NNS	O	mechanism	prep_of	24	SENT_381	[p26l831t2064r1472b2148],
27	.	.	O	.	_	0	SENT_381	[p26l831t2064r1472b2148],

1	“	NN	O	“	dep	7	SENT_382	[p26l831t2064r1472b2148],
2	Although	IN	O	although	dep	7	SENT_382	[p26l1491t2070r1888b2170],
3	some	DT	O	some	det	4	SENT_382	[p26l1912t2095r2135b2148],
4	interactions	NNS	O	interaction	nsubjpass	7	SENT_382	[p26l10t2198r510b2276],
5	were	VBD	O	be	auxpass	7	SENT_382	[p26l531t2224r732b2277],
6	previously	RB	DATE	previously	advmod	7	SENT_382	[p26l754t2198r1188b2298],
7	thought	VBN	O	think	advcl	25	SENT_382	[p26l1207t2198r1548b2298],
8	to	TO	O	to	aux	9	SENT_382	[p26l1566t2214r1645b2276],
9	result	VB	O	result	xcomp	7	SENT_382	[p26l1669t2198r1910b2277],
10	from	IN	O	from	_	0	SENT_382	[p26l1928t2197r2135b2276],
11	perturbation	NN	O	perturbation	prep_from	9	SENT_382	[p26l9t2326r542b2426],
12	in	IN	O	in	_	0	SENT_382	[p26l574t2326r655b2403],
13	the	DT	O	the	det	14	SENT_382	[p26l688t2326r818b2404],
14	binding	NN	O	binding	prep_in	11	SENT_382	[p26l851t2325r1184b2426],
15	of	IN	O	of	_	0	SENT_382	[p26l1215t2325r1315b2404],
16	Warfarin	NNP	MISC	Warfarin	prep_of	14	SENT_382	[p26l1325t2325r1685b2405],
17	to	TO	O	to	_	0	SENT_382	[p26l1718t2342r1797b2404],
18	plasma	NN	O	plasma	nn	19	SENT_382	[p26l1830t2326r2136b2426],
19	proteins	NNS	O	protein	prep_to	9	SENT_382	[p26l9t2454r379b2554],
20	,	,	O	,	_	0	SENT_382	[p26l9t2454r379b2554],
21	this	DT	O	this	nsubjpass	25	SENT_382	[p26l406t2453r557b2532],
22	is	VBZ	O	be	auxpass	25	SENT_382	[p26l579t2454r643b2532],
23	no	RB	O	no	advmod	24	SENT_382	[p26l666t2479r772b2532],
24	longer	RB	O	longer	advmod	25	SENT_382	[p26l793t2454r1067b2554],
25	considered	VBN	O	consider	_	0	SENT_382	[p26l1086t2453r1544b2532],
26	to	TO	O	to	aux	29	SENT_382	[p26l1565t2470r1643b2532],
27	be	VB	O	be	cop	29	SENT_382	[p26l1666t2454r1761b2532],
28	the	DT	O	the	det	29	SENT_382	[p26l1783t2454r1911b2532],
29	case	NN	O	case	xcomp	25	SENT_382	[p26l1933t2480r2130b2532],
30	.	.	O	.	_	0	SENT_382	[p26l1933t2480r2130b2532],

1	Instead	RB	O	instead	advmod	21	SENT_383	[p26l9t2582r343b2677],
2	,	,	O	,	_	0	SENT_383	[p26l9t2582r343b2677],
3	modulation	NN	O	modulation	nsubjpass	21	SENT_383	[p26l380t2581r873b2661],
4	of	IN	O	of	_	0	SENT_383	[p26l905t2581r1005b2660],
5	the	DT	O	the	det	7	SENT_383	[p26l1019t2581r1147b2660],
6	hepatic	JJ	O	hepatic	amod	7	SENT_383	[p26l1179t2582r1485b2682],
7	metabolism	NN	O	metabolism	prep_of	3	SENT_383	[p26l1516t2581r2021b2660],
8	of	IN	O	of	_	0	SENT_383	[p26l2053t2581r2154b2660],
9	Warfarin	NNP	MISC	Warfarin	prep_of	7	SENT_383	[p26l6t2709r389b2805],
10	,	,	O	,	_	0	SENT_383	[p26l6t2709r389b2805],
11	especially	RB	O	especially	advmod	12	SENT_383	[p26l417t2709r826b2810],
12	that	IN	O	that	ccomp	21	SENT_383	[p26l843t2710r1010b2788],
13	of	IN	O	of	_	0	SENT_383	[p26l1027t2709r1127b2788],
14	the	DT	O	the	det	17	SENT_383	[p26l1131t2709r1260b2788],
15	S	NN	O	s	nn	17	SENT_383	[p26l1283t2710r1874b2805],
16	—	NN	O	—	nn	17	SENT_383	[p26l1283t2710r1874b2805],
17	enantiomer	NN	O	enantiomer	prep_of	12	SENT_383	[p26l1283t2710r1874b2805],
18	,	,	O	,	_	0	SENT_383	[p26l1283t2710r1874b2805],
19	is	VBZ	O	be	auxpass	21	SENT_383	[p26l1901t2710r1966b2788],
20	frequently	RB	O	frequently	advmod	21	SENT_383	[p26l1989t2709r2134b2788, p26l11t2838r319b2938],
21	involved	VBN	O	involve	_	0	SENT_383	[p26l335t2837r677b2917],
22	in	IN	O	in	_	0	SENT_383	[p26l697t2838r776b2915],
23	clinically	RB	O	clinically	advmod	24	SENT_383	[p26l798t2837r1163b2938],
24	important	JJ	O	important	amod	25	SENT_383	[p26l1179t2838r1603b2938],
25	interactions	NNS	O	interaction	prep_in	21	SENT_383	[p26l1618t2838r2131b2916],
26	.	.	O	.	_	0	SENT_383	[p26l1618t2838r2131b2916],

1	Thus	RB	O	thus	advmod	25	SENT_384	[p26l7t2966r245b3061],
2	,	,	O	,	_	0	SENT_384	[p26l7t2966r245b3061],
3	potent	JJ	O	potent	amod	4	SENT_384	[p26l274t2982r552b3066],
4	inhibitors	NNS	O	inhibitor	nsubj	25	SENT_384	[p26l572t2965r986b3044],
5	of	IN	O	of	_	0	SENT_384	[p26l1015t2965r1114b3044],
6	CYPZC9	NN	O	cypzc9	prep_of	4	SENT_384	[p26l1122t2971r1459b3044],
7	such	JJ	O	such	_	0	SENT_384	[p26l1487t2966r1682b3045],
8	as	IN	O	as	_	0	SENT_384	[p26l1706t2992r1790b3044],
9	phenylbutazone	NN	O	phenylbutazone	prep_such_as	6	SENT_384	[p26l1817t2966r2134b3066, p26l11t3093r435b3189],
10	,	,	O	,	_	0	SENT_384	[p26l1817t2966r2134b3066, p26l11t3093r435b3189],
11	sulﬁnpyrazone	NN	O	sulﬁnpyrazone	prep_such_as	6	SENT_384	[p26l481t3093r1147b3194],
12	,	,	O	,	_	0	SENT_384	[p26l481t3093r1147b3194],
13	amiodarone	NN	O	amiodarone	prep_such_as	6	SENT_384	[p26l1190t3094r1735b3189],
14	,	,	O	,	_	0	SENT_384	[p26l1190t3094r1735b3189],
15	micona	NN	O	micona	nn	17	SENT_384	[p26l1779t3094r2132b3172],
16	—	NN	O	—	nn	17	SENT_384	[p26l1779t3094r2132b3172],
17	zole	NN	O	zole	prep_such_as	6	SENT_384	[p26l10t3221r210b3317],
18	,	,	O	,	_	0	SENT_384	[p26l10t3221r210b3317],
19	and	CC	O	and	_	0	SENT_384	[p26l242t3222r398b3300],
20	ﬂuconazole	NN	O	ﬂuconazole	prep_such_as	6	SENT_384	[p26l424t3221r915b3301],
21	all	DT	O	all	dep	22	SENT_384	[p26l941t3221r1041b3300],
22	predictably	RB	O	predictably	advmod	25	SENT_384	[p26l1065t3221r1540b3322],
23	and	CC	O	and	_	0	SENT_384	[p26l1561t3222r1717b3300],
24	markedly	RB	O	markedly	advmod	25	SENT_384	[p26l1743t3221r2140b3322],
25	produce	VBP	O	produce	_	0	SENT_384	[p26l9t3349r354b3450],
26	an	DT	O	a	det	29	SENT_384	[p26l382t3375r482b3428],
27	almost	RB	O	almost	advmod	29	SENT_384	[p26l509t3350r802b3428],
28	immediate	JJ	O	immediate	amod	29	SENT_384	[p26l824t3350r1274b3428],
29	increase	NN	O	increase	dobj	25	SENT_384	[p26l1302t3350r1647b3428],
30	in	IN	O	in	_	0	SENT_384	[p26l1675t3350r1757b3427],
31	the	DT	O	the	det	33	SENT_384	[p26l1785t3349r1914b3428],
32	anticoagulant	JJ	O	anticoagulant	amod	33	SENT_384	[p26l1941t3350r2134b3428, p26l11t3477r438b3578],
33	effect	NN	O	effect	prep_in	29	SENT_384	[p26l474t3477r733b3573],
34	,	,	O	,	_	0	SENT_384	[p26l474t3477r733b3573],
35	increasing	VBG	O	increase	partmod	29	SENT_384	[p26l777t3478r1229b3578],
36	the	DT	O	the	det	37	SENT_384	[p26l1266t3478r1398b3556],
37	risk	NN	O	risk	dobj	35	SENT_384	[p26l1438t3478r1603b3557],
38	of	IN	O	of	_	0	SENT_384	[p26l1639t3477r1740b3556],
39	bleeding	VBG	O	bleed	prepc_of	37	SENT_384	[p26l1762t3477r2137b3578],
40	When	WRB	O	when	advmod	41	SENT_384	[p26l6t3606r242b3685],
41	administered	VBN	O	administer	advcl	39	SENT_384	[p26l282t3606r842b3684],
42	along	IN	O	along	_	0	SENT_384	[p26l879t3606r1120b3706],
43	With	IN	O	with	_	0	SENT_384	[p26l1151t3606r1340b3685],
44	Warfarin	NNP	O	Warfarin	prep_along_with	41	SENT_384	[p26l1375t3605r1758b3701],
45	,	,	O	,	_	0	SENT_384	[p26l1375t3605r1758b3701],
46	because	IN	O	because	mark	49	SENT_384	[p26l1803t3606r2135b3685],
47	these	DT	O	these	det	48	SENT_384	[p27l11t21r229b99],
48	agents	NNS	O	agent	nsubj	49	SENT_384	[p27l260t37r533b121],
49	increase	VBP	O	increase	advcl	41	SENT_384	[p27l564t21r910b99],
50	the	DT	O	the	det	52	SENT_384	[p27l941t21r1070b99],
51	plasma	NN	O	plasma	nn	52	SENT_384	[p27l1100t20r1406b121],
52	concentration	NN	O	concentration	dobj	49	SENT_384	[p27l1435t21r2022b99],
53	of	IN	O	of	_	0	SENT_384	[p27l2053t20r2153b99],
54	the	DT	O	the	det	56	SENT_384	[p27l11t149r138b227],
55	active	JJ	O	active	amod	56	SENT_384	[p27l158t149r389b228],
56	enantiomer	NN	O	enantiomer	prep_of	52	SENT_384	[p27l411t149r908b227],
57	.	.	O	.	_	0	SENT_384	[p27l411t149r908b227],

1	In	IN	O	in	_	0	SENT_385	[p27l933t156r1019b226],
2	contrast	NN	O	contrast	prep_in	36	SENT_385	[p27l1040t165r1398b244],
3	,	,	O	,	_	0	SENT_385	[p27l1040t165r1398b244],
4	drugs	NNS	O	drug	nsubjpass	36	SENT_385	[p27l1425t149r1659b249],
5	that	WDT	O	that	nsubj	6	SENT_385	[p27l1682t148r1846b227],
6	impair	VBP	O	impair	rcmod	4	SENT_385	[p27l1861t149r2139b249],
7	the	DT	O	the	det	8	SENT_385	[p27l11t276r140b353],
8	metabolism	NN	O	metabolism	nsubj	18	SENT_385	[p27l174t275r679b354],
9	of	IN	O	of	_	0	SENT_385	[p27l713t275r814b354],
10	R-Warfarin	NN	O	r-warfarin	prep_of	8	SENT_385	[p27l826t275r1301b370],
11	,	,	O	,	_	0	SENT_385	[p27l826t275r1301b370],
12	such	JJ	O	such	_	0	SENT_385	[p27l1342t275r1536b355],
13	as	IN	O	as	_	0	SENT_385	[p27l1569t302r1653b353],
14	cimetidine	NN	O	cimetidine	prep_such_as	8	SENT_385	[p27l1689t276r2135b353],
15	and	CC	O	and	_	0	SENT_385	[p27l10t404r166b482],
16	omeprazole	NN	O	omeprazole	prep_such_as	8	SENT_385	[p27l198t403r720b504],
17	,	,	O	,	_	0	SENT_385	[p27l198t403r720b504],
18	have	VBP	O	have	ccomp	6	SENT_385	[p27l757t404r945b483],
19	only	RB	O	only	advmod	20	SENT_385	[p27l978t403r1160b504],
20	moderate	JJ	O	moderate	dobj	18	SENT_385	[p27l1186t404r1586b482],
21	potentiating	VBG	O	potentiate	partmod	20	SENT_385	[p27l1616t404r2139b504],
22	effects	NNS	O	effect	dobj	21	SENT_385	[p27l11t531r281b610],
23	on	IN	O	on	_	0	SENT_385	[p27l309t557r415b610],
24	anticoagulation	NN	O	anticoagulation	prep_on	21	SENT_385	[p27l439t532r1125b632],
25	;	:	O	;	_	0	SENT_385	[p27l439t532r1125b632],
26	thus	RB	O	thus	advmod	21	SENT_385	[p27l1154t532r1359b627],
27	,	,	O	,	_	0	SENT_385	[p27l1154t532r1359b627],
28	reducing	VBG	O	reduce	xcomp	21	SENT_385	[p27l1389t531r1766b632],
29	the	DT	O	the	det	30	SENT_385	[p27l1787t531r1916b610],
30	dose	NN	O	dose	dobj	28	SENT_385	[p27l1941t532r2135b610],
31	of	IN	O	of	_	0	SENT_385	[p27l11t659r112b738],
32	Warfarin	NNP	MISC	Warfarin	prep_of	30	SENT_385	[p27l114t659r474b739],
33	is	VBZ	O	be	auxpass	36	SENT_385	[p27l499t660r563b738],
34	generally	RB	O	generally	advmod	36	SENT_385	[p27l590t659r976b760],
35	not	RB	O	not	neg	36	SENT_385	[p27l997t676r1140b738],
36	required	VBN	O	require	_	0	SENT_385	[p27l1160t660r1539b760],
37	.	.	O	.	_	0	SENT_385	[p27l1160t660r1539b760],

1	The	DT	O	the	det	2	SENT_386	[p27l136t788r298b866],
2	5	CD	NUMBER	5	nsubjpass	68	SENT_386	[p27l321t794r388b866],
3	'	''	O	'	_	0	SENT_386	[p27l321t794r388b866],
4	regulatory	JJ	O	regulatory	amod	5	SENT_386	[p27l413t787r846b888],
5	region	NN	O	region	rcmod	2	SENT_386	[p27l862t788r1135b888],
6	of	IN	O	of	_	0	SENT_386	[p27l1157t787r1257b866],
7	the	DT	O	the	det	10	SENT_386	[p27l1260t788r1389b866],
8	CYPZC9	NN	O	cypzc9	nn	10	SENT_386	[p27l1410t794r1708b866],
9	gene	NN	O	gene	nn	10	SENT_386	[p27l1728t813r1927b888],
10	con	NN	O	con	prep_of	5	SENT_386	[p27l1949t813r2133b866],
11	—	CD	NUMBER	—	num	12	SENT_386	[p27l1949t813r2133b866],
12	tains	NNS	O	tain	dep	10	SENT_386	[p27l11t915r214b992],
13	a	DT	O	a	det	15	SENT_386	[p27l256t941r300b992],
14	PXR-RXR	NN	O	pxr-rxr	nn	15	SENT_386	[p27l338t921r762b998],
15	element	NN	O	element	dep	10	SENT_386	[p27l793t915r1154b1009],
16	;	:	O	;	_	0	SENT_386	[p27l793t915r1154b1009],
17	therefore	RB	O	therefore	advmod	10	SENT_386	[p27l1200t914r1607b1009],
18	,	,	O	,	_	0	SENT_386	[p27l1200t914r1607b1009],
19	as	IN	O	as	advmod	5	SENT_386	[p27l1652t941r1736b992],
20	with	IN	O	with	_	0	SENT_386	[p27l1775t915r1964b994],
21	the	DT	O	the	det	23	SENT_386	[p27l2006t914r2135b992],
22	CYP3A4	NN	O	cyp3a4	nn	23	SENT_386	[p27l11t1048r348b1121],
23	enzyme	NN	O	enzyme	prep_with	19	SENT_386	[p27l373t1068r718b1143],
24	,	,	O	,	_	0	SENT_386	[p27l373t1068r718b1143],
25	agents	NNS	O	agent	appos	2	SENT_386	[p27l747t1059r1020b1143],
26	such	JJ	O	such	_	0	SENT_386	[p27l1047t1043r1242b1122],
27	as	IN	O	as	_	0	SENT_386	[p27l1265t1069r1349b1121],
28	rifampin	NN	O	rifampin	prep_such_as	25	SENT_386	[p27l1375t1042r1767b1143],
29	,	,	O	,	_	0	SENT_386	[p27l1375t1042r1767b1143],
30	barbiturates	NNS	O	barbiturate	appos	2	SENT_386	[p27l1798t1043r2134b1122, p27l11t1187r234b1266],
31	,	,	O	,	_	0	SENT_386	[p27l1798t1043r2134b1122, p27l11t1187r234b1266],
32	carbamazepine	NN	O	carbamazepine	appos	2	SENT_386	[p27l274t1171r939b1271],
33	,	,	O	,	_	0	SENT_386	[p27l274t1171r939b1271],
34	and	CC	O	and	cc	40	SENT_386	[p27l978t1170r1134b1249],
35	St.	NNP	PERSON	St.	nn	36	SENT_386	[p27l1170t1176r1270b1249],
36	John	NNP	PERSON	John	poss	38	SENT_386	[p27l1300t1171r1574b1262],
37	’s	POS	O	’s	_	0	SENT_386	[p27l1300t1171r1574b1262],
38	Wort	NNP	O	Wort	nsubj	40	SENT_386	[p27l1605t1187r1806b1250],
39	will	MD	O	will	aux	40	SENT_386	[p27l1830t1171r1987b1250],
40	increase	VB	O	increase	dep	68	SENT_386	[p27l2020t1171r2134b1248, p27l11t1325r270b1377],
41	Warfarin	NNP	MISC	Warfarin	nn	42	SENT_386	[p27l301t1298r661b1378],
42	metabolism	NN	O	metabolism	dobj	40	SENT_386	[p27l696t1299r1201b1377],
43	and	CC	O	and	_	0	SENT_386	[p27l1235t1299r1390b1377],
44	the	DT	O	the	det	45	SENT_386	[p27l1426t1299r1555b1377],
45	likelihood	NN	O	likelihood	dobj	40	SENT_386	[p27l1589t1299r2017b1378],
46	of	IN	O	of	_	0	SENT_386	[p27l2053t1298r2153b1377],
47	nonefficacious	JJ	O	nonefficacious	amod	48	SENT_386	[p27l11t1426r631b1506],
48	therapy	NN	O	therapy	prep_of	45	SENT_386	[p27l665t1421r1184b1527],
49	.41	CD	NUMBER	.41	number	50	SENT_386	[p27l665t1421r1184b1527],
50	’42	CD	NUMBER	’42	npadvmod	40	SENT_386	[p27l665t1421r1184b1527],
51	In	IN	O	in	_	0	SENT_386	[p27l1215t1434r1302b1504],
52	these	DT	O	these	det	53	SENT_386	[p27l1335t1427r1553b1505],
53	cases	NNS	O	case	prep_in	40	SENT_386	[p27l1586t1453r1829b1522],
54	,	,	O	,	_	0	SENT_386	[p27l1586t1453r1829b1522],
55	a	DT	O	a	det	56	SENT_386	[p27l1866t1453r1910b1505],
56	dose	NN	O	dose	appos	53	SENT_386	[p27l1941t1427r2135b1505],
57	of	IN	O	of	_	0	SENT_386	[p27l11t1554r112b1633],
58	Warfarin	NNP	MISC	Warfarin	prep_of	56	SENT_386	[p27l110t1554r471b1634],
59	increased	VBN	O	increase	partmod	58	SENT_386	[p27l491t1555r892b1633],
60	by	IN	O	by	_	0	SENT_386	[p27l914t1554r1011b1655],
61	a	DT	O	a	det	62	SENT_386	[p27l1028t1581r1072b1633],
62	factor	NN	O	factor	agent	59	SENT_386	[p27l1092t1554r1338b1633],
63	of	IN	O	of	_	0	SENT_386	[p27l1357t1554r1458b1633],
64	two	CD	NUMBER	two	number	66	SENT_386	[p27l1461t1571r1613b1634],
65	to	TO	O	to	dep	66	SENT_386	[p27l1636t1571r1715b1633],
66	four	CD	NUMBER	four	prep_of	62	SENT_386	[p27l1738t1554r1916b1634],
67	is	VBZ	O	be	auxpass	68	SENT_386	[p27l1933t1555r1998b1633],
68	required	VBN	O	require	_	0	SENT_386	[p27l2022t1581r2134b1633, p27l11t1683r282b1783],
69	to	TO	O	to	aux	70	SENT_386	[p27l322t1699r401b1761],
70	maintain	VB	O	maintain	xcomp	68	SENT_386	[p27l442t1683r823b1761],
71	effective	JJ	O	effective	amod	72	SENT_386	[p27l864t1682r1208b1762],
72	anticoagulation	NN	O	anticoagulation	dobj	70	SENT_386	[p27l1247t1682r1932b1783],
73	.	.	O	.	_	0	SENT_386	[p27l1247t1682r1932b1783],

1	The	DT	O	the	det	2	SENT_387	[p27l1973t1682r2135b1761],
2	dose	NN	O	dose	nsubjpass	6	SENT_387	[p27l11t1811r203b1889],
3	must	MD	O	must	aux	6	SENT_387	[p27l224t1827r440b1890],
4	be	VB	O	be	auxpass	6	SENT_387	[p27l456t1811r551b1889],
5	appropriately	RB	O	appropriately	advmod	6	SENT_387	[p27l572t1811r1132b1911],
6	reduced	VBN	O	reduce	_	0	SENT_387	[p27l1149t1810r1481b1890],
7	once	IN	DATE	once	mark	14	SENT_387	[p27l1502t1836r1697b1889],
8	the	DT	O	the	det	10	SENT_387	[p27l1719t1811r1847b1889],
9	inducing	VBG	O	induce	amod	10	SENT_387	[p27l1867t1811r2134b1890, p27l10t1939r148b2039],
10	agent	NN	O	agent	nsubjpass	14	SENT_387	[p27l170t1955r406b2039],
11	is	VBZ	O	be	auxpass	14	SENT_387	[p27l425t1939r490b2017],
12	no	RB	O	no	advmod	13	SENT_387	[p27l517t1964r623b2017],
13	longer	RB	O	longer	advmod	14	SENT_387	[p27l647t1938r924b2039],
14	administered	VBN	O	administer	advcl	6	SENT_387	[p27l945t1939r1526b2034],
15	,	,	O	,	_	0	SENT_387	[p27l945t1939r1526b2034],
16	since	IN	O	since	mark	23	SENT_387	[p27l1557t1939r1770b2017],
17	the	DT	O	the	det	18	SENT_387	[p27l1795t1939r1925b2017],
18	level	NN	O	level	nsubj	23	SENT_387	[p27l1949t1939r2135b2018],
19	of	IN	O	of	_	0	SENT_387	[p27l11t2066r112b2145],
20	CYPZC9	NN	O	cypzc9	nn	21	SENT_387	[p27l121t2072r458b2145],
21	activity	NN	O	activity	prep_of	18	SENT_387	[p27l485t2067r780b2167],
22	will	MD	O	will	aux	23	SENT_387	[p27l798t2067r955b2146],
23	return	VB	O	return	advcl	14	SENT_387	[p27l981t2083r1241b2146],
24	to	TO	O	to	_	0	SENT_387	[p27l1268t2083r1347b2145],
25	its	PRP$	O	its	poss	28	SENT_387	[p27l1375t2067r1470b2145],
26	lower	JJR	O	lower	dep	27	SENT_387	[p27l1498t2066r1736b2146],
27	constitutive	JJ	O	constitutive	amod	28	SENT_387	[p27l1761t2067r2134b2146, p27l11t2195r153b2274],
28	level	NN	O	level	prep_to	23	SENT_387	[p27l173t2194r361b2274],
29	over	IN	O	over	_	0	SENT_387	[p27l381t2220r559b2274],
30	a	DT	O	a	det	31	SENT_387	[p27l576t2221r621b2273],
31	period	NN	O	period	prep_over	28	SENT_387	[p27l639t2194r912b2295],
32	of	IN	O	of	_	0	SENT_387	[p27l934t2194r1034b2273],
33	several	JJ	DURATION	several	amod	34	SENT_387	[p27l1038t2195r1322b2274],
34	Weeks	NNS	DURATION	week	prep_of	31	SENT_387	[p27l1338t2194r1624b2274],
35	.	.	O	.	_	0	SENT_387	[p27l1338t2194r1624b2274],

1	Given	VBN	O	give	prep	18	SENT_388	[p27l1650t2195r1895b2274],
2	these	DT	O	these	det	3	SENT_388	[p27l1916t2194r2135b2273],
3	considerations	NNS	O	consideration	dep	1	SENT_388	[p27l11t2322r632b2401],
4	and	CC	O	and	_	0	SENT_388	[p27l661t2323r816b2401],
5	the	DT	O	the	det	7	SENT_388	[p27l844t2322r973b2401],
6	large	JJ	O	large	amod	7	SENT_388	[p27l999t2322r1207b2423],
7	number	NN	O	number	conj_and	3	SENT_388	[p27l1235t2323r1571b2402],
8	of	IN	O	of	_	0	SENT_388	[p27l1596t2322r1697b2401],
9	drugs	NNS	O	drug	prep_of	7	SENT_388	[p27l1706t2322r1944b2423],
10	that	WDT	O	that	nsubj	12	SENT_388	[p27l1973t2323r2140b2401],
11	potentially	RB	O	potentially	advmod	12	SENT_388	[p27l9t2450r460b2551],
12	interact	VBP	O	interact	rcmod	9	SENT_388	[p27l491t2451r815b2529],
13	with	IN	O	with	_	0	SENT_388	[p27l841t2451r1030b2530],
14	Warfarin	NNP	O	Warfarin	prep_with	12	SENT_388	[p27l1061t2450r1445b2546],
15	,	,	O	,	_	0	SENT_388	[p27l1061t2450r1445b2546],
16	it	PRP	O	it	nsubj	20	SENT_388	[p27l1485t2451r1545b2529],
17	is	VBZ	O	be	cop	18	SENT_388	[p27l1575t2451r1640b2529],
18	reasonable	JJ	O	reasonable	_	0	SENT_388	[p27l1678t2451r2135b2529],
19	and	CC	O	and	_	0	SENT_388	[p27l10t2578r166b2657],
20	prudent	JJ	O	prudent	conj_and	18	SENT_388	[p27l186t2579r526b2679],
21	to	TO	O	to	aux	22	SENT_388	[p27l543t2595r622b2657],
22	monitor	VB	O	monitor	xcomp	18	SENT_388	[p27l645t2579r993b2657],
23	the	DT	O	the	det	24	SENT_388	[p27l1012t2579r1141b2657],
24	level	NN	O	level	dobj	22	SENT_388	[p27l1162t2579r1349b2658],
25	of	IN	O	of	_	0	SENT_388	[p27l1371t2578r1472b2657],
26	anticoagulation	NN	O	anticoagulation	prep_of	24	SENT_388	[p27l1474t2579r2135b2679],
27	more	RBR	O	more	advmod	28	SENT_388	[p27l11t2732r231b2785],
28	frequently	RB	O	frequently	advmod	22	SENT_388	[p27l273t2706r705b2807],
29	when	WRB	O	when	advmod	33	SENT_388	[p27l739t2707r972b2786],
30	interacting	VBG	O	interact	amod	31	SENT_388	[p27l1014t2707r1476b2807],
31	drugs	NNS	O	drug	nsubjpass	33	SENT_388	[p27l1516t2706r1753b2807],
32	are	VBP	O	be	auxpass	33	SENT_388	[p27l1798t2733r1923b2785],
33	prescribed	VBN	O	prescribe	dep	28	SENT_388	[p27l1964t2733r2134b2807, p27l12t2835r339b2914],
34	.	.	O	.	_	0	SENT_388	[p27l1964t2733r2134b2807, p27l12t2835r339b2914],

1	FUTURE	JJ	DATE	future	amod	2	SENT_389	[p27l415t3151r856b3210],
2	PERSPECTIVES	NNS	O	perspective	_	0	SENT_389	[p27l911t3151r1719b3210],

1	Interindividual	JJ	O	interindividual	amod	2	SENT_390	[p27l9t3345r628b3425],
2	differences	NNS	O	difference	nsubj	10	SENT_390	[p27l650t3345r1107b3424],
3	in	IN	O	in	_	0	SENT_390	[p27l1130t3346r1211b3423],
4	drug	NN	O	drug	nn	5	SENT_390	[p27l1233t3345r1431b3446],
5	response	NN	O	response	prep_in	2	SENT_390	[p27l1449t3371r1824b3446],
6	are	VBP	O	be	cop	7	SENT_390	[p27l1846t3372r1970b3424],
7	important	JJ	O	important	_	0	SENT_390	[p27l1991t3346r2135b3423, p27l9t3490r327b3574],
8	and	CC	O	and	_	0	SENT_390	[p27l353t3473r508b3552],
9	can	MD	O	can	aux	10	SENT_390	[p27l540t3499r685b3552],
10	cause	VB	O	cause	conj_and	7	SENT_390	[p27l717t3500r947b3553],
11	problems	NNS	O	problem	dobj	10	SENT_390	[p27l977t3473r1379b3574],
12	when	WRB	O	when	advmod	16	SENT_390	[p27l1408t3474r1642b3553],
13	a	DT	O	a	det	14	SENT_390	[p27l1673t3500r1717b3552],
14	person	NN	O	person	nsubjpass	16	SENT_390	[p27l1746t3499r2037b3574],
15	is	VBZ	O	be	auxpass	16	SENT_390	[p27l2067t3474r2132b3552],
16	prescribed	VBN	O	prescribe	advcl	10	SENT_390	[p27l9t3601r455b3702],
17	a	DT	O	a	det	18	SENT_390	[p27l480t3628r525b3680],
18	drug	NN	O	drug	dobj	16	SENT_390	[p27l549t3602r748b3702],
19	With	IN	O	with	_	0	SENT_390	[p27l767t3601r956b3681],
20	a	DT	O	a	det	23	SENT_390	[p27l981t3628r1025b3680],
21	narrow	JJ	O	narrow	amod	23	SENT_390	[p27l1049t3627r1354b3681],
22	therapeutic	JJ	O	therapeutic	amod	23	SENT_390	[p27l1377t3602r1852b3702],
23	index	NN	O	index	prep_with	18	SENT_390	[p27l1876t3602r2130b3680],
24	.	.	O	.	_	0	SENT_390	[p27l1876t3602r2130b3680],

1	Pharmacodynamics	NNS	O	pharmacodynamic	nsubj	33	SENT_391	[p28l9t21r826b121],
2	related	VBN	O	relate	partmod	1	SENT_391	[p28l850t20r1131b99],
3	to	TO	O	to	_	0	SENT_391	[p28l1153t37r1230b99],
4	drug	NN	O	drug	nn	6	SENT_391	[p28l1254t20r1731b121],
5	—	NN	O	—	nn	6	SENT_391	[p28l1254t20r1731b121],
6	target	NN	O	target	prep_to	2	SENT_391	[p28l1254t20r1731b121],
7	“	CD	NUMBER	“	num	8	SENT_391	[p28l1751t21r2135b100, p28l10t149r170b249],
8	sensitivity	NN	O	sensitivity	nsubj	19	SENT_391	[p28l1751t21r2135b100, p28l10t149r170b249],
9	,	,	O	,	_	0	SENT_391	[p28l1751t21r2135b100, p28l10t149r170b249],
10	”	CD	NUMBER	”	appos	8	SENT_391	[p28l1751t21r2135b100, p28l10t149r170b249],
11	determined	VBN	O	determine	partmod	10	SENT_391	[p28l202t148r681b227],
12	by	IN	O	by	_	0	SENT_391	[p28l709t149r805b249],
13	genetics	NNS	O	genetics	agent	11	SENT_391	[p28l828t149r1168b249],
14	and	CC	O	and	_	0	SENT_391	[p28l1197t149r1352b227],
15	other	JJ	O	other	amod	16	SENT_391	[p28l1380t149r1601b227],
16	factors	NNS	O	factor	agent	11	SENT_391	[p28l1625t148r1932b244],
17	,	,	O	,	_	0	SENT_391	[p28l1625t148r1932b244],
18	may	MD	O	may	aux	19	SENT_391	[p28l1964t175r2140b249],
19	contribute	VB	O	contribute	rcmod	6	SENT_391	[p28l11t271r557b372],
20	,	,	O	,	_	0	SENT_391	[p28l11t271r557b372],
21	”	NN	O	”	dobj	2	SENT_391	[p28l11t271r557b372],
22	but	CC	O	but	prep	21	SENT_391	[p28l592t277r733b356],
23	pharmacokinetic	JJ	O	pharmacokinetic	amod	24	SENT_391	[p28l760t277r1478b377],
24	considerations	NNS	O	consideration	dep	22	SENT_391	[p28l1513t277r2132b355],
25	related	VBN	O	relate	partmod	24	SENT_391	[p28l11t404r294b483],
26	to	TO	O	to	_	0	SENT_391	[p28l315t421r394b483],
27	drug	NN	O	drug	nn	28	SENT_391	[p28l418t404r615b505],
28	disposition	NN	O	disposition	prep_to	25	SENT_391	[p28l635t404r1103b505],
29	and	CC	O	and	_	0	SENT_391	[p28l1124t405r1279b483],
30	metabolism	NN	O	metabolism	prep_to	25	SENT_391	[p28l1301t405r1801b483],
31	are	VBP	O	be	cop	33	SENT_391	[p28l1822t431r1948b483],
32	also	RB	O	also	advmod	33	SENT_391	[p28l1968t405r2135b483],
33	important	JJ	O	important	_	0	SENT_391	[p28l10t535r462b634],
34	.	.	O	.	_	0	SENT_391	[p28l10t535r462b634],

1	The	DT	O	the	det	3	SENT_392	[p28l136t662r300b741],
2	clinical	JJ	O	clinical	amod	3	SENT_392	[p28l335t663r643b741],
3	consequence	NN	O	consequence	nsubjpass	16	SENT_392	[p28l678t688r1233b763],
4	of	IN	O	of	_	0	SENT_392	[p28l1269t662r1371b741],
5	drug	NN	O	drug	nn	6	SENT_392	[p28l1387t662r1589b763],
6	interactions	NNS	O	interaction	prep_of	3	SENT_392	[p28l1620t663r2132b741],
7	that	WDT	O	that	nsubj	8	SENT_392	[p28l11t791r175b869],
8	involve	VBP	O	involve	rcmod	6	SENT_392	[p28l189t790r479b870],
9	drug	NN	O	drug	nn	10	SENT_392	[p28l500t790r696b891],
10	metabolism	NN	O	metabolism	dobj	8	SENT_392	[p28l713t791r1211b869],
11	is	VBZ	O	be	auxpass	13	SENT_392	[p28l1230t791r1294b869],
12	well	RB	O	well	advmod	13	SENT_392	[p28l1312t791r1485b870],
13	recognized	VBN	O	recognize	_	0	SENT_392	[p28l1504t790r1963b891],
14	and	CC	O	and	_	0	SENT_392	[p28l1982t791r2136b869],
15	is	VBZ	O	be	auxpass	16	SENT_392	[p28l10t919r75b997],
16	emphasized	VBN	O	emphasize	conj_and	13	SENT_392	[p28l101t918r610b1019],
17	by	IN	O	by	_	0	SENT_392	[p28l634t918r731b1019],
18	blacl	NN	O	blacl	agent	16	SENT_392	[p28l751t919r1166b998],
19	<	JJR	O	<	acomp	13	SENT_392	[p28l751t919r1166b998],
20	.	.	O	.	_	0	SENT_392	[p28l751t919r1166b998],

1	—	NN	O	—	_	0	SENT_393	[p28l751t919r1166b998],
2	.	.	O	.	_	0	SENT_393	[p28l751t919r1166b998],

1	boX	NN	O	box	nn	4	SENT_394	[p28l751t919r1166b998],
2	and	CC	O	and	_	0	SENT_394	[p28l1186t919r1342b997],
3	other	JJ	O	other	nn	4	SENT_394	[p28l1367t919r1590b997],
4	warnings	NNS	O	warning	_	0	SENT_394	[p28l1607t919r2002b1019],
5	on	IN	O	on	prep	4	SENT_394	[p28l2029t944r2135b997],

1	N	NN	O	n	nn	3	SENT_395	[p28l519t1100r533b1115],
2	ENGLJ	NN	O	englj	nn	3	SENT_395	[p28l548t1099r632b1121],
3	MED	NN	O	med	_	0	SENT_395	[p28l647t1100r700b1115],
4	352	CD	NUMBER	352	num	6	SENT_395	[p28l712t1099r788b1121],
5	;	:	O	;	_	0	SENT_395	[p28l712t1099r788b1121],
6	21	CD	NUMBER	21	dep	3	SENT_395	[p28l712t1099r788b1121],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_395	[p28l825t1099r1037b1121],
8	MAY	NNP	DATE	MAY	dep	6	SENT_395	[p28l1076t1099r1127b1115],
9	26	CD	DATE	26	num	8	SENT_395	[p28l1139t1094r1178b1119],
10	,	,	DATE	,	_	0	SENT_395	[p28l1139t1094r1178b1119],
11	2005	CD	DATE	2005	num	8	SENT_395	[p28l1191t1099r1254b1121],
12	2219	CD	DATE	2219	dep	3	SENT_395	[p28l1940t1098r2016b1120],

1	The	DT	O	the	det	4	SENT_396	[p28l702t1132r753b1156],
2	New	NNP	O	New	nn	4	SENT_396	[p28l762t1133r824b1156],
3	England	NNP	O	England	nn	4	SENT_396	[p28l833t1132r944b1163],
4	Joumal	NNP	O	Joumal	_	0	SENT_396	[p28l953t1132r1050b1156],
5	of	IN	O	of	_	0	SENT_396	[p28l1060t1132r1089b1156],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_396	[p28l1095t1132r1220b1156],

1	Downloaded	VBN	O	download	_	0	SENT_397	[p28l144t1173r314b1196],
2	from	IN	O	from	_	0	SENT_397	[p28l323t1173r387b1196],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_397	[p28l396t1173r514b1203],
4	at	IN	O	at	_	0	SENT_397	[p28l524t1177r548b1196],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_397	[p28l556t1173r739b1196],
6	on	IN	O	on	_	0	SENT_397	[p28l748t1180r780b1196],
7	January	NNP	DATE	January	prep_on	1	SENT_397	[p28l789t1173r892b1203],
8	5	CD	DATE	5	num	7	SENT_397	[p28l902t1173r924b1201],
9	,	,	DATE	,	_	0	SENT_397	[p28l902t1173r924b1201],
10	2014	CD	DATE	2014	num	7	SENT_397	[p28l935t1173r1007b1196],
11	.	.	O	.	_	0	SENT_397	[p28l935t1173r1007b1196],

1	For	IN	O	for	_	0	SENT_398	[p28l1018t1173r1064b1196],
2	personal	JJ	O	personal	amod	3	SENT_398	[p28l1072t1173r1185b1203],
3	use	NN	O	use	pobj	1	SENT_398	[p28l1194t1180r1237b1196],
4	only	RB	O	only	advmod	3	SENT_398	[p28l1247t1173r1312b1203],
5	.	.	O	.	_	0	SENT_398	[p28l1247t1173r1312b1203],

1	No	DT	O	no	det	3	SENT_399	[p28l1322t1173r1362b1196],
2	other	JJ	O	other	amod	3	SENT_399	[p28l1372t1173r1440b1196],
3	uses	NNS	O	use	_	0	SENT_399	[p28l1449t1180r1504b1196],
4	without	IN	O	without	_	0	SENT_399	[p28l1515t1173r1616b1196],
5	permission	NN	O	permission	prep_without	3	SENT_399	[p28l1624t1173r1777b1203],
6	.	.	O	.	_	0	SENT_399	[p28l1624t1173r1777b1203],

1	Copyright	NN	O	copyright	_	0	SENT_400	[p28l494t1214r629b1245],
2	©	CD	NUMBER	©	num	6	SENT_400	[p28l638t1214r661b1238],
3	2005	CD	DATE	2005	num	6	SENT_400	[p28l672t1214r736b1238],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_400	[p28l746t1214r937b1238],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_400	[p28l947t1214r1055b1238],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_400	[p28l1065t1214r1170b1245],
7	.	.	O	.	_	0	SENT_400	[p28l1065t1214r1170b1245],

1	All	DT	O	all	det	2	SENT_401	[p28l1181t1214r1223b1238],
2	rights	NNS	O	rights	nsubj	3	SENT_401	[p28l1232t1214r1307b1245],
3	reserved	VBN	O	reserve	_	0	SENT_401	[p28l1316t1214r1435b1238],
4	.	.	O	.	_	0	SENT_401	[p28l1316t1214r1435b1238],

1	The	DT	O	the	det	4	SENT_402	[p28l715t1320r752b1341],
2	NEW	NNP	O	NEW	nn	4	SENT_402	[p28l764t1322r845b1341],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_402	[p28l859t1322r1034b1341],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_402	[p28l1048t1322r1214b1348],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_402	[p28l1228t1320r1444b1347],

1	drug	NN	O	drug	nn	2	SENT_403	[p28l11t1543r215b1644],
2	labels	NNS	O	label	_	0	SENT_403	[p28l244t1544r519b1622],
3	.	.	O	.	_	0	SENT_403	[p28l244t1544r519b1622],

1	Indeed	RB	O	indeed	advmod	24	SENT_404	[p28l557t1543r879b1639],
2	,	,	O	,	_	0	SENT_404	[p28l557t1543r879b1639],
3	several	JJ	O	several	nsubjpass	24	SENT_404	[p28l920t1544r1212b1623],
4	approved	VBN	O	approve	dep	3	SENT_404	[p28l1245t1543r1646b1644],
5	and	CC	O	and	_	0	SENT_404	[p28l1679t1543r1838b1622],
6	widely	RB	O	widely	advmod	7	SENT_404	[p28l1867t1543r2151b1644],
7	used	VBN	O	use	dep	3	SENT_404	[p28l10t1671r202b1751],
8	drugs	NNS	O	drug	dobj	7	SENT_404	[p28l225t1672r459b1772],
9	(	CD	NUMBER	(	num	11	SENT_404	[p28l487t1679r580b1763],
10	e.	NN	O	e.	nn	11	SENT_404	[p28l487t1679r580b1763],
11	g.	NN	O	g.	dobj	4	SENT_404	[p28l589t1698r689b1772],
12	,	,	O	,	_	0	SENT_404	[p28l589t1698r689b1772],
13	terfenadine	NN	O	terfenadine	conj_and	11	SENT_404	[p28l716t1671r1209b1767],
14	,	,	O	,	_	0	SENT_404	[p28l716t1671r1209b1767],
15	astemizole	NN	O	astemizole	conj_and	11	SENT_404	[p28l1235t1672r1705b1767],
16	,	,	O	,	_	0	SENT_404	[p28l1235t1672r1705b1767],
17	and	CC	O	and	_	0	SENT_404	[p28l1731t1672r1885b1750],
18	mibe	NN	O	mibe	nn	20	SENT_404	[p28l1906t1672r2148b1750],
19	—	NN	O	—	nn	20	SENT_404	[p28l1906t1672r2148b1750],
20	fradil	NN	O	fradil	dobj	4	SENT_404	[p28l10t1800r258b1892],
21	)	CD	NUMBER	)	dep	20	SENT_404	[p28l10t1800r258b1892],
22	have	VBP	O	have	aux	24	SENT_404	[p28l283t1800r472b1880],
23	been	VBN	O	be	auxpass	24	SENT_404	[p28l496t1801r697b1879],
24	removed	VBN	O	remove	_	0	SENT_404	[p28l718t1800r1085b1880],
25	from	IN	O	from	_	0	SENT_404	[p28l1107t1800r1316b1879],
26	the	DT	O	the	det	27	SENT_404	[p28l1339t1801r1469b1879],
27	market	NN	O	market	prep_from	24	SENT_404	[p28l1491t1800r1796b1880],
28	because	IN	O	because	_	0	SENT_404	[p28l1814t1801r2147b1880],
29	of	IN	O	of	_	0	SENT_404	[p28l11t1928r111b2007],
30	the	DT	O	the	det	33	SENT_404	[p28l114t1928r242b2007],
31	serious	JJ	O	serious	amod	33	SENT_404	[p28l265t1929r562b2008],
32	adverse	JJ	O	adverse	amod	33	SENT_404	[p28l584t1929r896b2008],
33	effects	NNS	O	effect	prep_because_of	24	SENT_404	[p28l917t1928r1186b2007],
34	that	WDT	O	that	nsubj	35	SENT_404	[p28l1209t1929r1375b2007],
35	followed	VBD	O	follow	rcmod	33	SENT_404	[p28l1390t1928r1756b2008],
36	concomitant	JJ	O	concomitant	amod	37	SENT_404	[p28l1777t1954r2147b2007, p28l10t2057r214b2135],
37	administration	NN	O	administration	dobj	35	SENT_404	[p28l256t2056r902b2135],
38	with	IN	O	with	_	0	SENT_404	[p28l946t2057r1139b2136],
39	other	JJ	O	other	prep_with	35	SENT_404	[p28l1189t2057r1418b2135],
40	commonly	RB	O	commonly	advmod	41	SENT_404	[p28l1464t2057r1930b2157],
41	prescribed	VBN	O	prescribe	partmod	39	SENT_404	[p28l1972t2083r2145b2157, p28l12t2184r324b2263],
42	drugs	NNS	O	drug	dobj	41	SENT_404	[p28l364t2185r600b2285],
43	metabolized	VBN	O	metabolize	partmod	42	SENT_404	[p28l637t2184r1159b2263],
44	by	IN	O	by	_	0	SENT_404	[p28l1195t2185r1291b2285],
45	CYP3A	NN	O	cyp3a	agent	43	SENT_404	[p28l1322t2190r1630b2263],
46	.	.	O	.	_	0	SENT_404	[p28l1322t2190r1630b2263],

1	Elucidation	NN	O	elucidation	nsubj	22	SENT_405	[p28l1668t2185r2148b2264],
2	of	IN	O	of	_	0	SENT_405	[p28l11t2312r113b2391],
3	the	DT	O	the	det	4	SENT_405	[p28l125t2313r258b2391],
4	mechanisms	NNS	O	mechanism	prep_of	1	SENT_405	[p28l288t2313r837b2391],
5	ofspeciﬁc	JJ	O	ofspeciﬁc	amod	6	SENT_405	[p28l869t2312r1313b2413],
6	interactions	NNS	O	interaction	dep	1	SENT_405	[p28l1343t2313r1884b2408],
7	,	,	O	,	_	0	SENT_405	[p28l1343t2313r1884b2408],
8	especially	RB	O	especially	advmod	1	SENT_405	[p28l1921t2339r2145b2413, p28l11t2440r235b2541],
9	those	DT	O	those	det	17	SENT_405	[p28l259t2441r484b2519],
10	related	JJ	O	related	amod	17	SENT_405	[p28l511t2440r794b2519],
11	to	TO	O	to	_	0	SENT_405	[p28l821t2457r899b2519],
12	the	DT	O	the	det	13	SENT_405	[p28l928t2440r1056b2519],
13	enzymes	NNS	O	enzyme	prep_to	10	SENT_405	[p28l1083t2466r1444b2541],
14	involved	VBN	O	involve	partmod	13	SENT_405	[p28l1472t2440r1820b2520],
15	in	IN	O	in	_	0	SENT_405	[p28l1845t2441r1926b2518],
16	drug	NN	O	drug	prep_in	14	SENT_405	[p28l1953t2440r2152b2541],
17	metabolism	NN	O	metabolism	dep	1	SENT_405	[p28l10t2568r536b2664],
18	,	,	O	,	_	0	SENT_405	[p28l10t2568r536b2664],
19	can	MD	O	can	aux	22	SENT_405	[p28l568t2594r711b2647],
20	and	CC	O	and	cc	22	SENT_405	[p28l736t2569r891b2647],
21	should	MD	O	should	aux	22	SENT_405	[p28l918t2568r1204b2648],
22	alert	VB	O	alert	_	0	SENT_405	[p28l1228t2568r1417b2647],
23	physicians	NNS	O	physician	dobj	22	SENT_405	[p28l1436t2568r1875b2669],
24	to	TO	O	to	_	0	SENT_405	[p28l1904t2585r1982b2647],
25	potential	JJ	O	potential	amod	26	SENT_405	[p28l2007t2594r2147b2669, p28l11t2696r276b2775],
26	problems	NNS	O	problem	prep_to	22	SENT_405	[p28l320t2697r724b2797],
27	if	IN	O	if	mark	32	SENT_405	[p28l771t2696r847b2774],
28	certain	JJ	O	certain	amod	29	SENT_405	[p28l874t2697r1165b2775],
29	drugs	NNS	O	drug	nsubj	32	SENT_405	[p28l1212t2697r1450b2797],
30	are	VBP	O	be	cop	32	SENT_405	[p28l1497t2723r1624b2775],
31	coadminis	JJ	O	coadminis	amod	32	SENT_405	[p28l1670t2696r2147b2775],
32	—	NN	O	—	advcl	22	SENT_405	[p28l1670t2696r2147b2775],
33	tered	VBN	O	ter	partmod	32	SENT_405	[p28l11t2824r241b2903],
34	.	.	O	.	_	0	SENT_405	[p28l11t2824r241b2903],

1	The	DT	ORGANIZATION	the	det	5	SENT_406	[p28l263t2824r424b2903],
2	Food	NNP	ORGANIZATION	Food	nn	5	SENT_406	[p28l443t2825r655b2903],
3	and	CC	ORGANIZATION	and	_	0	SENT_406	[p28l674t2825r829b2903],
4	Drug	NNP	ORGANIZATION	Drug	conj_and	2	SENT_406	[p28l848t2831r1064b2925],
5	Administration	NNP	ORGANIZATION	Administration	nsubj	9	SENT_406	[p28l1078t2825r1717b2903],
6	(	CD	NUMBER	(	num	8	SENT_406	[p28l1742t2831r1981b2916],
7	FDA	NNP	ORGANIZATION	FDA	nn	8	SENT_406	[p28l1742t2831r1981b2916],
8	)	NN	O	)	nsubj	9	SENT_406	[p28l1742t2831r1981b2916],
9	has	VBZ	O	have	_	0	SENT_406	[p28l2007t2824r2147b2903],
10	a	DT	O	a	det	14	SENT_406	[p28l10t2979r54b3031],
11	self	NN	O	self	nn	14	SENT_406	[p28l86t2952r629b3053],
12	—	NN	O	—	nn	14	SENT_406	[p28l86t2952r629b3053],
13	teaching	NN	O	teaching	nn	14	SENT_406	[p28l86t2952r629b3053],
14	tutorial	NN	O	tutorial	dobj	9	SENT_406	[p28l658t2953r962b3032],
15	on	IN	O	on	_	0	SENT_406	[p28l994t2978r1100b3031],
16	this	DT	O	this	det	17	SENT_406	[p28l1132t2952r1283b3031],
17	topic	NN	O	topic	prep_on	14	SENT_406	[p28l1317t2953r1526b3053],
18	at	IN	O	at	_	0	SENT_406	[p28l1556t2969r1635b3031],
19	its	PRP$	O	its	poss	21	SENT_406	[p28l1661t2953r1756b3031],
20	Web	NN	O	web	nn	21	SENT_406	[p28l1786t2953r1973b3031],
21	site	NN	O	site	prep_at	17	SENT_406	[p28l2007t2953r2148b3031],
22	(	CD	NUMBER	(	npadvmod	23	SENT_406	[p28l15t3080r398b3172],
23	available	JJ	O	available	amod	14	SENT_406	[p28l15t3080r398b3172],
24	at	IN	O	at	_	0	SENT_406	[p28l417t3097r495b3159],
25	W.	NNP	O	W.	nn	26	SENT_406	[p28l504t3108r737b3160],
26	fda	NN	O	fda	prep_at	9	SENT_406	[p28l746t3080r1077b3181],
27	.	.	O	.	_	0	SENT_406	[p28l746t3080r1077b3181],

1	gov	NN	O	gov	_	0	SENT_407	[p28l746t3080r1077b3181],
2	/	:	O	/	punct	1	SENT_407	[p28l746t3080r1077b3181],
3	cderl	NN	O	cderl	nn	5	SENT_407	[p28l1084t3080r1285b3171],
4	drugl	NN	O	drugl	nn	5	SENT_407	[p28l1292t3081r1512b3181],
5	drugReactions	NNS	O	drugreaction	nsubj	7	SENT_407	[p28l1518t3080r2118b3181],
6	I	PRP	O	I	dep	5	SENT_407	[p28l2124t3086r2147b3170],
7	default	VBP	O	default	dep	1	SENT_407	[p28l11t3209r559b3301],
8	.	.	O	.	_	0	SENT_407	[p28l11t3209r559b3301],

1	htm	NN	O	htm	_	0	SENT_408	[p28l11t3209r559b3301],
2	)	NN	O	)	dep	1	SENT_408	[p28l11t3209r559b3301],
3	.	.	O	.	_	0	SENT_408	[p28l11t3209r559b3301],

1	For	IN	O	for	_	0	SENT_409	[p28l138t3345r284b3416],
2	many	JJ	O	many	amod	3	SENT_409	[p28l306t3363r542b3438],
3	years	NNS	DURATION	year	prep_for	10	SENT_409	[p28l558t3364r799b3438],
4	,	,	O	,	_	0	SENT_409	[p28l558t3364r799b3438],
5	there	EX	O	there	expl	10	SENT_409	[p28l830t3338r1044b3416],
6	has	VBZ	O	have	aux	10	SENT_409	[p28l1069t3337r1212b3416],
7	been	VBN	O	be	cop	10	SENT_409	[p28l1239t3338r1440b3416],
8	strong	JJ	O	strong	amod	10	SENT_409	[p28l1467t3354r1743b3438],
9	scientiﬁc	NN	O	scientiﬁc	nn	10	SENT_409	[p28l1767t3337r2148b3416],
10	evidence	NN	O	evidence	_	0	SENT_409	[p28l11t3465r374b3545],
11	that	IN	O	that	complm	21	SENT_409	[p28l414t3466r581b3544],
12	the	DT	O	the	det	13	SENT_409	[p28l616t3466r746b3544],
13	presence	NN	O	presence	nsubj	21	SENT_409	[p28l784t3491r1160b3566],
14	of	IN	O	of	_	0	SENT_409	[p28l1200t3465r1301b3544],
15	variant	JJ	O	variant	amod	20	SENT_409	[p28l1317t3466r1614b3545],
16	cytochrome	NN	O	cytochrome	nn	20	SENT_409	[p28l1649t3466r2147b3566],
17	P	NN	O	p	nn	20	SENT_409	[p28l9t3599r253b3672],
18	—	CD	NUMBER	—	num	20	SENT_409	[p28l9t3599r253b3672],
19	45O	NN	O	45o	nn	20	SENT_409	[p28l9t3599r253b3672],
20	alleles	NNS	O	allele	prep_of	13	SENT_409	[p28l280t3593r541b3672],
21	has	VBZ	O	have	ccomp	10	SENT_409	[p28l569t3594r711b3672],
22	important	JJ	O	important	amod	24	SENT_409	[p28l739t3594r1175b3694],
23	clinical	JJ	O	clinical	amod	24	SENT_409	[p28l1197t3593r1499b3672],
24	consequences	NNS	O	consequence	dobj	21	SENT_409	[p28l1526t3619r2144b3694],
25	;	:	O	;	_	0	SENT_409	[p28l1526t3619r2144b3694],

1	nevertheless	RB	O	nevertheless	advmod	10	SENT_410	[p29l10t21r550b116],
2	,	,	O	,	_	0	SENT_410	[p29l10t21r550b116],
3	a	DT	O	a	det	4	SENT_410	[p29l579t47r624b99],
4	patient	NN	O	patient	poss	7	SENT_410	[p29l644t21r1004b121],
5	’s	POS	O	’s	_	0	SENT_410	[p29l644t21r1004b121],
6	particular	JJ	O	particular	amod	7	SENT_410	[p29l1029t20r1437b121],
7	genotype	NN	O	genotype	nsubjpass	10	SENT_410	[p29l1457t37r1839b121],
8	is	VBZ	O	be	auxpass	10	SENT_410	[p29l1862t21r1926b99],
9	rarely	RB	O	rarely	advmod	10	SENT_410	[p29l1952t47r2147b99, p29l10t149r81b249],
10	determined	VBN	O	determine	_	0	SENT_410	[p29l115t148r602b227],
11	in	IN	O	in	_	0	SENT_410	[p29l639t149r721b226],
12	clinical	JJ	O	clinical	amod	13	SENT_410	[p29l760t148r1063b227],
13	practice	NN	O	practice	prep_in	10	SENT_410	[p29l1100t149r1457b249],
14	.	.	O	.	_	0	SENT_410	[p29l1100t149r1457b249],

1	The	DT	O	the	det	2	SENT_411	[p29l1497t149r1660b227],
2	incorporation	NN	O	incorporation	nsubj	14	SENT_411	[p29l1697t149r2147b249, p29l11t277r178b355],
3	of	IN	O	of	_	0	SENT_411	[p29l209t276r310b355],
4	new	JJ	O	new	amod	6	SENT_411	[p29l323t302r499b356],
5	scientiﬁc	NN	O	scientiﬁc	nn	6	SENT_411	[p29l528t276r910b355],
6	information	NN	O	information	prep_of	2	SENT_411	[p29l939t276r1454b355],
7	into	IN	O	into	_	0	SENT_411	[p29l1484t277r1651b355],
8	the	DT	O	the	det	10	SENT_411	[p29l1684t276r1814b355],
9	clinical	JJ	O	clinical	amod	10	SENT_411	[p29l1846t276r2148b355],
10	arena	NN	O	arena	prep_into	6	SENT_411	[p29l10t430r244b483],
11	is	VBZ	O	be	cop	14	SENT_411	[p29l263t405r328b483],
12	generally	RB	O	generally	advmod	14	SENT_411	[p29l351t405r741b505],
13	sloW	JJ	O	slow	amod	14	SENT_411	[p29l759t404r1079b484],
14	—	NN	O	—	_	0	SENT_411	[p29l759t404r1079b484],
15	there	EX	O	there	expl	16	SENT_411	[p29l1096t405r1310b483],
16	is	VBZ	O	be	rcmod	14	SENT_411	[p29l1331t405r1422b500],
17	,	,	O	,	_	0	SENT_411	[p29l1331t405r1422b500],
18	on	IN	O	on	_	0	SENT_411	[p29l1451t430r1557b483],
19	average	NN	O	average	prep_on	16	SENT_411	[p29l1579t431r1921b505],
20	,	,	O	,	_	0	SENT_411	[p29l1579t431r1921b505],
21	a	DT	O	a	det	23	SENT_411	[p29l1947t431r1991b483],
22	17year	JJ	O	17year	amod	23	SENT_411	[p29l2015t410r2147b483, p29l6t560r183b634],
23	lag	NN	O	lag	nsubj	16	SENT_411	[p29l203t529r438b634],
24	.43	CD	NUMBER	.43	num	23	SENT_411	[p29l203t529r438b634],

1	However	RB	O	however	advmod	6	SENT_412	[p29l139t669r541b757],
2	,	,	O	,	_	0	SENT_412	[p29l139t669r541b757],
3	other	JJ	O	other	amod	4	SENT_412	[p29l582t662r811b740],
4	factors	NNS	O	factor	nsubj	6	SENT_412	[p29l842t661r1135b740],
5	may	MD	O	may	aux	6	SENT_412	[p29l1171t688r1351b762],
6	contribute	VB	O	contribute	_	0	SENT_412	[p29l1381t662r1853b741],
7	.	.	O	.	_	0	SENT_412	[p29l1381t662r1853b741],

1	In	IN	O	in	_	0	SENT_413	[p29l1892t669r1980b739],
2	the	DT	O	the	det	3	SENT_413	[p29l2014t662r2146b740],
3	case	NN	O	case	prep_in	17	SENT_413	[p29l11t816r191b868],
4	of	IN	O	of	_	0	SENT_413	[p29l229t789r332b868],
5	CYPZD6	NN	O	cypzd6	prep_of	3	SENT_413	[p29l350t795r729b885],
6	,	,	O	,	_	0	SENT_413	[p29l350t795r729b885],
7	adverse	JJ	O	adverse	amod	8	SENT_413	[p29l771t789r1093b869],
8	events	NNS	O	event	nsubj	17	SENT_413	[p29l1131t806r1398b869],
9	occurring	VBG	O	occur	partmod	8	SENT_413	[p29l1438t790r1860b890],
10	in	IN	O	in	_	0	SENT_413	[p29l1893t790r1977b867],
11	the	DT	O	the	det	15	SENT_413	[p29l2014t790r2146b868],
12	poor	JJ	O	poor	amod	15	SENT_413	[p29l9t918r772b1018],
13	—	NN	O	—	nn	15	SENT_413	[p29l9t918r772b1018],
14	metabolism	NN	O	metabolism	nn	15	SENT_413	[p29l9t918r772b1018],
15	phenotype	NN	O	phenotype	prep_in	9	SENT_413	[p29l807t917r1262b1018],
16	are	VBP	O	be	cop	17	SENT_413	[p29l1298t944r1427b996],
17	undesirable	JJ	O	undesirable	_	0	SENT_413	[p29l1464t917r1970b997],
18	but	CC	O	but	cc	17	SENT_413	[p29l2008t917r2152b997],
19	rarely	RB	O	rarely	advmod	17	SENT_413	[p29l10t1045r255b1146],
20	life	NN	O	life	npadvmod	22	SENT_413	[p29l285t1045r989b1146],
21	—	CD	NUMBER	—	num	20	SENT_413	[p29l285t1045r989b1146],
22	threatening	JJ	O	threatening	dep	17	SENT_413	[p29l285t1045r989b1146],
23	.	.	O	.	_	0	SENT_413	[p29l285t1045r989b1146],

1	Furthermore	RB	O	furthermore	advmod	4	SENT_414	[p29l1029t1046r1607b1141],
2	,	,	O	,	_	0	SENT_414	[p29l1029t1046r1607b1141],
3	these	DT	O	these	nsubj	4	SENT_414	[p29l1649t1046r1873b1124],
4	affect	VBP	O	affect	_	0	SENT_414	[p29l1909t1045r2152b1124],
5	only	RB	O	only	advmod	8	SENT_414	[p29l11t1174r196b1274],
6	a	DT	O	a	det	8	SENT_414	[p29l224t1200r268b1252],
7	small	JJ	O	small	amod	8	SENT_414	[p29l300t1174r528b1252],
8	percentage	NN	O	percentage	dobj	4	SENT_414	[p29l557t1190r1025b1274],
9	of	IN	O	of	_	0	SENT_414	[p29l1057t1173r1158b1252],
10	the	DT	O	the	det	11	SENT_414	[p29l1170t1174r1300b1252],
11	population	NN	O	population	prep_of	8	SENT_414	[p29l1330t1173r1820b1274],
12	,	,	O	,	_	0	SENT_414	[p29l1330t1173r1820b1274],
13	and	CC	O	and	_	0	SENT_414	[p29l1856t1173r2012b1252],
14	alternative	JJ	O	alternative	amod	15	SENT_414	[p29l2042t1173r2147b1252, p29l11t1302r374b1381],
15	treatments	NNS	O	treatment	nsubj	18	SENT_414	[p29l397t1318r850b1380],
16	are	VBP	O	be	cop	18	SENT_414	[p29l873t1328r999b1380],
17	usually	RB	O	usually	advmod	18	SENT_414	[p29l1021t1301r1321b1402],
18	available	JJ	O	available	conj_and	4	SENT_414	[p29l1338t1302r1727b1381],
19	.	.	O	.	_	0	SENT_414	[p29l1338t1302r1727b1381],

1	Thus	RB	O	thus	advmod	10	SENT_415	[p29l1751t1301r1990b1397],
2	,	,	O	,	_	0	SENT_415	[p29l1751t1301r1990b1397],
3	the	DT	O	the	det	5	SENT_415	[p29l2018t1302r2148b1380],
4	medical	JJ	O	medical	amod	5	SENT_415	[p29l10t1430r344b1508],
5	need	NN	O	need	nsubj	10	SENT_415	[p29l369t1429r570b1508],
6	for	IN	O	for	_	0	SENT_415	[p29l595t1429r719b1508],
7	genotyping	NN	O	genotyping	prep_for	5	SENT_415	[p29l741t1430r1224b1530],
8	is	VBZ	O	be	cop	10	SENT_415	[p29l1245t1430r1311b1508],
9	not	RB	O	not	neg	10	SENT_415	[p29l1338t1446r1482b1508],
10	critical	JJ	O	critical	_	0	SENT_415	[p29l1503t1430r1812b1508],
11	.	.	O	.	_	0	SENT_415	[p29l1503t1430r1812b1508],

1	When	WRB	O	when	advmod	13	SENT_416	[p29l137t1557r392b1636],
2	Warfarin	NNP	O	Warfarin	nsubjpass	13	SENT_416	[p29l419t1557r781b1637],
3	and	CC	O	and	_	0	SENT_416	[p29l812t1557r968b1636],
4	hypoglycemic	JJ	O	hypoglycemic	amod	5	SENT_416	[p29l1000t1557r1586b1658],
5	agents	NNS	O	agent	conj_and	2	SENT_416	[p29l1615t1574r1916b1658],
6	,	,	O	,	_	0	SENT_416	[p29l1615t1574r1916b1658],
7	both	DT	O	both	nsubj	8	SENT_416	[p29l1953t1557r2148b1636],
8	metabolized	VBN	O	metabolize	rcmod	2	SENT_416	[p29l10t1685r537b1764],
9	by	IN	O	by	_	0	SENT_416	[p29l561t1686r659b1786],
10	CYPZC9	NN	O	cypzc9	prep_by	8	SENT_416	[p29l677t1691r1041b1781],
11	,	,	O	,	_	0	SENT_416	[p29l677t1691r1041b1781],
12	are	VBP	O	be	auxpass	13	SENT_416	[p29l1069t1712r1195b1764],
13	used	VBN	O	use	advcl	24	SENT_416	[p29l1219t1685r1439b1781],
14	,	,	O	,	_	0	SENT_416	[p29l1219t1685r1439b1781],
15	surrogate	JJ	O	surrogate	amod	16	SENT_416	[p29l1469t1702r1870b1786],
16	markers	NNS	O	marker	nsubj	24	SENT_416	[p29l1894t1686r2147b1765, p29l11t1840r131b1892],
17	of	IN	O	of	_	0	SENT_416	[p29l157t1813r258b1892],
18	drug	NN	O	drug	nn	19	SENT_416	[p29l263t1813r463b1914],
19	effect	NN	O	effect	prep_of	16	SENT_416	[p29l484t1813r719b1892],
20	(	CD	NUMBER	(	num	19	SENT_416	[p29l742t1814r923b1909],
21	i.e.	FW	O	i.e.	dep	16	SENT_416	[p29l742t1814r923b1909],
22	,	,	O	,	_	0	SENT_416	[p29l742t1814r923b1909],
23	international	JJ	O	international	appos	16	SENT_416	[p29l951t1814r1501b1892],
24	normalized	VBD	O	normalize	_	0	SENT_416	[p29l1524t1814r2010b1892],
25	ratio	NN	O	ratio	nn	29	SENT_416	[p29l2033t1840r2147b1892, p29l11t1942r118b2020],
26	and	CC	O	and	_	0	SENT_416	[p29l142t1941r298b2020],
27	blood	NN	O	blood	conj_and	25	SENT_416	[p29l322t1942r566b2020],
28	glucose	NN	O	glucose	nn	29	SENT_416	[p29l587t1942r911b2042],
29	levels	NNS	O	level	dobj	24	SENT_416	[p29l933t1941r1187b2037],
30	,	,	O	,	_	0	SENT_416	[p29l933t1941r1187b2037],
31	respectively	RB	O	respectively	advmod	24	SENT_416	[p29l1216t1942r1735b2042],
32	)	CD	NUMBER	)	nsubj	34	SENT_416	[p29l1216t1942r1735b2042],
33	generally	RB	O	generally	advmod	34	SENT_416	[p29l1763t1942r2152b2042],
34	provide	VBP	O	provide	ccomp	24	SENT_416	[p29l9t2070r332b2170],
35	adequate	JJ	O	adequate	amod	36	SENT_416	[p29l377t2070r766b2170],
36	means	NNS	O	means	dobj	34	SENT_416	[p29l812t2095r1092b2148],
37	for	IN	O	for	_	0	SENT_416	[p29l1140t2069r1266b2148],
38	monitoring	VBG	O	monitor	prepc_for	34	SENT_416	[p29l1309t2070r1809b2170],
39	the	DT	O	the	det	40	SENT_416	[p29l1853t2069r1985b2148],
40	responses	NNS	O	response	dobj	38	SENT_416	[p29l2031t2096r2145b2148, p29l12t2223r356b2298],
41	of	IN	O	of	_	0	SENT_416	[p29l398t2197r500b2276],
42	individual	JJ	O	individual	amod	43	SENT_416	[p29l520t2197r953b2277],
43	patients	NNS	O	patient	prep_of	40	SENT_416	[p29l990t2198r1361b2298],
44	.	.	O	.	_	0	SENT_416	[p29l990t2198r1361b2298],

1	Such	JJ	O	such	nsubj	2	SENT_417	[p29l1408t2198r1616b2277],
2	established	VBN	O	establish	_	0	SENT_417	[p29l1655t2197r2147b2276],

1	REFERENCES	NNS	O	reference	_	0	SENT_418	[p29l14t2493r486b2535],

1	1	LS	NUMBER	1	_	0	SENT_419	[p29l22t2656r96b2733],
2	.	.	O	.	_	0	SENT_419	[p29l22t2656r96b2733],

1	Spear	NNP	O	Spear	nn	2	SENT_420	[p29l218t2650r490b2759],
2	BB	NNP	O	BB	_	0	SENT_420	[p29l558t2652r721b2753],
3	,	,	O	,	_	0	SENT_420	[p29l558t2652r721b2753],
4	Heath	NNP	PERSON	Heath	appos	2	SENT_420	[p29l800t2644r1515b2734],
5	.	.	O	.	_	0	SENT_420	[p29l800t2644r1515b2734],

1	—	NN	O	—	_	0	SENT_421	[p29l800t2644r1515b2734],
2	.	.	O	.	_	0	SENT_421	[p29l800t2644r1515b2734],

1	Chiozzi	NNP	MISC	Chiozzi	nn	2	SENT_422	[p29l800t2644r1515b2734],
2	M	NNP	O	M	_	0	SENT_422	[p29l1582t2652r1708b2753],
3	,	,	O	,	_	0	SENT_422	[p29l1582t2652r1708b2753],
4	Huff	NNP	PERSON	Huff	nn	7	SENT_422	[p29l1787t2642r2033b2735],
5	J.	NNP	PERSON	J.	nn	7	SENT_422	[p29l2073t2652r2140b2749],
6	Clinical	JJ	PERSON	clinical	amod	7	SENT_422	[p29l18t2793r389b2883],
7	application	NN	O	application	appos	2	SENT_422	[p29l449t2793r997b2908],
8	of	IN	O	of	_	0	SENT_422	[p29l1058t2791r1175b2883],
9	pharmacogenetics	NNS	O	pharmacogenetic	prep_of	7	SENT_422	[p29l1215t2793r2140b2908],
10	.	.	O	.	_	0	SENT_422	[p29l1215t2793r2140b2908],

1	Trends	NNS	O	trend	_	0	SENT_423	[p29l14t2942r350b3032],
2	Mol	NNP	O	Mol	nn	3	SENT_423	[p29l377t2942r572b3033],
3	Med	NNP	O	Med	dep	1	SENT_423	[p29l597t2942r812b3033],
4	2002	CD	DATE	2002	num	3	SENT_423	[p29l841t2948r1521b3051],
5	;	:	O	;	_	0	SENT_423	[p29l841t2948r1521b3051],
6	7:201	CD	NUMBER	7:201	number	7	SENT_423	[p29l841t2948r1521b3051],
7	—	CD	NUMBER	—	dep	1	SENT_423	[p29l841t2948r1521b3051],
8	4	CD	NUMBER	4	dep	7	SENT_423	[p29l841t2948r1521b3051],
9	.	.	O	.	_	0	SENT_423	[p29l841t2948r1521b3051],

1	2	LS	NUMBER	2	_	0	SENT_424	[p29l16t3101r96b3180],
2	.	.	O	.	_	0	SENT_424	[p29l16t3101r96b3180],

1	Lazarou	NNP	PERSON	Lazarou	nn	2	SENT_425	[p29l214t3099r606b3182],
2	J	NNP	PERSON	J	_	0	SENT_425	[p29l627t3099r695b3200],
3	,	,	O	,	_	0	SENT_425	[p29l627t3099r695b3200],
4	Pomeranz	NNP	PERSON	Pomeranz	nn	5	SENT_425	[p29l735t3099r1229b3181],
5	BH	NNP	O	BH	appos	2	SENT_425	[p29l1262t3099r1446b3200],
6	,	,	O	,	_	0	SENT_425	[p29l1262t3099r1446b3200],
7	Corey	NNP	PERSON	Corey	nn	8	SENT_425	[p29l1487t3097r1771b3206],
8	PN	NNP	PERSON	PN	appos	5	SENT_425	[p29l1798t3099r1966b3182],
9	.	.	O	.	_	0	SENT_425	[p29l1798t3099r1966b3182],

1	Incidence	NN	O	incidence	_	0	SENT_426	[p29l2005t3099r2144b3180, p29l18t3240r383b3330],
2	of	IN	O	of	_	0	SENT_426	[p29l423t3238r540b3330],
3	adverse	JJ	O	adverse	amod	5	SENT_426	[p29l556t3240r917b3331],
4	drug	NN	O	drug	nn	5	SENT_426	[p29l957t3240r1187b3355],
5	reactions	NNS	O	reaction	prep_of	1	SENT_426	[p29l1223t3240r1664b3330],
6	in	IN	O	in	_	0	SENT_426	[p29l1705t3242r1799b3329],
7	hospitalized	VBN	O	hospitalize	amod	8	SENT_426	[p29l1836t3240r2146b3355, p29l18t3389r342b3479],
8	patients	NNS	O	patient	prep_in	5	SENT_426	[p29l369t3391r786b3504],
9	:	:	O	:	_	0	SENT_426	[p29l369t3391r786b3504],
10	a	DT	O	a	det	13	SENT_426	[p29l820t3419r872b3478],
11	meta	NN	O	meta	nn	13	SENT_426	[p29l899t3389r1566b3504],
12	—	NN	O	—	nn	13	SENT_426	[p29l899t3389r1566b3504],
13	analysis	NN	O	analysis	dep	1	SENT_426	[p29l899t3389r1566b3504],
14	of	IN	O	of	_	0	SENT_426	[p29l1598t3387r1714b3479],
15	prospective	JJ	O	prospective	amod	16	SENT_426	[p29l1721t3418r2144b3504, p29l18t3538r181b3629],
16	studies	NNS	O	study	prep_of	13	SENT_426	[p29l212t3538r582b3629],
17	.	.	O	.	_	0	SENT_426	[p29l212t3538r582b3629],

1	JAMA	NN	O	jama	_	0	SENT_427	[p29l605t3546r898b3643],
2	1998	CD	DATE	1998	num	1	SENT_427	[p29l927t3544r1787b3647],
3	;	:	O	;	_	0	SENT_427	[p29l927t3544r1787b3647],
4	279:1200	CD	NUMBER	279:1200	number	5	SENT_427	[p29l927t3544r1787b3647],
5	—	CD	NUMBER	—	dep	1	SENT_427	[p29l927t3544r1787b3647],
6	5	CD	NUMBER	5	dep	5	SENT_427	[p29l927t3544r1787b3647],
7	.	.	O	.	_	0	SENT_427	[p29l927t3544r1787b3647],

1	3	LS	NUMBER	3	_	0	SENT_428	[p29l18t3697r96b3776],
2	.	.	O	.	_	0	SENT_428	[p29l18t3697r96b3776],

1	N	NN	O	n	nn	3	SENT_429	[p29l213t3695r300b3778],
2	ebert	NN	O	ebert	nn	3	SENT_429	[p29l304t3687r552b3777],
3	DW	NN	O	dw	_	0	SENT_429	[p29l572t3695r771b3796],
4	,	,	O	,	_	0	SENT_429	[p29l572t3695r771b3796],
5	Russell	NNP	PERSON	Russell	nn	6	SENT_429	[p29l802t3687r1156b3782],
6	DW	NNP	O	DW	appos	3	SENT_429	[p29l1179t3695r1380b3777],
7	.	.	O	.	_	0	SENT_429	[p29l1179t3695r1380b3777],

1	Clinical	JJ	O	clinical	amod	2	SENT_430	[p29l1412t3687r1783b3777],
2	importance	NN	O	importance	_	0	SENT_430	[p29l1808t3689r2144b3802, p30l18t44r276b114],

1	of	IN	O	of	_	0	SENT_431	[p30l359t23r475b115],
2	the	DT	O	the	det	4	SENT_431	[p30l538t25r687b114],
3	cytochromes	NNS	O	cytochrome	nn	4	SENT_431	[p30l770t25r1390b140],
4	P450	NN	O	p450	pobj	1	SENT_431	[p30l1473t31r1741b115],
5	.	.	O	.	_	0	SENT_431	[p30l1473t31r1741b115],

1	Lancet	NNP	O	Lancet	_	0	SENT_432	[p30l1828t33r2154b114],
2	2002	CD	DATE	2002	num	1	SENT_432	[p30l18t180r941b283],
3	;	:	O	;	_	0	SENT_432	[p30l18t180r941b283],
4	360:1155	CD	NUMBER	360:1155	number	5	SENT_432	[p30l18t180r941b283],
5	—	CD	NUMBER	—	dep	1	SENT_432	[p30l18t180r941b283],
6	62	CD	NUMBER	62	dep	5	SENT_432	[p30l18t180r941b283],
7	.	.	O	.	_	0	SENT_432	[p30l18t180r941b283],

1	4	LS	NUMBER	4	_	0	SENT_433	[p30l14t335r96b412],
2	.	.	O	.	_	0	SENT_433	[p30l14t335r96b412],

1	Kimura	NNP	PERSON	Kimura	nn	2	SENT_434	[p30l214t323r584b416],
2	S	NNP	PERSON	S	_	0	SENT_434	[p30l621t329r701b432],
3	,	,	O	,	_	0	SENT_434	[p30l621t329r701b432],
4	Umeno	NNP	O	Umeno	nn	5	SENT_434	[p30l744t331r1104b413],
5	M	NNP	O	M	appos	2	SENT_434	[p30l1139t331r1265b432],
6	,	,	O	,	_	0	SENT_434	[p30l1139t331r1265b432],
7	Skoda	NNP	ORGANIZATION	Skoda	nn	8	SENT_434	[p30l1310t323r1608b414],
8	RC	NNP	ORGANIZATION	RC	appos	2	SENT_434	[p30l1642t329r1809b432],
9	,	,	O	,	_	0	SENT_434	[p30l1642t329r1809b432],
10	Meyer	NNP	ORGANIZATION	Meyer	nn	11	SENT_434	[p30l1848t331r2150b438],
11	UA	NNP	ORGANIZATION	UA	appos	2	SENT_434	[p30l16t480r193b581],
12	,	,	O	,	_	0	SENT_434	[p30l16t480r193b581],
13	Gonzalez	NNP	PERSON	Gonzalez	nn	15	SENT_434	[p30l238t472r699b562],
14	F	NN	O	f	nn	15	SENT_434	[p30l736t480r856b577],
15	]	NN	O	]	appos	2	SENT_434	[p30l736t480r856b577],
16	.	.	O	.	_	0	SENT_434	[p30l736t480r856b577],

1	The	DT	O	the	det	6	SENT_435	[p30l895t472r1082b561],
2	human	JJ	O	human	amod	6	SENT_435	[p30l1120t472r1467b563],
3	debrisoquine	NN	O	debrisoquine	nn	6	SENT_435	[p30l1506t472r2146b587],
4	4	CD	NUMBER	4	num	6	SENT_435	[p30l16t621r691b736],
5	—	NN	O	—	nn	6	SENT_435	[p30l16t621r691b736],
6	hydroxylase	NN	O	hydroxylase	_	0	SENT_435	[p30l16t621r691b736],
7	(	CD	NUMBER	(	num	10	SENT_435	[p30l727t627r1134b726],
8	CYP2D	NN	O	cyp2d	nn	10	SENT_435	[p30l727t627r1134b726],
9	)	NN	O	)	nn	10	SENT_435	[p30l727t627r1134b726],
10	locus	NN	O	locus	dep	6	SENT_435	[p30l1169t621r1453b712],
11	:	:	O	:	_	0	SENT_435	[p30l1169t621r1453b712],
12	sequence	NN	O	sequence	dep	6	SENT_435	[p30l1491t651r1938b736],
13	and	CC	O	and	_	0	SENT_435	[p30l1967t621r2148b711],
14	identiﬁcation	NN	O	identiﬁcation	dep	6	SENT_435	[p30l16t768r669b860],
15	of	IN	O	of	_	0	SENT_435	[p30l722t768r838b860],
16	the	DT	O	the	det	19	SENT_435	[p30l869t770r1019b859],
17	polymorphic	JJ	O	polymorphic	amod	19	SENT_435	[p30l1070t770r1697b885],
18	CYPZD6	NN	O	cypzd6	nn	19	SENT_435	[p30l1747t776r2146b861],
19	gene	NN	O	gene	prep_of	12	SENT_435	[p30l18t948r274b1034],
20	,	,	O	,	_	0	SENT_435	[p30l18t948r274b1034],
21	a	DT	O	a	det	23	SENT_435	[p30l310t949r361b1008],
22	related	JJ	O	related	amod	23	SENT_435	[p30l389t919r719b1009],
23	gene	NN	O	gene	conj_and	19	SENT_435	[p30l748t949r1005b1034],
24	,	,	O	,	_	0	SENT_435	[p30l748t949r1005b1034],
25	and	CC	O	and	_	0	SENT_435	[p30l1040t919r1219b1009],
26	a	DT	O	a	det	27	SENT_435	[p30l1249t949r1300b1008],
27	pseudogene	NN	O	pseudogene	conj_and	19	SENT_435	[p30l1326t919r1942b1034],
28	.	.	O	.	_	0	SENT_435	[p30l1326t919r1942b1034],

1	Am	VBP	O	be	dep	4	SENT_436	[p30l1973t927r2148b1008],
2	J	NN	O	j	nn	4	SENT_436	[p30l6t1076r50b1173],
3	Hum	NNP	O	Hum	nn	4	SENT_436	[p30l75t1076r324b1159],
4	Genet	NNP	O	Genet	_	0	SENT_436	[p30l351t1074r649b1158],
5	1989	CD	DATE	1989	num	4	SENT_436	[p30l675t1074r1535b1177],
6	;	:	O	;	_	0	SENT_436	[p30l675t1074r1535b1177],
7	45:889	CD	NUMBER	45:889	num	8	SENT_436	[p30l675t1074r1535b1177],
8	-904	CD	NUMBER	-904	dep	4	SENT_436	[p30l675t1074r1535b1177],
9	.	.	O	.	_	0	SENT_436	[p30l675t1074r1535b1177],

1	5	CD	NUMBER	5	_	0	SENT_437	[p30l18t1229r96b1307],
2	.	.	O	.	_	0	SENT_437	[p30l18t1229r96b1307],

1	Bailey	NNP	PERSON	Bailey	nn	2	SENT_438	[p30l214t1217r507b1332],
2	DG	NNS	O	dg	_	0	SENT_438	[p30l528t1223r723b1326],
3	,	,	O	,	_	0	SENT_438	[p30l528t1223r723b1326],
4	Malcolm	NNP	PERSON	Malcolm	nn	5	SENT_438	[p30l752t1217r1185b1307],
5	J	NNP	PERSON	J	appos	2	SENT_438	[p30l1201t1225r1269b1326],
6	,	,	O	,	_	0	SENT_438	[p30l1201t1225r1269b1326],
7	Arnold	NNP	ORGANIZATION	Arnold	nn	8	SENT_438	[p30l1298t1217r1640b1307],
8	O	NNP	ORGANIZATION	O	appos	2	SENT_438	[p30l1667t1223r1769b1326],
9	,	,	O	,	_	0	SENT_438	[p30l1667t1223r1769b1326],
10	Spence	NNP	O	Spence	nn	11	SENT_438	[p30l1805t1223r2146b1332],
11	JD	NNP	O	JD	appos	2	SENT_438	[p30l6t1374r153b1471],
12	.	.	O	.	_	0	SENT_438	[p30l6t1374r153b1471],

1	Grapefruit	NN	O	grapefruit	nsubj	2	SENT_439	[p30l206t1364r723b1481],
2	juice	NN	O	juice	_	0	SENT_439	[p30l746t1366r1263b1481],
3	—	CD	NUMBER	—	num	5	SENT_439	[p30l746t1366r1263b1481],
4	drug	NN	O	drug	nn	5	SENT_439	[p30l746t1366r1263b1481],
5	interactions	NNS	O	interaction	dobj	2	SENT_439	[p30l1304t1366r1910b1456],
6	.	.	O	.	_	0	SENT_439	[p30l1304t1366r1910b1456],

1	Br	NN	O	br	nn	3	SENT_440	[p30l1961t1374r2075b1455],
2	J	NN	O	j	nn	3	SENT_440	[p30l2106t1374r2150b1471],
3	Clin	NN	O	clin	_	0	SENT_440	[p30l18t1515r217b1605],
4	Pharmacol	NN	O	pharmacol	dep	3	SENT_440	[p30l244t1515r769b1605],
5	1998	CD	DATE	1998	num	4	SENT_440	[p30l802t1521r1598b1624],
6	;	:	O	;	_	0	SENT_440	[p30l802t1521r1598b1624],
7	46:101	CD	NUMBER	46:101	num	8	SENT_440	[p30l802t1521r1598b1624],
8	-10	CD	NUMBER	-10	dep	3	SENT_440	[p30l802t1521r1598b1624],
9	.	.	O	.	_	0	SENT_440	[p30l802t1521r1598b1624],

1	6	CD	NUMBER	6	_	0	SENT_441	[p30l18t1674r96b1754],
2	.	.	O	.	_	0	SENT_441	[p30l18t1674r96b1754],

1	Bailey	NNP	PERSON	Bailey	nn	2	SENT_442	[p30l214t1664r507b1779],
2	DG	NNS	O	dg	nsubj	13	SENT_442	[p30l530t1670r725b1773],
3	,	,	O	,	_	0	SENT_442	[p30l530t1670r725b1773],
4	Spence	NNP	PERSON	Spence	nn	5	SENT_442	[p30l762t1670r1104b1779],
5	JD	NNP	O	JD	appos	2	SENT_442	[p30l1122t1672r1269b1773],
6	,	,	O	,	_	0	SENT_442	[p30l1122t1672r1269b1773],
7	Munoz	NNP	PERSON	Munoz	nn	8	SENT_442	[p30l1300t1672r1648b1755],
8	C	NNP	O	C	appos	2	SENT_442	[p30l1677t1670r1773b1773],
9	,	,	O	,	_	0	SENT_442	[p30l1677t1670r1773b1773],
10	Arnold	NNP	ORGANIZATION	Arnold	nn	12	SENT_442	[p30l1805t1664r2146b1754],
11	clinical	JJ	O	clinical	amod	12	SENT_442	[p30l12t1973r322b2052],
12	markers	NNS	O	marker	appos	2	SENT_442	[p30l352t1973r699b2053],
13	monitor	VBP	O	monitor	_	0	SENT_442	[p30l730t1974r1080b2052],
14	the	DT	O	the	det	16	SENT_442	[p30l1105t1974r1235b2052],
15	overall	JJ	O	overall	amod	16	SENT_442	[p30l1265t1973r1545b2053],
16	effect	NN	O	effect	dobj	13	SENT_442	[p30l1573t1973r1827b2069],
17	,	,	O	,	_	0	SENT_442	[p30l1573t1973r1827b2069],
18	so	RB	O	so	advmod	39	SENT_442	[p30l1863t1999r1953b2052],
19	that	IN	O	that	dep	39	SENT_442	[p30l1984t1973r2152b2052],
20	if	IN	O	if	mark	30	SENT_442	[p30l11t2102r86b2180],
21	genes	NNS	O	gene	nsubjpass	30	SENT_442	[p30l94t2128r335b2203],
22	other	JJ	O	other	dep	21	SENT_442	[p30l365t2102r589b2181],
23	than	IN	O	than	_	0	SENT_442	[p30l613t2103r802b2181],
24	those	DT	O	those	prep_than	21	SENT_442	[p30l828t2103r1056b2181],
25	associated	VBN	O	associate	partmod	24	SENT_442	[p30l1082t2103r1521b2181],
26	with	IN	O	with	_	0	SENT_442	[p30l1542t2103r1733b2182],
27	drug	NN	O	drug	nn	28	SENT_442	[p30l1760t2102r1960b2203],
28	metabolism	NN	O	metabolism	prep_with	25	SENT_442	[p30l1983t2129r2145b2181, p30l12t2231r386b2309],
29	are	VBP	O	be	auxpass	30	SENT_442	[p30l408t2257r535b2309],
30	involved	VBN	O	involve	advcl	39	SENT_442	[p30l558t2231r933b2326],
31	,	,	O	,	_	0	SENT_442	[p30l558t2231r933b2326],
32	the	DT	O	the	det	34	SENT_442	[p30l962t2230r1092b2309],
33	desired	VBN	O	desire	amod	34	SENT_442	[p30l1116t2230r1423b2309],
34	response	NN	O	response	nsubjpass	39	SENT_442	[p30l1446t2256r1828b2331],
35	itself	PRP	O	itself	nsubj	37	SENT_442	[p30l1851t2230r2075b2309],
36	is	VBZ	O	be	cop	37	SENT_442	[p30l2079t2231r2144b2309],
37	What	WP	O	what	rcmod	34	SENT_442	[p30l7t2359r218b2438],
38	is	VBZ	O	be	auxpass	39	SENT_442	[p30l233t2359r297b2437],
39	followed	VBN	O	follow	advcl	13	SENT_442	[p30l319t2358r703b2438],
40	.	.	O	.	_	0	SENT_442	[p30l319t2358r703b2438],

1	In	IN	O	in	_	0	SENT_443	[p30l728t2366r814b2436],
2	fact	NN	O	fact	prep_in	7	SENT_443	[p30l834t2358r1006b2454],
3	,	,	O	,	_	0	SENT_443	[p30l834t2358r1006b2454],
4	single-gene	JJ	O	single-gene	amod	5	SENT_443	[p30l1034t2359r1514b2459],
5	effects	NNS	O	effect	nsubj	7	SENT_443	[p30l1534t2358r1799b2437],
6	are	VBP	O	be	cop	7	SENT_443	[p30l1821t2385r1946b2437],
7	likely	JJ	O	likely	_	0	SENT_443	[p30l1965t2359r2146b2438, p30l10t2487r81b2587],
8	to	TO	O	to	aux	11	SENT_443	[p30l104t2503r184b2565],
9	be	VB	O	be	cop	11	SENT_443	[p30l216t2486r312b2565],
10	less	RBR	O	less	advmod	11	SENT_443	[p30l341t2486r497b2565],
11	common	JJ	O	common	xcomp	7	SENT_443	[p30l531t2512r912b2565],
12	than	IN	O	than	_	0	SENT_443	[p30l943t2487r1132b2565],
13	effects	NNS	O	effect	prep_than	11	SENT_443	[p30l1163t2486r1435b2565],
14	involving	VBG	O	involve	partmod	13	SENT_443	[p30l1466t2487r1860b2587],
15	multi	NNS	O	multus	dobj	14	SENT_443	[p30l1887t2486r2145b2566],
16	—	CD	NUMBER	—	num	18	SENT_443	[p30l1887t2486r2145b2566],
17	ple	NN	O	ple	nn	18	SENT_443	[p30l10t2615r137b2715],
18	genes	NNS	O	gene	tmod	14	SENT_443	[p30l158t2640r425b2715],
19	,	,	O	,	_	0	SENT_443	[p30l158t2640r425b2715],
20	each	DT	O	each	nsubj	24	SENT_443	[p30l453t2615r644b2693],
21	of	IN	O	of	_	0	SENT_443	[p30l666t2614r767b2693],
22	which	WDT	O	which	prep_of	20	SENT_443	[p30l764t2614r1026b2694],
23	partially	RB	O	partially	advmod	24	SENT_443	[p30l1047t2615r1394b2715],
24	contributes	VBZ	O	contribute	rcmod	18	SENT_443	[p30l1411t2615r1890b2694],
25	to	TO	O	to	_	0	SENT_443	[p30l1914t2631r1994b2693],
26	the	DT	O	the	det	29	SENT_443	[p30l2017t2615r2146b2693],
27	overall	JJ	O	overall	amod	29	SENT_443	[p30l12t2742r291b2822],
28	genetic	JJ	O	genetic	amod	29	SENT_443	[p30l317t2743r623b2843],
29	variability	NN	O	variability	prep_to	24	SENT_443	[p30l644t2742r1065b2843],
30	in	IN	O	in	_	0	SENT_443	[p30l1087t2743r1168b2820],
31	drug	NN	O	drug	nn	32	SENT_443	[p30l1195t2743r1396b2843],
32	response	NN	O	response	prep_in	29	SENT_443	[p30l1419t2768r1824b2843],
33	.	.	O	.	_	0	SENT_443	[p30l1419t2768r1824b2843],

1	For	IN	O	for	dep	5	SENT_444	[p30l1855t2750r2000b2821],
2	example	NN	O	example	pobj	1	SENT_444	[p30l2024t2769r2145b2821, p30l11t2870r295b2971],
3	,	,	O	,	_	0	SENT_444	[p30l2024t2769r2145b2821, p30l11t2870r295b2971],
4	a	DT	O	a	det	5	SENT_444	[p30l323t2897r368b2949],
5	variant	NN	O	variant	_	0	SENT_444	[p30l384t2871r681b2950],
6	of	IN	O	of	_	0	SENT_444	[p30l700t2870r801b2949],
7	the	DT	O	the	det	12	SENT_444	[p30l806t2871r936b2949],
8	vitamin	NN	O	vitamin	nn	12	SENT_444	[p30l955t2871r1279b2950],
9	K	NN	O	k	nn	12	SENT_444	[p30l1302t2878r1369b2952],
10	epoxide	NN	O	epoxide	nn	12	SENT_444	[p30l1389t2870r1717b2971],
11	reductase	NN	O	reductase	nn	12	SENT_444	[p30l1740t2871r2146b2950],
12	complex	NN	O	complex	prep_of	5	SENT_444	[p30l12t2999r395b3099],
13	,	,	O	,	_	0	SENT_444	[p30l12t2999r395b3099],
14	subunit	NN	O	subunit	appos	5	SENT_444	[p30l428t2998r753b3078],
15	1	CD	NUMBER	1	number	16	SENT_444	[p30l777t3004r821b3076],
16	—	CD	NUMBER	—	num	19	SENT_444	[p30l843t3043r951b3051],
17	the	DT	O	the	det	19	SENT_444	[p30l973t2999r1103b3077],
18	molecular	JJ	O	molecular	amod	19	SENT_444	[p30l1128t2999r1556b3078],
19	target	NN	O	target	nsubjpass	26	SENT_444	[p30l1580t3015r1830b3099],
20	of	IN	O	of	_	0	SENT_444	[p30l1851t2998r1952b3077],
21	warfarin	NN	O	warfarin	nn	22	SENT_444	[p30l1954t3025r2145b3078, p30l11t3126r206b3205],
22	—	NN	O	—	prep_of	19	SENT_444	[p30l222t3172r330b3179],
23	has	VBZ	O	have	aux	26	SENT_444	[p30l346t3126r486b3205],
24	recently	RB	DATE	recently	advmod	26	SENT_444	[p30l507t3127r835b3227],
25	been	VBN	O	be	auxpass	26	SENT_444	[p30l851t3127r1048b3205],
26	shown	VBN	O	show	rcmod	14	SENT_444	[p30l1069t3127r1346b3206],
27	to	TO	O	to	aux	28	SENT_444	[p30l1367t3143r1445b3205],
28	contribute	VB	O	contribute	xcomp	26	SENT_444	[p30l1467t3126r1894b3206],
29	along	IN	O	along	_	0	SENT_444	[p30l1914t3127r2151b3227],
30	With	IN	O	with	_	0	SENT_444	[p30l7t3255r200b3334],
31	the	DT	O	the	det	33	SENT_444	[p30l248t3254r380b3333],
32	CYPZC9	NN	O	cypzc9	nn	33	SENT_444	[p30l427t3260r772b3333],
33	polymorphism	NN	O	polymorphism	prep_along_with	28	SENT_444	[p30l819t3255r1462b3355],
34	to	TO	O	to	_	0	SENT_444	[p30l1510t3271r1590b3333],
35	interpatient	JJ	O	interpatient	amod	36	SENT_444	[p30l1638t3255r2151b3355],
36	variability	NN	O	variability	prep_to	28	SENT_444	[p30l7t3383r427b3483],
37	in	IN	O	in	_	0	SENT_444	[p30l444t3383r526b3460],
38	dosage	NN	O	dosage	nn	39	SENT_444	[p30l548t3383r845b3483],
39	requirements	NNS	O	requirement	prep_in	36	SENT_444	[p30l866t3383r1432b3483],
40	for	IN	O	for	_	0	SENT_444	[p30l1456t3382r1580b3461],
41	the	DT	O	the	det	43	SENT_444	[p30l1599t3382r1728b3461],
42	anticoagulant	JJ	O	anticoagulant	amod	43	SENT_444	[p30l1750t3383r2145b3483, p30l11t3506r338b3590],
43	.44	NN	NUMBER	.44	prep_for	39	SENT_444	[p30l1750t3383r2145b3483, p30l11t3506r338b3590],

1	There	EX	O	there	expl	8	SENT_445	[p30l138t3638r383b3717],
2	have	VBP	O	have	aux	8	SENT_445	[p30l413t3639r602b3718],
3	not	RB	O	not	neg	8	SENT_445	[p30l632t3655r776b3717],
4	yet	RB	O	yet	advmod	8	SENT_445	[p30l796t3655r921b3739],
5	been	VBN	O	be	cop	8	SENT_445	[p30l946t3638r1146b3717],
6	prospective	JJ	O	prospective	amod	8	SENT_445	[p30l1174t3639r1658b3739],
7	clinical	JJ	O	clinical	amod	8	SENT_445	[p30l1689t3639r1991b3717],
8	trials	NNS	O	trial	_	0	SENT_445	[p30l2021t3639r2145b3717, p31l11t20r123b99],

1	showing	VBG	O	show	partmod	43	SENT_446	[p31l151t21r517b121],
2	that	IN	O	that	complm	18	SENT_446	[p31l537t21r705b99],
3	knowledge	NN	O	knowledge	nsubj	18	SENT_446	[p31l723t20r1188b121],
4	of	IN	O	of	_	0	SENT_446	[p31l1213t20r1314b99],
5	a	DT	O	a	det	6	SENT_446	[p31l1318t47r1362b99],
6	patient	NN	O	patient	poss	9	SENT_446	[p31l1383t21r1747b121],
7	’s	POS	O	’s	_	0	SENT_446	[p31l1383t21r1747b121],
8	genotypic	JJ	O	genotypic	amod	9	SENT_446	[p31l1773t37r2145b121, p31l11t149r80b227],
9	proﬁle	NN	O	proﬁle	prep_of	3	SENT_446	[p31l104t148r385b249],
10	before	IN	O	before	_	0	SENT_446	[p31l413t148r680b227],
11	prescribing	VBG	O	prescribe	amod	12	SENT_446	[p31l706t149r1196b249],
12	drugs	NNS	O	drug	prep_before	9	SENT_446	[p31l1220t148r1458b249],
13	either	CC	O	either	prep	12	SENT_446	[p31l1488t149r1732b227],
14	increases	NNS	O	increase	nn	16	SENT_446	[p31l1755t149r2144b227],
15	drug	NN	O	drug	nn	16	SENT_446	[p31l12t276r212b377],
16	efficacy	NN	O	efficacy	dep	13	SENT_446	[p31l239t276r571b377],
17	,	,	O	,	_	0	SENT_446	[p31l239t276r571b377],
18	prevents	VBZ	O	prevent	ccomp	1	SENT_446	[p31l604t293r960b377],
19	or	CC	O	or	_	0	SENT_446	[p31l992t302r1082b355],
20	reduces	VBZ	O	reduce	conj_or	18	SENT_446	[p31l1108t276r1431b356],
21	adverse	JJ	O	adverse	amod	23	SENT_446	[p31l1462t277r1776b356],
22	drug	NN	O	drug	nn	23	SENT_446	[p31l1807t277r2007b377],
23	reactions	NNS	O	reaction	dobj	18	SENT_446	[p31l2033t303r2145b355, p31l11t405r338b500],
24	,	,	O	,	_	0	SENT_446	[p31l2033t303r2145b355, p31l11t405r338b500],
25	or	CC	O	or	_	0	SENT_446	[p31l377t430r466b483],
26	lowers	VBZ	O	lower	conj_or	18	SENT_446	[p31l494t405r772b484],
27	the	DT	O	the	det	29	SENT_446	[p31l807t405r937b483],
28	overall	JJ	O	overall	amod	29	SENT_446	[p31l970t404r1250b484],
29	costs	NNS	O	cost	nsubj	36	SENT_446	[p31l1283t421r1493b483],
30	of	IN	O	of	_	0	SENT_446	[p31l1529t404r1630b483],
31	therapy	NN	O	therapy	nn	34	SENT_446	[p31l1645t404r1963b505],
32	and	CC	O	and	_	0	SENT_446	[p31l1990t404r2147b483],
33	associated	VBN	O	associate	nn	34	SENT_446	[p31l11t533r449b612],
34	sequelae	NN	O	sequela	prep_of	29	SENT_446	[p31l497t526r1074b634],
35	.45	CD	NUMBER	.45	num	36	SENT_446	[p31l497t526r1074b634],
36	’46	CD	NUMBER	’46	xcomp	26	SENT_446	[p31l497t526r1074b634],
37	In	IN	O	in	dep	36	SENT_446	[p31l1119t540r1207b611],
38	December	NNP	DATE	December	pobj	37	SENT_446	[p31l1252t533r1689b612],
39	2004	CD	DATE	2004	num	38	SENT_446	[p31l1732t539r1964b629],
40	,	,	O	,	_	0	SENT_446	[p31l1732t539r1964b629],
41	the	DT	O	the	det	42	SENT_446	[p31l2016t533r2145b612],
42	FDA	NNP	ORGANIZATION	FDA	nsubj	43	SENT_446	[p31l10t668r198b740],
43	approved	VBD	O	approve	_	0	SENT_446	[p31l228t662r621b762],
44	a	DT	O	a	det	46	SENT_446	[p31l653t688r698b740],
45	microarray	NN	O	microarray	nn	46	SENT_446	[p31l729t662r1195b762],
46	chip	NN	O	chip	dobj	43	SENT_446	[p31l1224t662r1405b762],
47	designed	VBN	O	design	partmod	46	SENT_446	[p31l1440t661r1821b762],
48	to	TO	O	to	aux	50	SENT_446	[p31l1855t678r1934b740],
49	routinely	RB	O	routinely	advmod	50	SENT_446	[p31l1969t687r2145b741, p31l12t790r246b890],
50	identify	VB	O	identify	xcomp	47	SENT_446	[p31l274t789r597b890],
51	polymorphisms	NNS	O	polymorphism	dobj	50	SENT_446	[p31l624t790r1297b890],
52	of	IN	O	of	_	0	SENT_446	[p31l1334t789r1435b868],
53	drugmetabolizing	VBG	O	drugmetabolize	amod	54	SENT_446	[p31l1450t789r2145b890, p31l11t918r150b1018],
54	enzymes	NNS	O	enzyme	prep_of	51	SENT_446	[p31l170t943r535b1018],
55	related	VBN	O	relate	partmod	54	SENT_446	[p31l560t918r847b996],
56	to	TO	O	to	_	0	SENT_446	[p31l871t934r950b996],
57	cytochrome	NN	O	cytochrome	nn	60	SENT_446	[p31l975t918r1472b1018],
58	P-450	NN	MISC	p-450	nn	60	SENT_446	[p31l1494t923r1738b996],
59	drug	NN	O	drug	nn	60	SENT_446	[p31l1763t918r1964b1018],
60	metabolism	NN	O	metabolism	prep_to	55	SENT_446	[p31l1983t944r2145b996, p31l12t1042r496b1125],
61	.	.	O	.	_	0	SENT_446	[p31l1983t944r2145b996, p31l12t1042r496b1125],

1	“	NN	O	“	_	0	SENT_447	[p31l1983t944r2145b996, p31l12t1042r496b1125],
2	This	DT	DATE	this	nsubj	4	SENT_447	[p31l532t1047r718b1125],
3	may	MD	DATE	may	aux	4	SENT_447	[p31l759t1073r937b1147],
4	lead	VB	O	lead	rcmod	1	SENT_447	[p31l970t1047r1144b1125],
5	to	TO	O	to	_	0	SENT_447	[p31l1184t1063r1263b1125],
6	changes	NNS	O	change	prep_to	4	SENT_447	[p31l1305t1047r1649b1147],
7	in	IN	O	in	_	0	SENT_447	[p31l1690t1047r1772b1124],
8	how	WRB	O	how	advmod	10	SENT_447	[p31l1811t1047r1996b1126],
9	we	PRP	O	we	nsubj	10	SENT_447	[p31l2027t1073r2146b1126],
10	test	VBP	O	test	prepc_in	6	SENT_447	[p31l12t1191r164b1253],
11	patients	NNS	O	patient	dobj	10	SENT_447	[p31l178t1175r514b1275],
12	for	IN	O	for	_	0	SENT_447	[p31l538t1174r662b1253],
13	cytochrome	NN	O	cytochrome	nn	14	SENT_447	[p31l680t1175r1178b1275],
14	P	NN	O	p	prep_for	11	SENT_447	[p31l1197t1174r1894b1253],
15	—	CD	NUMBER	—	number	16	SENT_447	[p31l1197t1174r1894b1253],
16	450	CD	NUMBER	450	num	17	SENT_447	[p31l1197t1174r1894b1253],
17	—	NN	O	—	dep	1	SENT_447	[p31l1197t1174r1894b1253],
18	mediated	VBN	O	mediate	partmod	17	SENT_447	[p31l1197t1174r1894b1253],
19	drugmetabolizing	VBG	O	drugmetabolize	xcomp	18	SENT_447	[p31l1915t1175r2145b1275, p31l11t1303r579b1403],
20	capabilities	NNS	O	capability	dobj	19	SENT_447	[p31l618t1303r1095b1403],
21	in	IN	O	in	_	0	SENT_447	[p31l1138t1303r1219b1380],
22	clinical	JJ	O	clinical	amod	23	SENT_447	[p31l1261t1303r1563b1381],
23	practice	NN	O	practice	prep_in	19	SENT_447	[p31l1602t1303r1959b1403],
24	.	.	O	.	_	0	SENT_447	[p31l1602t1303r1959b1403],

1	For	IN	O	for	prep	12	SENT_448	[p31l2005t1310r2149b1381],
2	now	RB	DATE	now	pobj	1	SENT_448	[p31l11t1456r205b1526],
3	,	,	O	,	_	0	SENT_448	[p31l11t1456r205b1526],
4	however	RB	O	however	advmod	12	SENT_448	[p31l230t1431r596b1526],
5	,	,	O	,	_	0	SENT_448	[p31l230t1431r596b1526],
6	the	DT	O	the	det	8	SENT_448	[p31l623t1430r750b1509],
7	individual	JJ	O	individual	amod	8	SENT_448	[p31l769t1430r1182b1510],
8	patient	NN	O	patient	nsubjpass	12	SENT_448	[p31l1200t1431r1493b1531],
9	is	VBZ	O	be	auxpass	12	SENT_448	[p31l1507t1431r1572b1509],
10	probably	RB	O	probably	advmod	12	SENT_448	[p31l1593t1431r1964b1531],
11	best	RB	O	best	advmod	12	SENT_448	[p31l1979t1431r2153b1509],
12	served	VBN	O	serve	_	0	SENT_448	[p31l13t1558r278b1638],
13	by	IN	O	by	_	0	SENT_448	[p31l303t1559r400b1659],
14	an	DT	O	a	det	16	SENT_448	[p31l419t1584r520b1637],
15	alert	JJ	O	alert	amod	16	SENT_448	[p31l543t1559r735b1637],
16	physician	NN	O	physician	agent	12	SENT_448	[p31l752t1559r1155b1659],
17	aware	JJ	O	aware	amod	16	SENT_448	[p31l1179t1585r1426b1638],
18	of	IN	O	of	_	0	SENT_448	[p31l1450t1558r1552b1637],
19	the	DT	O	the	det	20	SENT_448	[p31l1558t1558r1687b1637],
20	possibility	NN	O	possibility	prep_of	16	SENT_448	[p31l1710t1559r2151b1659],
21	that	IN	O	that	complm	32	SENT_448	[p31l12t1687r179b1765],
22	a	DT	O	a	det	24	SENT_448	[p31l208t1713r253b1765],
23	genetic	JJ	O	genetic	amod	24	SENT_448	[p31l286t1687r591b1787],
24	polymorphism	NN	O	polymorphism	nsubj	32	SENT_448	[p31l624t1686r1256b1787],
25	in	IN	O	in	_	0	SENT_448	[p31l1289t1687r1371b1764],
26	drug	NN	O	drug	nn	27	SENT_448	[p31l1407t1686r1607b1787],
27	metabolism	NN	O	metabolism	prep_in	24	SENT_448	[p31l1638t1686r2147b1765],
28	may	MD	O	may	aux	32	SENT_448	[p31l11t1841r189b1915],
29	be	VB	O	be	cop	32	SENT_448	[p31l210t1815r306b1893],
30	a	DT	O	a	det	32	SENT_448	[p31l331t1841r375b1893],
31	potential	JJ	O	potential	amod	32	SENT_448	[p31l398t1814r776b1915],
32	factor	NN	O	factor	ccomp	12	SENT_448	[p31l801t1814r1048b1893],
33	in	IN	O	in	_	0	SENT_448	[p31l1070t1815r1151b1892],
34	an	DT	O	a	det	37	SENT_448	[p31l1176t1840r1277b1893],
35	unexpected	JJ	O	unexpected	amod	37	SENT_448	[p31l1302t1814r1785b1915],
36	drug	NN	O	drug	nn	37	SENT_448	[p31l1811t1815r2011b1915],
37	response	NN	O	response	prep_in	32	SENT_448	[p31l2033t1841r2145b1893, p31l13t1942r333b2017],
38	.	.	O	.	_	0	SENT_448	[p31l2033t1841r2145b1893, p31l13t1942r333b2017],

1	Supported	VBN	O	support	_	0	SENT_449	[p31l99t2034r428b2110],
2	in	IN	O	in	_	0	SENT_449	[p31l444t2034r505b2092],
3	part	NN	O	part	prep_in	1	SENT_449	[p31l522t2046r652b2110],
4	by	IN	O	by	_	0	SENT_449	[p31l666t2034r739b2110],
5	a	DT	O	a	det	6	SENT_449	[p31l752t2054r785b2093],
6	grant	NN	O	grant	prep_by	1	SENT_449	[p31l801t2046r973b2110],
7	from	IN	O	from	_	0	SENT_449	[p31l986t2033r1143b2093],
8	the	DT	O	the	det	10	SENT_449	[p31l1160t2034r1257b2093],
9	National	NNP	ORGANIZATION	National	nn	10	SENT_449	[p31l1272t2034r1550b2093],
10	Institute	NNP	ORGANIZATION	Institute	prep_from	1	SENT_449	[p31l1565t2034r1831b2094],
11	of	IN	ORGANIZATION	of	_	0	SENT_449	[p31l1848t2033r1925b2093],
12	General	NNP	ORGANIZATION	General	nn	14	SENT_449	[p31l1927t2038r2147b2093, p31l10t2119r64b2178],
13	Medical	NNP	ORGANIZATION	Medical	nn	14	SENT_449	[p31l80t2119r333b2178],
14	Sciences	NNPS	ORGANIZATION	Sciences	prep_of	10	SENT_449	[p31l352t2119r639b2191],
15	,	,	O	,	_	0	SENT_449	[p31l352t2119r639b2191],
16	National	NNP	ORGANIZATION	National	dep	22	SENT_449	[p31l660t2119r937b2178],
17	Institutes	NNPS	ORGANIZATION	Institutes	dep	16	SENT_449	[p31l954t2119r1252b2179],
18	of	IN	ORGANIZATION	of	_	0	SENT_449	[p31l1272t2118r1348b2178],
19	Health	NNP	ORGANIZATION	Health	prep_of	16	SENT_449	[p31l1353t2119r1566b2178],
20	(	CD	NUMBER	(	num	19	SENT_449	[p31l1589t2123r1974b2187],
21	GM31304	NN	O	gm31304	nn	22	SENT_449	[p31l1589t2123r1974b2187],
22	)	NN	O	)	appos	14	SENT_449	[p31l1589t2123r1974b2187],
23	.	.	O	.	_	0	SENT_449	[p31l1589t2123r1974b2187],

1	Dr.	NNP	O	Dr.	nn	2	SENT_450	[p31l96t2203r190b2257],
2	Wilkinson	NNP	PERSON	Wilkinson	nsubj	3	SENT_450	[p31l212t2198r546b2258],
3	reports	VBZ	O	report	_	0	SENT_450	[p31l566t2210r792b2274],
4	having	VBG	O	have	aux	5	SENT_450	[p31l813t2198r1029b2274],
5	received	VBN	O	receive	xcomp	3	SENT_450	[p31l1046t2198r1303b2259],
6	consulting	NN	O	consulting	nn	7	SENT_450	[p31l1323t2198r1664b2274],
7	fees	NNS	O	fee	dobj	5	SENT_450	[p31l1682t2197r1803b2257],
8	from	IN	O	from	_	0	SENT_450	[p31l1825t2197r1982b2257],
9	Xanthus	NNP	ORGANIZATION	Xanthus	nn	11	SENT_450	[p31l1999t2203r2147b2257, p31l11t2286r146b2346],
10	Life	NNP	ORGANIZATION	Life	nn	11	SENT_450	[p31l173t2285r290b2345],
11	Sciences	NNPS	ORGANIZATION	Sciences	prep_from	5	SENT_450	[p31l318t2287r604b2358],
12	,	,	O	,	_	0	SENT_450	[p31l318t2287r604b2358],
13	Simcyp	NNP	PERSON	Simcyp	appos	11	SENT_450	[p31l636t2287r882b2362],
14	,	,	O	,	_	0	SENT_450	[p31l636t2287r882b2362],
15	as	RB	O	as	_	0	SENT_450	[p31l912t2306r975b2345],
16	well	RB	O	well	_	0	SENT_450	[p31l999t2286r1131b2346],
17	as	IN	O	as	_	0	SENT_450	[p31l1156t2306r1219b2345],
18	lecture	NN	O	lecture	nn	19	SENT_450	[p31l1245t2286r1460b2346],
19	fees	NNS	O	fee	prep_from	5	SENT_450	[p31l1486t2285r1607b2345],
20	from	IN	O	from	_	0	SENT_450	[p31l1634t2285r1791b2345],
21	Merck	NNP	ORGANIZATION	Merck	nn	23	SENT_450	[p31l1814t2286r2020b2346],
22	Research	NNP	ORGANIZATION	Research	nn	23	SENT_450	[p31l2040t2291r2147b2349, p31l12t2372r215b2430],
23	Laboratories	NNPS	ORGANIZATION	Laboratories	prep_from	19	SENT_450	[p31l233t2372r651b2430],
24	.	.	O	.	_	0	SENT_450	[p31l233t2372r651b2430],

1	JMO	NN	O	jmo	_	0	SENT_451	[p31l7t2578r128b2626],
2	.	.	O	.	_	0	SENT_451	[p31l7t2578r128b2626],

1	Interaction	NN	O	interaction	_	0	SENT_452	[p31l152t2575r412b2619],
2	of	IN	O	of	_	0	SENT_452	[p31l435t2574r491b2619],
3	citrus	NN	O	citrus	nn	4	SENT_452	[p31l504t2575r633b2619],
4	juices	NNS	O	juice	prep_of	1	SENT_452	[p31l649t2575r788b2631],
5	with	IN	O	with	_	0	SENT_452	[p31l809t2575r915b2619],
6	felodipine	NN	O	felodipine	prep_with	1	SENT_452	[p31l937t2574r1044b2619, p31l13t2646r161b2702],
7	and	CC	O	and	_	0	SENT_452	[p31l198t2646r285b2690],
8	nifedipine	NN	O	nifedipine	prep_with	1	SENT_452	[p31l322t2645r576b2702],
9	.	.	O	.	_	0	SENT_452	[p31l322t2645r576b2702],

1	Lancet	NNP	O	Lancet	_	0	SENT_453	[p31l615t2650r772b2690],
2	1991	CD	DATE	1991	num	1	SENT_453	[p31l809t2649r1042b2699],
3	;	:	O	;	_	0	SENT_453	[p31l809t2649r1042b2699],
4	337	CD	NUMBER	337	num	6	SENT_453	[p31l809t2649r1042b2699],
5	:	:	O	:	_	0	SENT_453	[p31l809t2649r1042b2699],
6	268-9	CD	NUMBER	268-9	dep	1	SENT_453	[p31l13t2720r161b2760],
7	.	.	O	.	_	0	SENT_453	[p31l13t2720r161b2760],

1	7	CD	NUMBER	7	_	0	SENT_454	[p31l14t2793r50b2832],
2	.	.	O	.	_	0	SENT_454	[p31l14t2793r50b2832],

1	Thummel	NNP	O	Thummel	nn	2	SENT_455	[p31l107t2788r341b2832],
2	KE	NNP	O	KE	_	0	SENT_455	[p31l357t2792r438b2841],
3	,	,	O	,	_	0	SENT_455	[p31l357t2792r438b2841],
4	Kunze	NNP	ORGANIZATION	Kunze	nn	5	SENT_455	[p31l457t2792r607b2833],
5	KL	NNP	ORGANIZATION	KL	appos	2	SENT_455	[p31l624t2792r702b2841],
6	,	,	O	,	_	0	SENT_455	[p31l624t2792r702b2841],
7	Shen	NNP	O	Shen	nn	8	SENT_455	[p31l722t2788r838b2832],
8	DD	NNP	O	DD	appos	5	SENT_455	[p31l853t2792r943b2832],
9	.	.	O	.	_	0	SENT_455	[p31l853t2792r943b2832],

1	Enzyme-catalyzed	JJ	O	enzyme-catalyzed	amod	2	SENT_456	[p31l962t2792r1043b2831, p31l12t2859r374b2915],
2	processes	NNS	O	process	_	0	SENT_456	[p31l398t2873r627b2915],
3	of	IN	O	of	_	0	SENT_456	[p31l654t2858r710b2903],
4	ﬁrst-pass	JJ	O	ﬁrst-pass	dep	5	SENT_456	[p31l725t2858r943b2915],
5	hepatic	JJ	O	hepatic	amod	9	SENT_456	[p31l969t2859r1043b2903, p31l12t2930r126b2986],
6	and	CC	O	and	_	0	SENT_456	[p31l158t2930r245b2974],
7	intestinal	JJ	O	intestinal	amod	9	SENT_456	[p31l277t2930r497b2974],
8	drug	NN	O	drug	nn	9	SENT_456	[p31l530t2930r642b2986],
9	extraction	NN	O	extraction	prep_of	2	SENT_456	[p31l673t2930r920b2974],
10	.	.	O	.	_	0	SENT_456	[p31l673t2930r920b2974],

1	Adv	NNP	MISC	Adv	nn	4	SENT_457	[p31l954t2930r1046b2974],
2	Drug	NNP	MISC	Drug	nn	4	SENT_457	[p31l12t3005r134b3057],
3	Deliv	NNP	MISC	Deliv	nn	4	SENT_457	[p31l145t3001r267b3045],
4	Rev	NN	O	rev	_	0	SENT_457	[p31l278t3005r364b3048],
5	1997	CD	DATE	1997	num	4	SENT_457	[p31l378t3004r764b3054],
6	;	:	O	;	_	0	SENT_457	[p31l378t3004r764b3054],
7	27:99	CD	NUMBER	27:99	number	8	SENT_457	[p31l378t3004r764b3054],
8	-127	CD	NUMBER	-127	dep	4	SENT_457	[p31l378t3004r764b3054],
9	.	.	O	.	_	0	SENT_457	[p31l378t3004r764b3054],

1	8	CD	NUMBER	8	_	0	SENT_458	[p31l12t3076r50b3116],
2	.	.	O	.	_	0	SENT_458	[p31l12t3076r50b3116],

1	Capewell	NNP	O	Capewell	nn	2	SENT_459	[p31l109t3072r324b3128],
2	S	NNP	O	S	_	0	SENT_459	[p31l338t3075r377b3125],
3	,	,	O	,	_	0	SENT_459	[p31l338t3075r377b3125],
4	Freestone	NNP	PERSON	Freestone	nn	5	SENT_459	[p31l393t3076r623b3116],
5	S	NNP	O	S	appos	2	SENT_459	[p31l638t3075r677b3125],
6	,	,	O	,	_	0	SENT_459	[p31l638t3075r677b3125],
7	CritchleyJAJH	NNP	O	CritchleyJAJH	appos	2	SENT_459	[p31l694t3072r1041b3128],
8	,	,	O	,	_	0	SENT_459	[p31l694t3072r1041b3128],
9	Pottage	NNP	O	Pottage	nn	10	SENT_459	[p31l12t3147r189b3199],
10	A	NNP	O	A	appos	2	SENT_459	[p31l208t3147r257b3196],
11	,	,	O	,	_	0	SENT_459	[p31l208t3147r257b3196],
12	Prescott	NNP	PERSON	Prescott	nn	13	SENT_459	[p31l281t3147r473b3187],
13	LF	NNP	O	LF	appos	2	SENT_459	[p31l491t3147r555b3187],
14	.	.	O	.	_	0	SENT_459	[p31l491t3147r555b3187],

1	Reduced	VBN	O	reduce	_	0	SENT_460	[p31l579t3143r783b3190],
2	felodipine	NN	O	felodipine	nn	3	SENT_460	[p31l805t3142r1044b3199],
3	bioavailability	NN	O	bioavailability	dobj	1	SENT_460	[p31l13t3214r342b3270],
4	in	IN	O	in	_	0	SENT_460	[p31l353t3214r398b3257],
5	patients	NNS	O	patient	prep_in	1	SENT_460	[p31l412t3214r599b3270],
6	taking	VBG	O	take	partmod	5	SENT_460	[p31l614t3214r766b3270],
7	anticonvulsants	NNS	O	anticonvulsant	dobj	6	SENT_460	[p31l777t3214r1043b3258, p31l13t3294r147b3329],
8	.	.	O	.	_	0	SENT_460	[p31l777t3214r1043b3258, p31l13t3294r147b3329],

1	Lancet	NNP	O	Lancet	_	0	SENT_461	[p31l164t3289r321b3329],
2	1988	CD	DATE	1988	num	1	SENT_461	[p31l334t3288r661b3338],
3	;	:	O	;	_	0	SENT_461	[p31l334t3288r661b3338],
4	2:480	CD	NUMBER	2:480	number	5	SENT_461	[p31l334t3288r661b3338],
5	-2	CD	NUMBER	-2	dep	1	SENT_461	[p31l334t3288r661b3338],
6	.	.	O	.	_	0	SENT_461	[p31l334t3288r661b3338],

1	9	CD	NUMBER	9	_	0	SENT_462	[p31l12t3361r50b3400],
2	.	.	O	.	_	0	SENT_462	[p31l12t3361r50b3400],

1	Thummel	NNP	O	Thummel	nn	2	SENT_463	[p31l107t3356r341b3400],
2	KE	NNP	O	KE	_	0	SENT_463	[p31l369t3360r450b3409],
3	,	,	O	,	_	0	SENT_463	[p31l369t3360r450b3409],
4	Wilkinson	NNP	PERSON	Wilkinson	nn	5	SENT_463	[p31l480t3356r728b3400],
5	GR	NN	O	gr	appos	2	SENT_463	[p31l757t3359r847b3403],
6	.	.	O	.	_	0	SENT_463	[p31l757t3359r847b3403],

1	In	FW	O	in	nn	2	SENT_464	[p31l877t3360r920b3400],
2	vitro	FW	O	vitro	dep	6	SENT_464	[p31l950t3357r1044b3400],
3	and	CC	O	and	_	0	SENT_464	[p31l12t3427r99b3471],
4	in	FW	O	in	dep	6	SENT_464	[p31l132t3428r170b3471],
5	vivo	FW	O	vivo	pobj	4	SENT_464	[p31l203t3428r287b3471],
6	interactions	NNS	O	interaction	_	0	SENT_464	[p31l317t3427r597b3471],
7	involving	VBG	O	involve	_	0	SENT_464	[p31l628t3427r847b3483],
8	human	JJ	O	human	amod	9	SENT_464	[p31l876t3427r1044b3471],
9	CYP3A	NN	O	cyp3a	prep_involving	6	SENT_464	[p31l13t3501r185b3542],
10	.	.	O	.	_	0	SENT_464	[p31l13t3501r185b3542],

1	Annu	NNP	PERSON	Annu	nn	4	SENT_465	[p31l204t3502r334b3542],
2	Rev	NN	PERSON	rev	nn	4	SENT_465	[p31l351t3502r437b3545],
3	Pharmacol	NNP	PERSON	Pharmacol	nn	4	SENT_465	[p31l452t3498r706b3542],
4	Toxicol	NNP	PERSON	Toxicol	_	0	SENT_465	[p31l722t3498r894b3542],
5	1998	CD	DATE	1998	num	4	SENT_465	[p31l913t3501r1041b3551],
6	;	:	O	;	_	0	SENT_465	[p31l913t3501r1041b3551],
7	38:389	CD	NUMBER	38:389	number	8	SENT_465	[p31l13t3572r296b3613],
8	-430	CD	NUMBER	-430	dep	4	SENT_465	[p31l13t3572r296b3613],
9	.	.	O	.	_	0	SENT_465	[p31l13t3572r296b3613],

1	erythromycin	NN	O	erythromycin	_	0	SENT_466	[p31l1118t2575r1432b2631],
2	and	CC	O	and	_	0	SENT_466	[p31l1452t2575r1540b2619],
3	the	DT	O	the	det	4	SENT_466	[p31l1560t2575r1632b2619],
4	risk	NN	O	risk	conj_and	1	SENT_466	[p31l1653t2575r1743b2619],
5	of	IN	O	of	_	0	SENT_466	[p31l1761t2574r1818b2619],
6	sudden	JJ	O	sudden	amod	7	SENT_466	[p31l1828t2575r1999b2619],
7	death	NN	O	death	prep_of	1	SENT_466	[p31l2020t2575r2150b2619],
8	from	IN	O	from	_	0	SENT_466	[p31l1118t2645r1234b2690],
9	cardiac	JJ	O	cardiac	amod	10	SENT_466	[p31l1261t2646r1428b2690],
10	causes	NNS	O	cause	prep_from	1	SENT_466	[p31l1454t2660r1620b2690],
11	.	.	O	.	_	0	SENT_466	[p31l1454t2660r1620b2690],

1	N	NN	O	n	nn	3	SENT_467	[p31l1648t2650r1690b2690],
2	Engl	NNP	O	Engl	nn	3	SENT_467	[p31l1715t2646r1823b2702],
3	J	NNP	O	J	nsubj	4	SENT_467	[p31l1843t2650r1864b2697],
4	Med	VBD	O	med	_	0	SENT_467	[p31l1887t2646r1992b2690],
5	2004	CD	DATE	2004	dobj	4	SENT_467	[p31l2018t2649r2148b2699],
6	;	:	O	;	_	0	SENT_467	[p31l2018t2649r2148b2699],
7	351:1089	CD	NUMBER	351:1089	num	8	SENT_467	[p31l1118t2720r1431b2761],
8	-96	CD	NUMBER	-96	dep	5	SENT_467	[p31l1118t2720r1431b2761],
9	.	.	O	.	_	0	SENT_467	[p31l1118t2720r1431b2761],

1	12	CD	NUMBER	12	_	0	SENT_468	[p31l1120t2793r1184b2832],
2	.	.	O	.	_	0	SENT_468	[p31l1120t2793r1184b2832],

1	Kane	NNP	ORGANIZATION	Kane	nn	2	SENT_469	[p31l1214t2792r1333b2833],
2	GC	NN	ORGANIZATION	gc	_	0	SENT_469	[p31l1370t2791r1460b2841],
3	,	,	O	,	_	0	SENT_469	[p31l1370t2791r1460b2841],
4	Lipsky	NNP	PERSON	Lipsky	nn	6	SENT_469	[p31l1499t2788r1654b2844],
5	J	NNP	O	J	nn	6	SENT_469	[p31l1683t2792r1733b2839],
6	]	NN	O	]	appos	2	SENT_469	[p31l1683t2792r1733b2839],
7	.	.	O	.	_	0	SENT_469	[p31l1683t2792r1733b2839],

1	Drug-grapefruit	NN	O	drug-grapefruit	nsubj	2	SENT_470	[p31l1772t2787r2152b2844],
2	juice	NN	O	juice	_	0	SENT_470	[p31l1110t2859r1226b2915],
3	interactions	NNS	O	interaction	dobj	2	SENT_470	[p31l1244t2859r1538b2903],
4	.	.	O	.	_	0	SENT_470	[p31l1244t2859r1538b2903],

1	Mayo	NNP	O	Mayo	nn	3	SENT_471	[p31l1558t2863r1686b2915],
2	Clin	NNP	O	Clin	nn	3	SENT_471	[p31l1705t2859r1802b2903],
3	Proc	NNP	O	Proc	_	0	SENT_471	[p31l1819t2863r1924b2903],
4	2000	CD	DATE	2000	num	3	SENT_471	[p31l1942t2862r2148b2912],
5	;	:	O	;	_	0	SENT_471	[p31l1942t2862r2148b2912],
6	75	CD	NUMBER	75	num	8	SENT_471	[p31l1942t2862r2148b2912],
7	:	:	O	:	_	0	SENT_471	[p31l1942t2862r2148b2912],
8	933-42	CD	NUMBER	933-42	dep	3	SENT_471	[p31l1118t2933r1296b2974],
9	.	.	O	.	_	0	SENT_471	[p31l1118t2933r1296b2974],

1	13	CD	NUMBER	13	_	0	SENT_472	[p31l1120t3006r1184b3045],
2	.	.	O	.	_	0	SENT_472	[p31l1120t3006r1184b3045],

1	Flexner	NNP	PERSON	Flexner	nn	2	SENT_473	[p31l1214t3001r1389b3045],
2	C.	NNP	PERSON	C.	_	0	SENT_473	[p31l1404t3004r1451b3045],
3	Dual	JJ	PERSON	dual	amod	6	SENT_473	[p31l1469t3001r1581b3045],
4	protease	NN	O	protease	nn	6	SENT_473	[p31l1596t3010r1796b3057],
5	inhibitor	NN	O	inhibitor	nn	6	SENT_473	[p31l1812t3001r2022b3045],
6	therapy	NN	O	therapy	dep	2	SENT_473	[p31l2037t3001r2149b3045, p31l1118t3086r1199b3128],
7	in	IN	O	in	_	0	SENT_473	[p31l1209t3072r1254b3115],
8	HIV-infected	JJ	O	hiv-infected	amod	9	SENT_473	[p31l1265t3071r1566b3116],
9	patients	NNS	O	patient	prep_in	6	SENT_473	[p31l1577t3072r1780b3128],
10	:	:	O	:	_	0	SENT_473	[p31l1577t3072r1780b3128],
11	pharmacologic	JJ	O	pharmacologic	amod	12	SENT_473	[p31l1793t3072r2150b3128],
12	rationale	NN	O	rationale	dep	2	SENT_473	[p31l1118t3143r1326b3187],
13	and	CC	O	and	_	0	SENT_473	[p31l1356t3143r1444b3187],
14	clinical	JJ	O	clinical	amod	15	SENT_473	[p31l1474t3143r1642b3187],
15	beneﬁts	NNS	O	beneﬁts	conj_and	12	SENT_473	[p31l1673t3142r1873b3187],
16	.	.	O	.	_	0	SENT_473	[p31l1673t3142r1873b3187],

1	Annu	NNP	PERSON	Annu	nn	4	SENT_474	[p31l1905t3147r2036b3187],
2	Rev	NN	PERSON	rev	nn	4	SENT_474	[p31l2065t3147r2152b3190],
3	Pharmacol	NNP	PERSON	Pharmacol	nn	4	SENT_474	[p31l1117t3214r1371b3258],
4	Toxicol	NNP	PERSON	Toxicol	_	0	SENT_474	[p31l1383t3214r1556b3258],
5	2000	CD	DATE	2000	num	4	SENT_474	[p31l1569t3217r1958b3267],
6	;	:	O	;	_	0	SENT_474	[p31l1569t3217r1958b3267],
7	40:649	CD	NUMBER	40:649	number	8	SENT_474	[p31l1569t3217r1958b3267],
8	-74	CD	NUMBER	-74	dep	4	SENT_474	[p31l1569t3217r1958b3267],
9	.	.	O	.	_	0	SENT_474	[p31l1569t3217r1958b3267],

1	14	CD	NUMBER	14	_	0	SENT_475	[p31l1120t3290r1184b3329],
2	.	.	O	.	_	0	SENT_475	[p31l1120t3290r1184b3329],

1	Henderson	NNP	PERSON	Henderson	nn	2	SENT_476	[p31l1214t3285r1477b3329],
2	L	NNP	PERSON	L	_	0	SENT_476	[p31l1491t3289r1531b3338],
3	,	,	O	,	_	0	SENT_476	[p31l1491t3289r1531b3338],
4	Yue	NNP	O	Yue	nn	5	SENT_476	[p31l1547t3289r1630b3329],
5	QY	NNP	O	QY	appos	2	SENT_476	[p31l1645t3288r1721b3340],
6	,	,	O	,	_	0	SENT_476	[p31l1645t3288r1721b3340],
7	Bergquist	NNP	PERSON	Bergquist	nn	8	SENT_476	[p31l1738t3285r1968b3341],
8	C	NNP	O	C	appos	2	SENT_476	[p31l1980t3288r2026b3338],
9	,	,	O	,	_	0	SENT_476	[p31l1980t3288r2026b3338],
10	Gerden	NNP	PERSON	Gerden	nn	11	SENT_476	[p31l2043t3288r2149b3329, p31l1118t3356r1205b3400],
11	B	NNP	O	B	appos	2	SENT_476	[p31l1229t3360r1274b3409],
12	,	,	O	,	_	0	SENT_476	[p31l1229t3360r1274b3409],
13	Arlett	NNP	PERSON	Arlett	nn	16	SENT_476	[p31l1299t3356r1438b3400],
14	P.	NNP	PERSON	P.	nn	16	SENT_476	[p31l1458t3360r1494b3400],
15	St	NNP	PERSON	St	nn	16	SENT_476	[p31l1522t3359r1568b3400],
16	John	NNP	PERSON	John	poss	20	SENT_476	[p31l1584t3356r1740b3407],
17	’s	POS	O	’s	_	0	SENT_476	[p31l1584t3356r1740b3407],
18	wort	NN	O	wort	nn	20	SENT_476	[p31l1762t3365r1876b3400],
19	(	NN	O	(	nn	20	SENT_476	[p31l1900t3357r2148b3412],
20	Hypericum	NN	O	hypericum	appos	2	SENT_476	[p31l1900t3357r2148b3412],
21	peijﬁmitum	NN	O	peijﬁmitum	dep	20	SENT_476	[p31l1115t3427r1384b3483],
22	)	CD	NUMBER	)	num	21	SENT_476	[p31l1115t3427r1384b3483],
23	:	:	O	:	_	0	SENT_476	[p31l1115t3427r1384b3483],
24	drug	NN	O	drug	nn	25	SENT_476	[p31l1413t3427r1526b3483],
25	interactions	NNS	O	interaction	dep	2	SENT_476	[p31l1550t3427r1836b3471],
26	and	CC	O	and	_	0	SENT_476	[p31l1862t3427r1951b3471],
27	clinical	JJ	O	clinical	amod	28	SENT_476	[p31l1977t3427r2149b3471],
28	outcomes	NNS	O	outcome	conj_and	25	SENT_476	[p31l1118t3507r1359b3542],
29	.	.	O	.	_	0	SENT_476	[p31l1118t3507r1359b3542],

1	Br	NN	O	br	nn	4	SENT_477	[p31l1374t3502r1455b3549],
2	]	CD	NUMBER	]	num	4	SENT_477	[p31l1374t3502r1455b3549],
3	Clin	NNP	O	Clin	nn	4	SENT_477	[p31l1466t3498r1562b3542],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_477	[p31l1574t3498r1825b3542],
5	2002	CD	DATE	2002	num	7	SENT_477	[p31l1838t3501r2149b3551, p31l1119t3572r1188b3612],
6	;	:	O	;	_	0	SENT_477	[p31l1838t3501r2149b3551, p31l1119t3572r1188b3612],
7	54:34956	CD	NUMBER	54:34956	dep	4	SENT_477	[p31l1838t3501r2149b3551, p31l1119t3572r1188b3612],
8	.	.	O	.	_	0	SENT_477	[p31l1838t3501r2149b3551, p31l1119t3572r1188b3612],

1	10	CD	NUMBER	10	_	0	SENT_478	[p32l14t24r78b64],
2	.	.	O	.	_	0	SENT_478	[p32l14t24r78b64],

1	Levy	NNP	O	Levy	nn	2	SENT_479	[p32l108t24r212b76],
2	RH	NNP	O	RH	_	0	SENT_479	[p32l231t24r322b73],
3	,	,	O	,	_	0	SENT_479	[p32l231t24r322b73],
4	Thummel	NNP	ORGANIZATION	Thummel	nn	5	SENT_479	[p32l345t20r580b64],
5	KE	NNP	ORGANIZATION	KE	appos	2	SENT_479	[p32l601t24r682b73],
6	,	,	O	,	_	0	SENT_479	[p32l601t24r682b73],
7	Trager	NNP	PERSON	Trager	nn	8	SENT_479	[p32l706t23r862b76],
8	WE	NNP	O	WE	appos	2	SENT_479	[p32l880t24r978b73],
9	,	,	O	,	_	0	SENT_479	[p32l880t24r978b73],
10	et	FW	O	et	nn	11	SENT_479	[p32l1003t29r1046b64],
11	al.	FW	O	al.	appos	2	SENT_479	[p32l12t91r65b135],
12	.	.	O	.	_	0	SENT_479	[p32l12t91r65b135],

1	Metabolic	JJ	O	metabolic	amod	2	SENT_480	[p32l98t91r334b135],
2	drug	NN	O	drug	_	0	SENT_480	[p32l366t91r477b147],
3	interactions	NNS	O	interaction	dep	2	SENT_480	[p32l507t91r801b135],
4	.	.	O	.	_	0	SENT_480	[p32l507t91r801b135],

1	Philadelphia	NNP	LOCATION	Philadelphia	_	0	SENT_481	[p32l835t91r1043b135, p32l12t162r129b218],
2	:	:	O	:	_	0	SENT_481	[p32l835t91r1043b135, p32l12t162r129b218],
3	Lippincott	NNP	ORGANIZATION	Lippincott	nn	4	SENT_481	[p32l144t162r392b218],
4	Williams	NNP	ORGANIZATION	Williams	dep	1	SENT_481	[p32l401t162r613b206],
5	&	CC	ORGANIZATION	&	_	0	SENT_481	[p32l628t165r664b207],
6	Wilkins	NNP	ORGANIZATION	Wilkins	dep	1	SENT_481	[p32l677t162r875b215],
7	,	,	O	,	_	0	SENT_481	[p32l677t162r875b215],
8	2000	CD	DATE	2000	appos	4	SENT_481	[p32l892t165r1021b206],
9	.	.	O	.	_	0	SENT_481	[p32l892t165r1021b206],

1	11	CD	NUMBER	11	_	0	SENT_482	[p32l14t238r78b277],
2	.	.	O	.	_	0	SENT_482	[p32l14t238r78b277],

1	Ray	NNP	PERSON	Ray	nn	2	SENT_483	[p32l108t237r195b289],
2	WA	NNP	PERSON	WA	_	0	SENT_483	[p32l240t237r337b286],
3	,	,	O	,	_	0	SENT_483	[p32l240t237r337b286],
4	Murray	NNP	ORGANIZATION	Murray	nn	5	SENT_483	[p32l388t237r561b289],
5	KT	NNP	ORGANIZATION	KT	appos	2	SENT_483	[p32l607t236r685b286],
6	,	,	O	,	_	0	SENT_483	[p32l607t236r685b286],
7	Meredith	NNP	PERSON	Meredith	nn	8	SENT_483	[p32l736t233r951b277],
8	S	NNP	PERSON	S	appos	5	SENT_483	[p32l1002t236r1041b286],
9	,	,	O	,	_	0	SENT_483	[p32l1002t236r1041b286],
10	Narasimhulu	NNP	O	Narasimhulu	nn	11	SENT_483	[p32l11t304r324b348],
11	SS	NNP	O	SS	appos	5	SENT_483	[p32l355t307r423b357],
12	,	,	O	,	_	0	SENT_483	[p32l355t307r423b357],
13	Hall	NNP	O	Hall	nn	14	SENT_483	[p32l456t304r555b348],
14	K	NNP	O	K	appos	5	SENT_483	[p32l584t308r633b357],
15	,	,	O	,	_	0	SENT_483	[p32l584t308r633b357],
16	Stein	NNP	PERSON	Stein	nn	17	SENT_483	[p32l667t304r784b348],
17	CM	NN	O	cm	appos	5	SENT_483	[p32l814t307r909b348],
18	.	.	O	.	_	0	SENT_483	[p32l814t307r909b348],

1	Oral	JJ	O	oral	_	0	SENT_484	[p32l943t304r1044b348],

1	15	CD	NUMBER	15	_	0	SENT_485	[p32l1120t25r1184b64],
2	.	.	O	.	_	0	SENT_485	[p32l1120t25r1184b64],

1	Ruschitzka	FW	PERSON	ruschitzka	_	0	SENT_486	[p32l1214t20r1477b67],
2	F	NN	PERSON	f	dep	1	SENT_486	[p32l1521t24r1556b73],
3	,	,	O	,	_	0	SENT_486	[p32l1521t24r1556b73],
4	Meier	NNP	PERSON	Meier	nn	6	SENT_486	[p32l1602t20r1740b64],
5	P	NN	O	p	nn	6	SENT_486	[p32l1782t24r1840b73],
6	]	NN	O	]	appos	2	SENT_486	[p32l1782t24r1840b73],
7	,	,	O	,	_	0	SENT_486	[p32l1782t24r1840b73],
8	Turina	NNP	PERSON	Turina	nn	9	SENT_486	[p32l1886t20r2043b64],
9	M	NNP	O	M	appos	2	SENT_486	[p32l2085t24r2146b73],
10	,	,	O	,	_	0	SENT_486	[p32l2085t24r2146b73],
11	Liischer	NNP	O	Liischer	nn	12	SENT_486	[p32l1117t91r1306b135],
12	TF	NN	O	tf	appos	2	SENT_486	[p32l1323t94r1393b144],
13	,	,	O	,	_	0	SENT_486	[p32l1323t94r1393b144],
14	Noll	NNP	PERSON	Noll	nn	15	SENT_486	[p32l1415t91r1518b135],
15	G.	NNP	O	G.	appos	2	SENT_486	[p32l1538t94r1591b135],
16	Acute	JJ	O	acute	amod	19	SENT_486	[p32l1613t95r1747b135],
17	heart	NN	O	heart	nn	19	SENT_486	[p32l1768t91r1891b135],
18	transplant	NN	O	transplant	nn	19	SENT_486	[p32l1909t91r2152b147],
19	rejection	NN	O	rejection	dep	1	SENT_486	[p32l1118t162r1322b218],
20	due	JJ	O	due	_	0	SENT_486	[p32l1348t162r1432b206],
21	to	TO	O	to	_	0	SENT_486	[p32l1458t171r1502b206],
22	Saint	NNP	O	Saint	nn	23	SENT_486	[p32l1530t162r1650b206],
23	John	NNP	PERSON	John	poss	25	SENT_486	[p32l1667t162r1820b213],
24	’s	POS	O	’s	_	0	SENT_486	[p32l1667t162r1820b213],
25	wort	NN	O	wort	prep_due_to	19	SENT_486	[p32l1845t171r1967b206],
26	.	.	O	.	_	0	SENT_486	[p32l1845t171r1967b206],

1	Lancet	NNP	O	Lancet	_	0	SENT_487	[p32l1995t166r2153b206],
2	2000	CD	DATE	2000	num	1	SENT_487	[p32l1118t236r1506b286],
3	;	:	O	;	_	0	SENT_487	[p32l1118t236r1506b286],
4	355:548	CD	NUMBER	355:548	number	5	SENT_487	[p32l1118t236r1506b286],
5	-9	CD	NUMBER	-9	dep	1	SENT_487	[p32l1118t236r1506b286],
6	.	.	O	.	_	0	SENT_487	[p32l1118t236r1506b286],

1	16	CD	NUMBER	16	_	0	SENT_488	[p32l1120t309r1184b348],
2	.	.	O	.	_	0	SENT_488	[p32l1120t309r1184b348],

1	Piscitelli	NNP	ORGANIZATION	Piscitelli	nn	2	SENT_489	[p32l1214t304r1412b348],
2	SC	NNP	ORGANIZATION	SC	_	0	SENT_489	[p32l1431t307r1505b357],
3	,	,	O	,	_	0	SENT_489	[p32l1431t307r1505b357],
4	Burstein	NNP	PERSON	Burstein	nn	5	SENT_489	[p32l1525t304r1724b348],
5	AH	NNP	O	AH	appos	2	SENT_489	[p32l1740t308r1832b357],
6	,	,	O	,	_	0	SENT_489	[p32l1740t308r1832b357],
7	Chaitt	NNP	O	Chaitt	nn	8	SENT_489	[p32l1852t304r1997b348],
8	D	NNP	O	D	appos	2	SENT_489	[p32l2011t308r2061b357],
9	,	,	O	,	_	0	SENT_489	[p32l2011t308r2061b357],
10	A12220	NN	O	a12220	appos	2	SENT_489	[p32l2079t304r2148b347, p32l149t436r226b457],

1	N	NN	O	n	dep	7	SENT_490	[p32l912t438r925b453],
2	ENGL	NN	ORGANIZATION	engl	dep	1	SENT_490	[p32l941t437r1025b459],
3	)	CD	NUMBER	)	num	4	SENT_490	[p32l941t437r1025b459],
4	MED	NN	O	med	dep	7	SENT_490	[p32l1040t438r1092b453],
5	352	CD	NUMBER	352	num	7	SENT_490	[p32l1104t437r1181b459],
6	;	:	O	;	_	0	SENT_490	[p32l1104t437r1181b459],
7	21	CD	NUMBER	21	dep	16	SENT_490	[p32l1104t437r1181b459],
8	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	9	SENT_490	[p32l1218t437r1430b459],
9	MAY	NNP	DATE	MAY	dep	7	SENT_490	[p32l1469t437r1520b453],
10	26	CD	DATE	26	num	9	SENT_490	[p32l1532t432r1570b457],
11	,	,	DATE	,	_	0	SENT_490	[p32l1532t432r1570b457],
12	2005	CD	DATE	2005	num	9	SENT_490	[p32l1584t437r1647b459],
13	The	DT	O	the	det	16	SENT_490	[p32l936t470r987b494],
14	New	NNP	O	New	nn	16	SENT_490	[p32l996t471r1058b494],
15	England	NNP	O	England	nn	16	SENT_490	[p32l1067t470r1178b501],
16	Journal	NNP	O	Journal	_	0	SENT_490	[p32l1187t470r1284b494],
17	of	IN	O	of	_	0	SENT_490	[p32l1294t470r1323b494],
18	Medicine	NNP	O	Medicine	prep_of	16	SENT_490	[p32l1330t470r1455b494],

1	Downloaded	VBN	O	download	_	0	SENT_491	[p32l378t511r548b534],
2	from	IN	O	from	_	0	SENT_491	[p32l557t511r621b534],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_491	[p32l630t511r748b541],
4	at	IN	O	at	_	0	SENT_491	[p32l759t515r782b534],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_491	[p32l790t511r973b534],
6	on	IN	O	on	_	0	SENT_491	[p32l982t518r1015b534],
7	January	NNP	DATE	January	prep_on	1	SENT_491	[p32l1023t511r1126b541],
8	5	CD	DATE	5	num	7	SENT_491	[p32l1136t511r1159b538],
9	,	,	DATE	,	_	0	SENT_491	[p32l1136t511r1159b538],
10	2014	CD	DATE	2014	num	7	SENT_491	[p32l1170t511r1242b534],
11	.	.	O	.	_	0	SENT_491	[p32l1170t511r1242b534],

1	For	IN	O	for	_	0	SENT_492	[p32l1252t511r1299b534],
2	personal	JJ	O	personal	amod	3	SENT_492	[p32l1307t511r1419b541],
3	use	NN	O	use	pobj	1	SENT_492	[p32l1428t518r1472b534],
4	only	RB	O	only	advmod	3	SENT_492	[p32l1482t511r1546b541],
5	.	.	O	.	_	0	SENT_492	[p32l1482t511r1546b541],

1	No	DT	O	no	det	3	SENT_493	[p32l1557t511r1597b534],
2	other	JJ	O	other	amod	3	SENT_493	[p32l1607t511r1675b534],
3	uses	NNS	O	use	_	0	SENT_493	[p32l1683t518r1739b534],
4	without	IN	O	without	_	0	SENT_493	[p32l1749t511r1850b534],
5	permission	NN	O	permission	prep_without	3	SENT_493	[p32l1859t511r2011b541],
6	.	.	O	.	_	0	SENT_493	[p32l1859t511r2011b541],

1	Copyright	NN	O	copyright	_	0	SENT_494	[p32l728t552r863b583],
2	©	CD	NUMBER	©	num	6	SENT_494	[p32l872t552r896b576],
3	2005	CD	DATE	2005	num	6	SENT_494	[p32l906t552r970b576],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_494	[p32l980t552r1171b576],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_494	[p32l1181t552r1289b576],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_494	[p32l1300t552r1405b583],
7	.	.	O	.	_	0	SENT_494	[p32l1300t552r1405b583],

1	All	DT	O	all	det	2	SENT_495	[p32l1416t552r1457b576],
2	rights	NNS	O	rights	nsubj	3	SENT_495	[p32l1466t552r1541b583],
3	reserved	VBN	O	reserve	_	0	SENT_495	[p32l1551t552r1670b576],
4	.	.	O	.	_	0	SENT_495	[p32l1551t552r1670b576],

1	faro	NN	O	faro	nn	2	SENT_496	[p32l8t902r99b946],
2	RM	NN	O	rm	_	0	SENT_496	[p32l112t906r208b955],
3	,	,	O	,	_	0	SENT_496	[p32l112t906r208b955],
4	FalloonJ	NN	O	falloonj	appos	2	SENT_496	[p32l223t902r439b952],
5	.	.	O	.	_	0	SENT_496	[p32l223t902r439b952],

1	Indinavir	JJ	MISC	indinavir	amod	2	SENT_497	[p32l454t902r666b946],
2	concentrations	NNS	O	concentration	_	0	SENT_497	[p32l678t903r1025b946],
3	and	CC	O	and	_	0	SENT_497	[p32l7t972r93b1016],
4	St	NNP	PERSON	St	nn	5	SENT_497	[p32l111t976r156b1016],
5	John	NNP	PERSON	John	poss	7	SENT_497	[p32l164t972r315b1023],
6	’s	POS	O	’s	_	0	SENT_497	[p32l164t972r315b1023],
7	wort	NN	O	wort	conj_and	2	SENT_497	[p32l331t981r452b1016],
8	.	.	O	.	_	0	SENT_497	[p32l331t981r452b1016],

1	Lancet	NNP	O	Lancet	_	0	SENT_498	[p32l471t976r626b1016],
2	2000	CD	DATE	2000	num	1	SENT_498	[p32l639t976r1022b1025],
3	;	:	O	;	_	0	SENT_498	[p32l639t976r1022b1025],
4	355:547	CD	NUMBER	355:547	number	5	SENT_498	[p32l639t976r1022b1025],
5	-8	CD	NUMBER	-8	dep	1	SENT_498	[p32l639t976r1022b1025],
6	.	.	O	.	_	0	SENT_498	[p32l639t976r1022b1025],

1	[	NN	O	[	_	0	SENT_499	[p32l13t1046r233b1095],
2	Erratum	NN	O	erratum	dep	1	SENT_499	[p32l13t1046r233b1095],
3	,	,	O	,	_	0	SENT_499	[p32l13t1046r233b1095],
4	Lancet	NNP	O	Lancet	appos	2	SENT_499	[p32l249t1046r405b1086],
5	2001	CD	DATE	2001	rcmod	4	SENT_499	[p32l416t1046r798b1095],
6	;	:	O	;	_	0	SENT_499	[p32l416t1046r798b1095],
7	357:1210	CD	NUMBER	357:1210	dep	5	SENT_499	[p32l416t1046r798b1095],
8	.	.	O	.	_	0	SENT_499	[p32l416t1046r798b1095],
9	]	SYM	O	]	dep	5	SENT_499	[p32l416t1046r798b1095],

1	17	CD	NUMBER	17	_	0	SENT_500	[p32l10t1118r73b1155],
2	.	.	O	.	_	0	SENT_500	[p32l10t1118r73b1155],

1	Willson	NNP	PERSON	Willson	nn	2	SENT_501	[p32l101t1112r284b1156],
2	TM	NNP	O	TM	_	0	SENT_501	[p32l297t1115r390b1165],
3	,	,	O	,	_	0	SENT_501	[p32l297t1115r390b1165],
4	Kliewer	NNP	O	Kliewer	nn	5	SENT_501	[p32l408t1112r587b1157],
5	SA	NNP	O	SA	appos	2	SENT_501	[p32l601t1115r675b1156],
6	.	.	O	.	_	0	SENT_501	[p32l601t1115r675b1156],

1	PXR	NN	O	pxr	_	0	SENT_502	[p32l692t1116r802b1165],
2	,	,	O	,	_	0	SENT_502	[p32l692t1116r802b1165],
3	CAR	NN	O	car	nn	6	SENT_502	[p32l820t1115r931b1158],
4	and	CC	O	and	_	0	SENT_502	[p32l939t1112r1026b1156],
5	drug	NN	O	drug	nn	6	SENT_502	[p32l8t1182r118b1238],
6	metabolism	NN	O	metabolism	appos	1	SENT_502	[p32l152t1182r443b1226],
7	.	.	O	.	_	0	SENT_502	[p32l152t1182r443b1226],

1	Nat	NNP	MISC	Nat	nn	3	SENT_503	[p32l480t1186r567b1226],
2	Rev	NN	MISC	rev	nn	3	SENT_503	[p32l599t1186r684b1229],
3	Drug	NN	MISC	drug	_	0	SENT_503	[p32l716t1186r837b1238],
4	Discov	NNP	MISC	Discov	dep	3	SENT_503	[p32l870t1183r1028b1226],
5	2002	CD	DATE	2002	num	4	SENT_503	[p32l8t1256r362b1305],
6	;	:	O	;	_	0	SENT_503	[p32l8t1256r362b1305],
7	1:259	CD	NUMBER	1:259	num	8	SENT_503	[p32l8t1256r362b1305],
8	-66	CD	NUMBER	-66	dep	3	SENT_503	[p32l8t1256r362b1305],
9	.	.	O	.	_	0	SENT_503	[p32l8t1256r362b1305],

1	18	CD	NUMBER	18	_	0	SENT_504	[p32l10t1327r73b1366],
2	.	.	O	.	_	0	SENT_504	[p32l10t1327r73b1366],

1	Borst	NNP	PERSON	Borst	nn	2	SENT_505	[p32l102t1326r229b1366],
2	P	NN	O	p	_	0	SENT_505	[p32l246t1326r281b1375],
3	,	,	O	,	_	0	SENT_505	[p32l246t1326r281b1375],
4	Elferink	NNP	O	Elferink	nn	5	SENT_505	[p32l305t1322r494b1366],
5	RO	NN	O	ro	appos	2	SENT_505	[p32l511t1325r595b1368],
6	.	.	O	.	_	0	SENT_505	[p32l511t1325r595b1368],

1	Mammalian	JJ	O	mammalian	amod	3	SENT_506	[p32l618t1322r901b1365],
2	ABC	NNP	ORGANIZATION	ABC	nn	3	SENT_506	[p32l921t1325r1024b1366],
3	transporters	NNS	O	transporter	_	0	SENT_506	[p32l8t1401r292b1448],
4	in	IN	O	in	_	0	SENT_506	[p32l322t1393r367b1435],
5	health	NN	O	health	prep_in	3	SENT_506	[p32l397t1392r541b1436],
6	and	CC	O	and	_	0	SENT_506	[p32l570t1392r656b1436],
7	disease	NN	O	disease	prep_in	3	SENT_506	[p32l686t1392r866b1436],
8	.	.	O	.	_	0	SENT_506	[p32l686t1392r866b1436],

1	Annu	NNP	PERSON	Annu	nn	3	SENT_507	[p32l897t1396r1026b1436],
2	Rev	NN	PERSON	rev	nn	3	SENT_507	[p32l7t1466r93b1508],
3	Biochem	NNP	O	Biochem	_	0	SENT_507	[p32l103t1463r311b1506],
4	2002	CD	DATE	2002	dep	3	SENT_507	[p32l324t1466r707b1515],
5	;	:	O	;	_	0	SENT_507	[p32l324t1466r707b1515],
6	71:537	CD	NUMBER	71:537	num	7	SENT_507	[p32l324t1466r707b1515],
7	-92	CD	NUMBER	-92	dep	3	SENT_507	[p32l324t1466r707b1515],
8	.	.	O	.	_	0	SENT_507	[p32l324t1466r707b1515],

1	19	CD	NUMBER	19	_	0	SENT_508	[p32l10t1537r73b1576],
2	.	.	O	.	_	0	SENT_508	[p32l10t1537r73b1576],

1	Karpen	NNP	PERSON	Karpen	nn	2	SENT_509	[p32l102t1536r272b1587],
2	SJ	NNP	O	SJ	_	0	SENT_509	[p32l293t1535r348b1582],
3	.	.	O	.	_	0	SENT_509	[p32l293t1535r348b1582],

1	Nuclear	JJ	O	nuclear	amod	3	SENT_510	[p32l370t1532r555b1576],
2	receptor	NN	O	receptor	nn	3	SENT_510	[p32l574t1541r768b1587],
3	regulation	NN	O	regulation	_	0	SENT_510	[p32l786t1532r1026b1588],
4	of	IN	O	of	_	0	SENT_510	[p32l8t1602r64b1646],
5	hepatic	JJ	O	hepatic	amod	6	SENT_510	[p32l69t1602r239b1658],
6	function	NN	O	function	prep_of	3	SENT_510	[p32l254t1602r464b1646],
7	.	.	O	.	_	0	SENT_510	[p32l254t1602r464b1646],

1	J	NNP	O	J	nn	2	SENT_511	[p32l477t1606r498b1653],
2	Hepatol	NNP	O	Hepatol	_	0	SENT_511	[p32l513t1602r698b1658],
3	2002	CD	DATE	2002	num	2	SENT_511	[p32l714t1606r1025b1655, p32l9t1676r77b1716],
4	;	:	O	;	_	0	SENT_511	[p32l714t1606r1025b1655, p32l9t1676r77b1716],
5	36:83250	CD	NUMBER	36:83250	dep	2	SENT_511	[p32l714t1606r1025b1655, p32l9t1676r77b1716],
6	.	.	O	.	_	0	SENT_511	[p32l714t1606r1025b1655, p32l9t1676r77b1716],

1	20	CD	NUMBER	20	_	0	SENT_512	[p32l7t1747r73b1786],
2	.	.	O	.	_	0	SENT_512	[p32l7t1747r73b1786],

1	Weinshilboum	NNP	PERSON	Weinshilboum	_	0	SENT_513	[p32l101t1742r447b1786],
2	R.	NNP	PERSON	R.	nn	3	SENT_513	[p32l463t1746r510b1788],
3	Inheritance	NNP	PERSON	Inheritance	dep	1	SENT_513	[p32l530t1742r797b1786],
4	and	CC	O	and	_	0	SENT_513	[p32l814t1742r900b1786],
5	drug	NN	O	drug	nn	6	SENT_513	[p32l917t1742r1027b1798],
6	response	NN	O	response	dep	1	SENT_513	[p32l8t1826r230b1868],
7	.	.	O	.	_	0	SENT_513	[p32l8t1826r230b1868],

1	N	NN	O	n	nn	3	SENT_514	[p32l246t1816r287b1856],
2	Engl	NNP	O	Engl	nn	3	SENT_514	[p32l299t1812r435b1868],
3	]	NNP	O	]	nsubj	4	SENT_514	[p32l299t1812r435b1868],
4	Med	VBD	O	med	_	0	SENT_514	[p32l446t1812r549b1856],
5	2003	CD	DATE	2003	dobj	4	SENT_514	[p32l563t1816r974b1865],
6	;	:	O	;	_	0	SENT_514	[p32l563t1816r974b1865],
7	348:529	CD	NUMBER	348:529	num	8	SENT_514	[p32l563t1816r974b1865],
8	-37	CD	NUMBER	-37	dep	5	SENT_514	[p32l563t1816r974b1865],
9	.	.	O	.	_	0	SENT_514	[p32l563t1816r974b1865],

1	21	CD	NUMBER	21	_	0	SENT_515	[p32l7t1888r73b1926],
2	.	.	O	.	_	0	SENT_515	[p32l7t1888r73b1926],

1	Evans	NNP	PERSON	Evans	nn	2	SENT_516	[p32l102t1886r236b1926],
2	WE	NNP	O	WE	_	0	SENT_516	[p32l263t1886r359b1935],
3	,	,	O	,	_	0	SENT_516	[p32l263t1886r359b1935],
4	McLeod	NNP	PERSON	McLeod	nn	5	SENT_516	[p32l389t1882r575b1926],
5	HL	NNS	O	hl	appos	2	SENT_516	[p32l603t1886r686b1926],
6	.	.	O	.	_	0	SENT_516	[p32l603t1886r686b1926],

1	Pharmacogenomics	NNP	O	Pharmacogenomics	_	0	SENT_517	[p32l716t1882r1025b1938, p32l8t1953r178b1996],
2	—	CD	NUMBER	—	num	4	SENT_517	[p32l201t1977r261b1982],
3	drug	NN	O	drug	nn	4	SENT_517	[p32l283t1952r393b2008],
4	disposition	NN	O	disposition	dep	1	SENT_517	[p32l416t1952r690b2008],
5	,	,	O	,	_	0	SENT_517	[p32l416t1952r690b2008],
6	drug	NN	O	drug	nn	7	SENT_517	[p32l718t1952r828b2008],
7	targets	NNS	O	target	conj_and	4	SENT_517	[p32l851t1961r1022b2008],
8	,	,	O	,	_	0	SENT_517	[p32l851t1961r1022b2008],
9	and	CC	O	and	_	0	SENT_517	[p32l8t2022r94b2066],
10	side	JJ	O	side	amod	11	SENT_517	[p32l120t2022r211b2066],
11	effects	NNS	O	effect	dep	1	SENT_517	[p32l237t2022r401b2066],
12	.	.	O	.	_	0	SENT_517	[p32l237t2022r401b2066],

1	N	NN	O	n	nn	3	SENT_518	[p32l428t2026r469b2066],
2	Engl	NNP	O	Engl	nn	3	SENT_518	[p32l493t2022r600b2078],
3	J	NNP	O	J	nsubj	4	SENT_518	[p32l620t2026r641b2073],
4	Med	VBD	O	med	_	0	SENT_518	[p32l663t2022r766b2066],
5	2003	CD	DATE	2003	dobj	4	SENT_518	[p32l791t2026r1023b2075],
6	;	:	O	;	_	0	SENT_518	[p32l791t2026r1023b2075],
7	348	CD	NUMBER	348	num	9	SENT_518	[p32l791t2026r1023b2075],
8	:	:	O	:	_	0	SENT_518	[p32l791t2026r1023b2075],
9	538-49	CD	NUMBER	538-49	dep	5	SENT_518	[p32l9t2096r183b2136],
10	.	.	O	.	_	0	SENT_518	[p32l9t2096r183b2136],

1	22	CD	NUMBER	22	_	0	SENT_519	[p32l7t2168r73b2205],
2	.	.	O	.	_	0	SENT_519	[p32l7t2168r73b2205],

1	Xie	NNP	O	Xie	nn	2	SENT_520	[p32l101t2163r174b2205],
2	H-G	NNP	O	H-G	_	0	SENT_520	[p32l191t2165r305b2215],
3	,	,	O	,	_	0	SENT_520	[p32l191t2165r305b2215],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_520	[p32l325t2163r423b2207],
5	RB	NN	O	rb	appos	2	SENT_520	[p32l440t2166r521b2215],
6	,	,	O	,	_	0	SENT_520	[p32l440t2166r521b2215],
7	Wood	NNP	O	Wood	nn	8	SENT_520	[p32l539t2162r678b2206],
8	AH	NNP	O	AH	appos	2	SENT_520	[p32l693t2166r774b2215],
9	,	,	O	,	_	0	SENT_520	[p32l693t2166r774b2215],
10	Stein	NNP	PERSON	Stein	nn	11	SENT_520	[p32l796t2163r911b2206],
11	CM	NN	O	cm	appos	2	SENT_520	[p32l928t2165r1022b2206],
12	.	.	O	.	_	0	SENT_520	[p32l928t2165r1022b2206],

1	Molecular	JJ	O	molecular	amod	2	SENT_521	[p32l6t2232r243b2276],
2	basis	NN	O	basis	_	0	SENT_521	[p32l277t2232r392b2276],
3	of	IN	O	of	_	0	SENT_521	[p32l429t2232r485b2276],
4	ethnic	JJ	O	ethnic	amod	5	SENT_521	[p32l510t2233r654b2276],
5	differences	NNS	O	difference	prep_of	2	SENT_521	[p32l689t2232r945b2276],
6	in	IN	O	in	_	0	SENT_521	[p32l981t2233r1026b2275],
7	drug	NN	O	drug	nn	8	SENT_521	[p32l8t2302r118b2358],
8	disposition	NN	O	disposition	prep_in	2	SENT_521	[p32l142t2302r404b2358],
9	and	CC	O	and	_	0	SENT_521	[p32l429t2302r515b2346],
10	response	NN	O	response	prep_in	2	SENT_521	[p32l540t2316r763b2358],
11	.	.	O	.	_	0	SENT_521	[p32l540t2316r763b2358],

1	Annu	NNP	PERSON	Annu	nn	4	SENT_522	[p32l789t2306r918b2346],
2	Rev	NN	PERSON	rev	nn	4	SENT_522	[p32l942t2306r1028b2349],
3	Pharmacol	NNP	PERSON	Pharmacol	nn	4	SENT_522	[p32l7t2373r258b2416],
4	Toxicol	NNP	PERSON	Toxicol	_	0	SENT_522	[p32l269t2373r440b2416],
5	2001	CD	DATE	2001	num	4	SENT_522	[p32l453t2376r836b2425],
6	;	:	O	;	_	0	SENT_522	[p32l453t2376r836b2425],
7	41:815	CD	NUMBER	41:815	number	8	SENT_522	[p32l453t2376r836b2425],
8	-50	CD	NUMBER	-50	dep	4	SENT_522	[p32l453t2376r836b2425],
9	.	.	O	.	_	0	SENT_522	[p32l453t2376r836b2425],

1	23	CD	NUMBER	23	_	0	SENT_523	[p32l7t2447r73b2486],
2	.	.	O	.	_	0	SENT_523	[p32l7t2447r73b2486],

1	Burchard	NNP	PERSON	Burchard	nn	2	SENT_524	[p32l102t2442r318b2486],
2	EG	NNP	O	EG	_	0	SENT_524	[p32l336t2445r420b2495],
3	,	,	O	,	_	0	SENT_524	[p32l336t2445r420b2495],
4	Ziv	NNP	PERSON	Ziv	nn	5	SENT_524	[p32l440t2443r511b2486],
5	E	NNP	O	E	appos	2	SENT_524	[p32l526t2446r569b2495],
6	,	,	O	,	_	0	SENT_524	[p32l526t2446r569b2495],
7	Coyle	NNP	PERSON	Coyle	nn	8	SENT_524	[p32l590t2442r718b2497],
8	N	NNP	O	N	appos	2	SENT_524	[p32l734t2446r786b2495],
9	,	,	O	,	_	0	SENT_524	[p32l734t2446r786b2495],
10	et	FW	O	et	nn	11	SENT_524	[p32l807t2451r849b2485],
11	al.	FW	O	al.	appos	2	SENT_524	[p32l864t2442r916b2486],
12	.	.	O	.	_	0	SENT_524	[p32l864t2442r916b2486],

1	The	DT	O	the	det	2	SENT_525	[p32l936t2442r1025b2485],
2	importance	NN	O	importance	_	0	SENT_525	[p32l7t2513r276b2568],
3	of	IN	O	of	_	0	SENT_525	[p32l297t2512r352b2556],
4	race	NN	O	race	nn	7	SENT_525	[p32l362t2527r456b2556],
5	and	CC	O	and	_	0	SENT_525	[p32l475t2512r561b2556],
6	ethnic	JJ	O	ethnic	conj_and	4	SENT_525	[p32l581t2512r725b2556],
7	background	NN	O	background	prep_of	2	SENT_525	[p32l745t2512r1026b2568],
8	in	IN	O	in	_	0	SENT_525	[p32l7t2583r52b2625],
9	biomedical	JJ	O	biomedical	amod	10	SENT_525	[p32l66t2582r325b2626],
10	research	NN	O	research	prep_in	2	SENT_525	[p32l339t2582r534b2626],
11	and	CC	O	and	_	0	SENT_525	[p32l547t2582r634b2626],
12	clinical	JJ	O	clinical	amod	13	SENT_525	[p32l648t2582r814b2626],
13	practice	NN	O	practice	conj_and	10	SENT_525	[p32l826t2583r1022b2638],
14	.	.	O	.	_	0	SENT_525	[p32l826t2583r1022b2638],

1	N	NN	O	n	nn	3	SENT_526	[p32l7t2656r48b2696],
2	Engl	NNP	O	Engl	nn	3	SENT_526	[p32l60t2653r196b2708],
3	]	NNP	O	]	nsubj	4	SENT_526	[p32l60t2653r196b2708],
4	Med	VBD	O	med	_	0	SENT_526	[p32l207t2652r310b2696],
5	2003	CD	DATE	2003	dobj	4	SENT_526	[p32l323t2656r736b2705],
6	;	:	O	;	_	0	SENT_526	[p32l323t2656r736b2705],
7	348:1170	CD	NUMBER	348:1170	num	8	SENT_526	[p32l323t2656r736b2705],
8	-5	CD	NUMBER	-5	dep	5	SENT_526	[p32l323t2656r736b2705],
9	.	.	O	.	_	0	SENT_526	[p32l323t2656r736b2705],

1	24	CD	NUMBER	24	_	0	SENT_527	[p32l7t2728r73b2766],
2	.	.	O	.	_	0	SENT_527	[p32l7t2728r73b2766],

1	Lessard	NNP	PERSON	Lessard	nn	2	SENT_528	[p32l102t2722r280b2766],
2	E	NNP	O	E	_	0	SENT_528	[p32l309t2726r352b2775],
3	,	,	O	,	_	0	SENT_528	[p32l309t2726r352b2775],
4	Yessine	NNP	PERSON	Yessine	nn	5	SENT_528	[p32l382t2723r553b2766],
5	MA	NNP	PERSON	MA	appos	2	SENT_528	[p32l582t2726r678b2775],
6	,	,	O	,	_	0	SENT_528	[p32l582t2726r678b2775],
7	Hamelin	NNP	ORGANIZATION	Hamelin	nn	8	SENT_528	[p32l710t2722r913b2766],
8	BA	NN	ORGANIZATION	ba	appos	5	SENT_528	[p32l942t2726r1022b2775],
9	,	,	O	,	_	0	SENT_528	[p32l942t2726r1022b2775],
10	O’Hara	NN	O	o’hara	nn	11	SENT_528	[p32l8t2796r178b2836],
11	G	NN	O	g	appos	5	SENT_528	[p32l190t2796r242b2845],
12	,	,	O	,	_	0	SENT_528	[p32l190t2796r242b2845],
13	LeBlancJ	NN	O	leblancj	appos	5	SENT_528	[p32l257t2792r481b2845],
14	,	,	O	,	_	0	SENT_528	[p32l257t2792r481b2845],
15	TurgeonJ	NN	O	turgeonj	appos	5	SENT_528	[p32l495t2796r732b2848],
16	.	.	O	.	_	0	SENT_528	[p32l495t2796r732b2848],

1	Inﬂuence	NN	O	inﬂuence	_	0	SENT_529	[p32l747t2792r966b2836],
2	of	IN	O	of	_	0	SENT_529	[p32l980t2792r1035b2836],
3	CYP2D6	NN	O	cyp2d6	nn	4	SENT_529	[p32l8t2866r198b2906],
4	activity	NN	O	activity	prep_of	1	SENT_529	[p32l215t2863r378b2918],
5	on	IN	O	on	_	0	SENT_529	[p32l393t2876r452b2906],
6	the	DT	O	the	det	7	SENT_529	[p32l469t2863r540b2906],
7	disposition	NN	O	disposition	prep_on	1	SENT_529	[p32l558t2862r819b2918],
8	and	CC	O	and	_	0	SENT_529	[p32l835t2862r921b2906],
9	cardiovascular	JJ	O	cardiovascular	amod	10	SENT_529	[p32l938t2877r1025b2906, p32l8t2932r273b2976],
10	toxicity	NN	O	toxicity	prep_on	1	SENT_529	[p32l304t2933r473b2988],
11	of	IN	O	of	_	0	SENT_529	[p32l502t2932r558b2976],
12	the	DT	O	the	det	15	SENT_529	[p32l579t2932r651b2976],
13	antidepressant	JJ	O	antidepressant	amod	15	SENT_529	[p32l682t2932r1028b2988],
14	agent	NN	O	agent	nn	15	SENT_529	[p32l8t3011r138b3058],
15	venlafaxine	NN	O	venlafaxine	prep_of	1	SENT_529	[p32l150t3002r415b3046],
16	in	IN	O	in	_	0	SENT_529	[p32l432t3003r477b3045],
17	humans	NNS	O	human	prep_in	15	SENT_529	[p32l494t3002r696b3046],
18	.	.	O	.	_	0	SENT_529	[p32l494t3002r696b3046],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_530	[p32l716t3003r1025b3058, p32l8t3073r143b3116],
2	1999	CD	DATE	1999	num	1	SENT_530	[p32l159t3076r511b3125],
3	;	:	O	;	_	0	SENT_530	[p32l159t3076r511b3125],
4	9:435	CD	NUMBER	9:435	number	5	SENT_530	[p32l159t3076r511b3125],
5	-43	CD	NUMBER	-43	dep	1	SENT_530	[p32l159t3076r511b3125],
6	.	.	O	.	_	0	SENT_530	[p32l159t3076r511b3125],

1	25	CD	NUMBER	25	_	0	SENT_531	[p32l7t3147r73b3186],
2	.	.	O	.	_	0	SENT_531	[p32l7t3147r73b3186],

1	Bertilsson	NN	PERSON	bertilsson	nn	2	SENT_532	[p32l102t3142r337b3186],
2	L	NN	PERSON	l	_	0	SENT_532	[p32l367t3146r408b3195],
3	,	,	O	,	_	0	SENT_532	[p32l367t3146r408b3195],
4	Dahl	NNP	PERSON	Dahl	nn	5	SENT_532	[p32l441t3142r552b3185],
5	M-L	NNP	O	M-L	appos	2	SENT_532	[p32l581t3146r690b3195],
6	,	,	O	,	_	0	SENT_532	[p32l581t3146r690b3195],
7	Dalén	NNP	PERSON	Dalén	nn	8	SENT_532	[p32l723t3141r859b3186],
8	P	NN	PERSON	p	appos	2	SENT_532	[p32l889t3146r924b3195],
9	,	,	O	,	_	0	SENT_532	[p32l889t3146r924b3195],
10	AlShurbaji	NNP	O	AlShurbaji	nn	11	SENT_532	[p32l956t3142r1024b3185, p32l9t3212r202b3268],
11	A.	NNP	O	A.	appos	2	SENT_532	[p32l219t3216r267b3256],
12	Molecular	JJ	O	molecular	amod	13	SENT_532	[p32l288t3212r525b3256],
13	genetics	NNS	O	genetics	dep	11	SENT_532	[p32l543t3213r733b3268],
14	of	IN	O	of	_	0	SENT_532	[p32l754t3212r809b3256],
15	CYP2D6	NN	O	cyp2d6	prep_of	2	SENT_532	[p32l819t3216r1023b3256],
16	:	:	O	:	_	0	SENT_532	[p32l819t3216r1023b3256],
17	clinical	JJ	O	clinical	amod	18	SENT_532	[p32l8t3282r174b3326],
18	relevance	NN	O	relevance	dep	2	SENT_532	[p32l194t3282r409b3326],
19	with	IN	O	with	_	0	SENT_532	[p32l427t3283r532b3326],
20	focus	NN	O	focus	prep_with	18	SENT_532	[p32l552t3282r676b3326],
21	on	IN	O	on	_	0	SENT_532	[p32l697t3296r756b3326],
22	psychotropic	JJ	O	psychotropic	amod	23	SENT_532	[p32l775t3282r1025b3338, p32l7t3353r77b3408],
23	drugs	NNS	O	drug	prep_on	20	SENT_532	[p32l90t3352r235b3408],
24	.	.	O	.	_	0	SENT_532	[p32l90t3352r235b3408],

1	Br	NN	O	br	nn	4	SENT_533	[p32l250t3356r331b3403],
2	]	CD	NUMBER	]	num	4	SENT_533	[p32l250t3356r331b3403],
3	Clin	NNP	O	Clin	nn	4	SENT_533	[p32l343t3352r438b3396],
4	Pharmacol	NNP	O	Pharmacol	_	0	SENT_533	[p32l451t3352r701b3396],
5	2002	CD	DATE	2002	num	7	SENT_533	[p32l714t3356r1025b3405, p32l8t3426r77b3466],
6	;	:	O	;	_	0	SENT_533	[p32l714t3356r1025b3405, p32l8t3426r77b3466],
7	53:11122	CD	NUMBER	53:11122	dep	4	SENT_533	[p32l714t3356r1025b3405, p32l8t3426r77b3466],
8	.	.	O	.	_	0	SENT_533	[p32l714t3356r1025b3405, p32l8t3426r77b3466],

1	26	CD	NUMBER	26	_	0	SENT_534	[p32l7t3497r73b3536],
2	.	.	O	.	_	0	SENT_534	[p32l7t3497r73b3536],

1	Wuttke	NNP	PERSON	Wuttke	nn	2	SENT_535	[p32l101t3492r270b3536],
2	H	NNP	PERSON	H	_	0	SENT_535	[p32l297t3496r350b3545],
3	,	,	O	,	_	0	SENT_535	[p32l297t3496r350b3545],
4	Rau	NNP	PERSON	Rau	nn	5	SENT_535	[p32l380t3496r471b3538],
5	T	NN	O	t	appos	2	SENT_535	[p32l496t3496r537b3545],
6	,	,	O	,	_	0	SENT_535	[p32l496t3496r537b3545],
7	Heide	NNP	PERSON	Heide	nn	8	SENT_535	[p32l567t3492r704b3536],
8	R	NNP	PERSON	R	appos	2	SENT_535	[p32l731t3496r778b3545],
9	,	,	O	,	_	0	SENT_535	[p32l731t3496r778b3545],
10	et	FW	O	et	nn	11	SENT_535	[p32l809t3501r852b3536],
11	al.	FW	O	al.	appos	2	SENT_535	[p32l876t3492r928b3536],
12	.	.	O	.	_	0	SENT_535	[p32l876t3492r928b3536],

1	Increased	VBN	O	increase	amod	2	SENT_536	[p32l958t3496r1025b3535, p32l8t3562r182b3606],
2	frequency	NN	O	frequency	_	0	SENT_536	[p32l199t3562r429b3618],
3	of	IN	O	of	_	0	SENT_536	[p32l444t3562r500b3606],
4	cytochrome	NN	O	cytochrome	nn	8	SENT_536	[p32l507t3562r780b3618],
5	P450	NN	O	p450	nn	8	SENT_536	[p32l797t3566r912b3606],
6	2D6	NN	O	2d6	nn	8	SENT_536	[p32l930t3566r1025b3606],
7	poor	JJ	O	poor	amod	8	SENT_536	[p32l7t3646r118b3688],
8	metabolizers	NNS	O	metabolizer	prep_of	2	SENT_536	[p32l156t3632r457b3676],
9	among	IN	O	among	_	0	SENT_536	[p32l497t3646r662b3688],
10	patients	NNS	O	patient	prep_among	2	SENT_536	[p32l699t3633r883b3688],
11	with	IN	O	with	_	0	SENT_536	[p32l921t3633r1025b3676],
12	metoprolol-associated	JJ	O	metoprolol-associated	amod	14	SENT_536	[p32l8t3702r531b3758],
13	adverse	JJ	O	adverse	amod	14	SENT_536	[p32l550t3702r723b3746],
14	effects	NNS	O	effect	prep_with	2	SENT_536	[p32l744t3702r907b3746],
15	.	.	O	.	_	0	SENT_536	[p32l744t3702r907b3746],

1	Clin	NNP	O	Clin	nn	3	SENT_537	[p32l930t3702r1026b3746],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_537	[p32l7t3773r258b3816],
3	Ther	NNP	O	Ther	_	0	SENT_537	[p32l269t3772r381b3816],
4	2002	CD	DATE	2002	num	3	SENT_537	[p32l393t3776r776b3825],
5	;	:	O	;	_	0	SENT_537	[p32l393t3776r776b3825],
6	72:429	CD	NUMBER	72:429	number	7	SENT_537	[p32l393t3776r776b3825],
7	-37	CD	NUMBER	-37	dep	3	SENT_537	[p32l393t3776r776b3825],
8	.	.	O	.	_	0	SENT_537	[p32l393t3776r776b3825],

1	DRUG	NN	O	drug	nn	2	SENT_538	[p32l1360t725r1541b760],
2	THERAPY	NN	O	therapy	_	0	SENT_538	[p32l1563t725r1853b760],

1	F.	NNP	O	F.	nn	3	SENT_539	[p32l1097t906r1133b946],
2	Quick	NNP	O	Quick	nn	3	SENT_539	[p32l1152t902r1293b956],
3	onset	NN	O	onset	_	0	SENT_539	[p32l1307t911r1435b946],
4	of	IN	O	of	_	0	SENT_539	[p32l1450t902r1505b946],
5	severe	JJ	O	severe	amod	7	SENT_539	[p32l1513t917r1653b946],
6	abdominal	JJ	O	abdominal	amod	7	SENT_539	[p32l1670t902r1921b946],
7	pain	NN	O	pain	prep_of	3	SENT_539	[p32l1937t903r2039b958],
8	after	IN	O	after	_	0	SENT_539	[p32l2055t902r2115b946, p32l1099t981r1161b1016],
9	codeine	NN	O	codeine	prep_after	3	SENT_539	[p32l1180t972r1360b1016],
10	in	IN	O	in	_	0	SENT_539	[p32l1380t973r1425b1015],
11	an	DT	O	a	det	13	SENT_539	[p32l1445t986r1500b1016],
12	ultrarapid	JJ	O	ultrarapid	amod	13	SENT_539	[p32l1520t972r1751b1028],
13	metabolizer	NN	O	metabolizer	prep_in	3	SENT_539	[p32l1771t972r2051b1016],
14	of	IN	O	of	_	0	SENT_539	[p32l2070t972r2126b1016],
15	debrisoquine	NN	O	debrisoquine	prep_of	13	SENT_539	[p32l1099t1042r1418b1098],
16	.	.	O	.	_	0	SENT_539	[p32l1099t1042r1418b1098],

1	Ther	NNP	O	Ther	nn	3	SENT_540	[p32l1450t1042r1562b1086],
2	Drug	NNP	O	Drug	nn	3	SENT_540	[p32l1591t1046r1711b1098],
3	Monit	NNP	O	Monit	_	0	SENT_540	[p32l1739t1043r1883b1086],
4	1997	CD	DATE	1997	num	3	SENT_540	[p32l1913t1046r2114b1095],
5	;	:	O	;	_	0	SENT_540	[p32l1913t1046r2114b1095],
6	19	CD	NUMBER	19	num	8	SENT_540	[p32l1913t1046r2114b1095],
7	:	:	O	:	_	0	SENT_540	[p32l1913t1046r2114b1095],
8	543-4	CD	NUMBER	543-4	dep	3	SENT_540	[p32l1099t1116r1245b1156],
9	.	.	O	.	_	0	SENT_540	[p32l1099t1116r1245b1156],

1	29	CD	NUMBER	29	_	0	SENT_541	[p32l1098t1187r1163b1226],
2	.	.	O	.	_	0	SENT_541	[p32l1098t1187r1163b1226],

1	Gasche	NNP	O	Gasche	nn	2	SENT_542	[p32l1193t1182r1364b1226],
2	Y	NN	O	y	_	0	SENT_542	[p32l1387t1186r1425b1235],
3	,	,	O	,	_	0	SENT_542	[p32l1387t1186r1425b1235],
4	Daali	NNP	PERSON	Daali	nn	5	SENT_542	[p32l1452t1182r1573b1225],
5	Y	NN	PERSON	y	appos	2	SENT_542	[p32l1595t1186r1633b1235],
6	,	,	O	,	_	0	SENT_542	[p32l1595t1186r1633b1235],
7	Fathi	NNP	PERSON	Fathi	nn	8	SENT_542	[p32l1660t1182r1779b1225],
8	M	NNP	PERSON	M	appos	2	SENT_542	[p32l1801t1186r1861b1235],
9	,	,	O	,	_	0	SENT_542	[p32l1801t1186r1861b1235],
10	et	FW	O	et	nn	11	SENT_542	[p32l1889t1191r1932b1226],
11	al.	FW	O	al.	appos	2	SENT_542	[p32l1954t1182r2006b1226],
12	.	.	O	.	_	0	SENT_542	[p32l1954t1182r2006b1226],

1	Codeine	NNP	O	Codeine	nn	2	SENT_543	[p32l2033t1185r2115b1226, p32l1099t1252r1224b1296],
2	intoxication	NN	O	intoxication	nsubj	3	SENT_543	[p32l1241t1253r1519b1296],
3	associated	VBN	O	associate	_	0	SENT_543	[p32l1536t1252r1777b1296],
4	With	IN	O	with	_	0	SENT_543	[p32l1791t1252r1896b1296],
5	ultrarapid	NN	O	ultrarapid	nn	7	SENT_543	[p32l1913t1252r2115b1308, p32l1098t1322r1142b1366],
6	CYP2D6	NN	O	cyp2d6	nn	7	SENT_543	[p32l1156t1326r1346b1366],
7	metabolism	NN	O	metabolism	prep_with	3	SENT_543	[p32l1360t1322r1652b1366],
8	.	.	O	.	_	0	SENT_543	[p32l1360t1322r1652b1366],

1	N	NN	O	n	nn	3	SENT_544	[p32l1668t1326r1709b1366],
2	Engl	NNP	O	Engl	nn	3	SENT_544	[p32l1721t1322r1857b1378],
3	]	NNP	O	]	nsubj	4	SENT_544	[p32l1721t1322r1857b1378],
4	Med	VBD	O	med	_	0	SENT_544	[p32l1868t1322r1972b1366],
5	2004	CD	DATE	2004	dobj	4	SENT_544	[p32l1985t1326r2114b1375],
6	;	:	O	;	_	0	SENT_544	[p32l1985t1326r2114b1375],
7	351:2827	CD	NUMBER	351:2827	num	8	SENT_544	[p32l1099t1396r1407b1436],
8	-31	CD	NUMBER	-31	dep	5	SENT_544	[p32l1099t1396r1407b1436],
9	.	.	O	.	_	0	SENT_544	[p32l1099t1396r1407b1436],

1	[	NN	O	[	nn	2	SENT_545	[p32l1429t1396r1650b1445],
2	Erratum	NN	O	erratum	nsubj	7	SENT_545	[p32l1429t1396r1650b1445],
3	,	,	O	,	_	0	SENT_545	[p32l1429t1396r1650b1445],
4	N	NN	O	n	appos	2	SENT_545	[p32l1666t1396r1708b1436],
5	Engl	NNP	O	Engl	nn	6	SENT_545	[p32l1720t1392r1857b1448],
6	]	NNP	O	]	dep	4	SENT_545	[p32l1720t1392r1857b1448],
7	Med	VBD	O	med	_	0	SENT_545	[p32l1868t1392r1971b1436],
8	2005	CD	DATE	2005	dobj	7	SENT_545	[p32l1986t1396r2114b1445],
9	;	:	O	;	_	0	SENT_545	[p32l1986t1396r2114b1445],
10	352:638	CD	NUMBER	352:638	dep	8	SENT_545	[p32l1099t1466r1319b1512],
11	.	.	O	.	_	0	SENT_545	[p32l1099t1466r1319b1512],
12	]	SYM	O	]	dep	8	SENT_545	[p32l1099t1466r1319b1512],

1	30	CD	NUMBER	30	_	0	SENT_546	[p32l1098t1537r1163b1576],
2	.	.	O	.	_	0	SENT_546	[p32l1098t1537r1163b1576],

1	Steimer	NNP	PERSON	Steimer	nn	2	SENT_547	[p32l1194t1533r1373b1576],
2	W	NNP	O	W	_	0	SENT_547	[p32l1386t1536r1444b1585],
3	,	,	O	,	_	0	SENT_547	[p32l1386t1536r1444b1585],
4	Potter	NNP	PERSON	Potter	nn	5	SENT_547	[p32l1463t1536r1602b1576],
5	JM	NN	O	jm	appos	2	SENT_547	[p32l1612t1536r1692b1582],
6	.	.	O	.	_	0	SENT_547	[p32l1612t1536r1692b1582],

1	Pharmacogenetic	JJ	MISC	pharmacogenetic	amod	2	SENT_548	[p32l1711t1532r2116b1588],
2	screening	NN	O	screening	_	0	SENT_548	[p32l1099t1603r1326b1658],
3	and	CC	O	and	_	0	SENT_548	[p32l1338t1602r1425b1646],
4	therapeutic	JJ	O	therapeutic	amod	5	SENT_548	[p32l1439t1603r1701b1658],
5	drugs	NNS	O	drug	conj_and	2	SENT_548	[p32l1715t1602r1860b1658],
6	.	.	O	.	_	0	SENT_548	[p32l1715t1602r1860b1658],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_549	[p32l1878t1602r1973b1646],
2	Chim	NNP	PERSON	Chim	nn	3	SENT_549	[p32l1988t1603r2116b1646],
3	Acta	NNP	PERSON	Acta	_	0	SENT_549	[p32l1096t1677r1201b1716],
4	2002	CD	DATE	2002	num	3	SENT_549	[p32l1214t1676r1627b1725],
5	;	:	O	;	_	0	SENT_549	[p32l1214t1676r1627b1725],
6	315:137	CD	NUMBER	315:137	number	7	SENT_549	[p32l1214t1676r1627b1725],
7	-55	CD	NUMBER	-55	dep	3	SENT_549	[p32l1214t1676r1627b1725],
8	.	.	O	.	_	0	SENT_549	[p32l1214t1676r1627b1725],

1	31	CD	NUMBER	31	_	0	SENT_550	[p32l1098t1747r1163b1786],
2	.	.	O	.	_	0	SENT_550	[p32l1098t1747r1163b1786],

1	Richelson	NNP	PERSON	Richelson	nn	2	SENT_551	[p32l1192t1742r1425b1788],
2	E.	NNP	O	E.	_	0	SENT_551	[p32l1445t1746r1487b1786],
3	Pharmacokinetic	JJ	O	pharmacokinetic	amod	5	SENT_551	[p32l1510t1742r1904b1786],
4	drug	NN	O	drug	nn	5	SENT_551	[p32l1924t1742r2035b1798],
5	interactions	NNS	O	interaction	dep	2	SENT_551	[p32l2052t1743r2115b1785, p32l1099t1813r1327b1856],
6	of	IN	O	of	_	0	SENT_551	[p32l1347t1812r1403b1856],
7	new	JJ	O	new	amod	8	SENT_551	[p32l1411t1827r1508b1856],
8	antidepressants	NNS	O	antidepressant	prep_of	5	SENT_551	[p32l1524t1812r1905b1868],
9	:	:	O	:	_	0	SENT_551	[p32l1524t1812r1905b1868],
10	a	DT	O	a	det	11	SENT_551	[p32l1926t1827r1950b1856],
11	review	NN	O	review	dep	2	SENT_551	[p32l1968t1813r2118b1856],
12	of	IN	O	of	_	0	SENT_551	[p32l1099t1882r1154b1926],
13	the	DT	O	the	det	14	SENT_551	[p32l1169t1882r1240b1926],
14	effects	NNS	O	effect	prep_of	11	SENT_551	[p32l1265t1882r1414b1926],
15	on	IN	O	on	_	0	SENT_551	[p32l1441t1896r1499b1926],
16	the	DT	O	the	det	17	SENT_551	[p32l1524t1882r1595b1926],
17	metabolism	NN	O	metabolism	prep_on	14	SENT_551	[p32l1620t1882r1899b1926],
18	of	IN	O	of	_	0	SENT_551	[p32l1923t1882r1979b1926],
19	other	JJ	O	other	amod	20	SENT_551	[p32l1994t1882r2117b1926],
20	drugs	NNS	O	drug	prep_of	17	SENT_551	[p32l1099t1952r1244b2008],
21	.	.	O	.	_	0	SENT_551	[p32l1099t1952r1244b2008],

1	Mayo	NNP	O	Mayo	nn	3	SENT_552	[p32l1259t1956r1385b2008],
2	Clin	NNP	O	Clin	nn	3	SENT_552	[p32l1400t1952r1495b1996],
3	Proc	NNP	O	Proc	_	0	SENT_552	[p32l1508t1956r1612b1996],
4	1997	CD	DATE	1997	num	3	SENT_552	[p32l1627t1956r2008b2005],
5	;	:	O	;	_	0	SENT_552	[p32l1627t1956r2008b2005],
6	72:835	CD	NUMBER	72:835	number	7	SENT_552	[p32l1627t1956r2008b2005],
7	-47	CD	NUMBER	-47	dep	3	SENT_552	[p32l1627t1956r2008b2005],
8	.	.	O	.	_	0	SENT_552	[p32l1627t1956r2008b2005],

1	32	CD	NUMBER	32	_	0	SENT_553	[p32l1098t2027r1163b2066],
2	.	.	O	.	_	0	SENT_553	[p32l1098t2027r1163b2066],

1	Wedlund	NNP	PERSON	Wedlund	_	0	SENT_554	[p32l1191t2022r1403b2066],
2	P	NN	O	p	nn	3	SENT_554	[p32l1445t2026r1503b2073],
3	]	NN	O	]	dep	1	SENT_554	[p32l1445t2026r1503b2073],
4	.	.	O	.	_	0	SENT_554	[p32l1445t2026r1503b2073],

1	The	DT	O	the	det	2	SENT_555	[p32l1547t2022r1636b2066],
2	CYP2C19	NN	O	cyp2c19	_	0	SENT_555	[p32l1679t2025r1894b2066],
3	enzyme	NN	O	enzyme	nn	4	SENT_555	[p32l1939t2036r2116b2077],
4	polymorphism	NN	O	polymorphism	dep	2	SENT_555	[p32l1097t2092r1457b2148],
5	.	.	O	.	_	0	SENT_555	[p32l1097t2092r1457b2148],

1	Pharmacology	NN	O	pharmacology	_	0	SENT_556	[p32l1518t2092r1855b2148],
2	2000	CD	DATE	2000	num	1	SENT_556	[p32l1911t2096r2114b2145],
3	;	:	O	;	_	0	SENT_556	[p32l1911t2096r2114b2145],
4	61	CD	NUMBER	61	num	6	SENT_556	[p32l1911t2096r2114b2145],
5	:	:	O	:	_	0	SENT_556	[p32l1911t2096r2114b2145],
6	174-83	CD	NUMBER	174-83	dep	1	SENT_556	[p32l1100t2166r1274b2206],
7	.	.	O	.	_	0	SENT_556	[p32l1100t2166r1274b2206],

1	33	CD	NUMBER	33	_	0	SENT_557	[p32l1098t2237r1163b2276],
2	.	.	O	.	_	0	SENT_557	[p32l1098t2237r1163b2276],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_558	[p32l1192t2236r1347b2276],
2	T	NN	O	t	_	0	SENT_558	[p32l1371t2236r1412b2285],
3	,	,	O	,	_	0	SENT_558	[p32l1371t2236r1412b2285],
4	Ohashi	NNP	PERSON	Ohashi	nn	5	SENT_558	[p32l1442t2232r1610b2276],
5	K	NNP	PERSON	K	appos	2	SENT_558	[p32l1636t2236r1684b2285],
6	,	,	O	,	_	0	SENT_558	[p32l1636t2236r1684b2285],
7	Kosuge	NNP	PERSON	Kosuge	nn	8	SENT_558	[p32l1714t2236r1889b2288],
8	K	NNP	PERSON	K	appos	2	SENT_558	[p32l1916t2236r1964b2285],
9	,	,	O	,	_	0	SENT_558	[p32l1916t2236r1964b2285],
10	et	FW	O	et	nn	11	SENT_558	[p32l1994t2241r2037b2276],
11	al.	FW	O	al.	appos	2	SENT_558	[p32l2061t2232r2113b2276],
12	.	.	O	.	_	0	SENT_558	[p32l2061t2232r2113b2276],

1	CYP2C19	NN	O	cyp2c19	nn	2	SENT_559	[p32l1098t2306r1292b2346],
2	genotype	NN	O	genotype	_	0	SENT_559	[p32l1335t2311r1546b2358],
3	status	NN	O	status	dep	2	SENT_559	[p32l1591t2311r1726b2346],
4	and	CC	O	and	_	0	SENT_559	[p32l1770t2302r1856b2346],
5	effect	NN	O	effect	dep	2	SENT_559	[p32l1900t2302r2029b2346],
6	of	IN	O	of	_	0	SENT_559	[p32l2070t2302r2126b2346],
7	omeprazole	NN	O	omeprazole	prep_of	3	SENT_559	[p32l1099t2372r1374b2428],
8	on	IN	O	on	_	0	SENT_559	[p32l1394t2386r1452b2416],
9	intragastric	JJ	O	intragastric	amod	10	SENT_559	[p32l1471t2373r1738b2428],
10	pH	NN	O	ph	prep_on	7	SENT_559	[p32l1756t2376r1828b2428],
11	in	IN	O	in	_	0	SENT_559	[p32l1847t2373r1892b2415],
12	humans	NNS	O	human	prep_in	10	SENT_559	[p32l1911t2372r2113b2416],
13	.	.	O	.	_	0	SENT_559	[p32l1911t2372r2113b2416],

1	Clin	NNP	O	Clin	nn	3	SENT_560	[p32l1098t2442r1194b2486],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_560	[p32l1207t2442r1458b2486],
3	Ther	NNP	O	Ther	_	0	SENT_560	[p32l1469t2442r1581b2486],
4	1999	CD	DATE	1999	num	3	SENT_560	[p32l1595t2446r1976b2495],
5	;	:	O	;	_	0	SENT_560	[p32l1595t2446r1976b2495],
6	65:552	CD	NUMBER	65:552	number	7	SENT_560	[p32l1595t2446r1976b2495],
7	-61	CD	NUMBER	-61	dep	3	SENT_560	[p32l1595t2446r1976b2495],
8	.	.	O	.	_	0	SENT_560	[p32l1595t2446r1976b2495],

1	34	CD	NUMBER	34	_	0	SENT_561	[p32l1098t2517r1163b2556],
2	.	.	O	.	_	0	SENT_561	[p32l1098t2517r1163b2556],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_562	[p32l1192t2516r1347b2556],
2	T	NN	O	t	_	0	SENT_562	[p32l1360t2516r1401b2565],
3	,	,	O	,	_	0	SENT_562	[p32l1360t2516r1401b2565],
4	Ohashi	NNP	ORGANIZATION	Ohashi	nn	5	SENT_562	[p32l1420t2512r1587b2556],
5	K	NNP	ORGANIZATION	K	appos	2	SENT_562	[p32l1602t2516r1650b2565],
6	,	,	O	,	_	0	SENT_562	[p32l1602t2516r1650b2565],
7	Kamata	NNP	PERSON	Kamata	nn	8	SENT_562	[p32l1669t2516r1849b2557],
8	T	NN	O	t	appos	2	SENT_562	[p32l1862t2516r1904b2565],
9	,	,	O	,	_	0	SENT_562	[p32l1862t2516r1904b2565],
10	et	FW	O	et	nn	11	SENT_562	[p32l1923t2521r1965b2556],
11	al.	FW	O	al.	appos	2	SENT_562	[p32l1978t2512r2030b2556],
12	.	.	O	.	_	0	SENT_562	[p32l1978t2512r2030b2556],

1	Effect	NN	O	effect	_	0	SENT_563	[p32l2049t2512r2115b2555, p32l1098t2582r1184b2626],
2	of	IN	O	of	_	0	SENT_563	[p32l1211t2582r1266b2626],
3	genetic	JJ	O	genetic	amod	4	SENT_563	[p32l1285t2583r1453b2638],
4	differences	NNS	O	difference	prep_of	1	SENT_563	[p32l1481t2582r1737b2626],
5	in	IN	O	in	_	0	SENT_563	[p32l1767t2583r1812b2625],
6	omeprazole	NN	O	omeprazole	nn	7	SENT_563	[p32l1841t2583r2116b2638],
7	metabolism	NN	O	metabolism	prep_in	4	SENT_563	[p32l1098t2652r1377b2696],
8	on	IN	O	on	_	0	SENT_563	[p32l1393t2666r1452b2696],
9	cure	NN	O	cure	nn	10	SENT_563	[p32l1468t2667r1566b2696],
10	rates	NNS	O	rate	prep_on	1	SENT_563	[p32l1582t2661r1691b2696],
11	for	IN	O	for	_	0	SENT_563	[p32l1708t2652r1776b2696],
12	Helicobacter	NNP	PERSON	Helicobacter	nn	14	SENT_563	[p32l1788t2652r2036b2696],
13	pylori	NN	PERSON	pylorus	nn	14	SENT_563	[p32l2045t2666r2115b2708, p32l1100t2722r1166b2766],
14	infection	NN	O	infection	prep_for	1	SENT_563	[p32l1190t2722r1398b2766],
15	and	CC	O	and	_	0	SENT_563	[p32l1423t2722r1508b2766],
16	peptic	JJ	O	peptic	amod	17	SENT_563	[p32l1533t2723r1676b2778],
17	ulcer	NN	O	ulcer	conj_and	14	SENT_563	[p32l1700t2723r1824b2766],
18	.	.	O	.	_	0	SENT_563	[p32l1700t2723r1824b2766],

1	Ann	NNP	PERSON	Ann	nn	3	SENT_564	[p32l1850t2726r1948b2765],
2	Intern	NNP	O	Intern	nn	3	SENT_564	[p32l1973t2726r2115b2766],
3	Med	NNP	O	Med	_	0	SENT_564	[p32l1097t2792r1200b2836],
4	1998	CD	DATE	1998	num	3	SENT_564	[p32l1215t2796r1655b2845],
5	;	:	O	;	_	0	SENT_564	[p32l1215t2796r1655b2845],
6	129:1027	CD	NUMBER	129:1027	number	7	SENT_564	[p32l1215t2796r1655b2845],
7	-30	CD	NUMBER	-30	dep	3	SENT_564	[p32l1215t2796r1655b2845],
8	.	.	O	.	_	0	SENT_564	[p32l1215t2796r1655b2845],

1	35	CD	NUMBER	35	_	0	SENT_565	[p32l1098t2867r1163b2906],
2	.	.	O	.	_	0	SENT_565	[p32l1098t2867r1163b2906],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_566	[p32l1192t2866r1347b2906],
2	T	NN	O	t	_	0	SENT_566	[p32l1362t2866r1403b2915],
3	,	,	O	,	_	0	SENT_566	[p32l1362t2866r1403b2915],
4	Takashima	NNP	PERSON	Takashima	nn	5	SENT_566	[p32l1423t2862r1679b2906],
5	M	NNP	O	M	appos	2	SENT_566	[p32l1695t2866r1755b2915],
6	,	,	O	,	_	0	SENT_566	[p32l1695t2866r1755b2915],
7	Shirai	NNP	PERSON	Shirai	nn	8	SENT_566	[p32l1778t2862r1912b2906],
8	N	NNP	O	N	appos	2	SENT_566	[p32l1929t2866r1981b2915],
9	,	,	O	,	_	0	SENT_566	[p32l1929t2866r1981b2915],
10	et	FW	O	et	nn	11	SENT_566	[p32l2002t2871r2045b2906],
11	al.	FW	O	al.	appos	2	SENT_566	[p32l2060t2862r2112b2906],
12	.	.	O	.	_	0	SENT_566	[p32l2060t2862r2112b2906],

1	Cure	NN	O	cure	nsubj	8	SENT_567	[p32l1098t2936r1208b2976],
2	of	IN	O	of	_	0	SENT_567	[p32l1223t2932r1279b2976],
3	refractory	JJ	O	refractory	amod	5	SENT_567	[p32l1283t2932r1510b2988],
4	duodenal	JJ	O	duodenal	amod	5	SENT_567	[p32l1523t2932r1740b2976],
5	ulcer	NN	O	ulcer	prep_of	1	SENT_567	[p32l1755t2932r1871b2976],
6	and	CC	O	and	_	0	SENT_567	[p32l1883t2932r1969b2976],
7	infection	NN	O	infection	prep_of	1	SENT_567	[p32l1984t2932r2115b2976, p32l1099t3003r1190b3046],
8	caused	VBN	O	cause	_	0	SENT_567	[p32l1204t3002r1362b3046],
9	by	IN	O	by	_	0	SENT_567	[p32l1376t3002r1430b3058],
10	Helicobacter	NNP	PERSON	Helicobacter	nn	11	SENT_567	[p32l1439t3002r1687b3046],
11	pylori	NN	PERSON	pylorus	prep_by	8	SENT_567	[p32l1695t3002r1817b3058],
12	by	IN	O	by	_	0	SENT_567	[p32l1830t3002r1884b3058],
13	high	JJ	O	high	amod	14	SENT_567	[p32l1895t3002r2001b3058],
14	doses	NNS	O	dose	prep_by	8	SENT_567	[p32l2015t3002r2115b3046, p32l1099t3087r1144b3116],
15	of	IN	O	of	_	0	SENT_567	[p32l1168t3072r1224b3116],
16	omeprazole	NN	O	omeprazole	prep_of	14	SENT_567	[p32l1236t3072r1511b3128],
17	and	CC	O	and	_	0	SENT_567	[p32l1534t3072r1619b3116],
18	amoxicillin	NNP	O	amoxicillin	prep_by	8	SENT_567	[p32l1642t3072r1903b3116],
19	in	IN	O	in	_	0	SENT_567	[p32l1925t3073r1970b3115],
20	a	DT	O	a	det	25	SENT_567	[p32l1992t3087r2016b3116],
21	homozygous	JJ	O	homozygous	amod	25	SENT_567	[p32l2038t3072r2115b3116, p32l1098t3156r1337b3198],
22	CYP2C19	NN	O	cyp2c19	nn	25	SENT_567	[p32l1362t3146r1577b3186],
23	extensive	JJ	O	extensive	amod	25	SENT_567	[p32l1602t3143r1813b3186],
24	metabolizer	NN	O	metabolizer	nn	25	SENT_567	[p32l1837t3142r2117b3186],
25	patient	NN	O	patient	prep_in	18	SENT_567	[p32l1097t3213r1272b3268],
26	.	.	O	.	_	0	SENT_567	[p32l1097t3213r1272b3268],

1	Clin	NNP	O	Clin	nn	3	SENT_568	[p32l1295t3212r1390b3256],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_568	[p32l1408t3213r1659b3256],
3	Ther	NNP	O	Ther	_	0	SENT_568	[p32l1676t3212r1787b3256],
4	2000	CD	DATE	2000	num	3	SENT_568	[p32l1805t3216r2115b3265, p32l1098t3286r1138b3326],
5	;	:	O	;	_	0	SENT_568	[p32l1805t3216r2115b3265, p32l1098t3286r1138b3326],
6	67:6849	CD	NUMBER	67:6849	dep	3	SENT_568	[p32l1805t3216r2115b3265, p32l1098t3286r1138b3326],
7	.	.	O	.	_	0	SENT_568	[p32l1805t3216r2115b3265, p32l1098t3286r1138b3326],

1	36	CD	NUMBER	36	_	0	SENT_569	[p32l1098t3357r1163b3396],
2	.	.	O	.	_	0	SENT_569	[p32l1098t3357r1163b3396],

1	Furuta	NNP	PERSON	Furuta	nn	2	SENT_570	[p32l1192t3356r1347b3396],
2	T	NN	O	t	_	0	SENT_570	[p32l1362t3356r1403b3405],
3	,	,	O	,	_	0	SENT_570	[p32l1362t3356r1403b3405],
4	Shirai	NNP	PERSON	Shirai	nn	5	SENT_570	[p32l1426t3352r1561b3396],
5	N	NNP	O	N	appos	2	SENT_570	[p32l1577t3356r1629b3405],
6	,	,	O	,	_	0	SENT_570	[p32l1577t3356r1629b3405],
7	Takashima	NNP	PERSON	Takashima	nn	8	SENT_570	[p32l1649t3352r1905b3396],
8	M	NNP	O	M	appos	2	SENT_570	[p32l1921t3356r1981b3405],
9	,	,	O	,	_	0	SENT_570	[p32l1921t3356r1981b3405],
10	et	FW	O	et	nn	11	SENT_570	[p32l2003t3361r2045b3396],
11	al.	FW	O	al.	appos	2	SENT_570	[p32l2061t3352r2113b3396],
12	.	.	O	.	_	0	SENT_570	[p32l2061t3352r2113b3396],

1	Effect	NN	O	effect	_	0	SENT_571	[p32l1097t3422r1234b3466],
2	of	IN	O	of	_	0	SENT_571	[p32l1251t3422r1306b3466],
3	genotypic	JJ	O	genotypic	amod	4	SENT_571	[p32l1315t3423r1542b3478],
4	differences	NNS	O	difference	prep_of	1	SENT_571	[p32l1561t3422r1816b3466],
5	in	IN	O	in	_	0	SENT_571	[p32l1836t3423r1881b3465],
6	CYP2C19	NN	O	cyp2c19	prep_in	1	SENT_571	[p32l1900t3426r2115b3466],
7	on	IN	O	on	_	0	SENT_571	[p32l1099t3506r1158b3536],
8	cure	NN	O	cure	nn	9	SENT_571	[p32l1177t3507r1275b3536],
9	rates	NNS	O	rate	prep_on	1	SENT_571	[p32l1294t3501r1403b3536],
10	for	IN	O	for	_	0	SENT_571	[p32l1423t3492r1491b3536],
11	Helicobacter	NNP	PERSON	Helicobacter	nn	13	SENT_571	[p32l1507t3492r1754b3536],
12	pylori	NN	O	pylorus	nn	13	SENT_571	[p32l1767t3492r1890b3548],
13	infection	NN	O	infection	prep_for	1	SENT_571	[p32l1908t3492r2115b3536],
14	by	IN	O	by	_	0	SENT_571	[p32l1099t3562r1152b3618],
15	triple	JJ	O	triple	amod	16	SENT_571	[p32l1164t3562r1285b3618],
16	therapy	NN	O	therapy	prep_by	1	SENT_571	[p32l1299t3562r1474b3618],
17	with	IN	O	with	_	0	SENT_571	[p32l1482t3562r1587b3606],
18	a	DT	O	a	det	21	SENT_571	[p32l1600t3577r1625b3606],
19	proton	NN	O	proton	nn	21	SENT_571	[p32l1637t3571r1795b3618],
20	pump	NN	O	pump	nn	21	SENT_571	[p32l1808t3577r1946b3618],
21	inhibitor	NN	O	inhibitor	prep_with	1	SENT_571	[p32l1959t3562r2115b3606, p32l1099t3641r1174b3685],
22	,	,	O	,	_	0	SENT_571	[p32l1959t3562r2115b3606, p32l1099t3641r1174b3685],
23	amoxicillin	NNP	O	amoxicillin	prep_with	1	SENT_571	[p32l1207t3632r1482b3685],
24	,	,	O	,	_	0	SENT_571	[p32l1207t3632r1482b3685],
25	and	CC	O	and	_	0	SENT_571	[p32l1515t3632r1601b3676],
26	clarithromycin	NN	O	clarithromycin	prep_with	1	SENT_571	[p32l1632t3633r1987b3688],
27	.	.	O	.	_	0	SENT_571	[p32l1632t3633r1987b3688],

1	Clin	NNP	O	Clin	nn	3	SENT_572	[p32l2020t3632r2116b3676],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_572	[p32l1097t3702r1348b3746],
3	Ther	NNP	O	Ther	_	0	SENT_572	[p32l1360t3702r1471b3746],
4	2001	CD	DATE	2001	num	3	SENT_572	[p32l1483t3706r1867b3755],
5	;	:	O	;	_	0	SENT_572	[p32l1483t3706r1867b3755],
6	69:158	CD	NUMBER	69:158	number	7	SENT_572	[p32l1483t3706r1867b3755],
7	-68	CD	NUMBER	-68	dep	3	SENT_572	[p32l1483t3706r1867b3755],
8	.	.	O	.	_	0	SENT_572	[p32l1483t3706r1867b3755],

1	37	CD	NUMBER	37	_	0	SENT_573	[p32l1098t3777r1163b3816],
2	.	.	O	.	_	0	SENT_573	[p32l1098t3777r1163b3816],

1	Brandolese	NN	O	brandolese	nn	2	SENT_574	[p32l1192t3772r1453b3816],
2	R	NN	O	r	_	0	SENT_574	[p32l1487t3776r1534b3825],
3	,	,	O	,	_	0	SENT_574	[p32l1487t3776r1534b3825],
4	Scordo	NNP	O	Scordo	nn	5	SENT_574	[p32l1573t3772r1733b3816],
5	MG	NN	O	mg	dep	2	SENT_574	[p32l1767t3775r1869b3825],
6	,	,	O	,	_	0	SENT_574	[p32l1767t3775r1869b3825],
7	Spina	NNP	O	Spina	nn	8	SENT_574	[p32l1908t3773r2037b3827],
8	E	NNP	O	E	appos	5	SENT_574	[p32l2070t3776r2113b3825],
9	,	,	O	,	_	0	SENT_574	[p32l2070t3776r2113b3825],

1	27	CD	NUMBER	27	_	0	SENT_575	[p33l7t24r73b62],
2	.	.	O	.	_	0	SENT_575	[p33l7t24r73b62],

1	Sindrup	JJ	O	sindrup	amod	2	SENT_576	[p33l104t18r288b73],
2	SH	NN	O	sh	_	0	SENT_576	[p33l309t21r390b71],
3	,	,	O	,	_	0	SENT_576	[p33l309t21r390b71],
4	Brosen	NNP	PERSON	Brosen	nn	5	SENT_576	[p33l411t22r575b67],
5	K.	NNP	O	K.	appos	2	SENT_576	[p33l594t22r642b63],
6	The	DT	O	the	det	7	SENT_576	[p33l662t18r752b62],
7	pharmaco	NN	O	pharmaco	dep	5	SENT_576	[p33l770t18r1025b73],
8	-	:	O	-	_	0	SENT_576	[p33l770t18r1025b73],
9	Gusella	NN	PERSON	gusellum	nn	10	SENT_576	[p33l1098t18r1275b62],
10	M	NN	O	m	dep	2	SENT_576	[p33l1292t22r1352b71],
11	,	,	O	,	_	0	SENT_576	[p33l1292t22r1352b71],
12	Padrini	NNP	PERSON	Padrini	nn	13	SENT_576	[p33l1375t18r1542b62],
13	R.	NNP	PERSON	R.	appos	10	SENT_576	[p33l1561t22r1608b65],
14	Severe	JJ	PERSON	severe	amod	16	SENT_576	[p33l1633t22r1778b62],
15	phenytoin	NN	O	phenytoin	nn	16	SENT_576	[p33l1797t19r2033b74],
16	ingenetics	NNS	O	ingenetic	dep	13	SENT_576	[p33l2052t19r2115b61, p33l8t89r198b144],
17	of	IN	O	of	_	0	SENT_576	[p33l213t88r269b132],
18	codeine	NN	O	codeine	nn	19	SENT_576	[p33l273t88r453b132],
19	hypoalgesia	NN	O	hypoalgesium	prep_of	16	SENT_576	[p33l467t88r755b144],
20	.	.	O	.	_	0	SENT_576	[p33l467t88r755b144],

1	Pharmaco	NNP	ORGANIZATION	Pharmaco	_	0	SENT_577	[p33l771t88r1025b132],
2	-	:	O	-	_	0	SENT_577	[p33l771t88r1025b132],
3	toxication	NN	O	toxication	dep	1	SENT_577	[p33l1099t89r1329b132],
4	in	IN	O	in	_	0	SENT_577	[p33l1367t89r1412b131],
5	a	DT	O	a	det	7	SENT_577	[p33l1449t103r1473b132],
6	subject	JJ	O	subject	amod	7	SENT_577	[p33l1511t89r1676b144],
7	homozygous	JJ	O	homozygous	prep_in	3	SENT_577	[p33l1711t88r2011b144],
8	for	IN	O	for	_	0	SENT_577	[p33l2050t88r2118b132],
9	genetics	NNS	O	genetics	prep_for	7	SENT_577	[p33l8t159r198b214],
10	1995	CD	DATE	1995	num	7	SENT_577	[p33l214t162r566b211],
11	;	:	O	;	_	0	SENT_577	[p33l214t162r566b211],
12	5:335	CD	NUMBER	5:335	num	13	SENT_577	[p33l214t162r566b211],
13	-46	CD	NUMBER	-46	dep	7	SENT_577	[p33l214t162r566b211],
14	.	.	O	.	_	0	SENT_577	[p33l214t162r566b211],

1	CYP2C9	NN	O	cyp2c9	_	0	SENT_578	[p33l1098t160r1332b202],
2	‘	CD	NUMBER	‘	number	3	SENT_578	[p33l1098t160r1332b202],
3	*	CD	NUMBER	*	dep	1	SENT_578	[p33l1098t160r1332b202],
4	’	NN	O	’	dep	3	SENT_578	[p33l1098t160r1332b202],
5	3	CD	NUMBER	3	num	4	SENT_578	[p33l1098t160r1332b202],
6	.	.	O	.	_	0	SENT_578	[p33l1098t160r1332b202],

1	Clin	NNP	O	Clin	nn	3	SENT_579	[p33l1366t158r1462b202],
2	Pharmacol	NNP	O	Pharmacol	nn	3	SENT_579	[p33l1491t158r1742b202],
3	Ther	NNP	O	Ther	_	0	SENT_579	[p33l1771t158r1882b202],
4	2001	CD	DATE	2001	num	3	SENT_579	[p33l1911t162r2114b211],
5	;	:	O	;	_	0	SENT_579	[p33l1911t162r2114b211],
6	70	CD	NUMBER	70	num	8	SENT_579	[p33l1911t162r2114b211],
7	:	:	O	:	_	0	SENT_579	[p33l1911t162r2114b211],
8	28	CD	NUMBER	28	dep	3	SENT_579	[p33l7t232r73b272],
9	.	.	O	.	_	0	SENT_579	[p33l7t232r73b272],

1	Dalén	NN	PERSON	dalén	nn	2	SENT_580	[p33l102t227r239b272],
2	P	NN	PERSON	p	_	0	SENT_580	[p33l256t232r291b281],
3	,	,	O	,	_	0	SENT_580	[p33l256t232r291b281],
4	Frengell	NN	O	frengell	nn	5	SENT_580	[p33l312t228r503b284],
5	C	NN	O	c	appos	2	SENT_580	[p33l521t231r567b281],
6	,	,	O	,	_	0	SENT_580	[p33l521t231r567b281],
7	Dahl	NNP	PERSON	Dahl	nn	8	SENT_580	[p33l588t228r699b271],
8	M-L	NNP	O	M-L	appos	2	SENT_580	[p33l715t232r824b281],
9	,	,	O	,	_	0	SENT_580	[p33l715t232r824b281],
10	Sjoqvist	NNP	O	Sjoqvist	appos	2	SENT_580	[p33l846t229r1028b283],
11	391-4	CD	NUMBER	391-4	num	10	SENT_580	[p33l1099t232r1245b272],
12	.	.	O	.	_	0	SENT_580	[p33l1099t232r1245b272],

1	38	CD	NUMBER	38	_	0	SENT_581	[p33l77t725r207b804],
2	.	.	O	.	_	0	SENT_581	[p33l77t725r207b804],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_582	[p33l266t724r424b804],
2	CR	NN	O	cr	_	0	SENT_582	[p33l469t723r636b823],
3	,	,	O	,	_	0	SENT_582	[p33l469t723r636b823],
4	Goldstein	NNP	PERSON	Goldstein	nn	5	SENT_582	[p33l686t716r1149b804],
5	JA	NNP	O	JA	appos	2	SENT_582	[p33l1182t724r1318b823],
6	,	,	O	,	_	0	SENT_582	[p33l1182t724r1318b823],
7	Pieper	NNP	PERSON	Pieper	nn	8	SENT_582	[p33l1368t718r1665b827],
8	IA	NNP	O	IA	appos	5	SENT_582	[p33l1695t724r1833b818],
9	.	.	O	.	_	0	SENT_582	[p33l1695t724r1833b818],

1	Cytochrome	NN	O	cytochrome	nn	4	SENT_583	[p33l1883t723r2130b827, p33l77t862r435b948],
2	P450	NN	O	p450	nn	4	SENT_583	[p33l477t867r709b948],
3	2C9	NN	O	2c9	nn	4	SENT_583	[p33l753t867r937b948],
4	polymorphisms	NNS	O	polymorphism	_	0	SENT_583	[p33l979t860r1755b973],
5	:	:	O	:	_	0	SENT_583	[p33l979t860r1755b973],
6	a	DT	O	a	det	8	SENT_583	[p33l1801t890r1851b948],
7	comprehensive	JJ	O	comprehensive	amod	8	SENT_583	[p33l1892t889r2130b948, p33l75t1006r584b1117],
8	review	NN	O	review	dep	4	SENT_583	[p33l611t1006r914b1094],
9	of	IN	O	of	_	0	SENT_583	[p33l938t1004r1050b1092],
10	the	DT	O	the	prep_of	8	SENT_583	[p33l1057t1004r1201b1092],
11	in	IN	O	in	_	0	SENT_583	[p33l1228t1006r1569b1092],
12	—	FW	O	—	nn	13	SENT_583	[p33l1228t1006r1569b1092],
13	vitro	FW	O	vitro	prep_in	10	SENT_583	[p33l1228t1006r1569b1092],
14	and	CC	O	and	_	0	SENT_583	[p33l1598t1004r1772b1092],
15	human	JJ	O	human	amod	16	SENT_583	[p33l1798t1004r2132b1092],
16	data	NNS	O	datum	conj_and	13	SENT_583	[p33l77t1148r301b1236],
17	.	.	O	.	_	0	SENT_583	[p33l77t1148r301b1236],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_584	[p33l396t1148r1260b1261],
2	2002	CD	DATE	2002	num	1	SENT_584	[p33l1352t1155r2126b1255],
3	;	:	O	;	_	0	SENT_584	[p33l1352t1155r2126b1255],
4	12:251	CD	NUMBER	12:251	number	5	SENT_584	[p33l1352t1155r2126b1255],
5	—	CD	NUMBER	—	dep	1	SENT_584	[p33l1352t1155r2126b1255],
6	63	CD	NUMBER	63	dep	5	SENT_584	[p33l1352t1155r2126b1255],
7	.	.	O	.	_	0	SENT_584	[p33l1352t1155r2126b1255],

1	[	NNP	O	[	_	0	SENT_585	[p33l86t1300r533b1399],
2	Erratum	NNP	O	Erratum	nn	4	SENT_585	[p33l86t1300r533b1399],
3	,	,	O	,	_	0	SENT_585	[p33l86t1300r533b1399],
4	Pharmacogenetics	NNP	O	Pharmacogenetics	dep	1	SENT_585	[p33l565t1292r1427b1405],
5	2002	CD	DATE	2002	rcmod	4	SENT_585	[p33l1458t1299r2113b1399],
6	;	:	O	;	_	0	SENT_585	[p33l1458t1299r2113b1399],
7	12:343	CD	NUMBER	12:343	dep	5	SENT_585	[p33l1458t1299r2113b1399],
8	.	.	O	.	_	0	SENT_585	[p33l1458t1299r2113b1399],
9	]	SYM	O	]	dep	5	SENT_585	[p33l1458t1299r2113b1399],

1	39	CD	NUMBER	39	_	0	SENT_586	[p33l77t1447r209b1524],
2	.	.	O	.	_	0	SENT_586	[p33l77t1447r209b1524],

1	Daly	NNP	PERSON	Daly	nn	2	SENT_587	[p33l266t1436r479b1547],
2	AK	NNP	O	AK	_	0	SENT_587	[p33l502t1444r673b1543],
3	,	,	O	,	_	0	SENT_587	[p33l502t1444r673b1543],
4	King	NNP	O	King	nn	5	SENT_587	[p33l711t1438r941b1549],
5	BP	NNP	O	BP	appos	2	SENT_587	[p33l967t1444r1106b1524],
6	.	.	O	.	_	0	SENT_587	[p33l967t1444r1106b1524],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_588	[p33l1142t1436r2005b1549],
2	of	IN	O	of	_	0	SENT_588	[p33l2040t1436r2151b1524],
3	oral	JJ	O	oral	amod	4	SENT_588	[p33l77t1580r257b1668],
4	anticoagulants	NNS	O	anticoagulant	prep_of	1	SENT_588	[p33l399t1580r1119b1693],
5	.	.	O	.	_	0	SENT_588	[p33l399t1580r1119b1693],

1	Pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_589	[p33l1266t1582r2130b1693],
2	2003	CD	DATE	2003	num	1	SENT_589	[p33l77t1731r851b1831],
3	;	:	O	;	_	0	SENT_589	[p33l77t1731r851b1831],
4	13:247	CD	NUMBER	13:247	number	5	SENT_589	[p33l77t1731r851b1831],
5	—	CD	NUMBER	—	dep	1	SENT_589	[p33l77t1731r851b1831],
6	52	CD	NUMBER	52	dep	5	SENT_589	[p33l77t1731r851b1831],
7	.	.	O	.	_	0	SENT_589	[p33l77t1731r851b1831],

1	40	CD	NUMBER	40	_	0	SENT_590	[p33l75t1876r209b1955],
2	.	.	O	.	_	0	SENT_590	[p33l75t1876r209b1955],

1	Kirchheiner	NNP	PERSON	Kirchheiner	nn	2	SENT_591	[p33l268t1867r832b1957],
2	J	NNP	PERSON	J	_	0	SENT_591	[p33l877t1875r943b1974],
3	,	,	O	,	_	0	SENT_591	[p33l877t1875r943b1974],
4	Brockmoller	NNP	O	Brockmoller	nn	7	SENT_591	[p33l1006t1867r1598b1955],
5	J.	NNP	O	J.	nn	7	SENT_591	[p33l1643t1876r1709b1968],
6	Clinical	JJ	O	clinical	amod	7	SENT_591	[p33l1774t1867r2132b1955],
7	consequences	NNS	O	consequence	appos	2	SENT_591	[p33l77t2040r732b2124],
8	of	IN	O	of	_	0	SENT_591	[p33l818t2011r931b2099],
9	cytochrome	NN	O	cytochrome	nn	12	SENT_591	[p33l996t2011r1546b2124],
10	P450	NN	O	p450	nn	12	SENT_591	[p33l1630t2018r1862b2099],
11	2C9	NN	O	2c9	nn	12	SENT_591	[p33l1946t2018r2130b2099],
12	polymorphisms	NNS	O	polymorphism	prep_of	7	SENT_591	[p33l75t2157r851b2268],
13	.	.	O	.	_	0	SENT_591	[p33l75t2157r851b2268],

1	Clin	NNP	PERSON	Clin	nn	3	SENT_592	[p33l881t2155r1075b2243],
2	Pharmacol	NNP	PERSON	Pharmacol	nn	3	SENT_592	[p33l1096t2155r1603b2243],
3	T	NN	O	t	_	0	SENT_592	[p33l1622t2163r1691b2241],
4	her	PRP$	O	she	poss	7	SENT_592	[p33l1693t2155r1848b2243],
5	2005	CD	DATE	2005	num	7	SENT_592	[p33l1869t2162r2128b2262],
6	;	:	O	;	_	0	SENT_592	[p33l1869t2162r2128b2262],
7	77:1	CD	NUMBER	77:1	dep	3	SENT_592	[p33l78t2306r464b2386],
8	—	CD	NUMBER	—	number	9	SENT_592	[p33l78t2306r464b2386],
9	16	CD	NUMBER	16	dep	7	SENT_592	[p33l78t2306r464b2386],
10	.	.	O	.	_	0	SENT_592	[p33l78t2306r464b2386],

1	41	CD	NUMBER	41	_	0	SENT_593	[p33l75t2453r207b2530],
2	.	.	O	.	_	0	SENT_593	[p33l75t2453r207b2530],

1	Ansell	NNP	PERSON	Ansell	nn	2	SENT_594	[p33l264t2442r561b2530],
2	J	NNP	PERSON	J	_	0	SENT_594	[p33l584t2450r649b2549],
3	,	,	O	,	_	0	SENT_594	[p33l584t2450r649b2549],
4	Hirsh	NNP	PERSON	Hirsh	nn	5	SENT_594	[p33l690t2442r956b2530],
5	J	NNP	PERSON	J	appos	2	SENT_594	[p33l979t2450r1044b2549],
6	,	,	O	,	_	0	SENT_594	[p33l979t2450r1044b2549],
7	Poller	NNP	PERSON	Poller	nn	8	SENT_594	[p33l1084t2442r1360b2530],
8	L	NNP	O	L	appos	2	SENT_594	[p33l1389t2450r1471b2549],
9	,	,	O	,	_	0	SENT_594	[p33l1389t2450r1471b2549],
10	Bussey	NNP	PERSON	Bussey	nn	11	SENT_594	[p33l1509t2450r1835b2553],
11	H	NNP	PERSON	H	appos	2	SENT_594	[p33l1864t2450r1971b2549],
12	,	,	O	,	_	0	SENT_594	[p33l1864t2450r1971b2549],
13	Jacobson	NNP	PERSON	Jacobson	nn	14	SENT_594	[p33l2002t2450r2130b2544, p33l77t2586r418b2674],
14	A	NNP	O	A	appos	2	SENT_594	[p33l452t2595r548b2693],
15	,	,	O	,	_	0	SENT_594	[p33l452t2595r548b2693],
16	Hylek	NNP	O	Hylek	nn	18	SENT_594	[p33l592t2586r868b2699],
17	E.	NNP	O	E.	nn	18	SENT_594	[p33l899t2595r987b2674],
18	The	NNP	O	The	appos	2	SENT_594	[p33l1027t2586r1207b2674],
19	pharmacology	NN	O	pharmacology	dep	2	SENT_594	[p33l1245t2586r1925b2699],
20	and	CC	O	and	_	0	SENT_594	[p33l1959t2586r2132b2674],
21	management	NN	O	management	conj_and	19	SENT_594	[p33l77t2749r701b2843],
22	of	IN	O	of	_	0	SENT_594	[p33l736t2730r847b2818],
23	the	DT	O	the	det	26	SENT_594	[p33l866t2730r1010b2818],
24	vitamin	NN	O	vitamin	nn	26	SENT_594	[p33l1044t2732r1404b2818],
25	K	NN	O	k	nn	26	SENT_594	[p33l1440t2739r1515b2820],
26	antagonists	NNS	O	antagonist	prep_of	19	SENT_594	[p33l1549t2732r2126b2843],
27	:	:	O	:	_	0	SENT_594	[p33l1549t2732r2126b2843],
28	the	DT	O	the	det	31	SENT_594	[p33l77t2875r221b2961],
29	Seventh	NNP	ORDINAL	Seventh	nn	31	SENT_594	[p33l301t2873r665b2961],
30	ACCP	NNP	O	ACCP	nn	31	SENT_594	[p33l737t2880r1011b2961],
31	Conference	NNP	O	Conference	dep	19	SENT_594	[p33l1086t2873r1624b2961],
32	on	IN	O	on	_	0	SENT_594	[p33l1701t2902r1820b2961],
33	Antithrombotic	NNP	LOCATION	Antithrombotic	prep_on	31	SENT_594	[p33l1892t2875r2130b2961, p33l77t3017r609b3105],

1	and	CC	O	and	dep	3	SENT_595	[p33l709t3017r883b3105],
2	Thrombolytic	JJ	O	thrombolytic	amod	3	SENT_595	[p33l981t3017r1626b3130],
3	Therapy	NN	O	therapy	_	0	SENT_595	[p33l1724t3017r2124b3130],
4	.	.	O	.	_	0	SENT_595	[p33l1724t3017r2124b3130],

1	Chest	NN	O	chest	_	0	SENT_596	[p33l77t3161r347b3249],
2	2004	CD	DATE	2004	num	1	SENT_596	[p33l370t3163r1686b3274],
3	;	:	O	;	_	0	SENT_596	[p33l370t3163r1686b3274],
4	126	CD	NUMBER	126	dep	1	SENT_596	[p33l370t3163r1686b3274],
5	:	:	O	:	_	0	SENT_596	[p33l370t3163r1686b3274],
6	Suppl	NNP	O	Suppl	nn	8	SENT_596	[p33l370t3163r1686b3274],
7	:204	CD	NUMBER	:204	num	8	SENT_596	[p33l370t3163r1686b3274],
8	S	NN	O	s	dep	4	SENT_596	[p33l370t3163r1686b3274],
9	—	CD	NUMBER	—	num	10	SENT_596	[p33l370t3163r1686b3274],
10	233S	NN	O	233	dep	8	SENT_596	[p33l370t3163r1686b3274],
11	.	.	O	.	_	0	SENT_596	[p33l370t3163r1686b3274],

1	42	CD	NUMBER	42	_	0	SENT_597	[p33l75t3316r209b3393],
2	.	.	O	.	_	0	SENT_597	[p33l75t3316r209b3393],

1	Cropp	NNP	PERSON	Cropp	nn	2	SENT_598	[p33l268t3312r561b3416],
2	JS	NNP	O	JS	_	0	SENT_598	[p33l575t3312r698b3412],
3	,	,	O	,	_	0	SENT_598	[p33l575t3312r698b3412],
4	Bussey	NNP	PERSON	Bussey	nn	5	SENT_598	[p33l726t3313r1052b3416],
5	HI	NNP	O	HI	appos	2	SENT_598	[p33l1071t3313r1215b3393],
6	.	.	O	.	_	0	SENT_598	[p33l1071t3313r1215b3393],

1	A	DT	O	a	det	2	SENT_599	[p33l1241t3313r1314b3391],
2	review	NN	O	review	_	0	SENT_599	[p33l1335t3307r1638b3393],
3	of	IN	O	of	_	0	SENT_599	[p33l1657t3305r1770b3393],
4	enzyme	NN	O	enzyme	nn	5	SENT_599	[p33l1774t3334r2132b3416],
5	induction	NN	O	induction	prep_of	2	SENT_599	[p33l75t3449r531b3537],
6	of	IN	O	of	dep	2	SENT_599	[p33l565t3449r677b3537],
7	warfarin	NN	O	warfarin	nn	8	SENT_599	[p33l684t3449r1086b3539],
8	metabolism	NN	O	metabolism	pobj	6	SENT_599	[p33l1119t3449r1682b3537],
9	with	IN	O	with	dep	2	SENT_599	[p33l1710t3449r1922b3537],
10	recommendations	NNS	O	recommendation	pobj	9	SENT_599	[p33l1955t3479r2130b3537, p33l77t3593r792b3681],

1	for	IN	O	for	_	0	SENT_600	[p33l870t3593r1008b3681],
2	patient	NN	O	patient	nn	3	SENT_600	[p33l1077t3595r1410b3706],
3	management	NN	O	management	pobj	1	SENT_600	[p33l1480t3612r2126b3706],
4	.	.	O	.	_	0	SENT_600	[p33l1480t3612r2126b3706],

1	Pharmacotherapy	NNP	O	Pharmacotherapy	_	0	SENT_601	[p34l75t22r908b135],
2	1997	CD	DATE	1997	num	1	SENT_601	[p34l935t29r1705b129],
3	;	:	O	;	_	0	SENT_601	[p34l935t29r1705b129],
4	17:917	CD	NUMBER	17:917	number	5	SENT_601	[p34l935t29r1705b129],
5	—	CD	NUMBER	—	dep	1	SENT_601	[p34l935t29r1705b129],
6	28	CD	NUMBER	28	dep	5	SENT_601	[p34l935t29r1705b129],
7	.	.	O	.	_	0	SENT_601	[p34l935t29r1705b129],

1	43	CD	NUMBER	43	_	0	SENT_602	[p34l75t176r209b253],
2	.	.	O	.	_	0	SENT_602	[p34l75t176r209b253],

1	Lenfant	NNP	PERSON	Lenfant	nn	4	SENT_603	[p34l266t165r631b253],
2	C.	NNP	PERSON	C.	nn	4	SENT_603	[p34l657t172r751b253],
3	Shattuck	NNP	PERSON	Shattuck	nn	4	SENT_603	[p34l791t165r1203b253],
4	Lecture	NNP	O	Lecture	_	0	SENT_603	[p34l1228t173r1602b253],
5	:	:	O	:	_	0	SENT_603	[p34l1228t173r1602b253],
6	clinical	JJ	O	clinical	amod	7	SENT_603	[p34l1640t165r1975b253],
7	research	NN	O	research	dep	4	SENT_603	[p34l2006t194r2130b253, p34l79t309r380b397],

1	to	TO	O	to	_	0	SENT_604	[p34l412t328r500b397],
2	clinical	JJ	O	clinical	amod	3	SENT_604	[p34l536t309r872b397],
3	practice	NN	O	practice	pobj	1	SENT_604	[p34l902t311r1272b422],
4	—	CD	NUMBER	—	num	3	SENT_604	[p34l1301t360r1421b369],
5	lost	VBN	O	lose	partmod	3	SENT_604	[p34l1448t309r1624b397],
6	in	IN	O	in	_	0	SENT_604	[p34l1651t311r1741b395],
7	translation	NN	O	translation	prep_in	5	SENT_604	[p34l1775t311r2130b397, p34l77t451r305b541],
8	?	.	O	?	_	0	SENT_604	[p34l1775t311r2130b397, p34l77t451r305b541],

1	N	NN	O	n	nn	2	SENT_605	[p34l330t462r414b541],
2	EnglJ	NN	O	englj	nsubj	3	SENT_605	[p34l439t453r713b566],
3	Med	VBD	O	med	_	0	SENT_605	[p34l735t453r943b541],
4	2003	CD	DATE	2003	dobj	3	SENT_605	[p34l971t460r1803b560],
5	;	:	O	;	_	0	SENT_605	[p34l971t460r1803b560],
6	349:868	CD	NUMBER	349:868	number	7	SENT_605	[p34l971t460r1803b560],
7	—	CD	NUMBER	—	dep	4	SENT_605	[p34l971t460r1803b560],
8	74	CD	NUMBER	74	dep	7	SENT_605	[p34l971t460r1803b560],
9	.	.	O	.	_	0	SENT_605	[p34l971t460r1803b560],

1	44	CD	NUMBER	44	_	0	SENT_606	[p34l75t607r207b684],
2	.	.	O	.	_	0	SENT_606	[p34l75t607r207b684],

1	D’Andrea	NN	O	d’andrea	nn	2	SENT_607	[p34l266t596r709b684],
2	G	NN	O	g	_	0	SENT_607	[p34l751t603r855b703],
3	,	,	O	,	_	0	SENT_607	[p34l751t603r855b703],
4	D’Ambrosio	NNP	O	D’Ambrosio	nn	5	SENT_607	[p34l904t596r1471b684],
5	RL	NNP	O	RL	appos	2	SENT_607	[p34l1515t604r1669b703],
6	,	,	O	,	_	0	SENT_607	[p34l1515t604r1669b703],
7	Di	NNP	PERSON	Di	nn	9	SENT_607	[p34l1716t598r1826b682],
8	Perna	NNP	PERSON	Perna	nn	9	SENT_607	[p34l1866t604r2132b684],
9	P	NN	O	p	appos	2	SENT_607	[p34l75t748r146b847],
10	,	,	O	,	_	0	SENT_607	[p34l75t748r146b847],
11	et	FW	O	et	nn	12	SENT_607	[p34l178t759r265b828],
12	al.	FW	O	al.	appos	2	SENT_607	[p34l283t740r389b828],
13	.	.	O	.	_	0	SENT_607	[p34l283t740r389b828],

1	A	DT	O	a	det	2	SENT_608	[p34l416t749r489b826],
2	polymorphism	NN	O	polymorphism	nsubjpass	8	SENT_608	[p34l509t740r1209b853],
3	in	IN	O	in	_	0	SENT_608	[p34l1234t742r1324b826],
4	the	DT	O	the	det	6	SENT_608	[p34l1350t740r1494b828],
5	VKORCI	NN	O	vkorcus	nn	6	SENT_608	[p34l1517t748r1881b830],
6	gene	NN	O	gene	prep_in	2	SENT_608	[p34l1908t769r2130b853],
7	is	VBZ	O	be	auxpass	8	SENT_608	[p34l75t885r148b971],
8	associated	VBN	O	associate	_	0	SENT_608	[p34l207t883r694b971],
9	with	IN	O	with	_	0	SENT_608	[p34l745t885r956b971],
10	an	DT	O	a	det	12	SENT_608	[p34l1011t912r1123b971],
11	interindividual	JJ	O	interindividual	amod	12	SENT_608	[p34l1180t883r1870b971],
12	variability	NN	O	variability	prep_with	8	SENT_608	[p34l1921t885r2130b971, p34l77t1027r366b1140],

1	in	IN	O	in	_	0	SENT_609	[p34l416t1029r508b1113],
2	the	DT	O	the	det	6	SENT_609	[p34l565t1027r709b1115],
3	dose	NN	O	dose	nn	6	SENT_609	[p34l766t1027r1676b1140],
4	—	NN	O	—	nn	6	SENT_609	[p34l766t1027r1676b1140],
5	anticoagulant	JJ	O	anticoagulant	amod	6	SENT_609	[p34l766t1027r1676b1140],
6	effect	NN	O	effect	pobj	1	SENT_609	[p34l1728t1027r1988b1115],
7	of	IN	O	of	_	0	SENT_609	[p34l2040t1027r2153b1115],
8	warfarin	NN	O	warfarin	prep_of	6	SENT_609	[p34l71t1170r498b1258],
9	.	.	O	.	_	0	SENT_609	[p34l71t1170r498b1258],

1	Blood	NN	O	blood	_	0	SENT_610	[p34l531t1170r810b1258],
2	2005	CD	DATE	2005	num	1	SENT_610	[p34l837t1177r1611b1277],
3	;	:	O	;	_	0	SENT_610	[p34l837t1177r1611b1277],
4	105:645	CD	NUMBER	105:645	number	5	SENT_610	[p34l837t1177r1611b1277],
5	-9	CD	NUMBER	-9	dep	1	SENT_610	[p34l837t1177r1611b1277],
6	.	.	O	.	_	0	SENT_610	[p34l837t1177r1611b1277],

1	45	CD	NUMBER	45	_	0	SENT_611	[p34l75t1324r209b1401],
2	.	.	O	.	_	0	SENT_611	[p34l75t1324r209b1401],

1	Chou	NNP	PERSON	Chou	nn	2	SENT_612	[p34l268t1313r522b1401],
2	WH	NNP	PERSON	WH	_	0	SENT_612	[p34l550t1321r767b1420],
3	,	,	O	,	_	0	SENT_612	[p34l550t1321r767b1420],
4	Yan	NNP	PERSON	Yan	nn	5	SENT_612	[p34l803t1321r973b1401],
5	F	NN	O	f	appos	2	SENT_612	[p34l1004t1321r1186b1420],
6	.	.	O	.	_	0	SENT_612	[p34l1004t1321r1186b1420],

1	—	NN	O	—	_	0	SENT_613	[p34l1004t1321r1186b1420],
2	.	.	O	.	_	0	SENT_613	[p34l1004t1321r1186b1420],

1	X	NN	O	x	_	0	SENT_614	[p34l1004t1321r1186b1420],
2	,	,	O	,	_	0	SENT_614	[p34l1004t1321r1186b1420],
3	de	FW	PERSON	de	appos	1	SENT_614	[p34l1228t1313r1333b1401],
4	Leon	NNP	PERSON	Leon	nn	5	SENT_614	[p34l1366t1321r1597b1401],
5	J	NNP	PERSON	J	dep	3	SENT_614	[p34l1619t1322r1684b1420],
6	,	,	O	,	_	0	SENT_614	[p34l1619t1322r1684b1420],
7	et	FW	O	et	nn	8	SENT_614	[p34l1724t1332r1810b1401],
8	al.	FW	O	al.	appos	1	SENT_614	[p34l1837t1313r1942b1401],
9	.	.	O	.	_	0	SENT_614	[p34l1837t1313r1942b1401],

1	Extension	NNP	O	Extension	_	0	SENT_615	[p34l1980t1321r2130b1399, p34l77t1459r426b1545],
2	of	IN	O	of	_	0	SENT_615	[p34l458t1457r569b1545],
3	a	DT	O	a	det	5	SENT_615	[p34l578t1487r628b1545],
4	pilot	NN	O	pilot	nn	5	SENT_615	[p34l655t1459r876b1570],
5	study	NN	O	study	prep_of	1	SENT_615	[p34l902t1457r1178b1570],
6	:	:	O	:	_	0	SENT_615	[p34l902t1457r1178b1570],
7	impact	NN	O	impact	dep	1	SENT_615	[p34l1211t1459r1540b1570],
8	from	IN	O	from	_	0	SENT_615	[p34l1565t1457r1797b1545],
9	the	DT	O	the	det	13	SENT_615	[p34l1827t1457r1971b1545],
10	cytochrome	NN	O	cytochrome	nn	13	SENT_615	[p34l2002t1487r2130b1570, p34l77t1603r531b1689],
11	P450	NN	O	p450	nn	13	SENT_615	[p34l563t1608r795b1689],
12	2D6	NN	O	2d6	nn	13	SENT_615	[p34l831t1608r1023b1689],
13	polymorphism	NN	O	polymorphism	prep_from	7	SENT_615	[p34l1055t1601r1756b1714],
14	on	IN	O	on	_	0	SENT_615	[p34l1791t1630r1910b1689],
15	outcome	NN	O	outcome	prep_on	13	SENT_615	[p34l1944t1620r2130b1689, p34l77t1774r330b1833],
16	and	CC	O	and	_	0	SENT_615	[p34l412t1745r586b1833],
17	costs	NNS	O	cost	prep_on	13	SENT_615	[p34l670t1764r903b1833],
18	associated	VBN	O	associate	partmod	7	SENT_615	[p34l988t1745r1475b1833],
19	with	IN	O	with	_	0	SENT_615	[p34l1552t1745r1763b1835],
20	severe	JJ	O	severe	amod	22	SENT_615	[p34l1848t1775r2132b1833],
21	mental	JJ	O	mental	amod	22	SENT_615	[p34l77t1889r406b1977],
22	illness	NN	O	illness	prep_with	18	SENT_615	[p34l488t1889r814b1977],
23	.	.	O	.	_	0	SENT_615	[p34l488t1889r814b1977],

1	J	NNP	O	J	nn	3	SENT_616	[p34l894t1898r935b1991],
2	Clin	NNP	O	Clin	nn	3	SENT_616	[p34l1017t1889r1211b1977],
3	Psychopharmacol	NNP	O	Psychopharmacol	_	0	SENT_616	[p34l1293t1889r2132b2002],
4	2000	CD	DATE	2000	num	3	SENT_616	[p34l77t2040r851b2140],
5	;	:	O	;	_	0	SENT_616	[p34l77t2040r851b2140],
6	20:246	CD	NUMBER	20:246	number	7	SENT_616	[p34l77t2040r851b2140],
7	—	CD	NUMBER	—	dep	3	SENT_616	[p34l77t2040r851b2140],
8	51	CD	NUMBER	51	dep	7	SENT_616	[p34l77t2040r851b2140],
9	.	.	O	.	_	0	SENT_616	[p34l77t2040r851b2140],

1	46	CD	NUMBER	46	_	0	SENT_617	[p34l75t2188r209b2265],
2	.	.	O	.	_	0	SENT_617	[p34l75t2188r209b2265],

1	Higashi	NNP	PERSON	Higashi	nn	2	SENT_618	[p34l268t2177r638b2290],
2	MK	NNP	O	MK	_	0	SENT_618	[p34l707t2185r904b2284],
3	,	,	O	,	_	0	SENT_618	[p34l707t2185r904b2284],
4	Veenstra	NNP	PERSON	Veenstra	nn	5	SENT_618	[p34l979t2185r1385b2265],
5	DL	NNP	O	DL	appos	2	SENT_618	[p34l1456t2185r1617b2265],
6	.	.	O	.	_	0	SENT_618	[p34l1456t2185r1617b2265],

1	Managed	VBN	O	manage	_	0	SENT_619	[p34l1693t2177r2132b2290],
2	care	NN	O	care	dobj	1	SENT_619	[p34l77t2351r267b2409],
3	in	IN	O	in	_	0	SENT_619	[p34l297t2323r387b2407],
4	the	DT	O	the	det	6	SENT_619	[p34l420t2323r564b2409],
5	genomics	NNS	O	genomic	nn	6	SENT_619	[p34l596t2323r1050b2434],
6	era	NN	O	era	prep_in	1	SENT_619	[p34l1086t2351r1253b2409],
7	:	:	O	:	_	0	SENT_619	[p34l1086t2351r1253b2409],
8	assessing	VBG	O	assess	dep	6	SENT_619	[p34l1287t2323r1740b2434],
9	the	DT	O	the	det	11	SENT_619	[p34l1768t2321r1912b2409],
10	cost	NN	O	cost	nn	11	SENT_619	[p34l1944t2340r2138b2409],
11	effectiveness	NN	O	effectiveness	dobj	8	SENT_619	[p34l77t2465r672b2553],
12	of	IN	O	of	_	0	SENT_619	[p34l720t2465r832b2553],
13	genetic	JJ	O	genetic	amod	14	SENT_619	[p34l856t2467r1195b2578],
14	tests	NNS	O	test	prep_of	11	SENT_619	[p34l1240t2484r1477b2553],
15	.	.	O	.	_	0	SENT_619	[p34l1240t2484r1477b2553],

1	Am	VBP	O	be	dep	4	SENT_620	[p34l1525t2474r1692b2551],
2	J	NN	O	j	nn	4	SENT_620	[p34l1726t2474r1768b2567],
3	Manag	NNP	O	Manag	nn	4	SENT_620	[p34l1808t2474r2136b2578],
4	Care	NNP	O	Care	_	0	SENT_620	[p34l77t2616r289b2697],
5	2003	CD	DATE	2003	num	4	SENT_620	[p34l316t2616r1090b2716],
6	;	:	O	;	_	0	SENT_620	[p34l316t2616r1090b2716],
7	9:493	CD	NUMBER	9:493	dep	4	SENT_620	[p34l316t2616r1090b2716],
8	—	CD	NUMBER	—	num	9	SENT_620	[p34l316t2616r1090b2716],
9	500	CD	NUMBER	500	dep	7	SENT_620	[p34l316t2616r1090b2716],
10	.	.	O	.	_	0	SENT_620	[p34l316t2616r1090b2716],

1	47	CD	NUMBER	47	_	0	SENT_621	[p34l75t2764r209b2841],
2	.	.	O	.	_	0	SENT_621	[p34l75t2764r209b2841],

1	Food	NNP	O	Food	nn	4	SENT_622	[p34l266t2753r506b2841],
2	and	CC	O	and	_	0	SENT_622	[p34l529t2753r702b2841],
3	Drug	NNP	O	Drug	nn	4	SENT_622	[p34l724t2761r968b2866],
4	Administration	NNP	O	Administration	_	0	SENT_622	[p34l984t2753r1732b2841],
5	.	.	O	.	_	0	SENT_622	[p34l984t2753r1732b2841],

1	Medical	JJ	O	medical	amod	2	SENT_623	[p34l1760t2753r2132b2841],
2	devices	NNS	O	device	_	0	SENT_623	[p34l77t2897r441b2985],
3	:	:	O	:	_	0	SENT_623	[p34l77t2897r441b2985],
4	clinical	JJ	O	clinical	amod	5	SENT_623	[p34l481t2897r815b2985],
5	chemistry	NN	O	chemistry	dep	2	SENT_623	[p34l850t2899r1314b3010],
6	and	CC	O	and	_	0	SENT_623	[p34l1343t2897r1517b2985],
7	clinical	JJ	O	clinical	amod	9	SENT_623	[p34l1551t2897r1887b2985],
8	toxicology	NN	O	toxicology	nn	9	SENT_623	[p34l1921t2899r2130b2985, p34l77t3041r387b3154],
9	devices	NNS	O	device	conj_and	5	SENT_623	[p34l427t3041r790b3148],
10	;	:	O	;	_	0	SENT_623	[p34l427t3041r790b3148],
11	drug	NN	O	drug	dep	5	SENT_623	[p34l839t3041r1062b3154],
12	metabolizing	VBG	O	metabolize	partmod	11	SENT_623	[p34l1101t3041r1732b3154],
13	enzyme	NN	O	enzyme	nn	15	SENT_623	[p34l1772t3070r2130b3154],
14	genotyping	NN	O	genotyping	nn	15	SENT_623	[p34l77t3187r611b3298],
15	system	NN	O	system	dobj	12	SENT_623	[p34l634t3204r981b3298],
16	.	.	O	.	_	0	SENT_623	[p34l634t3204r981b3298],

1	Fed	NNP	ORGANIZATION	Fed	nn	2	SENT_624	[p34l1011t3185r1180b3273],
2	Regist	NNP	O	Regist	_	0	SENT_624	[p34l1203t3187r1504b3298],
3	2005	CD	DATE	2005	num	2	SENT_624	[p34l1523t3192r1751b3273],
4	;	:	O	;	_	0	SENT_624	[p34l1766t3192r2128b3292],
5	70	CD	NUMBER	70	number	6	SENT_624	[p34l1766t3192r2128b3292],
6	(	CD	NUMBER	(	dep	2	SENT_624	[p34l1766t3192r2128b3292],
7	46	CD	NUMBER	46	num	8	SENT_624	[p34l1766t3192r2128b3292],
8	)	NN	O	)	dep	6	SENT_624	[p34l1766t3192r2128b3292],
9	:	:	O	:	_	0	SENT_624	[p34l1766t3192r2128b3292],
10	11865-7	CD	NUMBER	11865-7	dep	6	SENT_624	[p34l81t3336r491b3416],
11	.	.	O	.	_	0	SENT_624	[p34l81t3336r491b3416],

1	Copyright	NN	O	copyright	_	0	SENT_625	[p34l79t3458r435b3554],
2	©	CD	NUMBER	©	num	6	SENT_625	[p34l466t3466r546b3545],
3	2005	CD	DATE	2005	num	6	SENT_625	[p34l580t3463r768b3531],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_625	[p34l797t3458r1335b3531],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_625	[p34l1366t3458r1661b3531],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_625	[p34l1686t3462r1958b3552],
7	.	.	O	.	_	0	SENT_625	[p34l1686t3462r1958b3552],

1	POWERPOINT	JJ	O	powerpoint	amod	2	SENT_626	[p35l507t206r685b223],
2	SLIDES	NNS	O	slide	_	0	SENT_626	[p35l697t206r786b223],
3	OF	IN	O	of	_	0	SENT_626	[p35l799t206r833b223],
4	_	NN	O	_	prep_of	2	SENT_626	[p35l840t206r966b229],
5	[	CD	NUMBER	[	num	4	SENT_626	[p35l840t206r966b229],
6	OURNAL	NNP	O	OURNAL	nn	7	SENT_626	[p35l840t206r966b229],
7	FIGURES	NNPS	O	FIGURES	dep	2	SENT_626	[p35l980t206r1092b223],
8	AND	CC	O	and	_	0	SENT_626	[p35l1104t207r1161b223],
9	TABLES	NNPS	O	TABLES	dep	2	SENT_626	[p35l1173t206r1266b223],

1	At	IN	O	at	_	0	SENT_627	[p35l394t260r423b280],
2	the	DT	O	the	det	3	SENT_627	[p35l431t258r469b280],
3	]	NN	O	]	poss	7	SENT_627	[p35l476t257r578b287],
4	oumal	JJ	O	oumal	amod	3	SENT_627	[p35l476t257r578b287],
5	’s	POS	O	’s	_	0	SENT_627	[p35l476t257r578b287],
6	Web	NN	O	web	nn	7	SENT_627	[p35l586t258r641b281],
7	site	NN	O	site	prep_at	12	SENT_627	[p35l650t258r698b285],
8	,	,	O	,	_	0	SENT_627	[p35l650t258r698b285],
9	subscribers	NNS	O	subscriber	nsubj	12	SENT_627	[p35l709t258r848b281],
10	can	MD	O	can	aux	12	SENT_627	[p35l857t265r899b280],
11	automatically	RB	O	automatically	advmod	12	SENT_627	[p35l907t258r1072b287],
12	create	VB	O	create	_	0	SENT_627	[p35l1080t262r1151b280],
13	PowerPoint	NNP	O	PowerPoint	nn	14	SENT_627	[p35l1160t258r1302b281],
14	slides	NNS	O	slide	nsubj	16	SENT_627	[p35l1309t258r1377b281],
15	ofjoumal	JJ	O	ofjoumal	amod	16	SENT_627	[p35l415t297r526b326],
16	ﬁgures	NNS	O	ﬁgures	xcomp	12	SENT_627	[p35l534t297r619b327],
17	and	CC	O	and	_	0	SENT_627	[p35l628t297r673b320],
18	tables	NNS	O	table	conj_and	16	SENT_627	[p35l682t297r761b320],
19	.	.	O	.	_	0	SENT_627	[p35l682t297r761b320],

1	Click	VB	O	click	_	0	SENT_628	[p35l771t297r835b320],
2	on	IN	O	on	_	0	SENT_628	[p35l843t305r874b320],
3	a	DT	O	a	det	4	SENT_628	[p35l882t305r895b320],
4	ﬁgure	NN	O	ﬁgure	prep_on	1	SENT_628	[p35l904t297r976b327],
5	or	CC	O	or	_	0	SENT_628	[p35l985t305r1011b320],
6	table	NN	O	table	prep_on	1	SENT_628	[p35l1019t297r1078b320],
7	in	IN	O	in	_	0	SENT_628	[p35l1087t297r1110b320],
8	the	DT	O	the	det	10	SENT_628	[p35l1119t297r1157b320],
9	ﬁlll-text	JJ	O	ﬁlll-text	amod	10	SENT_628	[p35l1166t297r1263b320],
10	Version	NN	O	version	prep_in	4	SENT_628	[p35l1269t297r1359b320],
11	of	IN	O	of	_	0	SENT_628	[p35l376t336r405b360],
12	any	DT	O	any	det	13	SENT_628	[p35l408t344r451b366],
13	article	NN	O	article	prep_of	10	SENT_628	[p35l458t337r534b360],
14	at	IN	O	at	_	0	SENT_628	[p35l542t342r565b360],
15	www.nejm.org	NN	O	www.nejm.org	prep_at	13	SENT_628	[p35l571t337r767b366],
16	,	,	O	,	_	0	SENT_628	[p35l571t337r767b366],
17	and	CC	O	and	cc	1	SENT_628	[p35l778t337r824b360],
18	then	RB	O	then	advmod	1	SENT_628	[p35l833t337r889b360],
19	click	VB	O	click	ccomp	1	SENT_628	[p35l898t337r957b360],
20	on	IN	O	on	_	0	SENT_628	[p35l966t344r997b360],
21	PowerPoint	NNP	O	PowerPoint	nn	22	SENT_628	[p35l1006t337r1152b360],
22	Slide	NNP	O	Slide	prep_on	19	SENT_628	[p35l1160t337r1220b360],
23	for	IN	O	for	_	0	SENT_628	[p35l1230t336r1266b360],
24	Teaching	NNP	O	Teaching	prep_for	22	SENT_628	[p35l1274t337r1395b366],
25	.	.	O	.	_	0	SENT_628	[p35l1274t337r1395b366],

1	A	DT	O	a	det	3	SENT_629	[p35l396t378r415b399],
2	PowerPoint	NN	O	powerpoint	nn	3	SENT_629	[p35l423t377r569b399],
3	slide	NN	O	slide	_	0	SENT_629	[p35l577t376r635b399],
4	containing	VBG	O	contain	dep	3	SENT_629	[p35l645t377r781b406],
5	the	DT	O	the	det	6	SENT_629	[p35l790t376r828b399],
6	image	NN	O	image	dobj	4	SENT_629	[p35l837t377r921b406],
7	,	,	O	,	_	0	SENT_629	[p35l837t377r921b406],
8	with	IN	O	with	_	0	SENT_629	[p35l931t376r987b399],
9	its	PRP$	O	its	poss	10	SENT_629	[p35l996t377r1025b399],
10	title	NN	O	title	prep_with	6	SENT_629	[p35l1035t376r1082b399],
11	and	CC	O	and	_	0	SENT_629	[p35l1091t376r1137b399],
12	reference	NN	O	reference	nn	13	SENT_629	[p35l1147t376r1263b399],
13	citation	NN	O	citation	prep_with	6	SENT_629	[p35l1272t377r1374b404],
14	,	,	O	,	_	0	SENT_629	[p35l1272t377r1374b404],

1	can	MD	O	can	aux	4	SENT_630	[p35l661t423r704b439],
2	then	RB	O	then	advmod	4	SENT_630	[p35l713t416r769b439],
3	be	VB	O	be	auxpass	4	SENT_630	[p35l778t416r806b439],
4	downloaded	VBN	O	download	_	0	SENT_630	[p35l816t416r971b439],
5	and	CC	O	and	_	0	SENT_630	[p35l980t416r1026b439],
6	saved	VBN	O	save	conj_and	4	SENT_630	[p35l1035t416r1110b439],
7	.	.	O	.	_	0	SENT_630	[p35l1035t416r1110b439],

1	N	NN	O	n	nn	3	SENT_631	[p35l519t563r533b578],
2	ENGLJ	NN	O	englj	nn	3	SENT_631	[p35l548t562r632b584],
3	MED	NN	O	med	_	0	SENT_631	[p35l647t563r700b578],
4	352	CD	NUMBER	352	num	6	SENT_631	[p35l712t562r788b584],
5	;	:	O	;	_	0	SENT_631	[p35l712t562r788b584],
6	21	CD	NUMBER	21	dep	3	SENT_631	[p35l712t562r788b584],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_631	[p35l825t562r1037b584],
8	MAY	NNP	DATE	MAY	dep	6	SENT_631	[p35l1076t562r1127b578],
9	26	CD	DATE	26	num	8	SENT_631	[p35l1139t557r1177b582],
10	,	,	DATE	,	_	0	SENT_631	[p35l1139t557r1177b582],
11	2005	CD	DATE	2005	num	8	SENT_631	[p35l1191t562r1254b584],
12	2221	CD	DATE	2221	dep	3	SENT_631	[p35l1939t561r2016b582],

1	The	DT	O	the	det	4	SENT_632	[p35l702t659r753b682],
2	New	NNP	O	New	nn	4	SENT_632	[p35l762t660r824b682],
3	England	NNP	O	England	nn	4	SENT_632	[p35l833t659r944b689],
4	Journal	NNP	O	Journal	_	0	SENT_632	[p35l952t659r1050b682],
5	of	IN	O	of	_	0	SENT_632	[p35l1060t659r1088b682],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_632	[p35l1095t659r1220b682],

1	Downloaded	VBN	O	download	_	0	SENT_633	[p35l144t699r314b722],
2	from	IN	O	from	_	0	SENT_633	[p35l323t699r387b722],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_633	[p35l396t699r514b729],
4	at	IN	O	at	_	0	SENT_633	[p35l524t703r547b722],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_633	[p35l556t699r739b722],
6	on	IN	O	on	_	0	SENT_633	[p35l748t706r780b722],
7	January	NNP	DATE	January	prep_on	1	SENT_633	[p35l789t699r892b729],
8	5	CD	DATE	5	num	7	SENT_633	[p35l902t699r924b726],
9	,	,	DATE	,	_	0	SENT_633	[p35l902t699r924b726],
10	2014	CD	DATE	2014	num	7	SENT_633	[p35l935t699r1007b722],
11	.	.	O	.	_	0	SENT_633	[p35l935t699r1007b722],

1	For	IN	O	for	_	0	SENT_634	[p35l1018t699r1064b722],
2	personal	JJ	O	personal	amod	3	SENT_634	[p35l1072t699r1184b729],
3	use	NN	O	use	pobj	1	SENT_634	[p35l1194t706r1237b722],
4	only	RB	O	only	advmod	3	SENT_634	[p35l1247t699r1311b729],
5	.	.	O	.	_	0	SENT_634	[p35l1247t699r1311b729],

1	No	DT	O	no	det	3	SENT_635	[p35l1322t699r1362b722],
2	other	JJ	O	other	amod	3	SENT_635	[p35l1372t699r1440b722],
3	uses	NNS	O	use	_	0	SENT_635	[p35l1448t706r1504b722],
4	without	IN	O	without	_	0	SENT_635	[p35l1514t699r1615b722],
5	permission	NN	O	permission	prep_without	3	SENT_635	[p35l1624t699r1776b729],
6	.	.	O	.	_	0	SENT_635	[p35l1624t699r1776b729],

1	Copyright	NN	O	copyright	_	0	SENT_636	[p35l494t740r629b770],
2	©	CD	NUMBER	©	num	6	SENT_636	[p35l638t740r661b763],
3	2005	CD	DATE	2005	num	6	SENT_636	[p35l672t740r735b763],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_636	[p35l746t740r937b763],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_636	[p35l947t740r1055b763],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_636	[p35l1065t740r1170b770],
7	.	.	O	.	_	0	SENT_636	[p35l1065t740r1170b770],

1	All	DT	O	all	det	2	SENT_637	[p35l1181t740r1223b763],
2	rights	NNS	O	rights	nsubj	3	SENT_637	[p35l1232t740r1306b770],
3	reserved	VBN	O	reserve	_	0	SENT_637	[p35l1316t740r1435b763],
4	.	.	O	.	_	0	SENT_637	[p35l1316t740r1435b763],

